data_2m8u_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m8u _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.411 ' HB3' ' CD2' ' A' ' 74' ' ' PHE . 0.0 OUTLIER . . . . . 0 CA--C 1.546 0.797 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.46 -47.18 85.16 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.83 0.452 . . . . 0.0 110.536 170.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -55.58 -41.86 73.97 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.495 1.118 . . . . 0.0 113.154 -174.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.0 p -67.76 -41.87 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 O-C-N 122.982 0.176 . . . . 0.0 110.542 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 62.0 mt -70.92 -27.62 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 123.603 0.761 . . . . 0.0 110.945 -178.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -75.49 -28.75 59.32 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.331 0.652 . . . . 0.0 110.751 175.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.66 -32.99 74.67 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.041 0.536 . . . . 0.0 110.629 174.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.402 ' CE1' HD11 ' A' ' 33' ' ' LEU . 69.3 m-85 -64.55 -33.47 75.99 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.258 0.623 . . . . 0.0 111.018 171.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.1 mttp -78.67 -17.81 55.37 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.442 0.697 . . . . 0.0 111.725 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 67.0 t -72.88 -37.77 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 171.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -69.36 -55.3 10.79 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.996 173.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -80.04 77.92 6.71 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.777 0.831 . . . . 0.0 109.047 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.7 -21.12 61.83 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.097 1.359 . . . . 0.0 109.325 -178.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -76.01 -27.74 57.5 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.005 0.922 . . . . 0.0 111.358 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.93 45.9 54.99 Favored Glycine 0 C--N 1.344 1.015 0 O-C-N 123.486 0.491 . . . . 0.0 112.183 -176.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -68.58 -28.02 66.58 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.289 1.036 . . . . 0.0 111.312 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.41 -11.66 36.32 Favored Glycine 0 C--N 1.343 0.925 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 -175.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -154.8 159.79 40.83 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.709 0.804 . . . . 0.0 110.535 -177.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.1 m -112.15 -177.15 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.762 0.825 . . . . 0.0 110.512 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 64.4 p -81.83 154.52 25.86 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.548 170.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.439 ' O ' ' HG3' ' A' ' 34' ' ' ARG . 9.8 p -68.41 -26.49 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 122.544 0.337 . . . . 0.0 111.062 -177.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -65.45 -48.14 73.73 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 122.978 0.511 . . . . 0.0 111.398 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -63.81 -39.02 93.23 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 123.313 0.383 . . . . 0.0 110.465 177.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.443 HD22 HG13 ' A' ' 64' ' ' VAL . 5.3 tp -55.47 -46.48 76.83 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.608 178.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.544 ' HG2' HD11 ' A' ' 53' ' ' ILE . 80.8 mtm180 -67.56 -35.64 79.41 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.443 0.697 . . . . 0.0 110.984 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -62.11 -52.11 65.19 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.274 1.03 . . . . 0.0 111.701 -176.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.9 p -74.25 -35.36 40.06 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.037 0 C-N-CA 123.085 0.554 . . . . 0.0 111.136 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.485 HD22 HD13 ' A' ' 40' ' ' LEU . 95.8 mt -80.22 -4.82 54.67 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.911 0.485 . . . . 0.0 111.295 178.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -75.68 -47.01 28.1 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.479 0.711 . . . . 0.0 109.964 173.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -75.35 -23.67 57.21 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.958 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.485 HD13 HD22 ' A' ' 37' ' ' LEU . 99.1 mt -82.94 -25.38 32.43 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.351 0.66 . . . . 0.0 110.025 170.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.29 14.13 46.91 Favored Glycine 0 C--N 1.354 1.562 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.278 174.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -75.76 -52.82 9.59 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 168.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -82.38 -37.62 25.33 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.284 0.634 . . . . 0.0 110.575 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 93.0 mmm -89.43 147.08 37.24 Favored Pre-proline 0 N--CA 1.477 0.925 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.69 111.57 0.83 Allowed 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 122.122 1.881 . . . . 0.0 111.2 170.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.14 -33.93 72.42 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.841 0.856 . . . . 0.0 111.047 -176.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -57.89 -38.98 76.79 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.101 0.96 . . . . 0.0 111.677 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -58.18 -53.25 60.38 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 123.848 0.718 . . . . 0.0 110.309 174.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 86.2 mt -58.17 -45.08 88.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.241 1.016 . . . . 0.0 111.023 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.495 ' HA ' HD12 ' A' ' 53' ' ' ILE . 45.3 mt-10 -63.75 -29.42 70.64 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.936 0.895 . . . . 0.0 111.843 -177.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -77.01 -41.7 41.66 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.301 0.572 . . . . 0.0 109.961 175.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.408 ' HB3' ' HE1' ' A' ' 69' ' ' PHE . 24.9 mmt -64.71 -24.67 67.64 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.036 177.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.544 HD11 ' HG2' ' A' ' 34' ' ' ARG . 41.6 mt -66.81 -32.52 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.766 1.226 . . . . 0.0 111.355 177.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -73.67 -27.4 61.22 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.801 0.44 . . . . 0.0 110.59 174.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -85.05 -17.38 37.62 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.177 0.591 . . . . 0.0 110.67 175.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.6 -51.25 10.95 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.816 0.846 . . . . 0.0 109.848 176.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -123.32 81.72 52.59 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 124.28 1.032 . . . . 0.0 108.468 175.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -73.34 -20.25 21.27 Favored 'Trans proline' 0 C--N 1.386 2.53 0 C-N-CA 123.076 2.517 . . . . 0.0 111.552 173.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -66.8 -23.57 66.07 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.578 174.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.5 m120 58.15 34.55 24.27 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 124.992 1.317 . . . . 0.0 111.122 175.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.7 m -82.61 -13.33 56.7 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.421 -176.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.05 25.39 44.94 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.268 -172.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -139.59 122.96 17.13 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.769 0.828 . . . . 0.0 109.759 -175.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.443 HG13 HD22 ' A' ' 33' ' ' LEU . 2.8 p -131.65 129.9 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.59 0.756 . . . . 0.0 110.685 -172.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -74.95 90.25 2.42 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 170.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -56.72 -27.06 58.42 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.072 177.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -51.33 -58.22 6.81 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.455 1.102 . . . . 0.0 111.544 178.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.1 t -79.15 -33.11 44.43 Favored 'General case' 0 CA--C 1.555 1.17 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.072 -178.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.44 ' HD2' HD12 ' A' ' 33' ' ' LEU . 37.9 t80 -76.08 -63.13 1.39 Allowed 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -173.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.5 ' HA ' HD22 ' A' ' 73' ' ' LEU . 57.5 t -60.91 -16.55 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 123.428 0.691 . . . . 0.0 110.585 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -56.06 -56.26 25.02 Favored Glycine 0 CA--C 1.536 1.352 0 CA-C-O 118.991 -0.894 . . . . 0.0 112.742 166.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 19.3 ptm -63.43 -30.6 71.7 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 118.068 0.934 . . . . 0.0 112.142 -176.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.5 HD22 ' HA ' ' A' ' 70' ' ' VAL . 4.0 mm? -59.83 -30.06 68.69 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.233 0.613 . . . . 0.0 110.92 176.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.411 ' CD2' ' HB3' ' A' ' 10' ' ' LYS . 76.7 m-85 -116.7 1.98 12.88 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.944 0.898 . . . . 0.0 111.799 -176.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 71.8 mt -97.55 5.8 49.01 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.497 0.719 . . . . 0.0 110.956 173.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 29.5 m0 . . . . . 0 N--CA 1.475 0.792 0 C-N-CA 122.643 0.377 . . . . 0.0 110.322 174.545 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt . . . . . 0 N--CA 1.48 1.068 0 N-CA-C 111.026 0.01 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.78 -40.37 75.76 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.707 0.803 . . . . 0.0 111.559 176.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -70.72 -47.86 57.58 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.968 0.507 . . . . 0.0 111.434 -176.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.9 p -69.32 -33.17 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.014 -176.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 90.2 mt -66.92 -38.39 81.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 174.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.427 ' HA ' ' HB2' ' A' ' 18' ' ' LYS . 70.8 mm-40 -66.87 -23.44 66.01 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 119.304 -0.379 . . . . 0.0 111.639 173.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.29 -37.98 86.71 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 120.94 0.4 . . . . 0.0 110.199 175.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -73.86 -37.68 64.7 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.892 173.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.54 ' HB3' ' HZ1' ' A' ' 18' ' ' LYS . 9.9 mtpm? -74.79 -24.19 58.61 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.481 0.712 . . . . 0.0 112.21 -176.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.6 p -86.4 -27.51 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 176.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -67.18 -56.26 10.68 Favored 'General case' 0 C--N 1.354 0.787 0 C-N-CA 123.704 0.802 . . . . 0.0 109.399 174.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -82.75 83.1 7.81 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.785 177.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -85.62 -14.95 44.07 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.474 169.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -70.19 -27.32 64.41 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.803 0.841 . . . . 0.0 110.676 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.59 44.28 8.64 Favored Glycine 0 C--N 1.347 1.14 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.961 173.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -78.8 -13.2 59.94 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 122.972 0.509 . . . . 0.0 110.38 173.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.39 -44.98 1.93 Allowed Glycine 0 C--N 1.348 1.235 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 177.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.42 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 46.8 p90 -126.78 162.59 25.49 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 123.851 0.86 . . . . 0.0 110.106 177.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 52.4 t -109.68 151.05 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.183 0.993 . . . . 0.0 109.507 -177.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 76.1 p -68.99 166.56 17.73 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.627 0.771 . . . . 0.0 111.578 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.7 p -71.7 -15.15 18.11 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 122.606 0.362 . . . . 0.0 111.518 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -54.39 -63.02 1.28 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.844 0.858 . . . . 0.0 111.806 175.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -72.33 -29.38 63.77 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.987 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.521 HD22 HG12 ' A' ' 64' ' ' VAL . 7.3 tp -55.35 -51.66 66.06 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 123.8 0.688 . . . . 0.0 110.208 176.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 67.1 mtp85 -62.06 -40.59 96.31 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.458 0.703 . . . . 0.0 111.489 177.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -60.35 -54.4 46.14 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 123.783 0.677 . . . . 0.0 111.877 -174.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.6 p -67.1 -29.16 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 122.812 0.445 . . . . 0.0 111.259 -178.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 66.6 mt -87.67 -6.65 58.14 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.165 0.586 . . . . 0.0 111.868 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -83.1 -44.77 14.76 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.499 0.72 . . . . 0.0 110.27 177.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -68.05 -28.78 67.68 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.534 175.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 91.9 mt -96.34 11.07 36.05 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.273 1.029 . . . . 0.0 110.838 175.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -73.2 -14.93 78.84 Favored Glycine 0 C--N 1.352 1.438 0 C-N-CA 123.354 0.502 . . . . 0.0 113.037 -177.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -66.53 -46.37 76.38 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.906 0.882 . . . . 0.0 110.706 176.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 59.9 mtt -90.32 -46.18 8.56 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.672 0.789 . . . . 0.0 110.234 -175.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -110.35 98.76 37.47 Favored Pre-proline 0 N--CA 1.474 0.751 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 176.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -48.93 111.54 0.49 Allowed 'Trans proline' 0 C--N 1.385 2.5 0 C-N-CA 123.789 2.992 . . . . 0.0 113.707 -173.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.402 ' O ' ' HG3' ' A' ' 50' ' ' GLU . . . -64.1 -30.28 71.36 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.183 0.993 . . . . 0.0 111.16 -178.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -56.95 -48.06 79.23 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.093 0.957 . . . . 0.0 111.899 174.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.418 ' HG3' ' HE1' ' A' ' 52' ' ' MET . 11.6 tp10 -68.54 -38.82 81.15 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.038 -178.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.69 -36.5 75.56 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.819 177.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.487 ' HA ' HD13 ' A' ' 53' ' ' ILE . 40.0 mt-10 -59.95 -35.44 74.95 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.42 0.688 . . . . 0.0 111.641 176.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -69.41 -42.69 74.72 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.244 0.545 . . . . 0.0 109.992 176.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.418 ' HE1' ' HG3' ' A' ' 48' ' ' GLU . 49.9 mtt -69.68 -22.4 63.44 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.39 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.487 HD13 ' HA ' ' A' ' 50' ' ' GLU . 23.3 mt -64.27 -28.53 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.416 1.086 . . . . 0.0 111.558 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -59.5 -37.09 77.36 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 122.89 0.476 . . . . 0.0 111.064 174.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -81.44 -38.09 27.0 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.406 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.28 -32.31 73.69 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.592 1.157 . . . . 0.0 111.673 -178.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -114.97 88.5 17.19 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 124.34 1.056 . . . . 0.0 108.416 172.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -85.2 3.35 7.37 Favored 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.647 2.231 . . . . 0.0 111.603 173.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -83.59 -21.87 32.46 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.749 0.82 . . . . 0.0 110.306 176.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.6 t30 64.51 30.65 12.84 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.52 1.128 . . . . 0.0 110.079 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.3 m -132.51 -4.65 3.32 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.581 0.752 . . . . 0.0 112.105 -172.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.71 37.26 8.07 Favored Glycine 0 N--CA 1.471 1.023 0 C-N-CA 122.885 0.278 . . . . 0.0 113.546 178.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -123.61 125.65 45.21 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.153 0.981 . . . . 0.0 109.993 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.521 HG12 HD22 ' A' ' 33' ' ' LEU . 3.1 p -139.86 135.6 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.347 0.659 . . . . 0.0 111.057 -171.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -79.87 103.6 9.88 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 167.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.42 ' CE2' ' HA ' ' A' ' 27' ' ' TYR . 39.3 p90 -64.06 -32.28 73.77 Favored 'General case' 0 C--O 1.208 -1.121 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.18 -177.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -61.4 -39.22 89.93 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 118.427 0.558 . . . . 0.0 111.343 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 77.8 p -77.01 -47.73 19.87 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.368 0.667 . . . . 0.0 110.805 -178.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -70.82 -53.5 15.08 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.751 0.82 . . . . 0.0 111.941 -176.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.4 t -67.77 -18.51 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.693 0.797 . . . . 0.0 110.85 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -59.24 -49.61 76.67 Favored Glycine 0 C--N 1.349 1.304 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 165.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 85.2 mtp -70.62 -24.43 62.73 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.78 0.832 . . . . 0.0 111.951 177.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 86.2 mt -70.85 -10.92 60.54 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.127 0.571 . . . . 0.0 112.436 178.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -118.08 24.1 11.21 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.417 0.687 . . . . 0.0 109.636 174.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 85.9 mt -126.72 -31.05 2.72 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.166 0.986 . . . . 0.0 111.672 178.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.393 0 CA-C-N 117.987 0.358 . . . . 0.0 111.262 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.449 ' HB3' ' HB3' ' A' ' 74' ' ' PHE . 17.1 ptmt . . . . . 0 CA--C 1.536 0.417 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.85 -45.33 94.93 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.785 0.434 . . . . 0.0 110.362 172.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -59.57 -44.16 93.38 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.554 0.742 . . . . 0.0 111.558 -175.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.6 p -74.34 -34.56 37.08 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 CA-C-O 118.986 -0.531 . . . . 0.0 111.143 -179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 90.2 mt -60.33 -40.38 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-N 118.584 0.629 . . . . 0.0 109.651 173.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -68.93 -24.16 64.25 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.004 0.921 . . . . 0.0 111.186 177.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.18 -13.13 61.1 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.448 0.699 . . . . 0.0 111.734 174.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.569 ' HA ' ' HE2' ' A' ' 32' ' ' TYR . 90.6 m-85 -93.58 -43.79 8.52 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.344 0.658 . . . . 0.0 110.539 170.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.575 ' HB3' ' HZ1' ' A' ' 18' ' ' LYS . 8.5 mtpm? -67.95 -22.2 65.05 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.201 -175.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.8 p -59.95 -31.59 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.313 0.645 . . . . 0.0 111.088 175.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -78.72 -49.19 13.5 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.828 0.851 . . . . 0.0 110.433 176.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -65.32 105.18 1.08 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.543 0.737 . . . . 0.0 111.129 -173.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 19.2 tpp180 -71.15 -50.98 27.69 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.407 1.083 . . . . 0.0 110.577 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.414 ' HB2' ' HB2' ' A' ' 25' ' ' ASN . 5.6 m-20 -73.79 -20.7 60.39 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 114.701 -1.136 . . . . 0.0 112.155 -167.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.96 37.78 88.16 Favored Glycine 0 C--N 1.346 1.129 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -166.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.414 ' HB2' ' HB2' ' A' ' 23' ' ' ASP . 16.5 t-20 -67.71 -30.02 69.42 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.265 1.426 . . . . 0.0 111.074 -167.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 142.07 -60.82 0.54 Allowed Glycine 0 C--N 1.342 0.894 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 176.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.513 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 46.3 p90 -142.73 -176.01 4.71 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -176.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.9 m -126.85 -176.26 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.337 1.055 . . . . 0.0 110.511 -177.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 35.3 p -78.46 160.84 27.5 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 124.195 0.998 . . . . 0.0 111.387 177.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.2 p -78.45 -16.5 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.208 -176.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -69.39 -37.85 77.74 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 120.727 0.298 . . . . 0.0 110.548 173.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.569 ' HE2' ' HA ' ' A' ' 17' ' ' PHE . 45.6 t80 -73.73 -30.49 62.85 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.368 0.667 . . . . 0.0 110.36 178.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 8.6 tp -64.53 -55.29 21.55 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.52 175.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.592 ' HG2' HD11 ' A' ' 53' ' ' ILE . 63.3 mtm180 -69.54 -17.1 63.54 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.631 -177.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -66.52 -61.75 1.82 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.904 0.882 . . . . 0.0 110.75 174.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.4 p -68.67 -28.2 39.1 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.135 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.975 -175.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 71.8 mt -88.4 -8.98 54.12 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.937 -0.477 . . . . 0.0 111.857 -177.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -73.71 -46.96 42.95 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.252 0.621 . . . . 0.0 109.642 171.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -73.35 -25.65 60.69 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.903 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 97.9 mt -89.45 11.22 19.95 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.511 0.724 . . . . 0.0 111.107 173.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.8 3.24 61.21 Favored Glycine 0 C--N 1.358 1.764 0 CA-C-N 116.327 -0.397 . . . . 0.0 113.413 177.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -67.12 -40.99 86.93 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.1 0.96 . . . . 0.0 111.462 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 88.3 mmm -76.49 -46.98 24.43 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 122.993 0.517 . . . . 0.0 111.39 -178.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.491 ' HE2' ' HG3' ' A' ' 48' ' ' GLU . 90.9 mmm -135.2 139.16 30.9 Favored Pre-proline 0 N--CA 1.48 1.06 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.421 ' HB2' ' HG2' ' A' ' 48' ' ' GLU . 85.8 Cg_exo -49.27 133.92 30.61 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 122.625 2.217 . . . . 0.0 111.755 174.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.411 ' O ' ' HG3' ' A' ' 50' ' ' GLU . . . -58.55 -25.39 62.45 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 123.549 0.53 . . . . 0.0 111.206 178.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -60.07 -39.19 85.21 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.058 0.943 . . . . 0.0 111.972 175.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.491 ' HG3' ' HE2' ' A' ' 44' ' ' MET . 9.6 mm-40 -56.73 -39.61 74.25 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.847 0.832 . . . . 0.0 109.776 176.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.409 ' HA ' ' HE1' ' A' ' 52' ' ' MET . 49.3 mt -77.37 -35.47 22.32 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 CA-C-N 113.999 -1.455 . . . . 0.0 110.356 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.411 ' HG3' ' O ' ' A' ' 46' ' ' ALA . 40.4 mt-10 -65.92 -32.04 73.32 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.739 0.815 . . . . 0.0 112.755 -175.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -66.18 -36.06 82.09 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 121.328 0.585 . . . . 0.0 109.768 174.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.409 ' HE1' ' HA ' ' A' ' 49' ' ' ILE . 23.6 mtm -75.71 -24.57 56.22 Favored 'General case' 0 CA--C 1.553 1.058 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.488 177.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.592 HD11 ' HG2' ' A' ' 34' ' ' ARG . 62.8 mt -71.93 -28.19 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 124.397 1.079 . . . . 0.0 111.018 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -65.16 -32.96 74.91 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.069 171.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -83.66 -23.75 31.63 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.864 0.866 . . . . 0.0 110.9 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.5 ' HB2' HG21 ' A' ' 64' ' ' VAL . . . -72.94 -49.28 30.38 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.764 0.826 . . . . 0.0 110.482 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -120.35 90.49 45.23 Favored Pre-proline 0 CA--C 1.546 0.825 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 172.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.24 -11.81 15.97 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 123.027 2.485 . . . . 0.0 111.384 168.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -70.17 -24.07 63.08 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.221 1.009 . . . . 0.0 111.65 -173.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 60.78 24.01 13.94 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 125.038 1.335 . . . . 0.0 110.384 -174.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.8 t -105.48 -5.25 20.45 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.407 1.083 . . . . 0.0 109.86 -177.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.24 43.81 62.01 Favored Glycine 0 C--N 1.347 1.175 0 O-C-N 123.851 0.719 . . . . 0.0 113.06 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.456 ' HB3' ' HE1' ' A' ' 27' ' ' TYR . 27.2 m-85 -131.02 109.86 10.81 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.671 0.789 . . . . 0.0 110.29 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.5 HG21 ' HB2' ' A' ' 56' ' ' ALA . 4.6 p -117.83 129.98 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 123.885 0.874 . . . . 0.0 110.824 -175.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -81.23 91.62 6.21 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 170.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.513 ' CE2' ' HA ' ' A' ' 27' ' ' TYR . 45.1 p90 -61.33 -23.59 65.84 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 122.968 0.507 . . . . 0.0 111.498 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -51.63 -56.78 11.64 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.302 1.041 . . . . 0.0 110.582 173.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.2 t -82.07 -30.54 31.26 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.004 -177.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -73.68 -63.06 1.28 Allowed 'General case' 0 N--CA 1.476 0.848 0 O-C-N 123.066 0.229 . . . . 0.0 111.038 -175.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.534 ' HA ' ' HB3' ' A' ' 73' ' ' LEU . 90.2 t -59.0 -24.81 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 124.366 1.067 . . . . 0.0 111.154 177.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -56.63 -54.62 35.0 Favored Glycine 0 CA--C 1.532 1.103 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.355 169.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.417 ' HA ' ' HG ' ' A' ' 75' ' ' LEU . 20.8 mmt -76.15 -32.25 59.0 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.334 0.653 . . . . 0.0 111.368 -178.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.534 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 18.7 tp -69.49 -31.11 69.17 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.551 1.54 . . . . 0.0 111.627 -178.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.449 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 16.0 m-85 -111.94 26.36 10.68 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.159 0.584 . . . . 0.0 111.315 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.417 ' HG ' ' HA ' ' A' ' 72' ' ' MET . 78.3 mt -72.85 -31.89 65.07 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 166.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 17.5 p-90 . . . . . 0 N--CA 1.478 0.972 0 C-N-CA 123.653 0.781 . . . . 0.0 111.777 177.181 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.7 pttp . . . . . 0 N--CA 1.473 0.677 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.89 -34.75 60.4 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.374 0.67 . . . . 0.0 112.631 -178.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -79.92 -38.72 31.9 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.428 0.691 . . . . 0.0 111.211 -176.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.4 p -72.74 -29.03 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 122.126 0.17 . . . . 0.0 110.602 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.7 mt -64.09 -34.22 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.568 0.747 . . . . 0.0 110.086 175.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -70.82 -22.96 62.27 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.25 0.62 . . . . 0.0 111.971 177.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.94 -41.29 95.63 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.248 0.547 . . . . 0.0 109.571 172.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -65.41 -35.22 80.28 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.861 173.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -84.92 -11.64 55.13 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -175.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.9 p -89.16 -29.27 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 172.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 93.5 t80 -70.37 -51.99 25.76 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.578 171.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -64.73 116.79 6.63 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 173.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -87.28 -53.37 4.87 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.32 0.648 . . . . 0.0 111.891 -169.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -95.65 -7.76 36.65 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.005 0.522 . . . . 0.0 112.378 -167.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.99 50.72 4.77 Favored Glycine 0 C--N 1.343 0.93 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -171.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -62.37 -28.63 69.9 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.058 1.743 . . . . 0.0 111.292 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.14 -22.46 29.34 Favored Glycine 0 C--N 1.347 1.147 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.984 178.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -154.03 167.62 29.18 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.696 0.798 . . . . 0.0 111.193 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.1 m -116.24 176.26 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.32 1.048 . . . . 0.0 109.823 176.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 42.6 p -79.27 150.38 31.56 Favored 'General case' 0 C--O 1.246 0.896 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.78 171.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.409 HG11 ' HA2' ' A' ' 62' ' ' GLY . 9.0 p -66.64 -23.69 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 122.65 0.38 . . . . 0.0 111.255 -177.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -57.64 -54.23 49.2 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.442 0.697 . . . . 0.0 111.538 176.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -64.14 -38.79 92.32 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.841 0.456 . . . . 0.0 110.752 176.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.7 tt -60.66 -35.61 76.66 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.238 -176.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 23.2 mtp180 -75.29 -34.41 61.3 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.186 0.594 . . . . 0.0 111.233 176.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.2 mttp -59.6 -50.97 71.81 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.96 0.904 . . . . 0.0 111.735 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.8 p -71.68 -40.21 70.15 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.47 -176.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 97.4 mt -76.39 -11.96 59.98 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.087 0.555 . . . . 0.0 112.184 -176.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -65.97 -29.74 70.19 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.373 0.669 . . . . 0.0 109.833 171.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -86.27 -8.09 58.01 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.483 1.113 . . . . 0.0 111.706 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -91.79 18.6 7.46 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.728 0.811 . . . . 0.0 111.251 177.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 140.17 88.42 0.15 Allowed Glycine 0 C--N 1.349 1.292 0 CA-C-O 119.864 -0.409 . . . . 0.0 112.407 173.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -77.99 -30.06 49.99 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.427 0.691 . . . . 0.0 110.225 175.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -76.89 -24.33 52.53 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.157 174.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 83.1 mtp -79.96 147.92 67.02 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 123.924 0.89 . . . . 0.0 109.524 176.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.63 110.84 2.41 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 121.785 1.657 . . . . 0.0 111.277 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.33 -21.86 66.75 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.628 174.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -48.83 -41.56 33.35 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.392 1.477 . . . . 0.0 112.327 177.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.48 ' O ' ' HG2' ' A' ' 52' ' ' MET . 38.7 tt0 -65.85 -50.28 65.13 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.489 0.493 . . . . 0.0 110.316 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 88.3 mt -58.61 -36.16 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 123.848 0.859 . . . . 0.0 110.74 178.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -63.45 -46.78 84.71 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.098 0.959 . . . . 0.0 110.285 176.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -62.38 -34.55 76.91 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.912 0.485 . . . . 0.0 111.209 177.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.48 ' HG2' ' O ' ' A' ' 48' ' ' GLU . 26.1 mmt -67.93 -35.97 79.35 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.556 0.742 . . . . 0.0 109.925 176.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 83.3 mt -66.19 -36.61 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 124.218 1.007 . . . . 0.0 110.729 176.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -70.93 -21.01 62.41 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.402 0.681 . . . . 0.0 111.126 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -80.2 -41.58 24.96 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 171.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.407 ' HB2' HG21 ' A' ' 64' ' ' VAL . . . -72.83 -30.04 63.72 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.061 0.944 . . . . 0.0 111.92 -176.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -150.63 83.07 5.94 Favored Pre-proline 0 CA--C 1.545 0.76 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.26 -20.57 21.11 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.904 2.403 . . . . 0.0 113.085 -178.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -87.09 -10.62 52.44 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.162 0.585 . . . . 0.0 111.619 -178.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.1 t30 61.46 40.63 13.67 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 122.422 1.106 . . . . 0.0 109.586 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.9 m -77.53 -15.03 59.51 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.569 -1.196 . . . . 0.0 112.03 -173.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.409 ' HA2' HG11 ' A' ' 30' ' ' VAL . . . 85.53 13.67 69.89 Favored Glycine 0 C--N 1.347 1.177 0 CA-C-N 115.91 -0.587 . . . . 0.0 112.327 -173.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -123.01 111.26 16.38 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.736 0.815 . . . . 0.0 109.509 -175.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.407 HG21 ' HB2' ' A' ' 56' ' ' ALA . 2.2 p -139.99 121.29 15.1 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 C-N-CA 123.383 0.673 . . . . 0.0 109.854 -178.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -69.49 94.77 0.77 Allowed 'General case' 0 C--N 1.348 0.514 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.057 173.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 48.2 p90 -57.35 -28.81 63.47 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 123.56 0.538 . . . . 0.0 111.19 177.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -62.19 -49.31 76.29 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.356 0.662 . . . . 0.0 110.851 -176.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 79.8 p -77.59 -33.75 53.76 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.467 0.707 . . . . 0.0 110.641 177.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -67.31 -68.75 0.36 Allowed 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.418 -176.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.573 ' HA ' ' HB3' ' A' ' 73' ' ' LEU . 75.9 t -50.37 -29.11 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 125.404 1.481 . . . . 0.0 112.781 176.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.76 -48.07 80.36 Favored Glycine 0 C--N 1.349 1.287 0 CA-C-O 121.123 0.291 . . . . 0.0 112.693 171.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 33.3 mmt -86.09 -5.72 59.15 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.929 0.892 . . . . 0.0 112.295 177.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.573 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 55.4 tp -88.97 -42.61 11.69 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.068 0.947 . . . . 0.0 109.424 -177.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -90.96 11.75 21.83 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.154 0.582 . . . . 0.0 112.474 -177.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 pp -70.8 -9.1 56.77 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 118.308 0.504 . . . . 0.0 111.895 178.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 14.2 m0 . . . . . 0 N--CA 1.476 0.849 0 C-N-CA 123.659 0.784 . . . . 0.0 109.895 175.946 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? . . . . . 0 N--CA 1.479 1.019 0 N-CA-C 111.372 0.138 . . . . 0.0 111.372 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.1 -51.17 69.01 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 122.995 0.518 . . . . 0.0 110.687 173.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.7 mm-40 -56.49 -37.82 70.88 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.428 1.091 . . . . 0.0 112.738 -175.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.5 p -85.53 -42.36 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 CA-C-O 119.052 -0.499 . . . . 0.0 111.36 -177.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 60.3 mt -59.77 -43.16 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 122.881 0.472 . . . . 0.0 110.876 178.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.45 ' O ' HG23 ' A' ' 19' ' ' VAL . 12.9 pt-20 -70.08 -27.13 64.37 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.692 -178.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.13 -34.6 77.94 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.134 0.573 . . . . 0.0 110.999 175.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.459 ' HE1' ' HA ' ' A' ' 33' ' ' LEU . 83.0 m-85 -64.46 -37.85 88.97 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.957 0.503 . . . . 0.0 110.964 172.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -72.68 -20.51 61.22 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.273 0.629 . . . . 0.0 111.23 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 15' ' ' GLU . 61.0 t -71.87 -34.58 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 123.133 0.573 . . . . 0.0 110.049 171.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -71.8 -54.08 11.3 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.176 0.59 . . . . 0.0 109.844 175.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -77.6 83.04 4.0 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.649 0.78 . . . . 0.0 109.355 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -71.71 -40.38 69.53 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.162 0.985 . . . . 0.0 111.127 -176.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -72.53 -26.22 61.67 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.357 0.663 . . . . 0.0 111.801 -173.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.2 59.42 2.42 Favored Glycine 0 C--N 1.347 1.145 0 N-CA-C 111.978 -0.449 . . . . 0.0 111.978 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -86.65 -11.19 52.03 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.616 1.166 . . . . 0.0 111.143 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.73 -27.04 21.34 Favored Glycine 0 C--N 1.343 0.957 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.962 175.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.406 ' HB2' ' O ' ' A' ' 64' ' ' VAL . 39.1 p90 -149.25 177.1 9.94 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.195 0.598 . . . . 0.0 111.205 -174.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.1 m -132.55 -178.33 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 124.141 0.976 . . . . 0.0 110.096 178.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.0 p -78.03 155.05 30.91 Favored 'General case' 0 C--O 1.245 0.862 0 C-N-CA 123.932 0.893 . . . . 0.0 111.268 174.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.6 p -69.76 -20.29 23.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.607 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -58.76 -59.46 5.39 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.79 0.836 . . . . 0.0 110.934 175.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.449 ' HE2' ' HA ' ' A' ' 17' ' ' PHE . 87.0 t80 -62.56 -35.52 79.72 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.538 0.735 . . . . 0.0 110.764 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.481 HD21 HG12 ' A' ' 64' ' ' VAL . 6.5 tp -59.59 -53.47 57.66 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.611 178.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.507 ' HG2' HD12 ' A' ' 53' ' ' ILE . 98.0 mtt180 -67.08 -28.91 68.57 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.358 0.663 . . . . 0.0 111.514 -176.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -64.62 -58.61 5.87 Favored 'General case' 0 CA--C 1.548 0.904 0 O-C-N 123.665 0.603 . . . . 0.0 111.1 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.1 p -64.57 -38.73 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 123.138 0.575 . . . . 0.0 111.849 -174.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.43 HD21 HD12 ' A' ' 40' ' ' LEU . 85.8 mt -74.79 -26.53 59.81 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.245 0.618 . . . . 0.0 111.285 -176.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.406 ' HA ' ' HB3' ' A' ' 46' ' ' ALA . 3.6 t-20 -67.51 -42.15 83.3 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 123.479 0.487 . . . . 0.0 109.817 171.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -70.42 -30.9 67.89 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.799 0.84 . . . . 0.0 111.717 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.431 HD11 ' HZ ' ' A' ' 74' ' ' PHE . 95.8 mt -71.04 -28.41 64.37 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 122.759 0.424 . . . . 0.0 110.61 172.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -82.39 62.83 4.52 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 169.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -75.29 -36.64 61.13 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.237 0.615 . . . . 0.0 110.485 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 64.5 mtt -124.3 8.11 8.46 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.707 0.803 . . . . 0.0 110.768 173.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 22.8 mmt -116.99 140.92 27.58 Favored Pre-proline 0 N--CA 1.482 1.151 0 C-N-CA 124.045 0.938 . . . . 0.0 108.595 176.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.401 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 40.2 Cg_endo -66.95 133.03 29.87 Favored 'Trans proline' 0 C--N 1.368 1.567 0 C-N-CA 121.738 1.625 . . . . 0.0 111.367 173.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.406 ' HB3' ' HA ' ' A' ' 38' ' ' ASN . . . -73.33 -20.88 60.68 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.453 0.301 . . . . 0.0 110.286 174.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -54.84 -37.24 65.95 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.589 1.156 . . . . 0.0 112.571 -178.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 45' ' ' PRO . 17.1 pt-20 -67.14 -39.15 86.51 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.005 0.431 . . . . 0.0 110.309 177.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 89.6 mt -69.62 -33.25 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.41 1.084 . . . . 0.0 110.321 177.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -69.39 -32.96 72.31 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.806 0.842 . . . . 0.0 111.679 -176.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -62.29 -42.18 99.13 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 121.554 0.692 . . . . 0.0 109.983 171.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 60.4 mmm -67.9 -31.21 70.83 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.487 177.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.507 HD12 ' HG2' ' A' ' 34' ' ' ARG . 54.9 mt -67.72 -31.47 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 124.452 1.101 . . . . 0.0 110.932 178.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -77.54 -20.56 53.97 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.803 0.441 . . . . 0.0 111.291 172.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -79.46 -20.69 46.77 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.499 0.319 . . . . 0.0 110.671 171.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.47 -37.13 18.59 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.922 0.889 . . . . 0.0 111.041 175.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -132.25 80.5 63.53 Favored Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 124.334 1.054 . . . . 0.0 108.47 176.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -81.88 -12.58 10.84 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 123.268 2.646 . . . . 0.0 112.181 174.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 58.8 mm-40 -76.04 -17.03 59.83 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.632 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.6 m120 63.4 26.81 15.09 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.867 1.267 . . . . 0.0 110.611 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 53.1 m -88.89 -15.45 34.37 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.054 0.942 . . . . 0.0 111.245 -175.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.71 21.15 75.29 Favored Glycine 0 C--N 1.348 1.222 0 CA-C-N 116.32 -0.4 . . . . 0.0 113.052 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -116.92 117.22 29.11 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 178.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.481 HG12 HD21 ' A' ' 33' ' ' LEU . 3.9 p -135.02 124.42 42.92 Favored 'Isoleucine or valine' 0 C--O 1.245 0.822 0 C-N-CA 123.237 0.615 . . . . 0.0 110.805 -173.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -73.43 92.22 1.84 Allowed 'General case' 0 C--O 1.238 0.45 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 171.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -50.08 -46.27 53.23 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 114.465 -1.243 . . . . 0.0 113.761 -172.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -72.43 -34.48 67.85 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.32 0.648 . . . . 0.0 111.58 -175.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.4 m -63.48 -44.04 95.54 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.501 0.72 . . . . 0.0 109.625 175.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.441 ' HD2' HD13 ' A' ' 33' ' ' LEU . 17.6 t80 -71.71 -73.43 0.18 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.532 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.554 ' HA ' ' HB3' ' A' ' 73' ' ' LEU . 89.7 t -47.03 -28.44 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 C-N-CA 126.171 1.789 . . . . 0.0 113.149 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -59.53 -54.14 40.19 Favored Glycine 0 CA--C 1.538 1.503 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 169.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 84.7 mtp -72.89 -28.42 62.48 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.124 0.97 . . . . 0.0 111.996 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.554 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 54.6 tp -67.36 -46.83 72.2 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.38 1.072 . . . . 0.0 110.164 -177.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.431 ' HZ ' HD11 ' A' ' 40' ' ' LEU . 7.5 m-85 -84.17 21.51 1.37 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.595 0.758 . . . . 0.0 111.992 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 69.0 mt -95.22 31.26 1.97 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.434 0.694 . . . . 0.0 110.576 170.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 26.1 m0 . . . . . 0 N--CA 1.478 0.963 0 C-N-CA 123.047 0.539 . . . . 0.0 110.422 176.572 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.444 ' O ' HG12 ' A' ' 14' ' ' ILE . 19.5 pttp . . . . . 0 N--CA 1.481 1.097 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.8 -30.84 67.9 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.059 0.544 . . . . 0.0 111.565 176.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -68.94 -47.08 66.56 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.35 0.66 . . . . 0.0 110.927 176.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.8 p -71.87 -24.65 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 -177.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.49 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 33.2 mm -63.16 -38.21 81.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 173.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -61.17 -30.3 70.32 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 122.595 0.358 . . . . 0.0 111.468 176.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.16 -36.93 80.43 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 123.565 0.54 . . . . 0.0 110.421 175.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.489 ' HE1' ' HA ' ' A' ' 33' ' ' LEU . 84.4 m-85 -70.23 -32.65 70.61 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.326 0.65 . . . . 0.0 111.401 174.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.518 ' HZ3' ' HB3' ' A' ' 18' ' ' LYS . 3.3 mmmp? -70.95 -11.72 61.13 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.048 0.539 . . . . 0.0 111.481 -179.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 89.8 t -68.46 -42.53 83.92 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 122.841 0.456 . . . . 0.0 110.296 173.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -74.04 -48.21 31.58 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 173.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -83.01 76.78 9.81 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.127 0.971 . . . . 0.0 109.713 -178.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -94.18 -29.1 15.29 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.045 0.538 . . . . 0.0 110.929 176.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -85.83 -12.05 51.81 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.301 0.641 . . . . 0.0 111.942 -176.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.65 50.8 5.13 Favored Glycine 0 C--N 1.338 0.674 0 N-CA-C 112.097 -0.401 . . . . 0.0 112.097 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -68.53 -24.1 64.6 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.211 1.004 . . . . 0.0 110.628 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.65 -22.13 42.43 Favored Glycine 0 C--N 1.345 1.045 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.018 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.416 ' HB2' ' O ' ' A' ' 64' ' ' VAL . 43.4 p90 -156.07 172.42 18.44 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.72 0.808 . . . . 0.0 111.466 -175.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.2 m -121.42 -177.07 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 123.87 0.868 . . . . 0.0 110.232 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 70.7 p -83.14 162.17 21.38 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.699 0.8 . . . . 0.0 111.024 175.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.489 ' HB ' ' HA2' ' A' ' 62' ' ' GLY . 9.9 p -64.93 -27.79 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 123.019 0.527 . . . . 0.0 110.285 173.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -67.62 -47.52 69.39 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.51 1.124 . . . . 0.0 110.284 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -71.74 -34.02 69.18 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.251 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.489 ' HA ' ' HE1' ' A' ' 17' ' ' PHE . 5.8 tp -63.11 -55.62 23.79 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.991 0.916 . . . . 0.0 111.12 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.482 ' HG2' HD13 ' A' ' 53' ' ' ILE . 62.1 mtp180 -64.3 -31.46 72.68 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.412 0.685 . . . . 0.0 111.243 -178.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -59.32 -64.02 1.09 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.516 0.726 . . . . 0.0 111.271 178.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.2 p -62.6 -36.25 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.359 0.664 . . . . 0.0 111.726 -176.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 91.4 mt -82.07 -12.44 58.25 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.023 0.529 . . . . 0.0 111.667 -176.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -85.8 -36.35 20.13 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 171.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -66.07 -41.56 90.59 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.505 0.722 . . . . 0.0 110.341 174.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.404 HD23 ' HZ ' ' A' ' 74' ' ' PHE . 64.1 tp -78.55 -28.35 46.03 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.333 1.053 . . . . 0.0 110.192 174.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -88.3 53.69 4.16 Favored Glycine 0 C--N 1.344 1.021 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 175.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -88.09 -56.87 3.15 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.481 0.713 . . . . 0.0 109.367 175.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 57.5 mtm -82.49 -32.41 28.82 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.38 177.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 23.9 mmt -88.4 146.89 38.69 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 123.537 0.735 . . . . 0.0 109.305 174.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -70.21 119.28 6.24 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 121.952 1.768 . . . . 0.0 111.597 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.498 ' O ' ' HG2' ' A' ' 50' ' ' GLU . . . -62.91 -33.7 75.87 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.155 -0.684 . . . . 0.0 109.155 171.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -51.84 -41.07 61.52 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 125.352 1.461 . . . . 0.0 111.845 176.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -64.44 -48.31 75.81 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.217 1.007 . . . . 0.0 110.236 177.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.443 ' O ' HG13 ' A' ' 53' ' ' ILE . 68.3 mt -61.32 -36.46 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.466 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.498 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 15.9 mm-40 -56.63 -47.3 79.99 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.811 0.845 . . . . 0.0 111.075 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -66.03 -26.69 67.64 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 122.878 0.471 . . . . 0.0 111.427 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.525 ' HE3' ' HA ' ' A' ' 73' ' ' LEU . 43.8 mtp -77.23 -29.54 54.13 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.057 0.543 . . . . 0.0 110.459 175.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.482 HD13 ' HG2' ' A' ' 34' ' ' ARG . 96.8 mt -71.96 -24.42 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 123.964 0.906 . . . . 0.0 110.639 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -65.85 -26.1 67.5 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.044 0.538 . . . . 0.0 110.88 169.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -90.13 -28.63 18.83 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.228 0.611 . . . . 0.0 110.283 177.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.0 -42.27 76.7 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.795 0.838 . . . . 0.0 110.41 176.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -140.57 95.6 7.95 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 176.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -74.56 -23.54 14.7 Favored 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 122.749 2.299 . . . . 0.0 112.31 177.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -86.68 -12.24 48.92 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.864 0.865 . . . . 0.0 111.066 -174.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.418 ' N ' HD21 ' A' ' 60' ' ' ASN . 0.8 OUTLIER 64.11 25.74 13.79 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.783 1.233 . . . . 0.0 110.702 179.453 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 37.9 m -69.12 -22.41 63.97 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.703 1.201 . . . . 0.0 112.061 -177.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.489 ' HA2' ' HB ' ' A' ' 30' ' ' VAL . . . 79.33 26.59 57.06 Favored Glycine 0 C--N 1.339 0.733 0 CA-C-N 115.889 -0.596 . . . . 0.0 113.127 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -126.9 95.65 4.38 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.235 1.014 . . . . 0.0 108.693 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.446 HG12 HD22 ' A' ' 33' ' ' LEU . 2.0 p -119.94 125.24 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.958 0.903 . . . . 0.0 110.478 -171.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -72.77 91.03 1.45 Allowed 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 173.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -55.07 -38.03 67.52 Favored 'General case' 0 C--O 1.211 -0.966 0 CA-C-N 114.965 -1.016 . . . . 0.0 113.298 -173.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -65.96 -47.32 75.0 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 117.773 0.261 . . . . 0.0 110.633 -172.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 70.4 p -69.85 -32.28 70.58 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.067 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -68.51 -66.73 0.53 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 122.95 0.5 . . . . 0.0 110.879 176.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.59 ' HA ' ' HB3' ' A' ' 73' ' ' LEU . 52.9 t -47.89 -27.08 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.114 0 C-N-CA 126.435 1.894 . . . . 0.0 113.063 174.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.88 -53.48 37.28 Favored Glycine 0 CA--C 1.534 1.238 0 N-CA-C 112.28 -0.328 . . . . 0.0 112.28 169.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 91.0 mtp -75.26 -15.24 60.54 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.742 0.817 . . . . 0.0 111.944 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.59 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 59.4 tp -82.8 -43.73 16.35 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.882 1.273 . . . . 0.0 109.957 -178.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.404 ' HZ ' HD23 ' A' ' 40' ' ' LEU . 13.1 m-85 -88.5 22.65 2.49 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.821 0.848 . . . . 0.0 112.166 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 79.0 mt -70.73 -8.83 55.07 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 166.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 46.4 m0 . . . . . 0 C--N 1.355 0.84 0 C-N-CA 123.999 0.92 . . . . 0.0 109.778 168.556 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 56.8 tttm . . . . . 0 N--CA 1.478 0.955 0 CA-C-O 120.822 0.344 . . . . 0.0 111.434 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.1 -47.91 69.74 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.471 175.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -57.7 -38.77 75.79 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.985 0.914 . . . . 0.0 113.15 -174.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.9 p -66.26 -44.03 91.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 75.9 mt -66.62 -34.1 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.044 0.538 . . . . 0.0 109.97 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.452 ' O ' HG21 ' A' ' 19' ' ' VAL . 47.1 mt-10 -73.06 -25.94 61.1 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.331 0.653 . . . . 0.0 111.107 177.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.7 -37.63 86.99 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 121.231 0.538 . . . . 0.0 110.256 174.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.438 ' HE1' ' HA ' ' A' ' 33' ' ' LEU . 89.7 m-85 -67.28 -34.97 78.52 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.929 172.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.473 ' HE3' ' HE1' ' A' ' 66' ' ' TYR . 33.2 mmtp -66.44 -28.6 68.72 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.193 0.597 . . . . 0.0 110.862 176.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.452 HG21 ' O ' ' A' ' 15' ' ' GLU . 93.4 t -65.98 -44.13 92.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.018 0.527 . . . . 0.0 109.747 175.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -67.69 -48.7 65.82 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.355 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -88.04 72.24 9.23 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.697 0.799 . . . . 0.0 109.168 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -31.9 68.94 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.369 177.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -66.2 -28.92 69.12 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.967 178.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.04 41.25 95.26 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-N 115.976 -0.556 . . . . 0.0 113.319 176.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.9 -18.46 60.9 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 122.61 0.364 . . . . 0.0 110.842 178.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.32 -6.86 14.54 Favored Glycine 0 C--N 1.349 1.255 0 CA-C-O 119.625 -0.542 . . . . 0.0 113.737 172.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -157.48 173.82 16.32 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 117.563 0.682 . . . . 0.0 112.365 -175.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.2 m -130.66 179.63 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 124.134 0.973 . . . . 0.0 110.26 178.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 66.7 p -74.31 153.53 39.3 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.919 171.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.56 -26.4 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 122.707 0.403 . . . . 0.0 110.912 177.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -64.38 -50.71 66.6 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.062 0.545 . . . . 0.0 111.144 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -62.1 -41.04 97.81 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.157 0.583 . . . . 0.0 110.444 175.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.622 HD23 HG11 ' A' ' 64' ' ' VAL . 2.8 tp -56.67 -53.28 59.47 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.556 -178.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -65.31 -37.03 85.89 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.631 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -57.25 -58.77 6.78 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 124.258 0.974 . . . . 0.0 111.052 -177.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.456 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 7.5 p -63.26 -46.13 96.51 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 O-C-N 123.506 0.504 . . . . 0.0 111.341 -177.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 95.7 mt -65.57 -30.63 71.4 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.233 0.613 . . . . 0.0 111.761 -176.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -77.47 -38.73 48.65 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.018 0.527 . . . . 0.0 110.234 177.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -78.34 -9.54 59.3 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.303 0.641 . . . . 0.0 111.974 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 36' ' ' VAL . 87.8 mt -73.63 -42.59 61.24 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.653 0.381 . . . . 0.0 110.025 170.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -166.81 89.75 0.1 OUTLIER Glycine 0 C--N 1.35 1.328 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.636 -177.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -69.46 -20.44 63.76 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.75 0.82 . . . . 0.0 110.927 176.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 23.1 mmt -59.84 -32.34 70.59 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.233 1.013 . . . . 0.0 110.711 175.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 21.8 mmt -84.51 141.25 38.96 Favored Pre-proline 0 C--O 1.245 0.867 0 C-N-CA 124.201 1.0 . . . . 0.0 108.849 177.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.59 110.38 2.07 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 121.645 1.564 . . . . 0.0 111.331 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.28 -19.27 64.69 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.272 174.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -48.61 -39.64 24.67 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 125.383 1.473 . . . . 0.0 111.496 175.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.96 -49.25 78.21 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.496 1.118 . . . . 0.0 110.537 177.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 53' ' ' ILE . 87.5 mt -60.88 -43.63 96.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.367 -179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.515 ' HA ' HD12 ' A' ' 53' ' ' ILE . 0.5 OUTLIER -55.66 -37.5 68.35 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.935 0.894 . . . . 0.0 112.639 177.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -72.96 -40.44 65.34 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 121.563 0.697 . . . . 0.0 110.268 177.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.421 ' HE2' ' HA ' ' A' ' 52' ' ' MET . 28.6 mmt -64.66 -26.86 68.57 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.669 -1.151 . . . . 0.0 111.201 178.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.515 HD12 ' HA ' ' A' ' 50' ' ' GLU . 90.8 mt -66.69 -40.04 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 123.566 0.746 . . . . 0.0 110.826 177.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -65.44 -28.2 69.06 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 122.601 0.361 . . . . 0.0 110.908 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -75.74 -42.67 49.94 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.435 0.694 . . . . 0.0 110.904 177.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.57 -26.67 45.59 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.76 0.824 . . . . 0.0 111.802 -176.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -124.51 86.7 55.03 Favored Pre-proline 0 CA--C 1.542 0.673 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 176.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -75.94 -8.51 19.02 Favored 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 123.011 2.474 . . . . 0.0 112.521 -177.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -88.6 -24.03 22.94 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.488 0.715 . . . . 0.0 110.8 174.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.407 HD21 ' N ' ' A' ' 60' ' ' ASN . 0.8 OUTLIER 60.89 37.04 18.7 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 124.323 1.014 . . . . 0.0 109.356 -174.25 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.9 t -74.79 -18.67 60.43 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.595 -176.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.79 23.85 34.55 Favored Glycine 0 C--N 1.337 0.617 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.597 -175.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -139.42 131.26 27.59 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.114 1.366 . . . . 0.0 108.937 -178.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.622 HG11 HD23 ' A' ' 33' ' ' LEU . 2.8 p -145.56 134.77 17.57 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 CA-C-O 121.266 0.555 . . . . 0.0 110.727 -170.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -75.89 89.06 2.9 Favored 'General case' 0 C--N 1.35 0.606 0 C-N-CA 124.294 1.038 . . . . 0.0 108.823 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.473 ' HE1' ' HE3' ' A' ' 18' ' ' LYS . 32.5 p90 -49.94 -39.83 41.68 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 115.629 1.714 . . . . 0.0 115.629 -171.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -67.07 -50.67 61.0 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 118.73 0.695 . . . . 0.0 111.366 -170.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.456 ' O ' ' HG2' ' A' ' 72' ' ' MET . 9.4 t -71.02 -21.2 62.31 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.854 178.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.431 ' CE2' HD21 ' A' ' 33' ' ' LEU . 55.6 t80 -81.97 -58.1 3.13 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.513 0.725 . . . . 0.0 111.307 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.8 t -66.23 -27.88 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.215 1.006 . . . . 0.0 110.743 -177.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -59.82 -32.29 74.23 Favored Glycine 0 CA--C 1.537 1.418 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.681 171.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.456 ' HG2' ' O ' ' A' ' 68' ' ' THR . 26.6 mmt -76.29 -49.76 16.14 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.57 0.748 . . . . 0.0 111.35 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.9 pp -81.02 -2.96 50.12 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -172.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -94.82 -2.37 50.97 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.589 0.356 . . . . 0.0 111.009 169.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 65.2 mt -78.72 -5.67 53.8 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.489 0.316 . . . . 0.0 111.052 173.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 52.5 m0 . . . . . 0 N--CA 1.487 1.39 0 C-N-CA 123.581 0.752 . . . . 0.0 111.078 176.035 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.533 ' HE2' ' HB3' ' A' ' 74' ' ' PHE . 16.2 ptpt . . . . . 0 CA--C 1.543 0.675 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.24 -38.38 90.85 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.147 0.579 . . . . 0.0 110.856 174.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -70.92 -38.11 72.92 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 112.432 0.531 . . . . 0.0 112.432 -176.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.83 -37.23 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 176.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.5 HG22 ' HE1' ' A' ' 66' ' ' TYR . 63.9 mt -63.01 -42.08 95.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.388 0.675 . . . . 0.0 110.219 173.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -62.01 -32.95 73.48 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.852 0.861 . . . . 0.0 111.175 177.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.23 -38.07 79.06 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.161 0.584 . . . . 0.0 111.193 177.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.433 ' CZ ' HD13 ' A' ' 33' ' ' LEU . 96.2 m-85 -68.74 -37.08 79.16 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.269 175.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.424 ' HG3' ' O ' ' A' ' 14' ' ' ILE . 21.3 mtpp -71.76 -35.01 69.94 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.104 0.562 . . . . 0.0 111.045 -175.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 91.4 t -71.01 -35.34 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.757 0.823 . . . . 0.0 110.07 176.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -66.48 -54.25 26.09 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.427 175.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.464 ' HB2' HG23 ' A' ' 28' ' ' VAL . 21.7 t70 -77.25 86.33 3.69 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.572 0.701 . . . . 0.0 109.922 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 42.5 mtp180 -88.96 -1.19 57.99 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.041 172.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -84.41 -26.85 28.02 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.004 0.922 . . . . 0.0 111.201 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.08 47.68 23.14 Favored Glycine 0 C--N 1.345 1.053 0 O-C-N 123.478 0.486 . . . . 0.0 112.274 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -91.38 17.6 8.27 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.442 0.697 . . . . 0.0 111.616 -178.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.33 -60.36 4.89 Favored Glycine 0 C--N 1.344 1.024 0 N-CA-C 111.784 -0.526 . . . . 0.0 111.784 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -124.73 -171.75 2.42 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.494 1.117 . . . . 0.0 110.322 -177.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.464 HG23 ' HB2' ' A' ' 21' ' ' ASP . 76.8 t -126.57 151.3 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.508 1.123 . . . . 0.0 109.675 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 58.5 p -66.98 165.32 15.83 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.143 0.977 . . . . 0.0 112.592 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.4 p -69.83 -18.92 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.491 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -63.63 -46.78 84.15 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.018 0.527 . . . . 0.0 111.41 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -79.83 -29.99 40.31 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.823 176.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.532 HD21 HG13 ' A' ' 64' ' ' VAL . 12.0 tp -57.02 -45.53 83.03 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.175 0.59 . . . . 0.0 110.689 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 75.5 mtt180 -67.28 -41.96 84.62 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.354 176.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -54.18 -51.08 65.51 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.812 0.845 . . . . 0.0 111.812 -176.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.5 p -73.82 -34.2 39.59 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.582 -175.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 91.8 mt -86.09 -10.42 54.93 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 122.04 -0.413 . . . . 0.0 111.883 -177.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -83.06 -42.08 17.87 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.128 0.571 . . . . 0.0 109.948 176.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -73.86 -40.1 63.49 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.507 0.723 . . . . 0.0 111.132 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 96.9 mt -76.69 -33.0 58.26 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.891 0.477 . . . . 0.0 110.61 177.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -87.52 65.07 3.65 Favored Glycine 0 C--N 1.347 1.18 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 176.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -84.07 -58.36 2.8 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.322 0.649 . . . . 0.0 109.443 177.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.426 ' HE2' ' HG2' ' A' ' 44' ' ' MET . 0.0 OUTLIER -78.3 -22.02 48.82 Favored 'General case' 0 CA--C 1.551 1.003 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.299 177.039 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.426 ' HG2' ' HE2' ' A' ' 43' ' ' MET . 96.9 mmm -87.92 128.3 54.56 Favored Pre-proline 0 N--CA 1.478 0.969 0 C-N-CA 123.65 0.78 . . . . 0.0 110.204 178.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -65.54 121.78 9.27 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 122.86 2.373 . . . . 0.0 111.485 172.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.96 -12.83 61.76 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.81 0.844 . . . . 0.0 111.897 -177.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.483 ' O ' ' HG2' ' A' ' 51' ' ' GLU . 5.8 m-20 -52.45 -52.65 53.07 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.632 1.173 . . . . 0.0 111.363 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -60.19 -46.85 88.31 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 124.058 0.849 . . . . 0.0 111.02 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.0 mt -57.99 -38.56 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.056 178.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.406 ' O ' ' HD1' ' A' ' 54' ' ' TYR . 75.2 mm-40 -67.41 -41.43 84.89 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.127 0.571 . . . . 0.0 111.547 178.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 47' ' ' ASP . 8.7 mm-40 -60.35 -43.3 96.63 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.798 0.809 . . . . 0.0 109.791 177.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.446 ' HG3' ' HZ2' ' A' ' 76' ' ' TRP . 76.5 mmm -66.66 -32.88 74.49 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 113.57 -1.65 . . . . 0.0 111.52 176.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.4 mt -64.29 -42.72 96.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 C-N-CA 124.089 0.956 . . . . 0.0 110.235 176.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.406 ' HD1' ' O ' ' A' ' 50' ' ' GLU . 24.7 m-85 -78.07 -9.39 59.12 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.712 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -99.15 -16.95 18.41 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.287 0.635 . . . . 0.0 111.405 170.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.72 -28.97 22.76 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.626 0.77 . . . . 0.0 110.324 173.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -138.83 76.54 34.29 Favored Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 175.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -78.77 -11.56 15.28 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 123.252 2.635 . . . . 0.0 113.512 -176.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -87.43 -11.8 48.06 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.213 0.605 . . . . 0.0 111.254 -178.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.5 t30 60.31 54.83 3.79 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 122.167 0.984 . . . . 0.0 109.277 -175.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.9 m -99.19 -17.2 18.26 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.527 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.61 15.22 81.4 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.354 -172.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -114.79 109.94 18.94 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.684 0.794 . . . . 0.0 109.645 -173.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.532 HG13 HD21 ' A' ' 33' ' ' LEU . 2.7 p -136.84 123.2 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 123.731 0.812 . . . . 0.0 110.121 -175.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -72.57 100.62 2.8 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 172.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.5 ' HE1' HG22 ' A' ' 14' ' ' ILE . 48.1 p90 -59.94 -37.79 80.54 Favored 'General case' 0 C--O 1.214 -0.785 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.681 -171.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -66.75 -33.84 76.52 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 118.076 0.398 . . . . 0.0 110.316 -177.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 19.1 m -67.2 -50.73 59.84 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 123.81 0.844 . . . . 0.0 110.446 175.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.432 ' HD2' HD11 ' A' ' 33' ' ' LEU . 63.0 t80 -70.63 -62.35 1.42 Allowed 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.982 -174.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 74.5 t -57.19 -30.62 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.63 1.172 . . . . 0.0 110.83 175.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.68 -55.4 30.08 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-N 116.298 -0.41 . . . . 0.0 112.458 172.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 24.4 ptp -72.68 -24.18 60.98 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -175.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.53 -26.9 29.74 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.533 ' HB3' ' HE2' ' A' ' 10' ' ' LYS . 22.8 m-85 -86.69 6.3 31.9 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 122.612 0.365 . . . . 0.0 111.03 170.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 76.9 mt -100.72 15.41 28.38 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.684 0.794 . . . . 0.0 110.602 168.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.446 ' HZ2' ' HG3' ' A' ' 52' ' ' MET . 54.6 m0 . . . . . 0 CA--C 1.553 1.089 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 170.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 120.517 0.199 . . . . 0.0 110.848 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.17 -42.23 98.2 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.008 0.923 . . . . 0.0 112.077 -175.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -56.19 -41.91 76.28 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 124.038 0.935 . . . . 0.0 112.611 -173.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.448 HG11 HG12 ' A' ' 70' ' ' VAL . 4.3 p -82.71 -35.96 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 123.583 0.753 . . . . 0.0 109.941 -174.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 71.2 mt -61.84 -32.63 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 123.328 0.651 . . . . 0.0 110.052 172.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -67.88 -38.11 82.62 Favored 'General case' 0 C--N 1.349 0.548 0 C-N-CA 123.682 0.793 . . . . 0.0 110.781 175.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.27 -40.01 76.83 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 122.899 0.48 . . . . 0.0 111.268 177.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.413 ' CE1' HD11 ' A' ' 33' ' ' LEU . 80.6 m-85 -64.54 -53.2 51.77 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.472 0.709 . . . . 0.0 112.001 178.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.605 ' HB3' ' HZ1' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -68.87 -25.99 64.9 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -175.978 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.3 t -70.37 -37.5 70.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 122.646 0.378 . . . . 0.0 110.11 172.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -66.68 -40.45 88.58 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.28 174.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -76.63 81.06 3.29 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.792 0.806 . . . . 0.0 109.887 -176.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 69.6 mtp180 -92.96 -14.86 26.95 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.036 -1.438 . . . . 0.0 109.703 175.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -74.65 -28.42 60.85 Favored 'General case' 0 C--N 1.356 0.848 0 C-N-CA 123.383 0.673 . . . . 0.0 110.253 176.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.22 56.09 3.32 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-N 116.329 -0.396 . . . . 0.0 113.279 175.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -88.27 -21.59 24.37 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.804 0.841 . . . . 0.0 110.413 175.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.33 -40.9 2.49 Favored Glycine 0 C--N 1.348 1.204 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 -173.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.4 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 44.5 p90 -119.47 -176.0 3.06 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.958 1.303 . . . . 0.0 109.518 174.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 55.2 t -127.64 159.51 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 124.244 1.017 . . . . 0.0 109.467 -177.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.3 p -72.81 166.81 22.18 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.655 1.182 . . . . 0.0 111.771 177.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.9 p -75.3 -14.8 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 122.999 0.52 . . . . 0.0 111.331 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -69.45 -57.63 5.0 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 122.578 0.351 . . . . 0.0 110.83 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -64.29 -30.56 71.61 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.643 0.377 . . . . 0.0 110.534 176.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.521 HD21 HG13 ' A' ' 64' ' ' VAL . 10.4 tp -56.69 -58.66 7.11 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.169 176.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 46.6 mtt85 -62.45 -28.24 69.67 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.794 0.838 . . . . 0.0 112.116 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -62.37 -62.79 1.51 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.278 0.631 . . . . 0.0 110.865 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.3 p -66.82 -28.3 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.169 0.588 . . . . 0.0 111.686 -175.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 84.1 mt -87.56 -11.93 47.24 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.223 0.609 . . . . 0.0 112.224 -177.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -76.84 -35.38 57.56 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 166.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -75.34 -35.03 61.23 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.129 0.971 . . . . 0.0 110.464 177.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -74.73 -43.36 55.4 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 175.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -87.2 61.32 4.28 Favored Glycine 0 C--N 1.345 1.078 0 N-CA-C 110.269 -1.133 . . . . 0.0 110.269 175.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -60.32 -47.91 84.0 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.358 1.063 . . . . 0.0 111.445 -173.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 64.4 mtm -125.88 1.0 7.36 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.699 0.8 . . . . 0.0 110.006 172.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 63.4 mtt -80.94 137.27 50.14 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 123.445 0.698 . . . . 0.0 109.38 175.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.7 122.54 10.67 Favored 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.64 2.227 . . . . 0.0 112.87 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.51 -18.48 65.39 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.702 0.801 . . . . 0.0 110.631 170.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -50.4 -43.13 54.58 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.766 1.227 . . . . 0.0 111.164 173.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -63.54 -53.28 54.29 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.431 0.693 . . . . 0.0 110.514 175.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 53' ' ' ILE . 88.5 mt -59.93 -37.26 71.4 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 CA-C-N 114.823 -1.08 . . . . 0.0 111.769 -174.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -71.68 -30.41 65.67 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.343 0.657 . . . . 0.0 112.024 -175.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -67.77 -39.96 84.07 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 121.53 0.681 . . . . 0.0 109.379 172.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.422 ' HG3' ' HZ2' ' A' ' 76' ' ' TRP . 69.7 mmm -68.55 -32.94 73.23 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.428 -1.26 . . . . 0.0 110.392 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 49' ' ' ILE . 58.4 mt -58.63 -42.59 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 123.821 0.848 . . . . 0.0 110.065 178.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -73.31 -9.74 59.02 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.556 0.743 . . . . 0.0 112.305 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -85.9 -29.94 23.25 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 120.975 0.417 . . . . 0.0 110.103 172.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -94.04 -19.68 20.64 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.791 0.837 . . . . 0.0 111.421 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -144.85 71.81 15.08 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 124.736 1.214 . . . . 0.0 107.897 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.03 -17.35 22.27 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 122.858 2.372 . . . . 0.0 112.609 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.508 ' HG3' ' H ' ' A' ' 61' ' ' SER . 27.7 pt20 -70.86 -20.26 62.55 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.303 1.041 . . . . 0.0 111.645 178.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.7 t30 67.7 6.95 5.34 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 124.877 1.271 . . . . 0.0 111.115 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.508 ' H ' ' HG3' ' A' ' 59' ' ' GLN . 34.8 t -78.61 -17.67 55.7 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.531 0.732 . . . . 0.0 111.313 -173.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.03 34.42 8.25 Favored Glycine 0 C--N 1.341 0.819 0 O-C-N 123.314 0.384 . . . . 0.0 113.87 172.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -127.38 96.14 4.48 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.252 1.021 . . . . 0.0 108.493 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.521 HG13 HD21 ' A' ' 33' ' ' LEU . 3.3 p -118.03 130.28 73.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 124.031 0.933 . . . . 0.0 111.312 -166.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -75.05 90.41 2.48 Favored 'General case' 0 C--N 1.351 0.644 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 170.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.4 ' CE2' ' HA ' ' A' ' 27' ' ' TYR . 42.3 p90 -57.37 -29.87 64.4 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.043 -0.981 . . . . 0.0 113.41 -173.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -60.65 -63.54 1.26 Allowed 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 118.105 0.411 . . . . 0.0 110.858 -174.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.7 t -64.68 -30.04 71.05 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.558 0.743 . . . . 0.0 111.623 -177.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.462 ' CD2' HD12 ' A' ' 33' ' ' LEU . 32.4 t80 -70.42 -55.11 9.83 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.522 0.729 . . . . 0.0 111.858 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.448 HG12 HG11 ' A' ' 13' ' ' VAL . 82.7 t -65.06 -24.86 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.472 0.709 . . . . 0.0 110.188 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.447 ' O ' ' HG ' ' A' ' 75' ' ' LEU . . . -56.4 -53.55 42.35 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.532 165.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.485 ' HA ' HD13 ' A' ' 75' ' ' LEU . 85.0 mtp -59.53 -35.97 75.23 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.896 0.878 . . . . 0.0 112.605 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 70' ' ' VAL . 92.5 mt -62.88 -42.06 99.63 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 121.419 0.628 . . . . 0.0 110.584 176.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -88.23 -0.07 56.68 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.163 -178.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.485 HD13 ' HA ' ' A' ' 72' ' ' MET . 82.0 mt -86.06 4.15 39.31 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.581 0.752 . . . . 0.0 110.869 170.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.422 ' HZ2' ' HG3' ' A' ' 52' ' ' MET . 51.4 m0 . . . . . 0 CA--C 1.547 0.84 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 171.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt . . . . . 0 N--CA 1.481 1.097 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.455 ' O ' ' HG2' ' A' ' 15' ' ' GLU . . . -71.23 -30.46 66.37 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.09 0.556 . . . . 0.0 111.461 174.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -58.0 -36.82 73.2 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.615 0.766 . . . . 0.0 112.521 -176.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.6 p -77.33 -34.45 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 122.633 0.373 . . . . 0.0 110.487 177.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.5 mt -65.6 -30.14 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 123.556 0.743 . . . . 0.0 110.516 178.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.478 ' HA ' ' HE2' ' A' ' 18' ' ' LYS . 26.1 mm-40 -59.09 -43.49 91.84 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.474 0.709 . . . . 0.0 109.911 172.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.34 -28.36 67.91 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.812 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -73.82 -54.29 8.33 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.971 0.509 . . . . 0.0 111.609 176.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.478 ' HE2' ' HA ' ' A' ' 15' ' ' GLU . 64.4 pttt -73.99 -17.5 60.99 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -170.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.6 p -69.14 -33.48 58.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 CA-C-N 117.917 0.326 . . . . 0.0 110.124 172.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -77.71 -45.48 24.67 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.96 0.904 . . . . 0.0 109.64 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -78.21 72.9 4.77 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 174.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.426 ' HA ' ' NE ' ' A' ' 22' ' ' ARG . 1.6 tpm_? -80.5 -28.43 37.48 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.992 -166.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -70.3 -25.67 63.43 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.823 0.449 . . . . 0.0 110.927 176.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.22 50.16 5.94 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 -173.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -75.82 -10.68 59.63 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.58 0.752 . . . . 0.0 110.597 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.39 -29.27 12.25 Favored Glycine 0 C--N 1.35 1.358 0 CA-C-N 116.121 -0.49 . . . . 0.0 112.174 176.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -145.09 164.03 32.47 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-O 121.09 0.472 . . . . 0.0 111.312 -172.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.6 m -117.74 178.61 2.0 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.846 0 CA-C-N 114.77 -1.104 . . . . 0.0 109.864 176.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.8 p -81.38 156.36 25.47 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.652 173.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.548 HG21 HG23 ' A' ' 53' ' ' ILE . 7.7 p -57.97 -37.35 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.95 0.9 . . . . 0.0 112.041 177.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -62.54 -47.83 82.16 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 123.618 0.574 . . . . 0.0 111.197 -174.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -66.76 -41.82 87.13 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.298 176.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.419 HD23 ' CE2' ' A' ' 69' ' ' PHE . 5.1 tt -63.39 -32.78 74.3 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.568 -176.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 47.9 mtm105 -74.12 -38.88 63.67 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.921 0.488 . . . . 0.0 110.679 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -60.43 -52.52 64.86 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.052 0.845 . . . . 0.0 111.508 -176.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.1 p -62.77 -41.44 92.47 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.651 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 86.1 mt -78.28 -16.32 57.89 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -177.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -80.77 -46.7 15.01 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.933 0.493 . . . . 0.0 110.292 176.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -67.98 -23.54 65.05 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.042 0.537 . . . . 0.0 111.982 -175.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.6 pp -98.13 -32.24 11.7 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.54 0.336 . . . . 0.0 110.726 173.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -106.7 39.6 2.82 Favored Glycine 0 C--N 1.345 1.06 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.648 -175.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -75.66 -26.87 58.04 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.201 1.0 . . . . 0.0 110.355 175.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 53.9 mtm -73.86 -33.38 64.06 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.191 0.996 . . . . 0.0 110.846 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 64.1 mtm -92.95 156.31 40.63 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 123.788 0.835 . . . . 0.0 109.647 176.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.07 111.59 2.91 Favored 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 121.551 1.501 . . . . 0.0 111.311 169.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.02 -12.47 61.54 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.478 0.711 . . . . 0.0 110.92 174.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -51.62 -55.49 19.02 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.011 1.324 . . . . 0.0 110.766 174.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.455 ' O ' ' HG2' ' A' ' 52' ' ' MET . 38.8 tt0 -68.04 -35.16 77.79 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.11 -178.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.469 ' O ' HG13 ' A' ' 53' ' ' ILE . 93.6 mt -58.96 -39.81 78.96 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 123.219 0.607 . . . . 0.0 110.506 173.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.526 ' HA ' HD13 ' A' ' 53' ' ' ILE . 49.6 mt-10 -67.09 -35.1 79.06 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.78 0.432 . . . . 0.0 110.947 177.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -62.83 -36.32 82.83 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.575 0.35 . . . . 0.0 110.803 173.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.455 ' HG2' ' O ' ' A' ' 48' ' ' GLU . 30.2 mmt -69.68 -33.04 72.0 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.466 0.706 . . . . 0.0 110.453 177.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.548 HG23 HG21 ' A' ' 30' ' ' VAL . 81.3 mt -69.23 -32.2 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.823 0.849 . . . . 0.0 110.303 174.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -71.59 -12.43 61.35 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.577 0.751 . . . . 0.0 111.459 175.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -94.95 -35.19 12.1 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.52 0.728 . . . . 0.0 110.138 174.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.94 -31.13 56.41 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.765 0.826 . . . . 0.0 111.07 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -137.81 91.32 13.63 Favored Pre-proline 0 CA--C 1.55 0.973 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 172.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -85.12 4.73 6.61 Favored 'Trans proline' 0 C--N 1.371 1.746 0 C-N-CA 122.898 2.399 . . . . 0.0 113.855 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -103.6 -11.18 17.87 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.178 0.591 . . . . 0.0 111.851 -176.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.2 t30 66.71 22.83 10.3 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 124.177 0.991 . . . . 0.0 109.847 -176.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 46.9 m -64.47 -39.99 94.84 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 124.718 1.207 . . . . 0.0 110.807 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.97 24.7 16.41 Favored Glycine 0 C--N 1.344 0.976 0 CA-C-N 114.995 -1.002 . . . . 0.0 113.191 176.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -127.42 95.27 4.21 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.496 1.119 . . . . 0.0 108.787 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 p -119.11 126.02 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 123.527 0.731 . . . . 0.0 110.407 -171.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -70.24 98.98 1.45 Allowed 'General case' 0 C--N 1.347 0.458 0 C-N-CA 124.152 0.981 . . . . 0.0 110.593 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -63.27 -33.4 75.42 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -176.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -64.91 -46.73 80.44 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 120.883 0.373 . . . . 0.0 110.955 -175.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 54.6 p -77.31 -38.15 51.19 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.407 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.419 ' CE2' HD23 ' A' ' 33' ' ' LEU . 41.8 t80 -65.12 -72.05 0.17 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.062 0.545 . . . . 0.0 110.975 -178.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.555 ' HA ' ' HB3' ' A' ' 73' ' ' LEU . 96.9 t -50.08 -29.56 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 125.162 1.385 . . . . 0.0 112.309 177.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.75 -53.44 45.26 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 121.048 0.249 . . . . 0.0 112.769 170.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 67.7 mtm -87.03 -2.13 58.39 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.281 1.033 . . . . 0.0 111.956 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.555 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 50.7 tp -90.24 -48.01 7.42 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.263 1.025 . . . . 0.0 109.363 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -78.41 27.89 0.2 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.105 0.962 . . . . 0.0 112.608 -177.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.2 0.33 19.48 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.361 0.665 . . . . 0.0 112.033 172.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 13.3 m0 . . . . . 0 C--N 1.351 0.636 0 C-N-CA 124.632 1.173 . . . . 0.0 110.948 179.21 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.424 ' H ' ' HD3' ' A' ' 10' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.455 ' O ' ' HG2' ' A' ' 15' ' ' GLU . . . -58.75 -43.08 90.18 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.469 0.308 . . . . 0.0 110.572 170.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 -67.25 -34.39 77.33 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.492 0.717 . . . . 0.0 111.991 -173.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.6 p -75.3 -37.14 38.33 Favored 'Isoleucine or valine' 0 C--N 1.355 0.828 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -178.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.4 mt -62.85 -37.28 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 174.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 68.0 mm-40 -59.99 -45.03 94.05 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 122.877 0.471 . . . . 0.0 110.161 172.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.26 -27.45 69.02 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.657 0.783 . . . . 0.0 112.138 -178.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.46 ' HE1' ' HA ' ' A' ' 33' ' ' LEU . 65.2 m-85 -77.7 -42.61 33.84 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.719 0.408 . . . . 0.0 111.179 173.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -70.4 -23.18 62.71 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.924 0.49 . . . . 0.0 112.114 -174.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 23.8 m -75.95 -28.61 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-O 120.663 0.268 . . . . 0.0 110.552 175.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -74.6 -42.04 59.37 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.74 0.816 . . . . 0.0 109.052 174.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -75.2 85.2 2.4 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.026 0.93 . . . . 0.0 108.824 175.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 68.5 ttt-85 -65.61 -48.49 72.09 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.789 -1.096 . . . . 0.0 112.456 -172.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -87.47 -3.5 59.0 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -170.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.69 41.74 63.66 Favored Glycine 0 C--N 1.345 1.03 0 N-CA-C 112.171 -0.372 . . . . 0.0 112.171 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -70.51 -17.99 62.95 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.919 0.888 . . . . 0.0 110.701 -178.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.29 -43.58 1.61 Allowed Glycine 0 C--N 1.346 1.108 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.498 175.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.489 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 50.9 p90 -136.6 176.19 8.92 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.186 0.594 . . . . 0.0 111.799 -172.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.0 m -123.64 -177.97 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 124.02 0.928 . . . . 0.0 110.529 -177.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 49.7 p -75.75 153.82 36.76 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 123.554 0.742 . . . . 0.0 110.235 173.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.6 p -63.06 -27.0 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.327 0.651 . . . . 0.0 111.343 178.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -59.96 -58.79 7.03 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.526 1.13 . . . . 0.0 110.624 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -61.77 -34.16 75.37 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 123.752 0.657 . . . . 0.0 110.975 -178.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.528 HD21 HG13 ' A' ' 64' ' ' VAL . 7.1 tp -58.69 -52.15 66.91 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.768 178.103 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 54.9 mtt180 -64.58 -35.29 80.52 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.369 0.668 . . . . 0.0 111.435 -178.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -63.46 -51.85 63.87 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.475 0.71 . . . . 0.0 111.828 -177.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.2 p -73.0 -30.38 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.46 -175.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 81.2 mt -85.28 -11.95 53.56 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.672 0.389 . . . . 0.0 111.371 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -85.46 -33.01 21.97 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.198 0.599 . . . . 0.0 110.078 173.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -80.43 -41.4 24.56 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 110.624 -0.139 . . . . 0.0 110.624 178.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 94.3 mt -74.07 -27.65 61.01 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.601 0.361 . . . . 0.0 110.233 174.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -96.68 52.09 1.51 Allowed Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.4 173.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -65.95 -51.07 61.77 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.748 0.819 . . . . 0.0 111.041 -175.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -92.4 -3.28 55.52 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.134 0.574 . . . . 0.0 111.029 177.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 74.8 mtp -94.4 144.66 28.35 Favored Pre-proline 0 N--CA 1.48 1.071 0 C-N-CA 123.611 0.765 . . . . 0.0 110.141 -176.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -66.52 111.39 2.08 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.684 2.256 . . . . 0.0 111.828 172.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.36 -27.77 63.58 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.305 0.642 . . . . 0.0 111.293 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -62.02 -34.34 76.03 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 122.703 0.401 . . . . 0.0 111.738 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -71.2 -39.15 71.96 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 176.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.484 ' O ' HG13 ' A' ' 53' ' ' ILE . 89.1 mt -64.4 -42.13 94.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 123.234 0.614 . . . . 0.0 109.776 176.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.502 ' HA ' HD12 ' A' ' 53' ' ' ILE . 46.9 mt-10 -75.05 -19.84 59.83 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.918 0.887 . . . . 0.0 111.032 -178.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -72.13 -45.02 62.21 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.685 0.794 . . . . 0.0 109.149 169.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.451 ' SD ' ' HZ2' ' A' ' 76' ' ' TRP . 48.8 mtp -67.7 -18.99 65.11 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.344 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.502 HD12 ' HA ' ' A' ' 50' ' ' GLU . 73.6 mt -68.03 -29.31 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.405 0.682 . . . . 0.0 111.38 176.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -60.37 -32.96 71.78 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.106 0.562 . . . . 0.0 110.484 173.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -85.3 -35.8 21.26 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.334 1.054 . . . . 0.0 110.448 178.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.18 -33.01 74.79 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.985 0.914 . . . . 0.0 111.569 -178.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -123.82 90.07 50.96 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 105.056 -2.202 . . . . 0.0 105.056 171.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -65.65 -23.35 56.72 Favored 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 123.148 2.566 . . . . 0.0 112.788 -175.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -86.39 -17.27 34.83 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.765 0.826 . . . . 0.0 109.332 179.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.405 ' N ' HD21 ' A' ' 60' ' ' ASN . 0.8 OUTLIER 59.03 43.57 17.43 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.354 1.061 . . . . 0.0 110.318 178.843 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.0 m -79.76 -26.86 40.55 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.241 1.016 . . . . 0.0 112.156 -177.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 96.9 9.33 56.28 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.351 -169.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -118.35 99.89 7.13 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.63 1.172 . . . . 0.0 108.415 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.528 HG13 HD21 ' A' ' 33' ' ' LEU . 7.3 p -112.87 136.66 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-O 121.158 0.504 . . . . 0.0 111.425 -170.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -85.24 99.2 10.95 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.005 173.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.489 ' CE2' ' HA ' ' A' ' 27' ' ' TYR . 34.1 p90 -59.95 -35.4 74.86 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.615 -177.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -63.1 -45.04 93.91 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 122.791 0.436 . . . . 0.0 111.032 -173.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.5 t -78.48 -24.8 45.73 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.111 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.433 ' HD2' HD12 ' A' ' 33' ' ' LEU . 26.3 t80 -79.89 -74.14 0.32 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.349 0.259 . . . . 0.0 110.486 178.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.501 ' HA ' ' HB3' ' A' ' 73' ' ' LEU . 87.0 t -49.91 -24.22 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 C-N-CA 126.158 1.783 . . . . 0.0 113.083 178.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.461 ' O ' ' HG ' ' A' ' 75' ' ' LEU . . . -64.44 -57.87 11.88 Favored Glycine 0 CA--C 1.539 1.557 0 CA-C-O 119.911 -0.383 . . . . 0.0 112.379 171.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -75.61 -21.1 58.07 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 123.363 0.665 . . . . 0.0 111.345 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.501 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 51.2 tp -68.71 -42.87 77.11 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.147 1.379 . . . . 0.0 110.16 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -85.84 -5.83 59.18 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.708 176.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 71' ' ' GLY . 54.2 mt -91.9 21.22 5.05 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.155 0.582 . . . . 0.0 111.593 174.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.451 ' HZ2' ' SD ' ' A' ' 52' ' ' MET . 30.8 m0 . . . . . 0 N--CA 1.48 1.028 0 C-N-CA 122.481 0.312 . . . . 0.0 110.264 171.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt . . . . . 0 N--CA 1.48 1.034 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.03 -42.37 63.24 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 122.959 0.504 . . . . 0.0 109.899 169.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -55.72 -39.42 71.05 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.33 1.052 . . . . 0.0 112.973 -175.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.1 p -66.03 -41.55 89.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 178.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 64.3 mt -68.91 -29.96 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.35 0.66 . . . . 0.0 110.245 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.445 ' HA ' ' HE2' ' A' ' 18' ' ' LYS . 42.5 mt-10 -76.38 -24.01 54.11 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.832 0.853 . . . . 0.0 111.397 177.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.0 -34.56 78.03 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.222 0.609 . . . . 0.0 110.718 175.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -64.47 -31.57 72.83 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.032 173.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.445 ' HE2' ' HA ' ' A' ' 15' ' ' GLU . 54.3 mtmt -81.06 -12.59 59.29 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.36 0.664 . . . . 0.0 111.906 -178.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.0 t -75.16 -35.18 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 169.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -74.55 -55.75 5.59 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.113 0.565 . . . . 0.0 109.797 175.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -85.54 89.09 7.62 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.872 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 32.2 ttm-85 -85.07 -23.95 28.31 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.953 172.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -64.65 -25.63 68.04 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.542 1.137 . . . . 0.0 111.841 -176.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.89 38.21 23.89 Favored Glycine 0 C--N 1.344 1.015 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 178.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -64.66 -25.24 67.87 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.555 1.142 . . . . 0.0 110.502 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.79 -35.99 4.3 Favored Glycine 0 C--N 1.347 1.162 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.478 ' HB2' ' O ' ' A' ' 64' ' ' VAL . 44.0 p90 -133.15 179.9 5.9 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 124.049 0.939 . . . . 0.0 109.647 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.0 p -134.1 173.88 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.213 0.605 . . . . 0.0 110.152 -172.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 44.5 p -73.39 145.99 45.46 Favored 'General case' 0 C--O 1.245 0.82 0 C-N-CA 123.404 0.682 . . . . 0.0 110.601 171.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.447 HG22 HG22 ' A' ' 53' ' ' ILE . 0.8 OUTLIER -70.47 -20.65 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 122.633 0.373 . . . . 0.0 110.594 -179.315 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -62.62 -53.85 48.38 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.631 0.772 . . . . 0.0 110.639 174.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 93.2 t80 -61.64 -39.64 92.04 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 122.94 0.496 . . . . 0.0 110.686 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.6 tp -53.86 -46.61 71.33 Favored 'General case' 0 CA--C 1.554 1.125 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.442 176.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.428 ' HG3' ' O ' ' A' ' 30' ' ' VAL . 69.4 mtt180 -62.3 -35.84 80.28 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.758 0.823 . . . . 0.0 111.942 -178.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 55.1 mttm -63.27 -60.97 2.7 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 123.679 0.612 . . . . 0.0 110.901 -176.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.4 p -62.25 -34.19 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 123.672 0.789 . . . . 0.0 112.351 -174.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.407 ' HB3' HG21 ' A' ' 49' ' ' ILE . 96.7 mt -77.39 -26.51 51.86 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.752 0.421 . . . . 0.0 111.359 -178.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -79.31 -30.91 43.06 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.795 0.438 . . . . 0.0 110.126 173.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -60.48 -44.98 95.37 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.853 0.861 . . . . 0.0 110.153 174.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.436 ' O ' ' HG2' ' A' ' 44' ' ' MET . 80.2 mt -84.14 3.06 36.61 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.487 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -73.47 -5.03 66.51 Favored Glycine 0 C--N 1.355 1.626 0 C-N-CA 123.635 0.636 . . . . 0.0 113.211 -176.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -72.79 -22.76 60.77 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 122.887 0.475 . . . . 0.0 110.485 170.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 69.3 mtm -114.29 1.0 14.33 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.37 1.068 . . . . 0.0 112.091 -173.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.436 ' HG2' ' O ' ' A' ' 40' ' ' LEU . 20.8 ptp -158.23 154.64 24.34 Favored Pre-proline 0 N--CA 1.488 1.47 0 C-N-CA 122.875 0.47 . . . . 0.0 110.584 -175.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.76 110.17 2.49 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 122.215 1.943 . . . . 0.0 112.377 -178.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.18 -24.32 35.04 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.823 -174.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -68.35 -39.19 81.96 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-O 121.317 0.58 . . . . 0.0 110.768 176.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -68.02 -46.8 70.2 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.096 176.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.407 HG21 ' HB3' ' A' ' 37' ' ' LEU . 81.6 mt -59.43 -44.68 93.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.429 0.692 . . . . 0.0 111.69 178.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -66.86 -32.46 73.75 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 118.169 0.441 . . . . 0.0 110.954 -175.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -63.85 -45.99 87.02 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 120.98 0.419 . . . . 0.0 110.116 172.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 22.9 mmt -60.94 -30.36 70.17 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.833 177.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.447 HG22 HG22 ' A' ' 30' ' ' VAL . 55.9 mt -67.8 -37.94 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.295 1.038 . . . . 0.0 111.491 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -62.84 -34.85 78.21 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 122.787 0.435 . . . . 0.0 110.623 173.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -76.33 -30.92 57.86 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.244 0.618 . . . . 0.0 110.603 177.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.65 -24.49 62.72 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.206 1.003 . . . . 0.0 111.745 -179.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -129.37 81.5 70.01 Favored Pre-proline 0 CA--C 1.547 0.852 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 171.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -79.3 -8.33 15.12 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 123.065 2.51 . . . . 0.0 112.451 -178.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -82.65 -21.72 34.91 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.65 0.78 . . . . 0.0 110.862 176.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.1 m120 59.12 32.92 22.55 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.472 1.109 . . . . 0.0 110.825 -175.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.7 m -97.21 -17.52 19.81 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.342 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.5 41.51 4.77 Favored Glycine 0 C--N 1.339 0.712 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.611 177.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -137.86 138.63 39.3 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.039 0.536 . . . . 0.0 111.143 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.478 ' O ' ' HB2' ' A' ' 27' ' ' TYR . 5.9 p -147.5 137.59 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.763 0.825 . . . . 0.0 110.363 -174.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -84.08 87.91 7.16 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 170.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.425 ' HH ' ' HG2' ' A' ' 18' ' ' LYS . 49.4 p90 -58.91 -35.19 72.66 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 114.613 -1.176 . . . . 0.0 113.373 -171.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -65.05 -39.51 93.42 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.772 0.429 . . . . 0.0 110.909 -169.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.448 ' O ' ' HG2' ' A' ' 72' ' ' MET . 11.2 t -83.28 -33.02 26.07 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.432 177.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -71.44 -56.38 6.06 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.407 0.623 . . . . 0.0 111.507 -177.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 99.6 t -65.67 -25.4 36.48 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.07 0 C-N-CA 124.393 1.077 . . . . 0.0 109.754 172.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -71.99 2.03 28.61 Favored Glycine 0 CA--C 1.543 1.828 0 CA-C-N 115.253 -0.885 . . . . 0.0 113.825 168.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.448 ' HG2' ' O ' ' A' ' 68' ' ' THR . 25.1 mmt -107.85 -45.39 4.01 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.775 0.83 . . . . 0.0 109.673 168.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 88.3 mt -58.24 -49.8 75.83 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.816 0.846 . . . . 0.0 112.142 -174.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -84.47 -11.91 55.29 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.161 -177.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -104.35 27.76 7.52 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.821 0.849 . . . . 0.0 110.701 178.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 32.6 m0 . . . . . 0 N--CA 1.488 1.427 0 C-N-CA 123.116 0.567 . . . . 0.0 110.99 171.186 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt . . . . . 0 N--CA 1.47 0.575 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.424 ' O ' ' HG2' ' A' ' 15' ' ' GLU . . . -63.04 -38.95 93.25 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 122.516 0.327 . . . . 0.0 110.186 172.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -71.03 -33.02 69.93 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.339 0.655 . . . . 0.0 112.369 -175.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.5 p -71.87 -36.64 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 176.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.433 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 75.1 mt -65.47 -33.42 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 174.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.424 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 23.5 mm-40 -62.01 -33.46 74.38 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.17 0.588 . . . . 0.0 111.491 174.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.25 -42.17 99.15 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 121.116 0.484 . . . . 0.0 110.195 174.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -69.37 -25.81 64.36 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.017 175.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' A' ' 14' ' ' ILE . 73.7 mmtt -73.4 -28.16 61.85 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.202 0.601 . . . . 0.0 111.18 177.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.413 HG22 ' O ' ' A' ' 15' ' ' GLU . 87.9 t -72.24 -40.94 66.2 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 C-N-CA 123.153 0.581 . . . . 0.0 110.167 176.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -73.12 -40.72 64.71 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.592 0.357 . . . . 0.0 110.375 176.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -97.25 45.64 1.04 Allowed 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.977 0.894 . . . . 0.0 108.846 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -63.09 -25.4 68.35 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.397 1.079 . . . . 0.0 110.965 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -72.19 -28.33 63.13 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.629 0.772 . . . . 0.0 111.088 177.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.08 58.56 2.94 Favored Glycine 0 C--N 1.344 0.987 0 CA-C-N 115.955 -0.566 . . . . 0.0 113.312 176.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -78.07 -17.32 57.15 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.33 0.652 . . . . 0.0 110.218 170.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.13 -18.57 56.92 Favored Glycine 0 C--N 1.354 1.53 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.961 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -150.55 166.11 31.23 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.272 1.029 . . . . 0.0 109.867 -174.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.4 m -116.36 177.94 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.609 0.764 . . . . 0.0 110.445 176.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 67.7 p -84.72 157.57 21.03 Favored 'General case' 0 C--O 1.246 0.876 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.516 170.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.9 p -67.09 -17.22 22.37 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 123.201 0.601 . . . . 0.0 111.547 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -63.63 -63.17 1.25 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.325 0.65 . . . . 0.0 111.04 177.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -60.6 -38.4 84.54 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.908 0.483 . . . . 0.0 110.504 178.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.498 HD22 HG11 ' A' ' 64' ' ' VAL . 6.3 tp -54.64 -58.75 6.27 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.82 -178.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 73.9 mtt180 -61.54 -33.41 73.79 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.045 0.538 . . . . 0.0 111.354 178.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -66.19 -46.33 77.69 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.755 0.822 . . . . 0.0 111.664 -174.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.4 p -76.65 -34.81 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 122.959 0.504 . . . . 0.0 110.86 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.478 HD22 HD13 ' A' ' 40' ' ' LEU . 84.6 mt -78.68 -5.88 54.26 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.03 0.532 . . . . 0.0 111.376 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 32.2 t-20 -72.26 -45.37 60.44 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.373 0.669 . . . . 0.0 109.77 178.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -71.38 -40.79 70.34 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.226 176.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.478 HD13 HD22 ' A' ' 37' ' ' LEU . 75.9 mt -67.57 -26.61 66.38 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.74 0.816 . . . . 0.0 110.549 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -89.62 63.17 3.31 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.062 171.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -81.72 -72.62 0.42 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.617 0.767 . . . . 0.0 109.701 178.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 20.6 ptp -85.85 -22.76 27.41 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.973 0.509 . . . . 0.0 110.367 175.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 25.3 mmt -81.8 112.41 34.49 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 172.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.06 130.64 37.39 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 122.113 1.875 . . . . 0.0 111.837 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.461 ' O ' ' HG2' ' A' ' 50' ' ' GLU . . . -63.05 -21.79 66.41 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.454 0.701 . . . . 0.0 110.527 174.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -52.67 -40.46 62.91 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.602 1.561 . . . . 0.0 111.887 173.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -65.12 -46.4 81.18 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.444 0.698 . . . . 0.0 110.114 175.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 66.8 mt -63.06 -32.07 54.9 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.416 -177.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 14.5 mm-40 -62.88 -44.15 96.89 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.99 0.516 . . . . 0.0 110.713 177.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -61.0 -42.66 98.88 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 121.414 0.626 . . . . 0.0 110.29 177.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.509 ' HB3' ' HE1' ' A' ' 69' ' ' PHE . 79.9 mmm -63.3 -34.21 77.18 Favored 'General case' 0 CA--C 1.558 1.273 0 CA-C-N 114.31 -1.314 . . . . 0.0 110.735 176.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 60.2 mt -69.35 -34.51 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 C-N-CA 124.469 1.108 . . . . 0.0 110.952 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 4.3 m-30 -64.62 -26.54 68.44 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.163 0.585 . . . . 0.0 110.251 176.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -93.45 -20.45 20.29 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.567 0.747 . . . . 0.0 111.117 178.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.472 ' HB2' HG23 ' A' ' 64' ' ' VAL . . . -77.27 -53.43 7.72 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.376 0.67 . . . . 0.0 110.229 177.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -116.14 95.75 45.58 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 124.801 1.241 . . . . 0.0 108.384 174.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -85.75 -1.61 8.9 Favored 'Trans proline' 0 C--N 1.368 1.553 0 C-N-CA 122.719 2.279 . . . . 0.0 112.028 170.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -92.06 -6.74 50.46 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.153 0.981 . . . . 0.0 112.042 -169.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 59.68 28.61 18.08 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.485 1.114 . . . . 0.0 110.847 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.3 m -105.28 -15.01 15.17 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.27 1.028 . . . . 0.0 110.571 -176.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.57 9.11 87.07 Favored Glycine 0 C--N 1.346 1.137 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.943 -175.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 22.2 m-30 -86.6 97.42 10.53 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.307 0.643 . . . . 0.0 109.519 -176.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.498 HG11 HD22 ' A' ' 33' ' ' LEU . 2.4 p -113.32 118.46 58.18 Favored 'Isoleucine or valine' 0 C--O 1.245 0.825 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.481 -175.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -73.58 86.59 1.61 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.225 175.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -53.62 -33.44 55.05 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -175.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -67.97 -36.47 80.11 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 120.755 0.312 . . . . 0.0 110.616 -170.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.0 p -82.32 -48.14 11.54 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.795 0.838 . . . . 0.0 110.19 174.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.509 ' HE1' ' HB3' ' A' ' 52' ' ' MET . 46.8 t80 -66.14 -54.05 30.17 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.246 1.018 . . . . 0.0 113.37 -170.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 56.3 t -68.31 -21.08 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 122.85 0.46 . . . . 0.0 109.831 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -62.18 -44.94 97.02 Favored Glycine 0 CA--C 1.538 1.473 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.147 164.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 65.0 mtt -66.09 -29.08 69.34 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 124.224 1.01 . . . . 0.0 112.041 178.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.4 mt -74.08 -43.03 59.2 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 121.374 0.606 . . . . 0.0 110.57 175.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -95.78 34.98 1.43 Allowed 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.647 -173.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.8 pp -125.6 10.09 7.8 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 122.701 0.4 . . . . 0.0 111.296 168.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 54.4 m0 . . . . . 0 N--CA 1.485 1.323 0 C-N-CA 123.252 0.621 . . . . 0.0 111.899 -176.4 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.517 ' HD2' ' H ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.361 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.471 ' O ' ' HG2' ' A' ' 15' ' ' GLU . . . -52.98 -42.08 65.2 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.456 0.702 . . . . 0.0 111.656 -178.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -61.06 -46.86 88.98 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.736 0.815 . . . . 0.0 112.199 -176.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.3 p -74.8 -31.39 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 122.722 0.409 . . . . 0.0 110.562 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.495 HG21 ' HE1' ' A' ' 66' ' ' TYR . 61.6 mt -65.11 -34.24 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.737 0.815 . . . . 0.0 110.811 178.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 19.1 mm-40 -69.37 -32.99 72.39 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.637 174.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.38 -37.25 82.7 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 122.938 0.495 . . . . 0.0 111.072 177.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -62.56 -41.23 98.78 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.972 173.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.47 ' HE3' HG22 ' A' ' 14' ' ' ILE . 92.9 mttt -71.46 -27.61 63.38 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.025 0.53 . . . . 0.0 111.508 -178.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.429 HG21 ' O ' ' A' ' 15' ' ' GLU . 92.3 t -69.97 -33.44 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.494 0.718 . . . . 0.0 109.963 174.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -74.61 -43.74 54.07 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.443 174.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -72.27 104.94 3.85 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -176.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -94.79 -15.36 23.86 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.52 0.728 . . . . 0.0 112.234 -178.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.404 ' HB2' ' ND2' ' A' ' 25' ' ' ASN . 20.8 m-20 -92.43 -26.35 18.05 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 120.87 0.367 . . . . 0.0 111.069 -176.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.66 42.78 12.95 Favored Glycine 0 C--N 1.338 0.649 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.865 -171.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.404 ' ND2' ' HB2' ' A' ' 23' ' ' ASP . 48.5 m-80 -65.94 -23.86 66.69 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.613 0.765 . . . . 0.0 111.11 178.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.05 -32.82 6.47 Favored Glycine 0 C--N 1.347 1.17 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 -178.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.431 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 45.2 p90 -133.62 160.69 36.75 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.406 1.082 . . . . 0.0 109.636 175.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 55.0 t -110.5 161.14 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.178 0.991 . . . . 0.0 110.41 -174.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 73.1 p -56.15 151.6 12.08 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 124.191 0.996 . . . . 0.0 111.982 172.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.8 p -67.21 -20.71 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.409 174.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -58.97 -62.19 2.07 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.74 1.216 . . . . 0.0 111.635 176.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -65.37 -30.11 70.9 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.973 0.509 . . . . 0.0 111.012 -178.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.633 HD23 HG11 ' A' ' 64' ' ' VAL . 6.5 tp -54.75 -50.92 67.24 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 123.717 0.635 . . . . 0.0 109.977 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.499 ' HG2' HD11 ' A' ' 53' ' ' ILE . 37.1 mtm180 -61.67 -37.96 86.02 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.862 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -65.7 -53.04 46.38 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.415 0.686 . . . . 0.0 112.179 -175.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.06 -26.88 35.47 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.957 -176.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 87.3 mt -86.81 -16.07 37.31 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.322 0.649 . . . . 0.0 111.779 178.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -74.79 -43.01 57.03 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.188 0.595 . . . . 0.0 110.124 175.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -72.75 -32.63 65.8 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 122.94 0.496 . . . . 0.0 110.794 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.418 HD12 ' HZ ' ' A' ' 74' ' ' PHE . 95.6 mt -78.46 -21.36 49.2 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.257 0.623 . . . . 0.0 110.514 174.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.717 ' HA2' ' HB2' ' A' ' 44' ' ' MET . . . -83.34 46.71 3.69 Favored Glycine 0 C--N 1.349 1.263 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 169.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -79.56 -55.16 5.23 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.886 0.874 . . . . 0.0 109.123 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 64.1 mtt -105.33 11.7 32.52 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.734 174.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.717 ' HB2' ' HA2' ' A' ' 41' ' ' GLY . 55.9 mtt -113.15 150.98 43.84 Favored Pre-proline 0 N--CA 1.48 1.068 0 C-N-CA 124.464 1.106 . . . . 0.0 108.579 176.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -68.7 115.39 3.91 Favored 'Trans proline' 0 C--N 1.374 1.886 0 C-N-CA 122.438 2.092 . . . . 0.0 110.926 172.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.44 -37.66 77.46 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.577 0.751 . . . . 0.0 110.824 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -63.46 -32.85 74.41 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.853 0.861 . . . . 0.0 111.644 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.472 ' O ' ' HG3' ' A' ' 52' ' ' MET . 40.3 tt0 -60.24 -39.4 86.56 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.625 1.17 . . . . 0.0 110.375 176.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 63.6 mt -77.89 -41.04 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.273 177.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -54.76 -46.0 74.27 Favored 'General case' 0 C--N 1.354 0.802 0 O-C-N 124.074 0.859 . . . . 0.0 111.091 -177.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -60.99 -37.37 82.24 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-O 120.66 0.267 . . . . 0.0 111.145 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.472 ' HG3' ' O ' ' A' ' 48' ' ' GLU . 43.0 mtm -72.73 -29.76 63.62 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.254 0.622 . . . . 0.0 110.653 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.499 HD11 ' HG2' ' A' ' 34' ' ' ARG . 77.1 mt -71.74 -33.87 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 124.136 0.975 . . . . 0.0 110.006 175.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -77.71 -10.6 59.61 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.02 0.928 . . . . 0.0 110.61 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -94.17 -27.61 16.11 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.316 1.047 . . . . 0.0 110.376 168.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.49 -30.74 59.97 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.55 0.74 . . . . 0.0 111.547 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -148.64 81.25 7.9 Favored Pre-proline 0 N--CA 1.478 0.961 0 C-N-CA 123.091 0.556 . . . . 0.0 109.836 172.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -83.32 -11.71 9.49 Favored 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.928 2.419 . . . . 0.0 113.132 172.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 20.7 tm0? -78.22 -23.35 47.5 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.671 0.789 . . . . 0.0 110.27 -174.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.3 t30 67.19 53.06 0.8 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.984 1.314 . . . . 0.0 108.926 -172.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.5 m -79.77 -24.36 41.56 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.742 173.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.91 23.9 63.06 Favored Glycine 0 C--N 1.346 1.113 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.995 -174.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -144.44 159.84 42.07 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.768 0.827 . . . . 0.0 111.438 -174.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.633 HG11 HD23 ' A' ' 33' ' ' LEU . 5.4 p -167.58 143.93 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.379 1.072 . . . . 0.0 109.406 175.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.404 ' HA ' ' HB2' ' A' ' 27' ' ' TYR . 74.7 mt-30 -82.2 104.99 12.93 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 172.146 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.495 ' HE1' HG21 ' A' ' 14' ' ' ILE . 53.2 p90 -64.48 -32.27 73.83 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.999 0.52 . . . . 0.0 111.013 178.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -55.06 -42.03 72.23 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.818 0.847 . . . . 0.0 110.87 174.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 19.1 m -76.83 -53.46 7.88 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.576 179.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -69.39 -54.33 14.95 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.109 -169.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.579 ' HA ' ' HB3' ' A' ' 73' ' ' LEU . 57.8 t -62.72 -19.09 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.372 0 C-N-CA 123.288 0.635 . . . . 0.0 111.283 177.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -71.29 -35.26 63.77 Favored Glycine 0 C--N 1.351 1.388 0 CA-C-N 116.435 -0.348 . . . . 0.0 113.39 172.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 28.3 ptm -98.24 -3.99 36.24 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.543 0.737 . . . . 0.0 111.527 177.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.579 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 9.8 tp -97.61 -53.02 3.56 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.448 1.099 . . . . 0.0 110.576 -178.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.461 ' HB3' ' HE3' ' A' ' 10' ' ' LYS . 3.4 m-85 -83.81 27.87 0.61 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.688 0.795 . . . . 0.0 112.893 -174.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.7 pp -77.86 -0.09 25.99 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.956 0.503 . . . . 0.0 111.127 169.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 49.5 m0 . . . . . 0 CA--C 1.545 0.763 0 C-N-CA 124.874 1.269 . . . . 0.0 110.816 177.983 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? . . . . . 0 N--CA 1.476 0.845 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.466 ' O ' ' HG2' ' A' ' 15' ' ' GLU . . . -75.82 -39.79 56.11 Favored 'General case' 0 C--O 1.216 -0.705 0 C-N-CA 123.117 0.567 . . . . 0.0 110.738 171.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -58.5 -38.58 77.95 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 123.272 0.629 . . . . 0.0 112.588 -174.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.3 p -65.9 -40.14 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 175.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.449 HG21 ' HE3' ' A' ' 18' ' ' LYS . 64.3 mt -64.77 -31.82 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 123.393 0.677 . . . . 0.0 110.423 176.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 10.4 mm-40 -71.4 -27.73 63.52 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.082 0.553 . . . . 0.0 110.983 178.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.9 -35.63 81.76 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 122.919 0.488 . . . . 0.0 110.996 177.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.491 ' CZ ' HD13 ' A' ' 33' ' ' LEU . 95.7 m-85 -64.03 -35.65 81.43 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.482 0.713 . . . . 0.0 110.951 174.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.449 ' HE3' HG21 ' A' ' 14' ' ' ILE . 90.9 mttt -77.19 -29.67 54.45 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.0 -177.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 74.1 t -69.33 -37.76 76.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 123.452 0.701 . . . . 0.0 109.769 172.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -71.48 -46.95 58.48 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.718 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -83.76 81.05 8.93 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.878 0.847 . . . . 0.0 109.014 -177.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 29.6 mtm180 -86.04 -18.42 32.52 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 113.947 -1.478 . . . . 0.0 110.076 177.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -80.01 -25.86 40.06 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.766 0.826 . . . . 0.0 111.568 -175.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.27 52.53 3.97 Favored Glycine 0 C--N 1.341 0.837 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.637 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.43 ' N ' HD21 ' A' ' 25' ' ' ASN . 0.8 OUTLIER -80.76 -19.17 45.48 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.24 1.016 . . . . 0.0 109.827 173.475 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.82 -56.17 3.74 Favored Glycine 0 C--N 1.347 1.175 0 N-CA-C 111.164 -0.775 . . . . 0.0 111.164 -175.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -118.97 156.91 28.75 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.326 1.05 . . . . 0.0 110.194 178.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.5 t -110.56 157.25 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 123.636 0.775 . . . . 0.0 109.503 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 68.7 p -65.28 166.5 9.83 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.107 0.963 . . . . 0.0 112.345 178.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.609 HG21 HG22 ' A' ' 53' ' ' ILE . 7.2 p -63.42 -33.48 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.332 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -64.09 -49.19 73.24 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.311 0.244 . . . . 0.0 111.627 -172.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -67.59 -36.88 81.72 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.488 176.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.514 HD23 HG13 ' A' ' 64' ' ' VAL . 12.1 tp -56.1 -43.88 78.51 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.665 0.603 . . . . 0.0 110.687 177.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' A' ' 30' ' ' VAL . 34.8 mtm105 -72.26 -34.67 68.41 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.097 0.559 . . . . 0.0 110.411 177.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -63.05 -50.7 69.6 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.651 0.78 . . . . 0.0 111.899 -174.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.3 p -64.82 -33.48 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 122.889 0.475 . . . . 0.0 110.83 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 80.5 mt -85.51 -8.51 58.29 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 123.766 0.827 . . . . 0.0 111.367 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -87.09 -36.2 18.27 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.1 1.36 . . . . 0.0 108.934 171.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -69.21 -35.17 75.92 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.848 0.859 . . . . 0.0 109.635 173.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 93.2 mt -89.23 15.52 8.8 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.762 0.825 . . . . 0.0 110.491 169.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 44' ' ' MET . . . -74.92 -10.05 83.69 Favored Glycine 0 C--N 1.353 1.515 0 C-N-CA 123.851 0.739 . . . . 0.0 113.626 -173.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -68.13 -32.77 73.28 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.324 0.649 . . . . 0.0 110.342 174.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 93.6 mmm -107.46 -31.1 8.29 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.62 0.768 . . . . 0.0 111.699 178.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.601 ' HB3' HD13 ' A' ' 49' ' ' ILE . 24.9 mmt -113.21 104.92 55.72 Favored Pre-proline 0 N--CA 1.479 1.002 0 C-N-CA 123.539 0.735 . . . . 0.0 109.778 -173.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.42 117.93 4.73 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.69 2.26 . . . . 0.0 111.866 -178.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.92 -47.71 85.16 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.766 0.826 . . . . 0.0 111.572 -176.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -53.93 -40.66 66.93 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 123.798 0.839 . . . . 0.0 111.723 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -62.47 -52.17 64.58 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.216 178.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.601 HD13 ' HB3' ' A' ' 44' ' ' MET . 79.1 mt -62.75 -40.32 88.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.859 -178.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.501 ' HA ' HD12 ' A' ' 53' ' ' ILE . 51.2 mt-10 -63.17 -34.05 76.79 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.139 0.576 . . . . 0.0 111.06 -175.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -67.78 -36.3 80.22 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 121.146 0.498 . . . . 0.0 110.379 175.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 20.0 mmt -67.14 -29.7 69.49 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.587 0.755 . . . . 0.0 110.807 177.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.609 HG22 HG21 ' A' ' 30' ' ' VAL . 50.2 mt -71.39 -31.1 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 123.118 0.567 . . . . 0.0 110.754 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -64.35 -28.95 70.05 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 122.898 0.479 . . . . 0.0 110.711 175.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -78.91 -37.51 39.75 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.032 0.533 . . . . 0.0 110.466 174.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.02 -25.6 61.02 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.9 0.88 . . . . 0.0 112.183 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -140.47 81.8 17.06 Favored Pre-proline 0 CA--C 1.548 0.889 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 175.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -65.58 -14.44 44.83 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 123.462 2.775 . . . . 0.0 112.788 175.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -69.2 -26.05 64.64 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.408 0.683 . . . . 0.0 110.911 176.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.1 t30 59.15 24.1 12.43 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.482 1.113 . . . . 0.0 110.824 -178.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.8 m -83.6 -16.46 45.17 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.791 0.836 . . . . 0.0 110.682 -178.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.86 29.84 22.34 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-N 115.589 -0.732 . . . . 0.0 113.28 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -126.82 107.75 10.4 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.872 0.869 . . . . 0.0 109.135 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.514 HG13 HD23 ' A' ' 33' ' ' LEU . 3.3 p -136.01 135.8 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 123.162 0.585 . . . . 0.0 110.89 -173.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -76.13 98.38 4.36 Favored 'General case' 0 C--N 1.35 0.609 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 174.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -55.08 -34.43 63.62 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.238 1.015 . . . . 0.0 112.809 -178.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -58.05 -57.01 14.7 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.522 0.729 . . . . 0.0 110.162 -176.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.2 p -68.76 -39.87 80.03 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.389 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -67.4 -67.27 0.47 Allowed 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 119.21 -0.424 . . . . 0.0 111.974 -177.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.571 ' HA ' ' HB3' ' A' ' 73' ' ' LEU . 57.6 t -52.4 -26.06 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 C-N-CA 124.808 1.243 . . . . 0.0 112.232 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.96 -54.58 29.72 Favored Glycine 0 CA--C 1.541 1.67 0 N-CA-C 112.469 -0.252 . . . . 0.0 112.469 168.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 64.0 mtm -73.59 -12.1 60.64 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.705 0.802 . . . . 0.0 112.236 178.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.571 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 52.3 tp -86.49 -41.57 14.27 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.375 1.07 . . . . 0.0 110.094 -178.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.403 ' HA ' ' CD1' ' A' ' 76' ' ' TRP . 8.2 m-85 -89.74 34.26 0.84 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.379 0.672 . . . . 0.0 111.699 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 92.2 mt -77.42 -15.33 59.4 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.849 0.46 . . . . 0.0 110.877 170.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.403 ' CD1' ' HA ' ' A' ' 74' ' ' PHE . 0.3 OUTLIER . . . . . 0 CA--C 1.556 1.197 0 C-N-CA 124.286 1.035 . . . . 0.0 112.176 174.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.426 ' O ' HG12 ' A' ' 14' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.497 ' O ' ' HG2' ' A' ' 15' ' ' GLU . . . -54.95 -48.94 72.54 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.406 0.683 . . . . 0.0 110.381 175.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -63.25 -38.45 91.2 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.982 0.913 . . . . 0.0 112.753 -171.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.5 p -69.01 -41.0 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 177.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.469 HG21 ' HE3' ' A' ' 18' ' ' LYS . 48.1 mm -63.35 -37.84 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 123.37 0.668 . . . . 0.0 110.958 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.497 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 20.3 mm-40 -73.07 -28.53 62.36 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.014 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.76 -35.3 80.14 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.288 0.635 . . . . 0.0 110.985 177.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -61.94 -41.88 98.47 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.025 173.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.469 ' HE3' HG21 ' A' ' 14' ' ' ILE . 96.5 mttt -68.03 -27.55 66.64 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.444 0.698 . . . . 0.0 112.072 -173.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.2 t -71.26 -39.85 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.129 0.572 . . . . 0.0 109.851 175.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -71.17 -40.35 71.34 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.756 177.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.402 ' HB2' HG23 ' A' ' 28' ' ' VAL . 27.7 t0 -85.28 70.79 10.88 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 122.12 0.962 . . . . 0.0 108.993 -179.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -67.45 -29.35 68.78 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 113.834 -1.53 . . . . 0.0 109.681 176.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -69.84 -25.99 64.0 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.673 -178.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.16 41.45 47.03 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.55 173.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -68.56 -20.36 64.53 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.502 0.721 . . . . 0.0 111.312 176.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.37 -26.17 25.51 Favored Glycine 0 C--N 1.348 1.24 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.686 -177.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -136.04 166.89 22.32 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.161 0.984 . . . . 0.0 109.557 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.402 HG23 ' HB2' ' A' ' 21' ' ' ASP . 81.3 t -118.79 153.45 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.046 0.938 . . . . 0.0 109.233 176.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.8 p -60.93 155.95 18.68 Favored 'General case' 0 C--O 1.248 0.983 0 C-N-CA 123.551 0.74 . . . . 0.0 111.247 173.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.409 ' O ' ' HG3' ' A' ' 34' ' ' ARG . 9.7 p -62.82 -24.09 34.77 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-N 116.167 -0.47 . . . . 0.0 112.196 -175.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -60.33 -60.1 4.35 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.195 0.598 . . . . 0.0 111.851 -176.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -63.74 -32.67 74.23 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.069 0.548 . . . . 0.0 110.479 178.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.439 HD13 HG12 ' A' ' 64' ' ' VAL . 4.4 tt -61.37 -44.48 97.1 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.879 0.872 . . . . 0.0 111.551 179.161 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' A' ' 30' ' ' VAL . 50.7 mtm180 -68.21 -38.99 82.51 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.941 0.496 . . . . 0.0 109.915 177.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -61.55 -47.14 86.91 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 124.165 0.916 . . . . 0.0 111.35 -177.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.4 p -73.43 -25.5 21.22 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.699 -176.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.623 HD13 HG23 ' A' ' 70' ' ' VAL . 96.6 mt -86.9 -15.19 39.74 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.821 0.448 . . . . 0.0 111.311 175.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -88.36 -30.95 19.15 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 176.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -78.15 -24.34 47.36 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 110.513 -0.18 . . . . 0.0 110.513 176.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 60.3 mt -95.81 12.22 30.85 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.595 0.758 . . . . 0.0 109.791 169.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.476 ' HA2' ' SD ' ' A' ' 44' ' ' MET . . . -144.84 55.83 0.55 Allowed Glycine 0 C--N 1.349 1.26 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 -175.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -68.69 -64.88 0.78 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.495 0.718 . . . . 0.0 110.359 -177.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.87 -4.34 43.81 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.75 177.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.476 ' SD ' ' HA2' ' A' ' 41' ' ' GLY . 1.2 mpt? -74.74 133.55 76.39 Favored Pre-proline 0 CA--C 1.546 0.801 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 172.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -65.54 114.99 3.12 Favored 'Trans proline' 0 C--N 1.37 1.69 0 C-N-CA 122.023 1.815 . . . . 0.0 110.438 173.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.85 -13.24 59.54 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.015 0.526 . . . . 0.0 111.343 177.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.417 ' O ' ' HG2' ' A' ' 51' ' ' GLU . 1.7 m-20 -53.59 -45.78 70.12 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.561 1.144 . . . . 0.0 111.925 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -59.88 -40.95 90.42 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.133 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 84.2 mt -67.89 -35.7 73.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 124.023 0.929 . . . . 0.0 110.274 178.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -66.09 -40.35 90.73 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.594 0.758 . . . . 0.0 110.769 177.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' A' ' 47' ' ' ASP . 16.3 mm-40 -65.55 -33.48 76.01 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.249 0.62 . . . . 0.0 110.966 177.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 21.3 mmt -68.4 -37.45 80.37 Favored 'General case' 0 CA--C 1.55 0.96 0 O-C-N 123.939 0.774 . . . . 0.0 110.117 174.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 70.4 mt -62.05 -38.39 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 124.243 1.017 . . . . 0.0 111.676 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -57.71 -32.0 66.97 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.086 0.554 . . . . 0.0 111.649 178.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -87.8 -38.71 15.49 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.799 0.84 . . . . 0.0 110.591 178.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.66 -20.98 60.41 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.08 0.952 . . . . 0.0 111.917 -175.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -138.95 83.67 18.17 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 174.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -77.76 -13.84 15.95 Favored 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 122.958 2.438 . . . . 0.0 112.276 -177.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.411 ' HG3' ' H ' ' A' ' 61' ' ' SER . 27.3 pt20 -79.16 -16.16 57.04 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.491 1.116 . . . . 0.0 112.081 -178.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.3 t30 63.29 18.6 11.12 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 124.708 1.203 . . . . 0.0 111.254 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.411 ' H ' ' HG3' ' A' ' 59' ' ' GLN . 19.4 m -92.67 -25.92 18.04 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.51 0.724 . . . . 0.0 110.152 -175.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.25 41.84 6.07 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 115.763 -0.653 . . . . 0.0 113.325 175.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -124.36 94.58 4.25 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.258 1.023 . . . . 0.0 108.601 175.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.439 HG12 HD13 ' A' ' 33' ' ' LEU . 3.9 p -126.9 134.27 66.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 124.01 0.924 . . . . 0.0 110.257 -170.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -76.79 108.06 9.55 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.891 0.877 . . . . 0.0 109.82 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -65.77 -38.01 87.87 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -170.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -71.02 -32.87 69.75 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 118.3 0.5 . . . . 0.0 110.126 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 31.3 m -72.19 -30.56 65.07 Favored 'General case' 0 CA--C 1.553 1.079 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.882 174.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.409 ' CE2' HD21 ' A' ' 33' ' ' LEU . 45.8 t80 -93.22 -72.1 0.62 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.083 0.553 . . . . 0.0 111.726 -176.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.623 HG23 HD13 ' A' ' 37' ' ' LEU . 57.6 t -59.49 -36.21 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.819 1.248 . . . . 0.0 111.346 -177.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -59.47 -37.42 92.07 Favored Glycine 0 C--N 1.348 1.219 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.934 174.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 94.2 mmm -81.59 -37.02 28.3 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.432 0.693 . . . . 0.0 112.26 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 pp -75.65 -24.66 56.41 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 118.303 0.501 . . . . 0.0 110.286 -175.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.411 ' CD2' ' HB3' ' A' ' 10' ' ' LYS . 6.1 m-85 -74.76 -8.05 55.23 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.573 0.349 . . . . 0.0 111.547 172.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 60.5 mt -89.05 9.25 25.98 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.995 0.518 . . . . 0.0 111.963 175.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 43.7 m0 . . . . . 0 N--CA 1.484 1.266 0 CA-C-O 121.227 0.537 . . . . 0.0 109.986 174.594 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? . . . . . 0 N--CA 1.476 0.85 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.03 -42.18 73.27 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 122.643 0.377 . . . . 0.0 110.36 170.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -64.54 -39.22 93.37 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.396 0.678 . . . . 0.0 112.146 -177.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.9 p -69.68 -35.51 66.12 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 CA-C-O 119.348 -0.358 . . . . 0.0 110.307 178.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 77.0 mt -61.92 -41.69 91.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 C-N-CA 122.824 0.45 . . . . 0.0 110.11 172.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.438 ' O ' HG22 ' A' ' 19' ' ' VAL . 33.7 mm-40 -63.19 -29.5 70.83 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.281 0.632 . . . . 0.0 111.21 176.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.92 -32.56 73.89 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.93 0.492 . . . . 0.0 111.616 178.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -70.25 -40.42 74.43 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 171.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -74.23 -9.13 58.3 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.227 -177.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 15' ' ' GLU . 93.3 t -68.73 -44.62 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 167.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -69.51 -55.15 11.02 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.157 179.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -75.15 95.84 3.17 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.557 178.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -88.27 -38.77 14.95 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.327 -176.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -76.55 -22.36 54.45 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.833 0.853 . . . . 0.0 112.393 -173.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.3 53.6 3.6 Favored Glycine 0 C--N 1.343 0.969 0 N-CA-C 111.491 -0.644 . . . . 0.0 111.491 -176.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -68.71 -30.1 68.67 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.624 1.17 . . . . 0.0 109.334 173.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.05 -59.74 0.46 Allowed Glycine 0 C--N 1.342 0.868 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.084 175.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.401 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 43.9 p90 -115.29 -171.66 2.0 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.628 0.771 . . . . 0.0 110.834 -171.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.0 p -139.65 178.2 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.221 0 C-N-CA 123.343 0.657 . . . . 0.0 110.484 -173.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 68.5 p -88.13 154.11 20.72 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.008 0.923 . . . . 0.0 110.358 175.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.6 p -67.59 -29.77 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-N 117.861 0.3 . . . . 0.0 110.856 178.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -62.5 -46.55 87.92 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.513 178.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -72.24 -32.79 67.02 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.614 179.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.9 tt -67.79 -39.12 84.07 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.947 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 37.4 mtp-105 -72.83 -30.59 64.16 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 122.42 0.288 . . . . 0.0 110.321 174.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -63.62 -49.33 73.72 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.593 1.157 . . . . 0.0 111.075 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.463 HG11 ' HG ' ' A' ' 37' ' ' LEU . 7.0 p -69.34 -40.17 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.137 0.575 . . . . 0.0 111.627 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.463 ' HG ' HG11 ' A' ' 36' ' ' VAL . 79.7 mt -82.1 -4.8 57.65 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.48 0.712 . . . . 0.0 111.862 -176.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -67.84 -29.12 68.19 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.489 0.716 . . . . 0.0 111.412 175.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -59.35 -40.04 85.14 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.292 0.637 . . . . 0.0 111.792 -177.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.2 pp -92.48 7.58 42.46 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.508 0.723 . . . . 0.0 110.919 -178.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -72.98 -19.33 79.53 Favored Glycine 0 C--N 1.352 1.447 0 O-C-N 123.48 0.487 . . . . 0.0 112.496 -178.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -75.28 -27.24 59.31 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.329 0.652 . . . . 0.0 111.215 177.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 82.3 mtp -100.02 -44.65 5.94 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.723 0.809 . . . . 0.0 110.769 -175.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 23.0 mmt -120.03 145.69 40.45 Favored Pre-proline 0 N--CA 1.482 1.171 0 C-N-CA 124.839 1.256 . . . . 0.0 109.649 -177.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -58.41 119.53 6.85 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.729 2.286 . . . . 0.0 112.761 179.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.01 -30.33 63.69 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.302 174.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -55.13 -40.89 71.06 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 124.026 0.93 . . . . 0.0 111.225 174.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -51.96 -53.81 36.93 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.382 1.073 . . . . 0.0 110.695 174.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.503 HG12 HD13 ' A' ' 73' ' ' LEU . 74.0 mt -60.39 -41.93 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.96 179.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.53 ' HA ' HD13 ' A' ' 53' ' ' ILE . 42.7 mt-10 -66.01 -34.69 78.68 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.502 0.721 . . . . 0.0 112.12 -175.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -70.07 -39.49 75.6 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 120.951 0.405 . . . . 0.0 110.32 175.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 48.0 mmm -59.53 -34.25 72.39 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.948 0.899 . . . . 0.0 110.568 174.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.53 HD13 ' HA ' ' A' ' 50' ' ' GLU . 85.1 mt -62.56 -34.42 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.851 0.86 . . . . 0.0 112.149 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -60.95 -25.96 67.18 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -177.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -89.91 -28.54 19.13 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 122.776 0.43 . . . . 0.0 111.219 176.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.2 -34.43 68.37 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.374 0.669 . . . . 0.0 111.164 178.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -132.03 80.81 63.8 Favored Pre-proline 0 CA--C 1.548 0.878 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 175.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -82.29 -3.8 11.59 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.988 2.459 . . . . 0.0 112.684 -179.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -86.73 -14.88 41.14 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.354 1.061 . . . . 0.0 111.586 -179.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 61.26 30.7 19.31 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 124.611 1.164 . . . . 0.0 110.615 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.6 t -109.19 -3.74 17.04 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.799 0.84 . . . . 0.0 111.111 -172.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.99 19.83 74.32 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 114.852 0.701 . . . . 0.0 114.852 172.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -110.05 94.75 5.18 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 177.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.3 p -111.99 130.64 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.55 0.74 . . . . 0.0 110.551 -174.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.401 ' HA ' ' HB2' ' A' ' 27' ' ' TYR . 46.0 mt-30 -85.71 93.98 8.99 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 175.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -55.26 -29.84 58.91 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.592 0.757 . . . . 0.0 111.746 176.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -48.84 -55.87 10.38 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.083 1.753 . . . . 0.0 111.168 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.1 t -87.43 -30.58 20.6 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 114.466 -1.243 . . . . 0.0 110.51 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -67.07 -65.3 0.7 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.865 0.466 . . . . 0.0 111.7 -174.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.521 ' HA ' ' HB3' ' A' ' 73' ' ' LEU . 99.1 t -50.41 -29.45 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 124.837 1.255 . . . . 0.0 112.3 175.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.17 -50.63 65.59 Favored Glycine 0 CA--C 1.535 1.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.849 171.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 24.7 ptm -84.59 -15.48 45.48 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.349 0.66 . . . . 0.0 111.706 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.521 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 66.8 tp -77.25 -51.76 10.37 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.186 0.994 . . . . 0.0 109.9 -174.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -83.59 34.96 0.49 Allowed 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 123.593 0.757 . . . . 0.0 111.546 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 53.5 mt -96.29 23.13 6.94 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.751 0.82 . . . . 0.0 110.989 169.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 7.0 m0 . . . . . 0 CA--C 1.545 0.751 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 170.962 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.448 ' HE3' ' HA2' ' A' ' 71' ' ' GLY . 13.3 ptmm? . . . . . 0 N--CA 1.479 0.981 0 CA-C-O 119.862 -0.113 . . . . 0.0 111.234 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.466 ' O ' ' HG2' ' A' ' 15' ' ' GLU . . . -55.84 -34.68 65.65 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.073 0.949 . . . . 0.0 111.703 178.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -60.41 -52.99 62.88 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.525 0.73 . . . . 0.0 112.176 -177.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.4 p -65.85 -29.87 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 122.5 0.32 . . . . 0.0 110.458 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.434 ' HA ' ' HD2' ' A' ' 17' ' ' PHE . 94.1 mt -70.05 -34.41 59.4 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 123.404 0.682 . . . . 0.0 110.873 177.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 18.7 mm-40 -62.49 -28.36 69.78 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.372 0.669 . . . . 0.0 110.961 175.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.14 -44.95 86.95 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.175 0.59 . . . . 0.0 110.444 175.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.434 ' HD2' ' HA ' ' A' ' 14' ' ' ILE . 99.6 m-85 -68.44 -32.96 73.35 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.489 178.06 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -79.24 -29.0 42.46 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.191 0.596 . . . . 0.0 112.097 -177.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.7 p -82.08 -15.55 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 CA-C-O 121.031 0.443 . . . . 0.0 110.079 173.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -78.38 -50.71 11.23 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 172.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -96.33 88.01 4.63 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.572 0.749 . . . . 0.0 109.627 178.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -94.44 1.95 55.76 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.502 173.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -90.95 -25.47 19.74 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.493 0.717 . . . . 0.0 111.279 -175.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.21 38.66 12.54 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.078 -175.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -64.23 -26.4 68.49 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.453 1.101 . . . . 0.0 109.049 169.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.32 -32.98 6.71 Favored Glycine 0 C--N 1.352 1.438 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.487 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.453 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 51.6 p90 -144.96 -179.42 6.6 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.476 0.71 . . . . 0.0 111.003 -176.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.6 t -126.43 156.01 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.528 1.131 . . . . 0.0 110.042 -172.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.4 p -66.3 149.57 50.17 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.856 0.862 . . . . 0.0 111.162 173.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.9 p -68.49 -19.1 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 122.74 0.416 . . . . 0.0 112.068 -173.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -56.49 -51.81 67.09 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.522 0.729 . . . . 0.0 111.313 175.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -69.73 -32.56 71.19 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.075 -179.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.408 HD12 ' CZ ' ' A' ' 17' ' ' PHE . 9.0 tp -58.41 -55.39 35.69 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 123.923 0.764 . . . . 0.0 110.331 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.518 ' HG2' HD12 ' A' ' 53' ' ' ILE . 94.3 mtt180 -65.94 -27.19 67.99 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.605 -178.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -70.01 -52.7 22.03 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.787 0.835 . . . . 0.0 111.27 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.5 p -75.19 -29.9 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.409 -175.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 95.4 mt -80.65 -10.51 59.73 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.917 0.487 . . . . 0.0 111.259 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -74.83 -44.24 50.31 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 165.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -62.88 -35.53 80.32 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.217 -179.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -85.43 -42.27 14.66 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.296 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -91.94 67.72 2.07 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.762 -168.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -86.62 -57.88 2.82 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.686 0.794 . . . . 0.0 109.539 173.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -71.73 -34.75 69.81 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.739 0.816 . . . . 0.0 110.758 178.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 19.5 mmt -95.99 101.19 7.79 Favored Pre-proline 0 N--CA 1.472 0.65 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 172.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.405 ' HB2' ' HG3' ' A' ' 48' ' ' GLU . 83.1 Cg_exo -48.85 129.68 21.5 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 123.338 2.692 . . . . 0.0 113.248 -171.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.02 -28.25 67.58 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.81 0.844 . . . . 0.0 111.336 -178.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -65.96 -41.76 90.81 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.958 0.903 . . . . 0.0 111.206 175.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.405 ' HG3' ' HB2' ' A' ' 45' ' ' PRO . 38.7 mt-10 -72.27 -31.72 66.0 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 122.566 0.346 . . . . 0.0 110.645 178.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.401 ' O ' HG13 ' A' ' 53' ' ' ILE . 96.4 mt -64.67 -36.89 78.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 123.261 0.624 . . . . 0.0 110.088 169.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.545 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 51.1 mt-10 -69.56 -28.31 65.88 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.457 0.303 . . . . 0.0 111.66 176.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -58.12 -34.13 69.9 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.562 0.696 . . . . 0.0 110.538 170.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 11.4 mmt -81.03 -37.76 28.59 Favored 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.038 177.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.545 ' HB ' ' HA ' ' A' ' 50' ' ' GLU . 69.0 mt -65.41 -43.02 94.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 124.467 1.107 . . . . 0.0 111.503 -175.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -59.74 -19.22 48.79 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.881 0.472 . . . . 0.0 112.049 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -84.32 -37.11 22.03 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.434 0.694 . . . . 0.0 110.92 172.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.99 -46.41 90.88 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.104 0.961 . . . . 0.0 111.09 179.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -109.53 82.3 2.14 Favored Pre-proline 0 CA--C 1.552 1.046 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 168.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -68.84 -34.17 18.69 Favored 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 123.341 2.694 . . . . 0.0 112.496 -167.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -87.65 -1.68 58.11 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.916 0.886 . . . . 0.0 111.149 177.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 56.68 49.99 13.48 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 124.802 1.241 . . . . 0.0 109.562 -172.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.2 m -70.42 -13.64 62.22 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 114.502 -1.226 . . . . 0.0 112.782 -172.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.43 11.23 82.36 Favored Glycine 0 C--N 1.348 1.241 0 N-CA-C 112.003 -0.439 . . . . 0.0 112.003 -173.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -135.17 145.83 48.15 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.55 1.14 . . . . 0.0 108.822 -177.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.4 ' O ' ' HB2' ' A' ' 27' ' ' TYR . 7.5 p -147.79 129.58 6.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 CA-C-O 121.251 0.548 . . . . 0.0 110.541 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -75.03 93.73 2.77 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 166.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.453 ' CE2' ' HA ' ' A' ' 27' ' ' TYR . 42.9 p90 -57.85 -40.18 79.5 Favored 'General case' 0 C--O 1.211 -0.936 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.269 -173.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -69.89 -33.41 72.18 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 120.976 0.417 . . . . 0.0 110.852 -177.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 25.4 m -66.64 -38.82 87.7 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.763 173.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.403 ' HD2' HD13 ' A' ' 33' ' ' LEU . 39.3 t80 -80.71 -72.17 0.43 Allowed 'General case' 0 C--O 1.213 -0.864 0 C-N-CA 122.915 0.486 . . . . 0.0 111.979 -178.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.573 ' HA ' ' HB3' ' A' ' 73' ' ' LEU . 87.6 t -43.37 -31.96 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 126.116 1.767 . . . . 0.0 112.565 174.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.448 ' HA2' ' HE3' ' A' ' 10' ' ' LYS . . . -56.4 -49.02 71.53 Favored Glycine 0 C--N 1.348 1.233 0 O-C-N 123.453 0.471 . . . . 0.0 112.925 170.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 81.8 mtp -83.04 -23.43 33.2 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.475 1.11 . . . . 0.0 112.157 178.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.573 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 52.5 tp -74.93 -49.55 19.8 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.044 0.938 . . . . 0.0 110.447 -172.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -80.38 22.14 0.57 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.139 0.976 . . . . 0.0 112.441 -178.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 59.4 mt -91.0 14.04 15.02 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 123.484 0.714 . . . . 0.0 111.402 172.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 13.4 m0 . . . . . 0 C--N 1.355 0.827 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 172.012 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.482 ' HD2' ' H ' ' A' ' 10' ' ' LYS . 3.0 mptp? . . . . . 0 N--CA 1.479 0.986 0 CA-C-O 120.628 0.252 . . . . 0.0 110.781 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.36 -38.47 91.27 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.973 0.909 . . . . 0.0 111.605 173.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -55.41 -41.14 72.32 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 123.472 0.709 . . . . 0.0 112.003 -172.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.9 p -77.5 -40.76 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.745 -175.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 88.1 mt -61.49 -41.63 90.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 C-N-CA 123.946 0.898 . . . . 0.0 110.522 177.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.442 ' O ' HG22 ' A' ' 19' ' ' VAL . 42.8 mt-10 -71.12 -29.12 64.86 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.143 0.977 . . . . 0.0 110.587 179.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.21 -37.23 85.06 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.934 0.494 . . . . 0.0 110.71 175.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.403 ' HE1' ' HA ' ' A' ' 33' ' ' LEU . 79.1 m-85 -67.48 -31.94 72.42 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.135 0.574 . . . . 0.0 110.967 174.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -67.96 -40.16 83.27 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.709 0.403 . . . . 0.0 109.93 175.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.442 HG22 ' O ' ' A' ' 15' ' ' GLU . 69.7 t -60.23 -34.01 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 123.989 0.916 . . . . 0.0 110.704 176.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -76.81 -57.86 3.61 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.742 0.417 . . . . 0.0 110.763 179.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -76.0 91.89 3.11 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.183 0.516 . . . . 0.0 109.933 -178.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 31.6 mmm180 -91.05 -14.01 32.14 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.304 1.042 . . . . 0.0 110.2 178.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -91.76 -10.66 39.18 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.017 0.927 . . . . 0.0 111.032 -173.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.46 45.35 30.0 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-N 116.582 -0.281 . . . . 0.0 113.386 170.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.45 ' N ' HD21 ' A' ' 25' ' ' ASN . 0.8 OUTLIER -76.17 -25.67 55.45 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.671 0.788 . . . . 0.0 110.78 178.193 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.17 -4.12 80.69 Favored Glycine 0 C--N 1.352 1.429 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.02 -174.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.411 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 53.6 p90 -154.21 174.27 14.99 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.705 1.202 . . . . 0.0 109.285 -178.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.9 m -123.51 -174.99 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.413 0.685 . . . . 0.0 110.831 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.5 p -91.24 162.02 14.81 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 123.741 0.817 . . . . 0.0 110.482 174.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.604 HG21 HG21 ' A' ' 53' ' ' ILE . 7.7 p -61.92 -33.05 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.909 0.884 . . . . 0.0 112.109 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -67.0 -52.07 47.19 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 122.983 0.513 . . . . 0.0 112.119 -173.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -63.74 -38.43 91.08 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 120.529 0.204 . . . . 0.0 110.6 177.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.565 HD22 HG13 ' A' ' 64' ' ' VAL . 9.0 tp -52.92 -48.82 66.97 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 124.24 0.963 . . . . 0.0 110.316 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 28.4 mtm180 -66.28 -39.13 89.2 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.419 0.688 . . . . 0.0 111.516 178.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -59.75 -48.72 80.53 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.293 1.037 . . . . 0.0 111.224 -176.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.8 p -78.48 -32.55 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.883 -176.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 63.0 mt -80.19 -6.09 57.2 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 121.789 -0.569 . . . . 0.0 111.085 178.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -77.32 -45.16 27.09 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.428 0.691 . . . . 0.0 109.83 170.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -76.55 -29.37 56.65 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.944 -178.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -75.73 -36.6 59.87 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 122.72 0.408 . . . . 0.0 110.015 170.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.23 56.77 1.75 Allowed Glycine 0 C--N 1.347 1.147 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.1 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -72.53 -32.8 66.39 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.821 0.848 . . . . 0.0 111.51 -176.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 52.4 mtt -118.35 14.99 13.89 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.75 0.82 . . . . 0.0 110.471 175.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.426 ' SD ' ' N ' ' A' ' 44' ' ' MET . 1.4 mpt? -110.43 142.66 26.51 Favored Pre-proline 0 N--CA 1.475 0.818 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -67.55 113.29 2.88 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 121.932 1.755 . . . . 0.0 111.442 178.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.95 -26.49 68.23 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.523 0.729 . . . . 0.0 110.577 174.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -55.47 -46.27 76.86 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.61 1.164 . . . . 0.0 110.83 172.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -63.83 -52.01 62.08 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.286 -178.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.481 ' O ' HG13 ' A' ' 53' ' ' ILE . 91.7 mt -59.85 -43.66 92.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.483 -176.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.469 ' HA ' HD13 ' A' ' 53' ' ' ILE . 12.9 pt-20 -68.67 -31.61 70.85 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 123.188 0.305 . . . . 0.0 111.573 -175.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -72.02 -32.56 67.28 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.581 0.353 . . . . 0.0 110.91 176.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.427 ' HB3' ' HE1' ' A' ' 69' ' ' PHE . 76.4 mmm -67.79 -23.75 65.24 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.876 0.87 . . . . 0.0 111.182 175.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.604 HG21 HG21 ' A' ' 30' ' ' VAL . 72.5 mt -70.19 -30.79 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 123.396 0.679 . . . . 0.0 111.482 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -62.88 -25.27 68.22 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.223 0.535 . . . . 0.0 110.855 178.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -86.42 -36.22 19.25 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.475 1.11 . . . . 0.0 110.508 176.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.73 -29.81 69.14 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.145 0.978 . . . . 0.0 111.841 -178.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -118.13 87.42 29.04 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.231 1.013 . . . . 0.0 108.465 173.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.6 -32.89 69.03 Favored 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 123.088 2.525 . . . . 0.0 112.139 173.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -73.3 -6.29 45.07 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.168 0.987 . . . . 0.0 112.551 -172.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.0 p30 51.33 30.54 6.1 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 125.642 1.577 . . . . 0.0 112.064 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 71.8 p -87.93 -15.13 37.44 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.525 1.13 . . . . 0.0 112.187 -171.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.76 3.5 90.47 Favored Glycine 0 C--N 1.347 1.139 0 CA-C-N 116.322 -0.399 . . . . 0.0 112.478 -171.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -107.44 128.92 54.91 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 175.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.565 HG13 HD22 ' A' ' 33' ' ' LEU . 5.0 p -127.97 130.77 69.93 Favored 'Isoleucine or valine' 0 C--O 1.246 0.893 0 C-N-CA 123.113 0.565 . . . . 0.0 110.831 -172.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -73.86 91.57 1.98 Allowed 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 168.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.411 ' CE2' ' HA ' ' A' ' 27' ' ' TYR . 43.4 p90 -59.07 -30.94 68.44 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.046 176.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -61.98 -38.42 88.52 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.935 0.894 . . . . 0.0 110.567 -171.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 69.9 p -83.29 -44.03 15.37 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.464 177.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.51 ' HA ' ' HE2' ' A' ' 72' ' ' MET . 28.2 t80 -67.82 -60.88 2.17 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.701 0.8 . . . . 0.0 112.809 -172.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.7 t -65.07 -21.45 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.345 1.058 . . . . 0.0 111.151 -177.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.434 ' O ' ' HG ' ' A' ' 75' ' ' LEU . . . -58.63 -51.65 57.65 Favored Glycine 0 CA--C 1.534 1.254 0 N-CA-C 111.608 -0.597 . . . . 0.0 111.608 166.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.51 ' HE2' ' HA ' ' A' ' 69' ' ' PHE . 61.8 mtm -66.16 -32.83 74.51 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.982 0.913 . . . . 0.0 112.435 -179.071 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.4 mt -63.72 -35.31 80.14 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 121.219 0.533 . . . . 0.0 111.067 177.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -99.82 10.34 41.49 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.66 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 71' ' ' GLY . 81.8 mt -90.24 -13.18 35.94 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.164 0.586 . . . . 0.0 109.582 162.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 51.0 m0 . . . . . 0 N--CA 1.49 1.537 0 C-N-CA 123.532 0.733 . . . . 0.0 109.998 171.639 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.431 ' O ' HG11 ' A' ' 13' ' ' VAL . 10.2 ptpp? . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 111.55 0.204 . . . . 0.0 111.55 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.438 ' O ' ' HG2' ' A' ' 15' ' ' GLU . . . -57.17 -23.67 49.12 Favored 'General case' 0 C--O 1.209 -1.051 0 C-N-CA 123.177 0.591 . . . . 0.0 112.422 177.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -51.89 -45.64 64.25 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.402 0.681 . . . . 0.0 112.296 177.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.431 HG11 ' O ' ' A' ' 10' ' ' LYS . 12.4 p -80.3 -36.79 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 68.2 mt -64.8 -36.53 77.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 123.524 0.729 . . . . 0.0 111.13 -177.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.473 ' O ' HG21 ' A' ' 19' ' ' VAL . 37.4 mm-40 -73.25 -31.06 63.88 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.788 0.435 . . . . 0.0 110.526 178.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.91 -35.69 73.49 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.146 0.498 . . . . 0.0 110.599 175.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.43 ' CZ ' HG22 ' A' ' 70' ' ' VAL . 81.5 m-85 -65.49 -42.53 92.06 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.009 172.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.459 ' HZ3' ' HB3' ' A' ' 18' ' ' LYS . 8.3 mtpm? -73.45 -17.52 61.23 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.463 0.705 . . . . 0.0 111.823 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.473 HG21 ' O ' ' A' ' 15' ' ' GLU . 70.7 t -76.93 -30.07 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.956 0.902 . . . . 0.0 109.565 171.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -77.88 -58.52 3.22 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 174.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -82.73 82.91 7.87 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.613 0.765 . . . . 0.0 109.822 178.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -93.26 -14.29 27.21 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 114.086 -1.415 . . . . 0.0 109.535 173.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -70.75 -25.4 62.9 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.813 0.845 . . . . 0.0 110.726 176.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.07 43.09 8.97 Favored Glycine 0 C--N 1.347 1.163 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.777 173.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -72.1 -16.92 62.02 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.508 0.723 . . . . 0.0 110.412 172.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.58 -28.71 13.69 Favored Glycine 0 C--N 1.348 1.22 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.08 178.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.494 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 36.9 p90 -142.13 164.28 30.59 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 124.397 1.079 . . . . 0.0 109.916 -178.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 79.6 t -109.65 149.29 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.03 0.932 . . . . 0.0 109.915 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 75.9 p -66.05 157.4 31.09 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.574 0.75 . . . . 0.0 111.0 174.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.563 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 7.1 p -65.25 -16.83 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 122.846 0.458 . . . . 0.0 111.463 178.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -55.38 -57.07 13.35 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.038 0.935 . . . . 0.0 111.219 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -76.99 -34.42 57.52 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.605 177.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.563 ' HB3' ' HA ' ' A' ' 30' ' ' VAL . 3.0 tt -61.46 -39.66 91.68 Favored 'General case' 0 CA--C 1.549 0.916 0 O-C-N 123.67 0.606 . . . . 0.0 111.723 -174.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.549 ' HG3' HG21 ' A' ' 30' ' ' VAL . 63.8 mtt180 -67.89 -40.34 83.53 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-O 119.559 -0.257 . . . . 0.0 110.923 175.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -55.07 -58.0 9.45 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 123.93 0.769 . . . . 0.0 111.458 -178.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.7 p -66.17 -34.22 68.72 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 CA-C-N 115.223 -0.898 . . . . 0.0 111.705 -175.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.53 HD11 HG21 ' A' ' 70' ' ' VAL . 92.7 mt -85.44 -7.97 58.64 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.074 0.55 . . . . 0.0 111.865 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -87.24 -35.02 18.75 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 170.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -62.88 -37.38 86.69 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.689 170.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.0 tt -73.9 -44.34 55.54 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.216 177.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.499 ' HA2' ' HB2' ' A' ' 44' ' ' MET . . . -90.59 50.82 3.26 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.778 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -74.96 -49.68 19.23 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.508 0.723 . . . . 0.0 110.147 -177.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 15.0 ptp -108.0 -1.03 20.92 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.606 0.762 . . . . 0.0 110.415 174.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.499 ' HB2' ' HA2' ' A' ' 41' ' ' GLY . 1.4 mpt? -97.65 147.05 32.46 Favored Pre-proline 0 N--CA 1.478 0.95 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 177.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -63.53 109.24 0.98 Allowed 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 121.787 1.658 . . . . 0.0 111.275 173.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.18 -13.96 60.17 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.28 176.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -53.83 -46.58 71.22 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.236 1.014 . . . . 0.0 110.88 172.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.45 ' O ' ' HG2' ' A' ' 52' ' ' MET . 46.8 mt-10 -58.95 -52.3 66.33 Favored 'General case' 0 C--N 1.356 0.866 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.842 178.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.429 ' O ' HG13 ' A' ' 53' ' ' ILE . 81.4 mt -57.36 -45.35 85.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.069 0.947 . . . . 0.0 111.549 -176.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.45 ' HA ' HD12 ' A' ' 53' ' ' ILE . 66.3 mt-10 -71.27 -31.52 67.59 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.738 0.415 . . . . 0.0 111.331 -179.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -68.36 -32.63 72.86 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-O 121.43 0.634 . . . . 0.0 109.671 176.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.45 ' HG2' ' O ' ' A' ' 48' ' ' GLU . 80.4 mmm -70.98 -34.29 71.25 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.243 1.017 . . . . 0.0 110.285 174.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.45 HD12 ' HA ' ' A' ' 50' ' ' GLU . 85.2 mt -60.11 -40.96 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 123.359 0.664 . . . . 0.0 110.629 178.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -69.05 -15.06 63.37 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.408 0.683 . . . . 0.0 111.539 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -90.21 -37.14 14.34 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.217 0.607 . . . . 0.0 110.658 172.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.8 -18.15 58.59 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.543 0.737 . . . . 0.0 111.524 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -152.6 83.23 4.92 Favored Pre-proline 0 CA--C 1.55 0.976 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 172.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -75.01 -8.44 20.06 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.389 2.726 . . . . 0.0 112.63 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -75.47 -22.34 57.34 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.243 177.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 58.21 30.82 19.99 Favored 'General case' 0 C--N 1.36 1.037 0 C-N-CA 124.656 1.182 . . . . 0.0 110.237 -176.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.3 t -75.62 -19.56 59.14 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 114.511 -1.222 . . . . 0.0 110.676 -176.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.94 24.56 31.93 Favored Glycine 0 C--N 1.338 0.685 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.848 -178.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -130.01 105.09 7.73 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.718 0.807 . . . . 0.0 109.899 -176.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.458 HG12 HD13 ' A' ' 33' ' ' LEU . 2.1 p -135.37 123.05 37.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 124.007 0.923 . . . . 0.0 109.857 -174.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -70.42 109.16 4.61 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.702 0.801 . . . . 0.0 110.352 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.494 ' CE2' ' HA ' ' A' ' 27' ' ' TYR . 38.1 p90 -64.25 -28.5 69.78 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.939 0.895 . . . . 0.0 112.96 -175.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -66.1 -54.77 21.53 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.374 0.27 . . . . 0.0 110.693 -177.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.5 t -71.8 -28.65 63.74 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.252 178.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.493 ' O ' ' HG2' ' A' ' 72' ' ' MET . 60.8 t80 -81.87 -73.78 0.37 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 122.59 0.356 . . . . 0.0 111.122 -178.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.53 HG21 HD11 ' A' ' 37' ' ' LEU . 38.7 t -60.26 -22.3 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 123.945 0.898 . . . . 0.0 111.655 -173.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -55.63 -53.46 41.35 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-N 116.242 -0.436 . . . . 0.0 112.662 169.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.493 ' HG2' ' O ' ' A' ' 69' ' ' PHE . 18.5 ptp -65.79 -26.15 67.57 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.977 0.511 . . . . 0.0 111.83 -176.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 70' ' ' VAL . 4.4 mm? -56.7 -38.66 72.61 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.73 0.812 . . . . 0.0 110.97 175.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -89.59 -16.99 29.36 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.284 1.034 . . . . 0.0 111.182 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.42 ' HB2' ' HA ' ' A' ' 72' ' ' MET . 85.4 mt -86.67 -3.32 59.02 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.357 0.663 . . . . 0.0 111.518 176.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 42.8 m0 . . . . . 0 N--CA 1.479 1.0 0 C-N-CA 122.969 0.507 . . . . 0.0 110.121 170.835 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.564 0 N-CA-C 112.397 -0.281 . . . . 0.0 112.397 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.6 m -76.52 86.22 3.23 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.113 0.565 . . . . 0.0 110.811 -176.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -167.76 105.72 0.52 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.214 1.005 . . . . 0.0 108.875 175.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 63.8 mtm 55.95 77.04 0.25 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.223 1.009 . . . . 0.0 111.573 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -112.38 124.76 53.21 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 27.9 m170 -68.89 84.51 0.32 Allowed 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 172.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.43 HG23 HG21 ' A' ' 9' ' ' THR . 49.2 mt -74.77 79.6 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.703 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -77.66 87.54 3.94 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.615 -173.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.43 HG21 HG23 ' A' ' 7' ' ' ILE . 9.5 t -150.86 150.6 31.11 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.472 176.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.411 ' HB3' ' CD2' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -76.11 -4.34 41.01 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.254 176.675 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.46 -47.18 85.16 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.83 0.452 . . . . 0.0 110.536 170.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -55.58 -41.86 73.97 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.495 1.118 . . . . 0.0 113.154 -174.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.0 p -67.76 -41.87 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 O-C-N 122.982 0.176 . . . . 0.0 110.542 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 62.0 mt -70.92 -27.62 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 123.603 0.761 . . . . 0.0 110.945 -178.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -75.49 -28.75 59.32 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.331 0.652 . . . . 0.0 110.751 175.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.66 -32.99 74.67 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.041 0.536 . . . . 0.0 110.629 174.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.402 ' CE1' HD11 ' A' ' 33' ' ' LEU . 69.3 m-85 -64.55 -33.47 75.99 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.258 0.623 . . . . 0.0 111.018 171.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.1 mttp -78.67 -17.81 55.37 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.442 0.697 . . . . 0.0 111.725 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 67.0 t -72.88 -37.77 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 171.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -69.36 -55.3 10.79 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.996 173.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -80.04 77.92 6.71 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.777 0.831 . . . . 0.0 109.047 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.7 -21.12 61.83 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.097 1.359 . . . . 0.0 109.325 -178.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -76.01 -27.74 57.5 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.005 0.922 . . . . 0.0 111.358 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.93 45.9 54.99 Favored Glycine 0 C--N 1.344 1.015 0 O-C-N 123.486 0.491 . . . . 0.0 112.183 -176.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -68.58 -28.02 66.58 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.289 1.036 . . . . 0.0 111.312 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.41 -11.66 36.32 Favored Glycine 0 C--N 1.343 0.925 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 -175.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -154.8 159.79 40.83 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.709 0.804 . . . . 0.0 110.535 -177.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.1 m -112.15 -177.15 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.762 0.825 . . . . 0.0 110.512 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 64.4 p -81.83 154.52 25.86 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.548 170.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.439 ' O ' ' HG3' ' A' ' 34' ' ' ARG . 9.8 p -68.41 -26.49 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 122.544 0.337 . . . . 0.0 111.062 -177.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -65.45 -48.14 73.73 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 122.978 0.511 . . . . 0.0 111.398 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -63.81 -39.02 93.23 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 123.313 0.383 . . . . 0.0 110.465 177.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.443 HD22 HG13 ' A' ' 64' ' ' VAL . 5.3 tp -55.47 -46.48 76.83 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.608 178.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.544 ' HG2' HD11 ' A' ' 53' ' ' ILE . 80.8 mtm180 -67.56 -35.64 79.41 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.443 0.697 . . . . 0.0 110.984 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -62.11 -52.11 65.19 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.274 1.03 . . . . 0.0 111.701 -176.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.9 p -74.25 -35.36 40.06 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.037 0 C-N-CA 123.085 0.554 . . . . 0.0 111.136 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.485 HD22 HD13 ' A' ' 40' ' ' LEU . 95.8 mt -80.22 -4.82 54.67 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.911 0.485 . . . . 0.0 111.295 178.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -75.68 -47.01 28.1 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.479 0.711 . . . . 0.0 109.964 173.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -75.35 -23.67 57.21 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.958 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.485 HD13 HD22 ' A' ' 37' ' ' LEU . 99.1 mt -82.94 -25.38 32.43 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.351 0.66 . . . . 0.0 110.025 170.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.29 14.13 46.91 Favored Glycine 0 C--N 1.354 1.562 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.278 174.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -75.76 -52.82 9.59 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 168.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -82.38 -37.62 25.33 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.284 0.634 . . . . 0.0 110.575 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 93.0 mmm -89.43 147.08 37.24 Favored Pre-proline 0 N--CA 1.477 0.925 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.69 111.57 0.83 Allowed 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 122.122 1.881 . . . . 0.0 111.2 170.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.14 -33.93 72.42 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.841 0.856 . . . . 0.0 111.047 -176.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -57.89 -38.98 76.79 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.101 0.96 . . . . 0.0 111.677 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -58.18 -53.25 60.38 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 123.848 0.718 . . . . 0.0 110.309 174.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 86.2 mt -58.17 -45.08 88.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.241 1.016 . . . . 0.0 111.023 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.495 ' HA ' HD12 ' A' ' 53' ' ' ILE . 45.3 mt-10 -63.75 -29.42 70.64 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.936 0.895 . . . . 0.0 111.843 -177.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -77.01 -41.7 41.66 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.301 0.572 . . . . 0.0 109.961 175.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.408 ' HB3' ' HE1' ' A' ' 69' ' ' PHE . 24.9 mmt -64.71 -24.67 67.64 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.036 177.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.544 HD11 ' HG2' ' A' ' 34' ' ' ARG . 41.6 mt -66.81 -32.52 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.766 1.226 . . . . 0.0 111.355 177.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -73.67 -27.4 61.22 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.801 0.44 . . . . 0.0 110.59 174.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -85.05 -17.38 37.62 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.177 0.591 . . . . 0.0 110.67 175.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.6 -51.25 10.95 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.816 0.846 . . . . 0.0 109.848 176.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -123.32 81.72 52.59 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 124.28 1.032 . . . . 0.0 108.468 175.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -73.34 -20.25 21.27 Favored 'Trans proline' 0 C--N 1.386 2.53 0 C-N-CA 123.076 2.517 . . . . 0.0 111.552 173.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -66.8 -23.57 66.07 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.578 174.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.5 m120 58.15 34.55 24.27 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 124.992 1.317 . . . . 0.0 111.122 175.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.7 m -82.61 -13.33 56.7 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.421 -176.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.05 25.39 44.94 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.268 -172.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -139.59 122.96 17.13 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.769 0.828 . . . . 0.0 109.759 -175.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.443 HG13 HD22 ' A' ' 33' ' ' LEU . 2.8 p -131.65 129.9 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.59 0.756 . . . . 0.0 110.685 -172.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -74.95 90.25 2.42 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 170.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -56.72 -27.06 58.42 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.072 177.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -51.33 -58.22 6.81 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.455 1.102 . . . . 0.0 111.544 178.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.1 t -79.15 -33.11 44.43 Favored 'General case' 0 CA--C 1.555 1.17 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.072 -178.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.44 ' HD2' HD12 ' A' ' 33' ' ' LEU . 37.9 t80 -76.08 -63.13 1.39 Allowed 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -173.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.5 ' HA ' HD22 ' A' ' 73' ' ' LEU . 57.5 t -60.91 -16.55 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 123.428 0.691 . . . . 0.0 110.585 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -56.06 -56.26 25.02 Favored Glycine 0 CA--C 1.536 1.352 0 CA-C-O 118.991 -0.894 . . . . 0.0 112.742 166.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 19.3 ptm -63.43 -30.6 71.7 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 118.068 0.934 . . . . 0.0 112.142 -176.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.5 HD22 ' HA ' ' A' ' 70' ' ' VAL . 4.0 mm? -59.83 -30.06 68.69 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.233 0.613 . . . . 0.0 110.92 176.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.411 ' CD2' ' HB3' ' A' ' 10' ' ' LYS . 76.7 m-85 -116.7 1.98 12.88 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.944 0.898 . . . . 0.0 111.799 -176.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 71.8 mt -97.55 5.8 49.01 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.497 0.719 . . . . 0.0 110.956 173.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 29.5 m0 -63.04 116.11 5.05 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.643 0.377 . . . . 0.0 110.322 174.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 . . . . . 0 C--O 1.254 1.293 0 C-N-CA 123.758 0.823 . . . . 0.0 110.228 -177.249 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.521 0 N-CA-C 112.178 -0.369 . . . . 0.0 112.178 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.3 t -91.22 -57.54 2.76 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.779 0.832 . . . . 0.0 109.997 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 69.4 m-70 -140.26 105.66 5.07 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.949 0.899 . . . . 0.0 108.718 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 60.1 mtt -74.11 -16.57 61.01 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 122.701 0.4 . . . . 0.0 111.082 175.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -125.52 167.97 14.29 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.885 0.874 . . . . 0.0 109.126 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -136.5 118.07 14.88 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.552 0.741 . . . . 0.0 109.629 -174.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.9 tp -137.76 111.44 8.28 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 CA-C-O 121.613 0.721 . . . . 0.0 109.734 176.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -102.63 118.56 37.12 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.248 -0.887 . . . . 0.0 108.784 173.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.575 ' HB ' ' HG2' ' A' ' 12' ' ' GLN . 19.9 m -149.96 141.88 23.82 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.305 0.642 . . . . 0.0 109.861 -178.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -63.03 -35.49 80.4 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.905 0.482 . . . . 0.0 111.026 176.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.78 -40.37 75.76 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.707 0.803 . . . . 0.0 111.559 176.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.575 ' HG2' ' HB ' ' A' ' 9' ' ' THR . 14.3 mm100 -70.72 -47.86 57.58 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.968 0.507 . . . . 0.0 111.434 -176.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.9 p -69.32 -33.17 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.014 -176.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 90.2 mt -66.92 -38.39 81.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 174.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.427 ' HA ' ' HB2' ' A' ' 18' ' ' LYS . 70.8 mm-40 -66.87 -23.44 66.01 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 119.304 -0.379 . . . . 0.0 111.639 173.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.29 -37.98 86.71 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 120.94 0.4 . . . . 0.0 110.199 175.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -73.86 -37.68 64.7 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.892 173.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.54 ' HB3' ' HZ1' ' A' ' 18' ' ' LYS . 9.9 mtpm? -74.79 -24.19 58.61 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.481 0.712 . . . . 0.0 112.21 -176.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.6 p -86.4 -27.51 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 176.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -67.18 -56.26 10.68 Favored 'General case' 0 C--N 1.354 0.787 0 C-N-CA 123.704 0.802 . . . . 0.0 109.399 174.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -82.75 83.1 7.81 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.785 177.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -85.62 -14.95 44.07 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.474 169.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -70.19 -27.32 64.41 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.803 0.841 . . . . 0.0 110.676 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.59 44.28 8.64 Favored Glycine 0 C--N 1.347 1.14 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.961 173.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -78.8 -13.2 59.94 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 122.972 0.509 . . . . 0.0 110.38 173.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.39 -44.98 1.93 Allowed Glycine 0 C--N 1.348 1.235 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 177.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.42 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 46.8 p90 -126.78 162.59 25.49 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 123.851 0.86 . . . . 0.0 110.106 177.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 52.4 t -109.68 151.05 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.183 0.993 . . . . 0.0 109.507 -177.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 76.1 p -68.99 166.56 17.73 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.627 0.771 . . . . 0.0 111.578 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.7 p -71.7 -15.15 18.11 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 122.606 0.362 . . . . 0.0 111.518 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -54.39 -63.02 1.28 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.844 0.858 . . . . 0.0 111.806 175.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -72.33 -29.38 63.77 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.987 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.521 HD22 HG12 ' A' ' 64' ' ' VAL . 7.3 tp -55.35 -51.66 66.06 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 123.8 0.688 . . . . 0.0 110.208 176.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 67.1 mtp85 -62.06 -40.59 96.31 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.458 0.703 . . . . 0.0 111.489 177.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -60.35 -54.4 46.14 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 123.783 0.677 . . . . 0.0 111.877 -174.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.6 p -67.1 -29.16 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 122.812 0.445 . . . . 0.0 111.259 -178.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 66.6 mt -87.67 -6.65 58.14 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.165 0.586 . . . . 0.0 111.868 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -83.1 -44.77 14.76 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.499 0.72 . . . . 0.0 110.27 177.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -68.05 -28.78 67.68 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.534 175.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 91.9 mt -96.34 11.07 36.05 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.273 1.029 . . . . 0.0 110.838 175.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -73.2 -14.93 78.84 Favored Glycine 0 C--N 1.352 1.438 0 C-N-CA 123.354 0.502 . . . . 0.0 113.037 -177.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -66.53 -46.37 76.38 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.906 0.882 . . . . 0.0 110.706 176.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 59.9 mtt -90.32 -46.18 8.56 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.672 0.789 . . . . 0.0 110.234 -175.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -110.35 98.76 37.47 Favored Pre-proline 0 N--CA 1.474 0.751 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 176.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -48.93 111.54 0.49 Allowed 'Trans proline' 0 C--N 1.385 2.5 0 C-N-CA 123.789 2.992 . . . . 0.0 113.707 -173.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.402 ' O ' ' HG3' ' A' ' 50' ' ' GLU . . . -64.1 -30.28 71.36 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.183 0.993 . . . . 0.0 111.16 -178.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -56.95 -48.06 79.23 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.093 0.957 . . . . 0.0 111.899 174.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.418 ' HG3' ' HE1' ' A' ' 52' ' ' MET . 11.6 tp10 -68.54 -38.82 81.15 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.038 -178.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.69 -36.5 75.56 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.819 177.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.487 ' HA ' HD13 ' A' ' 53' ' ' ILE . 40.0 mt-10 -59.95 -35.44 74.95 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.42 0.688 . . . . 0.0 111.641 176.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -69.41 -42.69 74.72 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.244 0.545 . . . . 0.0 109.992 176.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.418 ' HE1' ' HG3' ' A' ' 48' ' ' GLU . 49.9 mtt -69.68 -22.4 63.44 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.39 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.487 HD13 ' HA ' ' A' ' 50' ' ' GLU . 23.3 mt -64.27 -28.53 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.416 1.086 . . . . 0.0 111.558 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -59.5 -37.09 77.36 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 122.89 0.476 . . . . 0.0 111.064 174.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -81.44 -38.09 27.0 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.406 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.28 -32.31 73.69 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.592 1.157 . . . . 0.0 111.673 -178.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -114.97 88.5 17.19 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 124.34 1.056 . . . . 0.0 108.416 172.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -85.2 3.35 7.37 Favored 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.647 2.231 . . . . 0.0 111.603 173.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -83.59 -21.87 32.46 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.749 0.82 . . . . 0.0 110.306 176.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.6 t30 64.51 30.65 12.84 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.52 1.128 . . . . 0.0 110.079 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.3 m -132.51 -4.65 3.32 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.581 0.752 . . . . 0.0 112.105 -172.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.71 37.26 8.07 Favored Glycine 0 N--CA 1.471 1.023 0 C-N-CA 122.885 0.278 . . . . 0.0 113.546 178.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -123.61 125.65 45.21 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.153 0.981 . . . . 0.0 109.993 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.521 HG12 HD22 ' A' ' 33' ' ' LEU . 3.1 p -139.86 135.6 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.347 0.659 . . . . 0.0 111.057 -171.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -79.87 103.6 9.88 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 167.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.42 ' CE2' ' HA ' ' A' ' 27' ' ' TYR . 39.3 p90 -64.06 -32.28 73.77 Favored 'General case' 0 C--O 1.208 -1.121 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.18 -177.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -61.4 -39.22 89.93 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 118.427 0.558 . . . . 0.0 111.343 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 77.8 p -77.01 -47.73 19.87 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.368 0.667 . . . . 0.0 110.805 -178.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -70.82 -53.5 15.08 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.751 0.82 . . . . 0.0 111.941 -176.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.4 t -67.77 -18.51 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.693 0.797 . . . . 0.0 110.85 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -59.24 -49.61 76.67 Favored Glycine 0 C--N 1.349 1.304 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 165.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 85.2 mtp -70.62 -24.43 62.73 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.78 0.832 . . . . 0.0 111.951 177.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 86.2 mt -70.85 -10.92 60.54 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.127 0.571 . . . . 0.0 112.436 178.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -118.08 24.1 11.21 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.417 0.687 . . . . 0.0 109.636 174.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 85.9 mt -126.72 -31.05 2.72 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.166 0.986 . . . . 0.0 111.672 178.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -66.84 114.68 5.87 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 117.987 0.358 . . . . 0.0 111.262 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.9 t70 . . . . . 0 C--O 1.248 0.992 0 C-N-CA 123.636 0.775 . . . . 0.0 109.459 -177.395 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.825 0 N-CA-C 112.787 -0.125 . . . . 0.0 112.787 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.2 m -66.47 136.36 55.58 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.866 0.867 . . . . 0.0 110.543 176.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 73.8 m-70 -95.84 150.71 20.12 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.443 0.697 . . . . 0.0 111.044 -175.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 57.0 mtm -73.3 149.26 42.82 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.67 176.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -90.42 10.38 25.38 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.121 0.568 . . . . 0.0 111.399 176.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -73.23 82.57 1.34 Allowed 'General case' 0 C--N 1.353 0.73 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 168.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.6 tt -102.07 131.1 50.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.857 178.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -132.77 121.91 23.73 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 175.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.3 t -153.82 163.69 39.61 Favored 'General case' 0 C--O 1.244 0.804 0 C-N-CA 124.241 1.016 . . . . 0.0 109.429 -178.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.449 ' HB3' ' HB3' ' A' ' 74' ' ' PHE . 17.1 ptmt -64.94 -19.48 65.97 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.63 0.772 . . . . 0.0 112.079 177.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.85 -45.33 94.93 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.785 0.434 . . . . 0.0 110.362 172.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -59.57 -44.16 93.38 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.554 0.742 . . . . 0.0 111.558 -175.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.6 p -74.34 -34.56 37.08 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 CA-C-O 118.986 -0.531 . . . . 0.0 111.143 -179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 90.2 mt -60.33 -40.38 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-N 118.584 0.629 . . . . 0.0 109.651 173.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -68.93 -24.16 64.25 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.004 0.921 . . . . 0.0 111.186 177.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.18 -13.13 61.1 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.448 0.699 . . . . 0.0 111.734 174.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.569 ' HA ' ' HE2' ' A' ' 32' ' ' TYR . 90.6 m-85 -93.58 -43.79 8.52 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.344 0.658 . . . . 0.0 110.539 170.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.575 ' HB3' ' HZ1' ' A' ' 18' ' ' LYS . 8.5 mtpm? -67.95 -22.2 65.05 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.201 -175.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.8 p -59.95 -31.59 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.313 0.645 . . . . 0.0 111.088 175.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -78.72 -49.19 13.5 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.828 0.851 . . . . 0.0 110.433 176.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -65.32 105.18 1.08 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.543 0.737 . . . . 0.0 111.129 -173.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 19.2 tpp180 -71.15 -50.98 27.69 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.407 1.083 . . . . 0.0 110.577 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.414 ' HB2' ' HB2' ' A' ' 25' ' ' ASN . 5.6 m-20 -73.79 -20.7 60.39 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 114.701 -1.136 . . . . 0.0 112.155 -167.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.96 37.78 88.16 Favored Glycine 0 C--N 1.346 1.129 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -166.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.414 ' HB2' ' HB2' ' A' ' 23' ' ' ASP . 16.5 t-20 -67.71 -30.02 69.42 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.265 1.426 . . . . 0.0 111.074 -167.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 142.07 -60.82 0.54 Allowed Glycine 0 C--N 1.342 0.894 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 176.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.513 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 46.3 p90 -142.73 -176.01 4.71 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -176.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.9 m -126.85 -176.26 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.337 1.055 . . . . 0.0 110.511 -177.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 35.3 p -78.46 160.84 27.5 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 124.195 0.998 . . . . 0.0 111.387 177.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.2 p -78.45 -16.5 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.208 -176.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -69.39 -37.85 77.74 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 120.727 0.298 . . . . 0.0 110.548 173.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.569 ' HE2' ' HA ' ' A' ' 17' ' ' PHE . 45.6 t80 -73.73 -30.49 62.85 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.368 0.667 . . . . 0.0 110.36 178.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 8.6 tp -64.53 -55.29 21.55 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.52 175.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.592 ' HG2' HD11 ' A' ' 53' ' ' ILE . 63.3 mtm180 -69.54 -17.1 63.54 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.631 -177.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -66.52 -61.75 1.82 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.904 0.882 . . . . 0.0 110.75 174.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.4 p -68.67 -28.2 39.1 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.135 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.975 -175.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 71.8 mt -88.4 -8.98 54.12 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.937 -0.477 . . . . 0.0 111.857 -177.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -73.71 -46.96 42.95 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.252 0.621 . . . . 0.0 109.642 171.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -73.35 -25.65 60.69 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.903 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 97.9 mt -89.45 11.22 19.95 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.511 0.724 . . . . 0.0 111.107 173.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.8 3.24 61.21 Favored Glycine 0 C--N 1.358 1.764 0 CA-C-N 116.327 -0.397 . . . . 0.0 113.413 177.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -67.12 -40.99 86.93 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.1 0.96 . . . . 0.0 111.462 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 88.3 mmm -76.49 -46.98 24.43 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 122.993 0.517 . . . . 0.0 111.39 -178.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.491 ' HE2' ' HG3' ' A' ' 48' ' ' GLU . 90.9 mmm -135.2 139.16 30.9 Favored Pre-proline 0 N--CA 1.48 1.06 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.421 ' HB2' ' HG2' ' A' ' 48' ' ' GLU . 85.8 Cg_exo -49.27 133.92 30.61 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 122.625 2.217 . . . . 0.0 111.755 174.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.411 ' O ' ' HG3' ' A' ' 50' ' ' GLU . . . -58.55 -25.39 62.45 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 123.549 0.53 . . . . 0.0 111.206 178.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -60.07 -39.19 85.21 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.058 0.943 . . . . 0.0 111.972 175.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.491 ' HG3' ' HE2' ' A' ' 44' ' ' MET . 9.6 mm-40 -56.73 -39.61 74.25 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.847 0.832 . . . . 0.0 109.776 176.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.409 ' HA ' ' HE1' ' A' ' 52' ' ' MET . 49.3 mt -77.37 -35.47 22.32 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 CA-C-N 113.999 -1.455 . . . . 0.0 110.356 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.411 ' HG3' ' O ' ' A' ' 46' ' ' ALA . 40.4 mt-10 -65.92 -32.04 73.32 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.739 0.815 . . . . 0.0 112.755 -175.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -66.18 -36.06 82.09 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 121.328 0.585 . . . . 0.0 109.768 174.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.409 ' HE1' ' HA ' ' A' ' 49' ' ' ILE . 23.6 mtm -75.71 -24.57 56.22 Favored 'General case' 0 CA--C 1.553 1.058 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.488 177.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.592 HD11 ' HG2' ' A' ' 34' ' ' ARG . 62.8 mt -71.93 -28.19 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 124.397 1.079 . . . . 0.0 111.018 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -65.16 -32.96 74.91 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.069 171.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -83.66 -23.75 31.63 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.864 0.866 . . . . 0.0 110.9 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.5 ' HB2' HG21 ' A' ' 64' ' ' VAL . . . -72.94 -49.28 30.38 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.764 0.826 . . . . 0.0 110.482 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -120.35 90.49 45.23 Favored Pre-proline 0 CA--C 1.546 0.825 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 172.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.24 -11.81 15.97 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 123.027 2.485 . . . . 0.0 111.384 168.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -70.17 -24.07 63.08 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.221 1.009 . . . . 0.0 111.65 -173.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 60.78 24.01 13.94 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 125.038 1.335 . . . . 0.0 110.384 -174.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.8 t -105.48 -5.25 20.45 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.407 1.083 . . . . 0.0 109.86 -177.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.24 43.81 62.01 Favored Glycine 0 C--N 1.347 1.175 0 O-C-N 123.851 0.719 . . . . 0.0 113.06 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.456 ' HB3' ' HE1' ' A' ' 27' ' ' TYR . 27.2 m-85 -131.02 109.86 10.81 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.671 0.789 . . . . 0.0 110.29 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.5 HG21 ' HB2' ' A' ' 56' ' ' ALA . 4.6 p -117.83 129.98 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 123.885 0.874 . . . . 0.0 110.824 -175.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -81.23 91.62 6.21 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 170.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.513 ' CE2' ' HA ' ' A' ' 27' ' ' TYR . 45.1 p90 -61.33 -23.59 65.84 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 122.968 0.507 . . . . 0.0 111.498 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -51.63 -56.78 11.64 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.302 1.041 . . . . 0.0 110.582 173.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.2 t -82.07 -30.54 31.26 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.004 -177.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -73.68 -63.06 1.28 Allowed 'General case' 0 N--CA 1.476 0.848 0 O-C-N 123.066 0.229 . . . . 0.0 111.038 -175.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.534 ' HA ' ' HB3' ' A' ' 73' ' ' LEU . 90.2 t -59.0 -24.81 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 124.366 1.067 . . . . 0.0 111.154 177.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -56.63 -54.62 35.0 Favored Glycine 0 CA--C 1.532 1.103 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.355 169.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.417 ' HA ' ' HG ' ' A' ' 75' ' ' LEU . 20.8 mmt -76.15 -32.25 59.0 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.334 0.653 . . . . 0.0 111.368 -178.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.534 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 18.7 tp -69.49 -31.11 69.17 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.551 1.54 . . . . 0.0 111.627 -178.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.449 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 16.0 m-85 -111.94 26.36 10.68 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.159 0.584 . . . . 0.0 111.315 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.417 ' HG ' ' HA ' ' A' ' 72' ' ' MET . 78.3 mt -72.85 -31.89 65.07 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 166.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 17.5 p-90 -97.96 24.13 7.32 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.653 0.781 . . . . 0.0 111.777 177.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.0 t70 . . . . . 0 C--O 1.249 1.058 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 170.69 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.569 0 N-CA-C 112.459 -0.256 . . . . 0.0 112.459 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.7 p -149.04 98.56 2.85 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.423 0.689 . . . . 0.0 109.985 177.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -112.32 95.83 5.67 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.572 0.749 . . . . 0.0 109.085 174.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 61.0 mtt -94.39 46.71 1.16 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.147 0.979 . . . . 0.0 110.124 -177.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -138.36 153.42 48.95 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.293 1.037 . . . . 0.0 108.565 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 46.4 t60 -68.0 99.05 0.81 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 177.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.517 HG12 ' HG3' ' A' ' 12' ' ' GLN . 8.7 tp -91.58 112.68 25.85 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 CA-C-O 121.492 0.663 . . . . 0.0 109.799 -174.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -83.61 -3.49 57.75 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.478 0.711 . . . . 0.0 111.717 -176.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 84.8 m -67.19 120.85 14.44 Favored 'General case' 0 C--O 1.246 0.894 0 C-N-CA 123.226 0.61 . . . . 0.0 110.848 -178.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -53.25 -42.22 66.23 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.032 177.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.89 -34.75 60.4 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.374 0.67 . . . . 0.0 112.631 -178.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.517 ' HG3' HG12 ' A' ' 7' ' ' ILE . 79.8 mm-40 -79.92 -38.72 31.9 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.428 0.691 . . . . 0.0 111.211 -176.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.4 p -72.74 -29.03 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 122.126 0.17 . . . . 0.0 110.602 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.7 mt -64.09 -34.22 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.568 0.747 . . . . 0.0 110.086 175.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -70.82 -22.96 62.27 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.25 0.62 . . . . 0.0 111.971 177.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.94 -41.29 95.63 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.248 0.547 . . . . 0.0 109.571 172.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -65.41 -35.22 80.28 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.861 173.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -84.92 -11.64 55.13 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -175.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.9 p -89.16 -29.27 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 172.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 93.5 t80 -70.37 -51.99 25.76 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.578 171.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -64.73 116.79 6.63 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 173.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -87.28 -53.37 4.87 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.32 0.648 . . . . 0.0 111.891 -169.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -95.65 -7.76 36.65 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.005 0.522 . . . . 0.0 112.378 -167.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.99 50.72 4.77 Favored Glycine 0 C--N 1.343 0.93 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -171.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -62.37 -28.63 69.9 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.058 1.743 . . . . 0.0 111.292 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.14 -22.46 29.34 Favored Glycine 0 C--N 1.347 1.147 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.984 178.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -154.03 167.62 29.18 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.696 0.798 . . . . 0.0 111.193 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.1 m -116.24 176.26 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.32 1.048 . . . . 0.0 109.823 176.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 42.6 p -79.27 150.38 31.56 Favored 'General case' 0 C--O 1.246 0.896 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.78 171.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.409 HG11 ' HA2' ' A' ' 62' ' ' GLY . 9.0 p -66.64 -23.69 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 122.65 0.38 . . . . 0.0 111.255 -177.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -57.64 -54.23 49.2 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.442 0.697 . . . . 0.0 111.538 176.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -64.14 -38.79 92.32 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.841 0.456 . . . . 0.0 110.752 176.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.7 tt -60.66 -35.61 76.66 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.238 -176.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 23.2 mtp180 -75.29 -34.41 61.3 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.186 0.594 . . . . 0.0 111.233 176.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.2 mttp -59.6 -50.97 71.81 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.96 0.904 . . . . 0.0 111.735 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.8 p -71.68 -40.21 70.15 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.47 -176.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 97.4 mt -76.39 -11.96 59.98 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.087 0.555 . . . . 0.0 112.184 -176.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -65.97 -29.74 70.19 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.373 0.669 . . . . 0.0 109.833 171.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -86.27 -8.09 58.01 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.483 1.113 . . . . 0.0 111.706 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -91.79 18.6 7.46 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.728 0.811 . . . . 0.0 111.251 177.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 140.17 88.42 0.15 Allowed Glycine 0 C--N 1.349 1.292 0 CA-C-O 119.864 -0.409 . . . . 0.0 112.407 173.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -77.99 -30.06 49.99 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.427 0.691 . . . . 0.0 110.225 175.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -76.89 -24.33 52.53 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.157 174.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 83.1 mtp -79.96 147.92 67.02 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 123.924 0.89 . . . . 0.0 109.524 176.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.63 110.84 2.41 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 121.785 1.657 . . . . 0.0 111.277 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.33 -21.86 66.75 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.628 174.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -48.83 -41.56 33.35 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.392 1.477 . . . . 0.0 112.327 177.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.48 ' O ' ' HG2' ' A' ' 52' ' ' MET . 38.7 tt0 -65.85 -50.28 65.13 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.489 0.493 . . . . 0.0 110.316 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 88.3 mt -58.61 -36.16 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 123.848 0.859 . . . . 0.0 110.74 178.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -63.45 -46.78 84.71 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.098 0.959 . . . . 0.0 110.285 176.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -62.38 -34.55 76.91 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.912 0.485 . . . . 0.0 111.209 177.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.48 ' HG2' ' O ' ' A' ' 48' ' ' GLU . 26.1 mmt -67.93 -35.97 79.35 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.556 0.742 . . . . 0.0 109.925 176.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 83.3 mt -66.19 -36.61 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 124.218 1.007 . . . . 0.0 110.729 176.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -70.93 -21.01 62.41 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.402 0.681 . . . . 0.0 111.126 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -80.2 -41.58 24.96 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 171.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.407 ' HB2' HG21 ' A' ' 64' ' ' VAL . . . -72.83 -30.04 63.72 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.061 0.944 . . . . 0.0 111.92 -176.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -150.63 83.07 5.94 Favored Pre-proline 0 CA--C 1.545 0.76 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.26 -20.57 21.11 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.904 2.403 . . . . 0.0 113.085 -178.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -87.09 -10.62 52.44 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.162 0.585 . . . . 0.0 111.619 -178.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.1 t30 61.46 40.63 13.67 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 122.422 1.106 . . . . 0.0 109.586 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.9 m -77.53 -15.03 59.51 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.569 -1.196 . . . . 0.0 112.03 -173.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.409 ' HA2' HG11 ' A' ' 30' ' ' VAL . . . 85.53 13.67 69.89 Favored Glycine 0 C--N 1.347 1.177 0 CA-C-N 115.91 -0.587 . . . . 0.0 112.327 -173.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -123.01 111.26 16.38 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.736 0.815 . . . . 0.0 109.509 -175.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.407 HG21 ' HB2' ' A' ' 56' ' ' ALA . 2.2 p -139.99 121.29 15.1 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 C-N-CA 123.383 0.673 . . . . 0.0 109.854 -178.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -69.49 94.77 0.77 Allowed 'General case' 0 C--N 1.348 0.514 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.057 173.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 48.2 p90 -57.35 -28.81 63.47 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 123.56 0.538 . . . . 0.0 111.19 177.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -62.19 -49.31 76.29 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.356 0.662 . . . . 0.0 110.851 -176.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 79.8 p -77.59 -33.75 53.76 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.467 0.707 . . . . 0.0 110.641 177.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -67.31 -68.75 0.36 Allowed 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.418 -176.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.573 ' HA ' ' HB3' ' A' ' 73' ' ' LEU . 75.9 t -50.37 -29.11 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 125.404 1.481 . . . . 0.0 112.781 176.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.76 -48.07 80.36 Favored Glycine 0 C--N 1.349 1.287 0 CA-C-O 121.123 0.291 . . . . 0.0 112.693 171.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 33.3 mmt -86.09 -5.72 59.15 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.929 0.892 . . . . 0.0 112.295 177.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.573 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 55.4 tp -88.97 -42.61 11.69 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.068 0.947 . . . . 0.0 109.424 -177.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -90.96 11.75 21.83 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.154 0.582 . . . . 0.0 112.474 -177.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 pp -70.8 -9.1 56.77 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 118.308 0.504 . . . . 0.0 111.895 178.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 14.2 m0 -60.89 119.9 9.14 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.659 0.784 . . . . 0.0 109.895 175.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 . . . . . 0 N--CA 1.483 1.177 0 C-N-CA 123.394 0.678 . . . . 0.0 111.657 -173.884 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.589 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.7 m -82.11 76.21 9.0 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.966 0.906 . . . . 0.0 110.59 -177.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 11.7 m170 70.47 -62.95 0.42 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 125.645 1.578 . . . . 0.0 112.696 177.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.6 ptt? -54.33 131.93 42.9 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.37 1.068 . . . . 0.0 111.839 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -109.48 163.16 13.68 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.832 0.853 . . . . 0.0 110.323 -178.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 24.9 m-70 -78.07 97.13 5.31 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 173.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.6 tt -142.92 114.62 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.113 0.965 . . . . 0.0 109.561 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -92.73 103.92 16.24 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 85.1 m -141.13 149.0 40.96 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.639 1.176 . . . . 0.0 108.604 -176.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -59.58 -35.29 73.99 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.309 0.644 . . . . 0.0 111.372 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.1 -51.17 69.01 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 122.995 0.518 . . . . 0.0 110.687 173.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.7 mm-40 -56.49 -37.82 70.88 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.428 1.091 . . . . 0.0 112.738 -175.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.5 p -85.53 -42.36 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 CA-C-O 119.052 -0.499 . . . . 0.0 111.36 -177.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 60.3 mt -59.77 -43.16 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 122.881 0.472 . . . . 0.0 110.876 178.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.45 ' O ' HG23 ' A' ' 19' ' ' VAL . 12.9 pt-20 -70.08 -27.13 64.37 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.692 -178.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.13 -34.6 77.94 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.134 0.573 . . . . 0.0 110.999 175.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.459 ' HE1' ' HA ' ' A' ' 33' ' ' LEU . 83.0 m-85 -64.46 -37.85 88.97 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.957 0.503 . . . . 0.0 110.964 172.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -72.68 -20.51 61.22 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.273 0.629 . . . . 0.0 111.23 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 15' ' ' GLU . 61.0 t -71.87 -34.58 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 123.133 0.573 . . . . 0.0 110.049 171.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -71.8 -54.08 11.3 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.176 0.59 . . . . 0.0 109.844 175.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -77.6 83.04 4.0 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.649 0.78 . . . . 0.0 109.355 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -71.71 -40.38 69.53 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.162 0.985 . . . . 0.0 111.127 -176.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -72.53 -26.22 61.67 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.357 0.663 . . . . 0.0 111.801 -173.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.2 59.42 2.42 Favored Glycine 0 C--N 1.347 1.145 0 N-CA-C 111.978 -0.449 . . . . 0.0 111.978 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -86.65 -11.19 52.03 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.616 1.166 . . . . 0.0 111.143 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.73 -27.04 21.34 Favored Glycine 0 C--N 1.343 0.957 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.962 175.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.406 ' HB2' ' O ' ' A' ' 64' ' ' VAL . 39.1 p90 -149.25 177.1 9.94 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.195 0.598 . . . . 0.0 111.205 -174.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.1 m -132.55 -178.33 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 124.141 0.976 . . . . 0.0 110.096 178.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.0 p -78.03 155.05 30.91 Favored 'General case' 0 C--O 1.245 0.862 0 C-N-CA 123.932 0.893 . . . . 0.0 111.268 174.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.6 p -69.76 -20.29 23.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.607 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -58.76 -59.46 5.39 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.79 0.836 . . . . 0.0 110.934 175.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.449 ' HE2' ' HA ' ' A' ' 17' ' ' PHE . 87.0 t80 -62.56 -35.52 79.72 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.538 0.735 . . . . 0.0 110.764 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.481 HD21 HG12 ' A' ' 64' ' ' VAL . 6.5 tp -59.59 -53.47 57.66 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.611 178.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.507 ' HG2' HD12 ' A' ' 53' ' ' ILE . 98.0 mtt180 -67.08 -28.91 68.57 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.358 0.663 . . . . 0.0 111.514 -176.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -64.62 -58.61 5.87 Favored 'General case' 0 CA--C 1.548 0.904 0 O-C-N 123.665 0.603 . . . . 0.0 111.1 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.1 p -64.57 -38.73 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 123.138 0.575 . . . . 0.0 111.849 -174.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.43 HD21 HD12 ' A' ' 40' ' ' LEU . 85.8 mt -74.79 -26.53 59.81 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.245 0.618 . . . . 0.0 111.285 -176.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.406 ' HA ' ' HB3' ' A' ' 46' ' ' ALA . 3.6 t-20 -67.51 -42.15 83.3 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 123.479 0.487 . . . . 0.0 109.817 171.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -70.42 -30.9 67.89 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.799 0.84 . . . . 0.0 111.717 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.431 HD11 ' HZ ' ' A' ' 74' ' ' PHE . 95.8 mt -71.04 -28.41 64.37 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 122.759 0.424 . . . . 0.0 110.61 172.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -82.39 62.83 4.52 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 169.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -75.29 -36.64 61.13 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.237 0.615 . . . . 0.0 110.485 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 64.5 mtt -124.3 8.11 8.46 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.707 0.803 . . . . 0.0 110.768 173.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 22.8 mmt -116.99 140.92 27.58 Favored Pre-proline 0 N--CA 1.482 1.151 0 C-N-CA 124.045 0.938 . . . . 0.0 108.595 176.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.401 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 40.2 Cg_endo -66.95 133.03 29.87 Favored 'Trans proline' 0 C--N 1.368 1.567 0 C-N-CA 121.738 1.625 . . . . 0.0 111.367 173.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.406 ' HB3' ' HA ' ' A' ' 38' ' ' ASN . . . -73.33 -20.88 60.68 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.453 0.301 . . . . 0.0 110.286 174.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -54.84 -37.24 65.95 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.589 1.156 . . . . 0.0 112.571 -178.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 45' ' ' PRO . 17.1 pt-20 -67.14 -39.15 86.51 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.005 0.431 . . . . 0.0 110.309 177.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 89.6 mt -69.62 -33.25 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.41 1.084 . . . . 0.0 110.321 177.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -69.39 -32.96 72.31 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.806 0.842 . . . . 0.0 111.679 -176.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -62.29 -42.18 99.13 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 121.554 0.692 . . . . 0.0 109.983 171.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 60.4 mmm -67.9 -31.21 70.83 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.487 177.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.507 HD12 ' HG2' ' A' ' 34' ' ' ARG . 54.9 mt -67.72 -31.47 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 124.452 1.101 . . . . 0.0 110.932 178.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -77.54 -20.56 53.97 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.803 0.441 . . . . 0.0 111.291 172.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -79.46 -20.69 46.77 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.499 0.319 . . . . 0.0 110.671 171.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.47 -37.13 18.59 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.922 0.889 . . . . 0.0 111.041 175.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -132.25 80.5 63.53 Favored Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 124.334 1.054 . . . . 0.0 108.47 176.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -81.88 -12.58 10.84 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 123.268 2.646 . . . . 0.0 112.181 174.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 58.8 mm-40 -76.04 -17.03 59.83 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.632 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.6 m120 63.4 26.81 15.09 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.867 1.267 . . . . 0.0 110.611 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 53.1 m -88.89 -15.45 34.37 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.054 0.942 . . . . 0.0 111.245 -175.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.71 21.15 75.29 Favored Glycine 0 C--N 1.348 1.222 0 CA-C-N 116.32 -0.4 . . . . 0.0 113.052 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -116.92 117.22 29.11 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 178.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.481 HG12 HD21 ' A' ' 33' ' ' LEU . 3.9 p -135.02 124.42 42.92 Favored 'Isoleucine or valine' 0 C--O 1.245 0.822 0 C-N-CA 123.237 0.615 . . . . 0.0 110.805 -173.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -73.43 92.22 1.84 Allowed 'General case' 0 C--O 1.238 0.45 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 171.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -50.08 -46.27 53.23 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 114.465 -1.243 . . . . 0.0 113.761 -172.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -72.43 -34.48 67.85 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.32 0.648 . . . . 0.0 111.58 -175.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.4 m -63.48 -44.04 95.54 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.501 0.72 . . . . 0.0 109.625 175.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.441 ' HD2' HD13 ' A' ' 33' ' ' LEU . 17.6 t80 -71.71 -73.43 0.18 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.532 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.554 ' HA ' ' HB3' ' A' ' 73' ' ' LEU . 89.7 t -47.03 -28.44 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 C-N-CA 126.171 1.789 . . . . 0.0 113.149 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -59.53 -54.14 40.19 Favored Glycine 0 CA--C 1.538 1.503 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 169.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 84.7 mtp -72.89 -28.42 62.48 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.124 0.97 . . . . 0.0 111.996 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.554 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 54.6 tp -67.36 -46.83 72.2 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.38 1.072 . . . . 0.0 110.164 -177.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.431 ' HZ ' HD11 ' A' ' 40' ' ' LEU . 7.5 m-85 -84.17 21.51 1.37 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.595 0.758 . . . . 0.0 111.992 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 69.0 mt -95.22 31.26 1.97 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.434 0.694 . . . . 0.0 110.576 170.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 26.1 m0 -65.34 88.76 0.08 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.047 0.539 . . . . 0.0 110.422 176.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.0 t70 . . . . . 0 C--O 1.248 1.004 0 C-N-CA 123.915 0.886 . . . . 0.0 108.948 -179.219 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.416 0 N-CA-C 112.24 -0.344 . . . . 0.0 112.24 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.8 m -74.65 106.87 6.42 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.994 0.918 . . . . 0.0 109.882 178.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -62.12 153.62 29.51 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 122.954 0.502 . . . . 0.0 110.251 176.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -61.78 108.59 1.03 Allowed 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 121.067 0.46 . . . . 0.0 110.383 178.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -68.58 -25.16 64.75 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.066 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -70.89 99.75 1.82 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.063 0.945 . . . . 0.0 110.455 -178.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 38.3 mm -83.08 86.94 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.025 178.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -67.9 -39.83 83.56 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.086 176.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.0 t -139.22 163.07 33.43 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.117 0.967 . . . . 0.0 109.108 178.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.444 ' O ' HG12 ' A' ' 14' ' ' ILE . 19.5 pttp -58.28 -27.12 63.75 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.403 0.681 . . . . 0.0 112.389 176.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.8 -30.84 67.9 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.059 0.544 . . . . 0.0 111.565 176.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -68.94 -47.08 66.56 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.35 0.66 . . . . 0.0 110.927 176.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.8 p -71.87 -24.65 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 -177.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.49 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 33.2 mm -63.16 -38.21 81.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 173.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -61.17 -30.3 70.32 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 122.595 0.358 . . . . 0.0 111.468 176.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.16 -36.93 80.43 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 123.565 0.54 . . . . 0.0 110.421 175.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.489 ' HE1' ' HA ' ' A' ' 33' ' ' LEU . 84.4 m-85 -70.23 -32.65 70.61 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.326 0.65 . . . . 0.0 111.401 174.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.518 ' HZ3' ' HB3' ' A' ' 18' ' ' LYS . 3.3 mmmp? -70.95 -11.72 61.13 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.048 0.539 . . . . 0.0 111.481 -179.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 89.8 t -68.46 -42.53 83.92 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 122.841 0.456 . . . . 0.0 110.296 173.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -74.04 -48.21 31.58 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 173.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -83.01 76.78 9.81 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.127 0.971 . . . . 0.0 109.713 -178.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -94.18 -29.1 15.29 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.045 0.538 . . . . 0.0 110.929 176.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -85.83 -12.05 51.81 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.301 0.641 . . . . 0.0 111.942 -176.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.65 50.8 5.13 Favored Glycine 0 C--N 1.338 0.674 0 N-CA-C 112.097 -0.401 . . . . 0.0 112.097 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -68.53 -24.1 64.6 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.211 1.004 . . . . 0.0 110.628 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.65 -22.13 42.43 Favored Glycine 0 C--N 1.345 1.045 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.018 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.416 ' HB2' ' O ' ' A' ' 64' ' ' VAL . 43.4 p90 -156.07 172.42 18.44 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.72 0.808 . . . . 0.0 111.466 -175.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.2 m -121.42 -177.07 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 123.87 0.868 . . . . 0.0 110.232 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 70.7 p -83.14 162.17 21.38 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.699 0.8 . . . . 0.0 111.024 175.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.489 ' HB ' ' HA2' ' A' ' 62' ' ' GLY . 9.9 p -64.93 -27.79 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 123.019 0.527 . . . . 0.0 110.285 173.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -67.62 -47.52 69.39 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.51 1.124 . . . . 0.0 110.284 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -71.74 -34.02 69.18 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.251 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.489 ' HA ' ' HE1' ' A' ' 17' ' ' PHE . 5.8 tp -63.11 -55.62 23.79 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.991 0.916 . . . . 0.0 111.12 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.482 ' HG2' HD13 ' A' ' 53' ' ' ILE . 62.1 mtp180 -64.3 -31.46 72.68 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.412 0.685 . . . . 0.0 111.243 -178.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -59.32 -64.02 1.09 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.516 0.726 . . . . 0.0 111.271 178.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.2 p -62.6 -36.25 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.359 0.664 . . . . 0.0 111.726 -176.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 91.4 mt -82.07 -12.44 58.25 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.023 0.529 . . . . 0.0 111.667 -176.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -85.8 -36.35 20.13 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 171.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -66.07 -41.56 90.59 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.505 0.722 . . . . 0.0 110.341 174.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.404 HD23 ' HZ ' ' A' ' 74' ' ' PHE . 64.1 tp -78.55 -28.35 46.03 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.333 1.053 . . . . 0.0 110.192 174.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -88.3 53.69 4.16 Favored Glycine 0 C--N 1.344 1.021 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 175.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -88.09 -56.87 3.15 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.481 0.713 . . . . 0.0 109.367 175.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 57.5 mtm -82.49 -32.41 28.82 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.38 177.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 23.9 mmt -88.4 146.89 38.69 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 123.537 0.735 . . . . 0.0 109.305 174.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -70.21 119.28 6.24 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 121.952 1.768 . . . . 0.0 111.597 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.498 ' O ' ' HG2' ' A' ' 50' ' ' GLU . . . -62.91 -33.7 75.87 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.155 -0.684 . . . . 0.0 109.155 171.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -51.84 -41.07 61.52 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 125.352 1.461 . . . . 0.0 111.845 176.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -64.44 -48.31 75.81 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.217 1.007 . . . . 0.0 110.236 177.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.443 ' O ' HG13 ' A' ' 53' ' ' ILE . 68.3 mt -61.32 -36.46 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.466 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.498 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 15.9 mm-40 -56.63 -47.3 79.99 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.811 0.845 . . . . 0.0 111.075 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -66.03 -26.69 67.64 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 122.878 0.471 . . . . 0.0 111.427 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.525 ' HE3' ' HA ' ' A' ' 73' ' ' LEU . 43.8 mtp -77.23 -29.54 54.13 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.057 0.543 . . . . 0.0 110.459 175.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.482 HD13 ' HG2' ' A' ' 34' ' ' ARG . 96.8 mt -71.96 -24.42 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 123.964 0.906 . . . . 0.0 110.639 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -65.85 -26.1 67.5 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.044 0.538 . . . . 0.0 110.88 169.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -90.13 -28.63 18.83 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.228 0.611 . . . . 0.0 110.283 177.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.0 -42.27 76.7 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.795 0.838 . . . . 0.0 110.41 176.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -140.57 95.6 7.95 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 176.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -74.56 -23.54 14.7 Favored 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 122.749 2.299 . . . . 0.0 112.31 177.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -86.68 -12.24 48.92 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.864 0.865 . . . . 0.0 111.066 -174.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.418 ' N ' HD21 ' A' ' 60' ' ' ASN . 0.8 OUTLIER 64.11 25.74 13.79 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.783 1.233 . . . . 0.0 110.702 179.453 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 37.9 m -69.12 -22.41 63.97 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.703 1.201 . . . . 0.0 112.061 -177.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.489 ' HA2' ' HB ' ' A' ' 30' ' ' VAL . . . 79.33 26.59 57.06 Favored Glycine 0 C--N 1.339 0.733 0 CA-C-N 115.889 -0.596 . . . . 0.0 113.127 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -126.9 95.65 4.38 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.235 1.014 . . . . 0.0 108.693 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.446 HG12 HD22 ' A' ' 33' ' ' LEU . 2.0 p -119.94 125.24 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.958 0.903 . . . . 0.0 110.478 -171.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -72.77 91.03 1.45 Allowed 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 173.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -55.07 -38.03 67.52 Favored 'General case' 0 C--O 1.211 -0.966 0 CA-C-N 114.965 -1.016 . . . . 0.0 113.298 -173.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -65.96 -47.32 75.0 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 117.773 0.261 . . . . 0.0 110.633 -172.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 70.4 p -69.85 -32.28 70.58 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.067 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -68.51 -66.73 0.53 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 122.95 0.5 . . . . 0.0 110.879 176.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.59 ' HA ' ' HB3' ' A' ' 73' ' ' LEU . 52.9 t -47.89 -27.08 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.114 0 C-N-CA 126.435 1.894 . . . . 0.0 113.063 174.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.88 -53.48 37.28 Favored Glycine 0 CA--C 1.534 1.238 0 N-CA-C 112.28 -0.328 . . . . 0.0 112.28 169.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 91.0 mtp -75.26 -15.24 60.54 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.742 0.817 . . . . 0.0 111.944 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.59 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 59.4 tp -82.8 -43.73 16.35 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.882 1.273 . . . . 0.0 109.957 -178.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.404 ' HZ ' HD23 ' A' ' 40' ' ' LEU . 13.1 m-85 -88.5 22.65 2.49 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.821 0.848 . . . . 0.0 112.166 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 79.0 mt -70.73 -8.83 55.07 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 166.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 46.4 m0 -62.24 131.25 48.79 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 123.999 0.92 . . . . 0.0 109.778 168.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 . . . . . 0 CA--C 1.554 1.106 0 C-N-CA 123.314 0.646 . . . . 0.0 110.76 -177.161 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.706 0 N-CA-C 112.384 -0.287 . . . . 0.0 112.384 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.1 p -152.95 103.28 2.73 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.949 0.9 . . . . 0.0 109.578 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 28.3 m80 -138.06 -160.08 1.02 Allowed 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.279 1.032 . . . . 0.0 109.45 177.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 23.9 mmt -50.92 128.71 21.89 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.181 0.592 . . . . 0.0 110.571 174.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -62.68 134.46 56.34 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 123.976 0.798 . . . . 0.0 111.213 -174.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -82.53 72.1 9.6 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.33 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.3 pp -97.75 85.73 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.022 177.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -75.95 76.6 2.84 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.418 -178.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.0 m -153.98 132.65 12.21 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.317 1.047 . . . . 0.0 108.826 177.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -66.46 -30.06 70.32 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.127 0.971 . . . . 0.0 111.434 178.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.1 -47.91 69.74 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.471 175.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -57.7 -38.77 75.79 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.985 0.914 . . . . 0.0 113.15 -174.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.9 p -66.26 -44.03 91.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 75.9 mt -66.62 -34.1 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.044 0.538 . . . . 0.0 109.97 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.452 ' O ' HG21 ' A' ' 19' ' ' VAL . 47.1 mt-10 -73.06 -25.94 61.1 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.331 0.653 . . . . 0.0 111.107 177.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.7 -37.63 86.99 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 121.231 0.538 . . . . 0.0 110.256 174.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.438 ' HE1' ' HA ' ' A' ' 33' ' ' LEU . 89.7 m-85 -67.28 -34.97 78.52 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.929 172.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.473 ' HE3' ' HE1' ' A' ' 66' ' ' TYR . 33.2 mmtp -66.44 -28.6 68.72 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.193 0.597 . . . . 0.0 110.862 176.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.452 HG21 ' O ' ' A' ' 15' ' ' GLU . 93.4 t -65.98 -44.13 92.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.018 0.527 . . . . 0.0 109.747 175.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -67.69 -48.7 65.82 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.355 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -88.04 72.24 9.23 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.697 0.799 . . . . 0.0 109.168 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -31.9 68.94 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.369 177.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -66.2 -28.92 69.12 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.967 178.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.04 41.25 95.26 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-N 115.976 -0.556 . . . . 0.0 113.319 176.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.9 -18.46 60.9 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 122.61 0.364 . . . . 0.0 110.842 178.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.32 -6.86 14.54 Favored Glycine 0 C--N 1.349 1.255 0 CA-C-O 119.625 -0.542 . . . . 0.0 113.737 172.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -157.48 173.82 16.32 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 117.563 0.682 . . . . 0.0 112.365 -175.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.2 m -130.66 179.63 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 124.134 0.973 . . . . 0.0 110.26 178.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 66.7 p -74.31 153.53 39.3 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.919 171.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.56 -26.4 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 122.707 0.403 . . . . 0.0 110.912 177.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -64.38 -50.71 66.6 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.062 0.545 . . . . 0.0 111.144 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -62.1 -41.04 97.81 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.157 0.583 . . . . 0.0 110.444 175.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.622 HD23 HG11 ' A' ' 64' ' ' VAL . 2.8 tp -56.67 -53.28 59.47 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.556 -178.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -65.31 -37.03 85.89 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.631 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -57.25 -58.77 6.78 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 124.258 0.974 . . . . 0.0 111.052 -177.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.456 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 7.5 p -63.26 -46.13 96.51 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 O-C-N 123.506 0.504 . . . . 0.0 111.341 -177.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 95.7 mt -65.57 -30.63 71.4 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.233 0.613 . . . . 0.0 111.761 -176.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -77.47 -38.73 48.65 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.018 0.527 . . . . 0.0 110.234 177.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -78.34 -9.54 59.3 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.303 0.641 . . . . 0.0 111.974 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 36' ' ' VAL . 87.8 mt -73.63 -42.59 61.24 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.653 0.381 . . . . 0.0 110.025 170.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -166.81 89.75 0.1 OUTLIER Glycine 0 C--N 1.35 1.328 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.636 -177.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -69.46 -20.44 63.76 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.75 0.82 . . . . 0.0 110.927 176.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 23.1 mmt -59.84 -32.34 70.59 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.233 1.013 . . . . 0.0 110.711 175.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 21.8 mmt -84.51 141.25 38.96 Favored Pre-proline 0 C--O 1.245 0.867 0 C-N-CA 124.201 1.0 . . . . 0.0 108.849 177.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.59 110.38 2.07 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 121.645 1.564 . . . . 0.0 111.331 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.28 -19.27 64.69 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.272 174.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -48.61 -39.64 24.67 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 125.383 1.473 . . . . 0.0 111.496 175.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.96 -49.25 78.21 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.496 1.118 . . . . 0.0 110.537 177.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 53' ' ' ILE . 87.5 mt -60.88 -43.63 96.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.367 -179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.515 ' HA ' HD12 ' A' ' 53' ' ' ILE . 0.5 OUTLIER -55.66 -37.5 68.35 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.935 0.894 . . . . 0.0 112.639 177.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -72.96 -40.44 65.34 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 121.563 0.697 . . . . 0.0 110.268 177.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.421 ' HE2' ' HA ' ' A' ' 52' ' ' MET . 28.6 mmt -64.66 -26.86 68.57 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.669 -1.151 . . . . 0.0 111.201 178.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.515 HD12 ' HA ' ' A' ' 50' ' ' GLU . 90.8 mt -66.69 -40.04 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 123.566 0.746 . . . . 0.0 110.826 177.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -65.44 -28.2 69.06 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 122.601 0.361 . . . . 0.0 110.908 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -75.74 -42.67 49.94 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.435 0.694 . . . . 0.0 110.904 177.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.57 -26.67 45.59 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.76 0.824 . . . . 0.0 111.802 -176.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -124.51 86.7 55.03 Favored Pre-proline 0 CA--C 1.542 0.673 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 176.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -75.94 -8.51 19.02 Favored 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 123.011 2.474 . . . . 0.0 112.521 -177.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -88.6 -24.03 22.94 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.488 0.715 . . . . 0.0 110.8 174.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.407 HD21 ' N ' ' A' ' 60' ' ' ASN . 0.8 OUTLIER 60.89 37.04 18.7 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 124.323 1.014 . . . . 0.0 109.356 -174.25 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.9 t -74.79 -18.67 60.43 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.595 -176.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.79 23.85 34.55 Favored Glycine 0 C--N 1.337 0.617 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.597 -175.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -139.42 131.26 27.59 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.114 1.366 . . . . 0.0 108.937 -178.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.622 HG11 HD23 ' A' ' 33' ' ' LEU . 2.8 p -145.56 134.77 17.57 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 CA-C-O 121.266 0.555 . . . . 0.0 110.727 -170.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -75.89 89.06 2.9 Favored 'General case' 0 C--N 1.35 0.606 0 C-N-CA 124.294 1.038 . . . . 0.0 108.823 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.473 ' HE1' ' HE3' ' A' ' 18' ' ' LYS . 32.5 p90 -49.94 -39.83 41.68 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 115.629 1.714 . . . . 0.0 115.629 -171.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -67.07 -50.67 61.0 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 118.73 0.695 . . . . 0.0 111.366 -170.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.456 ' O ' ' HG2' ' A' ' 72' ' ' MET . 9.4 t -71.02 -21.2 62.31 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.854 178.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.431 ' CE2' HD21 ' A' ' 33' ' ' LEU . 55.6 t80 -81.97 -58.1 3.13 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.513 0.725 . . . . 0.0 111.307 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.8 t -66.23 -27.88 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.215 1.006 . . . . 0.0 110.743 -177.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -59.82 -32.29 74.23 Favored Glycine 0 CA--C 1.537 1.418 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.681 171.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.456 ' HG2' ' O ' ' A' ' 68' ' ' THR . 26.6 mmt -76.29 -49.76 16.14 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.57 0.748 . . . . 0.0 111.35 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.9 pp -81.02 -2.96 50.12 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -172.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -94.82 -2.37 50.97 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.589 0.356 . . . . 0.0 111.009 169.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 65.2 mt -78.72 -5.67 53.8 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.489 0.316 . . . . 0.0 111.052 173.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 52.5 m0 -61.88 -20.08 63.34 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.581 0.752 . . . . 0.0 111.078 176.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.3 t70 . . . . . 0 C--O 1.256 1.44 0 C-N-CA 124.379 1.072 . . . . 0.0 109.101 173.102 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.358 0 N-CA-C 111.837 -0.505 . . . . 0.0 111.837 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.7 p -65.57 123.62 20.16 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.459 0.704 . . . . 0.0 111.494 -176.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -92.67 -0.92 57.22 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.86 0.864 . . . . 0.0 110.473 176.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 46.4 mtm -74.85 84.27 2.18 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 123.292 0.637 . . . . 0.0 109.315 177.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -74.42 100.26 3.77 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.775 -177.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -82.83 107.27 15.33 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.179 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.1 mp -69.17 -29.04 41.34 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.178 0 C-N-CA 123.355 0.662 . . . . 0.0 109.37 178.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 67.28 21.7 9.81 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 125.207 1.403 . . . . 0.0 111.457 177.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.7 t -81.27 156.84 25.38 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.058 -178.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.533 ' HE2' ' HB3' ' A' ' 74' ' ' PHE . 16.2 ptpt -64.31 -20.75 66.3 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.665 173.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.24 -38.38 90.85 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.147 0.579 . . . . 0.0 110.856 174.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -70.92 -38.11 72.92 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 112.432 0.531 . . . . 0.0 112.432 -176.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.83 -37.23 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 176.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.5 HG22 ' HE1' ' A' ' 66' ' ' TYR . 63.9 mt -63.01 -42.08 95.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.388 0.675 . . . . 0.0 110.219 173.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -62.01 -32.95 73.48 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.852 0.861 . . . . 0.0 111.175 177.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.23 -38.07 79.06 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.161 0.584 . . . . 0.0 111.193 177.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.433 ' CZ ' HD13 ' A' ' 33' ' ' LEU . 96.2 m-85 -68.74 -37.08 79.16 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.269 175.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.424 ' HG3' ' O ' ' A' ' 14' ' ' ILE . 21.3 mtpp -71.76 -35.01 69.94 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.104 0.562 . . . . 0.0 111.045 -175.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 91.4 t -71.01 -35.34 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.757 0.823 . . . . 0.0 110.07 176.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -66.48 -54.25 26.09 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.427 175.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.464 ' HB2' HG23 ' A' ' 28' ' ' VAL . 21.7 t70 -77.25 86.33 3.69 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.572 0.701 . . . . 0.0 109.922 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 42.5 mtp180 -88.96 -1.19 57.99 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.041 172.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -84.41 -26.85 28.02 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.004 0.922 . . . . 0.0 111.201 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.08 47.68 23.14 Favored Glycine 0 C--N 1.345 1.053 0 O-C-N 123.478 0.486 . . . . 0.0 112.274 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -91.38 17.6 8.27 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.442 0.697 . . . . 0.0 111.616 -178.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.33 -60.36 4.89 Favored Glycine 0 C--N 1.344 1.024 0 N-CA-C 111.784 -0.526 . . . . 0.0 111.784 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -124.73 -171.75 2.42 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.494 1.117 . . . . 0.0 110.322 -177.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.464 HG23 ' HB2' ' A' ' 21' ' ' ASP . 76.8 t -126.57 151.3 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.508 1.123 . . . . 0.0 109.675 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 58.5 p -66.98 165.32 15.83 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.143 0.977 . . . . 0.0 112.592 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.4 p -69.83 -18.92 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.491 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -63.63 -46.78 84.15 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.018 0.527 . . . . 0.0 111.41 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -79.83 -29.99 40.31 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.823 176.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.532 HD21 HG13 ' A' ' 64' ' ' VAL . 12.0 tp -57.02 -45.53 83.03 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.175 0.59 . . . . 0.0 110.689 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 75.5 mtt180 -67.28 -41.96 84.62 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.354 176.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -54.18 -51.08 65.51 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.812 0.845 . . . . 0.0 111.812 -176.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.5 p -73.82 -34.2 39.59 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.582 -175.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 91.8 mt -86.09 -10.42 54.93 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 122.04 -0.413 . . . . 0.0 111.883 -177.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -83.06 -42.08 17.87 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.128 0.571 . . . . 0.0 109.948 176.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -73.86 -40.1 63.49 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.507 0.723 . . . . 0.0 111.132 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 96.9 mt -76.69 -33.0 58.26 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.891 0.477 . . . . 0.0 110.61 177.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -87.52 65.07 3.65 Favored Glycine 0 C--N 1.347 1.18 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 176.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -84.07 -58.36 2.8 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.322 0.649 . . . . 0.0 109.443 177.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.426 ' HE2' ' HG2' ' A' ' 44' ' ' MET . 0.0 OUTLIER -78.3 -22.02 48.82 Favored 'General case' 0 CA--C 1.551 1.003 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.299 177.039 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.426 ' HG2' ' HE2' ' A' ' 43' ' ' MET . 96.9 mmm -87.92 128.3 54.56 Favored Pre-proline 0 N--CA 1.478 0.969 0 C-N-CA 123.65 0.78 . . . . 0.0 110.204 178.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -65.54 121.78 9.27 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 122.86 2.373 . . . . 0.0 111.485 172.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.96 -12.83 61.76 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.81 0.844 . . . . 0.0 111.897 -177.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.483 ' O ' ' HG2' ' A' ' 51' ' ' GLU . 5.8 m-20 -52.45 -52.65 53.07 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.632 1.173 . . . . 0.0 111.363 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -60.19 -46.85 88.31 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 124.058 0.849 . . . . 0.0 111.02 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.0 mt -57.99 -38.56 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.056 178.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.406 ' O ' ' HD1' ' A' ' 54' ' ' TYR . 75.2 mm-40 -67.41 -41.43 84.89 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.127 0.571 . . . . 0.0 111.547 178.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 47' ' ' ASP . 8.7 mm-40 -60.35 -43.3 96.63 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.798 0.809 . . . . 0.0 109.791 177.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.446 ' HG3' ' HZ2' ' A' ' 76' ' ' TRP . 76.5 mmm -66.66 -32.88 74.49 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 113.57 -1.65 . . . . 0.0 111.52 176.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.4 mt -64.29 -42.72 96.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 C-N-CA 124.089 0.956 . . . . 0.0 110.235 176.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.406 ' HD1' ' O ' ' A' ' 50' ' ' GLU . 24.7 m-85 -78.07 -9.39 59.12 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.712 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -99.15 -16.95 18.41 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.287 0.635 . . . . 0.0 111.405 170.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.72 -28.97 22.76 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.626 0.77 . . . . 0.0 110.324 173.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -138.83 76.54 34.29 Favored Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 175.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -78.77 -11.56 15.28 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 123.252 2.635 . . . . 0.0 113.512 -176.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -87.43 -11.8 48.06 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.213 0.605 . . . . 0.0 111.254 -178.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.5 t30 60.31 54.83 3.79 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 122.167 0.984 . . . . 0.0 109.277 -175.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.9 m -99.19 -17.2 18.26 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.527 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.61 15.22 81.4 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.354 -172.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -114.79 109.94 18.94 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.684 0.794 . . . . 0.0 109.645 -173.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.532 HG13 HD21 ' A' ' 33' ' ' LEU . 2.7 p -136.84 123.2 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 123.731 0.812 . . . . 0.0 110.121 -175.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -72.57 100.62 2.8 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 172.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.5 ' HE1' HG22 ' A' ' 14' ' ' ILE . 48.1 p90 -59.94 -37.79 80.54 Favored 'General case' 0 C--O 1.214 -0.785 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.681 -171.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -66.75 -33.84 76.52 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 118.076 0.398 . . . . 0.0 110.316 -177.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 19.1 m -67.2 -50.73 59.84 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 123.81 0.844 . . . . 0.0 110.446 175.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.432 ' HD2' HD11 ' A' ' 33' ' ' LEU . 63.0 t80 -70.63 -62.35 1.42 Allowed 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.982 -174.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 74.5 t -57.19 -30.62 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.63 1.172 . . . . 0.0 110.83 175.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.68 -55.4 30.08 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-N 116.298 -0.41 . . . . 0.0 112.458 172.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 24.4 ptp -72.68 -24.18 60.98 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -175.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.53 -26.9 29.74 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.533 ' HB3' ' HE2' ' A' ' 10' ' ' LYS . 22.8 m-85 -86.69 6.3 31.9 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 122.612 0.365 . . . . 0.0 111.03 170.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 76.9 mt -100.72 15.41 28.38 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.684 0.794 . . . . 0.0 110.602 168.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.446 ' HZ2' ' HG3' ' A' ' 52' ' ' MET . 54.6 m0 -80.25 59.95 3.55 Favored 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 170.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.6 t70 . . . . . 0 C--O 1.247 0.954 0 C-N-CA 123.926 0.891 . . . . 0.0 109.618 -175.834 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.407 0 N-CA-C 111.771 -0.531 . . . . 0.0 111.771 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.9 p -155.19 145.18 21.64 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.661 0.785 . . . . 0.0 110.069 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.4 p-80 -158.66 87.05 0.87 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.703 1.201 . . . . 0.0 108.652 177.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.4 ttt -88.0 41.89 1.03 Allowed 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.376 0.67 . . . . 0.0 110.78 -174.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 73.37 -30.66 0.21 Allowed 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 125.305 1.442 . . . . 0.0 113.878 173.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.8 t60 -83.11 72.61 10.12 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.659 0.784 . . . . 0.0 109.678 -176.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.465 HG23 HG23 ' A' ' 9' ' ' THR . 19.5 mm -122.52 110.8 27.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 172.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -109.0 91.18 3.54 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.465 HG23 HG23 ' A' ' 7' ' ' ILE . 11.6 t -173.2 157.36 3.39 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.808 0.843 . . . . 0.0 110.92 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.15 -18.48 46.22 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.041 0.937 . . . . 0.0 110.848 171.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.17 -42.23 98.2 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.008 0.923 . . . . 0.0 112.077 -175.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -56.19 -41.91 76.28 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 124.038 0.935 . . . . 0.0 112.611 -173.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.448 HG11 HG12 ' A' ' 70' ' ' VAL . 4.3 p -82.71 -35.96 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 123.583 0.753 . . . . 0.0 109.941 -174.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 71.2 mt -61.84 -32.63 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 123.328 0.651 . . . . 0.0 110.052 172.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -67.88 -38.11 82.62 Favored 'General case' 0 C--N 1.349 0.548 0 C-N-CA 123.682 0.793 . . . . 0.0 110.781 175.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.27 -40.01 76.83 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 122.899 0.48 . . . . 0.0 111.268 177.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.413 ' CE1' HD11 ' A' ' 33' ' ' LEU . 80.6 m-85 -64.54 -53.2 51.77 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.472 0.709 . . . . 0.0 112.001 178.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.605 ' HB3' ' HZ1' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -68.87 -25.99 64.9 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -175.978 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.3 t -70.37 -37.5 70.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 122.646 0.378 . . . . 0.0 110.11 172.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -66.68 -40.45 88.58 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.28 174.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -76.63 81.06 3.29 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.792 0.806 . . . . 0.0 109.887 -176.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 69.6 mtp180 -92.96 -14.86 26.95 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.036 -1.438 . . . . 0.0 109.703 175.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -74.65 -28.42 60.85 Favored 'General case' 0 C--N 1.356 0.848 0 C-N-CA 123.383 0.673 . . . . 0.0 110.253 176.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.22 56.09 3.32 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-N 116.329 -0.396 . . . . 0.0 113.279 175.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -88.27 -21.59 24.37 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.804 0.841 . . . . 0.0 110.413 175.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.33 -40.9 2.49 Favored Glycine 0 C--N 1.348 1.204 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 -173.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.4 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 44.5 p90 -119.47 -176.0 3.06 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.958 1.303 . . . . 0.0 109.518 174.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 55.2 t -127.64 159.51 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 124.244 1.017 . . . . 0.0 109.467 -177.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.3 p -72.81 166.81 22.18 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.655 1.182 . . . . 0.0 111.771 177.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.9 p -75.3 -14.8 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 122.999 0.52 . . . . 0.0 111.331 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -69.45 -57.63 5.0 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 122.578 0.351 . . . . 0.0 110.83 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -64.29 -30.56 71.61 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.643 0.377 . . . . 0.0 110.534 176.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.521 HD21 HG13 ' A' ' 64' ' ' VAL . 10.4 tp -56.69 -58.66 7.11 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.169 176.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 46.6 mtt85 -62.45 -28.24 69.67 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.794 0.838 . . . . 0.0 112.116 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -62.37 -62.79 1.51 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.278 0.631 . . . . 0.0 110.865 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.3 p -66.82 -28.3 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.169 0.588 . . . . 0.0 111.686 -175.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 84.1 mt -87.56 -11.93 47.24 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.223 0.609 . . . . 0.0 112.224 -177.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -76.84 -35.38 57.56 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 166.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -75.34 -35.03 61.23 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.129 0.971 . . . . 0.0 110.464 177.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -74.73 -43.36 55.4 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 175.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -87.2 61.32 4.28 Favored Glycine 0 C--N 1.345 1.078 0 N-CA-C 110.269 -1.133 . . . . 0.0 110.269 175.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -60.32 -47.91 84.0 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.358 1.063 . . . . 0.0 111.445 -173.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 64.4 mtm -125.88 1.0 7.36 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.699 0.8 . . . . 0.0 110.006 172.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 63.4 mtt -80.94 137.27 50.14 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 123.445 0.698 . . . . 0.0 109.38 175.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.7 122.54 10.67 Favored 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.64 2.227 . . . . 0.0 112.87 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.51 -18.48 65.39 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.702 0.801 . . . . 0.0 110.631 170.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -50.4 -43.13 54.58 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.766 1.227 . . . . 0.0 111.164 173.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -63.54 -53.28 54.29 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.431 0.693 . . . . 0.0 110.514 175.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 53' ' ' ILE . 88.5 mt -59.93 -37.26 71.4 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 CA-C-N 114.823 -1.08 . . . . 0.0 111.769 -174.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -71.68 -30.41 65.67 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.343 0.657 . . . . 0.0 112.024 -175.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -67.77 -39.96 84.07 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 121.53 0.681 . . . . 0.0 109.379 172.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.422 ' HG3' ' HZ2' ' A' ' 76' ' ' TRP . 69.7 mmm -68.55 -32.94 73.23 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.428 -1.26 . . . . 0.0 110.392 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 49' ' ' ILE . 58.4 mt -58.63 -42.59 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 123.821 0.848 . . . . 0.0 110.065 178.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -73.31 -9.74 59.02 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.556 0.743 . . . . 0.0 112.305 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -85.9 -29.94 23.25 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 120.975 0.417 . . . . 0.0 110.103 172.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -94.04 -19.68 20.64 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.791 0.837 . . . . 0.0 111.421 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -144.85 71.81 15.08 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 124.736 1.214 . . . . 0.0 107.897 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.03 -17.35 22.27 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 122.858 2.372 . . . . 0.0 112.609 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.508 ' HG3' ' H ' ' A' ' 61' ' ' SER . 27.7 pt20 -70.86 -20.26 62.55 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.303 1.041 . . . . 0.0 111.645 178.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.7 t30 67.7 6.95 5.34 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 124.877 1.271 . . . . 0.0 111.115 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.508 ' H ' ' HG3' ' A' ' 59' ' ' GLN . 34.8 t -78.61 -17.67 55.7 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.531 0.732 . . . . 0.0 111.313 -173.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.03 34.42 8.25 Favored Glycine 0 C--N 1.341 0.819 0 O-C-N 123.314 0.384 . . . . 0.0 113.87 172.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -127.38 96.14 4.48 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.252 1.021 . . . . 0.0 108.493 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.521 HG13 HD21 ' A' ' 33' ' ' LEU . 3.3 p -118.03 130.28 73.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 124.031 0.933 . . . . 0.0 111.312 -166.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -75.05 90.41 2.48 Favored 'General case' 0 C--N 1.351 0.644 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 170.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.4 ' CE2' ' HA ' ' A' ' 27' ' ' TYR . 42.3 p90 -57.37 -29.87 64.4 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.043 -0.981 . . . . 0.0 113.41 -173.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -60.65 -63.54 1.26 Allowed 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 118.105 0.411 . . . . 0.0 110.858 -174.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.7 t -64.68 -30.04 71.05 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.558 0.743 . . . . 0.0 111.623 -177.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.462 ' CD2' HD12 ' A' ' 33' ' ' LEU . 32.4 t80 -70.42 -55.11 9.83 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.522 0.729 . . . . 0.0 111.858 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.448 HG12 HG11 ' A' ' 13' ' ' VAL . 82.7 t -65.06 -24.86 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.472 0.709 . . . . 0.0 110.188 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.447 ' O ' ' HG ' ' A' ' 75' ' ' LEU . . . -56.4 -53.55 42.35 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.532 165.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.485 ' HA ' HD13 ' A' ' 75' ' ' LEU . 85.0 mtp -59.53 -35.97 75.23 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.896 0.878 . . . . 0.0 112.605 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 70' ' ' VAL . 92.5 mt -62.88 -42.06 99.63 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 121.419 0.628 . . . . 0.0 110.584 176.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -88.23 -0.07 56.68 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.163 -178.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.485 HD13 ' HA ' ' A' ' 72' ' ' MET . 82.0 mt -86.06 4.15 39.31 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.581 0.752 . . . . 0.0 110.869 170.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.422 ' HZ2' ' HG3' ' A' ' 52' ' ' MET . 51.4 m0 -75.59 76.01 2.6 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 171.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 . . . . . 0 C--O 1.247 0.944 0 CA-C-O 118.286 -0.864 . . . . 0.0 109.254 178.163 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.632 0 CA-C-O 119.577 -0.568 . . . . 0.0 111.849 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.5 p -69.77 108.71 4.05 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.162 0.985 . . . . 0.0 110.488 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -79.89 -33.07 40.25 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.365 0.666 . . . . 0.0 111.091 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.9 mmt -68.38 97.07 0.72 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.966 0.506 . . . . 0.0 109.888 176.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -81.61 74.58 8.6 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 108.66 -0.866 . . . . 0.0 108.66 177.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -153.04 133.95 13.97 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.404 1.482 . . . . 0.0 107.533 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 36.8 mm -80.61 81.2 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -73.6 -41.98 62.13 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.402 -0.817 . . . . 0.0 108.902 173.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.2 t -131.98 164.07 26.98 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.769 176.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -68.94 -12.8 61.98 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.519 0.728 . . . . 0.0 111.785 -177.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.455 ' O ' ' HG2' ' A' ' 15' ' ' GLU . . . -71.23 -30.46 66.37 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.09 0.556 . . . . 0.0 111.461 174.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -58.0 -36.82 73.2 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.615 0.766 . . . . 0.0 112.521 -176.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.6 p -77.33 -34.45 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 122.633 0.373 . . . . 0.0 110.487 177.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.5 mt -65.6 -30.14 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 123.556 0.743 . . . . 0.0 110.516 178.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.478 ' HA ' ' HE2' ' A' ' 18' ' ' LYS . 26.1 mm-40 -59.09 -43.49 91.84 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.474 0.709 . . . . 0.0 109.911 172.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.34 -28.36 67.91 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.812 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -73.82 -54.29 8.33 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.971 0.509 . . . . 0.0 111.609 176.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.478 ' HE2' ' HA ' ' A' ' 15' ' ' GLU . 64.4 pttt -73.99 -17.5 60.99 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -170.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.6 p -69.14 -33.48 58.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 CA-C-N 117.917 0.326 . . . . 0.0 110.124 172.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -77.71 -45.48 24.67 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.96 0.904 . . . . 0.0 109.64 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -78.21 72.9 4.77 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 174.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.426 ' HA ' ' NE ' ' A' ' 22' ' ' ARG . 1.6 tpm_? -80.5 -28.43 37.48 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.992 -166.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -70.3 -25.67 63.43 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.823 0.449 . . . . 0.0 110.927 176.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.22 50.16 5.94 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 -173.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -75.82 -10.68 59.63 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.58 0.752 . . . . 0.0 110.597 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.39 -29.27 12.25 Favored Glycine 0 C--N 1.35 1.358 0 CA-C-N 116.121 -0.49 . . . . 0.0 112.174 176.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -145.09 164.03 32.47 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-O 121.09 0.472 . . . . 0.0 111.312 -172.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.6 m -117.74 178.61 2.0 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.846 0 CA-C-N 114.77 -1.104 . . . . 0.0 109.864 176.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.8 p -81.38 156.36 25.47 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.652 173.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.548 HG21 HG23 ' A' ' 53' ' ' ILE . 7.7 p -57.97 -37.35 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.95 0.9 . . . . 0.0 112.041 177.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -62.54 -47.83 82.16 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 123.618 0.574 . . . . 0.0 111.197 -174.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -66.76 -41.82 87.13 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.298 176.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.419 HD23 ' CE2' ' A' ' 69' ' ' PHE . 5.1 tt -63.39 -32.78 74.3 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.568 -176.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 47.9 mtm105 -74.12 -38.88 63.67 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.921 0.488 . . . . 0.0 110.679 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -60.43 -52.52 64.86 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.052 0.845 . . . . 0.0 111.508 -176.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.1 p -62.77 -41.44 92.47 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.651 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 86.1 mt -78.28 -16.32 57.89 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -177.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -80.77 -46.7 15.01 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.933 0.493 . . . . 0.0 110.292 176.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -67.98 -23.54 65.05 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.042 0.537 . . . . 0.0 111.982 -175.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.6 pp -98.13 -32.24 11.7 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.54 0.336 . . . . 0.0 110.726 173.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -106.7 39.6 2.82 Favored Glycine 0 C--N 1.345 1.06 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.648 -175.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -75.66 -26.87 58.04 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.201 1.0 . . . . 0.0 110.355 175.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 53.9 mtm -73.86 -33.38 64.06 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.191 0.996 . . . . 0.0 110.846 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 64.1 mtm -92.95 156.31 40.63 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 123.788 0.835 . . . . 0.0 109.647 176.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.07 111.59 2.91 Favored 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 121.551 1.501 . . . . 0.0 111.311 169.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.02 -12.47 61.54 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.478 0.711 . . . . 0.0 110.92 174.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -51.62 -55.49 19.02 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.011 1.324 . . . . 0.0 110.766 174.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.455 ' O ' ' HG2' ' A' ' 52' ' ' MET . 38.8 tt0 -68.04 -35.16 77.79 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.11 -178.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.469 ' O ' HG13 ' A' ' 53' ' ' ILE . 93.6 mt -58.96 -39.81 78.96 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 123.219 0.607 . . . . 0.0 110.506 173.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.526 ' HA ' HD13 ' A' ' 53' ' ' ILE . 49.6 mt-10 -67.09 -35.1 79.06 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.78 0.432 . . . . 0.0 110.947 177.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -62.83 -36.32 82.83 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.575 0.35 . . . . 0.0 110.803 173.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.455 ' HG2' ' O ' ' A' ' 48' ' ' GLU . 30.2 mmt -69.68 -33.04 72.0 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.466 0.706 . . . . 0.0 110.453 177.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.548 HG23 HG21 ' A' ' 30' ' ' VAL . 81.3 mt -69.23 -32.2 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.823 0.849 . . . . 0.0 110.303 174.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -71.59 -12.43 61.35 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.577 0.751 . . . . 0.0 111.459 175.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -94.95 -35.19 12.1 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.52 0.728 . . . . 0.0 110.138 174.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.94 -31.13 56.41 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.765 0.826 . . . . 0.0 111.07 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -137.81 91.32 13.63 Favored Pre-proline 0 CA--C 1.55 0.973 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 172.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -85.12 4.73 6.61 Favored 'Trans proline' 0 C--N 1.371 1.746 0 C-N-CA 122.898 2.399 . . . . 0.0 113.855 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -103.6 -11.18 17.87 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.178 0.591 . . . . 0.0 111.851 -176.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.2 t30 66.71 22.83 10.3 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 124.177 0.991 . . . . 0.0 109.847 -176.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 46.9 m -64.47 -39.99 94.84 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 124.718 1.207 . . . . 0.0 110.807 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.97 24.7 16.41 Favored Glycine 0 C--N 1.344 0.976 0 CA-C-N 114.995 -1.002 . . . . 0.0 113.191 176.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -127.42 95.27 4.21 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.496 1.119 . . . . 0.0 108.787 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 p -119.11 126.02 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 123.527 0.731 . . . . 0.0 110.407 -171.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -70.24 98.98 1.45 Allowed 'General case' 0 C--N 1.347 0.458 0 C-N-CA 124.152 0.981 . . . . 0.0 110.593 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -63.27 -33.4 75.42 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -176.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -64.91 -46.73 80.44 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 120.883 0.373 . . . . 0.0 110.955 -175.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 54.6 p -77.31 -38.15 51.19 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.407 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.419 ' CE2' HD23 ' A' ' 33' ' ' LEU . 41.8 t80 -65.12 -72.05 0.17 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.062 0.545 . . . . 0.0 110.975 -178.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.555 ' HA ' ' HB3' ' A' ' 73' ' ' LEU . 96.9 t -50.08 -29.56 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 125.162 1.385 . . . . 0.0 112.309 177.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.75 -53.44 45.26 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 121.048 0.249 . . . . 0.0 112.769 170.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 67.7 mtm -87.03 -2.13 58.39 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.281 1.033 . . . . 0.0 111.956 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.555 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 50.7 tp -90.24 -48.01 7.42 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.263 1.025 . . . . 0.0 109.363 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -78.41 27.89 0.2 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.105 0.962 . . . . 0.0 112.608 -177.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.2 0.33 19.48 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.361 0.665 . . . . 0.0 112.033 172.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 13.3 m0 -51.6 123.73 10.62 Favored 'General case' 0 C--N 1.351 0.636 0 C-N-CA 124.632 1.173 . . . . 0.0 110.948 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.2 t70 . . . . . 0 C--O 1.249 1.03 0 C-N-CA 123.5 0.72 . . . . 0.0 110.221 -176.872 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.297 0 CA-C-O 120.241 -0.199 . . . . 0.0 113.007 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.5 m -73.54 -47.98 36.61 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.397 0.679 . . . . 0.0 111.836 -175.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -120.45 146.39 46.28 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.038 0.535 . . . . 0.0 110.452 -177.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -78.21 -10.51 59.68 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.627 0.771 . . . . 0.0 111.705 -178.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -83.02 68.16 9.4 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.713 0.805 . . . . 0.0 110.368 -176.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -78.29 87.57 4.35 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 114.832 -1.077 . . . . 0.0 109.484 177.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.7 tt -75.81 124.78 34.54 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 CA-C-N 114.565 -1.198 . . . . 0.0 110.531 -175.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -106.24 83.83 1.95 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.183 0.993 . . . . 0.0 108.657 175.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.471 ' O ' ' HG2' ' A' ' 12' ' ' GLN . 91.1 m -144.21 123.78 13.24 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.027 0.931 . . . . 0.0 108.775 -177.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.424 ' H ' ' HD3' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -72.32 -4.98 33.01 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -176.927 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.455 ' O ' ' HG2' ' A' ' 15' ' ' GLU . . . -58.75 -43.08 90.18 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.469 0.308 . . . . 0.0 110.572 170.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 9' ' ' THR . 27.0 pt20 -67.25 -34.39 77.33 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.492 0.717 . . . . 0.0 111.991 -173.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.6 p -75.3 -37.14 38.33 Favored 'Isoleucine or valine' 0 C--N 1.355 0.828 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -178.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.4 mt -62.85 -37.28 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 174.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 68.0 mm-40 -59.99 -45.03 94.05 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 122.877 0.471 . . . . 0.0 110.161 172.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.26 -27.45 69.02 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.657 0.783 . . . . 0.0 112.138 -178.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.46 ' HE1' ' HA ' ' A' ' 33' ' ' LEU . 65.2 m-85 -77.7 -42.61 33.84 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.719 0.408 . . . . 0.0 111.179 173.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -70.4 -23.18 62.71 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.924 0.49 . . . . 0.0 112.114 -174.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 23.8 m -75.95 -28.61 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-O 120.663 0.268 . . . . 0.0 110.552 175.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -74.6 -42.04 59.37 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.74 0.816 . . . . 0.0 109.052 174.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -75.2 85.2 2.4 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.026 0.93 . . . . 0.0 108.824 175.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 68.5 ttt-85 -65.61 -48.49 72.09 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.789 -1.096 . . . . 0.0 112.456 -172.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -87.47 -3.5 59.0 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -170.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.69 41.74 63.66 Favored Glycine 0 C--N 1.345 1.03 0 N-CA-C 112.171 -0.372 . . . . 0.0 112.171 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -70.51 -17.99 62.95 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.919 0.888 . . . . 0.0 110.701 -178.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.29 -43.58 1.61 Allowed Glycine 0 C--N 1.346 1.108 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.498 175.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.489 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 50.9 p90 -136.6 176.19 8.92 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.186 0.594 . . . . 0.0 111.799 -172.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.0 m -123.64 -177.97 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 124.02 0.928 . . . . 0.0 110.529 -177.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 49.7 p -75.75 153.82 36.76 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 123.554 0.742 . . . . 0.0 110.235 173.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.6 p -63.06 -27.0 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.327 0.651 . . . . 0.0 111.343 178.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -59.96 -58.79 7.03 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.526 1.13 . . . . 0.0 110.624 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -61.77 -34.16 75.37 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 123.752 0.657 . . . . 0.0 110.975 -178.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.528 HD21 HG13 ' A' ' 64' ' ' VAL . 7.1 tp -58.69 -52.15 66.91 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.768 178.103 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 54.9 mtt180 -64.58 -35.29 80.52 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.369 0.668 . . . . 0.0 111.435 -178.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -63.46 -51.85 63.87 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.475 0.71 . . . . 0.0 111.828 -177.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.2 p -73.0 -30.38 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.46 -175.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 81.2 mt -85.28 -11.95 53.56 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.672 0.389 . . . . 0.0 111.371 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -85.46 -33.01 21.97 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.198 0.599 . . . . 0.0 110.078 173.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -80.43 -41.4 24.56 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 110.624 -0.139 . . . . 0.0 110.624 178.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 94.3 mt -74.07 -27.65 61.01 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.601 0.361 . . . . 0.0 110.233 174.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -96.68 52.09 1.51 Allowed Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.4 173.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -65.95 -51.07 61.77 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.748 0.819 . . . . 0.0 111.041 -175.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -92.4 -3.28 55.52 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.134 0.574 . . . . 0.0 111.029 177.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 74.8 mtp -94.4 144.66 28.35 Favored Pre-proline 0 N--CA 1.48 1.071 0 C-N-CA 123.611 0.765 . . . . 0.0 110.141 -176.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -66.52 111.39 2.08 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.684 2.256 . . . . 0.0 111.828 172.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.36 -27.77 63.58 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.305 0.642 . . . . 0.0 111.293 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -62.02 -34.34 76.03 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 122.703 0.401 . . . . 0.0 111.738 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -71.2 -39.15 71.96 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 176.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.484 ' O ' HG13 ' A' ' 53' ' ' ILE . 89.1 mt -64.4 -42.13 94.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 123.234 0.614 . . . . 0.0 109.776 176.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.502 ' HA ' HD12 ' A' ' 53' ' ' ILE . 46.9 mt-10 -75.05 -19.84 59.83 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.918 0.887 . . . . 0.0 111.032 -178.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -72.13 -45.02 62.21 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.685 0.794 . . . . 0.0 109.149 169.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.451 ' SD ' ' HZ2' ' A' ' 76' ' ' TRP . 48.8 mtp -67.7 -18.99 65.11 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.344 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.502 HD12 ' HA ' ' A' ' 50' ' ' GLU . 73.6 mt -68.03 -29.31 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.405 0.682 . . . . 0.0 111.38 176.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -60.37 -32.96 71.78 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.106 0.562 . . . . 0.0 110.484 173.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -85.3 -35.8 21.26 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.334 1.054 . . . . 0.0 110.448 178.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.18 -33.01 74.79 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.985 0.914 . . . . 0.0 111.569 -178.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -123.82 90.07 50.96 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 105.056 -2.202 . . . . 0.0 105.056 171.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -65.65 -23.35 56.72 Favored 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 123.148 2.566 . . . . 0.0 112.788 -175.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -86.39 -17.27 34.83 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.765 0.826 . . . . 0.0 109.332 179.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.405 ' N ' HD21 ' A' ' 60' ' ' ASN . 0.8 OUTLIER 59.03 43.57 17.43 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.354 1.061 . . . . 0.0 110.318 178.843 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.0 m -79.76 -26.86 40.55 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.241 1.016 . . . . 0.0 112.156 -177.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 96.9 9.33 56.28 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.351 -169.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -118.35 99.89 7.13 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.63 1.172 . . . . 0.0 108.415 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.528 HG13 HD21 ' A' ' 33' ' ' LEU . 7.3 p -112.87 136.66 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-O 121.158 0.504 . . . . 0.0 111.425 -170.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -85.24 99.2 10.95 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.005 173.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.489 ' CE2' ' HA ' ' A' ' 27' ' ' TYR . 34.1 p90 -59.95 -35.4 74.86 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.615 -177.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -63.1 -45.04 93.91 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 122.791 0.436 . . . . 0.0 111.032 -173.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.5 t -78.48 -24.8 45.73 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.111 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.433 ' HD2' HD12 ' A' ' 33' ' ' LEU . 26.3 t80 -79.89 -74.14 0.32 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.349 0.259 . . . . 0.0 110.486 178.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.501 ' HA ' ' HB3' ' A' ' 73' ' ' LEU . 87.0 t -49.91 -24.22 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 C-N-CA 126.158 1.783 . . . . 0.0 113.083 178.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.461 ' O ' ' HG ' ' A' ' 75' ' ' LEU . . . -64.44 -57.87 11.88 Favored Glycine 0 CA--C 1.539 1.557 0 CA-C-O 119.911 -0.383 . . . . 0.0 112.379 171.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -75.61 -21.1 58.07 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 123.363 0.665 . . . . 0.0 111.345 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.501 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 51.2 tp -68.71 -42.87 77.11 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.147 1.379 . . . . 0.0 110.16 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -85.84 -5.83 59.18 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.708 176.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 71' ' ' GLY . 54.2 mt -91.9 21.22 5.05 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.155 0.582 . . . . 0.0 111.593 174.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.451 ' HZ2' ' SD ' ' A' ' 52' ' ' MET . 30.8 m0 -64.12 104.64 0.76 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.481 0.312 . . . . 0.0 110.264 171.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 C--O 1.26 1.617 0 C-N-CA 123.715 0.806 . . . . 0.0 109.986 179.101 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.804 0 N-CA-C 112.284 -0.326 . . . . 0.0 112.284 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.7 m -114.56 171.49 7.6 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.814 0.846 . . . . 0.0 110.276 -179.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -70.76 -45.17 65.24 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.011 0.524 . . . . 0.0 110.43 176.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 62.5 mtm 61.55 97.96 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.113 1.365 . . . . 0.0 112.624 173.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -153.75 104.8 2.73 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.876 0.47 . . . . 0.0 110.077 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.8 p-80 -77.73 92.05 4.13 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 169.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.558 ' HB ' ' HG3' ' A' ' 12' ' ' GLN . 34.7 mt -71.04 133.0 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.348 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -73.41 7.63 2.2 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.974 0.909 . . . . 0.0 112.982 -176.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.0 m -65.34 131.16 45.74 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.187 0.595 . . . . 0.0 110.262 173.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -74.85 -11.17 60.08 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.83 0.852 . . . . 0.0 112.65 -176.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.03 -42.37 63.24 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 122.959 0.504 . . . . 0.0 109.899 169.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.558 ' HG3' ' HB ' ' A' ' 7' ' ' ILE . 23.5 mm-40 -55.72 -39.42 71.05 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.33 1.052 . . . . 0.0 112.973 -175.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.1 p -66.03 -41.55 89.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 178.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 64.3 mt -68.91 -29.96 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.35 0.66 . . . . 0.0 110.245 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.445 ' HA ' ' HE2' ' A' ' 18' ' ' LYS . 42.5 mt-10 -76.38 -24.01 54.11 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.832 0.853 . . . . 0.0 111.397 177.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.0 -34.56 78.03 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.222 0.609 . . . . 0.0 110.718 175.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -64.47 -31.57 72.83 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.032 173.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.445 ' HE2' ' HA ' ' A' ' 15' ' ' GLU . 54.3 mtmt -81.06 -12.59 59.29 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.36 0.664 . . . . 0.0 111.906 -178.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.0 t -75.16 -35.18 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 169.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -74.55 -55.75 5.59 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.113 0.565 . . . . 0.0 109.797 175.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -85.54 89.09 7.62 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.872 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 32.2 ttm-85 -85.07 -23.95 28.31 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.953 172.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -64.65 -25.63 68.04 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.542 1.137 . . . . 0.0 111.841 -176.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.89 38.21 23.89 Favored Glycine 0 C--N 1.344 1.015 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 178.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -64.66 -25.24 67.87 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.555 1.142 . . . . 0.0 110.502 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.79 -35.99 4.3 Favored Glycine 0 C--N 1.347 1.162 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.478 ' HB2' ' O ' ' A' ' 64' ' ' VAL . 44.0 p90 -133.15 179.9 5.9 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 124.049 0.939 . . . . 0.0 109.647 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.0 p -134.1 173.88 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.213 0.605 . . . . 0.0 110.152 -172.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 44.5 p -73.39 145.99 45.46 Favored 'General case' 0 C--O 1.245 0.82 0 C-N-CA 123.404 0.682 . . . . 0.0 110.601 171.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.447 HG22 HG22 ' A' ' 53' ' ' ILE . 0.8 OUTLIER -70.47 -20.65 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 122.633 0.373 . . . . 0.0 110.594 -179.315 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -62.62 -53.85 48.38 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.631 0.772 . . . . 0.0 110.639 174.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 93.2 t80 -61.64 -39.64 92.04 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 122.94 0.496 . . . . 0.0 110.686 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.6 tp -53.86 -46.61 71.33 Favored 'General case' 0 CA--C 1.554 1.125 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.442 176.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.428 ' HG3' ' O ' ' A' ' 30' ' ' VAL . 69.4 mtt180 -62.3 -35.84 80.28 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.758 0.823 . . . . 0.0 111.942 -178.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 55.1 mttm -63.27 -60.97 2.7 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 123.679 0.612 . . . . 0.0 110.901 -176.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.4 p -62.25 -34.19 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 123.672 0.789 . . . . 0.0 112.351 -174.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.407 ' HB3' HG21 ' A' ' 49' ' ' ILE . 96.7 mt -77.39 -26.51 51.86 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.752 0.421 . . . . 0.0 111.359 -178.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -79.31 -30.91 43.06 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.795 0.438 . . . . 0.0 110.126 173.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -60.48 -44.98 95.37 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.853 0.861 . . . . 0.0 110.153 174.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.436 ' O ' ' HG2' ' A' ' 44' ' ' MET . 80.2 mt -84.14 3.06 36.61 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.487 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -73.47 -5.03 66.51 Favored Glycine 0 C--N 1.355 1.626 0 C-N-CA 123.635 0.636 . . . . 0.0 113.211 -176.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -72.79 -22.76 60.77 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 122.887 0.475 . . . . 0.0 110.485 170.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 69.3 mtm -114.29 1.0 14.33 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.37 1.068 . . . . 0.0 112.091 -173.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.436 ' HG2' ' O ' ' A' ' 40' ' ' LEU . 20.8 ptp -158.23 154.64 24.34 Favored Pre-proline 0 N--CA 1.488 1.47 0 C-N-CA 122.875 0.47 . . . . 0.0 110.584 -175.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.76 110.17 2.49 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 122.215 1.943 . . . . 0.0 112.377 -178.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.18 -24.32 35.04 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.823 -174.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -68.35 -39.19 81.96 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-O 121.317 0.58 . . . . 0.0 110.768 176.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -68.02 -46.8 70.2 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.096 176.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.407 HG21 ' HB3' ' A' ' 37' ' ' LEU . 81.6 mt -59.43 -44.68 93.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.429 0.692 . . . . 0.0 111.69 178.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -66.86 -32.46 73.75 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 118.169 0.441 . . . . 0.0 110.954 -175.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -63.85 -45.99 87.02 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 120.98 0.419 . . . . 0.0 110.116 172.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 22.9 mmt -60.94 -30.36 70.17 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.833 177.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.447 HG22 HG22 ' A' ' 30' ' ' VAL . 55.9 mt -67.8 -37.94 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.295 1.038 . . . . 0.0 111.491 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -62.84 -34.85 78.21 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 122.787 0.435 . . . . 0.0 110.623 173.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -76.33 -30.92 57.86 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.244 0.618 . . . . 0.0 110.603 177.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.65 -24.49 62.72 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.206 1.003 . . . . 0.0 111.745 -179.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -129.37 81.5 70.01 Favored Pre-proline 0 CA--C 1.547 0.852 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 171.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -79.3 -8.33 15.12 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 123.065 2.51 . . . . 0.0 112.451 -178.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -82.65 -21.72 34.91 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.65 0.78 . . . . 0.0 110.862 176.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.1 m120 59.12 32.92 22.55 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.472 1.109 . . . . 0.0 110.825 -175.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.7 m -97.21 -17.52 19.81 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.342 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.5 41.51 4.77 Favored Glycine 0 C--N 1.339 0.712 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.611 177.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -137.86 138.63 39.3 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.039 0.536 . . . . 0.0 111.143 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.478 ' O ' ' HB2' ' A' ' 27' ' ' TYR . 5.9 p -147.5 137.59 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.763 0.825 . . . . 0.0 110.363 -174.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -84.08 87.91 7.16 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 170.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.425 ' HH ' ' HG2' ' A' ' 18' ' ' LYS . 49.4 p90 -58.91 -35.19 72.66 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 114.613 -1.176 . . . . 0.0 113.373 -171.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -65.05 -39.51 93.42 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.772 0.429 . . . . 0.0 110.909 -169.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.448 ' O ' ' HG2' ' A' ' 72' ' ' MET . 11.2 t -83.28 -33.02 26.07 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.432 177.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -71.44 -56.38 6.06 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.407 0.623 . . . . 0.0 111.507 -177.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 99.6 t -65.67 -25.4 36.48 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.07 0 C-N-CA 124.393 1.077 . . . . 0.0 109.754 172.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -71.99 2.03 28.61 Favored Glycine 0 CA--C 1.543 1.828 0 CA-C-N 115.253 -0.885 . . . . 0.0 113.825 168.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.448 ' HG2' ' O ' ' A' ' 68' ' ' THR . 25.1 mmt -107.85 -45.39 4.01 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.775 0.83 . . . . 0.0 109.673 168.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 88.3 mt -58.24 -49.8 75.83 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.816 0.846 . . . . 0.0 112.142 -174.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -84.47 -11.91 55.29 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.161 -177.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -104.35 27.76 7.52 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.821 0.849 . . . . 0.0 110.701 178.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 32.6 m0 -67.08 -178.55 0.8 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.116 0.567 . . . . 0.0 110.99 171.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 . . . . . 0 CA--C 1.564 1.519 0 C-N-CA 123.72 0.808 . . . . 0.0 111.722 -175.007 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.572 0 N-CA-C 112.177 -0.369 . . . . 0.0 112.177 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.7 t -81.73 80.18 8.11 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.448 0.699 . . . . 0.0 110.295 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -150.39 28.34 0.73 Allowed 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.499 1.12 . . . . 0.0 110.069 175.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 68.9 mtm -66.18 -27.46 68.02 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.318 0.647 . . . . 0.0 112.095 -175.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 63.88 17.43 10.53 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.482 1.113 . . . . 0.0 112.834 167.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -72.61 82.19 1.12 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.138 0.575 . . . . 0.0 110.318 176.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.4 tt -124.46 115.92 46.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.366 1.066 . . . . 0.0 108.592 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -86.73 107.51 18.27 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.458 0.703 . . . . 0.0 109.352 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.7 t -163.44 158.95 21.67 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.52 0.676 . . . . 0.0 111.337 175.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -68.17 -17.42 64.34 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.759 1.224 . . . . 0.0 112.172 177.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.424 ' O ' ' HG2' ' A' ' 15' ' ' GLU . . . -63.04 -38.95 93.25 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 122.516 0.327 . . . . 0.0 110.186 172.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -71.03 -33.02 69.93 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.339 0.655 . . . . 0.0 112.369 -175.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.5 p -71.87 -36.64 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 176.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.433 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 75.1 mt -65.47 -33.42 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 174.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.424 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 23.5 mm-40 -62.01 -33.46 74.38 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.17 0.588 . . . . 0.0 111.491 174.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.25 -42.17 99.15 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 121.116 0.484 . . . . 0.0 110.195 174.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -69.37 -25.81 64.36 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.017 175.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' A' ' 14' ' ' ILE . 73.7 mmtt -73.4 -28.16 61.85 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.202 0.601 . . . . 0.0 111.18 177.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.413 HG22 ' O ' ' A' ' 15' ' ' GLU . 87.9 t -72.24 -40.94 66.2 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 C-N-CA 123.153 0.581 . . . . 0.0 110.167 176.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -73.12 -40.72 64.71 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.592 0.357 . . . . 0.0 110.375 176.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -97.25 45.64 1.04 Allowed 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.977 0.894 . . . . 0.0 108.846 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -63.09 -25.4 68.35 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.397 1.079 . . . . 0.0 110.965 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -72.19 -28.33 63.13 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.629 0.772 . . . . 0.0 111.088 177.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.08 58.56 2.94 Favored Glycine 0 C--N 1.344 0.987 0 CA-C-N 115.955 -0.566 . . . . 0.0 113.312 176.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -78.07 -17.32 57.15 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.33 0.652 . . . . 0.0 110.218 170.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.13 -18.57 56.92 Favored Glycine 0 C--N 1.354 1.53 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.961 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -150.55 166.11 31.23 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.272 1.029 . . . . 0.0 109.867 -174.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.4 m -116.36 177.94 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.609 0.764 . . . . 0.0 110.445 176.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 67.7 p -84.72 157.57 21.03 Favored 'General case' 0 C--O 1.246 0.876 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.516 170.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.9 p -67.09 -17.22 22.37 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 123.201 0.601 . . . . 0.0 111.547 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -63.63 -63.17 1.25 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.325 0.65 . . . . 0.0 111.04 177.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -60.6 -38.4 84.54 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.908 0.483 . . . . 0.0 110.504 178.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.498 HD22 HG11 ' A' ' 64' ' ' VAL . 6.3 tp -54.64 -58.75 6.27 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.82 -178.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 73.9 mtt180 -61.54 -33.41 73.79 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.045 0.538 . . . . 0.0 111.354 178.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -66.19 -46.33 77.69 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.755 0.822 . . . . 0.0 111.664 -174.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.4 p -76.65 -34.81 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 122.959 0.504 . . . . 0.0 110.86 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.478 HD22 HD13 ' A' ' 40' ' ' LEU . 84.6 mt -78.68 -5.88 54.26 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.03 0.532 . . . . 0.0 111.376 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 32.2 t-20 -72.26 -45.37 60.44 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.373 0.669 . . . . 0.0 109.77 178.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -71.38 -40.79 70.34 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.226 176.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.478 HD13 HD22 ' A' ' 37' ' ' LEU . 75.9 mt -67.57 -26.61 66.38 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.74 0.816 . . . . 0.0 110.549 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -89.62 63.17 3.31 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.062 171.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -81.72 -72.62 0.42 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.617 0.767 . . . . 0.0 109.701 178.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 20.6 ptp -85.85 -22.76 27.41 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.973 0.509 . . . . 0.0 110.367 175.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 25.3 mmt -81.8 112.41 34.49 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 172.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.06 130.64 37.39 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 122.113 1.875 . . . . 0.0 111.837 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.461 ' O ' ' HG2' ' A' ' 50' ' ' GLU . . . -63.05 -21.79 66.41 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.454 0.701 . . . . 0.0 110.527 174.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -52.67 -40.46 62.91 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.602 1.561 . . . . 0.0 111.887 173.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -65.12 -46.4 81.18 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.444 0.698 . . . . 0.0 110.114 175.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 66.8 mt -63.06 -32.07 54.9 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.416 -177.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 14.5 mm-40 -62.88 -44.15 96.89 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.99 0.516 . . . . 0.0 110.713 177.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -61.0 -42.66 98.88 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 121.414 0.626 . . . . 0.0 110.29 177.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.509 ' HB3' ' HE1' ' A' ' 69' ' ' PHE . 79.9 mmm -63.3 -34.21 77.18 Favored 'General case' 0 CA--C 1.558 1.273 0 CA-C-N 114.31 -1.314 . . . . 0.0 110.735 176.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 60.2 mt -69.35 -34.51 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 C-N-CA 124.469 1.108 . . . . 0.0 110.952 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 4.3 m-30 -64.62 -26.54 68.44 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.163 0.585 . . . . 0.0 110.251 176.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -93.45 -20.45 20.29 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.567 0.747 . . . . 0.0 111.117 178.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.472 ' HB2' HG23 ' A' ' 64' ' ' VAL . . . -77.27 -53.43 7.72 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.376 0.67 . . . . 0.0 110.229 177.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -116.14 95.75 45.58 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 124.801 1.241 . . . . 0.0 108.384 174.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -85.75 -1.61 8.9 Favored 'Trans proline' 0 C--N 1.368 1.553 0 C-N-CA 122.719 2.279 . . . . 0.0 112.028 170.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -92.06 -6.74 50.46 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.153 0.981 . . . . 0.0 112.042 -169.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 59.68 28.61 18.08 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.485 1.114 . . . . 0.0 110.847 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.3 m -105.28 -15.01 15.17 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.27 1.028 . . . . 0.0 110.571 -176.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.57 9.11 87.07 Favored Glycine 0 C--N 1.346 1.137 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.943 -175.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 22.2 m-30 -86.6 97.42 10.53 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.307 0.643 . . . . 0.0 109.519 -176.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.498 HG11 HD22 ' A' ' 33' ' ' LEU . 2.4 p -113.32 118.46 58.18 Favored 'Isoleucine or valine' 0 C--O 1.245 0.825 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.481 -175.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -73.58 86.59 1.61 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.225 175.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -53.62 -33.44 55.05 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -175.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -67.97 -36.47 80.11 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 120.755 0.312 . . . . 0.0 110.616 -170.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.0 p -82.32 -48.14 11.54 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.795 0.838 . . . . 0.0 110.19 174.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.509 ' HE1' ' HB3' ' A' ' 52' ' ' MET . 46.8 t80 -66.14 -54.05 30.17 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.246 1.018 . . . . 0.0 113.37 -170.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 56.3 t -68.31 -21.08 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 122.85 0.46 . . . . 0.0 109.831 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -62.18 -44.94 97.02 Favored Glycine 0 CA--C 1.538 1.473 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.147 164.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 65.0 mtt -66.09 -29.08 69.34 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 124.224 1.01 . . . . 0.0 112.041 178.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.4 mt -74.08 -43.03 59.2 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 121.374 0.606 . . . . 0.0 110.57 175.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -95.78 34.98 1.43 Allowed 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.647 -173.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.8 pp -125.6 10.09 7.8 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 122.701 0.4 . . . . 0.0 111.296 168.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 54.4 m0 -66.05 166.75 11.05 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.252 0.621 . . . . 0.0 111.899 -176.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.7 t70 . . . . . 0 C--O 1.248 1.014 0 C-N-CA 123.532 0.733 . . . . 0.0 109.361 -176.72 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.799 0 N-CA-C 112.245 -0.342 . . . . 0.0 112.245 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 64.8 p -153.92 138.87 17.22 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.427 0.691 . . . . 0.0 109.859 176.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 52.4 m-70 -100.59 97.97 8.6 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.555 0.742 . . . . 0.0 109.727 -176.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 93.4 mmm -75.7 89.14 2.8 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 174.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -134.0 128.0 33.48 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.574 0.75 . . . . 0.0 109.152 -175.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -85.61 108.14 17.85 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.805 0.842 . . . . 0.0 109.326 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.6 tt -123.83 125.56 71.3 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.132 0 C-N-CA 124.12 0.968 . . . . 0.0 111.068 -173.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -86.07 97.82 10.51 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.658 0.783 . . . . 0.0 109.064 171.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.3 t -145.72 163.71 34.08 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.208 0.528 . . . . 0.0 110.718 176.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.517 ' HD2' ' H ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -91.03 -24.66 19.99 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.931 174.49 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.471 ' O ' ' HG2' ' A' ' 15' ' ' GLU . . . -52.98 -42.08 65.2 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.456 0.702 . . . . 0.0 111.656 -178.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -61.06 -46.86 88.98 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.736 0.815 . . . . 0.0 112.199 -176.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.3 p -74.8 -31.39 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 122.722 0.409 . . . . 0.0 110.562 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.495 HG21 ' HE1' ' A' ' 66' ' ' TYR . 61.6 mt -65.11 -34.24 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.737 0.815 . . . . 0.0 110.811 178.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 19.1 mm-40 -69.37 -32.99 72.39 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.637 174.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.38 -37.25 82.7 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 122.938 0.495 . . . . 0.0 111.072 177.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -62.56 -41.23 98.78 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.972 173.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.47 ' HE3' HG22 ' A' ' 14' ' ' ILE . 92.9 mttt -71.46 -27.61 63.38 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.025 0.53 . . . . 0.0 111.508 -178.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.429 HG21 ' O ' ' A' ' 15' ' ' GLU . 92.3 t -69.97 -33.44 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.494 0.718 . . . . 0.0 109.963 174.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -74.61 -43.74 54.07 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.443 174.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -72.27 104.94 3.85 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -176.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -94.79 -15.36 23.86 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.52 0.728 . . . . 0.0 112.234 -178.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.404 ' HB2' ' ND2' ' A' ' 25' ' ' ASN . 20.8 m-20 -92.43 -26.35 18.05 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 120.87 0.367 . . . . 0.0 111.069 -176.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.66 42.78 12.95 Favored Glycine 0 C--N 1.338 0.649 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.865 -171.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.404 ' ND2' ' HB2' ' A' ' 23' ' ' ASP . 48.5 m-80 -65.94 -23.86 66.69 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.613 0.765 . . . . 0.0 111.11 178.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.05 -32.82 6.47 Favored Glycine 0 C--N 1.347 1.17 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 -178.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.431 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 45.2 p90 -133.62 160.69 36.75 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.406 1.082 . . . . 0.0 109.636 175.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 55.0 t -110.5 161.14 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.178 0.991 . . . . 0.0 110.41 -174.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 73.1 p -56.15 151.6 12.08 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 124.191 0.996 . . . . 0.0 111.982 172.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.8 p -67.21 -20.71 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.409 174.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -58.97 -62.19 2.07 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.74 1.216 . . . . 0.0 111.635 176.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -65.37 -30.11 70.9 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.973 0.509 . . . . 0.0 111.012 -178.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.633 HD23 HG11 ' A' ' 64' ' ' VAL . 6.5 tp -54.75 -50.92 67.24 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 123.717 0.635 . . . . 0.0 109.977 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.499 ' HG2' HD11 ' A' ' 53' ' ' ILE . 37.1 mtm180 -61.67 -37.96 86.02 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.862 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -65.7 -53.04 46.38 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.415 0.686 . . . . 0.0 112.179 -175.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.06 -26.88 35.47 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.957 -176.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 87.3 mt -86.81 -16.07 37.31 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.322 0.649 . . . . 0.0 111.779 178.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -74.79 -43.01 57.03 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.188 0.595 . . . . 0.0 110.124 175.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -72.75 -32.63 65.8 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 122.94 0.496 . . . . 0.0 110.794 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.418 HD12 ' HZ ' ' A' ' 74' ' ' PHE . 95.6 mt -78.46 -21.36 49.2 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.257 0.623 . . . . 0.0 110.514 174.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.717 ' HA2' ' HB2' ' A' ' 44' ' ' MET . . . -83.34 46.71 3.69 Favored Glycine 0 C--N 1.349 1.263 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 169.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -79.56 -55.16 5.23 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.886 0.874 . . . . 0.0 109.123 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 64.1 mtt -105.33 11.7 32.52 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.734 174.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.717 ' HB2' ' HA2' ' A' ' 41' ' ' GLY . 55.9 mtt -113.15 150.98 43.84 Favored Pre-proline 0 N--CA 1.48 1.068 0 C-N-CA 124.464 1.106 . . . . 0.0 108.579 176.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -68.7 115.39 3.91 Favored 'Trans proline' 0 C--N 1.374 1.886 0 C-N-CA 122.438 2.092 . . . . 0.0 110.926 172.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.44 -37.66 77.46 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.577 0.751 . . . . 0.0 110.824 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -63.46 -32.85 74.41 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.853 0.861 . . . . 0.0 111.644 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.472 ' O ' ' HG3' ' A' ' 52' ' ' MET . 40.3 tt0 -60.24 -39.4 86.56 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.625 1.17 . . . . 0.0 110.375 176.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 63.6 mt -77.89 -41.04 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.273 177.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -54.76 -46.0 74.27 Favored 'General case' 0 C--N 1.354 0.802 0 O-C-N 124.074 0.859 . . . . 0.0 111.091 -177.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -60.99 -37.37 82.24 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-O 120.66 0.267 . . . . 0.0 111.145 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.472 ' HG3' ' O ' ' A' ' 48' ' ' GLU . 43.0 mtm -72.73 -29.76 63.62 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.254 0.622 . . . . 0.0 110.653 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.499 HD11 ' HG2' ' A' ' 34' ' ' ARG . 77.1 mt -71.74 -33.87 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 124.136 0.975 . . . . 0.0 110.006 175.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -77.71 -10.6 59.61 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.02 0.928 . . . . 0.0 110.61 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -94.17 -27.61 16.11 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.316 1.047 . . . . 0.0 110.376 168.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.49 -30.74 59.97 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.55 0.74 . . . . 0.0 111.547 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -148.64 81.25 7.9 Favored Pre-proline 0 N--CA 1.478 0.961 0 C-N-CA 123.091 0.556 . . . . 0.0 109.836 172.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -83.32 -11.71 9.49 Favored 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.928 2.419 . . . . 0.0 113.132 172.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 20.7 tm0? -78.22 -23.35 47.5 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.671 0.789 . . . . 0.0 110.27 -174.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.3 t30 67.19 53.06 0.8 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.984 1.314 . . . . 0.0 108.926 -172.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.5 m -79.77 -24.36 41.56 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.742 173.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.91 23.9 63.06 Favored Glycine 0 C--N 1.346 1.113 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.995 -174.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -144.44 159.84 42.07 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.768 0.827 . . . . 0.0 111.438 -174.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.633 HG11 HD23 ' A' ' 33' ' ' LEU . 5.4 p -167.58 143.93 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.379 1.072 . . . . 0.0 109.406 175.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.404 ' HA ' ' HB2' ' A' ' 27' ' ' TYR . 74.7 mt-30 -82.2 104.99 12.93 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 172.146 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.495 ' HE1' HG21 ' A' ' 14' ' ' ILE . 53.2 p90 -64.48 -32.27 73.83 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.999 0.52 . . . . 0.0 111.013 178.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -55.06 -42.03 72.23 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.818 0.847 . . . . 0.0 110.87 174.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 19.1 m -76.83 -53.46 7.88 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.576 179.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -69.39 -54.33 14.95 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.109 -169.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.579 ' HA ' ' HB3' ' A' ' 73' ' ' LEU . 57.8 t -62.72 -19.09 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.372 0 C-N-CA 123.288 0.635 . . . . 0.0 111.283 177.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -71.29 -35.26 63.77 Favored Glycine 0 C--N 1.351 1.388 0 CA-C-N 116.435 -0.348 . . . . 0.0 113.39 172.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 28.3 ptm -98.24 -3.99 36.24 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.543 0.737 . . . . 0.0 111.527 177.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.579 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 9.8 tp -97.61 -53.02 3.56 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.448 1.099 . . . . 0.0 110.576 -178.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.461 ' HB3' ' HE3' ' A' ' 10' ' ' LYS . 3.4 m-85 -83.81 27.87 0.61 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.688 0.795 . . . . 0.0 112.893 -174.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.7 pp -77.86 -0.09 25.99 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.956 0.503 . . . . 0.0 111.127 169.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 49.5 m0 -65.16 107.77 1.67 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.874 1.269 . . . . 0.0 110.816 177.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.7 t70 . . . . . 0 C--O 1.247 0.938 0 C-N-CA 124.981 1.313 . . . . 0.0 107.791 -179.947 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.289 0 N-CA-C 112.221 -0.351 . . . . 0.0 112.221 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.1 p -81.2 -5.14 57.4 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.541 0.737 . . . . 0.0 111.766 177.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.0 m80 -62.32 121.63 13.66 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.589 0.756 . . . . 0.0 110.799 174.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 59.3 mtt -120.16 123.11 42.51 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.517 1.127 . . . . 0.0 108.147 178.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -86.77 63.91 8.22 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 122.261 1.029 . . . . 0.0 109.62 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 60.1 m80 -129.68 -24.7 2.69 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.96 173.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.404 HG13 ' HG1' ' A' ' 9' ' ' THR . 5.9 tp -69.79 102.36 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 169.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -99.1 73.0 1.9 Allowed 'General case' 0 C--O 1.242 0.671 0 CA-C-N 115.418 -0.81 . . . . 0.0 108.967 -175.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.469 ' HB ' ' HG3' ' A' ' 12' ' ' GLN . 26.4 m -90.4 126.33 35.85 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.182 172.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -70.39 -11.84 61.18 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.15 0.58 . . . . 0.0 111.774 -177.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.466 ' O ' ' HG2' ' A' ' 15' ' ' GLU . . . -75.82 -39.79 56.11 Favored 'General case' 0 C--O 1.216 -0.705 0 C-N-CA 123.117 0.567 . . . . 0.0 110.738 171.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.469 ' HG3' ' HB ' ' A' ' 9' ' ' THR . 56.8 mt-30 -58.5 -38.58 77.95 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 123.272 0.629 . . . . 0.0 112.588 -174.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.3 p -65.9 -40.14 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 175.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.449 HG21 ' HE3' ' A' ' 18' ' ' LYS . 64.3 mt -64.77 -31.82 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 123.393 0.677 . . . . 0.0 110.423 176.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 10.4 mm-40 -71.4 -27.73 63.52 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.082 0.553 . . . . 0.0 110.983 178.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.9 -35.63 81.76 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 122.919 0.488 . . . . 0.0 110.996 177.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.491 ' CZ ' HD13 ' A' ' 33' ' ' LEU . 95.7 m-85 -64.03 -35.65 81.43 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.482 0.713 . . . . 0.0 110.951 174.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.449 ' HE3' HG21 ' A' ' 14' ' ' ILE . 90.9 mttt -77.19 -29.67 54.45 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.0 -177.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 74.1 t -69.33 -37.76 76.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 123.452 0.701 . . . . 0.0 109.769 172.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -71.48 -46.95 58.48 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.718 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -83.76 81.05 8.93 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.878 0.847 . . . . 0.0 109.014 -177.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 29.6 mtm180 -86.04 -18.42 32.52 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 113.947 -1.478 . . . . 0.0 110.076 177.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -80.01 -25.86 40.06 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.766 0.826 . . . . 0.0 111.568 -175.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.27 52.53 3.97 Favored Glycine 0 C--N 1.341 0.837 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.637 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.43 ' N ' HD21 ' A' ' 25' ' ' ASN . 0.8 OUTLIER -80.76 -19.17 45.48 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.24 1.016 . . . . 0.0 109.827 173.475 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.82 -56.17 3.74 Favored Glycine 0 C--N 1.347 1.175 0 N-CA-C 111.164 -0.775 . . . . 0.0 111.164 -175.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -118.97 156.91 28.75 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.326 1.05 . . . . 0.0 110.194 178.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.5 t -110.56 157.25 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 123.636 0.775 . . . . 0.0 109.503 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 68.7 p -65.28 166.5 9.83 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.107 0.963 . . . . 0.0 112.345 178.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.609 HG21 HG22 ' A' ' 53' ' ' ILE . 7.2 p -63.42 -33.48 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.332 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -64.09 -49.19 73.24 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.311 0.244 . . . . 0.0 111.627 -172.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -67.59 -36.88 81.72 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.488 176.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.514 HD23 HG13 ' A' ' 64' ' ' VAL . 12.1 tp -56.1 -43.88 78.51 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.665 0.603 . . . . 0.0 110.687 177.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' A' ' 30' ' ' VAL . 34.8 mtm105 -72.26 -34.67 68.41 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.097 0.559 . . . . 0.0 110.411 177.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -63.05 -50.7 69.6 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.651 0.78 . . . . 0.0 111.899 -174.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.3 p -64.82 -33.48 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 122.889 0.475 . . . . 0.0 110.83 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 80.5 mt -85.51 -8.51 58.29 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 123.766 0.827 . . . . 0.0 111.367 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -87.09 -36.2 18.27 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.1 1.36 . . . . 0.0 108.934 171.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -69.21 -35.17 75.92 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.848 0.859 . . . . 0.0 109.635 173.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 93.2 mt -89.23 15.52 8.8 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.762 0.825 . . . . 0.0 110.491 169.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 44' ' ' MET . . . -74.92 -10.05 83.69 Favored Glycine 0 C--N 1.353 1.515 0 C-N-CA 123.851 0.739 . . . . 0.0 113.626 -173.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -68.13 -32.77 73.28 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.324 0.649 . . . . 0.0 110.342 174.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 93.6 mmm -107.46 -31.1 8.29 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.62 0.768 . . . . 0.0 111.699 178.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.601 ' HB3' HD13 ' A' ' 49' ' ' ILE . 24.9 mmt -113.21 104.92 55.72 Favored Pre-proline 0 N--CA 1.479 1.002 0 C-N-CA 123.539 0.735 . . . . 0.0 109.778 -173.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.42 117.93 4.73 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.69 2.26 . . . . 0.0 111.866 -178.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.92 -47.71 85.16 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.766 0.826 . . . . 0.0 111.572 -176.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -53.93 -40.66 66.93 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 123.798 0.839 . . . . 0.0 111.723 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -62.47 -52.17 64.58 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.216 178.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.601 HD13 ' HB3' ' A' ' 44' ' ' MET . 79.1 mt -62.75 -40.32 88.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.859 -178.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.501 ' HA ' HD12 ' A' ' 53' ' ' ILE . 51.2 mt-10 -63.17 -34.05 76.79 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.139 0.576 . . . . 0.0 111.06 -175.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -67.78 -36.3 80.22 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 121.146 0.498 . . . . 0.0 110.379 175.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 20.0 mmt -67.14 -29.7 69.49 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.587 0.755 . . . . 0.0 110.807 177.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.609 HG22 HG21 ' A' ' 30' ' ' VAL . 50.2 mt -71.39 -31.1 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 123.118 0.567 . . . . 0.0 110.754 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -64.35 -28.95 70.05 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 122.898 0.479 . . . . 0.0 110.711 175.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -78.91 -37.51 39.75 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.032 0.533 . . . . 0.0 110.466 174.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.02 -25.6 61.02 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.9 0.88 . . . . 0.0 112.183 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -140.47 81.8 17.06 Favored Pre-proline 0 CA--C 1.548 0.889 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 175.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -65.58 -14.44 44.83 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 123.462 2.775 . . . . 0.0 112.788 175.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -69.2 -26.05 64.64 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.408 0.683 . . . . 0.0 110.911 176.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.1 t30 59.15 24.1 12.43 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.482 1.113 . . . . 0.0 110.824 -178.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.8 m -83.6 -16.46 45.17 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.791 0.836 . . . . 0.0 110.682 -178.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.86 29.84 22.34 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-N 115.589 -0.732 . . . . 0.0 113.28 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -126.82 107.75 10.4 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.872 0.869 . . . . 0.0 109.135 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.514 HG13 HD23 ' A' ' 33' ' ' LEU . 3.3 p -136.01 135.8 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 123.162 0.585 . . . . 0.0 110.89 -173.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -76.13 98.38 4.36 Favored 'General case' 0 C--N 1.35 0.609 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 174.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -55.08 -34.43 63.62 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.238 1.015 . . . . 0.0 112.809 -178.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -58.05 -57.01 14.7 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.522 0.729 . . . . 0.0 110.162 -176.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.2 p -68.76 -39.87 80.03 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.389 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -67.4 -67.27 0.47 Allowed 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 119.21 -0.424 . . . . 0.0 111.974 -177.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.571 ' HA ' ' HB3' ' A' ' 73' ' ' LEU . 57.6 t -52.4 -26.06 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 C-N-CA 124.808 1.243 . . . . 0.0 112.232 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.96 -54.58 29.72 Favored Glycine 0 CA--C 1.541 1.67 0 N-CA-C 112.469 -0.252 . . . . 0.0 112.469 168.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 64.0 mtm -73.59 -12.1 60.64 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.705 0.802 . . . . 0.0 112.236 178.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.571 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 52.3 tp -86.49 -41.57 14.27 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.375 1.07 . . . . 0.0 110.094 -178.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.403 ' HA ' ' CD1' ' A' ' 76' ' ' TRP . 8.2 m-85 -89.74 34.26 0.84 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.379 0.672 . . . . 0.0 111.699 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 92.2 mt -77.42 -15.33 59.4 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.849 0.46 . . . . 0.0 110.877 170.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.403 ' CD1' ' HA ' ' A' ' 74' ' ' PHE . 0.3 OUTLIER -82.6 2.27 34.11 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 124.286 1.035 . . . . 0.0 112.176 174.147 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.0 t70 . . . . . 0 C--O 1.251 1.168 0 C-N-CA 123.835 0.854 . . . . 0.0 111.06 -179.503 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.71 0 CA-C-O 120.073 -0.293 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.8 p -70.36 92.44 0.8 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.058 0.943 . . . . 0.0 111.649 -178.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -85.19 -43.09 14.12 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 170.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -93.34 106.33 18.3 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 170.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 33.2 p-10 -108.67 12.97 25.47 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.023 0.929 . . . . 0.0 110.822 -177.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 -67.86 -18.15 64.72 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.409 1.084 . . . . 0.0 111.594 -177.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.0 tt -74.35 103.16 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.142 0 CA-C-O 121.567 0.699 . . . . 0.0 110.502 176.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -102.59 98.77 8.78 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.389 1.076 . . . . 0.0 109.044 175.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.1 m -150.12 148.41 28.94 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.731 0.812 . . . . 0.0 109.998 -177.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.426 ' O ' HG12 ' A' ' 14' ' ' ILE . 0.0 OUTLIER -62.34 -20.17 64.09 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 175.243 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.497 ' O ' ' HG2' ' A' ' 15' ' ' GLU . . . -54.95 -48.94 72.54 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.406 0.683 . . . . 0.0 110.381 175.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -63.25 -38.45 91.2 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.982 0.913 . . . . 0.0 112.753 -171.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.5 p -69.01 -41.0 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 177.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.469 HG21 ' HE3' ' A' ' 18' ' ' LYS . 48.1 mm -63.35 -37.84 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 123.37 0.668 . . . . 0.0 110.958 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.497 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 20.3 mm-40 -73.07 -28.53 62.36 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.014 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.76 -35.3 80.14 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.288 0.635 . . . . 0.0 110.985 177.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -61.94 -41.88 98.47 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.025 173.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.469 ' HE3' HG21 ' A' ' 14' ' ' ILE . 96.5 mttt -68.03 -27.55 66.64 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.444 0.698 . . . . 0.0 112.072 -173.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.2 t -71.26 -39.85 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.129 0.572 . . . . 0.0 109.851 175.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -71.17 -40.35 71.34 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.756 177.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.402 ' HB2' HG23 ' A' ' 28' ' ' VAL . 27.7 t0 -85.28 70.79 10.88 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 122.12 0.962 . . . . 0.0 108.993 -179.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -67.45 -29.35 68.78 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 113.834 -1.53 . . . . 0.0 109.681 176.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -69.84 -25.99 64.0 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.673 -178.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.16 41.45 47.03 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.55 173.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -68.56 -20.36 64.53 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.502 0.721 . . . . 0.0 111.312 176.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.37 -26.17 25.51 Favored Glycine 0 C--N 1.348 1.24 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.686 -177.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -136.04 166.89 22.32 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.161 0.984 . . . . 0.0 109.557 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.402 HG23 ' HB2' ' A' ' 21' ' ' ASP . 81.3 t -118.79 153.45 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.046 0.938 . . . . 0.0 109.233 176.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.8 p -60.93 155.95 18.68 Favored 'General case' 0 C--O 1.248 0.983 0 C-N-CA 123.551 0.74 . . . . 0.0 111.247 173.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.409 ' O ' ' HG3' ' A' ' 34' ' ' ARG . 9.7 p -62.82 -24.09 34.77 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-N 116.167 -0.47 . . . . 0.0 112.196 -175.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -60.33 -60.1 4.35 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.195 0.598 . . . . 0.0 111.851 -176.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -63.74 -32.67 74.23 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.069 0.548 . . . . 0.0 110.479 178.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.439 HD13 HG12 ' A' ' 64' ' ' VAL . 4.4 tt -61.37 -44.48 97.1 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.879 0.872 . . . . 0.0 111.551 179.161 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' A' ' 30' ' ' VAL . 50.7 mtm180 -68.21 -38.99 82.51 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.941 0.496 . . . . 0.0 109.915 177.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -61.55 -47.14 86.91 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 124.165 0.916 . . . . 0.0 111.35 -177.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.4 p -73.43 -25.5 21.22 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.699 -176.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.623 HD13 HG23 ' A' ' 70' ' ' VAL . 96.6 mt -86.9 -15.19 39.74 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.821 0.448 . . . . 0.0 111.311 175.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -88.36 -30.95 19.15 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 176.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -78.15 -24.34 47.36 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 110.513 -0.18 . . . . 0.0 110.513 176.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 60.3 mt -95.81 12.22 30.85 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.595 0.758 . . . . 0.0 109.791 169.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.476 ' HA2' ' SD ' ' A' ' 44' ' ' MET . . . -144.84 55.83 0.55 Allowed Glycine 0 C--N 1.349 1.26 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 -175.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -68.69 -64.88 0.78 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.495 0.718 . . . . 0.0 110.359 -177.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.87 -4.34 43.81 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.75 177.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.476 ' SD ' ' HA2' ' A' ' 41' ' ' GLY . 1.2 mpt? -74.74 133.55 76.39 Favored Pre-proline 0 CA--C 1.546 0.801 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 172.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -65.54 114.99 3.12 Favored 'Trans proline' 0 C--N 1.37 1.69 0 C-N-CA 122.023 1.815 . . . . 0.0 110.438 173.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.85 -13.24 59.54 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.015 0.526 . . . . 0.0 111.343 177.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.417 ' O ' ' HG2' ' A' ' 51' ' ' GLU . 1.7 m-20 -53.59 -45.78 70.12 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.561 1.144 . . . . 0.0 111.925 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -59.88 -40.95 90.42 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.133 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 84.2 mt -67.89 -35.7 73.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 124.023 0.929 . . . . 0.0 110.274 178.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -66.09 -40.35 90.73 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.594 0.758 . . . . 0.0 110.769 177.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' A' ' 47' ' ' ASP . 16.3 mm-40 -65.55 -33.48 76.01 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.249 0.62 . . . . 0.0 110.966 177.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 21.3 mmt -68.4 -37.45 80.37 Favored 'General case' 0 CA--C 1.55 0.96 0 O-C-N 123.939 0.774 . . . . 0.0 110.117 174.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 70.4 mt -62.05 -38.39 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 124.243 1.017 . . . . 0.0 111.676 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -57.71 -32.0 66.97 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.086 0.554 . . . . 0.0 111.649 178.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -87.8 -38.71 15.49 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.799 0.84 . . . . 0.0 110.591 178.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.66 -20.98 60.41 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.08 0.952 . . . . 0.0 111.917 -175.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -138.95 83.67 18.17 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 174.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -77.76 -13.84 15.95 Favored 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 122.958 2.438 . . . . 0.0 112.276 -177.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.411 ' HG3' ' H ' ' A' ' 61' ' ' SER . 27.3 pt20 -79.16 -16.16 57.04 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.491 1.116 . . . . 0.0 112.081 -178.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.3 t30 63.29 18.6 11.12 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 124.708 1.203 . . . . 0.0 111.254 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.411 ' H ' ' HG3' ' A' ' 59' ' ' GLN . 19.4 m -92.67 -25.92 18.04 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.51 0.724 . . . . 0.0 110.152 -175.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.25 41.84 6.07 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 115.763 -0.653 . . . . 0.0 113.325 175.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -124.36 94.58 4.25 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.258 1.023 . . . . 0.0 108.601 175.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.439 HG12 HD13 ' A' ' 33' ' ' LEU . 3.9 p -126.9 134.27 66.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 124.01 0.924 . . . . 0.0 110.257 -170.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -76.79 108.06 9.55 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.891 0.877 . . . . 0.0 109.82 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -65.77 -38.01 87.87 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -170.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -71.02 -32.87 69.75 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 118.3 0.5 . . . . 0.0 110.126 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 31.3 m -72.19 -30.56 65.07 Favored 'General case' 0 CA--C 1.553 1.079 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.882 174.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.409 ' CE2' HD21 ' A' ' 33' ' ' LEU . 45.8 t80 -93.22 -72.1 0.62 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.083 0.553 . . . . 0.0 111.726 -176.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.623 HG23 HD13 ' A' ' 37' ' ' LEU . 57.6 t -59.49 -36.21 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.819 1.248 . . . . 0.0 111.346 -177.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -59.47 -37.42 92.07 Favored Glycine 0 C--N 1.348 1.219 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.934 174.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 94.2 mmm -81.59 -37.02 28.3 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.432 0.693 . . . . 0.0 112.26 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 pp -75.65 -24.66 56.41 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 118.303 0.501 . . . . 0.0 110.286 -175.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.411 ' CD2' ' HB3' ' A' ' 10' ' ' LYS . 6.1 m-85 -74.76 -8.05 55.23 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.573 0.349 . . . . 0.0 111.547 172.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 60.5 mt -89.05 9.25 25.98 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.995 0.518 . . . . 0.0 111.963 175.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 43.7 m0 -64.13 85.83 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 121.227 0.537 . . . . 0.0 109.986 174.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.5 t70 . . . . . 0 C--O 1.25 1.115 0 C-N-CA 125.367 1.467 . . . . 0.0 108.278 -170.458 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.271 0 N-CA-C 111.816 -0.514 . . . . 0.0 111.816 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.4 t -147.28 93.26 2.22 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.7 0.8 . . . . 0.0 109.071 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -79.87 80.17 6.3 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 176.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 17.0 tmm? -164.66 133.38 3.51 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -146.88 87.95 1.72 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.435 0.636 . . . . 0.0 109.832 179.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 18.4 t60 -55.49 108.33 0.42 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.801 1.24 . . . . 0.0 109.945 177.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.2 tt -74.75 85.08 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 CA-C-O 122.612 1.196 . . . . 0.0 111.011 -171.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -76.61 101.85 5.89 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.917 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.4 m -139.74 116.34 10.75 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -175.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -72.21 -15.84 61.94 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.029 0.532 . . . . 0.0 111.948 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.03 -42.18 73.27 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 122.643 0.377 . . . . 0.0 110.36 170.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -64.54 -39.22 93.37 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.396 0.678 . . . . 0.0 112.146 -177.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.9 p -69.68 -35.51 66.12 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 CA-C-O 119.348 -0.358 . . . . 0.0 110.307 178.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 77.0 mt -61.92 -41.69 91.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 C-N-CA 122.824 0.45 . . . . 0.0 110.11 172.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.438 ' O ' HG22 ' A' ' 19' ' ' VAL . 33.7 mm-40 -63.19 -29.5 70.83 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.281 0.632 . . . . 0.0 111.21 176.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.92 -32.56 73.89 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.93 0.492 . . . . 0.0 111.616 178.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -70.25 -40.42 74.43 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 171.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -74.23 -9.13 58.3 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.227 -177.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 15' ' ' GLU . 93.3 t -68.73 -44.62 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 167.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -69.51 -55.15 11.02 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.157 179.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -75.15 95.84 3.17 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.557 178.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -88.27 -38.77 14.95 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.327 -176.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -76.55 -22.36 54.45 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.833 0.853 . . . . 0.0 112.393 -173.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.3 53.6 3.6 Favored Glycine 0 C--N 1.343 0.969 0 N-CA-C 111.491 -0.644 . . . . 0.0 111.491 -176.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -68.71 -30.1 68.67 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.624 1.17 . . . . 0.0 109.334 173.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.05 -59.74 0.46 Allowed Glycine 0 C--N 1.342 0.868 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.084 175.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.401 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 43.9 p90 -115.29 -171.66 2.0 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.628 0.771 . . . . 0.0 110.834 -171.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.0 p -139.65 178.2 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.221 0 C-N-CA 123.343 0.657 . . . . 0.0 110.484 -173.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 68.5 p -88.13 154.11 20.72 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.008 0.923 . . . . 0.0 110.358 175.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.6 p -67.59 -29.77 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-N 117.861 0.3 . . . . 0.0 110.856 178.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -62.5 -46.55 87.92 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.513 178.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -72.24 -32.79 67.02 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.614 179.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.9 tt -67.79 -39.12 84.07 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.947 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 37.4 mtp-105 -72.83 -30.59 64.16 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 122.42 0.288 . . . . 0.0 110.321 174.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -63.62 -49.33 73.72 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.593 1.157 . . . . 0.0 111.075 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.463 HG11 ' HG ' ' A' ' 37' ' ' LEU . 7.0 p -69.34 -40.17 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.137 0.575 . . . . 0.0 111.627 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.463 ' HG ' HG11 ' A' ' 36' ' ' VAL . 79.7 mt -82.1 -4.8 57.65 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.48 0.712 . . . . 0.0 111.862 -176.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -67.84 -29.12 68.19 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.489 0.716 . . . . 0.0 111.412 175.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -59.35 -40.04 85.14 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.292 0.637 . . . . 0.0 111.792 -177.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.2 pp -92.48 7.58 42.46 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.508 0.723 . . . . 0.0 110.919 -178.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -72.98 -19.33 79.53 Favored Glycine 0 C--N 1.352 1.447 0 O-C-N 123.48 0.487 . . . . 0.0 112.496 -178.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -75.28 -27.24 59.31 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.329 0.652 . . . . 0.0 111.215 177.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 82.3 mtp -100.02 -44.65 5.94 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.723 0.809 . . . . 0.0 110.769 -175.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 23.0 mmt -120.03 145.69 40.45 Favored Pre-proline 0 N--CA 1.482 1.171 0 C-N-CA 124.839 1.256 . . . . 0.0 109.649 -177.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -58.41 119.53 6.85 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.729 2.286 . . . . 0.0 112.761 179.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.01 -30.33 63.69 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.302 174.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -55.13 -40.89 71.06 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 124.026 0.93 . . . . 0.0 111.225 174.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -51.96 -53.81 36.93 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.382 1.073 . . . . 0.0 110.695 174.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.503 HG12 HD13 ' A' ' 73' ' ' LEU . 74.0 mt -60.39 -41.93 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.96 179.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.53 ' HA ' HD13 ' A' ' 53' ' ' ILE . 42.7 mt-10 -66.01 -34.69 78.68 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.502 0.721 . . . . 0.0 112.12 -175.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -70.07 -39.49 75.6 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 120.951 0.405 . . . . 0.0 110.32 175.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 48.0 mmm -59.53 -34.25 72.39 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.948 0.899 . . . . 0.0 110.568 174.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.53 HD13 ' HA ' ' A' ' 50' ' ' GLU . 85.1 mt -62.56 -34.42 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.851 0.86 . . . . 0.0 112.149 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -60.95 -25.96 67.18 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -177.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -89.91 -28.54 19.13 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 122.776 0.43 . . . . 0.0 111.219 176.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.2 -34.43 68.37 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.374 0.669 . . . . 0.0 111.164 178.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -132.03 80.81 63.8 Favored Pre-proline 0 CA--C 1.548 0.878 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 175.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -82.29 -3.8 11.59 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.988 2.459 . . . . 0.0 112.684 -179.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -86.73 -14.88 41.14 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.354 1.061 . . . . 0.0 111.586 -179.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 61.26 30.7 19.31 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 124.611 1.164 . . . . 0.0 110.615 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.6 t -109.19 -3.74 17.04 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.799 0.84 . . . . 0.0 111.111 -172.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.99 19.83 74.32 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 114.852 0.701 . . . . 0.0 114.852 172.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -110.05 94.75 5.18 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 177.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.3 p -111.99 130.64 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.55 0.74 . . . . 0.0 110.551 -174.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.401 ' HA ' ' HB2' ' A' ' 27' ' ' TYR . 46.0 mt-30 -85.71 93.98 8.99 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 175.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -55.26 -29.84 58.91 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.592 0.757 . . . . 0.0 111.746 176.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -48.84 -55.87 10.38 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.083 1.753 . . . . 0.0 111.168 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.1 t -87.43 -30.58 20.6 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 114.466 -1.243 . . . . 0.0 110.51 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -67.07 -65.3 0.7 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.865 0.466 . . . . 0.0 111.7 -174.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.521 ' HA ' ' HB3' ' A' ' 73' ' ' LEU . 99.1 t -50.41 -29.45 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 124.837 1.255 . . . . 0.0 112.3 175.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.17 -50.63 65.59 Favored Glycine 0 CA--C 1.535 1.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.849 171.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 24.7 ptm -84.59 -15.48 45.48 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.349 0.66 . . . . 0.0 111.706 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.521 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 66.8 tp -77.25 -51.76 10.37 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.186 0.994 . . . . 0.0 109.9 -174.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -83.59 34.96 0.49 Allowed 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 123.593 0.757 . . . . 0.0 111.546 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 53.5 mt -96.29 23.13 6.94 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.751 0.82 . . . . 0.0 110.989 169.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 7.0 m0 -71.9 84.39 0.95 Allowed 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 170.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.9 t70 . . . . . 0 C--O 1.252 1.195 0 C-N-CA 123.65 0.78 . . . . 0.0 109.107 -176.611 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.318 0 CA-C-O 119.522 -0.599 . . . . 0.0 112.059 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.4 m 62.37 13.62 6.19 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 125.053 1.341 . . . . 0.0 112.411 -178.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 53.4 m80 -141.41 95.0 2.76 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.01 0.924 . . . . 0.0 110.043 -172.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 47.5 tpp -82.8 132.43 35.17 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.641 0.776 . . . . 0.0 109.955 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -83.19 73.71 10.07 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 122.148 0.975 . . . . 0.0 110.487 179.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -91.27 77.52 5.89 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.091 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.2 tt -101.41 100.74 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 CA-C-O 121.745 0.783 . . . . 0.0 109.496 -178.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -88.94 95.02 10.14 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.831 -174.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.1 t -154.67 152.02 29.46 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.162 177.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.448 ' HE3' ' HA2' ' A' ' 71' ' ' GLY . 13.3 ptmm? -70.68 -20.34 62.7 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.637 0.775 . . . . 0.0 111.234 175.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.466 ' O ' ' HG2' ' A' ' 15' ' ' GLU . . . -55.84 -34.68 65.65 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.073 0.949 . . . . 0.0 111.703 178.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -60.41 -52.99 62.88 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.525 0.73 . . . . 0.0 112.176 -177.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.4 p -65.85 -29.87 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 122.5 0.32 . . . . 0.0 110.458 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.434 ' HA ' ' HD2' ' A' ' 17' ' ' PHE . 94.1 mt -70.05 -34.41 59.4 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 123.404 0.682 . . . . 0.0 110.873 177.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 18.7 mm-40 -62.49 -28.36 69.78 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.372 0.669 . . . . 0.0 110.961 175.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.14 -44.95 86.95 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.175 0.59 . . . . 0.0 110.444 175.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.434 ' HD2' ' HA ' ' A' ' 14' ' ' ILE . 99.6 m-85 -68.44 -32.96 73.35 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.489 178.06 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -79.24 -29.0 42.46 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.191 0.596 . . . . 0.0 112.097 -177.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.7 p -82.08 -15.55 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 CA-C-O 121.031 0.443 . . . . 0.0 110.079 173.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -78.38 -50.71 11.23 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 172.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -96.33 88.01 4.63 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.572 0.749 . . . . 0.0 109.627 178.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -94.44 1.95 55.76 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.502 173.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -90.95 -25.47 19.74 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.493 0.717 . . . . 0.0 111.279 -175.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.21 38.66 12.54 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.078 -175.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -64.23 -26.4 68.49 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.453 1.101 . . . . 0.0 109.049 169.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.32 -32.98 6.71 Favored Glycine 0 C--N 1.352 1.438 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.487 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.453 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 51.6 p90 -144.96 -179.42 6.6 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.476 0.71 . . . . 0.0 111.003 -176.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.6 t -126.43 156.01 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.528 1.131 . . . . 0.0 110.042 -172.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.4 p -66.3 149.57 50.17 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.856 0.862 . . . . 0.0 111.162 173.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.9 p -68.49 -19.1 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 122.74 0.416 . . . . 0.0 112.068 -173.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -56.49 -51.81 67.09 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.522 0.729 . . . . 0.0 111.313 175.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -69.73 -32.56 71.19 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.075 -179.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.408 HD12 ' CZ ' ' A' ' 17' ' ' PHE . 9.0 tp -58.41 -55.39 35.69 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 123.923 0.764 . . . . 0.0 110.331 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.518 ' HG2' HD12 ' A' ' 53' ' ' ILE . 94.3 mtt180 -65.94 -27.19 67.99 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.605 -178.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -70.01 -52.7 22.03 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.787 0.835 . . . . 0.0 111.27 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.5 p -75.19 -29.9 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.409 -175.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 95.4 mt -80.65 -10.51 59.73 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.917 0.487 . . . . 0.0 111.259 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -74.83 -44.24 50.31 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 165.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -62.88 -35.53 80.32 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.217 -179.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -85.43 -42.27 14.66 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.296 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -91.94 67.72 2.07 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.762 -168.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -86.62 -57.88 2.82 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.686 0.794 . . . . 0.0 109.539 173.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -71.73 -34.75 69.81 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.739 0.816 . . . . 0.0 110.758 178.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 19.5 mmt -95.99 101.19 7.79 Favored Pre-proline 0 N--CA 1.472 0.65 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 172.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.405 ' HB2' ' HG3' ' A' ' 48' ' ' GLU . 83.1 Cg_exo -48.85 129.68 21.5 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 123.338 2.692 . . . . 0.0 113.248 -171.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.02 -28.25 67.58 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.81 0.844 . . . . 0.0 111.336 -178.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -65.96 -41.76 90.81 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.958 0.903 . . . . 0.0 111.206 175.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.405 ' HG3' ' HB2' ' A' ' 45' ' ' PRO . 38.7 mt-10 -72.27 -31.72 66.0 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 122.566 0.346 . . . . 0.0 110.645 178.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.401 ' O ' HG13 ' A' ' 53' ' ' ILE . 96.4 mt -64.67 -36.89 78.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 123.261 0.624 . . . . 0.0 110.088 169.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.545 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 51.1 mt-10 -69.56 -28.31 65.88 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.457 0.303 . . . . 0.0 111.66 176.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -58.12 -34.13 69.9 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.562 0.696 . . . . 0.0 110.538 170.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 11.4 mmt -81.03 -37.76 28.59 Favored 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.038 177.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.545 ' HB ' ' HA ' ' A' ' 50' ' ' GLU . 69.0 mt -65.41 -43.02 94.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 124.467 1.107 . . . . 0.0 111.503 -175.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -59.74 -19.22 48.79 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.881 0.472 . . . . 0.0 112.049 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -84.32 -37.11 22.03 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.434 0.694 . . . . 0.0 110.92 172.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.99 -46.41 90.88 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.104 0.961 . . . . 0.0 111.09 179.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -109.53 82.3 2.14 Favored Pre-proline 0 CA--C 1.552 1.046 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 168.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -68.84 -34.17 18.69 Favored 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 123.341 2.694 . . . . 0.0 112.496 -167.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -87.65 -1.68 58.11 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.916 0.886 . . . . 0.0 111.149 177.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 56.68 49.99 13.48 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 124.802 1.241 . . . . 0.0 109.562 -172.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.2 m -70.42 -13.64 62.22 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 114.502 -1.226 . . . . 0.0 112.782 -172.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.43 11.23 82.36 Favored Glycine 0 C--N 1.348 1.241 0 N-CA-C 112.003 -0.439 . . . . 0.0 112.003 -173.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -135.17 145.83 48.15 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.55 1.14 . . . . 0.0 108.822 -177.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.4 ' O ' ' HB2' ' A' ' 27' ' ' TYR . 7.5 p -147.79 129.58 6.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 CA-C-O 121.251 0.548 . . . . 0.0 110.541 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -75.03 93.73 2.77 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 166.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.453 ' CE2' ' HA ' ' A' ' 27' ' ' TYR . 42.9 p90 -57.85 -40.18 79.5 Favored 'General case' 0 C--O 1.211 -0.936 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.269 -173.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -69.89 -33.41 72.18 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 120.976 0.417 . . . . 0.0 110.852 -177.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 25.4 m -66.64 -38.82 87.7 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.763 173.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.403 ' HD2' HD13 ' A' ' 33' ' ' LEU . 39.3 t80 -80.71 -72.17 0.43 Allowed 'General case' 0 C--O 1.213 -0.864 0 C-N-CA 122.915 0.486 . . . . 0.0 111.979 -178.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.573 ' HA ' ' HB3' ' A' ' 73' ' ' LEU . 87.6 t -43.37 -31.96 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 126.116 1.767 . . . . 0.0 112.565 174.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.448 ' HA2' ' HE3' ' A' ' 10' ' ' LYS . . . -56.4 -49.02 71.53 Favored Glycine 0 C--N 1.348 1.233 0 O-C-N 123.453 0.471 . . . . 0.0 112.925 170.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 81.8 mtp -83.04 -23.43 33.2 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.475 1.11 . . . . 0.0 112.157 178.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.573 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 52.5 tp -74.93 -49.55 19.8 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.044 0.938 . . . . 0.0 110.447 -172.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -80.38 22.14 0.57 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.139 0.976 . . . . 0.0 112.441 -178.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 59.4 mt -91.0 14.04 15.02 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 123.484 0.714 . . . . 0.0 111.402 172.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 13.4 m0 -61.48 91.89 0.03 OUTLIER 'General case' 0 C--N 1.355 0.827 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 172.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 . . . . . 0 CA--C 1.555 1.165 0 C-N-CA 124.07 0.948 . . . . 0.0 110.931 -177.422 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.209 0 N-CA-C 112.227 -0.349 . . . . 0.0 112.227 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.5 m -84.38 121.0 26.93 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.434 0.693 . . . . 0.0 109.211 175.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -108.19 89.11 2.89 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.099 0.56 . . . . 0.0 109.638 -179.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.404 ' N ' ' SD ' ' A' ' 4' ' ' MET . 2.5 mpp? -80.12 85.77 5.64 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.155 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.431 HD21 ' N ' ' A' ' 5' ' ' ASN . 0.7 OUTLIER -79.5 114.5 18.48 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.307 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 74.2 t60 -70.47 88.93 0.68 Allowed 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 172.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.1 tt -76.84 -47.01 29.07 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.498 -176.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.7 t30 59.28 15.06 4.01 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 125.449 1.499 . . . . 0.0 112.918 171.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 91.5 m -74.77 127.59 33.51 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 176.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.482 ' HD2' ' H ' ' A' ' 10' ' ' LYS . 3.0 mptp? -68.34 -16.17 63.84 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 122.93 0.492 . . . . 0.0 110.781 -170.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.36 -38.47 91.27 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.973 0.909 . . . . 0.0 111.605 173.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -55.41 -41.14 72.32 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 123.472 0.709 . . . . 0.0 112.003 -172.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.9 p -77.5 -40.76 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.745 -175.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 88.1 mt -61.49 -41.63 90.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 C-N-CA 123.946 0.898 . . . . 0.0 110.522 177.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.442 ' O ' HG22 ' A' ' 19' ' ' VAL . 42.8 mt-10 -71.12 -29.12 64.86 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.143 0.977 . . . . 0.0 110.587 179.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.21 -37.23 85.06 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.934 0.494 . . . . 0.0 110.71 175.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.403 ' HE1' ' HA ' ' A' ' 33' ' ' LEU . 79.1 m-85 -67.48 -31.94 72.42 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.135 0.574 . . . . 0.0 110.967 174.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -67.96 -40.16 83.27 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.709 0.403 . . . . 0.0 109.93 175.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.442 HG22 ' O ' ' A' ' 15' ' ' GLU . 69.7 t -60.23 -34.01 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 123.989 0.916 . . . . 0.0 110.704 176.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -76.81 -57.86 3.61 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.742 0.417 . . . . 0.0 110.763 179.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -76.0 91.89 3.11 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.183 0.516 . . . . 0.0 109.933 -178.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 31.6 mmm180 -91.05 -14.01 32.14 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.304 1.042 . . . . 0.0 110.2 178.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -91.76 -10.66 39.18 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.017 0.927 . . . . 0.0 111.032 -173.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.46 45.35 30.0 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-N 116.582 -0.281 . . . . 0.0 113.386 170.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.45 ' N ' HD21 ' A' ' 25' ' ' ASN . 0.8 OUTLIER -76.17 -25.67 55.45 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.671 0.788 . . . . 0.0 110.78 178.193 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.17 -4.12 80.69 Favored Glycine 0 C--N 1.352 1.429 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.02 -174.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.411 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 53.6 p90 -154.21 174.27 14.99 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.705 1.202 . . . . 0.0 109.285 -178.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.9 m -123.51 -174.99 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.413 0.685 . . . . 0.0 110.831 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.5 p -91.24 162.02 14.81 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 123.741 0.817 . . . . 0.0 110.482 174.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.604 HG21 HG21 ' A' ' 53' ' ' ILE . 7.7 p -61.92 -33.05 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.909 0.884 . . . . 0.0 112.109 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -67.0 -52.07 47.19 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 122.983 0.513 . . . . 0.0 112.119 -173.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -63.74 -38.43 91.08 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 120.529 0.204 . . . . 0.0 110.6 177.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.565 HD22 HG13 ' A' ' 64' ' ' VAL . 9.0 tp -52.92 -48.82 66.97 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 124.24 0.963 . . . . 0.0 110.316 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 28.4 mtm180 -66.28 -39.13 89.2 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.419 0.688 . . . . 0.0 111.516 178.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -59.75 -48.72 80.53 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.293 1.037 . . . . 0.0 111.224 -176.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.8 p -78.48 -32.55 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.883 -176.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 63.0 mt -80.19 -6.09 57.2 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 121.789 -0.569 . . . . 0.0 111.085 178.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -77.32 -45.16 27.09 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.428 0.691 . . . . 0.0 109.83 170.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -76.55 -29.37 56.65 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.944 -178.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -75.73 -36.6 59.87 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 122.72 0.408 . . . . 0.0 110.015 170.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.23 56.77 1.75 Allowed Glycine 0 C--N 1.347 1.147 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.1 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -72.53 -32.8 66.39 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.821 0.848 . . . . 0.0 111.51 -176.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 52.4 mtt -118.35 14.99 13.89 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.75 0.82 . . . . 0.0 110.471 175.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.426 ' SD ' ' N ' ' A' ' 44' ' ' MET . 1.4 mpt? -110.43 142.66 26.51 Favored Pre-proline 0 N--CA 1.475 0.818 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -67.55 113.29 2.88 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 121.932 1.755 . . . . 0.0 111.442 178.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.95 -26.49 68.23 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.523 0.729 . . . . 0.0 110.577 174.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -55.47 -46.27 76.86 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.61 1.164 . . . . 0.0 110.83 172.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -63.83 -52.01 62.08 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.286 -178.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.481 ' O ' HG13 ' A' ' 53' ' ' ILE . 91.7 mt -59.85 -43.66 92.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.483 -176.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.469 ' HA ' HD13 ' A' ' 53' ' ' ILE . 12.9 pt-20 -68.67 -31.61 70.85 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 123.188 0.305 . . . . 0.0 111.573 -175.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -72.02 -32.56 67.28 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.581 0.353 . . . . 0.0 110.91 176.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.427 ' HB3' ' HE1' ' A' ' 69' ' ' PHE . 76.4 mmm -67.79 -23.75 65.24 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.876 0.87 . . . . 0.0 111.182 175.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.604 HG21 HG21 ' A' ' 30' ' ' VAL . 72.5 mt -70.19 -30.79 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 123.396 0.679 . . . . 0.0 111.482 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -62.88 -25.27 68.22 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.223 0.535 . . . . 0.0 110.855 178.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -86.42 -36.22 19.25 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.475 1.11 . . . . 0.0 110.508 176.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.73 -29.81 69.14 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.145 0.978 . . . . 0.0 111.841 -178.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -118.13 87.42 29.04 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.231 1.013 . . . . 0.0 108.465 173.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.6 -32.89 69.03 Favored 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 123.088 2.525 . . . . 0.0 112.139 173.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -73.3 -6.29 45.07 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.168 0.987 . . . . 0.0 112.551 -172.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.0 p30 51.33 30.54 6.1 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 125.642 1.577 . . . . 0.0 112.064 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 71.8 p -87.93 -15.13 37.44 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.525 1.13 . . . . 0.0 112.187 -171.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.76 3.5 90.47 Favored Glycine 0 C--N 1.347 1.139 0 CA-C-N 116.322 -0.399 . . . . 0.0 112.478 -171.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -107.44 128.92 54.91 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 175.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.565 HG13 HD22 ' A' ' 33' ' ' LEU . 5.0 p -127.97 130.77 69.93 Favored 'Isoleucine or valine' 0 C--O 1.246 0.893 0 C-N-CA 123.113 0.565 . . . . 0.0 110.831 -172.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -73.86 91.57 1.98 Allowed 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 168.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.411 ' CE2' ' HA ' ' A' ' 27' ' ' TYR . 43.4 p90 -59.07 -30.94 68.44 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.046 176.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -61.98 -38.42 88.52 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.935 0.894 . . . . 0.0 110.567 -171.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 69.9 p -83.29 -44.03 15.37 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.464 177.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.51 ' HA ' ' HE2' ' A' ' 72' ' ' MET . 28.2 t80 -67.82 -60.88 2.17 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.701 0.8 . . . . 0.0 112.809 -172.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.7 t -65.07 -21.45 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.345 1.058 . . . . 0.0 111.151 -177.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.434 ' O ' ' HG ' ' A' ' 75' ' ' LEU . . . -58.63 -51.65 57.65 Favored Glycine 0 CA--C 1.534 1.254 0 N-CA-C 111.608 -0.597 . . . . 0.0 111.608 166.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.51 ' HE2' ' HA ' ' A' ' 69' ' ' PHE . 61.8 mtm -66.16 -32.83 74.51 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.982 0.913 . . . . 0.0 112.435 -179.071 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.4 mt -63.72 -35.31 80.14 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 121.219 0.533 . . . . 0.0 111.067 177.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -99.82 10.34 41.49 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.66 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 71' ' ' GLY . 81.8 mt -90.24 -13.18 35.94 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.164 0.586 . . . . 0.0 109.582 162.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 51.0 m0 -56.8 -44.16 81.66 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.532 0.733 . . . . 0.0 109.998 171.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.2 t70 . . . . . 0 C--O 1.249 1.066 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.744 174.07 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.351 0 N-CA-C 111.859 -0.496 . . . . 0.0 111.859 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.3 t -70.35 113.4 7.46 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.741 0.816 . . . . 0.0 109.941 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -160.16 119.8 2.84 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.652 0.781 . . . . 0.0 109.068 177.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 59.9 ttp -75.63 134.33 40.66 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.159 0.584 . . . . 0.0 110.129 177.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -150.56 146.46 26.58 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.234 1.014 . . . . 0.0 109.32 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 19.3 t-80 -93.98 -57.38 2.55 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.717 0.407 . . . . 0.0 109.923 178.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.403 ' HB ' ' OE1' ' A' ' 12' ' ' GLN . 17.5 tt -120.46 74.36 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 122.828 1.299 . . . . 0.0 110.81 -174.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -91.9 -17.25 25.49 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.619 165.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.1 t -155.5 166.4 33.64 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.642 1.177 . . . . 0.0 109.655 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.431 ' O ' HG11 ' A' ' 13' ' ' VAL . 10.2 ptpp? -75.35 -6.42 49.83 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.09 0.956 . . . . 0.0 111.55 178.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.438 ' O ' ' HG2' ' A' ' 15' ' ' GLU . . . -57.17 -23.67 49.12 Favored 'General case' 0 C--O 1.209 -1.051 0 C-N-CA 123.177 0.591 . . . . 0.0 112.422 177.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.403 ' OE1' ' HB ' ' A' ' 7' ' ' ILE . 8.2 pt20 -51.89 -45.64 64.25 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.402 0.681 . . . . 0.0 112.296 177.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.431 HG11 ' O ' ' A' ' 10' ' ' LYS . 12.4 p -80.3 -36.79 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 68.2 mt -64.8 -36.53 77.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 123.524 0.729 . . . . 0.0 111.13 -177.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.473 ' O ' HG21 ' A' ' 19' ' ' VAL . 37.4 mm-40 -73.25 -31.06 63.88 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.788 0.435 . . . . 0.0 110.526 178.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.91 -35.69 73.49 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.146 0.498 . . . . 0.0 110.599 175.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.43 ' CZ ' HG22 ' A' ' 70' ' ' VAL . 81.5 m-85 -65.49 -42.53 92.06 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.009 172.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.459 ' HZ3' ' HB3' ' A' ' 18' ' ' LYS . 8.3 mtpm? -73.45 -17.52 61.23 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.463 0.705 . . . . 0.0 111.823 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.473 HG21 ' O ' ' A' ' 15' ' ' GLU . 70.7 t -76.93 -30.07 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.956 0.902 . . . . 0.0 109.565 171.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -77.88 -58.52 3.22 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 174.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -82.73 82.91 7.87 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.613 0.765 . . . . 0.0 109.822 178.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -93.26 -14.29 27.21 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 114.086 -1.415 . . . . 0.0 109.535 173.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -70.75 -25.4 62.9 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.813 0.845 . . . . 0.0 110.726 176.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.07 43.09 8.97 Favored Glycine 0 C--N 1.347 1.163 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.777 173.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -72.1 -16.92 62.02 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.508 0.723 . . . . 0.0 110.412 172.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.58 -28.71 13.69 Favored Glycine 0 C--N 1.348 1.22 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.08 178.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.494 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 36.9 p90 -142.13 164.28 30.59 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 124.397 1.079 . . . . 0.0 109.916 -178.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 79.6 t -109.65 149.29 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.03 0.932 . . . . 0.0 109.915 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 75.9 p -66.05 157.4 31.09 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.574 0.75 . . . . 0.0 111.0 174.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.563 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 7.1 p -65.25 -16.83 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 122.846 0.458 . . . . 0.0 111.463 178.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -55.38 -57.07 13.35 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.038 0.935 . . . . 0.0 111.219 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -76.99 -34.42 57.52 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.605 177.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.563 ' HB3' ' HA ' ' A' ' 30' ' ' VAL . 3.0 tt -61.46 -39.66 91.68 Favored 'General case' 0 CA--C 1.549 0.916 0 O-C-N 123.67 0.606 . . . . 0.0 111.723 -174.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.549 ' HG3' HG21 ' A' ' 30' ' ' VAL . 63.8 mtt180 -67.89 -40.34 83.53 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-O 119.559 -0.257 . . . . 0.0 110.923 175.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -55.07 -58.0 9.45 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 123.93 0.769 . . . . 0.0 111.458 -178.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.7 p -66.17 -34.22 68.72 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 CA-C-N 115.223 -0.898 . . . . 0.0 111.705 -175.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.53 HD11 HG21 ' A' ' 70' ' ' VAL . 92.7 mt -85.44 -7.97 58.64 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.074 0.55 . . . . 0.0 111.865 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -87.24 -35.02 18.75 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 170.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -62.88 -37.38 86.69 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.689 170.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.0 tt -73.9 -44.34 55.54 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.216 177.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.499 ' HA2' ' HB2' ' A' ' 44' ' ' MET . . . -90.59 50.82 3.26 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.778 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -74.96 -49.68 19.23 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.508 0.723 . . . . 0.0 110.147 -177.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 15.0 ptp -108.0 -1.03 20.92 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.606 0.762 . . . . 0.0 110.415 174.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.499 ' HB2' ' HA2' ' A' ' 41' ' ' GLY . 1.4 mpt? -97.65 147.05 32.46 Favored Pre-proline 0 N--CA 1.478 0.95 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 177.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -63.53 109.24 0.98 Allowed 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 121.787 1.658 . . . . 0.0 111.275 173.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.18 -13.96 60.17 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.28 176.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -53.83 -46.58 71.22 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.236 1.014 . . . . 0.0 110.88 172.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.45 ' O ' ' HG2' ' A' ' 52' ' ' MET . 46.8 mt-10 -58.95 -52.3 66.33 Favored 'General case' 0 C--N 1.356 0.866 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.842 178.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.429 ' O ' HG13 ' A' ' 53' ' ' ILE . 81.4 mt -57.36 -45.35 85.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.069 0.947 . . . . 0.0 111.549 -176.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.45 ' HA ' HD12 ' A' ' 53' ' ' ILE . 66.3 mt-10 -71.27 -31.52 67.59 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.738 0.415 . . . . 0.0 111.331 -179.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -68.36 -32.63 72.86 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-O 121.43 0.634 . . . . 0.0 109.671 176.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.45 ' HG2' ' O ' ' A' ' 48' ' ' GLU . 80.4 mmm -70.98 -34.29 71.25 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.243 1.017 . . . . 0.0 110.285 174.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.45 HD12 ' HA ' ' A' ' 50' ' ' GLU . 85.2 mt -60.11 -40.96 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 123.359 0.664 . . . . 0.0 110.629 178.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -69.05 -15.06 63.37 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.408 0.683 . . . . 0.0 111.539 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -90.21 -37.14 14.34 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.217 0.607 . . . . 0.0 110.658 172.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.8 -18.15 58.59 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.543 0.737 . . . . 0.0 111.524 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -152.6 83.23 4.92 Favored Pre-proline 0 CA--C 1.55 0.976 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 172.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -75.01 -8.44 20.06 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.389 2.726 . . . . 0.0 112.63 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -75.47 -22.34 57.34 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.243 177.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 58.21 30.82 19.99 Favored 'General case' 0 C--N 1.36 1.037 0 C-N-CA 124.656 1.182 . . . . 0.0 110.237 -176.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.3 t -75.62 -19.56 59.14 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 114.511 -1.222 . . . . 0.0 110.676 -176.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.94 24.56 31.93 Favored Glycine 0 C--N 1.338 0.685 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.848 -178.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -130.01 105.09 7.73 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.718 0.807 . . . . 0.0 109.899 -176.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.458 HG12 HD13 ' A' ' 33' ' ' LEU . 2.1 p -135.37 123.05 37.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 124.007 0.923 . . . . 0.0 109.857 -174.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -70.42 109.16 4.61 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.702 0.801 . . . . 0.0 110.352 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.494 ' CE2' ' HA ' ' A' ' 27' ' ' TYR . 38.1 p90 -64.25 -28.5 69.78 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.939 0.895 . . . . 0.0 112.96 -175.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -66.1 -54.77 21.53 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.374 0.27 . . . . 0.0 110.693 -177.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.5 t -71.8 -28.65 63.74 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.252 178.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.493 ' O ' ' HG2' ' A' ' 72' ' ' MET . 60.8 t80 -81.87 -73.78 0.37 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 122.59 0.356 . . . . 0.0 111.122 -178.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.53 HG21 HD11 ' A' ' 37' ' ' LEU . 38.7 t -60.26 -22.3 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 123.945 0.898 . . . . 0.0 111.655 -173.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -55.63 -53.46 41.35 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-N 116.242 -0.436 . . . . 0.0 112.662 169.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.493 ' HG2' ' O ' ' A' ' 69' ' ' PHE . 18.5 ptp -65.79 -26.15 67.57 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.977 0.511 . . . . 0.0 111.83 -176.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 70' ' ' VAL . 4.4 mm? -56.7 -38.66 72.61 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.73 0.812 . . . . 0.0 110.97 175.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -89.59 -16.99 29.36 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.284 1.034 . . . . 0.0 111.182 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.42 ' HB2' ' HA ' ' A' ' 72' ' ' MET . 85.4 mt -86.67 -3.32 59.02 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.357 0.663 . . . . 0.0 111.518 176.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 42.8 m0 -59.86 114.77 2.97 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.969 0.507 . . . . 0.0 110.121 170.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 . . . . . 0 C--O 1.255 1.349 0 C-N-CA 123.445 0.698 . . . . 0.0 110.703 179.868 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.429 ' HB3' ' CD2' ' A' ' 74' ' ' PHE . 0.0 OUTLIER . . . . . 0 CA--C 1.546 0.797 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.46 -47.18 85.16 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.83 0.452 . . . . 0.0 110.536 170.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -55.58 -41.86 73.97 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.495 1.118 . . . . 0.0 113.154 -174.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.0 p -67.76 -41.87 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 O-C-N 122.982 0.176 . . . . 0.0 110.542 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 62.0 mt -70.92 -27.62 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 123.603 0.761 . . . . 0.0 110.945 -178.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -75.49 -28.75 59.32 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.331 0.652 . . . . 0.0 110.751 175.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.66 -32.99 74.67 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.041 0.536 . . . . 0.0 110.629 174.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -64.55 -33.47 75.99 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.258 0.623 . . . . 0.0 111.018 171.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.1 mttp -78.67 -17.81 55.37 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.442 0.697 . . . . 0.0 111.725 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 67.0 t -72.88 -37.77 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 171.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -69.36 -55.3 10.79 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.996 173.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -80.04 77.92 6.71 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.777 0.831 . . . . 0.0 109.047 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.7 -21.12 61.83 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.097 1.359 . . . . 0.0 109.325 -178.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -76.01 -27.74 57.5 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.005 0.922 . . . . 0.0 111.358 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.93 45.9 54.99 Favored Glycine 0 C--N 1.344 1.015 0 O-C-N 123.486 0.491 . . . . 0.0 112.183 -176.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -68.58 -28.02 66.58 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.289 1.036 . . . . 0.0 111.312 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.41 -11.66 36.32 Favored Glycine 0 C--N 1.343 0.925 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 -175.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.4 ' HB2' ' O ' ' A' ' 64' ' ' VAL . 36.5 p90 -154.8 159.79 40.83 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.709 0.804 . . . . 0.0 110.535 -177.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.1 m -112.15 -177.15 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.762 0.825 . . . . 0.0 110.512 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 64.4 p -81.83 154.52 25.86 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.548 170.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.441 ' O ' ' HG3' ' A' ' 34' ' ' ARG . 9.8 p -68.41 -26.49 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 122.544 0.337 . . . . 0.0 111.062 -177.002 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -65.45 -48.14 73.73 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 122.978 0.511 . . . . 0.0 111.398 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -63.81 -39.02 93.23 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 123.313 0.383 . . . . 0.0 110.465 177.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.495 HD11 ' HD2' ' A' ' 69' ' ' PHE . 5.3 tp -55.47 -46.48 76.83 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.608 178.298 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.569 ' HG2' HD13 ' A' ' 53' ' ' ILE . 80.8 mtm180 -67.56 -35.64 79.41 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.443 0.697 . . . . 0.0 110.984 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -62.11 -52.11 65.19 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.274 1.03 . . . . 0.0 111.701 -176.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.9 p -74.25 -35.36 40.06 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.037 0 C-N-CA 123.085 0.554 . . . . 0.0 111.136 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.493 HD23 HD12 ' A' ' 40' ' ' LEU . 95.8 mt -80.22 -4.82 54.67 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.911 0.485 . . . . 0.0 111.295 178.005 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -75.68 -47.01 28.1 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.479 0.711 . . . . 0.0 109.964 173.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -75.35 -23.67 57.21 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.958 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.493 HD12 HD23 ' A' ' 37' ' ' LEU . 99.1 mt -82.94 -25.38 32.43 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.351 0.66 . . . . 0.0 110.025 170.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.29 14.13 46.91 Favored Glycine 0 C--N 1.354 1.562 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.278 174.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -75.76 -52.82 9.59 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 168.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -82.38 -37.62 25.33 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.284 0.634 . . . . 0.0 110.575 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 93.0 mmm -89.43 147.08 37.24 Favored Pre-proline 0 N--CA 1.477 0.925 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.69 111.57 0.83 Allowed 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 122.122 1.881 . . . . 0.0 111.2 170.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.14 -33.93 72.42 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.841 0.856 . . . . 0.0 111.047 -176.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -57.89 -38.98 76.79 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.101 0.96 . . . . 0.0 111.677 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.406 ' O ' ' HG2' ' A' ' 52' ' ' MET . 19.8 mm-40 -58.18 -53.25 60.38 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 123.848 0.718 . . . . 0.0 110.309 174.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 86.2 mt -58.17 -45.08 88.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.241 1.016 . . . . 0.0 111.023 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.499 ' HA ' HD12 ' A' ' 53' ' ' ILE . 45.3 mt-10 -63.75 -29.42 70.64 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.936 0.895 . . . . 0.0 111.843 -177.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -77.01 -41.7 41.66 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.301 0.572 . . . . 0.0 109.961 175.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.419 ' HB3' ' HE1' ' A' ' 69' ' ' PHE . 24.9 mmt -64.71 -24.67 67.64 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.036 177.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.569 HD13 ' HG2' ' A' ' 34' ' ' ARG . 41.6 mt -66.81 -32.52 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.766 1.226 . . . . 0.0 111.355 177.212 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -73.67 -27.4 61.22 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.801 0.44 . . . . 0.0 110.59 174.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -85.05 -17.38 37.62 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.177 0.591 . . . . 0.0 110.67 175.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.6 -51.25 10.95 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.816 0.846 . . . . 0.0 109.848 176.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -123.32 81.72 52.59 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 124.28 1.032 . . . . 0.0 108.468 175.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -73.34 -20.25 21.27 Favored 'Trans proline' 0 C--N 1.386 2.53 0 C-N-CA 123.076 2.517 . . . . 0.0 111.552 173.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -66.8 -23.57 66.07 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.578 174.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 58.15 34.55 24.27 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 124.992 1.317 . . . . 0.0 111.122 175.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.7 m -82.61 -13.33 56.7 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.421 -176.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.05 25.39 44.94 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.268 -172.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -139.59 122.96 17.13 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.769 0.828 . . . . 0.0 109.759 -175.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.482 HG11 HD22 ' A' ' 33' ' ' LEU . 2.8 p -131.65 129.9 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.59 0.756 . . . . 0.0 110.685 -172.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -74.95 90.25 2.42 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 170.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -56.72 -27.06 58.42 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.072 177.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -51.33 -58.22 6.81 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.455 1.102 . . . . 0.0 111.544 178.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.1 t -79.15 -33.11 44.43 Favored 'General case' 0 CA--C 1.555 1.17 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.072 -178.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.495 ' HD2' HD11 ' A' ' 33' ' ' LEU . 37.9 t80 -76.08 -63.13 1.39 Allowed 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -173.318 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.487 ' HA ' HD23 ' A' ' 73' ' ' LEU . 57.5 t -60.91 -16.55 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 123.428 0.691 . . . . 0.0 110.585 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -56.06 -56.26 25.02 Favored Glycine 0 CA--C 1.536 1.352 0 CA-C-O 118.991 -0.894 . . . . 0.0 112.742 166.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 19.3 ptm -63.43 -30.6 71.7 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 118.068 0.934 . . . . 0.0 112.142 -176.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.487 HD23 ' HA ' ' A' ' 70' ' ' VAL . 4.0 mm? -59.83 -30.06 68.69 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.233 0.613 . . . . 0.0 110.92 176.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.429 ' CD2' ' HB3' ' A' ' 10' ' ' LYS . 76.7 m-85 -116.7 1.98 12.88 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.944 0.898 . . . . 0.0 111.799 -176.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 71.8 mt -97.55 5.8 49.01 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.497 0.719 . . . . 0.0 110.956 173.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 29.5 m0 . . . . . 0 N--CA 1.475 0.792 0 C-N-CA 122.643 0.377 . . . . 0.0 110.322 174.545 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt . . . . . 0 N--CA 1.48 1.068 0 N-CA-C 111.026 0.01 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.78 -40.37 75.76 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.707 0.803 . . . . 0.0 111.559 176.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -70.72 -47.86 57.58 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.968 0.507 . . . . 0.0 111.434 -176.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.9 p -69.32 -33.17 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.014 -176.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 90.2 mt -66.92 -38.39 81.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 174.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.412 ' HA ' ' HB2' ' A' ' 18' ' ' LYS . 70.8 mm-40 -66.87 -23.44 66.01 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 119.304 -0.379 . . . . 0.0 111.639 173.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.29 -37.98 86.71 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 120.94 0.4 . . . . 0.0 110.199 175.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -73.86 -37.68 64.7 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.892 173.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.412 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 9.9 mtpm? -74.79 -24.19 58.61 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.481 0.712 . . . . 0.0 112.21 -176.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.6 p -86.4 -27.51 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 176.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -67.18 -56.26 10.68 Favored 'General case' 0 C--N 1.354 0.787 0 C-N-CA 123.704 0.802 . . . . 0.0 109.399 174.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -82.75 83.1 7.81 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.785 177.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -85.62 -14.95 44.07 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.474 169.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -70.19 -27.32 64.41 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.803 0.841 . . . . 0.0 110.676 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.59 44.28 8.64 Favored Glycine 0 C--N 1.347 1.14 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.961 173.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -78.8 -13.2 59.94 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 122.972 0.509 . . . . 0.0 110.38 173.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.39 -44.98 1.93 Allowed Glycine 0 C--N 1.348 1.235 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 177.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.419 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 46.8 p90 -126.78 162.59 25.49 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 123.851 0.86 . . . . 0.0 110.106 177.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 52.4 t -109.68 151.05 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.183 0.993 . . . . 0.0 109.507 -177.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 76.1 p -68.99 166.56 17.73 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.627 0.771 . . . . 0.0 111.578 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.7 p -71.7 -15.15 18.11 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 122.606 0.362 . . . . 0.0 111.518 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -54.39 -63.02 1.28 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.844 0.858 . . . . 0.0 111.806 175.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -72.33 -29.38 63.77 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.987 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.546 HD22 HG11 ' A' ' 64' ' ' VAL . 7.3 tp -55.35 -51.66 66.06 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 123.8 0.688 . . . . 0.0 110.208 176.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 67.1 mtp85 -62.06 -40.59 96.31 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.458 0.703 . . . . 0.0 111.489 177.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -60.35 -54.4 46.14 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 123.783 0.677 . . . . 0.0 111.877 -174.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.6 p -67.1 -29.16 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 122.812 0.445 . . . . 0.0 111.259 -178.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.408 HD13 HG21 ' A' ' 49' ' ' ILE . 66.6 mt -87.67 -6.65 58.14 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.165 0.586 . . . . 0.0 111.868 178.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -83.1 -44.77 14.76 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.499 0.72 . . . . 0.0 110.27 177.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -68.05 -28.78 67.68 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.534 175.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 91.9 mt -96.34 11.07 36.05 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.273 1.029 . . . . 0.0 110.838 175.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -73.2 -14.93 78.84 Favored Glycine 0 C--N 1.352 1.438 0 C-N-CA 123.354 0.502 . . . . 0.0 113.037 -177.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -66.53 -46.37 76.38 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.906 0.882 . . . . 0.0 110.706 176.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 59.9 mtt -90.32 -46.18 8.56 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.672 0.789 . . . . 0.0 110.234 -175.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -110.35 98.76 37.47 Favored Pre-proline 0 N--CA 1.474 0.751 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 176.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -48.93 111.54 0.49 Allowed 'Trans proline' 0 C--N 1.385 2.5 0 C-N-CA 123.789 2.992 . . . . 0.0 113.707 -173.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.402 ' O ' ' HG3' ' A' ' 50' ' ' GLU . . . -64.1 -30.28 71.36 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.183 0.993 . . . . 0.0 111.16 -178.154 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -56.95 -48.06 79.23 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.093 0.957 . . . . 0.0 111.899 174.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -68.54 -38.82 81.15 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.038 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 37' ' ' LEU . 96.6 mt -62.69 -36.5 75.56 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.819 177.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.499 ' HA ' HD12 ' A' ' 53' ' ' ILE . 40.0 mt-10 -59.95 -35.44 74.95 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.42 0.688 . . . . 0.0 111.641 176.186 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -69.41 -42.69 74.72 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.244 0.545 . . . . 0.0 109.992 176.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 49.9 mtt -69.68 -22.4 63.44 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.39 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.499 HD12 ' HA ' ' A' ' 50' ' ' GLU . 23.3 mt -64.27 -28.53 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.416 1.086 . . . . 0.0 111.558 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -59.5 -37.09 77.36 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 122.89 0.476 . . . . 0.0 111.064 174.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -81.44 -38.09 27.0 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.406 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.409 ' HB3' ' HA ' ' A' ' 53' ' ' ILE . . . -63.28 -32.31 73.69 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.592 1.157 . . . . 0.0 111.673 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -114.97 88.5 17.19 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 124.34 1.056 . . . . 0.0 108.416 172.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -85.2 3.35 7.37 Favored 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.647 2.231 . . . . 0.0 111.603 173.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -83.59 -21.87 32.46 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.749 0.82 . . . . 0.0 110.306 176.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.6 t30 64.51 30.65 12.84 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.52 1.128 . . . . 0.0 110.079 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.3 m -132.51 -4.65 3.32 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.581 0.752 . . . . 0.0 112.105 -172.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.71 37.26 8.07 Favored Glycine 0 N--CA 1.471 1.023 0 C-N-CA 122.885 0.278 . . . . 0.0 113.546 178.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -123.61 125.65 45.21 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.153 0.981 . . . . 0.0 109.993 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.546 HG11 HD22 ' A' ' 33' ' ' LEU . 3.1 p -139.86 135.6 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.347 0.659 . . . . 0.0 111.057 -171.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -79.87 103.6 9.88 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 167.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.419 ' CE2' ' HA ' ' A' ' 27' ' ' TYR . 39.3 p90 -64.06 -32.28 73.77 Favored 'General case' 0 C--O 1.208 -1.121 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.18 -177.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -61.4 -39.22 89.93 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 118.427 0.558 . . . . 0.0 111.343 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 77.8 p -77.01 -47.73 19.87 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.368 0.667 . . . . 0.0 110.805 -178.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.406 ' HD2' HD11 ' A' ' 33' ' ' LEU . 48.4 t80 -70.82 -53.5 15.08 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.751 0.82 . . . . 0.0 111.941 -176.267 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.413 ' HA ' HD12 ' A' ' 73' ' ' LEU . 45.4 t -67.77 -18.51 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.693 0.797 . . . . 0.0 110.85 178.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -59.24 -49.61 76.67 Favored Glycine 0 C--N 1.349 1.304 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 165.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 85.2 mtp -70.62 -24.43 62.73 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.78 0.832 . . . . 0.0 111.951 177.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 70' ' ' VAL . 86.2 mt -70.85 -10.92 60.54 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.127 0.571 . . . . 0.0 112.436 178.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -118.08 24.1 11.21 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.417 0.687 . . . . 0.0 109.636 174.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 85.9 mt -126.72 -31.05 2.72 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.166 0.986 . . . . 0.0 111.672 178.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.393 0 CA-C-N 117.987 0.358 . . . . 0.0 111.262 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.459 ' HB3' ' HB3' ' A' ' 74' ' ' PHE . 17.1 ptmt . . . . . 0 CA--C 1.536 0.417 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.85 -45.33 94.93 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.785 0.434 . . . . 0.0 110.362 172.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -59.57 -44.16 93.38 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.554 0.742 . . . . 0.0 111.558 -175.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.6 p -74.34 -34.56 37.08 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 CA-C-O 118.986 -0.531 . . . . 0.0 111.143 -179.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 90.2 mt -60.33 -40.38 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-N 118.584 0.629 . . . . 0.0 109.651 173.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -68.93 -24.16 64.25 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.004 0.921 . . . . 0.0 111.186 177.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.18 -13.13 61.1 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.448 0.699 . . . . 0.0 111.734 174.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.587 ' HA ' ' HE2' ' A' ' 32' ' ' TYR . 90.6 m-85 -93.58 -43.79 8.52 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.344 0.658 . . . . 0.0 110.539 170.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -67.95 -22.2 65.05 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.201 -175.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.8 p -59.95 -31.59 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.313 0.645 . . . . 0.0 111.088 175.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -78.72 -49.19 13.5 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.828 0.851 . . . . 0.0 110.433 176.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -65.32 105.18 1.08 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.543 0.737 . . . . 0.0 111.129 -173.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 19.2 tpp180 -71.15 -50.98 27.69 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.407 1.083 . . . . 0.0 110.577 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.421 ' HB2' ' HB2' ' A' ' 25' ' ' ASN . 5.6 m-20 -73.79 -20.7 60.39 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 114.701 -1.136 . . . . 0.0 112.155 -167.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.96 37.78 88.16 Favored Glycine 0 C--N 1.346 1.129 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -166.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.421 ' HB2' ' HB2' ' A' ' 23' ' ' ASP . 16.5 t-20 -67.71 -30.02 69.42 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.265 1.426 . . . . 0.0 111.074 -167.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 142.07 -60.82 0.54 Allowed Glycine 0 C--N 1.342 0.894 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 176.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.529 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 46.3 p90 -142.73 -176.01 4.71 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -176.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.9 m -126.85 -176.26 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.337 1.055 . . . . 0.0 110.511 -177.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 35.3 p -78.46 160.84 27.5 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 124.195 0.998 . . . . 0.0 111.387 177.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.2 p -78.45 -16.5 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.208 -176.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -69.39 -37.85 77.74 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 120.727 0.298 . . . . 0.0 110.548 173.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.587 ' HE2' ' HA ' ' A' ' 17' ' ' PHE . 45.6 t80 -73.73 -30.49 62.85 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.368 0.667 . . . . 0.0 110.36 178.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.408 HD12 ' CE2' ' A' ' 17' ' ' PHE . 8.6 tp -64.53 -55.29 21.55 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.52 175.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.636 ' HG2' HD13 ' A' ' 53' ' ' ILE . 63.3 mtm180 -69.54 -17.1 63.54 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.631 -177.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -66.52 -61.75 1.82 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.904 0.882 . . . . 0.0 110.75 174.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.4 p -68.67 -28.2 39.1 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.135 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.975 -175.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 71.8 mt -88.4 -8.98 54.12 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.937 -0.477 . . . . 0.0 111.857 -177.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -73.71 -46.96 42.95 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.252 0.621 . . . . 0.0 109.642 171.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -73.35 -25.65 60.69 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.903 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 97.9 mt -89.45 11.22 19.95 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.511 0.724 . . . . 0.0 111.107 173.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.8 3.24 61.21 Favored Glycine 0 C--N 1.358 1.764 0 CA-C-N 116.327 -0.397 . . . . 0.0 113.413 177.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -67.12 -40.99 86.93 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.1 0.96 . . . . 0.0 111.462 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 88.3 mmm -76.49 -46.98 24.43 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 122.993 0.517 . . . . 0.0 111.39 -178.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 90.9 mmm -135.2 139.16 30.9 Favored Pre-proline 0 N--CA 1.48 1.06 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.412 ' HB2' ' HG2' ' A' ' 48' ' ' GLU . 85.8 Cg_exo -49.27 133.92 30.61 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 122.625 2.217 . . . . 0.0 111.755 174.164 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.412 ' O ' ' HG3' ' A' ' 50' ' ' GLU . . . -58.55 -25.39 62.45 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 123.549 0.53 . . . . 0.0 111.206 178.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -60.07 -39.19 85.21 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.058 0.943 . . . . 0.0 111.972 175.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.412 ' HG2' ' HB2' ' A' ' 45' ' ' PRO . 9.6 mm-40 -56.73 -39.61 74.25 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.847 0.832 . . . . 0.0 109.776 176.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.407 ' O ' HG13 ' A' ' 53' ' ' ILE . 49.3 mt -77.37 -35.47 22.32 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 CA-C-N 113.999 -1.455 . . . . 0.0 110.356 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 46' ' ' ALA . 40.4 mt-10 -65.92 -32.04 73.32 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.739 0.815 . . . . 0.0 112.755 -175.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -66.18 -36.06 82.09 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 121.328 0.585 . . . . 0.0 109.768 174.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 23.6 mtm -75.71 -24.57 56.22 Favored 'General case' 0 CA--C 1.553 1.058 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.488 177.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.636 HD13 ' HG2' ' A' ' 34' ' ' ARG . 62.8 mt -71.93 -28.19 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 124.397 1.079 . . . . 0.0 111.018 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -65.16 -32.96 74.91 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.069 171.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -83.66 -23.75 31.63 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.864 0.866 . . . . 0.0 110.9 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.585 ' HB1' HG23 ' A' ' 64' ' ' VAL . . . -72.94 -49.28 30.38 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.764 0.826 . . . . 0.0 110.482 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -120.35 90.49 45.23 Favored Pre-proline 0 CA--C 1.546 0.825 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 172.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.24 -11.81 15.97 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 123.027 2.485 . . . . 0.0 111.384 168.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -70.17 -24.07 63.08 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.221 1.009 . . . . 0.0 111.65 -173.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 60.78 24.01 13.94 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 125.038 1.335 . . . . 0.0 110.384 -174.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.8 t -105.48 -5.25 20.45 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.407 1.083 . . . . 0.0 109.86 -177.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.24 43.81 62.01 Favored Glycine 0 C--N 1.347 1.175 0 O-C-N 123.851 0.719 . . . . 0.0 113.06 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.445 ' HB3' ' HE1' ' A' ' 27' ' ' TYR . 27.2 m-85 -131.02 109.86 10.81 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.671 0.789 . . . . 0.0 110.29 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.585 HG23 ' HB1' ' A' ' 56' ' ' ALA . 4.6 p -117.83 129.98 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 123.885 0.874 . . . . 0.0 110.824 -175.194 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -81.23 91.62 6.21 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 170.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.529 ' CE2' ' HA ' ' A' ' 27' ' ' TYR . 45.1 p90 -61.33 -23.59 65.84 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 122.968 0.507 . . . . 0.0 111.498 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -51.63 -56.78 11.64 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.302 1.041 . . . . 0.0 110.582 173.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.2 t -82.07 -30.54 31.26 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.004 -177.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -73.68 -63.06 1.28 Allowed 'General case' 0 N--CA 1.476 0.848 0 O-C-N 123.066 0.229 . . . . 0.0 111.038 -175.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.54 ' HA ' ' HB3' ' A' ' 73' ' ' LEU . 90.2 t -59.0 -24.81 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 124.366 1.067 . . . . 0.0 111.154 177.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -56.63 -54.62 35.0 Favored Glycine 0 CA--C 1.532 1.103 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.355 169.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.414 ' HA ' ' HG ' ' A' ' 75' ' ' LEU . 20.8 mmt -76.15 -32.25 59.0 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.334 0.653 . . . . 0.0 111.368 -178.174 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.54 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 18.7 tp -69.49 -31.11 69.17 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.551 1.54 . . . . 0.0 111.627 -178.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.459 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 16.0 m-85 -111.94 26.36 10.68 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.159 0.584 . . . . 0.0 111.315 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.414 ' HG ' ' HA ' ' A' ' 72' ' ' MET . 78.3 mt -72.85 -31.89 65.07 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 166.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 17.5 p-90 . . . . . 0 N--CA 1.478 0.972 0 C-N-CA 123.653 0.781 . . . . 0.0 111.777 177.181 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.7 pttp . . . . . 0 N--CA 1.473 0.677 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.89 -34.75 60.4 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.374 0.67 . . . . 0.0 112.631 -178.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -79.92 -38.72 31.9 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.428 0.691 . . . . 0.0 111.211 -176.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.4 p -72.74 -29.03 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 122.126 0.17 . . . . 0.0 110.602 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.7 mt -64.09 -34.22 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.568 0.747 . . . . 0.0 110.086 175.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -70.82 -22.96 62.27 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.25 0.62 . . . . 0.0 111.971 177.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.94 -41.29 95.63 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.248 0.547 . . . . 0.0 109.571 172.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -65.41 -35.22 80.28 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.861 173.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -84.92 -11.64 55.13 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -175.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.9 p -89.16 -29.27 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 172.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 93.5 t80 -70.37 -51.99 25.76 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.578 171.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -64.73 116.79 6.63 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 173.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -87.28 -53.37 4.87 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.32 0.648 . . . . 0.0 111.891 -169.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -95.65 -7.76 36.65 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.005 0.522 . . . . 0.0 112.378 -167.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.99 50.72 4.77 Favored Glycine 0 C--N 1.343 0.93 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -171.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -62.37 -28.63 69.9 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.058 1.743 . . . . 0.0 111.292 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.14 -22.46 29.34 Favored Glycine 0 C--N 1.347 1.147 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.984 178.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -154.03 167.62 29.18 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.696 0.798 . . . . 0.0 111.193 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.1 m -116.24 176.26 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.32 1.048 . . . . 0.0 109.823 176.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 42.6 p -79.27 150.38 31.56 Favored 'General case' 0 C--O 1.246 0.896 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.78 171.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.457 HG12 ' HA2' ' A' ' 62' ' ' GLY . 9.0 p -66.64 -23.69 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 122.65 0.38 . . . . 0.0 111.255 -177.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -57.64 -54.23 49.2 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.442 0.697 . . . . 0.0 111.538 176.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -64.14 -38.79 92.32 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.841 0.456 . . . . 0.0 110.752 176.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.7 tt -60.66 -35.61 76.66 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.238 -176.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 23.2 mtp180 -75.29 -34.41 61.3 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.186 0.594 . . . . 0.0 111.233 176.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.2 mttp -59.6 -50.97 71.81 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.96 0.904 . . . . 0.0 111.735 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.8 p -71.68 -40.21 70.15 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.47 -176.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 97.4 mt -76.39 -11.96 59.98 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.087 0.555 . . . . 0.0 112.184 -176.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -65.97 -29.74 70.19 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.373 0.669 . . . . 0.0 109.833 171.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -86.27 -8.09 58.01 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.483 1.113 . . . . 0.0 111.706 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -91.79 18.6 7.46 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.728 0.811 . . . . 0.0 111.251 177.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 140.17 88.42 0.15 Allowed Glycine 0 C--N 1.349 1.292 0 CA-C-O 119.864 -0.409 . . . . 0.0 112.407 173.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -77.99 -30.06 49.99 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.427 0.691 . . . . 0.0 110.225 175.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -76.89 -24.33 52.53 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.157 174.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 83.1 mtp -79.96 147.92 67.02 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 123.924 0.89 . . . . 0.0 109.524 176.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.63 110.84 2.41 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 121.785 1.657 . . . . 0.0 111.277 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.33 -21.86 66.75 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.628 174.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -48.83 -41.56 33.35 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.392 1.477 . . . . 0.0 112.327 177.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.486 ' O ' ' HG2' ' A' ' 52' ' ' MET . 38.7 tt0 -65.85 -50.28 65.13 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.489 0.493 . . . . 0.0 110.316 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 88.3 mt -58.61 -36.16 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 123.848 0.859 . . . . 0.0 110.74 178.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -63.45 -46.78 84.71 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.098 0.959 . . . . 0.0 110.285 176.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -62.38 -34.55 76.91 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.912 0.485 . . . . 0.0 111.209 177.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.486 ' HG2' ' O ' ' A' ' 48' ' ' GLU . 26.1 mmt -67.93 -35.97 79.35 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.556 0.742 . . . . 0.0 109.925 176.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 83.3 mt -66.19 -36.61 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 124.218 1.007 . . . . 0.0 110.729 176.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -70.93 -21.01 62.41 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.402 0.681 . . . . 0.0 111.126 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -80.2 -41.58 24.96 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 171.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.462 ' HB1' HG23 ' A' ' 64' ' ' VAL . . . -72.83 -30.04 63.72 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.061 0.944 . . . . 0.0 111.92 -176.333 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -150.63 83.07 5.94 Favored Pre-proline 0 CA--C 1.545 0.76 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.26 -20.57 21.11 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.904 2.403 . . . . 0.0 113.085 -178.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -87.09 -10.62 52.44 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.162 0.585 . . . . 0.0 111.619 -178.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.1 t30 61.46 40.63 13.67 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 122.422 1.106 . . . . 0.0 109.586 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.9 m -77.53 -15.03 59.51 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.569 -1.196 . . . . 0.0 112.03 -173.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.457 ' HA2' HG12 ' A' ' 30' ' ' VAL . . . 85.53 13.67 69.89 Favored Glycine 0 C--N 1.347 1.177 0 CA-C-N 115.91 -0.587 . . . . 0.0 112.327 -173.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -123.01 111.26 16.38 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.736 0.815 . . . . 0.0 109.509 -175.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.462 HG23 ' HB1' ' A' ' 56' ' ' ALA . 2.2 p -139.99 121.29 15.1 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 C-N-CA 123.383 0.673 . . . . 0.0 109.854 -178.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -69.49 94.77 0.77 Allowed 'General case' 0 C--N 1.348 0.514 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.057 173.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 48.2 p90 -57.35 -28.81 63.47 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 123.56 0.538 . . . . 0.0 111.19 177.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -62.19 -49.31 76.29 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.356 0.662 . . . . 0.0 110.851 -176.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 79.8 p -77.59 -33.75 53.76 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.467 0.707 . . . . 0.0 110.641 177.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -67.31 -68.75 0.36 Allowed 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.418 -176.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.621 ' HA ' ' HB3' ' A' ' 73' ' ' LEU . 75.9 t -50.37 -29.11 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 125.404 1.481 . . . . 0.0 112.781 176.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.76 -48.07 80.36 Favored Glycine 0 C--N 1.349 1.287 0 CA-C-O 121.123 0.291 . . . . 0.0 112.693 171.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 33.3 mmt -86.09 -5.72 59.15 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.929 0.892 . . . . 0.0 112.295 177.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.621 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 55.4 tp -88.97 -42.61 11.69 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.068 0.947 . . . . 0.0 109.424 -177.557 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -90.96 11.75 21.83 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.154 0.582 . . . . 0.0 112.474 -177.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 pp -70.8 -9.1 56.77 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 118.308 0.504 . . . . 0.0 111.895 178.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 14.2 m0 . . . . . 0 N--CA 1.476 0.849 0 C-N-CA 123.659 0.784 . . . . 0.0 109.895 175.946 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? . . . . . 0 N--CA 1.479 1.019 0 N-CA-C 111.372 0.138 . . . . 0.0 111.372 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.1 -51.17 69.01 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 122.995 0.518 . . . . 0.0 110.687 173.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.7 mm-40 -56.49 -37.82 70.88 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.428 1.091 . . . . 0.0 112.738 -175.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.5 p -85.53 -42.36 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 CA-C-O 119.052 -0.499 . . . . 0.0 111.36 -177.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 60.3 mt -59.77 -43.16 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 122.881 0.472 . . . . 0.0 110.876 178.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.461 ' O ' HG23 ' A' ' 19' ' ' VAL . 12.9 pt-20 -70.08 -27.13 64.37 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.692 -178.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.13 -34.6 77.94 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.134 0.573 . . . . 0.0 110.999 175.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.473 ' HA ' ' HE2' ' A' ' 32' ' ' TYR . 83.0 m-85 -64.46 -37.85 88.97 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.957 0.503 . . . . 0.0 110.964 172.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -72.68 -20.51 61.22 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.273 0.629 . . . . 0.0 111.23 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 15' ' ' GLU . 61.0 t -71.87 -34.58 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 123.133 0.573 . . . . 0.0 110.049 171.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -71.8 -54.08 11.3 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.176 0.59 . . . . 0.0 109.844 175.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -77.6 83.04 4.0 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.649 0.78 . . . . 0.0 109.355 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -71.71 -40.38 69.53 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.162 0.985 . . . . 0.0 111.127 -176.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -72.53 -26.22 61.67 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.357 0.663 . . . . 0.0 111.801 -173.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.2 59.42 2.42 Favored Glycine 0 C--N 1.347 1.145 0 N-CA-C 111.978 -0.449 . . . . 0.0 111.978 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -86.65 -11.19 52.03 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.616 1.166 . . . . 0.0 111.143 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.73 -27.04 21.34 Favored Glycine 0 C--N 1.343 0.957 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.962 175.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.41 ' HB2' ' O ' ' A' ' 64' ' ' VAL . 39.1 p90 -149.25 177.1 9.94 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.195 0.598 . . . . 0.0 111.205 -174.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.1 m -132.55 -178.33 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 124.141 0.976 . . . . 0.0 110.096 178.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.0 p -78.03 155.05 30.91 Favored 'General case' 0 C--O 1.245 0.862 0 C-N-CA 123.932 0.893 . . . . 0.0 111.268 174.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.6 p -69.76 -20.29 23.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.607 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -58.76 -59.46 5.39 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.79 0.836 . . . . 0.0 110.934 175.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.473 ' HE2' ' HA ' ' A' ' 17' ' ' PHE . 87.0 t80 -62.56 -35.52 79.72 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.538 0.735 . . . . 0.0 110.764 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.524 HD22 HG11 ' A' ' 64' ' ' VAL . 6.5 tp -59.59 -53.47 57.66 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.611 178.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.556 ' HG2' HD13 ' A' ' 53' ' ' ILE . 98.0 mtt180 -67.08 -28.91 68.57 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.358 0.663 . . . . 0.0 111.514 -176.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -64.62 -58.61 5.87 Favored 'General case' 0 CA--C 1.548 0.904 0 O-C-N 123.665 0.603 . . . . 0.0 111.1 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.1 p -64.57 -38.73 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 123.138 0.575 . . . . 0.0 111.849 -174.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.442 HD23 HD12 ' A' ' 40' ' ' LEU . 85.8 mt -74.79 -26.53 59.81 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.245 0.618 . . . . 0.0 111.285 -176.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.461 ' HA ' ' HB2' ' A' ' 46' ' ' ALA . 39.7 t30 -67.51 -42.15 83.3 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 123.479 0.487 . . . . 0.0 109.817 171.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -70.42 -30.9 67.89 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.799 0.84 . . . . 0.0 111.717 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.442 HD12 HD23 ' A' ' 37' ' ' LEU . 95.8 mt -71.04 -28.41 64.37 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 122.759 0.424 . . . . 0.0 110.61 172.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -82.39 62.83 4.52 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 169.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -75.29 -36.64 61.13 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.237 0.615 . . . . 0.0 110.485 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 64.5 mtt -124.3 8.11 8.46 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.707 0.803 . . . . 0.0 110.768 173.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 22.8 mmt -116.99 140.92 27.58 Favored Pre-proline 0 N--CA 1.482 1.151 0 C-N-CA 124.045 0.938 . . . . 0.0 108.595 176.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.412 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 40.2 Cg_endo -66.95 133.03 29.87 Favored 'Trans proline' 0 C--N 1.368 1.567 0 C-N-CA 121.738 1.625 . . . . 0.0 111.367 173.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.461 ' HB2' ' HA ' ' A' ' 38' ' ' ASN . . . -73.33 -20.88 60.68 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.453 0.301 . . . . 0.0 110.286 174.045 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -54.84 -37.24 65.95 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.589 1.156 . . . . 0.0 112.571 -178.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 45' ' ' PRO . 17.1 pt-20 -67.14 -39.15 86.51 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.005 0.431 . . . . 0.0 110.309 177.168 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 89.6 mt -69.62 -33.25 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.41 1.084 . . . . 0.0 110.321 177.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -69.39 -32.96 72.31 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.806 0.842 . . . . 0.0 111.679 -176.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -62.29 -42.18 99.13 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 121.554 0.692 . . . . 0.0 109.983 171.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 60.4 mmm -67.9 -31.21 70.83 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.487 177.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.556 HD13 ' HG2' ' A' ' 34' ' ' ARG . 54.9 mt -67.72 -31.47 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 124.452 1.101 . . . . 0.0 110.932 178.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -77.54 -20.56 53.97 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.803 0.441 . . . . 0.0 111.291 172.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -79.46 -20.69 46.77 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.499 0.319 . . . . 0.0 110.671 171.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.47 -37.13 18.59 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.922 0.889 . . . . 0.0 111.041 175.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -132.25 80.5 63.53 Favored Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 124.334 1.054 . . . . 0.0 108.47 176.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -81.88 -12.58 10.84 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 123.268 2.646 . . . . 0.0 112.181 174.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 58.8 mm-40 -76.04 -17.03 59.83 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.632 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.6 m120 63.4 26.81 15.09 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.867 1.267 . . . . 0.0 110.611 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 53.1 m -88.89 -15.45 34.37 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.054 0.942 . . . . 0.0 111.245 -175.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.71 21.15 75.29 Favored Glycine 0 C--N 1.348 1.222 0 CA-C-N 116.32 -0.4 . . . . 0.0 113.052 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -116.92 117.22 29.11 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 178.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.524 HG11 HD22 ' A' ' 33' ' ' LEU . 3.9 p -135.02 124.42 42.92 Favored 'Isoleucine or valine' 0 C--O 1.245 0.822 0 C-N-CA 123.237 0.615 . . . . 0.0 110.805 -173.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -73.43 92.22 1.84 Allowed 'General case' 0 C--O 1.238 0.45 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 171.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -50.08 -46.27 53.23 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 114.465 -1.243 . . . . 0.0 113.761 -172.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -72.43 -34.48 67.85 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.32 0.648 . . . . 0.0 111.58 -175.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.4 m -63.48 -44.04 95.54 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.501 0.72 . . . . 0.0 109.625 175.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.468 ' HD2' HD11 ' A' ' 33' ' ' LEU . 17.6 t80 -71.71 -73.43 0.18 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.532 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.605 ' HA ' ' HB3' ' A' ' 73' ' ' LEU . 89.7 t -47.03 -28.44 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 C-N-CA 126.171 1.789 . . . . 0.0 113.149 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -59.53 -54.14 40.19 Favored Glycine 0 CA--C 1.538 1.503 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 169.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 84.7 mtp -72.89 -28.42 62.48 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.124 0.97 . . . . 0.0 111.996 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.605 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 54.6 tp -67.36 -46.83 72.2 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.38 1.072 . . . . 0.0 110.164 -177.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.435 ' HZ ' HD13 ' A' ' 40' ' ' LEU . 7.5 m-85 -84.17 21.51 1.37 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.595 0.758 . . . . 0.0 111.992 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 69.0 mt -95.22 31.26 1.97 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.434 0.694 . . . . 0.0 110.576 170.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 26.1 m0 . . . . . 0 N--CA 1.478 0.963 0 C-N-CA 123.047 0.539 . . . . 0.0 110.422 176.572 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.467 ' O ' HG12 ' A' ' 14' ' ' ILE . 19.5 pttp . . . . . 0 N--CA 1.481 1.097 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.8 -30.84 67.9 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.059 0.544 . . . . 0.0 111.565 176.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -68.94 -47.08 66.56 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.35 0.66 . . . . 0.0 110.927 176.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.8 p -71.87 -24.65 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 -177.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.491 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 33.2 mm -63.16 -38.21 81.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 173.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -61.17 -30.3 70.32 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 122.595 0.358 . . . . 0.0 111.468 176.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.16 -36.93 80.43 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 123.565 0.54 . . . . 0.0 110.421 175.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.496 ' HE1' ' HA ' ' A' ' 33' ' ' LEU . 84.4 m-85 -70.23 -32.65 70.61 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.326 0.65 . . . . 0.0 111.401 174.099 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 14' ' ' ILE . 3.3 mmmp? -70.95 -11.72 61.13 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.048 0.539 . . . . 0.0 111.481 -179.182 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 89.8 t -68.46 -42.53 83.92 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 122.841 0.456 . . . . 0.0 110.296 173.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -74.04 -48.21 31.58 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 173.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -83.01 76.78 9.81 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.127 0.971 . . . . 0.0 109.713 -178.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -94.18 -29.1 15.29 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.045 0.538 . . . . 0.0 110.929 176.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -85.83 -12.05 51.81 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.301 0.641 . . . . 0.0 111.942 -176.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.65 50.8 5.13 Favored Glycine 0 C--N 1.338 0.674 0 N-CA-C 112.097 -0.401 . . . . 0.0 112.097 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -68.53 -24.1 64.6 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.211 1.004 . . . . 0.0 110.628 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.65 -22.13 42.43 Favored Glycine 0 C--N 1.345 1.045 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.018 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.424 ' HB2' ' O ' ' A' ' 64' ' ' VAL . 43.4 p90 -156.07 172.42 18.44 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.72 0.808 . . . . 0.0 111.466 -175.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.2 m -121.42 -177.07 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 123.87 0.868 . . . . 0.0 110.232 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 70.7 p -83.14 162.17 21.38 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.699 0.8 . . . . 0.0 111.024 175.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.505 ' HB ' ' HA2' ' A' ' 62' ' ' GLY . 9.9 p -64.93 -27.79 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 123.019 0.527 . . . . 0.0 110.285 173.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -67.62 -47.52 69.39 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.51 1.124 . . . . 0.0 110.284 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -71.74 -34.02 69.18 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.251 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.496 ' HA ' ' HE1' ' A' ' 17' ' ' PHE . 5.8 tp -63.11 -55.62 23.79 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.991 0.916 . . . . 0.0 111.12 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.502 ' HG2' HD13 ' A' ' 53' ' ' ILE . 62.1 mtp180 -64.3 -31.46 72.68 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.412 0.685 . . . . 0.0 111.243 -178.191 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -59.32 -64.02 1.09 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.516 0.726 . . . . 0.0 111.271 178.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.2 p -62.6 -36.25 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.359 0.664 . . . . 0.0 111.726 -176.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 91.4 mt -82.07 -12.44 58.25 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.023 0.529 . . . . 0.0 111.667 -176.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -85.8 -36.35 20.13 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 171.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -66.07 -41.56 90.59 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.505 0.722 . . . . 0.0 110.341 174.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.408 HD21 ' HZ ' ' A' ' 74' ' ' PHE . 64.1 tp -78.55 -28.35 46.03 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.333 1.053 . . . . 0.0 110.192 174.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -88.3 53.69 4.16 Favored Glycine 0 C--N 1.344 1.021 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 175.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -88.09 -56.87 3.15 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.481 0.713 . . . . 0.0 109.367 175.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 57.5 mtm -82.49 -32.41 28.82 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.38 177.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 23.9 mmt -88.4 146.89 38.69 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 123.537 0.735 . . . . 0.0 109.305 174.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -70.21 119.28 6.24 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 121.952 1.768 . . . . 0.0 111.597 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.505 ' O ' ' HG2' ' A' ' 50' ' ' GLU . . . -62.91 -33.7 75.87 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.155 -0.684 . . . . 0.0 109.155 171.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -51.84 -41.07 61.52 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 125.352 1.461 . . . . 0.0 111.845 176.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -64.44 -48.31 75.81 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.217 1.007 . . . . 0.0 110.236 177.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.444 ' O ' HG13 ' A' ' 53' ' ' ILE . 68.3 mt -61.32 -36.46 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.466 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.505 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 15.9 mm-40 -56.63 -47.3 79.99 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.811 0.845 . . . . 0.0 111.075 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -66.03 -26.69 67.64 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 122.878 0.471 . . . . 0.0 111.427 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 43.8 mtp -77.23 -29.54 54.13 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.057 0.543 . . . . 0.0 110.459 175.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.502 HD13 ' HG2' ' A' ' 34' ' ' ARG . 96.8 mt -71.96 -24.42 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 123.964 0.906 . . . . 0.0 110.639 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -65.85 -26.1 67.5 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.044 0.538 . . . . 0.0 110.88 169.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -90.13 -28.63 18.83 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.228 0.611 . . . . 0.0 110.283 177.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.0 -42.27 76.7 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.795 0.838 . . . . 0.0 110.41 176.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -140.57 95.6 7.95 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 176.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -74.56 -23.54 14.7 Favored 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 122.749 2.299 . . . . 0.0 112.31 177.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -86.68 -12.24 48.92 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.864 0.865 . . . . 0.0 111.066 -174.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 64.11 25.74 13.79 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.783 1.233 . . . . 0.0 110.702 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 37.9 m -69.12 -22.41 63.97 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.703 1.201 . . . . 0.0 112.061 -177.138 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.505 ' HA2' ' HB ' ' A' ' 30' ' ' VAL . . . 79.33 26.59 57.06 Favored Glycine 0 C--N 1.339 0.733 0 CA-C-N 115.889 -0.596 . . . . 0.0 113.127 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -126.9 95.65 4.38 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.235 1.014 . . . . 0.0 108.693 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.477 HG11 HD22 ' A' ' 33' ' ' LEU . 2.0 p -119.94 125.24 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.958 0.903 . . . . 0.0 110.478 -171.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -72.77 91.03 1.45 Allowed 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 173.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -55.07 -38.03 67.52 Favored 'General case' 0 C--O 1.211 -0.966 0 CA-C-N 114.965 -1.016 . . . . 0.0 113.298 -173.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -65.96 -47.32 75.0 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 117.773 0.261 . . . . 0.0 110.633 -172.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 70.4 p -69.85 -32.28 70.58 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.067 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -68.51 -66.73 0.53 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 122.95 0.5 . . . . 0.0 110.879 176.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.65 ' HA ' ' HB3' ' A' ' 73' ' ' LEU . 52.9 t -47.89 -27.08 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.114 0 C-N-CA 126.435 1.894 . . . . 0.0 113.063 174.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.88 -53.48 37.28 Favored Glycine 0 CA--C 1.534 1.238 0 N-CA-C 112.28 -0.328 . . . . 0.0 112.28 169.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 91.0 mtp -75.26 -15.24 60.54 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.742 0.817 . . . . 0.0 111.944 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.65 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 59.4 tp -82.8 -43.73 16.35 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.882 1.273 . . . . 0.0 109.957 -178.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.408 ' HZ ' HD21 ' A' ' 40' ' ' LEU . 13.1 m-85 -88.5 22.65 2.49 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.821 0.848 . . . . 0.0 112.166 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 79.0 mt -70.73 -8.83 55.07 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 166.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 46.4 m0 . . . . . 0 C--N 1.355 0.84 0 C-N-CA 123.999 0.92 . . . . 0.0 109.778 168.556 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 56.8 tttm . . . . . 0 N--CA 1.478 0.955 0 CA-C-O 120.822 0.344 . . . . 0.0 111.434 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.1 -47.91 69.74 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.471 175.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -57.7 -38.77 75.79 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.985 0.914 . . . . 0.0 113.15 -174.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.9 p -66.26 -44.03 91.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 75.9 mt -66.62 -34.1 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.044 0.538 . . . . 0.0 109.97 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.458 ' O ' HG23 ' A' ' 19' ' ' VAL . 47.1 mt-10 -73.06 -25.94 61.1 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.331 0.653 . . . . 0.0 111.107 177.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.7 -37.63 86.99 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 121.231 0.538 . . . . 0.0 110.256 174.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.439 ' HE1' ' HA ' ' A' ' 33' ' ' LEU . 89.7 m-85 -67.28 -34.97 78.52 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.929 172.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.481 ' HE3' ' HE1' ' A' ' 66' ' ' TYR . 33.2 mmtp -66.44 -28.6 68.72 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.193 0.597 . . . . 0.0 110.862 176.069 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 15' ' ' GLU . 93.4 t -65.98 -44.13 92.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.018 0.527 . . . . 0.0 109.747 175.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -67.69 -48.7 65.82 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.355 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -88.04 72.24 9.23 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.697 0.799 . . . . 0.0 109.168 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -31.9 68.94 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.369 177.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -66.2 -28.92 69.12 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.967 178.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.04 41.25 95.26 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-N 115.976 -0.556 . . . . 0.0 113.319 176.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -73.9 -18.46 60.9 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 122.61 0.364 . . . . 0.0 110.842 178.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.32 -6.86 14.54 Favored Glycine 0 C--N 1.349 1.255 0 CA-C-O 119.625 -0.542 . . . . 0.0 113.737 172.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -157.48 173.82 16.32 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 117.563 0.682 . . . . 0.0 112.365 -175.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.2 m -130.66 179.63 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 124.134 0.973 . . . . 0.0 110.26 178.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 66.7 p -74.31 153.53 39.3 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.919 171.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.56 -26.4 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 122.707 0.403 . . . . 0.0 110.912 177.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -64.38 -50.71 66.6 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.062 0.545 . . . . 0.0 111.144 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -62.1 -41.04 97.81 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.157 0.583 . . . . 0.0 110.444 175.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.669 HD22 HG11 ' A' ' 64' ' ' VAL . 2.8 tp -56.67 -53.28 59.47 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.556 -178.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -65.31 -37.03 85.89 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.631 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -57.25 -58.77 6.78 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 124.258 0.974 . . . . 0.0 111.052 -177.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.462 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 7.5 p -63.26 -46.13 96.51 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 O-C-N 123.506 0.504 . . . . 0.0 111.341 -177.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 95.7 mt -65.57 -30.63 71.4 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.233 0.613 . . . . 0.0 111.761 -176.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -77.47 -38.73 48.65 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.018 0.527 . . . . 0.0 110.234 177.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -78.34 -9.54 59.3 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.303 0.641 . . . . 0.0 111.974 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 36' ' ' VAL . 87.8 mt -73.63 -42.59 61.24 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.653 0.381 . . . . 0.0 110.025 170.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -166.81 89.75 0.1 OUTLIER Glycine 0 C--N 1.35 1.328 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.636 -177.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -69.46 -20.44 63.76 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.75 0.82 . . . . 0.0 110.927 176.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 23.1 mmt -59.84 -32.34 70.59 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.233 1.013 . . . . 0.0 110.711 175.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 21.8 mmt -84.51 141.25 38.96 Favored Pre-proline 0 C--O 1.245 0.867 0 C-N-CA 124.201 1.0 . . . . 0.0 108.849 177.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.59 110.38 2.07 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 121.645 1.564 . . . . 0.0 111.331 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.28 -19.27 64.69 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.272 174.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -48.61 -39.64 24.67 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 125.383 1.473 . . . . 0.0 111.496 175.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.96 -49.25 78.21 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.496 1.118 . . . . 0.0 110.537 177.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.458 ' O ' HG13 ' A' ' 53' ' ' ILE . 87.5 mt -60.88 -43.63 96.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.367 -179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.525 ' HA ' HD12 ' A' ' 53' ' ' ILE . 0.5 OUTLIER -55.66 -37.5 68.35 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.935 0.894 . . . . 0.0 112.639 177.957 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -72.96 -40.44 65.34 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 121.563 0.697 . . . . 0.0 110.268 177.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 28.6 mmt -64.66 -26.86 68.57 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.669 -1.151 . . . . 0.0 111.201 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.525 HD12 ' HA ' ' A' ' 50' ' ' GLU . 90.8 mt -66.69 -40.04 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 123.566 0.746 . . . . 0.0 110.826 177.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -65.44 -28.2 69.06 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 122.601 0.361 . . . . 0.0 110.908 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -75.74 -42.67 49.94 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.435 0.694 . . . . 0.0 110.904 177.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.57 -26.67 45.59 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.76 0.824 . . . . 0.0 111.802 -176.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -124.51 86.7 55.03 Favored Pre-proline 0 CA--C 1.542 0.673 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 176.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -75.94 -8.51 19.02 Favored 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 123.011 2.474 . . . . 0.0 112.521 -177.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -88.6 -24.03 22.94 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.488 0.715 . . . . 0.0 110.8 174.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 60.89 37.04 18.7 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 124.323 1.014 . . . . 0.0 109.356 -174.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.9 t -74.79 -18.67 60.43 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.595 -176.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.79 23.85 34.55 Favored Glycine 0 C--N 1.337 0.617 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.597 -175.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -139.42 131.26 27.59 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.114 1.366 . . . . 0.0 108.937 -178.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.669 HG11 HD22 ' A' ' 33' ' ' LEU . 2.8 p -145.56 134.77 17.57 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 CA-C-O 121.266 0.555 . . . . 0.0 110.727 -170.249 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -75.89 89.06 2.9 Favored 'General case' 0 C--N 1.35 0.606 0 C-N-CA 124.294 1.038 . . . . 0.0 108.823 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.481 ' HE1' ' HE3' ' A' ' 18' ' ' LYS . 32.5 p90 -49.94 -39.83 41.68 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 115.629 1.714 . . . . 0.0 115.629 -171.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -67.07 -50.67 61.0 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 118.73 0.695 . . . . 0.0 111.366 -170.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.467 ' O ' ' HG2' ' A' ' 72' ' ' MET . 9.4 t -71.02 -21.2 62.31 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.854 178.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.446 ' CE2' HD21 ' A' ' 33' ' ' LEU . 55.6 t80 -81.97 -58.1 3.13 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.513 0.725 . . . . 0.0 111.307 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.8 t -66.23 -27.88 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.215 1.006 . . . . 0.0 110.743 -177.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -59.82 -32.29 74.23 Favored Glycine 0 CA--C 1.537 1.418 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.681 171.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.467 ' HG2' ' O ' ' A' ' 68' ' ' THR . 26.6 mmt -76.29 -49.76 16.14 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.57 0.748 . . . . 0.0 111.35 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.402 HD22 HG12 ' A' ' 49' ' ' ILE . 1.9 pp -81.02 -2.96 50.12 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -172.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -94.82 -2.37 50.97 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.589 0.356 . . . . 0.0 111.009 169.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 65.2 mt -78.72 -5.67 53.8 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.489 0.316 . . . . 0.0 111.052 173.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 52.5 m0 . . . . . 0 N--CA 1.487 1.39 0 C-N-CA 123.581 0.752 . . . . 0.0 111.078 176.035 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.523 ' HE2' ' HB3' ' A' ' 74' ' ' PHE . 16.2 ptpt . . . . . 0 CA--C 1.543 0.675 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.24 -38.38 90.85 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.147 0.579 . . . . 0.0 110.856 174.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -70.92 -38.11 72.92 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 112.432 0.531 . . . . 0.0 112.432 -176.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.83 -37.23 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 176.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.515 HG23 ' HE1' ' A' ' 66' ' ' TYR . 63.9 mt -63.01 -42.08 95.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.388 0.675 . . . . 0.0 110.219 173.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.417 ' O ' HG23 ' A' ' 19' ' ' VAL . 37.4 mt-10 -62.01 -32.95 73.48 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.852 0.861 . . . . 0.0 111.175 177.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.23 -38.07 79.06 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.161 0.584 . . . . 0.0 111.193 177.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.442 ' CZ ' HD12 ' A' ' 33' ' ' LEU . 96.2 m-85 -68.74 -37.08 79.16 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.269 175.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 14' ' ' ILE . 21.3 mtpp -71.76 -35.01 69.94 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.104 0.562 . . . . 0.0 111.045 -175.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 15' ' ' GLU . 91.4 t -71.01 -35.34 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.757 0.823 . . . . 0.0 110.07 176.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -66.48 -54.25 26.09 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.427 175.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.489 ' HB2' HG22 ' A' ' 28' ' ' VAL . 21.7 t70 -77.25 86.33 3.69 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.572 0.701 . . . . 0.0 109.922 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 42.5 mtp180 -88.96 -1.19 57.99 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.041 172.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -84.41 -26.85 28.02 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.004 0.922 . . . . 0.0 111.201 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.08 47.68 23.14 Favored Glycine 0 C--N 1.345 1.053 0 O-C-N 123.478 0.486 . . . . 0.0 112.274 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -91.38 17.6 8.27 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.442 0.697 . . . . 0.0 111.616 -178.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.33 -60.36 4.89 Favored Glycine 0 C--N 1.344 1.024 0 N-CA-C 111.784 -0.526 . . . . 0.0 111.784 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -124.73 -171.75 2.42 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.494 1.117 . . . . 0.0 110.322 -177.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.489 HG22 ' HB2' ' A' ' 21' ' ' ASP . 76.8 t -126.57 151.3 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.508 1.123 . . . . 0.0 109.675 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 58.5 p -66.98 165.32 15.83 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.143 0.977 . . . . 0.0 112.592 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.4 p -69.83 -18.92 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.491 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -63.63 -46.78 84.15 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.018 0.527 . . . . 0.0 111.41 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -79.83 -29.99 40.31 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.823 176.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.598 HD22 HG11 ' A' ' 64' ' ' VAL . 12.0 tp -57.02 -45.53 83.03 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.175 0.59 . . . . 0.0 110.689 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 75.5 mtt180 -67.28 -41.96 84.62 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.354 176.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -54.18 -51.08 65.51 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.812 0.845 . . . . 0.0 111.812 -176.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.5 p -73.82 -34.2 39.59 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.582 -175.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 91.8 mt -86.09 -10.42 54.93 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 122.04 -0.413 . . . . 0.0 111.883 -177.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -83.06 -42.08 17.87 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.128 0.571 . . . . 0.0 109.948 176.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -73.86 -40.1 63.49 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.507 0.723 . . . . 0.0 111.132 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 96.9 mt -76.69 -33.0 58.26 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.891 0.477 . . . . 0.0 110.61 177.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -87.52 65.07 3.65 Favored Glycine 0 C--N 1.347 1.18 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 176.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -84.07 -58.36 2.8 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.322 0.649 . . . . 0.0 109.443 177.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.3 -22.02 48.82 Favored 'General case' 0 CA--C 1.551 1.003 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.299 177.039 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 96.9 mmm -87.92 128.3 54.56 Favored Pre-proline 0 N--CA 1.478 0.969 0 C-N-CA 123.65 0.78 . . . . 0.0 110.204 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -65.54 121.78 9.27 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 122.86 2.373 . . . . 0.0 111.485 172.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.96 -12.83 61.76 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.81 0.844 . . . . 0.0 111.897 -177.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.484 ' O ' ' HG2' ' A' ' 51' ' ' GLU . 5.8 m-20 -52.45 -52.65 53.07 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.632 1.173 . . . . 0.0 111.363 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -60.19 -46.85 88.31 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 124.058 0.849 . . . . 0.0 111.02 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.0 mt -57.99 -38.56 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.056 178.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.4 ' O ' ' HD1' ' A' ' 54' ' ' TYR . 75.2 mm-40 -67.41 -41.43 84.89 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.127 0.571 . . . . 0.0 111.547 178.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 47' ' ' ASP . 8.7 mm-40 -60.35 -43.3 96.63 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.798 0.809 . . . . 0.0 109.791 177.253 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.434 ' HG3' ' HZ2' ' A' ' 76' ' ' TRP . 76.5 mmm -66.66 -32.88 74.49 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 113.57 -1.65 . . . . 0.0 111.52 176.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.4 mt -64.29 -42.72 96.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 C-N-CA 124.089 0.956 . . . . 0.0 110.235 176.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.4 ' HD1' ' O ' ' A' ' 50' ' ' GLU . 24.7 m-85 -78.07 -9.39 59.12 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.712 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -99.15 -16.95 18.41 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.287 0.635 . . . . 0.0 111.405 170.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.72 -28.97 22.76 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.626 0.77 . . . . 0.0 110.324 173.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -138.83 76.54 34.29 Favored Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 175.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -78.77 -11.56 15.28 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 123.252 2.635 . . . . 0.0 113.512 -176.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -87.43 -11.8 48.06 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.213 0.605 . . . . 0.0 111.254 -178.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.5 t30 60.31 54.83 3.79 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 122.167 0.984 . . . . 0.0 109.277 -175.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.9 m -99.19 -17.2 18.26 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.527 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.61 15.22 81.4 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.354 -172.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -114.79 109.94 18.94 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.684 0.794 . . . . 0.0 109.645 -173.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.598 HG11 HD22 ' A' ' 33' ' ' LEU . 2.7 p -136.84 123.2 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 123.731 0.812 . . . . 0.0 110.121 -175.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -72.57 100.62 2.8 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 172.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.515 ' HE1' HG23 ' A' ' 14' ' ' ILE . 48.1 p90 -59.94 -37.79 80.54 Favored 'General case' 0 C--O 1.214 -0.785 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.681 -171.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -66.75 -33.84 76.52 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 118.076 0.398 . . . . 0.0 110.316 -177.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 19.1 m -67.2 -50.73 59.84 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 123.81 0.844 . . . . 0.0 110.446 175.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.445 ' HD2' HD11 ' A' ' 33' ' ' LEU . 63.0 t80 -70.63 -62.35 1.42 Allowed 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.982 -174.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 74.5 t -57.19 -30.62 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.63 1.172 . . . . 0.0 110.83 175.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.68 -55.4 30.08 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-N 116.298 -0.41 . . . . 0.0 112.458 172.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 24.4 ptp -72.68 -24.18 60.98 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -175.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.53 -26.9 29.74 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.523 ' HB3' ' HE2' ' A' ' 10' ' ' LYS . 22.8 m-85 -86.69 6.3 31.9 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 122.612 0.365 . . . . 0.0 111.03 170.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 76.9 mt -100.72 15.41 28.38 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.684 0.794 . . . . 0.0 110.602 168.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.434 ' HZ2' ' HG3' ' A' ' 52' ' ' MET . 54.6 m0 . . . . . 0 CA--C 1.553 1.089 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 170.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 120.517 0.199 . . . . 0.0 110.848 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.17 -42.23 98.2 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.008 0.923 . . . . 0.0 112.077 -175.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -56.19 -41.91 76.28 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 124.038 0.935 . . . . 0.0 112.611 -173.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.434 HG13 HG11 ' A' ' 70' ' ' VAL . 4.3 p -82.71 -35.96 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 123.583 0.753 . . . . 0.0 109.941 -174.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 71.2 mt -61.84 -32.63 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 123.328 0.651 . . . . 0.0 110.052 172.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -67.88 -38.11 82.62 Favored 'General case' 0 C--N 1.349 0.548 0 C-N-CA 123.682 0.793 . . . . 0.0 110.781 175.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.27 -40.01 76.83 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 122.899 0.48 . . . . 0.0 111.268 177.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.426 ' CE1' HD12 ' A' ' 33' ' ' LEU . 80.6 m-85 -64.54 -53.2 51.77 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.472 0.709 . . . . 0.0 112.001 178.365 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.87 -25.99 64.9 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -175.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.3 t -70.37 -37.5 70.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 122.646 0.378 . . . . 0.0 110.11 172.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -66.68 -40.45 88.58 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.28 174.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -76.63 81.06 3.29 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.792 0.806 . . . . 0.0 109.887 -176.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 69.6 mtp180 -92.96 -14.86 26.95 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.036 -1.438 . . . . 0.0 109.703 175.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -74.65 -28.42 60.85 Favored 'General case' 0 C--N 1.356 0.848 0 C-N-CA 123.383 0.673 . . . . 0.0 110.253 176.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.22 56.09 3.32 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-N 116.329 -0.396 . . . . 0.0 113.279 175.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -88.27 -21.59 24.37 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.804 0.841 . . . . 0.0 110.413 175.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.33 -40.9 2.49 Favored Glycine 0 C--N 1.348 1.204 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 -173.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.401 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 44.5 p90 -119.47 -176.0 3.06 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.958 1.303 . . . . 0.0 109.518 174.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 55.2 t -127.64 159.51 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 124.244 1.017 . . . . 0.0 109.467 -177.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.3 p -72.81 166.81 22.18 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.655 1.182 . . . . 0.0 111.771 177.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.9 p -75.3 -14.8 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 122.999 0.52 . . . . 0.0 111.331 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -69.45 -57.63 5.0 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 122.578 0.351 . . . . 0.0 110.83 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -64.29 -30.56 71.61 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.643 0.377 . . . . 0.0 110.534 176.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.551 HD22 HG11 ' A' ' 64' ' ' VAL . 10.4 tp -56.69 -58.66 7.11 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.169 176.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 46.6 mtt85 -62.45 -28.24 69.67 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.794 0.838 . . . . 0.0 112.116 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -62.37 -62.79 1.51 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.278 0.631 . . . . 0.0 110.865 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.3 p -66.82 -28.3 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.169 0.588 . . . . 0.0 111.686 -175.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 84.1 mt -87.56 -11.93 47.24 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.223 0.609 . . . . 0.0 112.224 -177.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -76.84 -35.38 57.56 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 166.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -75.34 -35.03 61.23 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.129 0.971 . . . . 0.0 110.464 177.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -74.73 -43.36 55.4 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 175.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -87.2 61.32 4.28 Favored Glycine 0 C--N 1.345 1.078 0 N-CA-C 110.269 -1.133 . . . . 0.0 110.269 175.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -60.32 -47.91 84.0 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.358 1.063 . . . . 0.0 111.445 -173.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 64.4 mtm -125.88 1.0 7.36 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.699 0.8 . . . . 0.0 110.006 172.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 63.4 mtt -80.94 137.27 50.14 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 123.445 0.698 . . . . 0.0 109.38 175.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.7 122.54 10.67 Favored 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.64 2.227 . . . . 0.0 112.87 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.51 -18.48 65.39 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.702 0.801 . . . . 0.0 110.631 170.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -50.4 -43.13 54.58 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.766 1.227 . . . . 0.0 111.164 173.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -63.54 -53.28 54.29 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.431 0.693 . . . . 0.0 110.514 175.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.462 ' O ' HG13 ' A' ' 53' ' ' ILE . 88.5 mt -59.93 -37.26 71.4 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 CA-C-N 114.823 -1.08 . . . . 0.0 111.769 -174.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -71.68 -30.41 65.67 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.343 0.657 . . . . 0.0 112.024 -175.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -67.77 -39.96 84.07 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 121.53 0.681 . . . . 0.0 109.379 172.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.422 ' HG3' ' HZ2' ' A' ' 76' ' ' TRP . 69.7 mmm -68.55 -32.94 73.23 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.428 -1.26 . . . . 0.0 110.392 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 49' ' ' ILE . 58.4 mt -58.63 -42.59 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 123.821 0.848 . . . . 0.0 110.065 178.203 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -73.31 -9.74 59.02 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.556 0.743 . . . . 0.0 112.305 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -85.9 -29.94 23.25 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 120.975 0.417 . . . . 0.0 110.103 172.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -94.04 -19.68 20.64 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.791 0.837 . . . . 0.0 111.421 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -144.85 71.81 15.08 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 124.736 1.214 . . . . 0.0 107.897 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.03 -17.35 22.27 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 122.858 2.372 . . . . 0.0 112.609 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.592 ' HG3' ' H ' ' A' ' 61' ' ' SER . 27.7 pt20 -70.86 -20.26 62.55 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.303 1.041 . . . . 0.0 111.645 178.036 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.7 t30 67.7 6.95 5.34 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 124.877 1.271 . . . . 0.0 111.115 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.592 ' H ' ' HG3' ' A' ' 59' ' ' GLN . 34.8 t -78.61 -17.67 55.7 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.531 0.732 . . . . 0.0 111.313 -173.066 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.03 34.42 8.25 Favored Glycine 0 C--N 1.341 0.819 0 O-C-N 123.314 0.384 . . . . 0.0 113.87 172.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -127.38 96.14 4.48 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.252 1.021 . . . . 0.0 108.493 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.551 HG11 HD22 ' A' ' 33' ' ' LEU . 3.3 p -118.03 130.28 73.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 124.031 0.933 . . . . 0.0 111.312 -166.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -75.05 90.41 2.48 Favored 'General case' 0 C--N 1.351 0.644 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 170.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.401 ' CE2' ' HA ' ' A' ' 27' ' ' TYR . 42.3 p90 -57.37 -29.87 64.4 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.043 -0.981 . . . . 0.0 113.41 -173.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -60.65 -63.54 1.26 Allowed 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 118.105 0.411 . . . . 0.0 110.858 -174.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.7 t -64.68 -30.04 71.05 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.558 0.743 . . . . 0.0 111.623 -177.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.476 ' CD2' HD11 ' A' ' 33' ' ' LEU . 32.4 t80 -70.42 -55.11 9.83 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.522 0.729 . . . . 0.0 111.858 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.468 ' HA ' HD12 ' A' ' 73' ' ' LEU . 82.7 t -65.06 -24.86 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.472 0.709 . . . . 0.0 110.188 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.457 ' O ' ' HG ' ' A' ' 75' ' ' LEU . . . -56.4 -53.55 42.35 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.532 165.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.505 ' HA ' HD12 ' A' ' 75' ' ' LEU . 85.0 mtp -59.53 -35.97 75.23 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.896 0.878 . . . . 0.0 112.605 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.468 HD12 ' HA ' ' A' ' 70' ' ' VAL . 92.5 mt -62.88 -42.06 99.63 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 121.419 0.628 . . . . 0.0 110.584 176.117 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -88.23 -0.07 56.68 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.163 -178.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.505 HD12 ' HA ' ' A' ' 72' ' ' MET . 82.0 mt -86.06 4.15 39.31 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.581 0.752 . . . . 0.0 110.869 170.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.422 ' HZ2' ' HG3' ' A' ' 52' ' ' MET . 51.4 m0 . . . . . 0 CA--C 1.547 0.84 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 171.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt . . . . . 0 N--CA 1.481 1.097 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.458 ' O ' ' HG2' ' A' ' 15' ' ' GLU . . . -71.23 -30.46 66.37 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.09 0.556 . . . . 0.0 111.461 174.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -58.0 -36.82 73.2 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.615 0.766 . . . . 0.0 112.521 -176.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.6 p -77.33 -34.45 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 122.633 0.373 . . . . 0.0 110.487 177.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.5 mt -65.6 -30.14 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 123.556 0.743 . . . . 0.0 110.516 178.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.5 ' HA ' ' HE2' ' A' ' 18' ' ' LYS . 26.1 mm-40 -59.09 -43.49 91.84 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.474 0.709 . . . . 0.0 109.911 172.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.34 -28.36 67.91 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.812 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -73.82 -54.29 8.33 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.971 0.509 . . . . 0.0 111.609 176.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.5 ' HE2' ' HA ' ' A' ' 15' ' ' GLU . 64.4 pttt -73.99 -17.5 60.99 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -170.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.6 p -69.14 -33.48 58.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 CA-C-N 117.917 0.326 . . . . 0.0 110.124 172.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -77.71 -45.48 24.67 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.96 0.904 . . . . 0.0 109.64 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -78.21 72.9 4.77 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 174.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.423 ' HA ' ' NE ' ' A' ' 22' ' ' ARG . 1.6 tpm_? -80.5 -28.43 37.48 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.992 -166.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -70.3 -25.67 63.43 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.823 0.449 . . . . 0.0 110.927 176.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.22 50.16 5.94 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 -173.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -75.82 -10.68 59.63 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.58 0.752 . . . . 0.0 110.597 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.39 -29.27 12.25 Favored Glycine 0 C--N 1.35 1.358 0 CA-C-N 116.121 -0.49 . . . . 0.0 112.174 176.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -145.09 164.03 32.47 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-O 121.09 0.472 . . . . 0.0 111.312 -172.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.6 m -117.74 178.61 2.0 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.846 0 CA-C-N 114.77 -1.104 . . . . 0.0 109.864 176.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.8 p -81.38 156.36 25.47 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.652 173.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.592 HG23 HG21 ' A' ' 53' ' ' ILE . 7.7 p -57.97 -37.35 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.95 0.9 . . . . 0.0 112.041 177.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -62.54 -47.83 82.16 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 123.618 0.574 . . . . 0.0 111.197 -174.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -66.76 -41.82 87.13 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.298 176.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.436 HD21 ' CE2' ' A' ' 69' ' ' PHE . 5.1 tt -63.39 -32.78 74.3 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.568 -176.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 47.9 mtm105 -74.12 -38.88 63.67 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.921 0.488 . . . . 0.0 110.679 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -60.43 -52.52 64.86 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.052 0.845 . . . . 0.0 111.508 -176.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.1 p -62.77 -41.44 92.47 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.651 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 86.1 mt -78.28 -16.32 57.89 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -177.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -80.77 -46.7 15.01 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.933 0.493 . . . . 0.0 110.292 176.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -67.98 -23.54 65.05 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.042 0.537 . . . . 0.0 111.982 -175.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.6 pp -98.13 -32.24 11.7 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.54 0.336 . . . . 0.0 110.726 173.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -106.7 39.6 2.82 Favored Glycine 0 C--N 1.345 1.06 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.648 -175.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -75.66 -26.87 58.04 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.201 1.0 . . . . 0.0 110.355 175.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 53.9 mtm -73.86 -33.38 64.06 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.191 0.996 . . . . 0.0 110.846 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 64.1 mtm -92.95 156.31 40.63 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 123.788 0.835 . . . . 0.0 109.647 176.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.07 111.59 2.91 Favored 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 121.551 1.501 . . . . 0.0 111.311 169.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.02 -12.47 61.54 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.478 0.711 . . . . 0.0 110.92 174.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -51.62 -55.49 19.02 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.011 1.324 . . . . 0.0 110.766 174.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.467 ' O ' ' HG2' ' A' ' 52' ' ' MET . 38.8 tt0 -68.04 -35.16 77.79 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.11 -178.244 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.467 ' O ' HG13 ' A' ' 53' ' ' ILE . 93.6 mt -58.96 -39.81 78.96 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 123.219 0.607 . . . . 0.0 110.506 173.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.541 ' HA ' HD12 ' A' ' 53' ' ' ILE . 49.6 mt-10 -67.09 -35.1 79.06 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.78 0.432 . . . . 0.0 110.947 177.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -62.83 -36.32 82.83 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.575 0.35 . . . . 0.0 110.803 173.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.467 ' HG2' ' O ' ' A' ' 48' ' ' GLU . 30.2 mmt -69.68 -33.04 72.0 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.466 0.706 . . . . 0.0 110.453 177.106 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.592 HG21 HG23 ' A' ' 30' ' ' VAL . 81.3 mt -69.23 -32.2 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.823 0.849 . . . . 0.0 110.303 174.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -71.59 -12.43 61.35 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.577 0.751 . . . . 0.0 111.459 175.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -94.95 -35.19 12.1 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.52 0.728 . . . . 0.0 110.138 174.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.94 -31.13 56.41 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.765 0.826 . . . . 0.0 111.07 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -137.81 91.32 13.63 Favored Pre-proline 0 CA--C 1.55 0.973 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 172.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -85.12 4.73 6.61 Favored 'Trans proline' 0 C--N 1.371 1.746 0 C-N-CA 122.898 2.399 . . . . 0.0 113.855 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -103.6 -11.18 17.87 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.178 0.591 . . . . 0.0 111.851 -176.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.2 t30 66.71 22.83 10.3 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 124.177 0.991 . . . . 0.0 109.847 -176.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 46.9 m -64.47 -39.99 94.84 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 124.718 1.207 . . . . 0.0 110.807 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.97 24.7 16.41 Favored Glycine 0 C--N 1.344 0.976 0 CA-C-N 114.995 -1.002 . . . . 0.0 113.191 176.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -127.42 95.27 4.21 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.496 1.119 . . . . 0.0 108.787 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 p -119.11 126.02 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 123.527 0.731 . . . . 0.0 110.407 -171.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -70.24 98.98 1.45 Allowed 'General case' 0 C--N 1.347 0.458 0 C-N-CA 124.152 0.981 . . . . 0.0 110.593 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -63.27 -33.4 75.42 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -176.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -64.91 -46.73 80.44 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 120.883 0.373 . . . . 0.0 110.955 -175.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 54.6 p -77.31 -38.15 51.19 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.407 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.436 ' CE2' HD21 ' A' ' 33' ' ' LEU . 41.8 t80 -65.12 -72.05 0.17 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.062 0.545 . . . . 0.0 110.975 -178.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.589 ' HA ' ' HB3' ' A' ' 73' ' ' LEU . 96.9 t -50.08 -29.56 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 125.162 1.385 . . . . 0.0 112.309 177.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.75 -53.44 45.26 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 121.048 0.249 . . . . 0.0 112.769 170.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 67.7 mtm -87.03 -2.13 58.39 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.281 1.033 . . . . 0.0 111.956 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.589 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 50.7 tp -90.24 -48.01 7.42 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.263 1.025 . . . . 0.0 109.363 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -78.41 27.89 0.2 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.105 0.962 . . . . 0.0 112.608 -177.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.2 0.33 19.48 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.361 0.665 . . . . 0.0 112.033 172.291 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 13.3 m0 . . . . . 0 C--N 1.351 0.636 0 C-N-CA 124.632 1.173 . . . . 0.0 110.948 179.21 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.459 ' O ' ' HG2' ' A' ' 15' ' ' GLU . . . -58.75 -43.08 90.18 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.469 0.308 . . . . 0.0 110.572 170.252 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 -67.25 -34.39 77.33 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.492 0.717 . . . . 0.0 111.991 -173.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.6 p -75.3 -37.14 38.33 Favored 'Isoleucine or valine' 0 C--N 1.355 0.828 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -178.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.4 mt -62.85 -37.28 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 174.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 68.0 mm-40 -59.99 -45.03 94.05 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 122.877 0.471 . . . . 0.0 110.161 172.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.26 -27.45 69.02 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.657 0.783 . . . . 0.0 112.138 -178.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.459 ' HE1' ' HA ' ' A' ' 33' ' ' LEU . 65.2 m-85 -77.7 -42.61 33.84 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.719 0.408 . . . . 0.0 111.179 173.16 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -70.4 -23.18 62.71 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.924 0.49 . . . . 0.0 112.114 -174.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 23.8 m -75.95 -28.61 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-O 120.663 0.268 . . . . 0.0 110.552 175.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -74.6 -42.04 59.37 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.74 0.816 . . . . 0.0 109.052 174.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -75.2 85.2 2.4 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.026 0.93 . . . . 0.0 108.824 175.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 68.5 ttt-85 -65.61 -48.49 72.09 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.789 -1.096 . . . . 0.0 112.456 -172.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -87.47 -3.5 59.0 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -170.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.69 41.74 63.66 Favored Glycine 0 C--N 1.345 1.03 0 N-CA-C 112.171 -0.372 . . . . 0.0 112.171 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -70.51 -17.99 62.95 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.919 0.888 . . . . 0.0 110.701 -178.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.29 -43.58 1.61 Allowed Glycine 0 C--N 1.346 1.108 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.498 175.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.505 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 50.9 p90 -136.6 176.19 8.92 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.186 0.594 . . . . 0.0 111.799 -172.361 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.0 m -123.64 -177.97 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 124.02 0.928 . . . . 0.0 110.529 -177.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 49.7 p -75.75 153.82 36.76 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 123.554 0.742 . . . . 0.0 110.235 173.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.6 p -63.06 -27.0 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.327 0.651 . . . . 0.0 111.343 178.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -59.96 -58.79 7.03 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.526 1.13 . . . . 0.0 110.624 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -61.77 -34.16 75.37 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 123.752 0.657 . . . . 0.0 110.975 -178.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.643 HD22 HG11 ' A' ' 64' ' ' VAL . 7.1 tp -58.69 -52.15 66.91 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.768 178.103 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 54.9 mtt180 -64.58 -35.29 80.52 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.369 0.668 . . . . 0.0 111.435 -178.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -63.46 -51.85 63.87 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.475 0.71 . . . . 0.0 111.828 -177.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.2 p -73.0 -30.38 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.46 -175.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 81.2 mt -85.28 -11.95 53.56 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.672 0.389 . . . . 0.0 111.371 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -85.46 -33.01 21.97 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.198 0.599 . . . . 0.0 110.078 173.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -80.43 -41.4 24.56 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 110.624 -0.139 . . . . 0.0 110.624 178.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 94.3 mt -74.07 -27.65 61.01 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.601 0.361 . . . . 0.0 110.233 174.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -96.68 52.09 1.51 Allowed Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.4 173.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -65.95 -51.07 61.77 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.748 0.819 . . . . 0.0 111.041 -175.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -92.4 -3.28 55.52 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.134 0.574 . . . . 0.0 111.029 177.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 74.8 mtp -94.4 144.66 28.35 Favored Pre-proline 0 N--CA 1.48 1.071 0 C-N-CA 123.611 0.765 . . . . 0.0 110.141 -176.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -66.52 111.39 2.08 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.684 2.256 . . . . 0.0 111.828 172.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.36 -27.77 63.58 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.305 0.642 . . . . 0.0 111.293 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -62.02 -34.34 76.03 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 122.703 0.401 . . . . 0.0 111.738 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -71.2 -39.15 71.96 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 176.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.491 ' O ' HG13 ' A' ' 53' ' ' ILE . 89.1 mt -64.4 -42.13 94.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 123.234 0.614 . . . . 0.0 109.776 176.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.534 ' HA ' HD12 ' A' ' 53' ' ' ILE . 46.9 mt-10 -75.05 -19.84 59.83 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.918 0.887 . . . . 0.0 111.032 -178.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -72.13 -45.02 62.21 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.685 0.794 . . . . 0.0 109.149 169.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.457 ' SD ' ' HZ2' ' A' ' 76' ' ' TRP . 48.8 mtp -67.7 -18.99 65.11 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.344 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.534 HD12 ' HA ' ' A' ' 50' ' ' GLU . 73.6 mt -68.03 -29.31 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.405 0.682 . . . . 0.0 111.38 176.332 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -60.37 -32.96 71.78 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.106 0.562 . . . . 0.0 110.484 173.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -85.3 -35.8 21.26 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.334 1.054 . . . . 0.0 110.448 178.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.18 -33.01 74.79 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.985 0.914 . . . . 0.0 111.569 -178.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -123.82 90.07 50.96 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 105.056 -2.202 . . . . 0.0 105.056 171.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -65.65 -23.35 56.72 Favored 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 123.148 2.566 . . . . 0.0 112.788 -175.166 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -86.39 -17.27 34.83 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.765 0.826 . . . . 0.0 109.332 179.246 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 59.03 43.57 17.43 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.354 1.061 . . . . 0.0 110.318 178.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.0 m -79.76 -26.86 40.55 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.241 1.016 . . . . 0.0 112.156 -177.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 96.9 9.33 56.28 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.351 -169.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -118.35 99.89 7.13 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.63 1.172 . . . . 0.0 108.415 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.643 HG11 HD22 ' A' ' 33' ' ' LEU . 7.3 p -112.87 136.66 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-O 121.158 0.504 . . . . 0.0 111.425 -170.149 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -85.24 99.2 10.95 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.005 173.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.505 ' CE2' ' HA ' ' A' ' 27' ' ' TYR . 34.1 p90 -59.95 -35.4 74.86 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.615 -177.091 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -63.1 -45.04 93.91 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 122.791 0.436 . . . . 0.0 111.032 -173.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.5 t -78.48 -24.8 45.73 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.111 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.445 ' HD2' HD11 ' A' ' 33' ' ' LEU . 26.3 t80 -79.89 -74.14 0.32 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.349 0.259 . . . . 0.0 110.486 178.452 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.542 ' HA ' ' HB3' ' A' ' 73' ' ' LEU . 87.0 t -49.91 -24.22 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 C-N-CA 126.158 1.783 . . . . 0.0 113.083 178.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.466 ' O ' ' HG ' ' A' ' 75' ' ' LEU . . . -64.44 -57.87 11.88 Favored Glycine 0 CA--C 1.539 1.557 0 CA-C-O 119.911 -0.383 . . . . 0.0 112.379 171.229 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -75.61 -21.1 58.07 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 123.363 0.665 . . . . 0.0 111.345 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.542 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 51.2 tp -68.71 -42.87 77.11 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.147 1.379 . . . . 0.0 110.16 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -85.84 -5.83 59.18 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.708 176.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 71' ' ' GLY . 54.2 mt -91.9 21.22 5.05 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.155 0.582 . . . . 0.0 111.593 174.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.457 ' HZ2' ' SD ' ' A' ' 52' ' ' MET . 30.8 m0 . . . . . 0 N--CA 1.48 1.028 0 C-N-CA 122.481 0.312 . . . . 0.0 110.264 171.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt . . . . . 0 N--CA 1.48 1.034 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.03 -42.37 63.24 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 122.959 0.504 . . . . 0.0 109.899 169.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -55.72 -39.42 71.05 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.33 1.052 . . . . 0.0 112.973 -175.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.1 p -66.03 -41.55 89.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 178.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 64.3 mt -68.91 -29.96 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.35 0.66 . . . . 0.0 110.245 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.468 ' HA ' ' HE2' ' A' ' 18' ' ' LYS . 42.5 mt-10 -76.38 -24.01 54.11 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.832 0.853 . . . . 0.0 111.397 177.095 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.0 -34.56 78.03 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.222 0.609 . . . . 0.0 110.718 175.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -64.47 -31.57 72.83 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.032 173.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.468 ' HE2' ' HA ' ' A' ' 15' ' ' GLU . 54.3 mtmt -81.06 -12.59 59.29 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.36 0.664 . . . . 0.0 111.906 -178.538 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.0 t -75.16 -35.18 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 169.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -74.55 -55.75 5.59 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.113 0.565 . . . . 0.0 109.797 175.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -85.54 89.09 7.62 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.872 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 32.2 ttm-85 -85.07 -23.95 28.31 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.953 172.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -64.65 -25.63 68.04 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.542 1.137 . . . . 0.0 111.841 -176.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.89 38.21 23.89 Favored Glycine 0 C--N 1.344 1.015 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 178.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -64.66 -25.24 67.87 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.555 1.142 . . . . 0.0 110.502 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.79 -35.99 4.3 Favored Glycine 0 C--N 1.347 1.162 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.485 ' HB2' ' O ' ' A' ' 64' ' ' VAL . 44.0 p90 -133.15 179.9 5.9 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 124.049 0.939 . . . . 0.0 109.647 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.0 p -134.1 173.88 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.213 0.605 . . . . 0.0 110.152 -172.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 44.5 p -73.39 145.99 45.46 Favored 'General case' 0 C--O 1.245 0.82 0 C-N-CA 123.404 0.682 . . . . 0.0 110.601 171.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.436 HG22 HG23 ' A' ' 53' ' ' ILE . 0.8 OUTLIER -70.47 -20.65 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 122.633 0.373 . . . . 0.0 110.594 -179.315 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -62.62 -53.85 48.38 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.631 0.772 . . . . 0.0 110.639 174.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 93.2 t80 -61.64 -39.64 92.04 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 122.94 0.496 . . . . 0.0 110.686 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.4 HD22 HG11 ' A' ' 64' ' ' VAL . 6.6 tp -53.86 -46.61 71.33 Favored 'General case' 0 CA--C 1.554 1.125 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.442 176.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.429 ' HG3' ' O ' ' A' ' 30' ' ' VAL . 69.4 mtt180 -62.3 -35.84 80.28 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.758 0.823 . . . . 0.0 111.942 -178.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 55.1 mttm -63.27 -60.97 2.7 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 123.679 0.612 . . . . 0.0 110.901 -176.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.4 p -62.25 -34.19 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 123.672 0.789 . . . . 0.0 112.351 -174.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.422 ' HB3' HG21 ' A' ' 49' ' ' ILE . 96.7 mt -77.39 -26.51 51.86 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.752 0.421 . . . . 0.0 111.359 -178.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -79.31 -30.91 43.06 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.795 0.438 . . . . 0.0 110.126 173.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -60.48 -44.98 95.37 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.853 0.861 . . . . 0.0 110.153 174.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.443 ' O ' ' HG2' ' A' ' 44' ' ' MET . 80.2 mt -84.14 3.06 36.61 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.487 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -73.47 -5.03 66.51 Favored Glycine 0 C--N 1.355 1.626 0 C-N-CA 123.635 0.636 . . . . 0.0 113.211 -176.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -72.79 -22.76 60.77 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 122.887 0.475 . . . . 0.0 110.485 170.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 69.3 mtm -114.29 1.0 14.33 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.37 1.068 . . . . 0.0 112.091 -173.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.443 ' HG2' ' O ' ' A' ' 40' ' ' LEU . 20.8 ptp -158.23 154.64 24.34 Favored Pre-proline 0 N--CA 1.488 1.47 0 C-N-CA 122.875 0.47 . . . . 0.0 110.584 -175.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.76 110.17 2.49 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 122.215 1.943 . . . . 0.0 112.377 -178.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.18 -24.32 35.04 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.823 -174.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -68.35 -39.19 81.96 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-O 121.317 0.58 . . . . 0.0 110.768 176.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -68.02 -46.8 70.2 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.096 176.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.422 HG21 ' HB3' ' A' ' 37' ' ' LEU . 81.6 mt -59.43 -44.68 93.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.429 0.692 . . . . 0.0 111.69 178.079 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -66.86 -32.46 73.75 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 118.169 0.441 . . . . 0.0 110.954 -175.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -63.85 -45.99 87.02 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 120.98 0.419 . . . . 0.0 110.116 172.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 22.9 mmt -60.94 -30.36 70.17 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.833 177.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.436 HG23 HG22 ' A' ' 30' ' ' VAL . 55.9 mt -67.8 -37.94 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.295 1.038 . . . . 0.0 111.491 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -62.84 -34.85 78.21 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 122.787 0.435 . . . . 0.0 110.623 173.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -76.33 -30.92 57.86 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.244 0.618 . . . . 0.0 110.603 177.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.425 ' HB1' HG23 ' A' ' 64' ' ' VAL . . . -70.65 -24.49 62.72 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.206 1.003 . . . . 0.0 111.745 -179.151 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -129.37 81.5 70.01 Favored Pre-proline 0 CA--C 1.547 0.852 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 171.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -79.3 -8.33 15.12 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 123.065 2.51 . . . . 0.0 112.451 -178.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -82.65 -21.72 34.91 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.65 0.78 . . . . 0.0 110.862 176.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 59.12 32.92 22.55 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.472 1.109 . . . . 0.0 110.825 -175.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.7 m -97.21 -17.52 19.81 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.342 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.407 ' HA2' HG12 ' A' ' 30' ' ' VAL . . . 92.5 41.51 4.77 Favored Glycine 0 C--N 1.339 0.712 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.611 177.344 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -137.86 138.63 39.3 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.039 0.536 . . . . 0.0 111.143 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.485 ' O ' ' HB2' ' A' ' 27' ' ' TYR . 5.9 p -147.5 137.59 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.763 0.825 . . . . 0.0 110.363 -174.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -84.08 87.91 7.16 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 170.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -58.91 -35.19 72.66 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 114.613 -1.176 . . . . 0.0 113.373 -171.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -65.05 -39.51 93.42 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.772 0.429 . . . . 0.0 110.909 -169.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.455 ' O ' ' HG2' ' A' ' 72' ' ' MET . 11.2 t -83.28 -33.02 26.07 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.432 177.046 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -71.44 -56.38 6.06 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.407 0.623 . . . . 0.0 111.507 -177.075 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 99.6 t -65.67 -25.4 36.48 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.07 0 C-N-CA 124.393 1.077 . . . . 0.0 109.754 172.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -71.99 2.03 28.61 Favored Glycine 0 CA--C 1.543 1.828 0 CA-C-N 115.253 -0.885 . . . . 0.0 113.825 168.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.455 ' HG2' ' O ' ' A' ' 68' ' ' THR . 25.1 mmt -107.85 -45.39 4.01 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.775 0.83 . . . . 0.0 109.673 168.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 88.3 mt -58.24 -49.8 75.83 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.816 0.846 . . . . 0.0 112.142 -174.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -84.47 -11.91 55.29 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.161 -177.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -104.35 27.76 7.52 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.821 0.849 . . . . 0.0 110.701 178.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 32.6 m0 . . . . . 0 N--CA 1.488 1.427 0 C-N-CA 123.116 0.567 . . . . 0.0 110.99 171.186 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt . . . . . 0 N--CA 1.47 0.575 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.43 ' O ' ' HG2' ' A' ' 15' ' ' GLU . . . -63.04 -38.95 93.25 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 122.516 0.327 . . . . 0.0 110.186 172.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -71.03 -33.02 69.93 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.339 0.655 . . . . 0.0 112.369 -175.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.5 p -71.87 -36.64 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 176.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.438 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 75.1 mt -65.47 -33.42 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 174.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 23.5 mm-40 -62.01 -33.46 74.38 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.17 0.588 . . . . 0.0 111.491 174.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.25 -42.17 99.15 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 121.116 0.484 . . . . 0.0 110.195 174.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -69.37 -25.81 64.36 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.017 175.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.438 ' HG2' ' O ' ' A' ' 14' ' ' ILE . 73.7 mmtt -73.4 -28.16 61.85 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.202 0.601 . . . . 0.0 111.18 177.435 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 15' ' ' GLU . 87.9 t -72.24 -40.94 66.2 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 C-N-CA 123.153 0.581 . . . . 0.0 110.167 176.219 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -73.12 -40.72 64.71 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.592 0.357 . . . . 0.0 110.375 176.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -97.25 45.64 1.04 Allowed 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.977 0.894 . . . . 0.0 108.846 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -63.09 -25.4 68.35 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.397 1.079 . . . . 0.0 110.965 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -72.19 -28.33 63.13 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.629 0.772 . . . . 0.0 111.088 177.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.08 58.56 2.94 Favored Glycine 0 C--N 1.344 0.987 0 CA-C-N 115.955 -0.566 . . . . 0.0 113.312 176.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -78.07 -17.32 57.15 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.33 0.652 . . . . 0.0 110.218 170.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.13 -18.57 56.92 Favored Glycine 0 C--N 1.354 1.53 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.961 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -150.55 166.11 31.23 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.272 1.029 . . . . 0.0 109.867 -174.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.405 HG13 ' CD2' ' A' ' 66' ' ' TYR . 23.4 m -116.36 177.94 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.609 0.764 . . . . 0.0 110.445 176.323 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 67.7 p -84.72 157.57 21.03 Favored 'General case' 0 C--O 1.246 0.876 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.516 170.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.9 p -67.09 -17.22 22.37 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 123.201 0.601 . . . . 0.0 111.547 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -63.63 -63.17 1.25 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.325 0.65 . . . . 0.0 111.04 177.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -60.6 -38.4 84.54 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.908 0.483 . . . . 0.0 110.504 178.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.531 HD22 HG11 ' A' ' 64' ' ' VAL . 6.3 tp -54.64 -58.75 6.27 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.82 -178.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 73.9 mtt180 -61.54 -33.41 73.79 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.045 0.538 . . . . 0.0 111.354 178.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -66.19 -46.33 77.69 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.755 0.822 . . . . 0.0 111.664 -174.034 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.4 p -76.65 -34.81 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 122.959 0.504 . . . . 0.0 110.86 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.471 HD23 HD12 ' A' ' 40' ' ' LEU . 84.6 mt -78.68 -5.88 54.26 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.03 0.532 . . . . 0.0 111.376 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 32.2 t-20 -72.26 -45.37 60.44 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.373 0.669 . . . . 0.0 109.77 178.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -71.38 -40.79 70.34 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.226 176.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.471 HD12 HD23 ' A' ' 37' ' ' LEU . 75.9 mt -67.57 -26.61 66.38 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.74 0.816 . . . . 0.0 110.549 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -89.62 63.17 3.31 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.062 171.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -81.72 -72.62 0.42 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.617 0.767 . . . . 0.0 109.701 178.048 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 20.6 ptp -85.85 -22.76 27.41 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.973 0.509 . . . . 0.0 110.367 175.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 25.3 mmt -81.8 112.41 34.49 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 172.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.06 130.64 37.39 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 122.113 1.875 . . . . 0.0 111.837 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.469 ' O ' ' HG2' ' A' ' 50' ' ' GLU . . . -63.05 -21.79 66.41 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.454 0.701 . . . . 0.0 110.527 174.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -52.67 -40.46 62.91 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.602 1.561 . . . . 0.0 111.887 173.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -65.12 -46.4 81.18 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.444 0.698 . . . . 0.0 110.114 175.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 66.8 mt -63.06 -32.07 54.9 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.416 -177.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 14.5 mm-40 -62.88 -44.15 96.89 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.99 0.516 . . . . 0.0 110.713 177.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -61.0 -42.66 98.88 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 121.414 0.626 . . . . 0.0 110.29 177.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.525 ' HB3' ' HE1' ' A' ' 69' ' ' PHE . 79.9 mmm -63.3 -34.21 77.18 Favored 'General case' 0 CA--C 1.558 1.273 0 CA-C-N 114.31 -1.314 . . . . 0.0 110.735 176.29 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 60.2 mt -69.35 -34.51 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 C-N-CA 124.469 1.108 . . . . 0.0 110.952 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 4.3 m-30 -64.62 -26.54 68.44 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.163 0.585 . . . . 0.0 110.251 176.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -93.45 -20.45 20.29 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.567 0.747 . . . . 0.0 111.117 178.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.522 ' HB1' HG23 ' A' ' 64' ' ' VAL . . . -77.27 -53.43 7.72 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.376 0.67 . . . . 0.0 110.229 177.169 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -116.14 95.75 45.58 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 124.801 1.241 . . . . 0.0 108.384 174.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -85.75 -1.61 8.9 Favored 'Trans proline' 0 C--N 1.368 1.553 0 C-N-CA 122.719 2.279 . . . . 0.0 112.028 170.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -92.06 -6.74 50.46 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.153 0.981 . . . . 0.0 112.042 -169.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 59.68 28.61 18.08 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.485 1.114 . . . . 0.0 110.847 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.3 m -105.28 -15.01 15.17 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.27 1.028 . . . . 0.0 110.571 -176.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.57 9.11 87.07 Favored Glycine 0 C--N 1.346 1.137 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.943 -175.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 22.2 m-30 -86.6 97.42 10.53 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.307 0.643 . . . . 0.0 109.519 -176.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.531 HG11 HD22 ' A' ' 33' ' ' LEU . 2.4 p -113.32 118.46 58.18 Favored 'Isoleucine or valine' 0 C--O 1.245 0.825 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.481 -175.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -73.58 86.59 1.61 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.225 175.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.405 ' CD2' HG13 ' A' ' 28' ' ' VAL . 35.4 p90 -53.62 -33.44 55.05 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -175.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -67.97 -36.47 80.11 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 120.755 0.312 . . . . 0.0 110.616 -170.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.0 p -82.32 -48.14 11.54 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.795 0.838 . . . . 0.0 110.19 174.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.525 ' HE1' ' HB3' ' A' ' 52' ' ' MET . 46.8 t80 -66.14 -54.05 30.17 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.246 1.018 . . . . 0.0 113.37 -170.456 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 56.3 t -68.31 -21.08 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 122.85 0.46 . . . . 0.0 109.831 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -62.18 -44.94 97.02 Favored Glycine 0 CA--C 1.538 1.473 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.147 164.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 65.0 mtt -66.09 -29.08 69.34 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 124.224 1.01 . . . . 0.0 112.041 178.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.4 mt -74.08 -43.03 59.2 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 121.374 0.606 . . . . 0.0 110.57 175.028 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -95.78 34.98 1.43 Allowed 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.647 -173.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.8 pp -125.6 10.09 7.8 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 122.701 0.4 . . . . 0.0 111.296 168.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 54.4 m0 . . . . . 0 N--CA 1.485 1.323 0 C-N-CA 123.252 0.621 . . . . 0.0 111.899 -176.4 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.472 ' HE3' ' HB3' ' A' ' 74' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.361 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.476 ' O ' ' HG2' ' A' ' 15' ' ' GLU . . . -52.98 -42.08 65.2 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.456 0.702 . . . . 0.0 111.656 -178.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -61.06 -46.86 88.98 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.736 0.815 . . . . 0.0 112.199 -176.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.3 p -74.8 -31.39 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 122.722 0.409 . . . . 0.0 110.562 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.5 HG23 ' HE1' ' A' ' 66' ' ' TYR . 61.6 mt -65.11 -34.24 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.737 0.815 . . . . 0.0 110.811 178.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 19.1 mm-40 -69.37 -32.99 72.39 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.637 174.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.38 -37.25 82.7 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 122.938 0.495 . . . . 0.0 111.072 177.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -62.56 -41.23 98.78 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.972 173.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.465 ' HE3' HG22 ' A' ' 14' ' ' ILE . 92.9 mttt -71.46 -27.61 63.38 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.025 0.53 . . . . 0.0 111.508 -178.051 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 15' ' ' GLU . 92.3 t -69.97 -33.44 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.494 0.718 . . . . 0.0 109.963 174.323 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -74.61 -43.74 54.07 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.443 174.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -72.27 104.94 3.85 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -176.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -94.79 -15.36 23.86 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.52 0.728 . . . . 0.0 112.234 -178.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.406 ' HB2' ' ND2' ' A' ' 25' ' ' ASN . 20.8 m-20 -92.43 -26.35 18.05 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 120.87 0.367 . . . . 0.0 111.069 -176.105 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.66 42.78 12.95 Favored Glycine 0 C--N 1.338 0.649 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.865 -171.147 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.406 ' ND2' ' HB2' ' A' ' 23' ' ' ASP . 48.5 m-80 -65.94 -23.86 66.69 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.613 0.765 . . . . 0.0 111.11 178.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.05 -32.82 6.47 Favored Glycine 0 C--N 1.347 1.17 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 -178.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.424 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 45.2 p90 -133.62 160.69 36.75 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.406 1.082 . . . . 0.0 109.636 175.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 55.0 t -110.5 161.14 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.178 0.991 . . . . 0.0 110.41 -174.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 63' ' ' TYR . 73.1 p -56.15 151.6 12.08 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 124.191 0.996 . . . . 0.0 111.982 172.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.8 p -67.21 -20.71 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.409 174.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -58.97 -62.19 2.07 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.74 1.216 . . . . 0.0 111.635 176.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -65.37 -30.11 70.9 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.973 0.509 . . . . 0.0 111.012 -178.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.692 HD22 HG11 ' A' ' 64' ' ' VAL . 6.5 tp -54.75 -50.92 67.24 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 123.717 0.635 . . . . 0.0 109.977 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.546 ' HG2' HD13 ' A' ' 53' ' ' ILE . 37.1 mtm180 -61.67 -37.96 86.02 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.862 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -65.7 -53.04 46.38 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.415 0.686 . . . . 0.0 112.179 -175.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.06 -26.88 35.47 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.957 -176.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 87.3 mt -86.81 -16.07 37.31 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.322 0.649 . . . . 0.0 111.779 178.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -74.79 -43.01 57.03 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.188 0.595 . . . . 0.0 110.124 175.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -72.75 -32.63 65.8 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 122.94 0.496 . . . . 0.0 110.794 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.424 HD13 ' HZ ' ' A' ' 74' ' ' PHE . 95.6 mt -78.46 -21.36 49.2 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.257 0.623 . . . . 0.0 110.514 174.048 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.73 ' HA2' ' HB2' ' A' ' 44' ' ' MET . . . -83.34 46.71 3.69 Favored Glycine 0 C--N 1.349 1.263 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 169.129 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -79.56 -55.16 5.23 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.886 0.874 . . . . 0.0 109.123 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 64.1 mtt -105.33 11.7 32.52 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.734 174.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.73 ' HB2' ' HA2' ' A' ' 41' ' ' GLY . 55.9 mtt -113.15 150.98 43.84 Favored Pre-proline 0 N--CA 1.48 1.068 0 C-N-CA 124.464 1.106 . . . . 0.0 108.579 176.454 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -68.7 115.39 3.91 Favored 'Trans proline' 0 C--N 1.374 1.886 0 C-N-CA 122.438 2.092 . . . . 0.0 110.926 172.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.44 -37.66 77.46 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.577 0.751 . . . . 0.0 110.824 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -63.46 -32.85 74.41 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.853 0.861 . . . . 0.0 111.644 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.473 ' O ' ' HG3' ' A' ' 52' ' ' MET . 40.3 tt0 -60.24 -39.4 86.56 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.625 1.17 . . . . 0.0 110.375 176.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 63.6 mt -77.89 -41.04 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.273 177.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -54.76 -46.0 74.27 Favored 'General case' 0 C--N 1.354 0.802 0 O-C-N 124.074 0.859 . . . . 0.0 111.091 -177.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -60.99 -37.37 82.24 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-O 120.66 0.267 . . . . 0.0 111.145 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.473 ' HG3' ' O ' ' A' ' 48' ' ' GLU . 43.0 mtm -72.73 -29.76 63.62 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.254 0.622 . . . . 0.0 110.653 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.546 HD13 ' HG2' ' A' ' 34' ' ' ARG . 77.1 mt -71.74 -33.87 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 124.136 0.975 . . . . 0.0 110.006 175.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -77.71 -10.6 59.61 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.02 0.928 . . . . 0.0 110.61 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -94.17 -27.61 16.11 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.316 1.047 . . . . 0.0 110.376 168.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.49 -30.74 59.97 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.55 0.74 . . . . 0.0 111.547 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -148.64 81.25 7.9 Favored Pre-proline 0 N--CA 1.478 0.961 0 C-N-CA 123.091 0.556 . . . . 0.0 109.836 172.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -83.32 -11.71 9.49 Favored 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.928 2.419 . . . . 0.0 113.132 172.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 20.7 tm0? -78.22 -23.35 47.5 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.671 0.789 . . . . 0.0 110.27 -174.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.3 t30 67.19 53.06 0.8 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.984 1.314 . . . . 0.0 108.926 -172.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.5 m -79.77 -24.36 41.56 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.742 173.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.91 23.9 63.06 Favored Glycine 0 C--N 1.346 1.113 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.995 -174.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 29' ' ' THR . 72.9 m-85 -144.44 159.84 42.07 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.768 0.827 . . . . 0.0 111.438 -174.21 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.692 HG11 HD22 ' A' ' 33' ' ' LEU . 5.4 p -167.58 143.93 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.379 1.072 . . . . 0.0 109.406 175.42 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -82.2 104.99 12.93 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 172.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.5 ' HE1' HG23 ' A' ' 14' ' ' ILE . 53.2 p90 -64.48 -32.27 73.83 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.999 0.52 . . . . 0.0 111.013 178.14 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -55.06 -42.03 72.23 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.818 0.847 . . . . 0.0 110.87 174.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 19.1 m -76.83 -53.46 7.88 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.576 179.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -69.39 -54.33 14.95 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.109 -169.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.59 ' HA ' ' HB3' ' A' ' 73' ' ' LEU . 57.8 t -62.72 -19.09 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.372 0 C-N-CA 123.288 0.635 . . . . 0.0 111.283 177.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -71.29 -35.26 63.77 Favored Glycine 0 C--N 1.351 1.388 0 CA-C-N 116.435 -0.348 . . . . 0.0 113.39 172.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 28.3 ptm -98.24 -3.99 36.24 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.543 0.737 . . . . 0.0 111.527 177.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.59 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 9.8 tp -97.61 -53.02 3.56 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.448 1.099 . . . . 0.0 110.576 -178.631 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.472 ' HB3' ' HE3' ' A' ' 10' ' ' LYS . 3.4 m-85 -83.81 27.87 0.61 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.688 0.795 . . . . 0.0 112.893 -174.449 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.7 pp -77.86 -0.09 25.99 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.956 0.503 . . . . 0.0 111.127 169.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 49.5 m0 . . . . . 0 CA--C 1.545 0.763 0 C-N-CA 124.874 1.269 . . . . 0.0 110.816 177.983 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? . . . . . 0 N--CA 1.476 0.845 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.463 ' O ' ' HG2' ' A' ' 15' ' ' GLU . . . -75.82 -39.79 56.11 Favored 'General case' 0 C--O 1.216 -0.705 0 C-N-CA 123.117 0.567 . . . . 0.0 110.738 171.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -58.5 -38.58 77.95 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 123.272 0.629 . . . . 0.0 112.588 -174.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.3 p -65.9 -40.14 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 175.008 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.432 HG22 ' HE3' ' A' ' 18' ' ' LYS . 64.3 mt -64.77 -31.82 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 123.393 0.677 . . . . 0.0 110.423 176.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 10.4 mm-40 -71.4 -27.73 63.52 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.082 0.553 . . . . 0.0 110.983 178.266 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.9 -35.63 81.76 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 122.919 0.488 . . . . 0.0 110.996 177.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.515 ' CZ ' HD12 ' A' ' 33' ' ' LEU . 95.7 m-85 -64.03 -35.65 81.43 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.482 0.713 . . . . 0.0 110.951 174.209 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.432 ' HE3' HG22 ' A' ' 14' ' ' ILE . 90.9 mttt -77.19 -29.67 54.45 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.0 -177.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 74.1 t -69.33 -37.76 76.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 123.452 0.701 . . . . 0.0 109.769 172.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -71.48 -46.95 58.48 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.718 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -83.76 81.05 8.93 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.878 0.847 . . . . 0.0 109.014 -177.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 29.6 mtm180 -86.04 -18.42 32.52 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 113.947 -1.478 . . . . 0.0 110.076 177.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -80.01 -25.86 40.06 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.766 0.826 . . . . 0.0 111.568 -175.342 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.27 52.53 3.97 Favored Glycine 0 C--N 1.341 0.837 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.637 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -80.76 -19.17 45.48 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.24 1.016 . . . . 0.0 109.827 173.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.82 -56.17 3.74 Favored Glycine 0 C--N 1.347 1.175 0 N-CA-C 111.164 -0.775 . . . . 0.0 111.164 -175.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -118.97 156.91 28.75 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.326 1.05 . . . . 0.0 110.194 178.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.5 t -110.56 157.25 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 123.636 0.775 . . . . 0.0 109.503 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 68.7 p -65.28 166.5 9.83 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.107 0.963 . . . . 0.0 112.345 178.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.656 HG23 HG21 ' A' ' 53' ' ' ILE . 7.2 p -63.42 -33.48 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.332 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -64.09 -49.19 73.24 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.311 0.244 . . . . 0.0 111.627 -172.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -67.59 -36.88 81.72 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.488 176.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.592 HD22 HG11 ' A' ' 64' ' ' VAL . 12.1 tp -56.1 -43.88 78.51 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.665 0.603 . . . . 0.0 110.687 177.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 34.8 mtm105 -72.26 -34.67 68.41 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.097 0.559 . . . . 0.0 110.411 177.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -63.05 -50.7 69.6 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.651 0.78 . . . . 0.0 111.899 -174.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.3 p -64.82 -33.48 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 122.889 0.475 . . . . 0.0 110.83 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.419 HD13 HG21 ' A' ' 49' ' ' ILE . 80.5 mt -85.51 -8.51 58.29 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 123.766 0.827 . . . . 0.0 111.367 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -87.09 -36.2 18.27 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.1 1.36 . . . . 0.0 108.934 171.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -69.21 -35.17 75.92 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.848 0.859 . . . . 0.0 109.635 173.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 93.2 mt -89.23 15.52 8.8 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.762 0.825 . . . . 0.0 110.491 169.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 44' ' ' MET . . . -74.92 -10.05 83.69 Favored Glycine 0 C--N 1.353 1.515 0 C-N-CA 123.851 0.739 . . . . 0.0 113.626 -173.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -68.13 -32.77 73.28 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.324 0.649 . . . . 0.0 110.342 174.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 93.6 mmm -107.46 -31.1 8.29 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.62 0.768 . . . . 0.0 111.699 178.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.618 ' HB3' HD11 ' A' ' 49' ' ' ILE . 24.9 mmt -113.21 104.92 55.72 Favored Pre-proline 0 N--CA 1.479 1.002 0 C-N-CA 123.539 0.735 . . . . 0.0 109.778 -173.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.42 117.93 4.73 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.69 2.26 . . . . 0.0 111.866 -178.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.92 -47.71 85.16 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.766 0.826 . . . . 0.0 111.572 -176.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -53.93 -40.66 66.93 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 123.798 0.839 . . . . 0.0 111.723 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -62.47 -52.17 64.58 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.216 178.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.618 HD11 ' HB3' ' A' ' 44' ' ' MET . 79.1 mt -62.75 -40.32 88.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.859 -178.285 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.513 ' HA ' HD12 ' A' ' 53' ' ' ILE . 51.2 mt-10 -63.17 -34.05 76.79 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.139 0.576 . . . . 0.0 111.06 -175.478 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -67.78 -36.3 80.22 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 121.146 0.498 . . . . 0.0 110.379 175.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 20.0 mmt -67.14 -29.7 69.49 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.587 0.755 . . . . 0.0 110.807 177.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.656 HG21 HG23 ' A' ' 30' ' ' VAL . 50.2 mt -71.39 -31.1 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 123.118 0.567 . . . . 0.0 110.754 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -64.35 -28.95 70.05 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 122.898 0.479 . . . . 0.0 110.711 175.33 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -78.91 -37.51 39.75 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.032 0.533 . . . . 0.0 110.466 174.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.02 -25.6 61.02 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.9 0.88 . . . . 0.0 112.183 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -140.47 81.8 17.06 Favored Pre-proline 0 CA--C 1.548 0.889 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 175.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -65.58 -14.44 44.83 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 123.462 2.775 . . . . 0.0 112.788 175.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -69.2 -26.05 64.64 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.408 0.683 . . . . 0.0 110.911 176.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.1 t30 59.15 24.1 12.43 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.482 1.113 . . . . 0.0 110.824 -178.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.8 m -83.6 -16.46 45.17 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.791 0.836 . . . . 0.0 110.682 -178.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.86 29.84 22.34 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-N 115.589 -0.732 . . . . 0.0 113.28 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -126.82 107.75 10.4 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.872 0.869 . . . . 0.0 109.135 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.592 HG11 HD22 ' A' ' 33' ' ' LEU . 3.3 p -136.01 135.8 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 123.162 0.585 . . . . 0.0 110.89 -173.372 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -76.13 98.38 4.36 Favored 'General case' 0 C--N 1.35 0.609 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 174.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -55.08 -34.43 63.62 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.238 1.015 . . . . 0.0 112.809 -178.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -58.05 -57.01 14.7 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.522 0.729 . . . . 0.0 110.162 -176.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.2 p -68.76 -39.87 80.03 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.389 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -67.4 -67.27 0.47 Allowed 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 119.21 -0.424 . . . . 0.0 111.974 -177.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.616 ' HA ' ' HB3' ' A' ' 73' ' ' LEU . 57.6 t -52.4 -26.06 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 C-N-CA 124.808 1.243 . . . . 0.0 112.232 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.96 -54.58 29.72 Favored Glycine 0 CA--C 1.541 1.67 0 N-CA-C 112.469 -0.252 . . . . 0.0 112.469 168.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 64.0 mtm -73.59 -12.1 60.64 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.705 0.802 . . . . 0.0 112.236 178.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.616 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 52.3 tp -86.49 -41.57 14.27 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.375 1.07 . . . . 0.0 110.094 -178.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.414 ' HA ' ' CD1' ' A' ' 76' ' ' TRP . 8.2 m-85 -89.74 34.26 0.84 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.379 0.672 . . . . 0.0 111.699 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 92.2 mt -77.42 -15.33 59.4 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.849 0.46 . . . . 0.0 110.877 170.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.414 ' CD1' ' HA ' ' A' ' 74' ' ' PHE . 0.3 OUTLIER . . . . . 0 CA--C 1.556 1.197 0 C-N-CA 124.286 1.035 . . . . 0.0 112.176 174.147 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.447 ' O ' HG12 ' A' ' 14' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.503 ' O ' ' HG2' ' A' ' 15' ' ' GLU . . . -54.95 -48.94 72.54 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.406 0.683 . . . . 0.0 110.381 175.546 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -63.25 -38.45 91.2 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.982 0.913 . . . . 0.0 112.753 -171.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.5 p -69.01 -41.0 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 177.197 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.467 HG22 ' HE3' ' A' ' 18' ' ' LYS . 48.1 mm -63.35 -37.84 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 123.37 0.668 . . . . 0.0 110.958 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.503 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 20.3 mm-40 -73.07 -28.53 62.36 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.014 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.76 -35.3 80.14 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.288 0.635 . . . . 0.0 110.985 177.107 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -61.94 -41.88 98.47 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.025 173.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.467 ' HE3' HG22 ' A' ' 14' ' ' ILE . 96.5 mttt -68.03 -27.55 66.64 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.444 0.698 . . . . 0.0 112.072 -173.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.2 t -71.26 -39.85 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.129 0.572 . . . . 0.0 109.851 175.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -71.17 -40.35 71.34 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.756 177.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.428 ' HB2' HG22 ' A' ' 28' ' ' VAL . 27.7 t0 -85.28 70.79 10.88 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 122.12 0.962 . . . . 0.0 108.993 -179.332 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -67.45 -29.35 68.78 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 113.834 -1.53 . . . . 0.0 109.681 176.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -69.84 -25.99 64.0 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.673 -178.202 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.16 41.45 47.03 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.55 173.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -68.56 -20.36 64.53 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.502 0.721 . . . . 0.0 111.312 176.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.37 -26.17 25.51 Favored Glycine 0 C--N 1.348 1.24 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.686 -177.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -136.04 166.89 22.32 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.161 0.984 . . . . 0.0 109.557 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.428 HG22 ' HB2' ' A' ' 21' ' ' ASP . 81.3 t -118.79 153.45 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.046 0.938 . . . . 0.0 109.233 176.278 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.8 p -60.93 155.95 18.68 Favored 'General case' 0 C--O 1.248 0.983 0 C-N-CA 123.551 0.74 . . . . 0.0 111.247 173.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.407 ' O ' ' HG3' ' A' ' 34' ' ' ARG . 9.7 p -62.82 -24.09 34.77 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-N 116.167 -0.47 . . . . 0.0 112.196 -175.106 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -60.33 -60.1 4.35 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.195 0.598 . . . . 0.0 111.851 -176.002 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -63.74 -32.67 74.23 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.069 0.548 . . . . 0.0 110.479 178.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.423 HD13 HG13 ' A' ' 64' ' ' VAL . 4.4 tt -61.37 -44.48 97.1 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.879 0.872 . . . . 0.0 111.551 179.161 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.407 ' HG3' ' O ' ' A' ' 30' ' ' VAL . 50.7 mtm180 -68.21 -38.99 82.51 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.941 0.496 . . . . 0.0 109.915 177.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -61.55 -47.14 86.91 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 124.165 0.916 . . . . 0.0 111.35 -177.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.4 p -73.43 -25.5 21.22 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.699 -176.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.633 HD11 HG22 ' A' ' 70' ' ' VAL . 96.6 mt -86.9 -15.19 39.74 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.821 0.448 . . . . 0.0 111.311 175.422 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -88.36 -30.95 19.15 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 176.713 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -78.15 -24.34 47.36 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 110.513 -0.18 . . . . 0.0 110.513 176.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 60.3 mt -95.81 12.22 30.85 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.595 0.758 . . . . 0.0 109.791 169.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.468 ' HA2' ' SD ' ' A' ' 44' ' ' MET . . . -144.84 55.83 0.55 Allowed Glycine 0 C--N 1.349 1.26 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 -175.082 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -68.69 -64.88 0.78 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.495 0.718 . . . . 0.0 110.359 -177.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.87 -4.34 43.81 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.75 177.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.468 ' SD ' ' HA2' ' A' ' 41' ' ' GLY . 1.2 mpt? -74.74 133.55 76.39 Favored Pre-proline 0 CA--C 1.546 0.801 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 172.532 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -65.54 114.99 3.12 Favored 'Trans proline' 0 C--N 1.37 1.69 0 C-N-CA 122.023 1.815 . . . . 0.0 110.438 173.007 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.85 -13.24 59.54 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.015 0.526 . . . . 0.0 111.343 177.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.42 ' O ' ' HG2' ' A' ' 51' ' ' GLU . 1.7 m-20 -53.59 -45.78 70.12 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.561 1.144 . . . . 0.0 111.925 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -59.88 -40.95 90.42 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.133 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 84.2 mt -67.89 -35.7 73.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 124.023 0.929 . . . . 0.0 110.274 178.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -66.09 -40.35 90.73 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.594 0.758 . . . . 0.0 110.769 177.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 47' ' ' ASP . 16.3 mm-40 -65.55 -33.48 76.01 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.249 0.62 . . . . 0.0 110.966 177.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.407 ' HB3' ' HE1' ' A' ' 69' ' ' PHE . 21.3 mmt -68.4 -37.45 80.37 Favored 'General case' 0 CA--C 1.55 0.96 0 O-C-N 123.939 0.774 . . . . 0.0 110.117 174.661 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 70.4 mt -62.05 -38.39 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 124.243 1.017 . . . . 0.0 111.676 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -57.71 -32.0 66.97 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.086 0.554 . . . . 0.0 111.649 178.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -87.8 -38.71 15.49 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.799 0.84 . . . . 0.0 110.591 178.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.66 -20.98 60.41 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.08 0.952 . . . . 0.0 111.917 -175.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -138.95 83.67 18.17 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 174.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -77.76 -13.84 15.95 Favored 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 122.958 2.438 . . . . 0.0 112.276 -177.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.487 ' HG3' ' H ' ' A' ' 61' ' ' SER . 27.3 pt20 -79.16 -16.16 57.04 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.491 1.116 . . . . 0.0 112.081 -178.127 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.3 t30 63.29 18.6 11.12 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 124.708 1.203 . . . . 0.0 111.254 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.487 ' H ' ' HG3' ' A' ' 59' ' ' GLN . 19.4 m -92.67 -25.92 18.04 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.51 0.724 . . . . 0.0 110.152 -175.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.25 41.84 6.07 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 115.763 -0.653 . . . . 0.0 113.325 175.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -124.36 94.58 4.25 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.258 1.023 . . . . 0.0 108.601 175.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.423 HG13 HD13 ' A' ' 33' ' ' LEU . 3.9 p -126.9 134.27 66.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 124.01 0.924 . . . . 0.0 110.257 -170.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -76.79 108.06 9.55 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.891 0.877 . . . . 0.0 109.82 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -65.77 -38.01 87.87 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -170.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -71.02 -32.87 69.75 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 118.3 0.5 . . . . 0.0 110.126 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 31.3 m -72.19 -30.56 65.07 Favored 'General case' 0 CA--C 1.553 1.079 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.882 174.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.42 ' CE2' HD21 ' A' ' 33' ' ' LEU . 45.8 t80 -93.22 -72.1 0.62 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.083 0.553 . . . . 0.0 111.726 -176.618 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.633 HG22 HD11 ' A' ' 37' ' ' LEU . 57.6 t -59.49 -36.21 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.819 1.248 . . . . 0.0 111.346 -177.124 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -59.47 -37.42 92.07 Favored Glycine 0 C--N 1.348 1.219 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.934 174.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 94.2 mmm -81.59 -37.02 28.3 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.432 0.693 . . . . 0.0 112.26 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 pp -75.65 -24.66 56.41 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 118.303 0.501 . . . . 0.0 110.286 -175.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.423 ' CD2' ' HB3' ' A' ' 10' ' ' LYS . 6.1 m-85 -74.76 -8.05 55.23 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.573 0.349 . . . . 0.0 111.547 172.532 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 60.5 mt -89.05 9.25 25.98 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.995 0.518 . . . . 0.0 111.963 175.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 43.7 m0 . . . . . 0 N--CA 1.484 1.266 0 CA-C-O 121.227 0.537 . . . . 0.0 109.986 174.594 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.429 ' HA ' HG12 ' A' ' 13' ' ' VAL . 14.0 ptmm? . . . . . 0 N--CA 1.476 0.85 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.03 -42.18 73.27 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 122.643 0.377 . . . . 0.0 110.36 170.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -64.54 -39.22 93.37 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.396 0.678 . . . . 0.0 112.146 -177.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.429 HG12 ' HA ' ' A' ' 10' ' ' LYS . 11.9 p -69.68 -35.51 66.12 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 CA-C-O 119.348 -0.358 . . . . 0.0 110.307 178.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 77.0 mt -61.92 -41.69 91.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 C-N-CA 122.824 0.45 . . . . 0.0 110.11 172.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.447 ' O ' HG23 ' A' ' 19' ' ' VAL . 33.7 mm-40 -63.19 -29.5 70.83 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.281 0.632 . . . . 0.0 111.21 176.276 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.92 -32.56 73.89 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.93 0.492 . . . . 0.0 111.616 178.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.406 ' HE2' ' HA ' ' A' ' 33' ' ' LEU . 93.6 m-85 -70.25 -40.42 74.43 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 171.081 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -74.23 -9.13 58.3 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.227 -177.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 15' ' ' GLU . 93.3 t -68.73 -44.62 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 167.212 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -69.51 -55.15 11.02 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.157 179.016 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -75.15 95.84 3.17 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.557 178.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -88.27 -38.77 14.95 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.327 -176.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -76.55 -22.36 54.45 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.833 0.853 . . . . 0.0 112.393 -173.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.3 53.6 3.6 Favored Glycine 0 C--N 1.343 0.969 0 N-CA-C 111.491 -0.644 . . . . 0.0 111.491 -176.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -68.71 -30.1 68.67 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.624 1.17 . . . . 0.0 109.334 173.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.05 -59.74 0.46 Allowed Glycine 0 C--N 1.342 0.868 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.084 175.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.402 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 43.9 p90 -115.29 -171.66 2.0 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.628 0.771 . . . . 0.0 110.834 -171.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.428 HG22 ' H ' ' A' ' 29' ' ' THR . 3.0 p -139.65 178.2 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.221 0 C-N-CA 123.343 0.657 . . . . 0.0 110.484 -173.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.428 ' H ' HG22 ' A' ' 28' ' ' VAL . 68.5 p -88.13 154.11 20.72 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.008 0.923 . . . . 0.0 110.358 175.121 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.6 p -67.59 -29.77 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-N 117.861 0.3 . . . . 0.0 110.856 178.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -62.5 -46.55 87.92 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.513 178.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -72.24 -32.79 67.02 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.614 179.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.426 HD21 ' CE2' ' A' ' 69' ' ' PHE . 2.9 tt -67.79 -39.12 84.07 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.947 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 37.4 mtp-105 -72.83 -30.59 64.16 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 122.42 0.288 . . . . 0.0 110.321 174.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -63.62 -49.33 73.72 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.593 1.157 . . . . 0.0 111.075 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.474 HG13 ' HG ' ' A' ' 37' ' ' LEU . 7.0 p -69.34 -40.17 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.137 0.575 . . . . 0.0 111.627 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.474 ' HG ' HG13 ' A' ' 36' ' ' VAL . 79.7 mt -82.1 -4.8 57.65 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.48 0.712 . . . . 0.0 111.862 -176.176 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -67.84 -29.12 68.19 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.489 0.716 . . . . 0.0 111.412 175.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -59.35 -40.04 85.14 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.292 0.637 . . . . 0.0 111.792 -177.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.2 pp -92.48 7.58 42.46 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.508 0.723 . . . . 0.0 110.919 -178.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -72.98 -19.33 79.53 Favored Glycine 0 C--N 1.352 1.447 0 O-C-N 123.48 0.487 . . . . 0.0 112.496 -178.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -75.28 -27.24 59.31 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.329 0.652 . . . . 0.0 111.215 177.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 82.3 mtp -100.02 -44.65 5.94 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.723 0.809 . . . . 0.0 110.769 -175.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 23.0 mmt -120.03 145.69 40.45 Favored Pre-proline 0 N--CA 1.482 1.171 0 C-N-CA 124.839 1.256 . . . . 0.0 109.649 -177.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -58.41 119.53 6.85 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.729 2.286 . . . . 0.0 112.761 179.115 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.01 -30.33 63.69 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.302 174.03 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -55.13 -40.89 71.06 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 124.026 0.93 . . . . 0.0 111.225 174.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -51.96 -53.81 36.93 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.382 1.073 . . . . 0.0 110.695 174.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.518 HG12 HD11 ' A' ' 73' ' ' LEU . 74.0 mt -60.39 -41.93 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.96 179.124 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.561 ' HA ' HD12 ' A' ' 53' ' ' ILE . 42.7 mt-10 -66.01 -34.69 78.68 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.502 0.721 . . . . 0.0 112.12 -175.199 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -70.07 -39.49 75.6 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 120.951 0.405 . . . . 0.0 110.32 175.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 48.0 mmm -59.53 -34.25 72.39 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.948 0.899 . . . . 0.0 110.568 174.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.561 HD12 ' HA ' ' A' ' 50' ' ' GLU . 85.1 mt -62.56 -34.42 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.851 0.86 . . . . 0.0 112.149 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -60.95 -25.96 67.18 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -177.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -89.91 -28.54 19.13 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 122.776 0.43 . . . . 0.0 111.219 176.001 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.2 -34.43 68.37 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.374 0.669 . . . . 0.0 111.164 178.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -132.03 80.81 63.8 Favored Pre-proline 0 CA--C 1.548 0.878 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 175.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -82.29 -3.8 11.59 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.988 2.459 . . . . 0.0 112.684 -179.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -86.73 -14.88 41.14 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.354 1.061 . . . . 0.0 111.586 -179.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 61.26 30.7 19.31 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 124.611 1.164 . . . . 0.0 110.615 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.6 t -109.19 -3.74 17.04 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.799 0.84 . . . . 0.0 111.111 -172.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.99 19.83 74.32 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 114.852 0.701 . . . . 0.0 114.852 172.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -110.05 94.75 5.18 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 177.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.3 p -111.99 130.64 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.55 0.74 . . . . 0.0 110.551 -174.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.402 ' HA ' ' HB2' ' A' ' 27' ' ' TYR . 46.0 mt-30 -85.71 93.98 8.99 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 175.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -55.26 -29.84 58.91 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.592 0.757 . . . . 0.0 111.746 176.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -48.84 -55.87 10.38 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.083 1.753 . . . . 0.0 111.168 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.1 t -87.43 -30.58 20.6 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 114.466 -1.243 . . . . 0.0 110.51 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.426 ' CE2' HD21 ' A' ' 33' ' ' LEU . 52.1 t80 -67.07 -65.3 0.7 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.865 0.466 . . . . 0.0 111.7 -174.315 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.55 ' HA ' ' HB3' ' A' ' 73' ' ' LEU . 99.1 t -50.41 -29.45 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 124.837 1.255 . . . . 0.0 112.3 175.569 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.17 -50.63 65.59 Favored Glycine 0 CA--C 1.535 1.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.849 171.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 24.7 ptm -84.59 -15.48 45.48 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.349 0.66 . . . . 0.0 111.706 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.55 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 66.8 tp -77.25 -51.76 10.37 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.186 0.994 . . . . 0.0 109.9 -174.639 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -83.59 34.96 0.49 Allowed 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 123.593 0.757 . . . . 0.0 111.546 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 53.5 mt -96.29 23.13 6.94 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.751 0.82 . . . . 0.0 110.989 169.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 7.0 m0 . . . . . 0 CA--C 1.545 0.751 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 170.962 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.464 ' HE3' ' HA2' ' A' ' 71' ' ' GLY . 13.3 ptmm? . . . . . 0 N--CA 1.479 0.981 0 CA-C-O 119.862 -0.113 . . . . 0.0 111.234 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.471 ' O ' ' HG2' ' A' ' 15' ' ' GLU . . . -55.84 -34.68 65.65 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.073 0.949 . . . . 0.0 111.703 178.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -60.41 -52.99 62.88 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.525 0.73 . . . . 0.0 112.176 -177.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.4 p -65.85 -29.87 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 122.5 0.32 . . . . 0.0 110.458 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.438 ' HA ' ' HD2' ' A' ' 17' ' ' PHE . 94.1 mt -70.05 -34.41 59.4 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 123.404 0.682 . . . . 0.0 110.873 177.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 18.7 mm-40 -62.49 -28.36 69.78 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.372 0.669 . . . . 0.0 110.961 175.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.14 -44.95 86.95 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.175 0.59 . . . . 0.0 110.444 175.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.438 ' HD2' ' HA ' ' A' ' 14' ' ' ILE . 99.6 m-85 -68.44 -32.96 73.35 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.489 178.06 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -79.24 -29.0 42.46 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.191 0.596 . . . . 0.0 112.097 -177.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.7 p -82.08 -15.55 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 CA-C-O 121.031 0.443 . . . . 0.0 110.079 173.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -78.38 -50.71 11.23 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 172.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -96.33 88.01 4.63 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.572 0.749 . . . . 0.0 109.627 178.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -94.44 1.95 55.76 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.502 173.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -90.95 -25.47 19.74 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.493 0.717 . . . . 0.0 111.279 -175.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.21 38.66 12.54 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.078 -175.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -64.23 -26.4 68.49 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.453 1.101 . . . . 0.0 109.049 169.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.32 -32.98 6.71 Favored Glycine 0 C--N 1.352 1.438 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.487 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.462 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 51.6 p90 -144.96 -179.42 6.6 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.476 0.71 . . . . 0.0 111.003 -176.503 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.6 t -126.43 156.01 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.528 1.131 . . . . 0.0 110.042 -172.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.4 p -66.3 149.57 50.17 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.856 0.862 . . . . 0.0 111.162 173.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.9 p -68.49 -19.1 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 122.74 0.416 . . . . 0.0 112.068 -173.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -56.49 -51.81 67.09 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.522 0.729 . . . . 0.0 111.313 175.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -69.73 -32.56 71.19 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.075 -179.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.422 HD12 ' CZ ' ' A' ' 17' ' ' PHE . 9.0 tp -58.41 -55.39 35.69 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 123.923 0.764 . . . . 0.0 110.331 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.561 ' HG2' HD13 ' A' ' 53' ' ' ILE . 94.3 mtt180 -65.94 -27.19 67.99 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.605 -178.469 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -70.01 -52.7 22.03 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.787 0.835 . . . . 0.0 111.27 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.5 p -75.19 -29.9 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.409 -175.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 95.4 mt -80.65 -10.51 59.73 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.917 0.487 . . . . 0.0 111.259 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -74.83 -44.24 50.31 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 165.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -62.88 -35.53 80.32 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.217 -179.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -85.43 -42.27 14.66 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.296 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -91.94 67.72 2.07 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.762 -168.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -86.62 -57.88 2.82 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.686 0.794 . . . . 0.0 109.539 173.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -71.73 -34.75 69.81 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.739 0.816 . . . . 0.0 110.758 178.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 19.5 mmt -95.99 101.19 7.79 Favored Pre-proline 0 N--CA 1.472 0.65 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 172.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.406 ' HB2' ' HG3' ' A' ' 48' ' ' GLU . 83.1 Cg_exo -48.85 129.68 21.5 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 123.338 2.692 . . . . 0.0 113.248 -171.575 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.02 -28.25 67.58 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.81 0.844 . . . . 0.0 111.336 -178.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -65.96 -41.76 90.81 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.958 0.903 . . . . 0.0 111.206 175.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 52' ' ' MET . 38.7 mt-10 -72.27 -31.72 66.0 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 122.566 0.346 . . . . 0.0 110.645 178.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.407 ' O ' HG13 ' A' ' 53' ' ' ILE . 96.4 mt -64.67 -36.89 78.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 123.261 0.624 . . . . 0.0 110.088 169.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.542 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 51.1 mt-10 -69.56 -28.31 65.88 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.457 0.303 . . . . 0.0 111.66 176.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -58.12 -34.13 69.9 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.562 0.696 . . . . 0.0 110.538 170.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.421 ' HG2' ' O ' ' A' ' 48' ' ' GLU . 11.4 mmt -81.03 -37.76 28.59 Favored 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.038 177.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.561 HD13 ' HG2' ' A' ' 34' ' ' ARG . 69.0 mt -65.41 -43.02 94.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 124.467 1.107 . . . . 0.0 111.503 -175.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -59.74 -19.22 48.79 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.881 0.472 . . . . 0.0 112.049 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -84.32 -37.11 22.03 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.434 0.694 . . . . 0.0 110.92 172.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.423 ' HB2' ' CD1' ' A' ' 69' ' ' PHE . . . -60.99 -46.41 90.88 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.104 0.961 . . . . 0.0 111.09 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -109.53 82.3 2.14 Favored Pre-proline 0 CA--C 1.552 1.046 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 168.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -68.84 -34.17 18.69 Favored 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 123.341 2.694 . . . . 0.0 112.496 -167.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -87.65 -1.68 58.11 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.916 0.886 . . . . 0.0 111.149 177.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 56.68 49.99 13.48 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 124.802 1.241 . . . . 0.0 109.562 -172.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.2 m -70.42 -13.64 62.22 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 114.502 -1.226 . . . . 0.0 112.782 -172.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.43 11.23 82.36 Favored Glycine 0 C--N 1.348 1.241 0 N-CA-C 112.003 -0.439 . . . . 0.0 112.003 -173.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -135.17 145.83 48.15 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.55 1.14 . . . . 0.0 108.822 -177.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.404 ' O ' ' HB2' ' A' ' 27' ' ' TYR . 7.5 p -147.79 129.58 6.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 CA-C-O 121.251 0.548 . . . . 0.0 110.541 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -75.03 93.73 2.77 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 166.511 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.462 ' CE2' ' HA ' ' A' ' 27' ' ' TYR . 42.9 p90 -57.85 -40.18 79.5 Favored 'General case' 0 C--O 1.211 -0.936 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.269 -173.317 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -69.89 -33.41 72.18 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 120.976 0.417 . . . . 0.0 110.852 -177.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 25.4 m -66.64 -38.82 87.7 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.763 173.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.423 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 39.3 t80 -80.71 -72.17 0.43 Allowed 'General case' 0 C--O 1.213 -0.864 0 C-N-CA 122.915 0.486 . . . . 0.0 111.979 -178.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.616 ' HA ' ' HB3' ' A' ' 73' ' ' LEU . 87.6 t -43.37 -31.96 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 126.116 1.767 . . . . 0.0 112.565 174.244 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.464 ' HA2' ' HE3' ' A' ' 10' ' ' LYS . . . -56.4 -49.02 71.53 Favored Glycine 0 C--N 1.348 1.233 0 O-C-N 123.453 0.471 . . . . 0.0 112.925 170.505 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 81.8 mtp -83.04 -23.43 33.2 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.475 1.11 . . . . 0.0 112.157 178.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.616 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 52.5 tp -74.93 -49.55 19.8 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.044 0.938 . . . . 0.0 110.447 -172.167 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -80.38 22.14 0.57 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.139 0.976 . . . . 0.0 112.441 -178.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 59.4 mt -91.0 14.04 15.02 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 123.484 0.714 . . . . 0.0 111.402 172.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 13.4 m0 . . . . . 0 C--N 1.355 0.827 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 172.012 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? . . . . . 0 N--CA 1.479 0.986 0 CA-C-O 120.628 0.252 . . . . 0.0 110.781 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.36 -38.47 91.27 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.973 0.909 . . . . 0.0 111.605 173.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -55.41 -41.14 72.32 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 123.472 0.709 . . . . 0.0 112.003 -172.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.9 p -77.5 -40.76 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.745 -175.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 88.1 mt -61.49 -41.63 90.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 C-N-CA 123.946 0.898 . . . . 0.0 110.522 177.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.456 ' O ' HG23 ' A' ' 19' ' ' VAL . 42.8 mt-10 -71.12 -29.12 64.86 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.143 0.977 . . . . 0.0 110.587 179.235 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.21 -37.23 85.06 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.934 0.494 . . . . 0.0 110.71 175.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.403 ' HE1' ' HA ' ' A' ' 33' ' ' LEU . 79.1 m-85 -67.48 -31.94 72.42 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.135 0.574 . . . . 0.0 110.967 174.212 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -67.96 -40.16 83.27 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.709 0.403 . . . . 0.0 109.93 175.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 15' ' ' GLU . 69.7 t -60.23 -34.01 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 123.989 0.916 . . . . 0.0 110.704 176.131 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -76.81 -57.86 3.61 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.742 0.417 . . . . 0.0 110.763 179.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -76.0 91.89 3.11 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.183 0.516 . . . . 0.0 109.933 -178.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 31.6 mmm180 -91.05 -14.01 32.14 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.304 1.042 . . . . 0.0 110.2 178.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -91.76 -10.66 39.18 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.017 0.927 . . . . 0.0 111.032 -173.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.46 45.35 30.0 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-N 116.582 -0.281 . . . . 0.0 113.386 170.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -76.17 -25.67 55.45 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.671 0.788 . . . . 0.0 110.78 178.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.17 -4.12 80.69 Favored Glycine 0 C--N 1.352 1.429 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.02 -174.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -154.21 174.27 14.99 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.705 1.202 . . . . 0.0 109.285 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.9 m -123.51 -174.99 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.413 0.685 . . . . 0.0 110.831 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.5 p -91.24 162.02 14.81 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 123.741 0.817 . . . . 0.0 110.482 174.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.638 HG23 HG21 ' A' ' 53' ' ' ILE . 7.7 p -61.92 -33.05 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.909 0.884 . . . . 0.0 112.109 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -67.0 -52.07 47.19 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 122.983 0.513 . . . . 0.0 112.119 -173.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -63.74 -38.43 91.08 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 120.529 0.204 . . . . 0.0 110.6 177.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.654 HD22 HG11 ' A' ' 64' ' ' VAL . 9.0 tp -52.92 -48.82 66.97 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 124.24 0.963 . . . . 0.0 110.316 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 28.4 mtm180 -66.28 -39.13 89.2 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.419 0.688 . . . . 0.0 111.516 178.053 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -59.75 -48.72 80.53 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.293 1.037 . . . . 0.0 111.224 -176.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.8 p -78.48 -32.55 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.883 -176.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 63.0 mt -80.19 -6.09 57.2 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 121.789 -0.569 . . . . 0.0 111.085 178.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -77.32 -45.16 27.09 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.428 0.691 . . . . 0.0 109.83 170.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -76.55 -29.37 56.65 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.944 -178.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -75.73 -36.6 59.87 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 122.72 0.408 . . . . 0.0 110.015 170.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.23 56.77 1.75 Allowed Glycine 0 C--N 1.347 1.147 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.1 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -72.53 -32.8 66.39 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.821 0.848 . . . . 0.0 111.51 -176.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 52.4 mtt -118.35 14.99 13.89 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.75 0.82 . . . . 0.0 110.471 175.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.426 ' SD ' ' N ' ' A' ' 44' ' ' MET . 1.4 mpt? -110.43 142.66 26.51 Favored Pre-proline 0 N--CA 1.475 0.818 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -67.55 113.29 2.88 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 121.932 1.755 . . . . 0.0 111.442 178.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.95 -26.49 68.23 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.523 0.729 . . . . 0.0 110.577 174.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -55.47 -46.27 76.86 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.61 1.164 . . . . 0.0 110.83 172.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -63.83 -52.01 62.08 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.286 -178.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.49 ' O ' HG13 ' A' ' 53' ' ' ILE . 91.7 mt -59.85 -43.66 92.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.483 -176.009 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.501 ' HA ' HD12 ' A' ' 53' ' ' ILE . 12.9 pt-20 -68.67 -31.61 70.85 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 123.188 0.305 . . . . 0.0 111.573 -175.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -72.02 -32.56 67.28 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.581 0.353 . . . . 0.0 110.91 176.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.439 ' HB3' ' HE1' ' A' ' 69' ' ' PHE . 76.4 mmm -67.79 -23.75 65.24 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.876 0.87 . . . . 0.0 111.182 175.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.638 HG21 HG23 ' A' ' 30' ' ' VAL . 72.5 mt -70.19 -30.79 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 123.396 0.679 . . . . 0.0 111.482 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -62.88 -25.27 68.22 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.223 0.535 . . . . 0.0 110.855 178.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -86.42 -36.22 19.25 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.475 1.11 . . . . 0.0 110.508 176.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.73 -29.81 69.14 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.145 0.978 . . . . 0.0 111.841 -178.204 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -118.13 87.42 29.04 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.231 1.013 . . . . 0.0 108.465 173.146 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.6 -32.89 69.03 Favored 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 123.088 2.525 . . . . 0.0 112.139 173.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -73.3 -6.29 45.07 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.168 0.987 . . . . 0.0 112.551 -172.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.0 p30 51.33 30.54 6.1 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 125.642 1.577 . . . . 0.0 112.064 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 71.8 p -87.93 -15.13 37.44 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.525 1.13 . . . . 0.0 112.187 -171.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.76 3.5 90.47 Favored Glycine 0 C--N 1.347 1.139 0 CA-C-N 116.322 -0.399 . . . . 0.0 112.478 -171.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -107.44 128.92 54.91 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 175.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.654 HG11 HD22 ' A' ' 33' ' ' LEU . 5.0 p -127.97 130.77 69.93 Favored 'Isoleucine or valine' 0 C--O 1.246 0.893 0 C-N-CA 123.113 0.565 . . . . 0.0 110.831 -172.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -73.86 91.57 1.98 Allowed 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 168.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -59.07 -30.94 68.44 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.046 176.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -61.98 -38.42 88.52 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.935 0.894 . . . . 0.0 110.567 -171.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 69.9 p -83.29 -44.03 15.37 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.464 177.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.439 ' HE1' ' HB3' ' A' ' 52' ' ' MET . 28.2 t80 -67.82 -60.88 2.17 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.701 0.8 . . . . 0.0 112.809 -172.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.7 t -65.07 -21.45 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.345 1.058 . . . . 0.0 111.151 -177.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.446 ' O ' ' HG ' ' A' ' 75' ' ' LEU . . . -58.63 -51.65 57.65 Favored Glycine 0 CA--C 1.534 1.254 0 N-CA-C 111.608 -0.597 . . . . 0.0 111.608 166.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 61.8 mtm -66.16 -32.83 74.51 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.982 0.913 . . . . 0.0 112.435 -179.071 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.4 mt -63.72 -35.31 80.14 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 121.219 0.533 . . . . 0.0 111.067 177.002 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -99.82 10.34 41.49 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.66 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 71' ' ' GLY . 81.8 mt -90.24 -13.18 35.94 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.164 0.586 . . . . 0.0 109.582 162.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 51.0 m0 . . . . . 0 N--CA 1.49 1.537 0 C-N-CA 123.532 0.733 . . . . 0.0 109.998 171.639 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.442 ' O ' HG12 ' A' ' 13' ' ' VAL . 10.2 ptpp? . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 111.55 0.204 . . . . 0.0 111.55 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.436 ' O ' ' HG2' ' A' ' 15' ' ' GLU . . . -57.17 -23.67 49.12 Favored 'General case' 0 C--O 1.209 -1.051 0 C-N-CA 123.177 0.591 . . . . 0.0 112.422 177.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -51.89 -45.64 64.25 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.402 0.681 . . . . 0.0 112.296 177.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 10' ' ' LYS . 12.4 p -80.3 -36.79 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 68.2 mt -64.8 -36.53 77.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 123.524 0.729 . . . . 0.0 111.13 -177.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.494 ' O ' HG23 ' A' ' 19' ' ' VAL . 37.4 mm-40 -73.25 -31.06 63.88 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.788 0.435 . . . . 0.0 110.526 178.629 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.91 -35.69 73.49 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.146 0.498 . . . . 0.0 110.599 175.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.445 ' CZ ' HG21 ' A' ' 70' ' ' VAL . 81.5 m-85 -65.49 -42.53 92.06 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.009 172.532 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -73.45 -17.52 61.23 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.463 0.705 . . . . 0.0 111.823 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 15' ' ' GLU . 70.7 t -76.93 -30.07 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.956 0.902 . . . . 0.0 109.565 171.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -77.88 -58.52 3.22 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 174.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -82.73 82.91 7.87 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.613 0.765 . . . . 0.0 109.822 178.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -93.26 -14.29 27.21 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 114.086 -1.415 . . . . 0.0 109.535 173.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -70.75 -25.4 62.9 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.813 0.845 . . . . 0.0 110.726 176.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.07 43.09 8.97 Favored Glycine 0 C--N 1.347 1.163 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.777 173.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -72.1 -16.92 62.02 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.508 0.723 . . . . 0.0 110.412 172.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.58 -28.71 13.69 Favored Glycine 0 C--N 1.348 1.22 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.08 178.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.493 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 36.9 p90 -142.13 164.28 30.59 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 124.397 1.079 . . . . 0.0 109.916 -178.474 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 79.6 t -109.65 149.29 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.03 0.932 . . . . 0.0 109.915 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 75.9 p -66.05 157.4 31.09 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.574 0.75 . . . . 0.0 111.0 174.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.572 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 7.1 p -65.25 -16.83 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 122.846 0.458 . . . . 0.0 111.463 178.537 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -55.38 -57.07 13.35 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.038 0.935 . . . . 0.0 111.219 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -76.99 -34.42 57.52 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.605 177.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.572 ' HB3' ' HA ' ' A' ' 30' ' ' VAL . 3.0 tt -61.46 -39.66 91.68 Favored 'General case' 0 CA--C 1.549 0.916 0 O-C-N 123.67 0.606 . . . . 0.0 111.723 -174.379 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.566 ' HG3' HG22 ' A' ' 30' ' ' VAL . 63.8 mtt180 -67.89 -40.34 83.53 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-O 119.559 -0.257 . . . . 0.0 110.923 175.558 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -55.07 -58.0 9.45 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 123.93 0.769 . . . . 0.0 111.458 -178.135 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.7 p -66.17 -34.22 68.72 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 CA-C-N 115.223 -0.898 . . . . 0.0 111.705 -175.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.536 HD11 HG22 ' A' ' 70' ' ' VAL . 92.7 mt -85.44 -7.97 58.64 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.074 0.55 . . . . 0.0 111.865 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -87.24 -35.02 18.75 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 170.113 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -62.88 -37.38 86.69 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.689 170.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.0 tt -73.9 -44.34 55.54 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.216 177.121 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.498 ' HA2' ' HB2' ' A' ' 44' ' ' MET . . . -90.59 50.82 3.26 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.778 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -74.96 -49.68 19.23 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.508 0.723 . . . . 0.0 110.147 -177.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 15.0 ptp -108.0 -1.03 20.92 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.606 0.762 . . . . 0.0 110.415 174.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.498 ' HB2' ' HA2' ' A' ' 41' ' ' GLY . 1.4 mpt? -97.65 147.05 32.46 Favored Pre-proline 0 N--CA 1.478 0.95 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 177.325 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -63.53 109.24 0.98 Allowed 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 121.787 1.658 . . . . 0.0 111.275 173.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.18 -13.96 60.17 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.28 176.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -53.83 -46.58 71.22 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.236 1.014 . . . . 0.0 110.88 172.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.464 ' O ' ' HG2' ' A' ' 52' ' ' MET . 46.8 mt-10 -58.95 -52.3 66.33 Favored 'General case' 0 C--N 1.356 0.866 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.842 178.57 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.434 ' O ' HG13 ' A' ' 53' ' ' ILE . 81.4 mt -57.36 -45.35 85.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.069 0.947 . . . . 0.0 111.549 -176.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.479 ' HA ' HD12 ' A' ' 53' ' ' ILE . 66.3 mt-10 -71.27 -31.52 67.59 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.738 0.415 . . . . 0.0 111.331 -179.332 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -68.36 -32.63 72.86 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-O 121.43 0.634 . . . . 0.0 109.671 176.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.464 ' HG2' ' O ' ' A' ' 48' ' ' GLU . 80.4 mmm -70.98 -34.29 71.25 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.243 1.017 . . . . 0.0 110.285 174.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.479 HD12 ' HA ' ' A' ' 50' ' ' GLU . 85.2 mt -60.11 -40.96 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 123.359 0.664 . . . . 0.0 110.629 178.187 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -69.05 -15.06 63.37 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.408 0.683 . . . . 0.0 111.539 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -90.21 -37.14 14.34 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.217 0.607 . . . . 0.0 110.658 172.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.8 -18.15 58.59 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.543 0.737 . . . . 0.0 111.524 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -152.6 83.23 4.92 Favored Pre-proline 0 CA--C 1.55 0.976 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 172.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -75.01 -8.44 20.06 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.389 2.726 . . . . 0.0 112.63 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -75.47 -22.34 57.34 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.243 177.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 58.21 30.82 19.99 Favored 'General case' 0 C--N 1.36 1.037 0 C-N-CA 124.656 1.182 . . . . 0.0 110.237 -176.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.3 t -75.62 -19.56 59.14 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 114.511 -1.222 . . . . 0.0 110.676 -176.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.94 24.56 31.93 Favored Glycine 0 C--N 1.338 0.685 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.848 -178.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -130.01 105.09 7.73 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.718 0.807 . . . . 0.0 109.899 -176.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.473 HG13 HD13 ' A' ' 33' ' ' LEU . 2.1 p -135.37 123.05 37.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 124.007 0.923 . . . . 0.0 109.857 -174.036 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -70.42 109.16 4.61 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.702 0.801 . . . . 0.0 110.352 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.493 ' CE2' ' HA ' ' A' ' 27' ' ' TYR . 38.1 p90 -64.25 -28.5 69.78 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.939 0.895 . . . . 0.0 112.96 -175.1 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -66.1 -54.77 21.53 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.374 0.27 . . . . 0.0 110.693 -177.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.5 t -71.8 -28.65 63.74 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.252 178.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.507 ' O ' ' HG2' ' A' ' 72' ' ' MET . 60.8 t80 -81.87 -73.78 0.37 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 122.59 0.356 . . . . 0.0 111.122 -178.288 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.536 HG22 HD11 ' A' ' 37' ' ' LEU . 38.7 t -60.26 -22.3 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 123.945 0.898 . . . . 0.0 111.655 -173.768 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -55.63 -53.46 41.35 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-N 116.242 -0.436 . . . . 0.0 112.662 169.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.507 ' HG2' ' O ' ' A' ' 69' ' ' PHE . 18.5 ptp -65.79 -26.15 67.57 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.977 0.511 . . . . 0.0 111.83 -176.276 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 70' ' ' VAL . 4.4 mm? -56.7 -38.66 72.61 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.73 0.812 . . . . 0.0 110.97 175.213 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -89.59 -16.99 29.36 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.284 1.034 . . . . 0.0 111.182 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.417 ' HB2' ' HA ' ' A' ' 72' ' ' MET . 85.4 mt -86.67 -3.32 59.02 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.357 0.663 . . . . 0.0 111.518 176.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 42.8 m0 . . . . . 0 N--CA 1.479 1.0 0 C-N-CA 122.969 0.507 . . . . 0.0 110.121 170.835 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.564 0 N-CA-C 112.397 -0.281 . . . . 0.0 112.397 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.6 m -76.52 86.22 3.23 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.113 0.565 . . . . 0.0 110.811 -176.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -167.76 105.72 0.52 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.214 1.005 . . . . 0.0 108.875 175.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 63.8 mtm 55.95 77.04 0.25 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.223 1.009 . . . . 0.0 111.573 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -112.38 124.76 53.21 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 27.9 m170 -68.89 84.51 0.32 Allowed 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 172.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.449 HG22 HG22 ' A' ' 9' ' ' THR . 49.2 mt -74.77 79.6 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.703 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -77.66 87.54 3.94 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.615 -173.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.449 HG22 HG22 ' A' ' 7' ' ' ILE . 9.5 t -150.86 150.6 31.11 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.472 176.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.429 ' HB3' ' CD2' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -76.11 -4.34 41.01 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.254 176.675 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.46 -47.18 85.16 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.83 0.452 . . . . 0.0 110.536 170.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -55.58 -41.86 73.97 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.495 1.118 . . . . 0.0 113.154 -174.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.0 p -67.76 -41.87 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 O-C-N 122.982 0.176 . . . . 0.0 110.542 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 62.0 mt -70.92 -27.62 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 123.603 0.761 . . . . 0.0 110.945 -178.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -75.49 -28.75 59.32 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.331 0.652 . . . . 0.0 110.751 175.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.66 -32.99 74.67 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.041 0.536 . . . . 0.0 110.629 174.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -64.55 -33.47 75.99 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.258 0.623 . . . . 0.0 111.018 171.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.1 mttp -78.67 -17.81 55.37 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.442 0.697 . . . . 0.0 111.725 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 67.0 t -72.88 -37.77 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 171.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -69.36 -55.3 10.79 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.996 173.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -80.04 77.92 6.71 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.777 0.831 . . . . 0.0 109.047 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.7 -21.12 61.83 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.097 1.359 . . . . 0.0 109.325 -178.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -76.01 -27.74 57.5 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.005 0.922 . . . . 0.0 111.358 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.93 45.9 54.99 Favored Glycine 0 C--N 1.344 1.015 0 O-C-N 123.486 0.491 . . . . 0.0 112.183 -176.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -68.58 -28.02 66.58 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.289 1.036 . . . . 0.0 111.312 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.41 -11.66 36.32 Favored Glycine 0 C--N 1.343 0.925 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 -175.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.4 ' HB2' ' O ' ' A' ' 64' ' ' VAL . 36.5 p90 -154.8 159.79 40.83 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.709 0.804 . . . . 0.0 110.535 -177.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.1 m -112.15 -177.15 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.762 0.825 . . . . 0.0 110.512 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 64.4 p -81.83 154.52 25.86 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.548 170.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.441 ' O ' ' HG3' ' A' ' 34' ' ' ARG . 9.8 p -68.41 -26.49 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 122.544 0.337 . . . . 0.0 111.062 -177.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -65.45 -48.14 73.73 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 122.978 0.511 . . . . 0.0 111.398 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -63.81 -39.02 93.23 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 123.313 0.383 . . . . 0.0 110.465 177.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.495 HD11 ' HD2' ' A' ' 69' ' ' PHE . 5.3 tp -55.47 -46.48 76.83 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.608 178.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.569 ' HG2' HD13 ' A' ' 53' ' ' ILE . 80.8 mtm180 -67.56 -35.64 79.41 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.443 0.697 . . . . 0.0 110.984 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -62.11 -52.11 65.19 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.274 1.03 . . . . 0.0 111.701 -176.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.9 p -74.25 -35.36 40.06 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.037 0 C-N-CA 123.085 0.554 . . . . 0.0 111.136 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.493 HD23 HD12 ' A' ' 40' ' ' LEU . 95.8 mt -80.22 -4.82 54.67 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.911 0.485 . . . . 0.0 111.295 178.005 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -75.68 -47.01 28.1 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.479 0.711 . . . . 0.0 109.964 173.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -75.35 -23.67 57.21 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.958 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.493 HD12 HD23 ' A' ' 37' ' ' LEU . 99.1 mt -82.94 -25.38 32.43 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.351 0.66 . . . . 0.0 110.025 170.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.29 14.13 46.91 Favored Glycine 0 C--N 1.354 1.562 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.278 174.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -75.76 -52.82 9.59 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 168.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -82.38 -37.62 25.33 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.284 0.634 . . . . 0.0 110.575 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 93.0 mmm -89.43 147.08 37.24 Favored Pre-proline 0 N--CA 1.477 0.925 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.69 111.57 0.83 Allowed 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 122.122 1.881 . . . . 0.0 111.2 170.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.14 -33.93 72.42 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.841 0.856 . . . . 0.0 111.047 -176.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -57.89 -38.98 76.79 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.101 0.96 . . . . 0.0 111.677 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.406 ' O ' ' HG2' ' A' ' 52' ' ' MET . 19.8 mm-40 -58.18 -53.25 60.38 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 123.848 0.718 . . . . 0.0 110.309 174.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 86.2 mt -58.17 -45.08 88.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.241 1.016 . . . . 0.0 111.023 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.499 ' HA ' HD12 ' A' ' 53' ' ' ILE . 45.3 mt-10 -63.75 -29.42 70.64 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.936 0.895 . . . . 0.0 111.843 -177.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -77.01 -41.7 41.66 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.301 0.572 . . . . 0.0 109.961 175.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.419 ' HB3' ' HE1' ' A' ' 69' ' ' PHE . 24.9 mmt -64.71 -24.67 67.64 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.036 177.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.569 HD13 ' HG2' ' A' ' 34' ' ' ARG . 41.6 mt -66.81 -32.52 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.766 1.226 . . . . 0.0 111.355 177.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -73.67 -27.4 61.22 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.801 0.44 . . . . 0.0 110.59 174.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -85.05 -17.38 37.62 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.177 0.591 . . . . 0.0 110.67 175.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.6 -51.25 10.95 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.816 0.846 . . . . 0.0 109.848 176.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -123.32 81.72 52.59 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 124.28 1.032 . . . . 0.0 108.468 175.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -73.34 -20.25 21.27 Favored 'Trans proline' 0 C--N 1.386 2.53 0 C-N-CA 123.076 2.517 . . . . 0.0 111.552 173.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -66.8 -23.57 66.07 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.578 174.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 58.15 34.55 24.27 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 124.992 1.317 . . . . 0.0 111.122 175.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.7 m -82.61 -13.33 56.7 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.421 -176.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.05 25.39 44.94 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.268 -172.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -139.59 122.96 17.13 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.769 0.828 . . . . 0.0 109.759 -175.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.482 HG11 HD22 ' A' ' 33' ' ' LEU . 2.8 p -131.65 129.9 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.59 0.756 . . . . 0.0 110.685 -172.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -74.95 90.25 2.42 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 170.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -56.72 -27.06 58.42 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.072 177.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -51.33 -58.22 6.81 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.455 1.102 . . . . 0.0 111.544 178.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.1 t -79.15 -33.11 44.43 Favored 'General case' 0 CA--C 1.555 1.17 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.072 -178.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.495 ' HD2' HD11 ' A' ' 33' ' ' LEU . 37.9 t80 -76.08 -63.13 1.39 Allowed 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -173.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.487 ' HA ' HD23 ' A' ' 73' ' ' LEU . 57.5 t -60.91 -16.55 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 123.428 0.691 . . . . 0.0 110.585 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -56.06 -56.26 25.02 Favored Glycine 0 CA--C 1.536 1.352 0 CA-C-O 118.991 -0.894 . . . . 0.0 112.742 166.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 19.3 ptm -63.43 -30.6 71.7 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 118.068 0.934 . . . . 0.0 112.142 -176.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.487 HD23 ' HA ' ' A' ' 70' ' ' VAL . 4.0 mm? -59.83 -30.06 68.69 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.233 0.613 . . . . 0.0 110.92 176.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.429 ' CD2' ' HB3' ' A' ' 10' ' ' LYS . 76.7 m-85 -116.7 1.98 12.88 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.944 0.898 . . . . 0.0 111.799 -176.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 71.8 mt -97.55 5.8 49.01 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.497 0.719 . . . . 0.0 110.956 173.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 29.5 m0 -63.04 116.11 5.05 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.643 0.377 . . . . 0.0 110.322 174.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 . . . . . 0 C--O 1.254 1.293 0 C-N-CA 123.758 0.823 . . . . 0.0 110.228 -177.249 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.521 0 N-CA-C 112.178 -0.369 . . . . 0.0 112.178 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.3 t -91.22 -57.54 2.76 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.779 0.832 . . . . 0.0 109.997 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 78.0 m80 -140.26 105.66 5.07 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.949 0.899 . . . . 0.0 108.718 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 60.1 mtt -74.11 -16.57 61.01 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 122.701 0.4 . . . . 0.0 111.082 175.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -125.52 167.97 14.29 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.885 0.874 . . . . 0.0 109.126 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -136.5 118.07 14.88 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.552 0.741 . . . . 0.0 109.629 -174.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.9 tp -137.76 111.44 8.28 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 CA-C-O 121.613 0.721 . . . . 0.0 109.734 176.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -102.63 118.56 37.12 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.248 -0.887 . . . . 0.0 108.784 173.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.584 ' HB ' ' HG2' ' A' ' 12' ' ' GLN . 19.9 m -149.96 141.88 23.82 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.305 0.642 . . . . 0.0 109.861 -178.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -63.03 -35.49 80.4 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.905 0.482 . . . . 0.0 111.026 176.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.471 ' H ' HG22 ' A' ' 9' ' ' THR . . . -56.78 -40.37 75.76 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.707 0.803 . . . . 0.0 111.559 176.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.584 ' HG2' ' HB ' ' A' ' 9' ' ' THR . 14.3 mm100 -70.72 -47.86 57.58 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.968 0.507 . . . . 0.0 111.434 -176.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.9 p -69.32 -33.17 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.014 -176.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 90.2 mt -66.92 -38.39 81.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 174.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.412 ' HA ' ' HB2' ' A' ' 18' ' ' LYS . 70.8 mm-40 -66.87 -23.44 66.01 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 119.304 -0.379 . . . . 0.0 111.639 173.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.29 -37.98 86.71 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 120.94 0.4 . . . . 0.0 110.199 175.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -73.86 -37.68 64.7 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.892 173.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.412 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 9.9 mtpm? -74.79 -24.19 58.61 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.481 0.712 . . . . 0.0 112.21 -176.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.6 p -86.4 -27.51 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 176.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -67.18 -56.26 10.68 Favored 'General case' 0 C--N 1.354 0.787 0 C-N-CA 123.704 0.802 . . . . 0.0 109.399 174.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -82.75 83.1 7.81 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.785 177.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -85.62 -14.95 44.07 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.474 169.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -70.19 -27.32 64.41 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.803 0.841 . . . . 0.0 110.676 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.59 44.28 8.64 Favored Glycine 0 C--N 1.347 1.14 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.961 173.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -78.8 -13.2 59.94 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 122.972 0.509 . . . . 0.0 110.38 173.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.39 -44.98 1.93 Allowed Glycine 0 C--N 1.348 1.235 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 177.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.419 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 46.8 p90 -126.78 162.59 25.49 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 123.851 0.86 . . . . 0.0 110.106 177.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 52.4 t -109.68 151.05 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.183 0.993 . . . . 0.0 109.507 -177.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 76.1 p -68.99 166.56 17.73 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.627 0.771 . . . . 0.0 111.578 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.7 p -71.7 -15.15 18.11 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 122.606 0.362 . . . . 0.0 111.518 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -54.39 -63.02 1.28 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.844 0.858 . . . . 0.0 111.806 175.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -72.33 -29.38 63.77 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.987 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.546 HD22 HG11 ' A' ' 64' ' ' VAL . 7.3 tp -55.35 -51.66 66.06 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 123.8 0.688 . . . . 0.0 110.208 176.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 67.1 mtp85 -62.06 -40.59 96.31 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.458 0.703 . . . . 0.0 111.489 177.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -60.35 -54.4 46.14 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 123.783 0.677 . . . . 0.0 111.877 -174.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.6 p -67.1 -29.16 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 122.812 0.445 . . . . 0.0 111.259 -178.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.408 HD13 HG21 ' A' ' 49' ' ' ILE . 66.6 mt -87.67 -6.65 58.14 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.165 0.586 . . . . 0.0 111.868 178.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -83.1 -44.77 14.76 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.499 0.72 . . . . 0.0 110.27 177.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -68.05 -28.78 67.68 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.534 175.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 91.9 mt -96.34 11.07 36.05 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.273 1.029 . . . . 0.0 110.838 175.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -73.2 -14.93 78.84 Favored Glycine 0 C--N 1.352 1.438 0 C-N-CA 123.354 0.502 . . . . 0.0 113.037 -177.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -66.53 -46.37 76.38 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.906 0.882 . . . . 0.0 110.706 176.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 59.9 mtt -90.32 -46.18 8.56 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.672 0.789 . . . . 0.0 110.234 -175.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -110.35 98.76 37.47 Favored Pre-proline 0 N--CA 1.474 0.751 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 176.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -48.93 111.54 0.49 Allowed 'Trans proline' 0 C--N 1.385 2.5 0 C-N-CA 123.789 2.992 . . . . 0.0 113.707 -173.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.402 ' O ' ' HG3' ' A' ' 50' ' ' GLU . . . -64.1 -30.28 71.36 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.183 0.993 . . . . 0.0 111.16 -178.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -56.95 -48.06 79.23 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.093 0.957 . . . . 0.0 111.899 174.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -68.54 -38.82 81.15 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.038 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 37' ' ' LEU . 96.6 mt -62.69 -36.5 75.56 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.819 177.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.499 ' HA ' HD12 ' A' ' 53' ' ' ILE . 40.0 mt-10 -59.95 -35.44 74.95 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.42 0.688 . . . . 0.0 111.641 176.186 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -69.41 -42.69 74.72 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.244 0.545 . . . . 0.0 109.992 176.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 49.9 mtt -69.68 -22.4 63.44 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.39 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.499 HD12 ' HA ' ' A' ' 50' ' ' GLU . 23.3 mt -64.27 -28.53 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.416 1.086 . . . . 0.0 111.558 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -59.5 -37.09 77.36 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 122.89 0.476 . . . . 0.0 111.064 174.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -81.44 -38.09 27.0 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.406 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.409 ' HB3' ' HA ' ' A' ' 53' ' ' ILE . . . -63.28 -32.31 73.69 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.592 1.157 . . . . 0.0 111.673 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -114.97 88.5 17.19 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 124.34 1.056 . . . . 0.0 108.416 172.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -85.2 3.35 7.37 Favored 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.647 2.231 . . . . 0.0 111.603 173.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -83.59 -21.87 32.46 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.749 0.82 . . . . 0.0 110.306 176.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.6 t30 64.51 30.65 12.84 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.52 1.128 . . . . 0.0 110.079 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.3 m -132.51 -4.65 3.32 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.581 0.752 . . . . 0.0 112.105 -172.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.71 37.26 8.07 Favored Glycine 0 N--CA 1.471 1.023 0 C-N-CA 122.885 0.278 . . . . 0.0 113.546 178.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -123.61 125.65 45.21 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.153 0.981 . . . . 0.0 109.993 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.546 HG11 HD22 ' A' ' 33' ' ' LEU . 3.1 p -139.86 135.6 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.347 0.659 . . . . 0.0 111.057 -171.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -79.87 103.6 9.88 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 167.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.419 ' CE2' ' HA ' ' A' ' 27' ' ' TYR . 39.3 p90 -64.06 -32.28 73.77 Favored 'General case' 0 C--O 1.208 -1.121 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.18 -177.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -61.4 -39.22 89.93 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 118.427 0.558 . . . . 0.0 111.343 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 77.8 p -77.01 -47.73 19.87 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.368 0.667 . . . . 0.0 110.805 -178.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.406 ' HD2' HD11 ' A' ' 33' ' ' LEU . 48.4 t80 -70.82 -53.5 15.08 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.751 0.82 . . . . 0.0 111.941 -176.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.413 ' HA ' HD12 ' A' ' 73' ' ' LEU . 45.4 t -67.77 -18.51 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.693 0.797 . . . . 0.0 110.85 178.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -59.24 -49.61 76.67 Favored Glycine 0 C--N 1.349 1.304 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 165.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 85.2 mtp -70.62 -24.43 62.73 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.78 0.832 . . . . 0.0 111.951 177.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 70' ' ' VAL . 86.2 mt -70.85 -10.92 60.54 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.127 0.571 . . . . 0.0 112.436 178.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -118.08 24.1 11.21 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.417 0.687 . . . . 0.0 109.636 174.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 85.9 mt -126.72 -31.05 2.72 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.166 0.986 . . . . 0.0 111.672 178.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -66.84 114.68 5.87 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 117.987 0.358 . . . . 0.0 111.262 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.9 t70 . . . . . 0 C--O 1.248 0.992 0 C-N-CA 123.636 0.775 . . . . 0.0 109.459 -177.395 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.825 0 N-CA-C 112.787 -0.125 . . . . 0.0 112.787 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.2 m -66.47 136.36 55.58 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.866 0.867 . . . . 0.0 110.543 176.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 73.8 m-70 -95.84 150.71 20.12 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.443 0.697 . . . . 0.0 111.044 -175.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 57.0 mtm -73.3 149.26 42.82 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.67 176.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -90.42 10.38 25.38 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.121 0.568 . . . . 0.0 111.399 176.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -73.23 82.57 1.34 Allowed 'General case' 0 C--N 1.353 0.73 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 168.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.6 tt -102.07 131.1 50.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.857 178.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -132.77 121.91 23.73 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 175.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.3 t -153.82 163.69 39.61 Favored 'General case' 0 C--O 1.244 0.804 0 C-N-CA 124.241 1.016 . . . . 0.0 109.429 -178.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.459 ' HB3' ' HB3' ' A' ' 74' ' ' PHE . 17.1 ptmt -64.94 -19.48 65.97 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.63 0.772 . . . . 0.0 112.079 177.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.85 -45.33 94.93 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.785 0.434 . . . . 0.0 110.362 172.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -59.57 -44.16 93.38 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.554 0.742 . . . . 0.0 111.558 -175.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.6 p -74.34 -34.56 37.08 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 CA-C-O 118.986 -0.531 . . . . 0.0 111.143 -179.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 90.2 mt -60.33 -40.38 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-N 118.584 0.629 . . . . 0.0 109.651 173.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -68.93 -24.16 64.25 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.004 0.921 . . . . 0.0 111.186 177.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.18 -13.13 61.1 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.448 0.699 . . . . 0.0 111.734 174.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.587 ' HA ' ' HE2' ' A' ' 32' ' ' TYR . 90.6 m-85 -93.58 -43.79 8.52 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.344 0.658 . . . . 0.0 110.539 170.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -67.95 -22.2 65.05 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.201 -175.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.8 p -59.95 -31.59 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.313 0.645 . . . . 0.0 111.088 175.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -78.72 -49.19 13.5 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.828 0.851 . . . . 0.0 110.433 176.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -65.32 105.18 1.08 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.543 0.737 . . . . 0.0 111.129 -173.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 19.2 tpp180 -71.15 -50.98 27.69 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.407 1.083 . . . . 0.0 110.577 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.421 ' HB2' ' HB2' ' A' ' 25' ' ' ASN . 5.6 m-20 -73.79 -20.7 60.39 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 114.701 -1.136 . . . . 0.0 112.155 -167.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.96 37.78 88.16 Favored Glycine 0 C--N 1.346 1.129 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -166.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.421 ' HB2' ' HB2' ' A' ' 23' ' ' ASP . 16.5 t-20 -67.71 -30.02 69.42 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.265 1.426 . . . . 0.0 111.074 -167.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 142.07 -60.82 0.54 Allowed Glycine 0 C--N 1.342 0.894 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 176.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.529 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 46.3 p90 -142.73 -176.01 4.71 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -176.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.9 m -126.85 -176.26 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.337 1.055 . . . . 0.0 110.511 -177.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 35.3 p -78.46 160.84 27.5 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 124.195 0.998 . . . . 0.0 111.387 177.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.2 p -78.45 -16.5 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.208 -176.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -69.39 -37.85 77.74 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 120.727 0.298 . . . . 0.0 110.548 173.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.587 ' HE2' ' HA ' ' A' ' 17' ' ' PHE . 45.6 t80 -73.73 -30.49 62.85 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.368 0.667 . . . . 0.0 110.36 178.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.408 HD12 ' CE2' ' A' ' 17' ' ' PHE . 8.6 tp -64.53 -55.29 21.55 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.52 175.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.636 ' HG2' HD13 ' A' ' 53' ' ' ILE . 63.3 mtm180 -69.54 -17.1 63.54 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.631 -177.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -66.52 -61.75 1.82 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.904 0.882 . . . . 0.0 110.75 174.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.4 p -68.67 -28.2 39.1 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.135 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.975 -175.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 71.8 mt -88.4 -8.98 54.12 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.937 -0.477 . . . . 0.0 111.857 -177.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -73.71 -46.96 42.95 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.252 0.621 . . . . 0.0 109.642 171.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -73.35 -25.65 60.69 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.903 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 97.9 mt -89.45 11.22 19.95 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.511 0.724 . . . . 0.0 111.107 173.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.8 3.24 61.21 Favored Glycine 0 C--N 1.358 1.764 0 CA-C-N 116.327 -0.397 . . . . 0.0 113.413 177.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -67.12 -40.99 86.93 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.1 0.96 . . . . 0.0 111.462 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 88.3 mmm -76.49 -46.98 24.43 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 122.993 0.517 . . . . 0.0 111.39 -178.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 90.9 mmm -135.2 139.16 30.9 Favored Pre-proline 0 N--CA 1.48 1.06 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.412 ' HB2' ' HG2' ' A' ' 48' ' ' GLU . 85.8 Cg_exo -49.27 133.92 30.61 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 122.625 2.217 . . . . 0.0 111.755 174.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.412 ' O ' ' HG3' ' A' ' 50' ' ' GLU . . . -58.55 -25.39 62.45 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 123.549 0.53 . . . . 0.0 111.206 178.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -60.07 -39.19 85.21 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.058 0.943 . . . . 0.0 111.972 175.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.412 ' HG2' ' HB2' ' A' ' 45' ' ' PRO . 9.6 mm-40 -56.73 -39.61 74.25 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.847 0.832 . . . . 0.0 109.776 176.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.407 ' O ' HG13 ' A' ' 53' ' ' ILE . 49.3 mt -77.37 -35.47 22.32 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 CA-C-N 113.999 -1.455 . . . . 0.0 110.356 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 46' ' ' ALA . 40.4 mt-10 -65.92 -32.04 73.32 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.739 0.815 . . . . 0.0 112.755 -175.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -66.18 -36.06 82.09 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 121.328 0.585 . . . . 0.0 109.768 174.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 23.6 mtm -75.71 -24.57 56.22 Favored 'General case' 0 CA--C 1.553 1.058 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.488 177.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.636 HD13 ' HG2' ' A' ' 34' ' ' ARG . 62.8 mt -71.93 -28.19 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 124.397 1.079 . . . . 0.0 111.018 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -65.16 -32.96 74.91 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.069 171.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -83.66 -23.75 31.63 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.864 0.866 . . . . 0.0 110.9 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.585 ' HB1' HG23 ' A' ' 64' ' ' VAL . . . -72.94 -49.28 30.38 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.764 0.826 . . . . 0.0 110.482 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -120.35 90.49 45.23 Favored Pre-proline 0 CA--C 1.546 0.825 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 172.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.24 -11.81 15.97 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 123.027 2.485 . . . . 0.0 111.384 168.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -70.17 -24.07 63.08 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.221 1.009 . . . . 0.0 111.65 -173.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 60.78 24.01 13.94 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 125.038 1.335 . . . . 0.0 110.384 -174.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.8 t -105.48 -5.25 20.45 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.407 1.083 . . . . 0.0 109.86 -177.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.24 43.81 62.01 Favored Glycine 0 C--N 1.347 1.175 0 O-C-N 123.851 0.719 . . . . 0.0 113.06 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.445 ' HB3' ' HE1' ' A' ' 27' ' ' TYR . 27.2 m-85 -131.02 109.86 10.81 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.671 0.789 . . . . 0.0 110.29 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.585 HG23 ' HB1' ' A' ' 56' ' ' ALA . 4.6 p -117.83 129.98 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 123.885 0.874 . . . . 0.0 110.824 -175.194 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -81.23 91.62 6.21 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 170.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.529 ' CE2' ' HA ' ' A' ' 27' ' ' TYR . 45.1 p90 -61.33 -23.59 65.84 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 122.968 0.507 . . . . 0.0 111.498 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -51.63 -56.78 11.64 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.302 1.041 . . . . 0.0 110.582 173.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.2 t -82.07 -30.54 31.26 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.004 -177.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -73.68 -63.06 1.28 Allowed 'General case' 0 N--CA 1.476 0.848 0 O-C-N 123.066 0.229 . . . . 0.0 111.038 -175.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.54 ' HA ' ' HB3' ' A' ' 73' ' ' LEU . 90.2 t -59.0 -24.81 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 124.366 1.067 . . . . 0.0 111.154 177.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -56.63 -54.62 35.0 Favored Glycine 0 CA--C 1.532 1.103 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.355 169.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.414 ' HA ' ' HG ' ' A' ' 75' ' ' LEU . 20.8 mmt -76.15 -32.25 59.0 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.334 0.653 . . . . 0.0 111.368 -178.174 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.54 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 18.7 tp -69.49 -31.11 69.17 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.551 1.54 . . . . 0.0 111.627 -178.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.459 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 16.0 m-85 -111.94 26.36 10.68 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.159 0.584 . . . . 0.0 111.315 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.414 ' HG ' ' HA ' ' A' ' 72' ' ' MET . 78.3 mt -72.85 -31.89 65.07 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 166.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 17.5 p-90 -97.96 24.13 7.32 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.653 0.781 . . . . 0.0 111.777 177.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.0 t70 . . . . . 0 C--O 1.249 1.058 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 170.69 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.569 0 N-CA-C 112.459 -0.256 . . . . 0.0 112.459 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.7 p -149.04 98.56 2.85 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.423 0.689 . . . . 0.0 109.985 177.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -112.32 95.83 5.67 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.572 0.749 . . . . 0.0 109.085 174.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 61.0 mtt -94.39 46.71 1.16 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.147 0.979 . . . . 0.0 110.124 -177.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -138.36 153.42 48.95 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.293 1.037 . . . . 0.0 108.565 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 46.4 t60 -68.0 99.05 0.81 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 177.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.542 HG12 ' HG3' ' A' ' 12' ' ' GLN . 8.7 tp -91.58 112.68 25.85 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 CA-C-O 121.492 0.663 . . . . 0.0 109.799 -174.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -83.61 -3.49 57.75 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.478 0.711 . . . . 0.0 111.717 -176.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 84.8 m -67.19 120.85 14.44 Favored 'General case' 0 C--O 1.246 0.894 0 C-N-CA 123.226 0.61 . . . . 0.0 110.848 -178.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -53.25 -42.22 66.23 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.032 177.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.89 -34.75 60.4 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.374 0.67 . . . . 0.0 112.631 -178.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.542 ' HG3' HG12 ' A' ' 7' ' ' ILE . 79.8 mm-40 -79.92 -38.72 31.9 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.428 0.691 . . . . 0.0 111.211 -176.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.4 p -72.74 -29.03 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 122.126 0.17 . . . . 0.0 110.602 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.7 mt -64.09 -34.22 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.568 0.747 . . . . 0.0 110.086 175.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -70.82 -22.96 62.27 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.25 0.62 . . . . 0.0 111.971 177.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.94 -41.29 95.63 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.248 0.547 . . . . 0.0 109.571 172.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -65.41 -35.22 80.28 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.861 173.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -84.92 -11.64 55.13 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -175.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.9 p -89.16 -29.27 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 172.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 93.5 t80 -70.37 -51.99 25.76 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.578 171.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -64.73 116.79 6.63 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 173.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -87.28 -53.37 4.87 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.32 0.648 . . . . 0.0 111.891 -169.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -95.65 -7.76 36.65 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.005 0.522 . . . . 0.0 112.378 -167.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.99 50.72 4.77 Favored Glycine 0 C--N 1.343 0.93 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -171.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -62.37 -28.63 69.9 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.058 1.743 . . . . 0.0 111.292 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.14 -22.46 29.34 Favored Glycine 0 C--N 1.347 1.147 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.984 178.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -154.03 167.62 29.18 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.696 0.798 . . . . 0.0 111.193 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.1 m -116.24 176.26 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.32 1.048 . . . . 0.0 109.823 176.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 42.6 p -79.27 150.38 31.56 Favored 'General case' 0 C--O 1.246 0.896 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.78 171.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.457 HG12 ' HA2' ' A' ' 62' ' ' GLY . 9.0 p -66.64 -23.69 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 122.65 0.38 . . . . 0.0 111.255 -177.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -57.64 -54.23 49.2 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.442 0.697 . . . . 0.0 111.538 176.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -64.14 -38.79 92.32 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.841 0.456 . . . . 0.0 110.752 176.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.7 tt -60.66 -35.61 76.66 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.238 -176.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 23.2 mtp180 -75.29 -34.41 61.3 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.186 0.594 . . . . 0.0 111.233 176.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.2 mttp -59.6 -50.97 71.81 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.96 0.904 . . . . 0.0 111.735 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.8 p -71.68 -40.21 70.15 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.47 -176.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 97.4 mt -76.39 -11.96 59.98 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.087 0.555 . . . . 0.0 112.184 -176.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -65.97 -29.74 70.19 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.373 0.669 . . . . 0.0 109.833 171.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -86.27 -8.09 58.01 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.483 1.113 . . . . 0.0 111.706 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -91.79 18.6 7.46 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.728 0.811 . . . . 0.0 111.251 177.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 140.17 88.42 0.15 Allowed Glycine 0 C--N 1.349 1.292 0 CA-C-O 119.864 -0.409 . . . . 0.0 112.407 173.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -77.99 -30.06 49.99 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.427 0.691 . . . . 0.0 110.225 175.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -76.89 -24.33 52.53 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.157 174.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 83.1 mtp -79.96 147.92 67.02 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 123.924 0.89 . . . . 0.0 109.524 176.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.63 110.84 2.41 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 121.785 1.657 . . . . 0.0 111.277 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.33 -21.86 66.75 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.628 174.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -48.83 -41.56 33.35 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.392 1.477 . . . . 0.0 112.327 177.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.486 ' O ' ' HG2' ' A' ' 52' ' ' MET . 38.7 tt0 -65.85 -50.28 65.13 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.489 0.493 . . . . 0.0 110.316 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 88.3 mt -58.61 -36.16 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 123.848 0.859 . . . . 0.0 110.74 178.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -63.45 -46.78 84.71 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.098 0.959 . . . . 0.0 110.285 176.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -62.38 -34.55 76.91 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.912 0.485 . . . . 0.0 111.209 177.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.486 ' HG2' ' O ' ' A' ' 48' ' ' GLU . 26.1 mmt -67.93 -35.97 79.35 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.556 0.742 . . . . 0.0 109.925 176.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 83.3 mt -66.19 -36.61 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 124.218 1.007 . . . . 0.0 110.729 176.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -70.93 -21.01 62.41 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.402 0.681 . . . . 0.0 111.126 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -80.2 -41.58 24.96 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 171.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.462 ' HB1' HG23 ' A' ' 64' ' ' VAL . . . -72.83 -30.04 63.72 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.061 0.944 . . . . 0.0 111.92 -176.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -150.63 83.07 5.94 Favored Pre-proline 0 CA--C 1.545 0.76 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.26 -20.57 21.11 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.904 2.403 . . . . 0.0 113.085 -178.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -87.09 -10.62 52.44 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.162 0.585 . . . . 0.0 111.619 -178.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.1 t30 61.46 40.63 13.67 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 122.422 1.106 . . . . 0.0 109.586 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.9 m -77.53 -15.03 59.51 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.569 -1.196 . . . . 0.0 112.03 -173.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.457 ' HA2' HG12 ' A' ' 30' ' ' VAL . . . 85.53 13.67 69.89 Favored Glycine 0 C--N 1.347 1.177 0 CA-C-N 115.91 -0.587 . . . . 0.0 112.327 -173.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -123.01 111.26 16.38 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.736 0.815 . . . . 0.0 109.509 -175.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.462 HG23 ' HB1' ' A' ' 56' ' ' ALA . 2.2 p -139.99 121.29 15.1 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 C-N-CA 123.383 0.673 . . . . 0.0 109.854 -178.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -69.49 94.77 0.77 Allowed 'General case' 0 C--N 1.348 0.514 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.057 173.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 48.2 p90 -57.35 -28.81 63.47 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 123.56 0.538 . . . . 0.0 111.19 177.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -62.19 -49.31 76.29 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.356 0.662 . . . . 0.0 110.851 -176.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 79.8 p -77.59 -33.75 53.76 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.467 0.707 . . . . 0.0 110.641 177.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -67.31 -68.75 0.36 Allowed 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.418 -176.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.621 ' HA ' ' HB3' ' A' ' 73' ' ' LEU . 75.9 t -50.37 -29.11 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 125.404 1.481 . . . . 0.0 112.781 176.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.76 -48.07 80.36 Favored Glycine 0 C--N 1.349 1.287 0 CA-C-O 121.123 0.291 . . . . 0.0 112.693 171.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 33.3 mmt -86.09 -5.72 59.15 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.929 0.892 . . . . 0.0 112.295 177.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.621 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 55.4 tp -88.97 -42.61 11.69 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.068 0.947 . . . . 0.0 109.424 -177.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -90.96 11.75 21.83 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.154 0.582 . . . . 0.0 112.474 -177.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 pp -70.8 -9.1 56.77 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 118.308 0.504 . . . . 0.0 111.895 178.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 14.2 m0 -60.89 119.9 9.14 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.659 0.784 . . . . 0.0 109.895 175.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 . . . . . 0 N--CA 1.483 1.177 0 C-N-CA 123.394 0.678 . . . . 0.0 111.657 -173.884 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.589 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.7 m -82.11 76.21 9.0 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.966 0.906 . . . . 0.0 110.59 -177.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 11.7 m170 70.47 -62.95 0.42 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 125.645 1.578 . . . . 0.0 112.696 177.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.6 ptt? -54.33 131.93 42.9 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.37 1.068 . . . . 0.0 111.839 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -109.48 163.16 13.68 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.832 0.853 . . . . 0.0 110.323 -178.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 24.9 m-70 -78.07 97.13 5.31 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 173.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.6 tt -142.92 114.62 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.113 0.965 . . . . 0.0 109.561 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -92.73 103.92 16.24 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.447 HG22 ' H ' ' A' ' 11' ' ' ALA . 85.1 m -141.13 149.0 40.96 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.639 1.176 . . . . 0.0 108.604 -176.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -59.58 -35.29 73.99 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.309 0.644 . . . . 0.0 111.372 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.447 ' H ' HG22 ' A' ' 9' ' ' THR . . . -62.1 -51.17 69.01 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 122.995 0.518 . . . . 0.0 110.687 173.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.7 mm-40 -56.49 -37.82 70.88 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.428 1.091 . . . . 0.0 112.738 -175.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.5 p -85.53 -42.36 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 CA-C-O 119.052 -0.499 . . . . 0.0 111.36 -177.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 60.3 mt -59.77 -43.16 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 122.881 0.472 . . . . 0.0 110.876 178.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.461 ' O ' HG23 ' A' ' 19' ' ' VAL . 12.9 pt-20 -70.08 -27.13 64.37 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.692 -178.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.13 -34.6 77.94 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.134 0.573 . . . . 0.0 110.999 175.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.473 ' HA ' ' HE2' ' A' ' 32' ' ' TYR . 83.0 m-85 -64.46 -37.85 88.97 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.957 0.503 . . . . 0.0 110.964 172.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -72.68 -20.51 61.22 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.273 0.629 . . . . 0.0 111.23 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 15' ' ' GLU . 61.0 t -71.87 -34.58 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 123.133 0.573 . . . . 0.0 110.049 171.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -71.8 -54.08 11.3 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.176 0.59 . . . . 0.0 109.844 175.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -77.6 83.04 4.0 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.649 0.78 . . . . 0.0 109.355 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -71.71 -40.38 69.53 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.162 0.985 . . . . 0.0 111.127 -176.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -72.53 -26.22 61.67 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.357 0.663 . . . . 0.0 111.801 -173.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.2 59.42 2.42 Favored Glycine 0 C--N 1.347 1.145 0 N-CA-C 111.978 -0.449 . . . . 0.0 111.978 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -86.65 -11.19 52.03 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.616 1.166 . . . . 0.0 111.143 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.73 -27.04 21.34 Favored Glycine 0 C--N 1.343 0.957 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.962 175.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.41 ' HB2' ' O ' ' A' ' 64' ' ' VAL . 39.1 p90 -149.25 177.1 9.94 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.195 0.598 . . . . 0.0 111.205 -174.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.1 m -132.55 -178.33 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 124.141 0.976 . . . . 0.0 110.096 178.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.0 p -78.03 155.05 30.91 Favored 'General case' 0 C--O 1.245 0.862 0 C-N-CA 123.932 0.893 . . . . 0.0 111.268 174.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.6 p -69.76 -20.29 23.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.607 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -58.76 -59.46 5.39 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.79 0.836 . . . . 0.0 110.934 175.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.473 ' HE2' ' HA ' ' A' ' 17' ' ' PHE . 87.0 t80 -62.56 -35.52 79.72 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.538 0.735 . . . . 0.0 110.764 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.524 HD22 HG11 ' A' ' 64' ' ' VAL . 6.5 tp -59.59 -53.47 57.66 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.611 178.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.556 ' HG2' HD13 ' A' ' 53' ' ' ILE . 98.0 mtt180 -67.08 -28.91 68.57 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.358 0.663 . . . . 0.0 111.514 -176.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -64.62 -58.61 5.87 Favored 'General case' 0 CA--C 1.548 0.904 0 O-C-N 123.665 0.603 . . . . 0.0 111.1 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.1 p -64.57 -38.73 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 123.138 0.575 . . . . 0.0 111.849 -174.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.442 HD23 HD12 ' A' ' 40' ' ' LEU . 85.8 mt -74.79 -26.53 59.81 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.245 0.618 . . . . 0.0 111.285 -176.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.461 ' HA ' ' HB2' ' A' ' 46' ' ' ALA . 39.7 t30 -67.51 -42.15 83.3 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 123.479 0.487 . . . . 0.0 109.817 171.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -70.42 -30.9 67.89 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.799 0.84 . . . . 0.0 111.717 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.442 HD12 HD23 ' A' ' 37' ' ' LEU . 95.8 mt -71.04 -28.41 64.37 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 122.759 0.424 . . . . 0.0 110.61 172.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -82.39 62.83 4.52 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 169.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -75.29 -36.64 61.13 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.237 0.615 . . . . 0.0 110.485 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 64.5 mtt -124.3 8.11 8.46 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.707 0.803 . . . . 0.0 110.768 173.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 22.8 mmt -116.99 140.92 27.58 Favored Pre-proline 0 N--CA 1.482 1.151 0 C-N-CA 124.045 0.938 . . . . 0.0 108.595 176.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.412 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 40.2 Cg_endo -66.95 133.03 29.87 Favored 'Trans proline' 0 C--N 1.368 1.567 0 C-N-CA 121.738 1.625 . . . . 0.0 111.367 173.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.461 ' HB2' ' HA ' ' A' ' 38' ' ' ASN . . . -73.33 -20.88 60.68 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.453 0.301 . . . . 0.0 110.286 174.045 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -54.84 -37.24 65.95 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.589 1.156 . . . . 0.0 112.571 -178.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 45' ' ' PRO . 17.1 pt-20 -67.14 -39.15 86.51 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.005 0.431 . . . . 0.0 110.309 177.168 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 89.6 mt -69.62 -33.25 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.41 1.084 . . . . 0.0 110.321 177.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -69.39 -32.96 72.31 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.806 0.842 . . . . 0.0 111.679 -176.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -62.29 -42.18 99.13 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 121.554 0.692 . . . . 0.0 109.983 171.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 60.4 mmm -67.9 -31.21 70.83 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.487 177.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.556 HD13 ' HG2' ' A' ' 34' ' ' ARG . 54.9 mt -67.72 -31.47 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 124.452 1.101 . . . . 0.0 110.932 178.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -77.54 -20.56 53.97 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.803 0.441 . . . . 0.0 111.291 172.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -79.46 -20.69 46.77 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.499 0.319 . . . . 0.0 110.671 171.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.47 -37.13 18.59 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.922 0.889 . . . . 0.0 111.041 175.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -132.25 80.5 63.53 Favored Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 124.334 1.054 . . . . 0.0 108.47 176.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -81.88 -12.58 10.84 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 123.268 2.646 . . . . 0.0 112.181 174.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 58.8 mm-40 -76.04 -17.03 59.83 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.632 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.6 m120 63.4 26.81 15.09 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.867 1.267 . . . . 0.0 110.611 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 53.1 m -88.89 -15.45 34.37 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.054 0.942 . . . . 0.0 111.245 -175.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.71 21.15 75.29 Favored Glycine 0 C--N 1.348 1.222 0 CA-C-N 116.32 -0.4 . . . . 0.0 113.052 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -116.92 117.22 29.11 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 178.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.524 HG11 HD22 ' A' ' 33' ' ' LEU . 3.9 p -135.02 124.42 42.92 Favored 'Isoleucine or valine' 0 C--O 1.245 0.822 0 C-N-CA 123.237 0.615 . . . . 0.0 110.805 -173.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -73.43 92.22 1.84 Allowed 'General case' 0 C--O 1.238 0.45 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 171.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -50.08 -46.27 53.23 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 114.465 -1.243 . . . . 0.0 113.761 -172.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -72.43 -34.48 67.85 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.32 0.648 . . . . 0.0 111.58 -175.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.4 m -63.48 -44.04 95.54 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.501 0.72 . . . . 0.0 109.625 175.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.468 ' HD2' HD11 ' A' ' 33' ' ' LEU . 17.6 t80 -71.71 -73.43 0.18 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.532 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.605 ' HA ' ' HB3' ' A' ' 73' ' ' LEU . 89.7 t -47.03 -28.44 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 C-N-CA 126.171 1.789 . . . . 0.0 113.149 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -59.53 -54.14 40.19 Favored Glycine 0 CA--C 1.538 1.503 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 169.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 84.7 mtp -72.89 -28.42 62.48 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.124 0.97 . . . . 0.0 111.996 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.605 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 54.6 tp -67.36 -46.83 72.2 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.38 1.072 . . . . 0.0 110.164 -177.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.435 ' HZ ' HD13 ' A' ' 40' ' ' LEU . 7.5 m-85 -84.17 21.51 1.37 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.595 0.758 . . . . 0.0 111.992 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 69.0 mt -95.22 31.26 1.97 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.434 0.694 . . . . 0.0 110.576 170.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 26.1 m0 -65.34 88.76 0.08 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.047 0.539 . . . . 0.0 110.422 176.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.0 t70 . . . . . 0 C--O 1.248 1.004 0 C-N-CA 123.915 0.886 . . . . 0.0 108.948 -179.219 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.416 0 N-CA-C 112.24 -0.344 . . . . 0.0 112.24 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.8 m -74.65 106.87 6.42 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.994 0.918 . . . . 0.0 109.882 178.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -62.12 153.62 29.51 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 122.954 0.502 . . . . 0.0 110.251 176.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -61.78 108.59 1.03 Allowed 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 121.067 0.46 . . . . 0.0 110.383 178.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -68.58 -25.16 64.75 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.066 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -70.89 99.75 1.82 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.063 0.945 . . . . 0.0 110.455 -178.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 38.3 mm -83.08 86.94 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.025 178.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -67.9 -39.83 83.56 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.086 176.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.0 t -139.22 163.07 33.43 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.117 0.967 . . . . 0.0 109.108 178.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.467 ' O ' HG12 ' A' ' 14' ' ' ILE . 19.5 pttp -58.28 -27.12 63.75 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.403 0.681 . . . . 0.0 112.389 176.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.8 -30.84 67.9 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.059 0.544 . . . . 0.0 111.565 176.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -68.94 -47.08 66.56 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.35 0.66 . . . . 0.0 110.927 176.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.8 p -71.87 -24.65 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 -177.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.491 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 33.2 mm -63.16 -38.21 81.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 173.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -61.17 -30.3 70.32 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 122.595 0.358 . . . . 0.0 111.468 176.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.16 -36.93 80.43 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 123.565 0.54 . . . . 0.0 110.421 175.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.496 ' HE1' ' HA ' ' A' ' 33' ' ' LEU . 84.4 m-85 -70.23 -32.65 70.61 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.326 0.65 . . . . 0.0 111.401 174.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 14' ' ' ILE . 3.3 mmmp? -70.95 -11.72 61.13 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.048 0.539 . . . . 0.0 111.481 -179.182 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 89.8 t -68.46 -42.53 83.92 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 122.841 0.456 . . . . 0.0 110.296 173.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -74.04 -48.21 31.58 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 173.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -83.01 76.78 9.81 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.127 0.971 . . . . 0.0 109.713 -178.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -94.18 -29.1 15.29 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.045 0.538 . . . . 0.0 110.929 176.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -85.83 -12.05 51.81 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.301 0.641 . . . . 0.0 111.942 -176.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.65 50.8 5.13 Favored Glycine 0 C--N 1.338 0.674 0 N-CA-C 112.097 -0.401 . . . . 0.0 112.097 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -68.53 -24.1 64.6 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.211 1.004 . . . . 0.0 110.628 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.65 -22.13 42.43 Favored Glycine 0 C--N 1.345 1.045 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.018 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.424 ' HB2' ' O ' ' A' ' 64' ' ' VAL . 43.4 p90 -156.07 172.42 18.44 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.72 0.808 . . . . 0.0 111.466 -175.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.2 m -121.42 -177.07 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 123.87 0.868 . . . . 0.0 110.232 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 70.7 p -83.14 162.17 21.38 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.699 0.8 . . . . 0.0 111.024 175.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.505 ' HB ' ' HA2' ' A' ' 62' ' ' GLY . 9.9 p -64.93 -27.79 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 123.019 0.527 . . . . 0.0 110.285 173.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -67.62 -47.52 69.39 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.51 1.124 . . . . 0.0 110.284 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -71.74 -34.02 69.18 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.251 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.496 ' HA ' ' HE1' ' A' ' 17' ' ' PHE . 5.8 tp -63.11 -55.62 23.79 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.991 0.916 . . . . 0.0 111.12 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.502 ' HG2' HD13 ' A' ' 53' ' ' ILE . 62.1 mtp180 -64.3 -31.46 72.68 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.412 0.685 . . . . 0.0 111.243 -178.191 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -59.32 -64.02 1.09 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.516 0.726 . . . . 0.0 111.271 178.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.2 p -62.6 -36.25 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.359 0.664 . . . . 0.0 111.726 -176.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 91.4 mt -82.07 -12.44 58.25 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.023 0.529 . . . . 0.0 111.667 -176.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -85.8 -36.35 20.13 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 171.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -66.07 -41.56 90.59 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.505 0.722 . . . . 0.0 110.341 174.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.408 HD21 ' HZ ' ' A' ' 74' ' ' PHE . 64.1 tp -78.55 -28.35 46.03 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.333 1.053 . . . . 0.0 110.192 174.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -88.3 53.69 4.16 Favored Glycine 0 C--N 1.344 1.021 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 175.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -88.09 -56.87 3.15 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.481 0.713 . . . . 0.0 109.367 175.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 57.5 mtm -82.49 -32.41 28.82 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.38 177.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 23.9 mmt -88.4 146.89 38.69 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 123.537 0.735 . . . . 0.0 109.305 174.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -70.21 119.28 6.24 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 121.952 1.768 . . . . 0.0 111.597 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.505 ' O ' ' HG2' ' A' ' 50' ' ' GLU . . . -62.91 -33.7 75.87 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.155 -0.684 . . . . 0.0 109.155 171.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -51.84 -41.07 61.52 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 125.352 1.461 . . . . 0.0 111.845 176.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -64.44 -48.31 75.81 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.217 1.007 . . . . 0.0 110.236 177.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.444 ' O ' HG13 ' A' ' 53' ' ' ILE . 68.3 mt -61.32 -36.46 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.466 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.505 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 15.9 mm-40 -56.63 -47.3 79.99 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.811 0.845 . . . . 0.0 111.075 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -66.03 -26.69 67.64 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 122.878 0.471 . . . . 0.0 111.427 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 43.8 mtp -77.23 -29.54 54.13 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.057 0.543 . . . . 0.0 110.459 175.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.502 HD13 ' HG2' ' A' ' 34' ' ' ARG . 96.8 mt -71.96 -24.42 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 123.964 0.906 . . . . 0.0 110.639 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -65.85 -26.1 67.5 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.044 0.538 . . . . 0.0 110.88 169.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -90.13 -28.63 18.83 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.228 0.611 . . . . 0.0 110.283 177.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.0 -42.27 76.7 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.795 0.838 . . . . 0.0 110.41 176.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -140.57 95.6 7.95 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 176.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -74.56 -23.54 14.7 Favored 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 122.749 2.299 . . . . 0.0 112.31 177.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -86.68 -12.24 48.92 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.864 0.865 . . . . 0.0 111.066 -174.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 64.11 25.74 13.79 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.783 1.233 . . . . 0.0 110.702 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 37.9 m -69.12 -22.41 63.97 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.703 1.201 . . . . 0.0 112.061 -177.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.505 ' HA2' ' HB ' ' A' ' 30' ' ' VAL . . . 79.33 26.59 57.06 Favored Glycine 0 C--N 1.339 0.733 0 CA-C-N 115.889 -0.596 . . . . 0.0 113.127 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -126.9 95.65 4.38 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.235 1.014 . . . . 0.0 108.693 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.477 HG11 HD22 ' A' ' 33' ' ' LEU . 2.0 p -119.94 125.24 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.958 0.903 . . . . 0.0 110.478 -171.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -72.77 91.03 1.45 Allowed 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 173.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -55.07 -38.03 67.52 Favored 'General case' 0 C--O 1.211 -0.966 0 CA-C-N 114.965 -1.016 . . . . 0.0 113.298 -173.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -65.96 -47.32 75.0 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 117.773 0.261 . . . . 0.0 110.633 -172.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 70.4 p -69.85 -32.28 70.58 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.067 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -68.51 -66.73 0.53 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 122.95 0.5 . . . . 0.0 110.879 176.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.65 ' HA ' ' HB3' ' A' ' 73' ' ' LEU . 52.9 t -47.89 -27.08 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.114 0 C-N-CA 126.435 1.894 . . . . 0.0 113.063 174.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.88 -53.48 37.28 Favored Glycine 0 CA--C 1.534 1.238 0 N-CA-C 112.28 -0.328 . . . . 0.0 112.28 169.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 91.0 mtp -75.26 -15.24 60.54 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.742 0.817 . . . . 0.0 111.944 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.65 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 59.4 tp -82.8 -43.73 16.35 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.882 1.273 . . . . 0.0 109.957 -178.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.408 ' HZ ' HD21 ' A' ' 40' ' ' LEU . 13.1 m-85 -88.5 22.65 2.49 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.821 0.848 . . . . 0.0 112.166 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 79.0 mt -70.73 -8.83 55.07 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 166.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 46.4 m0 -62.24 131.25 48.79 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 123.999 0.92 . . . . 0.0 109.778 168.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 . . . . . 0 CA--C 1.554 1.106 0 C-N-CA 123.314 0.646 . . . . 0.0 110.76 -177.161 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.706 0 N-CA-C 112.384 -0.287 . . . . 0.0 112.384 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.1 p -152.95 103.28 2.73 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.949 0.9 . . . . 0.0 109.578 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 28.3 m80 -138.06 -160.08 1.02 Allowed 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.279 1.032 . . . . 0.0 109.45 177.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 23.9 mmt -50.92 128.71 21.89 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.181 0.592 . . . . 0.0 110.571 174.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -62.68 134.46 56.34 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 123.976 0.798 . . . . 0.0 111.213 -174.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -82.53 72.1 9.6 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.33 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.3 pp -97.75 85.73 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.022 177.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -75.95 76.6 2.84 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.418 -178.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.42 HG22 ' H ' ' A' ' 11' ' ' ALA . 35.0 m -153.98 132.65 12.21 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.317 1.047 . . . . 0.0 108.826 177.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -66.46 -30.06 70.32 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.127 0.971 . . . . 0.0 111.434 178.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.42 ' H ' HG22 ' A' ' 9' ' ' THR . . . -67.1 -47.91 69.74 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.471 175.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -57.7 -38.77 75.79 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.985 0.914 . . . . 0.0 113.15 -174.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.9 p -66.26 -44.03 91.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 75.9 mt -66.62 -34.1 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.044 0.538 . . . . 0.0 109.97 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.458 ' O ' HG23 ' A' ' 19' ' ' VAL . 47.1 mt-10 -73.06 -25.94 61.1 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.331 0.653 . . . . 0.0 111.107 177.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.7 -37.63 86.99 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 121.231 0.538 . . . . 0.0 110.256 174.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.439 ' HE1' ' HA ' ' A' ' 33' ' ' LEU . 89.7 m-85 -67.28 -34.97 78.52 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.929 172.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.481 ' HE3' ' HE1' ' A' ' 66' ' ' TYR . 33.2 mmtp -66.44 -28.6 68.72 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.193 0.597 . . . . 0.0 110.862 176.069 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 15' ' ' GLU . 93.4 t -65.98 -44.13 92.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.018 0.527 . . . . 0.0 109.747 175.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -67.69 -48.7 65.82 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.355 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -88.04 72.24 9.23 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.697 0.799 . . . . 0.0 109.168 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -31.9 68.94 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.369 177.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -66.2 -28.92 69.12 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.967 178.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.04 41.25 95.26 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-N 115.976 -0.556 . . . . 0.0 113.319 176.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -73.9 -18.46 60.9 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 122.61 0.364 . . . . 0.0 110.842 178.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.32 -6.86 14.54 Favored Glycine 0 C--N 1.349 1.255 0 CA-C-O 119.625 -0.542 . . . . 0.0 113.737 172.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -157.48 173.82 16.32 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 117.563 0.682 . . . . 0.0 112.365 -175.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.2 m -130.66 179.63 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 124.134 0.973 . . . . 0.0 110.26 178.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 66.7 p -74.31 153.53 39.3 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.919 171.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.56 -26.4 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 122.707 0.403 . . . . 0.0 110.912 177.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -64.38 -50.71 66.6 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.062 0.545 . . . . 0.0 111.144 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -62.1 -41.04 97.81 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.157 0.583 . . . . 0.0 110.444 175.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.669 HD22 HG11 ' A' ' 64' ' ' VAL . 2.8 tp -56.67 -53.28 59.47 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.556 -178.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -65.31 -37.03 85.89 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.631 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -57.25 -58.77 6.78 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 124.258 0.974 . . . . 0.0 111.052 -177.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.462 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 7.5 p -63.26 -46.13 96.51 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 O-C-N 123.506 0.504 . . . . 0.0 111.341 -177.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 95.7 mt -65.57 -30.63 71.4 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.233 0.613 . . . . 0.0 111.761 -176.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -77.47 -38.73 48.65 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.018 0.527 . . . . 0.0 110.234 177.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -78.34 -9.54 59.3 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.303 0.641 . . . . 0.0 111.974 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 36' ' ' VAL . 87.8 mt -73.63 -42.59 61.24 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.653 0.381 . . . . 0.0 110.025 170.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -166.81 89.75 0.1 OUTLIER Glycine 0 C--N 1.35 1.328 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.636 -177.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -69.46 -20.44 63.76 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.75 0.82 . . . . 0.0 110.927 176.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 23.1 mmt -59.84 -32.34 70.59 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.233 1.013 . . . . 0.0 110.711 175.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 21.8 mmt -84.51 141.25 38.96 Favored Pre-proline 0 C--O 1.245 0.867 0 C-N-CA 124.201 1.0 . . . . 0.0 108.849 177.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.59 110.38 2.07 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 121.645 1.564 . . . . 0.0 111.331 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.28 -19.27 64.69 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.272 174.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -48.61 -39.64 24.67 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 125.383 1.473 . . . . 0.0 111.496 175.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.96 -49.25 78.21 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.496 1.118 . . . . 0.0 110.537 177.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.458 ' O ' HG13 ' A' ' 53' ' ' ILE . 87.5 mt -60.88 -43.63 96.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.367 -179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.525 ' HA ' HD12 ' A' ' 53' ' ' ILE . 0.5 OUTLIER -55.66 -37.5 68.35 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.935 0.894 . . . . 0.0 112.639 177.957 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -72.96 -40.44 65.34 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 121.563 0.697 . . . . 0.0 110.268 177.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 28.6 mmt -64.66 -26.86 68.57 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.669 -1.151 . . . . 0.0 111.201 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.525 HD12 ' HA ' ' A' ' 50' ' ' GLU . 90.8 mt -66.69 -40.04 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 123.566 0.746 . . . . 0.0 110.826 177.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -65.44 -28.2 69.06 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 122.601 0.361 . . . . 0.0 110.908 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -75.74 -42.67 49.94 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.435 0.694 . . . . 0.0 110.904 177.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.57 -26.67 45.59 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.76 0.824 . . . . 0.0 111.802 -176.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -124.51 86.7 55.03 Favored Pre-proline 0 CA--C 1.542 0.673 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 176.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -75.94 -8.51 19.02 Favored 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 123.011 2.474 . . . . 0.0 112.521 -177.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -88.6 -24.03 22.94 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.488 0.715 . . . . 0.0 110.8 174.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 60.89 37.04 18.7 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 124.323 1.014 . . . . 0.0 109.356 -174.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.9 t -74.79 -18.67 60.43 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.595 -176.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.79 23.85 34.55 Favored Glycine 0 C--N 1.337 0.617 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.597 -175.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -139.42 131.26 27.59 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.114 1.366 . . . . 0.0 108.937 -178.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.669 HG11 HD22 ' A' ' 33' ' ' LEU . 2.8 p -145.56 134.77 17.57 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 CA-C-O 121.266 0.555 . . . . 0.0 110.727 -170.249 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -75.89 89.06 2.9 Favored 'General case' 0 C--N 1.35 0.606 0 C-N-CA 124.294 1.038 . . . . 0.0 108.823 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.481 ' HE1' ' HE3' ' A' ' 18' ' ' LYS . 32.5 p90 -49.94 -39.83 41.68 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 115.629 1.714 . . . . 0.0 115.629 -171.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -67.07 -50.67 61.0 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 118.73 0.695 . . . . 0.0 111.366 -170.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.467 ' O ' ' HG2' ' A' ' 72' ' ' MET . 9.4 t -71.02 -21.2 62.31 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.854 178.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.446 ' CE2' HD21 ' A' ' 33' ' ' LEU . 55.6 t80 -81.97 -58.1 3.13 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.513 0.725 . . . . 0.0 111.307 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.8 t -66.23 -27.88 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.215 1.006 . . . . 0.0 110.743 -177.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -59.82 -32.29 74.23 Favored Glycine 0 CA--C 1.537 1.418 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.681 171.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.467 ' HG2' ' O ' ' A' ' 68' ' ' THR . 26.6 mmt -76.29 -49.76 16.14 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.57 0.748 . . . . 0.0 111.35 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.402 HD22 HG12 ' A' ' 49' ' ' ILE . 1.9 pp -81.02 -2.96 50.12 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -172.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -94.82 -2.37 50.97 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.589 0.356 . . . . 0.0 111.009 169.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 65.2 mt -78.72 -5.67 53.8 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.489 0.316 . . . . 0.0 111.052 173.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 52.5 m0 -61.88 -20.08 63.34 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.581 0.752 . . . . 0.0 111.078 176.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.3 t70 . . . . . 0 C--O 1.256 1.44 0 C-N-CA 124.379 1.072 . . . . 0.0 109.101 173.102 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.358 0 N-CA-C 111.837 -0.505 . . . . 0.0 111.837 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.7 p -65.57 123.62 20.16 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.459 0.704 . . . . 0.0 111.494 -176.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -92.67 -0.92 57.22 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.86 0.864 . . . . 0.0 110.473 176.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 46.4 mtm -74.85 84.27 2.18 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 123.292 0.637 . . . . 0.0 109.315 177.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -74.42 100.26 3.77 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.775 -177.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -82.83 107.27 15.33 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.179 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.464 ' H ' HD12 ' A' ' 7' ' ' ILE . 4.1 mp -69.17 -29.04 41.34 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.178 0 C-N-CA 123.355 0.662 . . . . 0.0 109.37 178.008 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 67.28 21.7 9.81 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 125.207 1.403 . . . . 0.0 111.457 177.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.7 t -81.27 156.84 25.38 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.058 -178.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.523 ' HE2' ' HB3' ' A' ' 74' ' ' PHE . 16.2 ptpt -64.31 -20.75 66.3 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.665 173.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.24 -38.38 90.85 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.147 0.579 . . . . 0.0 110.856 174.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -70.92 -38.11 72.92 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 112.432 0.531 . . . . 0.0 112.432 -176.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.83 -37.23 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 176.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.515 HG23 ' HE1' ' A' ' 66' ' ' TYR . 63.9 mt -63.01 -42.08 95.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.388 0.675 . . . . 0.0 110.219 173.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.417 ' O ' HG23 ' A' ' 19' ' ' VAL . 37.4 mt-10 -62.01 -32.95 73.48 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.852 0.861 . . . . 0.0 111.175 177.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.23 -38.07 79.06 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.161 0.584 . . . . 0.0 111.193 177.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.442 ' CZ ' HD12 ' A' ' 33' ' ' LEU . 96.2 m-85 -68.74 -37.08 79.16 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.269 175.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 14' ' ' ILE . 21.3 mtpp -71.76 -35.01 69.94 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.104 0.562 . . . . 0.0 111.045 -175.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 15' ' ' GLU . 91.4 t -71.01 -35.34 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.757 0.823 . . . . 0.0 110.07 176.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -66.48 -54.25 26.09 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.427 175.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.489 ' HB2' HG22 ' A' ' 28' ' ' VAL . 21.7 t70 -77.25 86.33 3.69 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.572 0.701 . . . . 0.0 109.922 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 42.5 mtp180 -88.96 -1.19 57.99 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.041 172.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -84.41 -26.85 28.02 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.004 0.922 . . . . 0.0 111.201 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.08 47.68 23.14 Favored Glycine 0 C--N 1.345 1.053 0 O-C-N 123.478 0.486 . . . . 0.0 112.274 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -91.38 17.6 8.27 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.442 0.697 . . . . 0.0 111.616 -178.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.33 -60.36 4.89 Favored Glycine 0 C--N 1.344 1.024 0 N-CA-C 111.784 -0.526 . . . . 0.0 111.784 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -124.73 -171.75 2.42 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.494 1.117 . . . . 0.0 110.322 -177.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.489 HG22 ' HB2' ' A' ' 21' ' ' ASP . 76.8 t -126.57 151.3 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.508 1.123 . . . . 0.0 109.675 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 58.5 p -66.98 165.32 15.83 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.143 0.977 . . . . 0.0 112.592 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.4 p -69.83 -18.92 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.491 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -63.63 -46.78 84.15 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.018 0.527 . . . . 0.0 111.41 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -79.83 -29.99 40.31 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.823 176.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.598 HD22 HG11 ' A' ' 64' ' ' VAL . 12.0 tp -57.02 -45.53 83.03 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.175 0.59 . . . . 0.0 110.689 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 75.5 mtt180 -67.28 -41.96 84.62 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.354 176.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -54.18 -51.08 65.51 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.812 0.845 . . . . 0.0 111.812 -176.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.5 p -73.82 -34.2 39.59 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.582 -175.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 91.8 mt -86.09 -10.42 54.93 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 122.04 -0.413 . . . . 0.0 111.883 -177.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -83.06 -42.08 17.87 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.128 0.571 . . . . 0.0 109.948 176.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -73.86 -40.1 63.49 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.507 0.723 . . . . 0.0 111.132 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 96.9 mt -76.69 -33.0 58.26 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.891 0.477 . . . . 0.0 110.61 177.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -87.52 65.07 3.65 Favored Glycine 0 C--N 1.347 1.18 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 176.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -84.07 -58.36 2.8 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.322 0.649 . . . . 0.0 109.443 177.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.3 -22.02 48.82 Favored 'General case' 0 CA--C 1.551 1.003 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.299 177.039 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 96.9 mmm -87.92 128.3 54.56 Favored Pre-proline 0 N--CA 1.478 0.969 0 C-N-CA 123.65 0.78 . . . . 0.0 110.204 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -65.54 121.78 9.27 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 122.86 2.373 . . . . 0.0 111.485 172.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.96 -12.83 61.76 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.81 0.844 . . . . 0.0 111.897 -177.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.484 ' O ' ' HG2' ' A' ' 51' ' ' GLU . 5.8 m-20 -52.45 -52.65 53.07 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.632 1.173 . . . . 0.0 111.363 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -60.19 -46.85 88.31 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 124.058 0.849 . . . . 0.0 111.02 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.0 mt -57.99 -38.56 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.056 178.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.4 ' O ' ' HD1' ' A' ' 54' ' ' TYR . 75.2 mm-40 -67.41 -41.43 84.89 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.127 0.571 . . . . 0.0 111.547 178.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 47' ' ' ASP . 8.7 mm-40 -60.35 -43.3 96.63 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.798 0.809 . . . . 0.0 109.791 177.253 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.434 ' HG3' ' HZ2' ' A' ' 76' ' ' TRP . 76.5 mmm -66.66 -32.88 74.49 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 113.57 -1.65 . . . . 0.0 111.52 176.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.4 mt -64.29 -42.72 96.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 C-N-CA 124.089 0.956 . . . . 0.0 110.235 176.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.4 ' HD1' ' O ' ' A' ' 50' ' ' GLU . 24.7 m-85 -78.07 -9.39 59.12 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.712 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -99.15 -16.95 18.41 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.287 0.635 . . . . 0.0 111.405 170.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.72 -28.97 22.76 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.626 0.77 . . . . 0.0 110.324 173.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -138.83 76.54 34.29 Favored Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 175.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -78.77 -11.56 15.28 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 123.252 2.635 . . . . 0.0 113.512 -176.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -87.43 -11.8 48.06 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.213 0.605 . . . . 0.0 111.254 -178.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.5 t30 60.31 54.83 3.79 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 122.167 0.984 . . . . 0.0 109.277 -175.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.9 m -99.19 -17.2 18.26 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.527 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.61 15.22 81.4 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.354 -172.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -114.79 109.94 18.94 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.684 0.794 . . . . 0.0 109.645 -173.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.598 HG11 HD22 ' A' ' 33' ' ' LEU . 2.7 p -136.84 123.2 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 123.731 0.812 . . . . 0.0 110.121 -175.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -72.57 100.62 2.8 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 172.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.515 ' HE1' HG23 ' A' ' 14' ' ' ILE . 48.1 p90 -59.94 -37.79 80.54 Favored 'General case' 0 C--O 1.214 -0.785 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.681 -171.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -66.75 -33.84 76.52 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 118.076 0.398 . . . . 0.0 110.316 -177.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 19.1 m -67.2 -50.73 59.84 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 123.81 0.844 . . . . 0.0 110.446 175.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.445 ' HD2' HD11 ' A' ' 33' ' ' LEU . 63.0 t80 -70.63 -62.35 1.42 Allowed 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.982 -174.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 74.5 t -57.19 -30.62 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.63 1.172 . . . . 0.0 110.83 175.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.68 -55.4 30.08 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-N 116.298 -0.41 . . . . 0.0 112.458 172.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 24.4 ptp -72.68 -24.18 60.98 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -175.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.53 -26.9 29.74 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.523 ' HB3' ' HE2' ' A' ' 10' ' ' LYS . 22.8 m-85 -86.69 6.3 31.9 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 122.612 0.365 . . . . 0.0 111.03 170.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 76.9 mt -100.72 15.41 28.38 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.684 0.794 . . . . 0.0 110.602 168.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.434 ' HZ2' ' HG3' ' A' ' 52' ' ' MET . 54.6 m0 -80.25 59.95 3.55 Favored 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 170.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.6 t70 . . . . . 0 C--O 1.247 0.954 0 C-N-CA 123.926 0.891 . . . . 0.0 109.618 -175.834 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.407 0 N-CA-C 111.771 -0.531 . . . . 0.0 111.771 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.9 p -155.19 145.18 21.64 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.661 0.785 . . . . 0.0 110.069 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.4 p-80 -158.66 87.05 0.87 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.703 1.201 . . . . 0.0 108.652 177.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.4 ttt -88.0 41.89 1.03 Allowed 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.376 0.67 . . . . 0.0 110.78 -174.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 73.37 -30.66 0.21 Allowed 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 125.305 1.442 . . . . 0.0 113.878 173.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.8 t60 -83.11 72.61 10.12 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.659 0.784 . . . . 0.0 109.678 -176.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.463 HG22 HG22 ' A' ' 9' ' ' THR . 19.5 mm -122.52 110.8 27.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 172.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -109.0 91.18 3.54 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.463 HG22 HG22 ' A' ' 7' ' ' ILE . 11.6 t -173.2 157.36 3.39 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.808 0.843 . . . . 0.0 110.92 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.459 ' HD2' ' H ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -81.15 -18.48 46.22 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.041 0.937 . . . . 0.0 110.848 171.714 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.17 -42.23 98.2 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.008 0.923 . . . . 0.0 112.077 -175.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -56.19 -41.91 76.28 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 124.038 0.935 . . . . 0.0 112.611 -173.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.434 HG13 HG11 ' A' ' 70' ' ' VAL . 4.3 p -82.71 -35.96 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 123.583 0.753 . . . . 0.0 109.941 -174.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 71.2 mt -61.84 -32.63 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 123.328 0.651 . . . . 0.0 110.052 172.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -67.88 -38.11 82.62 Favored 'General case' 0 C--N 1.349 0.548 0 C-N-CA 123.682 0.793 . . . . 0.0 110.781 175.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.27 -40.01 76.83 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 122.899 0.48 . . . . 0.0 111.268 177.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.426 ' CE1' HD12 ' A' ' 33' ' ' LEU . 80.6 m-85 -64.54 -53.2 51.77 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.472 0.709 . . . . 0.0 112.001 178.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.87 -25.99 64.9 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -175.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.3 t -70.37 -37.5 70.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 122.646 0.378 . . . . 0.0 110.11 172.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -66.68 -40.45 88.58 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.28 174.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -76.63 81.06 3.29 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.792 0.806 . . . . 0.0 109.887 -176.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 69.6 mtp180 -92.96 -14.86 26.95 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.036 -1.438 . . . . 0.0 109.703 175.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -74.65 -28.42 60.85 Favored 'General case' 0 C--N 1.356 0.848 0 C-N-CA 123.383 0.673 . . . . 0.0 110.253 176.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.22 56.09 3.32 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-N 116.329 -0.396 . . . . 0.0 113.279 175.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -88.27 -21.59 24.37 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.804 0.841 . . . . 0.0 110.413 175.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.33 -40.9 2.49 Favored Glycine 0 C--N 1.348 1.204 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 -173.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.401 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 44.5 p90 -119.47 -176.0 3.06 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.958 1.303 . . . . 0.0 109.518 174.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 55.2 t -127.64 159.51 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 124.244 1.017 . . . . 0.0 109.467 -177.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.3 p -72.81 166.81 22.18 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.655 1.182 . . . . 0.0 111.771 177.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.9 p -75.3 -14.8 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 122.999 0.52 . . . . 0.0 111.331 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -69.45 -57.63 5.0 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 122.578 0.351 . . . . 0.0 110.83 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -64.29 -30.56 71.61 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.643 0.377 . . . . 0.0 110.534 176.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.551 HD22 HG11 ' A' ' 64' ' ' VAL . 10.4 tp -56.69 -58.66 7.11 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.169 176.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 46.6 mtt85 -62.45 -28.24 69.67 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.794 0.838 . . . . 0.0 112.116 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -62.37 -62.79 1.51 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.278 0.631 . . . . 0.0 110.865 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.3 p -66.82 -28.3 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.169 0.588 . . . . 0.0 111.686 -175.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 84.1 mt -87.56 -11.93 47.24 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.223 0.609 . . . . 0.0 112.224 -177.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -76.84 -35.38 57.56 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 166.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -75.34 -35.03 61.23 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.129 0.971 . . . . 0.0 110.464 177.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -74.73 -43.36 55.4 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 175.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -87.2 61.32 4.28 Favored Glycine 0 C--N 1.345 1.078 0 N-CA-C 110.269 -1.133 . . . . 0.0 110.269 175.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -60.32 -47.91 84.0 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.358 1.063 . . . . 0.0 111.445 -173.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 64.4 mtm -125.88 1.0 7.36 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.699 0.8 . . . . 0.0 110.006 172.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 63.4 mtt -80.94 137.27 50.14 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 123.445 0.698 . . . . 0.0 109.38 175.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.7 122.54 10.67 Favored 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.64 2.227 . . . . 0.0 112.87 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.51 -18.48 65.39 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.702 0.801 . . . . 0.0 110.631 170.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -50.4 -43.13 54.58 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.766 1.227 . . . . 0.0 111.164 173.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -63.54 -53.28 54.29 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.431 0.693 . . . . 0.0 110.514 175.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.462 ' O ' HG13 ' A' ' 53' ' ' ILE . 88.5 mt -59.93 -37.26 71.4 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 CA-C-N 114.823 -1.08 . . . . 0.0 111.769 -174.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -71.68 -30.41 65.67 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.343 0.657 . . . . 0.0 112.024 -175.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -67.77 -39.96 84.07 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 121.53 0.681 . . . . 0.0 109.379 172.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.422 ' HG3' ' HZ2' ' A' ' 76' ' ' TRP . 69.7 mmm -68.55 -32.94 73.23 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.428 -1.26 . . . . 0.0 110.392 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 49' ' ' ILE . 58.4 mt -58.63 -42.59 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 123.821 0.848 . . . . 0.0 110.065 178.203 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -73.31 -9.74 59.02 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.556 0.743 . . . . 0.0 112.305 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -85.9 -29.94 23.25 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 120.975 0.417 . . . . 0.0 110.103 172.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -94.04 -19.68 20.64 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.791 0.837 . . . . 0.0 111.421 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -144.85 71.81 15.08 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 124.736 1.214 . . . . 0.0 107.897 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.03 -17.35 22.27 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 122.858 2.372 . . . . 0.0 112.609 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.592 ' HG3' ' H ' ' A' ' 61' ' ' SER . 27.7 pt20 -70.86 -20.26 62.55 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.303 1.041 . . . . 0.0 111.645 178.036 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.7 t30 67.7 6.95 5.34 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 124.877 1.271 . . . . 0.0 111.115 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.592 ' H ' ' HG3' ' A' ' 59' ' ' GLN . 34.8 t -78.61 -17.67 55.7 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.531 0.732 . . . . 0.0 111.313 -173.066 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.03 34.42 8.25 Favored Glycine 0 C--N 1.341 0.819 0 O-C-N 123.314 0.384 . . . . 0.0 113.87 172.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -127.38 96.14 4.48 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.252 1.021 . . . . 0.0 108.493 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.551 HG11 HD22 ' A' ' 33' ' ' LEU . 3.3 p -118.03 130.28 73.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 124.031 0.933 . . . . 0.0 111.312 -166.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -75.05 90.41 2.48 Favored 'General case' 0 C--N 1.351 0.644 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 170.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.401 ' CE2' ' HA ' ' A' ' 27' ' ' TYR . 42.3 p90 -57.37 -29.87 64.4 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.043 -0.981 . . . . 0.0 113.41 -173.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -60.65 -63.54 1.26 Allowed 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 118.105 0.411 . . . . 0.0 110.858 -174.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.7 t -64.68 -30.04 71.05 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.558 0.743 . . . . 0.0 111.623 -177.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.476 ' CD2' HD11 ' A' ' 33' ' ' LEU . 32.4 t80 -70.42 -55.11 9.83 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.522 0.729 . . . . 0.0 111.858 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.468 ' HA ' HD12 ' A' ' 73' ' ' LEU . 82.7 t -65.06 -24.86 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.472 0.709 . . . . 0.0 110.188 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.457 ' O ' ' HG ' ' A' ' 75' ' ' LEU . . . -56.4 -53.55 42.35 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.532 165.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.505 ' HA ' HD12 ' A' ' 75' ' ' LEU . 85.0 mtp -59.53 -35.97 75.23 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.896 0.878 . . . . 0.0 112.605 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.468 HD12 ' HA ' ' A' ' 70' ' ' VAL . 92.5 mt -62.88 -42.06 99.63 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 121.419 0.628 . . . . 0.0 110.584 176.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -88.23 -0.07 56.68 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.163 -178.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.505 HD12 ' HA ' ' A' ' 72' ' ' MET . 82.0 mt -86.06 4.15 39.31 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.581 0.752 . . . . 0.0 110.869 170.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.422 ' HZ2' ' HG3' ' A' ' 52' ' ' MET . 51.4 m0 -75.59 76.01 2.6 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 171.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 . . . . . 0 C--O 1.247 0.944 0 CA-C-O 118.286 -0.864 . . . . 0.0 109.254 178.163 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.632 0 CA-C-O 119.577 -0.568 . . . . 0.0 111.849 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.5 p -69.77 108.71 4.05 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.162 0.985 . . . . 0.0 110.488 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -79.89 -33.07 40.25 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.365 0.666 . . . . 0.0 111.091 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.9 mmt -68.38 97.07 0.72 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.966 0.506 . . . . 0.0 109.888 176.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -81.61 74.58 8.6 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 108.66 -0.866 . . . . 0.0 108.66 177.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -153.04 133.95 13.97 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.404 1.482 . . . . 0.0 107.533 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 36.8 mm -80.61 81.2 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -73.6 -41.98 62.13 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.402 -0.817 . . . . 0.0 108.902 173.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.2 t -131.98 164.07 26.98 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.769 176.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -68.94 -12.8 61.98 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.519 0.728 . . . . 0.0 111.785 -177.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.458 ' O ' ' HG2' ' A' ' 15' ' ' GLU . . . -71.23 -30.46 66.37 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.09 0.556 . . . . 0.0 111.461 174.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -58.0 -36.82 73.2 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.615 0.766 . . . . 0.0 112.521 -176.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.6 p -77.33 -34.45 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 122.633 0.373 . . . . 0.0 110.487 177.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.5 mt -65.6 -30.14 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 123.556 0.743 . . . . 0.0 110.516 178.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.5 ' HA ' ' HE2' ' A' ' 18' ' ' LYS . 26.1 mm-40 -59.09 -43.49 91.84 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.474 0.709 . . . . 0.0 109.911 172.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.34 -28.36 67.91 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.812 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -73.82 -54.29 8.33 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.971 0.509 . . . . 0.0 111.609 176.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.5 ' HE2' ' HA ' ' A' ' 15' ' ' GLU . 64.4 pttt -73.99 -17.5 60.99 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -170.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.6 p -69.14 -33.48 58.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 CA-C-N 117.917 0.326 . . . . 0.0 110.124 172.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -77.71 -45.48 24.67 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.96 0.904 . . . . 0.0 109.64 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -78.21 72.9 4.77 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 174.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.423 ' HA ' ' NE ' ' A' ' 22' ' ' ARG . 1.6 tpm_? -80.5 -28.43 37.48 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.992 -166.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -70.3 -25.67 63.43 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.823 0.449 . . . . 0.0 110.927 176.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.22 50.16 5.94 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 -173.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -75.82 -10.68 59.63 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.58 0.752 . . . . 0.0 110.597 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.39 -29.27 12.25 Favored Glycine 0 C--N 1.35 1.358 0 CA-C-N 116.121 -0.49 . . . . 0.0 112.174 176.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -145.09 164.03 32.47 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-O 121.09 0.472 . . . . 0.0 111.312 -172.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.6 m -117.74 178.61 2.0 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.846 0 CA-C-N 114.77 -1.104 . . . . 0.0 109.864 176.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.8 p -81.38 156.36 25.47 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.652 173.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.592 HG23 HG21 ' A' ' 53' ' ' ILE . 7.7 p -57.97 -37.35 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.95 0.9 . . . . 0.0 112.041 177.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -62.54 -47.83 82.16 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 123.618 0.574 . . . . 0.0 111.197 -174.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -66.76 -41.82 87.13 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.298 176.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.436 HD21 ' CE2' ' A' ' 69' ' ' PHE . 5.1 tt -63.39 -32.78 74.3 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.568 -176.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 47.9 mtm105 -74.12 -38.88 63.67 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.921 0.488 . . . . 0.0 110.679 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -60.43 -52.52 64.86 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.052 0.845 . . . . 0.0 111.508 -176.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.1 p -62.77 -41.44 92.47 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.651 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 86.1 mt -78.28 -16.32 57.89 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -177.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -80.77 -46.7 15.01 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.933 0.493 . . . . 0.0 110.292 176.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -67.98 -23.54 65.05 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.042 0.537 . . . . 0.0 111.982 -175.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.6 pp -98.13 -32.24 11.7 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.54 0.336 . . . . 0.0 110.726 173.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -106.7 39.6 2.82 Favored Glycine 0 C--N 1.345 1.06 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.648 -175.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -75.66 -26.87 58.04 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.201 1.0 . . . . 0.0 110.355 175.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 53.9 mtm -73.86 -33.38 64.06 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.191 0.996 . . . . 0.0 110.846 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 64.1 mtm -92.95 156.31 40.63 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 123.788 0.835 . . . . 0.0 109.647 176.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.07 111.59 2.91 Favored 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 121.551 1.501 . . . . 0.0 111.311 169.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.02 -12.47 61.54 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.478 0.711 . . . . 0.0 110.92 174.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -51.62 -55.49 19.02 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.011 1.324 . . . . 0.0 110.766 174.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.467 ' O ' ' HG2' ' A' ' 52' ' ' MET . 38.8 tt0 -68.04 -35.16 77.79 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.11 -178.244 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.467 ' O ' HG13 ' A' ' 53' ' ' ILE . 93.6 mt -58.96 -39.81 78.96 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 123.219 0.607 . . . . 0.0 110.506 173.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.541 ' HA ' HD12 ' A' ' 53' ' ' ILE . 49.6 mt-10 -67.09 -35.1 79.06 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.78 0.432 . . . . 0.0 110.947 177.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -62.83 -36.32 82.83 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.575 0.35 . . . . 0.0 110.803 173.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.467 ' HG2' ' O ' ' A' ' 48' ' ' GLU . 30.2 mmt -69.68 -33.04 72.0 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.466 0.706 . . . . 0.0 110.453 177.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.592 HG21 HG23 ' A' ' 30' ' ' VAL . 81.3 mt -69.23 -32.2 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.823 0.849 . . . . 0.0 110.303 174.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -71.59 -12.43 61.35 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.577 0.751 . . . . 0.0 111.459 175.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -94.95 -35.19 12.1 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.52 0.728 . . . . 0.0 110.138 174.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.94 -31.13 56.41 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.765 0.826 . . . . 0.0 111.07 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -137.81 91.32 13.63 Favored Pre-proline 0 CA--C 1.55 0.973 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 172.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -85.12 4.73 6.61 Favored 'Trans proline' 0 C--N 1.371 1.746 0 C-N-CA 122.898 2.399 . . . . 0.0 113.855 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -103.6 -11.18 17.87 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.178 0.591 . . . . 0.0 111.851 -176.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.2 t30 66.71 22.83 10.3 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 124.177 0.991 . . . . 0.0 109.847 -176.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 46.9 m -64.47 -39.99 94.84 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 124.718 1.207 . . . . 0.0 110.807 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.97 24.7 16.41 Favored Glycine 0 C--N 1.344 0.976 0 CA-C-N 114.995 -1.002 . . . . 0.0 113.191 176.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -127.42 95.27 4.21 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.496 1.119 . . . . 0.0 108.787 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 p -119.11 126.02 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 123.527 0.731 . . . . 0.0 110.407 -171.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -70.24 98.98 1.45 Allowed 'General case' 0 C--N 1.347 0.458 0 C-N-CA 124.152 0.981 . . . . 0.0 110.593 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -63.27 -33.4 75.42 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -176.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -64.91 -46.73 80.44 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 120.883 0.373 . . . . 0.0 110.955 -175.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 54.6 p -77.31 -38.15 51.19 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.407 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.436 ' CE2' HD21 ' A' ' 33' ' ' LEU . 41.8 t80 -65.12 -72.05 0.17 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.062 0.545 . . . . 0.0 110.975 -178.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.589 ' HA ' ' HB3' ' A' ' 73' ' ' LEU . 96.9 t -50.08 -29.56 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 125.162 1.385 . . . . 0.0 112.309 177.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.75 -53.44 45.26 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 121.048 0.249 . . . . 0.0 112.769 170.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 67.7 mtm -87.03 -2.13 58.39 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.281 1.033 . . . . 0.0 111.956 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.589 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 50.7 tp -90.24 -48.01 7.42 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.263 1.025 . . . . 0.0 109.363 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -78.41 27.89 0.2 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.105 0.962 . . . . 0.0 112.608 -177.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.2 0.33 19.48 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.361 0.665 . . . . 0.0 112.033 172.291 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 13.3 m0 -51.6 123.73 10.62 Favored 'General case' 0 C--N 1.351 0.636 0 C-N-CA 124.632 1.173 . . . . 0.0 110.948 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.2 t70 . . . . . 0 C--O 1.249 1.03 0 C-N-CA 123.5 0.72 . . . . 0.0 110.221 -176.872 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.297 0 CA-C-O 120.241 -0.199 . . . . 0.0 113.007 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.5 m -73.54 -47.98 36.61 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.397 0.679 . . . . 0.0 111.836 -175.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -120.45 146.39 46.28 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.038 0.535 . . . . 0.0 110.452 -177.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -78.21 -10.51 59.68 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.627 0.771 . . . . 0.0 111.705 -178.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -83.02 68.16 9.4 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.713 0.805 . . . . 0.0 110.368 -176.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -78.29 87.57 4.35 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 114.832 -1.077 . . . . 0.0 109.484 177.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.7 tt -75.81 124.78 34.54 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 CA-C-N 114.565 -1.198 . . . . 0.0 110.531 -175.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -106.24 83.83 1.95 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.183 0.993 . . . . 0.0 108.657 175.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.474 ' O ' ' HG2' ' A' ' 12' ' ' GLN . 91.1 m -144.21 123.78 13.24 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.027 0.931 . . . . 0.0 108.775 -177.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.511 ' H ' ' HD3' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -72.32 -4.98 33.01 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -176.927 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.459 ' O ' ' HG2' ' A' ' 15' ' ' GLU . . . -58.75 -43.08 90.18 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.469 0.308 . . . . 0.0 110.572 170.252 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 9' ' ' THR . 27.0 pt20 -67.25 -34.39 77.33 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.492 0.717 . . . . 0.0 111.991 -173.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.6 p -75.3 -37.14 38.33 Favored 'Isoleucine or valine' 0 C--N 1.355 0.828 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -178.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.4 mt -62.85 -37.28 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 174.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 68.0 mm-40 -59.99 -45.03 94.05 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 122.877 0.471 . . . . 0.0 110.161 172.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.26 -27.45 69.02 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.657 0.783 . . . . 0.0 112.138 -178.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.459 ' HE1' ' HA ' ' A' ' 33' ' ' LEU . 65.2 m-85 -77.7 -42.61 33.84 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.719 0.408 . . . . 0.0 111.179 173.16 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -70.4 -23.18 62.71 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.924 0.49 . . . . 0.0 112.114 -174.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 23.8 m -75.95 -28.61 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-O 120.663 0.268 . . . . 0.0 110.552 175.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -74.6 -42.04 59.37 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.74 0.816 . . . . 0.0 109.052 174.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -75.2 85.2 2.4 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.026 0.93 . . . . 0.0 108.824 175.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 68.5 ttt-85 -65.61 -48.49 72.09 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.789 -1.096 . . . . 0.0 112.456 -172.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -87.47 -3.5 59.0 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -170.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.69 41.74 63.66 Favored Glycine 0 C--N 1.345 1.03 0 N-CA-C 112.171 -0.372 . . . . 0.0 112.171 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -70.51 -17.99 62.95 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.919 0.888 . . . . 0.0 110.701 -178.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.29 -43.58 1.61 Allowed Glycine 0 C--N 1.346 1.108 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.498 175.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.505 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 50.9 p90 -136.6 176.19 8.92 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.186 0.594 . . . . 0.0 111.799 -172.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.0 m -123.64 -177.97 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 124.02 0.928 . . . . 0.0 110.529 -177.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 49.7 p -75.75 153.82 36.76 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 123.554 0.742 . . . . 0.0 110.235 173.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.6 p -63.06 -27.0 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.327 0.651 . . . . 0.0 111.343 178.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -59.96 -58.79 7.03 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.526 1.13 . . . . 0.0 110.624 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -61.77 -34.16 75.37 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 123.752 0.657 . . . . 0.0 110.975 -178.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.643 HD22 HG11 ' A' ' 64' ' ' VAL . 7.1 tp -58.69 -52.15 66.91 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.768 178.103 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 54.9 mtt180 -64.58 -35.29 80.52 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.369 0.668 . . . . 0.0 111.435 -178.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -63.46 -51.85 63.87 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.475 0.71 . . . . 0.0 111.828 -177.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.2 p -73.0 -30.38 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.46 -175.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 81.2 mt -85.28 -11.95 53.56 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.672 0.389 . . . . 0.0 111.371 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -85.46 -33.01 21.97 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.198 0.599 . . . . 0.0 110.078 173.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -80.43 -41.4 24.56 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 110.624 -0.139 . . . . 0.0 110.624 178.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 94.3 mt -74.07 -27.65 61.01 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.601 0.361 . . . . 0.0 110.233 174.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -96.68 52.09 1.51 Allowed Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.4 173.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -65.95 -51.07 61.77 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.748 0.819 . . . . 0.0 111.041 -175.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -92.4 -3.28 55.52 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.134 0.574 . . . . 0.0 111.029 177.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 74.8 mtp -94.4 144.66 28.35 Favored Pre-proline 0 N--CA 1.48 1.071 0 C-N-CA 123.611 0.765 . . . . 0.0 110.141 -176.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -66.52 111.39 2.08 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.684 2.256 . . . . 0.0 111.828 172.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.36 -27.77 63.58 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.305 0.642 . . . . 0.0 111.293 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -62.02 -34.34 76.03 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 122.703 0.401 . . . . 0.0 111.738 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -71.2 -39.15 71.96 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 176.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.491 ' O ' HG13 ' A' ' 53' ' ' ILE . 89.1 mt -64.4 -42.13 94.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 123.234 0.614 . . . . 0.0 109.776 176.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.534 ' HA ' HD12 ' A' ' 53' ' ' ILE . 46.9 mt-10 -75.05 -19.84 59.83 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.918 0.887 . . . . 0.0 111.032 -178.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -72.13 -45.02 62.21 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.685 0.794 . . . . 0.0 109.149 169.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.457 ' SD ' ' HZ2' ' A' ' 76' ' ' TRP . 48.8 mtp -67.7 -18.99 65.11 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.344 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.534 HD12 ' HA ' ' A' ' 50' ' ' GLU . 73.6 mt -68.03 -29.31 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.405 0.682 . . . . 0.0 111.38 176.332 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -60.37 -32.96 71.78 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.106 0.562 . . . . 0.0 110.484 173.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -85.3 -35.8 21.26 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.334 1.054 . . . . 0.0 110.448 178.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.18 -33.01 74.79 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.985 0.914 . . . . 0.0 111.569 -178.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -123.82 90.07 50.96 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 105.056 -2.202 . . . . 0.0 105.056 171.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -65.65 -23.35 56.72 Favored 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 123.148 2.566 . . . . 0.0 112.788 -175.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -86.39 -17.27 34.83 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.765 0.826 . . . . 0.0 109.332 179.246 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 59.03 43.57 17.43 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.354 1.061 . . . . 0.0 110.318 178.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.0 m -79.76 -26.86 40.55 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.241 1.016 . . . . 0.0 112.156 -177.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 96.9 9.33 56.28 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.351 -169.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -118.35 99.89 7.13 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.63 1.172 . . . . 0.0 108.415 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.643 HG11 HD22 ' A' ' 33' ' ' LEU . 7.3 p -112.87 136.66 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-O 121.158 0.504 . . . . 0.0 111.425 -170.149 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -85.24 99.2 10.95 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.005 173.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.505 ' CE2' ' HA ' ' A' ' 27' ' ' TYR . 34.1 p90 -59.95 -35.4 74.86 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.615 -177.091 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -63.1 -45.04 93.91 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 122.791 0.436 . . . . 0.0 111.032 -173.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.5 t -78.48 -24.8 45.73 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.111 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.445 ' HD2' HD11 ' A' ' 33' ' ' LEU . 26.3 t80 -79.89 -74.14 0.32 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.349 0.259 . . . . 0.0 110.486 178.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.542 ' HA ' ' HB3' ' A' ' 73' ' ' LEU . 87.0 t -49.91 -24.22 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 C-N-CA 126.158 1.783 . . . . 0.0 113.083 178.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.466 ' O ' ' HG ' ' A' ' 75' ' ' LEU . . . -64.44 -57.87 11.88 Favored Glycine 0 CA--C 1.539 1.557 0 CA-C-O 119.911 -0.383 . . . . 0.0 112.379 171.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -75.61 -21.1 58.07 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 123.363 0.665 . . . . 0.0 111.345 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.542 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 51.2 tp -68.71 -42.87 77.11 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.147 1.379 . . . . 0.0 110.16 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -85.84 -5.83 59.18 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.708 176.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 71' ' ' GLY . 54.2 mt -91.9 21.22 5.05 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.155 0.582 . . . . 0.0 111.593 174.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.457 ' HZ2' ' SD ' ' A' ' 52' ' ' MET . 30.8 m0 -64.12 104.64 0.76 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.481 0.312 . . . . 0.0 110.264 171.533 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 C--O 1.26 1.617 0 C-N-CA 123.715 0.806 . . . . 0.0 109.986 179.101 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.804 0 N-CA-C 112.284 -0.326 . . . . 0.0 112.284 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.7 m -114.56 171.49 7.6 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.814 0.846 . . . . 0.0 110.276 -179.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -70.76 -45.17 65.24 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.011 0.524 . . . . 0.0 110.43 176.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 62.5 mtm 61.55 97.96 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.113 1.365 . . . . 0.0 112.624 173.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -153.75 104.8 2.73 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.876 0.47 . . . . 0.0 110.077 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.8 p-80 -77.73 92.05 4.13 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 169.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.565 ' HB ' ' HG3' ' A' ' 12' ' ' GLN . 34.7 mt -71.04 133.0 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.348 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -73.41 7.63 2.2 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.974 0.909 . . . . 0.0 112.982 -176.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.493 HG22 ' H ' ' A' ' 11' ' ' ALA . 44.0 m -65.34 131.16 45.74 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.187 0.595 . . . . 0.0 110.262 173.066 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -74.85 -11.17 60.08 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.83 0.852 . . . . 0.0 112.65 -176.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.493 ' H ' HG22 ' A' ' 9' ' ' THR . . . -73.03 -42.37 63.24 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 122.959 0.504 . . . . 0.0 109.899 169.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.565 ' HG3' ' HB ' ' A' ' 7' ' ' ILE . 23.5 mm-40 -55.72 -39.42 71.05 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.33 1.052 . . . . 0.0 112.973 -175.412 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.1 p -66.03 -41.55 89.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 178.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 64.3 mt -68.91 -29.96 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.35 0.66 . . . . 0.0 110.245 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.468 ' HA ' ' HE2' ' A' ' 18' ' ' LYS . 42.5 mt-10 -76.38 -24.01 54.11 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.832 0.853 . . . . 0.0 111.397 177.095 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.0 -34.56 78.03 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.222 0.609 . . . . 0.0 110.718 175.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -64.47 -31.57 72.83 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.032 173.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.468 ' HE2' ' HA ' ' A' ' 15' ' ' GLU . 54.3 mtmt -81.06 -12.59 59.29 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.36 0.664 . . . . 0.0 111.906 -178.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.0 t -75.16 -35.18 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 169.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -74.55 -55.75 5.59 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.113 0.565 . . . . 0.0 109.797 175.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -85.54 89.09 7.62 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.872 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 32.2 ttm-85 -85.07 -23.95 28.31 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.953 172.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -64.65 -25.63 68.04 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.542 1.137 . . . . 0.0 111.841 -176.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.89 38.21 23.89 Favored Glycine 0 C--N 1.344 1.015 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 178.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -64.66 -25.24 67.87 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.555 1.142 . . . . 0.0 110.502 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.79 -35.99 4.3 Favored Glycine 0 C--N 1.347 1.162 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.485 ' HB2' ' O ' ' A' ' 64' ' ' VAL . 44.0 p90 -133.15 179.9 5.9 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 124.049 0.939 . . . . 0.0 109.647 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.0 p -134.1 173.88 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.213 0.605 . . . . 0.0 110.152 -172.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 44.5 p -73.39 145.99 45.46 Favored 'General case' 0 C--O 1.245 0.82 0 C-N-CA 123.404 0.682 . . . . 0.0 110.601 171.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.436 HG22 HG23 ' A' ' 53' ' ' ILE . 0.8 OUTLIER -70.47 -20.65 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 122.633 0.373 . . . . 0.0 110.594 -179.315 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -62.62 -53.85 48.38 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.631 0.772 . . . . 0.0 110.639 174.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 93.2 t80 -61.64 -39.64 92.04 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 122.94 0.496 . . . . 0.0 110.686 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.4 HD22 HG11 ' A' ' 64' ' ' VAL . 6.6 tp -53.86 -46.61 71.33 Favored 'General case' 0 CA--C 1.554 1.125 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.442 176.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.429 ' HG3' ' O ' ' A' ' 30' ' ' VAL . 69.4 mtt180 -62.3 -35.84 80.28 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.758 0.823 . . . . 0.0 111.942 -178.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 55.1 mttm -63.27 -60.97 2.7 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 123.679 0.612 . . . . 0.0 110.901 -176.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.4 p -62.25 -34.19 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 123.672 0.789 . . . . 0.0 112.351 -174.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.422 ' HB3' HG21 ' A' ' 49' ' ' ILE . 96.7 mt -77.39 -26.51 51.86 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.752 0.421 . . . . 0.0 111.359 -178.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -79.31 -30.91 43.06 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.795 0.438 . . . . 0.0 110.126 173.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -60.48 -44.98 95.37 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.853 0.861 . . . . 0.0 110.153 174.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.443 ' O ' ' HG2' ' A' ' 44' ' ' MET . 80.2 mt -84.14 3.06 36.61 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.487 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -73.47 -5.03 66.51 Favored Glycine 0 C--N 1.355 1.626 0 C-N-CA 123.635 0.636 . . . . 0.0 113.211 -176.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -72.79 -22.76 60.77 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 122.887 0.475 . . . . 0.0 110.485 170.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 69.3 mtm -114.29 1.0 14.33 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.37 1.068 . . . . 0.0 112.091 -173.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.443 ' HG2' ' O ' ' A' ' 40' ' ' LEU . 20.8 ptp -158.23 154.64 24.34 Favored Pre-proline 0 N--CA 1.488 1.47 0 C-N-CA 122.875 0.47 . . . . 0.0 110.584 -175.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.76 110.17 2.49 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 122.215 1.943 . . . . 0.0 112.377 -178.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.18 -24.32 35.04 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.823 -174.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -68.35 -39.19 81.96 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-O 121.317 0.58 . . . . 0.0 110.768 176.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -68.02 -46.8 70.2 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.096 176.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.422 HG21 ' HB3' ' A' ' 37' ' ' LEU . 81.6 mt -59.43 -44.68 93.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.429 0.692 . . . . 0.0 111.69 178.079 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -66.86 -32.46 73.75 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 118.169 0.441 . . . . 0.0 110.954 -175.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -63.85 -45.99 87.02 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 120.98 0.419 . . . . 0.0 110.116 172.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 22.9 mmt -60.94 -30.36 70.17 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.833 177.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.436 HG23 HG22 ' A' ' 30' ' ' VAL . 55.9 mt -67.8 -37.94 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.295 1.038 . . . . 0.0 111.491 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -62.84 -34.85 78.21 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 122.787 0.435 . . . . 0.0 110.623 173.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -76.33 -30.92 57.86 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.244 0.618 . . . . 0.0 110.603 177.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.425 ' HB1' HG23 ' A' ' 64' ' ' VAL . . . -70.65 -24.49 62.72 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.206 1.003 . . . . 0.0 111.745 -179.151 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -129.37 81.5 70.01 Favored Pre-proline 0 CA--C 1.547 0.852 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 171.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -79.3 -8.33 15.12 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 123.065 2.51 . . . . 0.0 112.451 -178.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -82.65 -21.72 34.91 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.65 0.78 . . . . 0.0 110.862 176.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 59.12 32.92 22.55 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.472 1.109 . . . . 0.0 110.825 -175.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.7 m -97.21 -17.52 19.81 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.342 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.407 ' HA2' HG12 ' A' ' 30' ' ' VAL . . . 92.5 41.51 4.77 Favored Glycine 0 C--N 1.339 0.712 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.611 177.344 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -137.86 138.63 39.3 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.039 0.536 . . . . 0.0 111.143 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.485 ' O ' ' HB2' ' A' ' 27' ' ' TYR . 5.9 p -147.5 137.59 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.763 0.825 . . . . 0.0 110.363 -174.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -84.08 87.91 7.16 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 170.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -58.91 -35.19 72.66 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 114.613 -1.176 . . . . 0.0 113.373 -171.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -65.05 -39.51 93.42 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.772 0.429 . . . . 0.0 110.909 -169.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.455 ' O ' ' HG2' ' A' ' 72' ' ' MET . 11.2 t -83.28 -33.02 26.07 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.432 177.046 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -71.44 -56.38 6.06 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.407 0.623 . . . . 0.0 111.507 -177.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 99.6 t -65.67 -25.4 36.48 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.07 0 C-N-CA 124.393 1.077 . . . . 0.0 109.754 172.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -71.99 2.03 28.61 Favored Glycine 0 CA--C 1.543 1.828 0 CA-C-N 115.253 -0.885 . . . . 0.0 113.825 168.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.455 ' HG2' ' O ' ' A' ' 68' ' ' THR . 25.1 mmt -107.85 -45.39 4.01 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.775 0.83 . . . . 0.0 109.673 168.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 88.3 mt -58.24 -49.8 75.83 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.816 0.846 . . . . 0.0 112.142 -174.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -84.47 -11.91 55.29 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.161 -177.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -104.35 27.76 7.52 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.821 0.849 . . . . 0.0 110.701 178.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 32.6 m0 -67.08 -178.55 0.8 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.116 0.567 . . . . 0.0 110.99 171.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 . . . . . 0 CA--C 1.564 1.519 0 C-N-CA 123.72 0.808 . . . . 0.0 111.722 -175.007 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.572 0 N-CA-C 112.177 -0.369 . . . . 0.0 112.177 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.7 t -81.73 80.18 8.11 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.448 0.699 . . . . 0.0 110.295 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -150.39 28.34 0.73 Allowed 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.499 1.12 . . . . 0.0 110.069 175.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 68.9 mtm -66.18 -27.46 68.02 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.318 0.647 . . . . 0.0 112.095 -175.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 63.88 17.43 10.53 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.482 1.113 . . . . 0.0 112.834 167.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 48.5 m80 -72.61 82.19 1.12 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.138 0.575 . . . . 0.0 110.318 176.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.4 tt -124.46 115.92 46.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.366 1.066 . . . . 0.0 108.592 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -86.73 107.51 18.27 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.458 0.703 . . . . 0.0 109.352 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.7 t -163.44 158.95 21.67 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.52 0.676 . . . . 0.0 111.337 175.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -68.17 -17.42 64.34 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.759 1.224 . . . . 0.0 112.172 177.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.43 ' O ' ' HG2' ' A' ' 15' ' ' GLU . . . -63.04 -38.95 93.25 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 122.516 0.327 . . . . 0.0 110.186 172.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -71.03 -33.02 69.93 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.339 0.655 . . . . 0.0 112.369 -175.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.5 p -71.87 -36.64 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 176.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.438 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 75.1 mt -65.47 -33.42 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 174.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 23.5 mm-40 -62.01 -33.46 74.38 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.17 0.588 . . . . 0.0 111.491 174.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.25 -42.17 99.15 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 121.116 0.484 . . . . 0.0 110.195 174.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -69.37 -25.81 64.36 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.017 175.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.438 ' HG2' ' O ' ' A' ' 14' ' ' ILE . 73.7 mmtt -73.4 -28.16 61.85 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.202 0.601 . . . . 0.0 111.18 177.435 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 15' ' ' GLU . 87.9 t -72.24 -40.94 66.2 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 C-N-CA 123.153 0.581 . . . . 0.0 110.167 176.219 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -73.12 -40.72 64.71 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.592 0.357 . . . . 0.0 110.375 176.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -97.25 45.64 1.04 Allowed 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.977 0.894 . . . . 0.0 108.846 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -63.09 -25.4 68.35 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.397 1.079 . . . . 0.0 110.965 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -72.19 -28.33 63.13 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.629 0.772 . . . . 0.0 111.088 177.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.08 58.56 2.94 Favored Glycine 0 C--N 1.344 0.987 0 CA-C-N 115.955 -0.566 . . . . 0.0 113.312 176.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -78.07 -17.32 57.15 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.33 0.652 . . . . 0.0 110.218 170.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.13 -18.57 56.92 Favored Glycine 0 C--N 1.354 1.53 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.961 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -150.55 166.11 31.23 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.272 1.029 . . . . 0.0 109.867 -174.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.405 HG13 ' CD2' ' A' ' 66' ' ' TYR . 23.4 m -116.36 177.94 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.609 0.764 . . . . 0.0 110.445 176.323 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 67.7 p -84.72 157.57 21.03 Favored 'General case' 0 C--O 1.246 0.876 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.516 170.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.9 p -67.09 -17.22 22.37 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 123.201 0.601 . . . . 0.0 111.547 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -63.63 -63.17 1.25 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.325 0.65 . . . . 0.0 111.04 177.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -60.6 -38.4 84.54 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.908 0.483 . . . . 0.0 110.504 178.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.531 HD22 HG11 ' A' ' 64' ' ' VAL . 6.3 tp -54.64 -58.75 6.27 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.82 -178.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 73.9 mtt180 -61.54 -33.41 73.79 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.045 0.538 . . . . 0.0 111.354 178.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -66.19 -46.33 77.69 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.755 0.822 . . . . 0.0 111.664 -174.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.4 p -76.65 -34.81 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 122.959 0.504 . . . . 0.0 110.86 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.471 HD23 HD12 ' A' ' 40' ' ' LEU . 84.6 mt -78.68 -5.88 54.26 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.03 0.532 . . . . 0.0 111.376 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 32.2 t-20 -72.26 -45.37 60.44 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.373 0.669 . . . . 0.0 109.77 178.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -71.38 -40.79 70.34 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.226 176.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.471 HD12 HD23 ' A' ' 37' ' ' LEU . 75.9 mt -67.57 -26.61 66.38 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.74 0.816 . . . . 0.0 110.549 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -89.62 63.17 3.31 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.062 171.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -81.72 -72.62 0.42 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.617 0.767 . . . . 0.0 109.701 178.048 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 20.6 ptp -85.85 -22.76 27.41 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.973 0.509 . . . . 0.0 110.367 175.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 25.3 mmt -81.8 112.41 34.49 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 172.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.06 130.64 37.39 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 122.113 1.875 . . . . 0.0 111.837 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.469 ' O ' ' HG2' ' A' ' 50' ' ' GLU . . . -63.05 -21.79 66.41 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.454 0.701 . . . . 0.0 110.527 174.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -52.67 -40.46 62.91 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.602 1.561 . . . . 0.0 111.887 173.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -65.12 -46.4 81.18 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.444 0.698 . . . . 0.0 110.114 175.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 66.8 mt -63.06 -32.07 54.9 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.416 -177.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 14.5 mm-40 -62.88 -44.15 96.89 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.99 0.516 . . . . 0.0 110.713 177.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -61.0 -42.66 98.88 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 121.414 0.626 . . . . 0.0 110.29 177.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.525 ' HB3' ' HE1' ' A' ' 69' ' ' PHE . 79.9 mmm -63.3 -34.21 77.18 Favored 'General case' 0 CA--C 1.558 1.273 0 CA-C-N 114.31 -1.314 . . . . 0.0 110.735 176.29 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 60.2 mt -69.35 -34.51 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 C-N-CA 124.469 1.108 . . . . 0.0 110.952 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 4.3 m-30 -64.62 -26.54 68.44 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.163 0.585 . . . . 0.0 110.251 176.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -93.45 -20.45 20.29 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.567 0.747 . . . . 0.0 111.117 178.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.522 ' HB1' HG23 ' A' ' 64' ' ' VAL . . . -77.27 -53.43 7.72 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.376 0.67 . . . . 0.0 110.229 177.169 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -116.14 95.75 45.58 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 124.801 1.241 . . . . 0.0 108.384 174.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -85.75 -1.61 8.9 Favored 'Trans proline' 0 C--N 1.368 1.553 0 C-N-CA 122.719 2.279 . . . . 0.0 112.028 170.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -92.06 -6.74 50.46 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.153 0.981 . . . . 0.0 112.042 -169.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 59.68 28.61 18.08 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.485 1.114 . . . . 0.0 110.847 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.3 m -105.28 -15.01 15.17 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.27 1.028 . . . . 0.0 110.571 -176.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.57 9.11 87.07 Favored Glycine 0 C--N 1.346 1.137 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.943 -175.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 22.2 m-30 -86.6 97.42 10.53 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.307 0.643 . . . . 0.0 109.519 -176.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.531 HG11 HD22 ' A' ' 33' ' ' LEU . 2.4 p -113.32 118.46 58.18 Favored 'Isoleucine or valine' 0 C--O 1.245 0.825 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.481 -175.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -73.58 86.59 1.61 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.225 175.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.405 ' CD2' HG13 ' A' ' 28' ' ' VAL . 35.4 p90 -53.62 -33.44 55.05 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -175.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -67.97 -36.47 80.11 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 120.755 0.312 . . . . 0.0 110.616 -170.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.0 p -82.32 -48.14 11.54 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.795 0.838 . . . . 0.0 110.19 174.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.525 ' HE1' ' HB3' ' A' ' 52' ' ' MET . 46.8 t80 -66.14 -54.05 30.17 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.246 1.018 . . . . 0.0 113.37 -170.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 56.3 t -68.31 -21.08 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 122.85 0.46 . . . . 0.0 109.831 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -62.18 -44.94 97.02 Favored Glycine 0 CA--C 1.538 1.473 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.147 164.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 65.0 mtt -66.09 -29.08 69.34 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 124.224 1.01 . . . . 0.0 112.041 178.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.4 mt -74.08 -43.03 59.2 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 121.374 0.606 . . . . 0.0 110.57 175.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -95.78 34.98 1.43 Allowed 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.647 -173.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.8 pp -125.6 10.09 7.8 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 122.701 0.4 . . . . 0.0 111.296 168.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 54.4 m0 -66.05 166.75 11.05 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.252 0.621 . . . . 0.0 111.899 -176.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.7 t70 . . . . . 0 C--O 1.248 1.014 0 C-N-CA 123.532 0.733 . . . . 0.0 109.361 -176.72 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.799 0 N-CA-C 112.245 -0.342 . . . . 0.0 112.245 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 64.8 p -153.92 138.87 17.22 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.427 0.691 . . . . 0.0 109.859 176.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 52.4 m-70 -100.59 97.97 8.6 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.555 0.742 . . . . 0.0 109.727 -176.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 93.4 mmm -75.7 89.14 2.8 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 174.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -134.0 128.0 33.48 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.574 0.75 . . . . 0.0 109.152 -175.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -85.61 108.14 17.85 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.805 0.842 . . . . 0.0 109.326 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.6 tt -123.83 125.56 71.3 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.132 0 C-N-CA 124.12 0.968 . . . . 0.0 111.068 -173.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -86.07 97.82 10.51 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.658 0.783 . . . . 0.0 109.064 171.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.3 t -145.72 163.71 34.08 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.208 0.528 . . . . 0.0 110.718 176.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.601 ' HD2' ' H ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -91.03 -24.66 19.99 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.931 174.49 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.476 ' O ' ' HG2' ' A' ' 15' ' ' GLU . . . -52.98 -42.08 65.2 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.456 0.702 . . . . 0.0 111.656 -178.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -61.06 -46.86 88.98 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.736 0.815 . . . . 0.0 112.199 -176.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.3 p -74.8 -31.39 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 122.722 0.409 . . . . 0.0 110.562 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.5 HG23 ' HE1' ' A' ' 66' ' ' TYR . 61.6 mt -65.11 -34.24 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.737 0.815 . . . . 0.0 110.811 178.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 19.1 mm-40 -69.37 -32.99 72.39 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.637 174.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.38 -37.25 82.7 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 122.938 0.495 . . . . 0.0 111.072 177.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -62.56 -41.23 98.78 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.972 173.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.465 ' HE3' HG22 ' A' ' 14' ' ' ILE . 92.9 mttt -71.46 -27.61 63.38 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.025 0.53 . . . . 0.0 111.508 -178.051 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 15' ' ' GLU . 92.3 t -69.97 -33.44 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.494 0.718 . . . . 0.0 109.963 174.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -74.61 -43.74 54.07 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.443 174.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -72.27 104.94 3.85 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -176.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -94.79 -15.36 23.86 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.52 0.728 . . . . 0.0 112.234 -178.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.406 ' HB2' ' ND2' ' A' ' 25' ' ' ASN . 20.8 m-20 -92.43 -26.35 18.05 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 120.87 0.367 . . . . 0.0 111.069 -176.105 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.66 42.78 12.95 Favored Glycine 0 C--N 1.338 0.649 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.865 -171.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.406 ' ND2' ' HB2' ' A' ' 23' ' ' ASP . 48.5 m-80 -65.94 -23.86 66.69 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.613 0.765 . . . . 0.0 111.11 178.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.05 -32.82 6.47 Favored Glycine 0 C--N 1.347 1.17 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 -178.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.424 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 45.2 p90 -133.62 160.69 36.75 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.406 1.082 . . . . 0.0 109.636 175.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 55.0 t -110.5 161.14 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.178 0.991 . . . . 0.0 110.41 -174.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 63' ' ' TYR . 73.1 p -56.15 151.6 12.08 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 124.191 0.996 . . . . 0.0 111.982 172.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.8 p -67.21 -20.71 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.409 174.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -58.97 -62.19 2.07 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.74 1.216 . . . . 0.0 111.635 176.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -65.37 -30.11 70.9 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.973 0.509 . . . . 0.0 111.012 -178.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.692 HD22 HG11 ' A' ' 64' ' ' VAL . 6.5 tp -54.75 -50.92 67.24 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 123.717 0.635 . . . . 0.0 109.977 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.546 ' HG2' HD13 ' A' ' 53' ' ' ILE . 37.1 mtm180 -61.67 -37.96 86.02 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.862 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -65.7 -53.04 46.38 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.415 0.686 . . . . 0.0 112.179 -175.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.06 -26.88 35.47 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.957 -176.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 87.3 mt -86.81 -16.07 37.31 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.322 0.649 . . . . 0.0 111.779 178.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -74.79 -43.01 57.03 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.188 0.595 . . . . 0.0 110.124 175.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -72.75 -32.63 65.8 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 122.94 0.496 . . . . 0.0 110.794 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.424 HD13 ' HZ ' ' A' ' 74' ' ' PHE . 95.6 mt -78.46 -21.36 49.2 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.257 0.623 . . . . 0.0 110.514 174.048 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.73 ' HA2' ' HB2' ' A' ' 44' ' ' MET . . . -83.34 46.71 3.69 Favored Glycine 0 C--N 1.349 1.263 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 169.129 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -79.56 -55.16 5.23 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.886 0.874 . . . . 0.0 109.123 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 64.1 mtt -105.33 11.7 32.52 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.734 174.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.73 ' HB2' ' HA2' ' A' ' 41' ' ' GLY . 55.9 mtt -113.15 150.98 43.84 Favored Pre-proline 0 N--CA 1.48 1.068 0 C-N-CA 124.464 1.106 . . . . 0.0 108.579 176.454 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -68.7 115.39 3.91 Favored 'Trans proline' 0 C--N 1.374 1.886 0 C-N-CA 122.438 2.092 . . . . 0.0 110.926 172.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.44 -37.66 77.46 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.577 0.751 . . . . 0.0 110.824 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -63.46 -32.85 74.41 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.853 0.861 . . . . 0.0 111.644 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.473 ' O ' ' HG3' ' A' ' 52' ' ' MET . 40.3 tt0 -60.24 -39.4 86.56 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.625 1.17 . . . . 0.0 110.375 176.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 63.6 mt -77.89 -41.04 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.273 177.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -54.76 -46.0 74.27 Favored 'General case' 0 C--N 1.354 0.802 0 O-C-N 124.074 0.859 . . . . 0.0 111.091 -177.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -60.99 -37.37 82.24 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-O 120.66 0.267 . . . . 0.0 111.145 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.473 ' HG3' ' O ' ' A' ' 48' ' ' GLU . 43.0 mtm -72.73 -29.76 63.62 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.254 0.622 . . . . 0.0 110.653 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.546 HD13 ' HG2' ' A' ' 34' ' ' ARG . 77.1 mt -71.74 -33.87 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 124.136 0.975 . . . . 0.0 110.006 175.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -77.71 -10.6 59.61 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.02 0.928 . . . . 0.0 110.61 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -94.17 -27.61 16.11 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.316 1.047 . . . . 0.0 110.376 168.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.49 -30.74 59.97 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.55 0.74 . . . . 0.0 111.547 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -148.64 81.25 7.9 Favored Pre-proline 0 N--CA 1.478 0.961 0 C-N-CA 123.091 0.556 . . . . 0.0 109.836 172.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -83.32 -11.71 9.49 Favored 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.928 2.419 . . . . 0.0 113.132 172.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 20.7 tm0? -78.22 -23.35 47.5 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.671 0.789 . . . . 0.0 110.27 -174.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.3 t30 67.19 53.06 0.8 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.984 1.314 . . . . 0.0 108.926 -172.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.5 m -79.77 -24.36 41.56 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.742 173.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.91 23.9 63.06 Favored Glycine 0 C--N 1.346 1.113 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.995 -174.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 29' ' ' THR . 72.9 m-85 -144.44 159.84 42.07 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.768 0.827 . . . . 0.0 111.438 -174.21 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.692 HG11 HD22 ' A' ' 33' ' ' LEU . 5.4 p -167.58 143.93 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.379 1.072 . . . . 0.0 109.406 175.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -82.2 104.99 12.93 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 172.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.5 ' HE1' HG23 ' A' ' 14' ' ' ILE . 53.2 p90 -64.48 -32.27 73.83 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.999 0.52 . . . . 0.0 111.013 178.14 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -55.06 -42.03 72.23 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.818 0.847 . . . . 0.0 110.87 174.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 19.1 m -76.83 -53.46 7.88 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.576 179.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -69.39 -54.33 14.95 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.109 -169.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.59 ' HA ' ' HB3' ' A' ' 73' ' ' LEU . 57.8 t -62.72 -19.09 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.372 0 C-N-CA 123.288 0.635 . . . . 0.0 111.283 177.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -71.29 -35.26 63.77 Favored Glycine 0 C--N 1.351 1.388 0 CA-C-N 116.435 -0.348 . . . . 0.0 113.39 172.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 28.3 ptm -98.24 -3.99 36.24 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.543 0.737 . . . . 0.0 111.527 177.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.59 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 9.8 tp -97.61 -53.02 3.56 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.448 1.099 . . . . 0.0 110.576 -178.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.472 ' HB3' ' HE3' ' A' ' 10' ' ' LYS . 3.4 m-85 -83.81 27.87 0.61 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.688 0.795 . . . . 0.0 112.893 -174.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.7 pp -77.86 -0.09 25.99 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.956 0.503 . . . . 0.0 111.127 169.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 49.5 m0 -65.16 107.77 1.67 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.874 1.269 . . . . 0.0 110.816 177.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.7 t70 . . . . . 0 C--O 1.247 0.938 0 C-N-CA 124.981 1.313 . . . . 0.0 107.791 -179.947 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.289 0 N-CA-C 112.221 -0.351 . . . . 0.0 112.221 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.1 p -81.2 -5.14 57.4 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.541 0.737 . . . . 0.0 111.766 177.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.0 m80 -62.32 121.63 13.66 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.589 0.756 . . . . 0.0 110.799 174.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 59.3 mtt -120.16 123.11 42.51 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.517 1.127 . . . . 0.0 108.147 178.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -86.77 63.91 8.22 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 122.261 1.029 . . . . 0.0 109.62 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 60.1 m80 -129.68 -24.7 2.69 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.96 173.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.9 tp -69.79 102.36 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 169.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -99.1 73.0 1.9 Allowed 'General case' 0 C--O 1.242 0.671 0 CA-C-N 115.418 -0.81 . . . . 0.0 108.967 -175.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.453 ' HB ' ' HG3' ' A' ' 12' ' ' GLN . 26.4 m -90.4 126.33 35.85 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.182 172.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -70.39 -11.84 61.18 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.15 0.58 . . . . 0.0 111.774 -177.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.463 ' O ' ' HG2' ' A' ' 15' ' ' GLU . . . -75.82 -39.79 56.11 Favored 'General case' 0 C--O 1.216 -0.705 0 C-N-CA 123.117 0.567 . . . . 0.0 110.738 171.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.453 ' HG3' ' HB ' ' A' ' 9' ' ' THR . 56.8 mt-30 -58.5 -38.58 77.95 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 123.272 0.629 . . . . 0.0 112.588 -174.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.3 p -65.9 -40.14 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 175.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.432 HG22 ' HE3' ' A' ' 18' ' ' LYS . 64.3 mt -64.77 -31.82 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 123.393 0.677 . . . . 0.0 110.423 176.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 10.4 mm-40 -71.4 -27.73 63.52 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.082 0.553 . . . . 0.0 110.983 178.266 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.9 -35.63 81.76 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 122.919 0.488 . . . . 0.0 110.996 177.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.515 ' CZ ' HD12 ' A' ' 33' ' ' LEU . 95.7 m-85 -64.03 -35.65 81.43 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.482 0.713 . . . . 0.0 110.951 174.209 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.432 ' HE3' HG22 ' A' ' 14' ' ' ILE . 90.9 mttt -77.19 -29.67 54.45 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.0 -177.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 74.1 t -69.33 -37.76 76.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 123.452 0.701 . . . . 0.0 109.769 172.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -71.48 -46.95 58.48 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.718 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -83.76 81.05 8.93 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.878 0.847 . . . . 0.0 109.014 -177.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 29.6 mtm180 -86.04 -18.42 32.52 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 113.947 -1.478 . . . . 0.0 110.076 177.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -80.01 -25.86 40.06 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.766 0.826 . . . . 0.0 111.568 -175.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.27 52.53 3.97 Favored Glycine 0 C--N 1.341 0.837 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.637 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -80.76 -19.17 45.48 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.24 1.016 . . . . 0.0 109.827 173.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.82 -56.17 3.74 Favored Glycine 0 C--N 1.347 1.175 0 N-CA-C 111.164 -0.775 . . . . 0.0 111.164 -175.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -118.97 156.91 28.75 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.326 1.05 . . . . 0.0 110.194 178.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.5 t -110.56 157.25 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 123.636 0.775 . . . . 0.0 109.503 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 68.7 p -65.28 166.5 9.83 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.107 0.963 . . . . 0.0 112.345 178.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.656 HG23 HG21 ' A' ' 53' ' ' ILE . 7.2 p -63.42 -33.48 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.332 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -64.09 -49.19 73.24 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.311 0.244 . . . . 0.0 111.627 -172.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -67.59 -36.88 81.72 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.488 176.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.592 HD22 HG11 ' A' ' 64' ' ' VAL . 12.1 tp -56.1 -43.88 78.51 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.665 0.603 . . . . 0.0 110.687 177.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 34.8 mtm105 -72.26 -34.67 68.41 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.097 0.559 . . . . 0.0 110.411 177.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -63.05 -50.7 69.6 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.651 0.78 . . . . 0.0 111.899 -174.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.3 p -64.82 -33.48 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 122.889 0.475 . . . . 0.0 110.83 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.419 HD13 HG21 ' A' ' 49' ' ' ILE . 80.5 mt -85.51 -8.51 58.29 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 123.766 0.827 . . . . 0.0 111.367 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -87.09 -36.2 18.27 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.1 1.36 . . . . 0.0 108.934 171.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -69.21 -35.17 75.92 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.848 0.859 . . . . 0.0 109.635 173.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 93.2 mt -89.23 15.52 8.8 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.762 0.825 . . . . 0.0 110.491 169.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 44' ' ' MET . . . -74.92 -10.05 83.69 Favored Glycine 0 C--N 1.353 1.515 0 C-N-CA 123.851 0.739 . . . . 0.0 113.626 -173.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -68.13 -32.77 73.28 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.324 0.649 . . . . 0.0 110.342 174.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 93.6 mmm -107.46 -31.1 8.29 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.62 0.768 . . . . 0.0 111.699 178.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.618 ' HB3' HD11 ' A' ' 49' ' ' ILE . 24.9 mmt -113.21 104.92 55.72 Favored Pre-proline 0 N--CA 1.479 1.002 0 C-N-CA 123.539 0.735 . . . . 0.0 109.778 -173.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.42 117.93 4.73 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.69 2.26 . . . . 0.0 111.866 -178.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.92 -47.71 85.16 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.766 0.826 . . . . 0.0 111.572 -176.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -53.93 -40.66 66.93 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 123.798 0.839 . . . . 0.0 111.723 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -62.47 -52.17 64.58 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.216 178.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.618 HD11 ' HB3' ' A' ' 44' ' ' MET . 79.1 mt -62.75 -40.32 88.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.859 -178.285 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.513 ' HA ' HD12 ' A' ' 53' ' ' ILE . 51.2 mt-10 -63.17 -34.05 76.79 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.139 0.576 . . . . 0.0 111.06 -175.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -67.78 -36.3 80.22 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 121.146 0.498 . . . . 0.0 110.379 175.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 20.0 mmt -67.14 -29.7 69.49 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.587 0.755 . . . . 0.0 110.807 177.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.656 HG21 HG23 ' A' ' 30' ' ' VAL . 50.2 mt -71.39 -31.1 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 123.118 0.567 . . . . 0.0 110.754 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -64.35 -28.95 70.05 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 122.898 0.479 . . . . 0.0 110.711 175.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -78.91 -37.51 39.75 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.032 0.533 . . . . 0.0 110.466 174.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.02 -25.6 61.02 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.9 0.88 . . . . 0.0 112.183 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -140.47 81.8 17.06 Favored Pre-proline 0 CA--C 1.548 0.889 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 175.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -65.58 -14.44 44.83 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 123.462 2.775 . . . . 0.0 112.788 175.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -69.2 -26.05 64.64 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.408 0.683 . . . . 0.0 110.911 176.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.1 t30 59.15 24.1 12.43 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.482 1.113 . . . . 0.0 110.824 -178.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.8 m -83.6 -16.46 45.17 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.791 0.836 . . . . 0.0 110.682 -178.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.86 29.84 22.34 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-N 115.589 -0.732 . . . . 0.0 113.28 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -126.82 107.75 10.4 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.872 0.869 . . . . 0.0 109.135 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.592 HG11 HD22 ' A' ' 33' ' ' LEU . 3.3 p -136.01 135.8 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 123.162 0.585 . . . . 0.0 110.89 -173.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -76.13 98.38 4.36 Favored 'General case' 0 C--N 1.35 0.609 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 174.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -55.08 -34.43 63.62 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.238 1.015 . . . . 0.0 112.809 -178.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -58.05 -57.01 14.7 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.522 0.729 . . . . 0.0 110.162 -176.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.2 p -68.76 -39.87 80.03 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.389 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -67.4 -67.27 0.47 Allowed 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 119.21 -0.424 . . . . 0.0 111.974 -177.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.616 ' HA ' ' HB3' ' A' ' 73' ' ' LEU . 57.6 t -52.4 -26.06 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 C-N-CA 124.808 1.243 . . . . 0.0 112.232 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.96 -54.58 29.72 Favored Glycine 0 CA--C 1.541 1.67 0 N-CA-C 112.469 -0.252 . . . . 0.0 112.469 168.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 64.0 mtm -73.59 -12.1 60.64 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.705 0.802 . . . . 0.0 112.236 178.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.616 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 52.3 tp -86.49 -41.57 14.27 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.375 1.07 . . . . 0.0 110.094 -178.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.414 ' HA ' ' CD1' ' A' ' 76' ' ' TRP . 8.2 m-85 -89.74 34.26 0.84 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.379 0.672 . . . . 0.0 111.699 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 92.2 mt -77.42 -15.33 59.4 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.849 0.46 . . . . 0.0 110.877 170.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.414 ' CD1' ' HA ' ' A' ' 74' ' ' PHE . 0.3 OUTLIER -82.6 2.27 34.11 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 124.286 1.035 . . . . 0.0 112.176 174.147 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.0 t70 . . . . . 0 C--O 1.251 1.168 0 C-N-CA 123.835 0.854 . . . . 0.0 111.06 -179.503 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.71 0 CA-C-O 120.073 -0.293 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.8 p -70.36 92.44 0.8 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.058 0.943 . . . . 0.0 111.649 -178.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -85.19 -43.09 14.12 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 170.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -93.34 106.33 18.3 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 170.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 33.2 p-10 -108.67 12.97 25.47 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.023 0.929 . . . . 0.0 110.822 -177.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 -67.86 -18.15 64.72 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.409 1.084 . . . . 0.0 111.594 -177.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.0 tt -74.35 103.16 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.142 0 CA-C-O 121.567 0.699 . . . . 0.0 110.502 176.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -102.59 98.77 8.78 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.389 1.076 . . . . 0.0 109.044 175.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.1 m -150.12 148.41 28.94 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.731 0.812 . . . . 0.0 109.998 -177.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.447 ' O ' HG12 ' A' ' 14' ' ' ILE . 0.0 OUTLIER -62.34 -20.17 64.09 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 175.243 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.503 ' O ' ' HG2' ' A' ' 15' ' ' GLU . . . -54.95 -48.94 72.54 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.406 0.683 . . . . 0.0 110.381 175.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -63.25 -38.45 91.2 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.982 0.913 . . . . 0.0 112.753 -171.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.5 p -69.01 -41.0 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 177.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.467 HG22 ' HE3' ' A' ' 18' ' ' LYS . 48.1 mm -63.35 -37.84 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 123.37 0.668 . . . . 0.0 110.958 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.503 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 20.3 mm-40 -73.07 -28.53 62.36 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.014 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.76 -35.3 80.14 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.288 0.635 . . . . 0.0 110.985 177.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -61.94 -41.88 98.47 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.025 173.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.467 ' HE3' HG22 ' A' ' 14' ' ' ILE . 96.5 mttt -68.03 -27.55 66.64 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.444 0.698 . . . . 0.0 112.072 -173.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.2 t -71.26 -39.85 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.129 0.572 . . . . 0.0 109.851 175.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -71.17 -40.35 71.34 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.756 177.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.428 ' HB2' HG22 ' A' ' 28' ' ' VAL . 27.7 t0 -85.28 70.79 10.88 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 122.12 0.962 . . . . 0.0 108.993 -179.332 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -67.45 -29.35 68.78 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 113.834 -1.53 . . . . 0.0 109.681 176.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -69.84 -25.99 64.0 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.673 -178.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.16 41.45 47.03 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.55 173.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -68.56 -20.36 64.53 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.502 0.721 . . . . 0.0 111.312 176.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.37 -26.17 25.51 Favored Glycine 0 C--N 1.348 1.24 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.686 -177.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -136.04 166.89 22.32 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.161 0.984 . . . . 0.0 109.557 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.428 HG22 ' HB2' ' A' ' 21' ' ' ASP . 81.3 t -118.79 153.45 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.046 0.938 . . . . 0.0 109.233 176.278 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.8 p -60.93 155.95 18.68 Favored 'General case' 0 C--O 1.248 0.983 0 C-N-CA 123.551 0.74 . . . . 0.0 111.247 173.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.407 ' O ' ' HG3' ' A' ' 34' ' ' ARG . 9.7 p -62.82 -24.09 34.77 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-N 116.167 -0.47 . . . . 0.0 112.196 -175.106 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -60.33 -60.1 4.35 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.195 0.598 . . . . 0.0 111.851 -176.002 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -63.74 -32.67 74.23 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.069 0.548 . . . . 0.0 110.479 178.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.423 HD13 HG13 ' A' ' 64' ' ' VAL . 4.4 tt -61.37 -44.48 97.1 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.879 0.872 . . . . 0.0 111.551 179.161 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.407 ' HG3' ' O ' ' A' ' 30' ' ' VAL . 50.7 mtm180 -68.21 -38.99 82.51 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.941 0.496 . . . . 0.0 109.915 177.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -61.55 -47.14 86.91 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 124.165 0.916 . . . . 0.0 111.35 -177.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.4 p -73.43 -25.5 21.22 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.699 -176.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.633 HD11 HG22 ' A' ' 70' ' ' VAL . 96.6 mt -86.9 -15.19 39.74 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.821 0.448 . . . . 0.0 111.311 175.422 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -88.36 -30.95 19.15 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 176.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -78.15 -24.34 47.36 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 110.513 -0.18 . . . . 0.0 110.513 176.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 60.3 mt -95.81 12.22 30.85 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.595 0.758 . . . . 0.0 109.791 169.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.468 ' HA2' ' SD ' ' A' ' 44' ' ' MET . . . -144.84 55.83 0.55 Allowed Glycine 0 C--N 1.349 1.26 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 -175.082 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -68.69 -64.88 0.78 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.495 0.718 . . . . 0.0 110.359 -177.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.87 -4.34 43.81 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.75 177.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.468 ' SD ' ' HA2' ' A' ' 41' ' ' GLY . 1.2 mpt? -74.74 133.55 76.39 Favored Pre-proline 0 CA--C 1.546 0.801 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 172.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -65.54 114.99 3.12 Favored 'Trans proline' 0 C--N 1.37 1.69 0 C-N-CA 122.023 1.815 . . . . 0.0 110.438 173.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.85 -13.24 59.54 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.015 0.526 . . . . 0.0 111.343 177.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.42 ' O ' ' HG2' ' A' ' 51' ' ' GLU . 1.7 m-20 -53.59 -45.78 70.12 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.561 1.144 . . . . 0.0 111.925 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -59.88 -40.95 90.42 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.133 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 84.2 mt -67.89 -35.7 73.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 124.023 0.929 . . . . 0.0 110.274 178.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -66.09 -40.35 90.73 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.594 0.758 . . . . 0.0 110.769 177.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 47' ' ' ASP . 16.3 mm-40 -65.55 -33.48 76.01 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.249 0.62 . . . . 0.0 110.966 177.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.407 ' HB3' ' HE1' ' A' ' 69' ' ' PHE . 21.3 mmt -68.4 -37.45 80.37 Favored 'General case' 0 CA--C 1.55 0.96 0 O-C-N 123.939 0.774 . . . . 0.0 110.117 174.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 70.4 mt -62.05 -38.39 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 124.243 1.017 . . . . 0.0 111.676 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -57.71 -32.0 66.97 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.086 0.554 . . . . 0.0 111.649 178.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -87.8 -38.71 15.49 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.799 0.84 . . . . 0.0 110.591 178.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.66 -20.98 60.41 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.08 0.952 . . . . 0.0 111.917 -175.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -138.95 83.67 18.17 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 174.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -77.76 -13.84 15.95 Favored 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 122.958 2.438 . . . . 0.0 112.276 -177.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.487 ' HG3' ' H ' ' A' ' 61' ' ' SER . 27.3 pt20 -79.16 -16.16 57.04 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.491 1.116 . . . . 0.0 112.081 -178.127 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.3 t30 63.29 18.6 11.12 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 124.708 1.203 . . . . 0.0 111.254 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.487 ' H ' ' HG3' ' A' ' 59' ' ' GLN . 19.4 m -92.67 -25.92 18.04 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.51 0.724 . . . . 0.0 110.152 -175.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.25 41.84 6.07 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 115.763 -0.653 . . . . 0.0 113.325 175.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -124.36 94.58 4.25 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.258 1.023 . . . . 0.0 108.601 175.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.423 HG13 HD13 ' A' ' 33' ' ' LEU . 3.9 p -126.9 134.27 66.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 124.01 0.924 . . . . 0.0 110.257 -170.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -76.79 108.06 9.55 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.891 0.877 . . . . 0.0 109.82 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -65.77 -38.01 87.87 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -170.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -71.02 -32.87 69.75 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 118.3 0.5 . . . . 0.0 110.126 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 31.3 m -72.19 -30.56 65.07 Favored 'General case' 0 CA--C 1.553 1.079 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.882 174.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.42 ' CE2' HD21 ' A' ' 33' ' ' LEU . 45.8 t80 -93.22 -72.1 0.62 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.083 0.553 . . . . 0.0 111.726 -176.618 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.633 HG22 HD11 ' A' ' 37' ' ' LEU . 57.6 t -59.49 -36.21 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.819 1.248 . . . . 0.0 111.346 -177.124 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -59.47 -37.42 92.07 Favored Glycine 0 C--N 1.348 1.219 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.934 174.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 94.2 mmm -81.59 -37.02 28.3 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.432 0.693 . . . . 0.0 112.26 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 pp -75.65 -24.66 56.41 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 118.303 0.501 . . . . 0.0 110.286 -175.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.423 ' CD2' ' HB3' ' A' ' 10' ' ' LYS . 6.1 m-85 -74.76 -8.05 55.23 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.573 0.349 . . . . 0.0 111.547 172.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 60.5 mt -89.05 9.25 25.98 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.995 0.518 . . . . 0.0 111.963 175.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 43.7 m0 -64.13 85.83 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 121.227 0.537 . . . . 0.0 109.986 174.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.5 t70 . . . . . 0 C--O 1.25 1.115 0 C-N-CA 125.367 1.467 . . . . 0.0 108.278 -170.458 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.271 0 N-CA-C 111.816 -0.514 . . . . 0.0 111.816 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.4 t -147.28 93.26 2.22 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.7 0.8 . . . . 0.0 109.071 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -79.87 80.17 6.3 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 176.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 17.0 tmm? -164.66 133.38 3.51 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -146.88 87.95 1.72 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.435 0.636 . . . . 0.0 109.832 179.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 18.4 t60 -55.49 108.33 0.42 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.801 1.24 . . . . 0.0 109.945 177.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.2 tt -74.75 85.08 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 CA-C-O 122.612 1.196 . . . . 0.0 111.011 -171.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -76.61 101.85 5.89 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.917 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.4 m -139.74 116.34 10.75 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -175.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.429 ' HA ' HG12 ' A' ' 13' ' ' VAL . 14.0 ptmm? -72.21 -15.84 61.94 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.029 0.532 . . . . 0.0 111.948 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.03 -42.18 73.27 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 122.643 0.377 . . . . 0.0 110.36 170.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -64.54 -39.22 93.37 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.396 0.678 . . . . 0.0 112.146 -177.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.429 HG12 ' HA ' ' A' ' 10' ' ' LYS . 11.9 p -69.68 -35.51 66.12 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 CA-C-O 119.348 -0.358 . . . . 0.0 110.307 178.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 77.0 mt -61.92 -41.69 91.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 C-N-CA 122.824 0.45 . . . . 0.0 110.11 172.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.447 ' O ' HG23 ' A' ' 19' ' ' VAL . 33.7 mm-40 -63.19 -29.5 70.83 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.281 0.632 . . . . 0.0 111.21 176.276 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.92 -32.56 73.89 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.93 0.492 . . . . 0.0 111.616 178.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.406 ' HE2' ' HA ' ' A' ' 33' ' ' LEU . 93.6 m-85 -70.25 -40.42 74.43 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 171.081 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -74.23 -9.13 58.3 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.227 -177.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 15' ' ' GLU . 93.3 t -68.73 -44.62 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 167.212 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -69.51 -55.15 11.02 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.157 179.016 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -75.15 95.84 3.17 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.557 178.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -88.27 -38.77 14.95 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.327 -176.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -76.55 -22.36 54.45 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.833 0.853 . . . . 0.0 112.393 -173.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.3 53.6 3.6 Favored Glycine 0 C--N 1.343 0.969 0 N-CA-C 111.491 -0.644 . . . . 0.0 111.491 -176.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -68.71 -30.1 68.67 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.624 1.17 . . . . 0.0 109.334 173.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.05 -59.74 0.46 Allowed Glycine 0 C--N 1.342 0.868 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.084 175.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.402 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 43.9 p90 -115.29 -171.66 2.0 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.628 0.771 . . . . 0.0 110.834 -171.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.428 HG22 ' H ' ' A' ' 29' ' ' THR . 3.0 p -139.65 178.2 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.221 0 C-N-CA 123.343 0.657 . . . . 0.0 110.484 -173.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.428 ' H ' HG22 ' A' ' 28' ' ' VAL . 68.5 p -88.13 154.11 20.72 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.008 0.923 . . . . 0.0 110.358 175.121 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.6 p -67.59 -29.77 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-N 117.861 0.3 . . . . 0.0 110.856 178.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -62.5 -46.55 87.92 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.513 178.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -72.24 -32.79 67.02 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.614 179.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.426 HD21 ' CE2' ' A' ' 69' ' ' PHE . 2.9 tt -67.79 -39.12 84.07 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.947 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 37.4 mtp-105 -72.83 -30.59 64.16 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 122.42 0.288 . . . . 0.0 110.321 174.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -63.62 -49.33 73.72 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.593 1.157 . . . . 0.0 111.075 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.474 HG13 ' HG ' ' A' ' 37' ' ' LEU . 7.0 p -69.34 -40.17 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.137 0.575 . . . . 0.0 111.627 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.474 ' HG ' HG13 ' A' ' 36' ' ' VAL . 79.7 mt -82.1 -4.8 57.65 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.48 0.712 . . . . 0.0 111.862 -176.176 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -67.84 -29.12 68.19 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.489 0.716 . . . . 0.0 111.412 175.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -59.35 -40.04 85.14 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.292 0.637 . . . . 0.0 111.792 -177.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.2 pp -92.48 7.58 42.46 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.508 0.723 . . . . 0.0 110.919 -178.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -72.98 -19.33 79.53 Favored Glycine 0 C--N 1.352 1.447 0 O-C-N 123.48 0.487 . . . . 0.0 112.496 -178.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -75.28 -27.24 59.31 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.329 0.652 . . . . 0.0 111.215 177.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 82.3 mtp -100.02 -44.65 5.94 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.723 0.809 . . . . 0.0 110.769 -175.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 23.0 mmt -120.03 145.69 40.45 Favored Pre-proline 0 N--CA 1.482 1.171 0 C-N-CA 124.839 1.256 . . . . 0.0 109.649 -177.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -58.41 119.53 6.85 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.729 2.286 . . . . 0.0 112.761 179.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.01 -30.33 63.69 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.302 174.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -55.13 -40.89 71.06 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 124.026 0.93 . . . . 0.0 111.225 174.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -51.96 -53.81 36.93 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.382 1.073 . . . . 0.0 110.695 174.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.518 HG12 HD11 ' A' ' 73' ' ' LEU . 74.0 mt -60.39 -41.93 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.96 179.124 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.561 ' HA ' HD12 ' A' ' 53' ' ' ILE . 42.7 mt-10 -66.01 -34.69 78.68 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.502 0.721 . . . . 0.0 112.12 -175.199 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -70.07 -39.49 75.6 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 120.951 0.405 . . . . 0.0 110.32 175.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 48.0 mmm -59.53 -34.25 72.39 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.948 0.899 . . . . 0.0 110.568 174.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.561 HD12 ' HA ' ' A' ' 50' ' ' GLU . 85.1 mt -62.56 -34.42 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.851 0.86 . . . . 0.0 112.149 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -60.95 -25.96 67.18 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -177.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -89.91 -28.54 19.13 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 122.776 0.43 . . . . 0.0 111.219 176.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.2 -34.43 68.37 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.374 0.669 . . . . 0.0 111.164 178.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -132.03 80.81 63.8 Favored Pre-proline 0 CA--C 1.548 0.878 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 175.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -82.29 -3.8 11.59 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.988 2.459 . . . . 0.0 112.684 -179.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -86.73 -14.88 41.14 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.354 1.061 . . . . 0.0 111.586 -179.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 61.26 30.7 19.31 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 124.611 1.164 . . . . 0.0 110.615 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.6 t -109.19 -3.74 17.04 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.799 0.84 . . . . 0.0 111.111 -172.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.99 19.83 74.32 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 114.852 0.701 . . . . 0.0 114.852 172.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -110.05 94.75 5.18 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 177.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.3 p -111.99 130.64 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.55 0.74 . . . . 0.0 110.551 -174.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.402 ' HA ' ' HB2' ' A' ' 27' ' ' TYR . 46.0 mt-30 -85.71 93.98 8.99 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 175.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -55.26 -29.84 58.91 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.592 0.757 . . . . 0.0 111.746 176.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -48.84 -55.87 10.38 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.083 1.753 . . . . 0.0 111.168 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.1 t -87.43 -30.58 20.6 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 114.466 -1.243 . . . . 0.0 110.51 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.426 ' CE2' HD21 ' A' ' 33' ' ' LEU . 52.1 t80 -67.07 -65.3 0.7 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.865 0.466 . . . . 0.0 111.7 -174.315 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.55 ' HA ' ' HB3' ' A' ' 73' ' ' LEU . 99.1 t -50.41 -29.45 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 124.837 1.255 . . . . 0.0 112.3 175.569 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.17 -50.63 65.59 Favored Glycine 0 CA--C 1.535 1.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.849 171.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 24.7 ptm -84.59 -15.48 45.48 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.349 0.66 . . . . 0.0 111.706 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.55 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 66.8 tp -77.25 -51.76 10.37 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.186 0.994 . . . . 0.0 109.9 -174.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -83.59 34.96 0.49 Allowed 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 123.593 0.757 . . . . 0.0 111.546 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 53.5 mt -96.29 23.13 6.94 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.751 0.82 . . . . 0.0 110.989 169.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 7.0 m0 -71.9 84.39 0.95 Allowed 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 170.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.9 t70 . . . . . 0 C--O 1.252 1.195 0 C-N-CA 123.65 0.78 . . . . 0.0 109.107 -176.611 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.318 0 CA-C-O 119.522 -0.599 . . . . 0.0 112.059 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.4 m 62.37 13.62 6.19 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 125.053 1.341 . . . . 0.0 112.411 -178.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 53.4 m80 -141.41 95.0 2.76 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.01 0.924 . . . . 0.0 110.043 -172.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 47.5 tpp -82.8 132.43 35.17 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.641 0.776 . . . . 0.0 109.955 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -83.19 73.71 10.07 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 122.148 0.975 . . . . 0.0 110.487 179.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -91.27 77.52 5.89 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.091 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.2 tt -101.41 100.74 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 CA-C-O 121.745 0.783 . . . . 0.0 109.496 -178.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -88.94 95.02 10.14 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.831 -174.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.1 t -154.67 152.02 29.46 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.162 177.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.464 ' HE3' ' HA2' ' A' ' 71' ' ' GLY . 13.3 ptmm? -70.68 -20.34 62.7 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.637 0.775 . . . . 0.0 111.234 175.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.471 ' O ' ' HG2' ' A' ' 15' ' ' GLU . . . -55.84 -34.68 65.65 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.073 0.949 . . . . 0.0 111.703 178.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.4 mm100 -60.41 -52.99 62.88 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.525 0.73 . . . . 0.0 112.176 -177.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.4 p -65.85 -29.87 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 122.5 0.32 . . . . 0.0 110.458 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.438 ' HA ' ' HD2' ' A' ' 17' ' ' PHE . 94.1 mt -70.05 -34.41 59.4 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 123.404 0.682 . . . . 0.0 110.873 177.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 18.7 mm-40 -62.49 -28.36 69.78 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.372 0.669 . . . . 0.0 110.961 175.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.14 -44.95 86.95 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.175 0.59 . . . . 0.0 110.444 175.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.438 ' HD2' ' HA ' ' A' ' 14' ' ' ILE . 99.6 m-85 -68.44 -32.96 73.35 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.489 178.06 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -79.24 -29.0 42.46 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.191 0.596 . . . . 0.0 112.097 -177.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.7 p -82.08 -15.55 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 CA-C-O 121.031 0.443 . . . . 0.0 110.079 173.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -78.38 -50.71 11.23 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 172.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -96.33 88.01 4.63 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.572 0.749 . . . . 0.0 109.627 178.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -94.44 1.95 55.76 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.502 173.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -90.95 -25.47 19.74 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.493 0.717 . . . . 0.0 111.279 -175.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.21 38.66 12.54 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.078 -175.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -64.23 -26.4 68.49 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.453 1.101 . . . . 0.0 109.049 169.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.32 -32.98 6.71 Favored Glycine 0 C--N 1.352 1.438 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.487 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.462 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 51.6 p90 -144.96 -179.42 6.6 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.476 0.71 . . . . 0.0 111.003 -176.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.6 t -126.43 156.01 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.528 1.131 . . . . 0.0 110.042 -172.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.4 p -66.3 149.57 50.17 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.856 0.862 . . . . 0.0 111.162 173.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.9 p -68.49 -19.1 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 122.74 0.416 . . . . 0.0 112.068 -173.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -56.49 -51.81 67.09 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.522 0.729 . . . . 0.0 111.313 175.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -69.73 -32.56 71.19 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.075 -179.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.422 HD12 ' CZ ' ' A' ' 17' ' ' PHE . 9.0 tp -58.41 -55.39 35.69 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 123.923 0.764 . . . . 0.0 110.331 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.561 ' HG2' HD13 ' A' ' 53' ' ' ILE . 94.3 mtt180 -65.94 -27.19 67.99 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.605 -178.469 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -70.01 -52.7 22.03 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.787 0.835 . . . . 0.0 111.27 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.5 p -75.19 -29.9 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.409 -175.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 95.4 mt -80.65 -10.51 59.73 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.917 0.487 . . . . 0.0 111.259 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -74.83 -44.24 50.31 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 165.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -62.88 -35.53 80.32 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.217 -179.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -85.43 -42.27 14.66 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.296 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -91.94 67.72 2.07 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.762 -168.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -86.62 -57.88 2.82 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.686 0.794 . . . . 0.0 109.539 173.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -71.73 -34.75 69.81 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.739 0.816 . . . . 0.0 110.758 178.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 19.5 mmt -95.99 101.19 7.79 Favored Pre-proline 0 N--CA 1.472 0.65 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 172.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.406 ' HB2' ' HG3' ' A' ' 48' ' ' GLU . 83.1 Cg_exo -48.85 129.68 21.5 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 123.338 2.692 . . . . 0.0 113.248 -171.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.02 -28.25 67.58 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.81 0.844 . . . . 0.0 111.336 -178.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -65.96 -41.76 90.81 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.958 0.903 . . . . 0.0 111.206 175.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 52' ' ' MET . 38.7 mt-10 -72.27 -31.72 66.0 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 122.566 0.346 . . . . 0.0 110.645 178.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.407 ' O ' HG13 ' A' ' 53' ' ' ILE . 96.4 mt -64.67 -36.89 78.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 123.261 0.624 . . . . 0.0 110.088 169.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.542 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 51.1 mt-10 -69.56 -28.31 65.88 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.457 0.303 . . . . 0.0 111.66 176.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -58.12 -34.13 69.9 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.562 0.696 . . . . 0.0 110.538 170.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.421 ' HG2' ' O ' ' A' ' 48' ' ' GLU . 11.4 mmt -81.03 -37.76 28.59 Favored 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.038 177.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.561 HD13 ' HG2' ' A' ' 34' ' ' ARG . 69.0 mt -65.41 -43.02 94.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 124.467 1.107 . . . . 0.0 111.503 -175.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -59.74 -19.22 48.79 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.881 0.472 . . . . 0.0 112.049 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -84.32 -37.11 22.03 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.434 0.694 . . . . 0.0 110.92 172.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.423 ' HB2' ' CD1' ' A' ' 69' ' ' PHE . . . -60.99 -46.41 90.88 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.104 0.961 . . . . 0.0 111.09 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -109.53 82.3 2.14 Favored Pre-proline 0 CA--C 1.552 1.046 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 168.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -68.84 -34.17 18.69 Favored 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 123.341 2.694 . . . . 0.0 112.496 -167.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -87.65 -1.68 58.11 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.916 0.886 . . . . 0.0 111.149 177.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 56.68 49.99 13.48 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 124.802 1.241 . . . . 0.0 109.562 -172.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.2 m -70.42 -13.64 62.22 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 114.502 -1.226 . . . . 0.0 112.782 -172.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.43 11.23 82.36 Favored Glycine 0 C--N 1.348 1.241 0 N-CA-C 112.003 -0.439 . . . . 0.0 112.003 -173.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -135.17 145.83 48.15 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.55 1.14 . . . . 0.0 108.822 -177.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.404 ' O ' ' HB2' ' A' ' 27' ' ' TYR . 7.5 p -147.79 129.58 6.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 CA-C-O 121.251 0.548 . . . . 0.0 110.541 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -75.03 93.73 2.77 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 166.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.462 ' CE2' ' HA ' ' A' ' 27' ' ' TYR . 42.9 p90 -57.85 -40.18 79.5 Favored 'General case' 0 C--O 1.211 -0.936 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.269 -173.317 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -69.89 -33.41 72.18 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 120.976 0.417 . . . . 0.0 110.852 -177.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 25.4 m -66.64 -38.82 87.7 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.763 173.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.423 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 39.3 t80 -80.71 -72.17 0.43 Allowed 'General case' 0 C--O 1.213 -0.864 0 C-N-CA 122.915 0.486 . . . . 0.0 111.979 -178.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.616 ' HA ' ' HB3' ' A' ' 73' ' ' LEU . 87.6 t -43.37 -31.96 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 126.116 1.767 . . . . 0.0 112.565 174.244 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.464 ' HA2' ' HE3' ' A' ' 10' ' ' LYS . . . -56.4 -49.02 71.53 Favored Glycine 0 C--N 1.348 1.233 0 O-C-N 123.453 0.471 . . . . 0.0 112.925 170.505 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 81.8 mtp -83.04 -23.43 33.2 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.475 1.11 . . . . 0.0 112.157 178.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.616 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 52.5 tp -74.93 -49.55 19.8 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.044 0.938 . . . . 0.0 110.447 -172.167 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -80.38 22.14 0.57 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.139 0.976 . . . . 0.0 112.441 -178.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 59.4 mt -91.0 14.04 15.02 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 123.484 0.714 . . . . 0.0 111.402 172.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 13.4 m0 -61.48 91.89 0.03 OUTLIER 'General case' 0 C--N 1.355 0.827 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 172.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 . . . . . 0 CA--C 1.555 1.165 0 C-N-CA 124.07 0.948 . . . . 0.0 110.931 -177.422 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.209 0 N-CA-C 112.227 -0.349 . . . . 0.0 112.227 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.5 m -84.38 121.0 26.93 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.434 0.693 . . . . 0.0 109.211 175.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -108.19 89.11 2.89 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.099 0.56 . . . . 0.0 109.638 -179.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.404 ' N ' ' SD ' ' A' ' 4' ' ' MET . 2.5 mpp? -80.12 85.77 5.64 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.155 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -79.5 114.5 18.48 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 74.2 t60 -70.47 88.93 0.68 Allowed 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 172.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.1 tt -76.84 -47.01 29.07 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.498 -176.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.7 t30 59.28 15.06 4.01 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 125.449 1.499 . . . . 0.0 112.918 171.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 91.5 m -74.77 127.59 33.51 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 176.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.585 ' HD2' ' H ' ' A' ' 10' ' ' LYS . 3.0 mptp? -68.34 -16.17 63.84 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 122.93 0.492 . . . . 0.0 110.781 -170.138 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.36 -38.47 91.27 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.973 0.909 . . . . 0.0 111.605 173.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -55.41 -41.14 72.32 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 123.472 0.709 . . . . 0.0 112.003 -172.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.9 p -77.5 -40.76 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.745 -175.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 88.1 mt -61.49 -41.63 90.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 C-N-CA 123.946 0.898 . . . . 0.0 110.522 177.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.456 ' O ' HG23 ' A' ' 19' ' ' VAL . 42.8 mt-10 -71.12 -29.12 64.86 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.143 0.977 . . . . 0.0 110.587 179.235 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.21 -37.23 85.06 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.934 0.494 . . . . 0.0 110.71 175.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.403 ' HE1' ' HA ' ' A' ' 33' ' ' LEU . 79.1 m-85 -67.48 -31.94 72.42 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.135 0.574 . . . . 0.0 110.967 174.212 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -67.96 -40.16 83.27 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.709 0.403 . . . . 0.0 109.93 175.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 15' ' ' GLU . 69.7 t -60.23 -34.01 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 123.989 0.916 . . . . 0.0 110.704 176.131 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -76.81 -57.86 3.61 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.742 0.417 . . . . 0.0 110.763 179.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -76.0 91.89 3.11 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.183 0.516 . . . . 0.0 109.933 -178.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 31.6 mmm180 -91.05 -14.01 32.14 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.304 1.042 . . . . 0.0 110.2 178.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -91.76 -10.66 39.18 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.017 0.927 . . . . 0.0 111.032 -173.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.46 45.35 30.0 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-N 116.582 -0.281 . . . . 0.0 113.386 170.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -76.17 -25.67 55.45 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.671 0.788 . . . . 0.0 110.78 178.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.17 -4.12 80.69 Favored Glycine 0 C--N 1.352 1.429 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.02 -174.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -154.21 174.27 14.99 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.705 1.202 . . . . 0.0 109.285 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.9 m -123.51 -174.99 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.413 0.685 . . . . 0.0 110.831 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.5 p -91.24 162.02 14.81 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 123.741 0.817 . . . . 0.0 110.482 174.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.638 HG23 HG21 ' A' ' 53' ' ' ILE . 7.7 p -61.92 -33.05 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.909 0.884 . . . . 0.0 112.109 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -67.0 -52.07 47.19 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 122.983 0.513 . . . . 0.0 112.119 -173.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -63.74 -38.43 91.08 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 120.529 0.204 . . . . 0.0 110.6 177.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.654 HD22 HG11 ' A' ' 64' ' ' VAL . 9.0 tp -52.92 -48.82 66.97 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 124.24 0.963 . . . . 0.0 110.316 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 28.4 mtm180 -66.28 -39.13 89.2 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.419 0.688 . . . . 0.0 111.516 178.053 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -59.75 -48.72 80.53 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.293 1.037 . . . . 0.0 111.224 -176.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.8 p -78.48 -32.55 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.883 -176.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 63.0 mt -80.19 -6.09 57.2 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 121.789 -0.569 . . . . 0.0 111.085 178.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -77.32 -45.16 27.09 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.428 0.691 . . . . 0.0 109.83 170.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -76.55 -29.37 56.65 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.944 -178.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -75.73 -36.6 59.87 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 122.72 0.408 . . . . 0.0 110.015 170.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.23 56.77 1.75 Allowed Glycine 0 C--N 1.347 1.147 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.1 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -72.53 -32.8 66.39 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.821 0.848 . . . . 0.0 111.51 -176.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 52.4 mtt -118.35 14.99 13.89 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.75 0.82 . . . . 0.0 110.471 175.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.426 ' SD ' ' N ' ' A' ' 44' ' ' MET . 1.4 mpt? -110.43 142.66 26.51 Favored Pre-proline 0 N--CA 1.475 0.818 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -67.55 113.29 2.88 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 121.932 1.755 . . . . 0.0 111.442 178.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.95 -26.49 68.23 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.523 0.729 . . . . 0.0 110.577 174.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -55.47 -46.27 76.86 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.61 1.164 . . . . 0.0 110.83 172.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -63.83 -52.01 62.08 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.286 -178.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.49 ' O ' HG13 ' A' ' 53' ' ' ILE . 91.7 mt -59.85 -43.66 92.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.483 -176.009 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.501 ' HA ' HD12 ' A' ' 53' ' ' ILE . 12.9 pt-20 -68.67 -31.61 70.85 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 123.188 0.305 . . . . 0.0 111.573 -175.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -72.02 -32.56 67.28 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.581 0.353 . . . . 0.0 110.91 176.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.439 ' HB3' ' HE1' ' A' ' 69' ' ' PHE . 76.4 mmm -67.79 -23.75 65.24 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.876 0.87 . . . . 0.0 111.182 175.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.638 HG21 HG23 ' A' ' 30' ' ' VAL . 72.5 mt -70.19 -30.79 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 123.396 0.679 . . . . 0.0 111.482 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -62.88 -25.27 68.22 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.223 0.535 . . . . 0.0 110.855 178.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -86.42 -36.22 19.25 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.475 1.11 . . . . 0.0 110.508 176.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.73 -29.81 69.14 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.145 0.978 . . . . 0.0 111.841 -178.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -118.13 87.42 29.04 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.231 1.013 . . . . 0.0 108.465 173.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.6 -32.89 69.03 Favored 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 123.088 2.525 . . . . 0.0 112.139 173.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -73.3 -6.29 45.07 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.168 0.987 . . . . 0.0 112.551 -172.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.0 p30 51.33 30.54 6.1 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 125.642 1.577 . . . . 0.0 112.064 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 71.8 p -87.93 -15.13 37.44 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.525 1.13 . . . . 0.0 112.187 -171.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.76 3.5 90.47 Favored Glycine 0 C--N 1.347 1.139 0 CA-C-N 116.322 -0.399 . . . . 0.0 112.478 -171.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -107.44 128.92 54.91 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 175.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.654 HG11 HD22 ' A' ' 33' ' ' LEU . 5.0 p -127.97 130.77 69.93 Favored 'Isoleucine or valine' 0 C--O 1.246 0.893 0 C-N-CA 123.113 0.565 . . . . 0.0 110.831 -172.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -73.86 91.57 1.98 Allowed 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 168.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -59.07 -30.94 68.44 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.046 176.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -61.98 -38.42 88.52 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.935 0.894 . . . . 0.0 110.567 -171.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 69.9 p -83.29 -44.03 15.37 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.464 177.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.439 ' HE1' ' HB3' ' A' ' 52' ' ' MET . 28.2 t80 -67.82 -60.88 2.17 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.701 0.8 . . . . 0.0 112.809 -172.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.7 t -65.07 -21.45 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.345 1.058 . . . . 0.0 111.151 -177.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.446 ' O ' ' HG ' ' A' ' 75' ' ' LEU . . . -58.63 -51.65 57.65 Favored Glycine 0 CA--C 1.534 1.254 0 N-CA-C 111.608 -0.597 . . . . 0.0 111.608 166.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 61.8 mtm -66.16 -32.83 74.51 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.982 0.913 . . . . 0.0 112.435 -179.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.4 mt -63.72 -35.31 80.14 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 121.219 0.533 . . . . 0.0 111.067 177.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -99.82 10.34 41.49 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.66 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 71' ' ' GLY . 81.8 mt -90.24 -13.18 35.94 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.164 0.586 . . . . 0.0 109.582 162.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 51.0 m0 -56.8 -44.16 81.66 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.532 0.733 . . . . 0.0 109.998 171.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.2 t70 . . . . . 0 C--O 1.249 1.066 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.744 174.07 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.351 0 N-CA-C 111.859 -0.496 . . . . 0.0 111.859 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.3 t -70.35 113.4 7.46 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.741 0.816 . . . . 0.0 109.941 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -160.16 119.8 2.84 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.652 0.781 . . . . 0.0 109.068 177.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 59.9 ttp -75.63 134.33 40.66 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.159 0.584 . . . . 0.0 110.129 177.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -150.56 146.46 26.58 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.234 1.014 . . . . 0.0 109.32 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 19.3 t-80 -93.98 -57.38 2.55 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.717 0.407 . . . . 0.0 109.923 178.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.5 tt -120.46 74.36 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 122.828 1.299 . . . . 0.0 110.81 -174.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -91.9 -17.25 25.49 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.619 165.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.1 t -155.5 166.4 33.64 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.642 1.177 . . . . 0.0 109.655 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.442 ' O ' HG12 ' A' ' 13' ' ' VAL . 10.2 ptpp? -75.35 -6.42 49.83 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.09 0.956 . . . . 0.0 111.55 178.109 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.436 ' O ' ' HG2' ' A' ' 15' ' ' GLU . . . -57.17 -23.67 49.12 Favored 'General case' 0 C--O 1.209 -1.051 0 C-N-CA 123.177 0.591 . . . . 0.0 112.422 177.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -51.89 -45.64 64.25 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.402 0.681 . . . . 0.0 112.296 177.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 10' ' ' LYS . 12.4 p -80.3 -36.79 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 68.2 mt -64.8 -36.53 77.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 123.524 0.729 . . . . 0.0 111.13 -177.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.494 ' O ' HG23 ' A' ' 19' ' ' VAL . 37.4 mm-40 -73.25 -31.06 63.88 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.788 0.435 . . . . 0.0 110.526 178.629 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.91 -35.69 73.49 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.146 0.498 . . . . 0.0 110.599 175.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.445 ' CZ ' HG21 ' A' ' 70' ' ' VAL . 81.5 m-85 -65.49 -42.53 92.06 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.009 172.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -73.45 -17.52 61.23 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.463 0.705 . . . . 0.0 111.823 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 15' ' ' GLU . 70.7 t -76.93 -30.07 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.956 0.902 . . . . 0.0 109.565 171.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -77.88 -58.52 3.22 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 174.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -82.73 82.91 7.87 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.613 0.765 . . . . 0.0 109.822 178.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -93.26 -14.29 27.21 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 114.086 -1.415 . . . . 0.0 109.535 173.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -70.75 -25.4 62.9 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.813 0.845 . . . . 0.0 110.726 176.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.07 43.09 8.97 Favored Glycine 0 C--N 1.347 1.163 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.777 173.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -72.1 -16.92 62.02 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.508 0.723 . . . . 0.0 110.412 172.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.58 -28.71 13.69 Favored Glycine 0 C--N 1.348 1.22 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.08 178.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.493 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 36.9 p90 -142.13 164.28 30.59 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 124.397 1.079 . . . . 0.0 109.916 -178.474 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 79.6 t -109.65 149.29 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.03 0.932 . . . . 0.0 109.915 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 75.9 p -66.05 157.4 31.09 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.574 0.75 . . . . 0.0 111.0 174.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.572 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 7.1 p -65.25 -16.83 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 122.846 0.458 . . . . 0.0 111.463 178.537 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -55.38 -57.07 13.35 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.038 0.935 . . . . 0.0 111.219 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -76.99 -34.42 57.52 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.605 177.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.572 ' HB3' ' HA ' ' A' ' 30' ' ' VAL . 3.0 tt -61.46 -39.66 91.68 Favored 'General case' 0 CA--C 1.549 0.916 0 O-C-N 123.67 0.606 . . . . 0.0 111.723 -174.379 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.566 ' HG3' HG22 ' A' ' 30' ' ' VAL . 63.8 mtt180 -67.89 -40.34 83.53 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-O 119.559 -0.257 . . . . 0.0 110.923 175.558 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -55.07 -58.0 9.45 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 123.93 0.769 . . . . 0.0 111.458 -178.135 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.7 p -66.17 -34.22 68.72 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 CA-C-N 115.223 -0.898 . . . . 0.0 111.705 -175.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.536 HD11 HG22 ' A' ' 70' ' ' VAL . 92.7 mt -85.44 -7.97 58.64 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.074 0.55 . . . . 0.0 111.865 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -87.24 -35.02 18.75 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 170.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -62.88 -37.38 86.69 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.689 170.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.0 tt -73.9 -44.34 55.54 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.216 177.121 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.498 ' HA2' ' HB2' ' A' ' 44' ' ' MET . . . -90.59 50.82 3.26 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.778 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -74.96 -49.68 19.23 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.508 0.723 . . . . 0.0 110.147 -177.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 15.0 ptp -108.0 -1.03 20.92 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.606 0.762 . . . . 0.0 110.415 174.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.498 ' HB2' ' HA2' ' A' ' 41' ' ' GLY . 1.4 mpt? -97.65 147.05 32.46 Favored Pre-proline 0 N--CA 1.478 0.95 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 177.325 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -63.53 109.24 0.98 Allowed 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 121.787 1.658 . . . . 0.0 111.275 173.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.18 -13.96 60.17 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.28 176.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -53.83 -46.58 71.22 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.236 1.014 . . . . 0.0 110.88 172.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.464 ' O ' ' HG2' ' A' ' 52' ' ' MET . 46.8 mt-10 -58.95 -52.3 66.33 Favored 'General case' 0 C--N 1.356 0.866 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.842 178.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.434 ' O ' HG13 ' A' ' 53' ' ' ILE . 81.4 mt -57.36 -45.35 85.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.069 0.947 . . . . 0.0 111.549 -176.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.479 ' HA ' HD12 ' A' ' 53' ' ' ILE . 66.3 mt-10 -71.27 -31.52 67.59 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.738 0.415 . . . . 0.0 111.331 -179.332 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -68.36 -32.63 72.86 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-O 121.43 0.634 . . . . 0.0 109.671 176.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.464 ' HG2' ' O ' ' A' ' 48' ' ' GLU . 80.4 mmm -70.98 -34.29 71.25 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.243 1.017 . . . . 0.0 110.285 174.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.479 HD12 ' HA ' ' A' ' 50' ' ' GLU . 85.2 mt -60.11 -40.96 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 123.359 0.664 . . . . 0.0 110.629 178.187 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -69.05 -15.06 63.37 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.408 0.683 . . . . 0.0 111.539 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -90.21 -37.14 14.34 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.217 0.607 . . . . 0.0 110.658 172.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.8 -18.15 58.59 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.543 0.737 . . . . 0.0 111.524 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -152.6 83.23 4.92 Favored Pre-proline 0 CA--C 1.55 0.976 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 172.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -75.01 -8.44 20.06 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.389 2.726 . . . . 0.0 112.63 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -75.47 -22.34 57.34 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.243 177.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 58.21 30.82 19.99 Favored 'General case' 0 C--N 1.36 1.037 0 C-N-CA 124.656 1.182 . . . . 0.0 110.237 -176.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.3 t -75.62 -19.56 59.14 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 114.511 -1.222 . . . . 0.0 110.676 -176.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.94 24.56 31.93 Favored Glycine 0 C--N 1.338 0.685 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.848 -178.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -130.01 105.09 7.73 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.718 0.807 . . . . 0.0 109.899 -176.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.473 HG13 HD13 ' A' ' 33' ' ' LEU . 2.1 p -135.37 123.05 37.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 124.007 0.923 . . . . 0.0 109.857 -174.036 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -70.42 109.16 4.61 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.702 0.801 . . . . 0.0 110.352 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.493 ' CE2' ' HA ' ' A' ' 27' ' ' TYR . 38.1 p90 -64.25 -28.5 69.78 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.939 0.895 . . . . 0.0 112.96 -175.1 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -66.1 -54.77 21.53 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.374 0.27 . . . . 0.0 110.693 -177.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.5 t -71.8 -28.65 63.74 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.252 178.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.507 ' O ' ' HG2' ' A' ' 72' ' ' MET . 60.8 t80 -81.87 -73.78 0.37 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 122.59 0.356 . . . . 0.0 111.122 -178.288 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.536 HG22 HD11 ' A' ' 37' ' ' LEU . 38.7 t -60.26 -22.3 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 123.945 0.898 . . . . 0.0 111.655 -173.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -55.63 -53.46 41.35 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-N 116.242 -0.436 . . . . 0.0 112.662 169.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.507 ' HG2' ' O ' ' A' ' 69' ' ' PHE . 18.5 ptp -65.79 -26.15 67.57 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.977 0.511 . . . . 0.0 111.83 -176.276 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 70' ' ' VAL . 4.4 mm? -56.7 -38.66 72.61 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.73 0.812 . . . . 0.0 110.97 175.213 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -89.59 -16.99 29.36 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.284 1.034 . . . . 0.0 111.182 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.417 ' HB2' ' HA ' ' A' ' 72' ' ' MET . 85.4 mt -86.67 -3.32 59.02 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.357 0.663 . . . . 0.0 111.518 176.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 42.8 m0 -59.86 114.77 2.97 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.969 0.507 . . . . 0.0 110.121 170.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 . . . . . 0 C--O 1.255 1.349 0 C-N-CA 123.445 0.698 . . . . 0.0 110.703 179.868 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.429 ' HB3' ' CD2' ' A' ' 74' ' ' PHE . 0.0 OUTLIER . . . . . 0 CA--C 1.546 0.797 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.46 -47.18 85.16 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.83 0.452 . . . . 0.0 110.536 170.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -55.58 -41.86 73.97 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.495 1.118 . . . . 0.0 113.154 -174.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.0 p -67.76 -41.87 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 O-C-N 122.982 0.176 . . . . 0.0 110.542 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 62.0 mt -70.92 -27.62 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 123.603 0.761 . . . . 0.0 110.945 -178.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -75.49 -28.75 59.32 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.331 0.652 . . . . 0.0 110.751 175.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.66 -32.99 74.67 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.041 0.536 . . . . 0.0 110.629 174.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -64.55 -33.47 75.99 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.258 0.623 . . . . 0.0 111.018 171.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.1 mttp -78.67 -17.81 55.37 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.442 0.697 . . . . 0.0 111.725 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 67.0 t -72.88 -37.77 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 171.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -69.36 -55.3 10.79 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.996 173.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -80.04 77.92 6.71 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.777 0.831 . . . . 0.0 109.047 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.7 -21.12 61.83 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.097 1.359 . . . . 0.0 109.325 -178.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -76.01 -27.74 57.5 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.005 0.922 . . . . 0.0 111.358 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.93 45.9 54.99 Favored Glycine 0 C--N 1.344 1.015 0 O-C-N 123.486 0.491 . . . . 0.0 112.183 -176.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -68.58 -28.02 66.58 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.289 1.036 . . . . 0.0 111.312 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.41 -11.66 36.32 Favored Glycine 0 C--N 1.343 0.925 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 -175.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.4 ' HB2' ' O ' ' A' ' 64' ' ' VAL . 36.5 p90 -154.8 159.79 40.83 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.709 0.804 . . . . 0.0 110.535 -177.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.1 m -112.15 -177.15 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.762 0.825 . . . . 0.0 110.512 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 64.4 p -81.83 154.52 25.86 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.548 170.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.441 ' O ' ' HG3' ' A' ' 34' ' ' ARG . 9.8 p -68.41 -26.49 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 122.544 0.337 . . . . 0.0 111.062 -177.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -65.45 -48.14 73.73 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 122.978 0.511 . . . . 0.0 111.398 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -63.81 -39.02 93.23 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 123.313 0.383 . . . . 0.0 110.465 177.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.495 HD11 ' HD2' ' A' ' 69' ' ' PHE . 5.3 tp -55.47 -46.48 76.83 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.608 178.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.569 ' HG2' HD13 ' A' ' 53' ' ' ILE . 80.8 mtm180 -67.56 -35.64 79.41 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.443 0.697 . . . . 0.0 110.984 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -62.11 -52.11 65.19 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.274 1.03 . . . . 0.0 111.701 -176.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.9 p -74.25 -35.36 40.06 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.037 0 C-N-CA 123.085 0.554 . . . . 0.0 111.136 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.493 HD23 HD12 ' A' ' 40' ' ' LEU . 95.8 mt -80.22 -4.82 54.67 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.911 0.485 . . . . 0.0 111.295 178.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -75.68 -47.01 28.1 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.479 0.711 . . . . 0.0 109.964 173.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -75.35 -23.67 57.21 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.958 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.493 HD12 HD23 ' A' ' 37' ' ' LEU . 99.1 mt -82.94 -25.38 32.43 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.351 0.66 . . . . 0.0 110.025 170.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.29 14.13 46.91 Favored Glycine 0 C--N 1.354 1.562 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.278 174.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -75.76 -52.82 9.59 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 168.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -82.38 -37.62 25.33 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.284 0.634 . . . . 0.0 110.575 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 93.0 mmm -89.43 147.08 37.24 Favored Pre-proline 0 N--CA 1.477 0.925 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.69 111.57 0.83 Allowed 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 122.122 1.881 . . . . 0.0 111.2 170.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.14 -33.93 72.42 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.841 0.856 . . . . 0.0 111.047 -176.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -57.89 -38.98 76.79 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.101 0.96 . . . . 0.0 111.677 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.406 ' O ' ' HG2' ' A' ' 52' ' ' MET . 19.8 mm-40 -58.18 -53.25 60.38 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 123.848 0.718 . . . . 0.0 110.309 174.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 86.2 mt -58.17 -45.08 88.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.241 1.016 . . . . 0.0 111.023 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.499 ' HA ' HD12 ' A' ' 53' ' ' ILE . 45.3 mt-10 -63.75 -29.42 70.64 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.936 0.895 . . . . 0.0 111.843 -177.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -77.01 -41.7 41.66 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.301 0.572 . . . . 0.0 109.961 175.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.419 ' HB3' ' HE1' ' A' ' 69' ' ' PHE . 24.9 mmt -64.71 -24.67 67.64 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.036 177.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.569 HD13 ' HG2' ' A' ' 34' ' ' ARG . 41.6 mt -66.81 -32.52 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.766 1.226 . . . . 0.0 111.355 177.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -73.67 -27.4 61.22 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.801 0.44 . . . . 0.0 110.59 174.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -85.05 -17.38 37.62 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.177 0.591 . . . . 0.0 110.67 175.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.6 -51.25 10.95 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.816 0.846 . . . . 0.0 109.848 176.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -123.32 81.72 52.59 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 124.28 1.032 . . . . 0.0 108.468 175.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -73.34 -20.25 21.27 Favored 'Trans proline' 0 C--N 1.386 2.53 0 C-N-CA 123.076 2.517 . . . . 0.0 111.552 173.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -66.8 -23.57 66.07 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.578 174.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.5 m120 58.15 34.55 24.27 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 124.992 1.317 . . . . 0.0 111.122 175.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.7 m -82.61 -13.33 56.7 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.421 -176.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.05 25.39 44.94 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.268 -172.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -139.59 122.96 17.13 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.769 0.828 . . . . 0.0 109.759 -175.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.482 HG11 HD22 ' A' ' 33' ' ' LEU . 2.8 p -131.65 129.9 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.59 0.756 . . . . 0.0 110.685 -172.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -74.95 90.25 2.42 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 170.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -56.72 -27.06 58.42 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.072 177.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -51.33 -58.22 6.81 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.455 1.102 . . . . 0.0 111.544 178.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.1 t -79.15 -33.11 44.43 Favored 'General case' 0 CA--C 1.555 1.17 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.072 -178.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.495 ' HD2' HD11 ' A' ' 33' ' ' LEU . 37.9 t80 -76.08 -63.13 1.39 Allowed 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -173.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.487 ' HA ' HD23 ' A' ' 73' ' ' LEU . 57.5 t -60.91 -16.55 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 123.428 0.691 . . . . 0.0 110.585 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -56.06 -56.26 25.02 Favored Glycine 0 CA--C 1.536 1.352 0 CA-C-O 118.991 -0.894 . . . . 0.0 112.742 166.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 19.3 ptm -63.43 -30.6 71.7 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 118.068 0.934 . . . . 0.0 112.142 -176.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.487 HD23 ' HA ' ' A' ' 70' ' ' VAL . 4.0 mm? -59.83 -30.06 68.69 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.233 0.613 . . . . 0.0 110.92 176.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.429 ' CD2' ' HB3' ' A' ' 10' ' ' LYS . 76.7 m-85 -116.7 1.98 12.88 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.944 0.898 . . . . 0.0 111.799 -176.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 71.8 mt -97.55 5.8 49.01 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.497 0.719 . . . . 0.0 110.956 173.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 29.5 m0 . . . . . 0 N--CA 1.475 0.792 0 C-N-CA 122.643 0.377 . . . . 0.0 110.322 174.545 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt . . . . . 0 N--CA 1.48 1.068 0 N-CA-C 111.026 0.01 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.78 -40.37 75.76 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.707 0.803 . . . . 0.0 111.559 176.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -70.72 -47.86 57.58 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.968 0.507 . . . . 0.0 111.434 -176.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.9 p -69.32 -33.17 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.014 -176.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 90.2 mt -66.92 -38.39 81.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 174.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.412 ' HA ' ' HB2' ' A' ' 18' ' ' LYS . 70.8 mm-40 -66.87 -23.44 66.01 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 119.304 -0.379 . . . . 0.0 111.639 173.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.29 -37.98 86.71 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 120.94 0.4 . . . . 0.0 110.199 175.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -73.86 -37.68 64.7 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.892 173.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.412 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 9.9 mtpm? -74.79 -24.19 58.61 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.481 0.712 . . . . 0.0 112.21 -176.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.6 p -86.4 -27.51 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 176.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -67.18 -56.26 10.68 Favored 'General case' 0 C--N 1.354 0.787 0 C-N-CA 123.704 0.802 . . . . 0.0 109.399 174.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -82.75 83.1 7.81 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.785 177.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -85.62 -14.95 44.07 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.474 169.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -70.19 -27.32 64.41 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.803 0.841 . . . . 0.0 110.676 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.59 44.28 8.64 Favored Glycine 0 C--N 1.347 1.14 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.961 173.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -78.8 -13.2 59.94 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 122.972 0.509 . . . . 0.0 110.38 173.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.39 -44.98 1.93 Allowed Glycine 0 C--N 1.348 1.235 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 177.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.419 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 46.8 p90 -126.78 162.59 25.49 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 123.851 0.86 . . . . 0.0 110.106 177.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 52.4 t -109.68 151.05 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.183 0.993 . . . . 0.0 109.507 -177.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 76.1 p -68.99 166.56 17.73 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.627 0.771 . . . . 0.0 111.578 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.7 p -71.7 -15.15 18.11 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 122.606 0.362 . . . . 0.0 111.518 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -54.39 -63.02 1.28 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.844 0.858 . . . . 0.0 111.806 175.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -72.33 -29.38 63.77 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.987 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.546 HD22 HG11 ' A' ' 64' ' ' VAL . 7.3 tp -55.35 -51.66 66.06 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 123.8 0.688 . . . . 0.0 110.208 176.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 67.1 mtp85 -62.06 -40.59 96.31 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.458 0.703 . . . . 0.0 111.489 177.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -60.35 -54.4 46.14 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 123.783 0.677 . . . . 0.0 111.877 -174.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.6 p -67.1 -29.16 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 122.812 0.445 . . . . 0.0 111.259 -178.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.408 HD13 HG21 ' A' ' 49' ' ' ILE . 66.6 mt -87.67 -6.65 58.14 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.165 0.586 . . . . 0.0 111.868 178.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -83.1 -44.77 14.76 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.499 0.72 . . . . 0.0 110.27 177.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -68.05 -28.78 67.68 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.534 175.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 91.9 mt -96.34 11.07 36.05 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.273 1.029 . . . . 0.0 110.838 175.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -73.2 -14.93 78.84 Favored Glycine 0 C--N 1.352 1.438 0 C-N-CA 123.354 0.502 . . . . 0.0 113.037 -177.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -66.53 -46.37 76.38 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.906 0.882 . . . . 0.0 110.706 176.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 59.9 mtt -90.32 -46.18 8.56 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.672 0.789 . . . . 0.0 110.234 -175.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -110.35 98.76 37.47 Favored Pre-proline 0 N--CA 1.474 0.751 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 176.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -48.93 111.54 0.49 Allowed 'Trans proline' 0 C--N 1.385 2.5 0 C-N-CA 123.789 2.992 . . . . 0.0 113.707 -173.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.402 ' O ' ' HG3' ' A' ' 50' ' ' GLU . . . -64.1 -30.28 71.36 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.183 0.993 . . . . 0.0 111.16 -178.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -56.95 -48.06 79.23 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.093 0.957 . . . . 0.0 111.899 174.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -68.54 -38.82 81.15 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.038 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 37' ' ' LEU . 96.6 mt -62.69 -36.5 75.56 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.819 177.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.499 ' HA ' HD12 ' A' ' 53' ' ' ILE . 40.0 mt-10 -59.95 -35.44 74.95 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.42 0.688 . . . . 0.0 111.641 176.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -69.41 -42.69 74.72 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.244 0.545 . . . . 0.0 109.992 176.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 49.9 mtt -69.68 -22.4 63.44 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.39 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.499 HD12 ' HA ' ' A' ' 50' ' ' GLU . 23.3 mt -64.27 -28.53 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.416 1.086 . . . . 0.0 111.558 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -59.5 -37.09 77.36 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 122.89 0.476 . . . . 0.0 111.064 174.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -81.44 -38.09 27.0 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.406 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.409 ' HB3' ' HA ' ' A' ' 53' ' ' ILE . . . -63.28 -32.31 73.69 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.592 1.157 . . . . 0.0 111.673 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -114.97 88.5 17.19 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 124.34 1.056 . . . . 0.0 108.416 172.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -85.2 3.35 7.37 Favored 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.647 2.231 . . . . 0.0 111.603 173.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -83.59 -21.87 32.46 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.749 0.82 . . . . 0.0 110.306 176.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.6 t30 64.51 30.65 12.84 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.52 1.128 . . . . 0.0 110.079 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.3 m -132.51 -4.65 3.32 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.581 0.752 . . . . 0.0 112.105 -172.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.71 37.26 8.07 Favored Glycine 0 N--CA 1.471 1.023 0 C-N-CA 122.885 0.278 . . . . 0.0 113.546 178.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -123.61 125.65 45.21 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.153 0.981 . . . . 0.0 109.993 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.546 HG11 HD22 ' A' ' 33' ' ' LEU . 3.1 p -139.86 135.6 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.347 0.659 . . . . 0.0 111.057 -171.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -79.87 103.6 9.88 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 167.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.419 ' CE2' ' HA ' ' A' ' 27' ' ' TYR . 39.3 p90 -64.06 -32.28 73.77 Favored 'General case' 0 C--O 1.208 -1.121 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.18 -177.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -61.4 -39.22 89.93 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 118.427 0.558 . . . . 0.0 111.343 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 77.8 p -77.01 -47.73 19.87 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.368 0.667 . . . . 0.0 110.805 -178.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.406 ' HD2' HD11 ' A' ' 33' ' ' LEU . 48.4 t80 -70.82 -53.5 15.08 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.751 0.82 . . . . 0.0 111.941 -176.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.413 ' HA ' HD12 ' A' ' 73' ' ' LEU . 45.4 t -67.77 -18.51 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.693 0.797 . . . . 0.0 110.85 178.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -59.24 -49.61 76.67 Favored Glycine 0 C--N 1.349 1.304 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 165.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 85.2 mtp -70.62 -24.43 62.73 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.78 0.832 . . . . 0.0 111.951 177.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 70' ' ' VAL . 86.2 mt -70.85 -10.92 60.54 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.127 0.571 . . . . 0.0 112.436 178.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -118.08 24.1 11.21 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.417 0.687 . . . . 0.0 109.636 174.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 85.9 mt -126.72 -31.05 2.72 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.166 0.986 . . . . 0.0 111.672 178.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.393 0 CA-C-N 117.987 0.358 . . . . 0.0 111.262 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.459 ' HB3' ' HB3' ' A' ' 74' ' ' PHE . 17.1 ptmt . . . . . 0 CA--C 1.536 0.417 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.85 -45.33 94.93 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.785 0.434 . . . . 0.0 110.362 172.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -59.57 -44.16 93.38 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.554 0.742 . . . . 0.0 111.558 -175.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.6 p -74.34 -34.56 37.08 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 CA-C-O 118.986 -0.531 . . . . 0.0 111.143 -179.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 90.2 mt -60.33 -40.38 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-N 118.584 0.629 . . . . 0.0 109.651 173.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -68.93 -24.16 64.25 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.004 0.921 . . . . 0.0 111.186 177.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.18 -13.13 61.1 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.448 0.699 . . . . 0.0 111.734 174.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.587 ' HA ' ' HE2' ' A' ' 32' ' ' TYR . 90.6 m-85 -93.58 -43.79 8.52 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.344 0.658 . . . . 0.0 110.539 170.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -67.95 -22.2 65.05 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.201 -175.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.8 p -59.95 -31.59 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.313 0.645 . . . . 0.0 111.088 175.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -78.72 -49.19 13.5 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.828 0.851 . . . . 0.0 110.433 176.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -65.32 105.18 1.08 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.543 0.737 . . . . 0.0 111.129 -173.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 19.2 tpp180 -71.15 -50.98 27.69 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.407 1.083 . . . . 0.0 110.577 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.421 ' HB2' ' HB2' ' A' ' 25' ' ' ASN . 5.6 m-20 -73.79 -20.7 60.39 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 114.701 -1.136 . . . . 0.0 112.155 -167.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.96 37.78 88.16 Favored Glycine 0 C--N 1.346 1.129 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -166.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.421 ' HB2' ' HB2' ' A' ' 23' ' ' ASP . 16.5 t-20 -67.71 -30.02 69.42 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.265 1.426 . . . . 0.0 111.074 -167.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 142.07 -60.82 0.54 Allowed Glycine 0 C--N 1.342 0.894 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 176.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.529 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 46.3 p90 -142.73 -176.01 4.71 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -176.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.9 m -126.85 -176.26 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.337 1.055 . . . . 0.0 110.511 -177.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 35.3 p -78.46 160.84 27.5 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 124.195 0.998 . . . . 0.0 111.387 177.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.2 p -78.45 -16.5 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.208 -176.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -69.39 -37.85 77.74 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 120.727 0.298 . . . . 0.0 110.548 173.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.587 ' HE2' ' HA ' ' A' ' 17' ' ' PHE . 45.6 t80 -73.73 -30.49 62.85 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.368 0.667 . . . . 0.0 110.36 178.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.408 HD12 ' CE2' ' A' ' 17' ' ' PHE . 8.6 tp -64.53 -55.29 21.55 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.52 175.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.636 ' HG2' HD13 ' A' ' 53' ' ' ILE . 63.3 mtm180 -69.54 -17.1 63.54 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.631 -177.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -66.52 -61.75 1.82 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.904 0.882 . . . . 0.0 110.75 174.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.4 p -68.67 -28.2 39.1 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.135 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.975 -175.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 71.8 mt -88.4 -8.98 54.12 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.937 -0.477 . . . . 0.0 111.857 -177.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -73.71 -46.96 42.95 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.252 0.621 . . . . 0.0 109.642 171.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -73.35 -25.65 60.69 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.903 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 97.9 mt -89.45 11.22 19.95 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.511 0.724 . . . . 0.0 111.107 173.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.8 3.24 61.21 Favored Glycine 0 C--N 1.358 1.764 0 CA-C-N 116.327 -0.397 . . . . 0.0 113.413 177.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -67.12 -40.99 86.93 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.1 0.96 . . . . 0.0 111.462 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 88.3 mmm -76.49 -46.98 24.43 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 122.993 0.517 . . . . 0.0 111.39 -178.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 90.9 mmm -135.2 139.16 30.9 Favored Pre-proline 0 N--CA 1.48 1.06 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.412 ' HB2' ' HG2' ' A' ' 48' ' ' GLU . 85.8 Cg_exo -49.27 133.92 30.61 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 122.625 2.217 . . . . 0.0 111.755 174.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.412 ' O ' ' HG3' ' A' ' 50' ' ' GLU . . . -58.55 -25.39 62.45 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 123.549 0.53 . . . . 0.0 111.206 178.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -60.07 -39.19 85.21 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.058 0.943 . . . . 0.0 111.972 175.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.412 ' HG2' ' HB2' ' A' ' 45' ' ' PRO . 9.6 mm-40 -56.73 -39.61 74.25 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.847 0.832 . . . . 0.0 109.776 176.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.407 ' O ' HG13 ' A' ' 53' ' ' ILE . 49.3 mt -77.37 -35.47 22.32 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 CA-C-N 113.999 -1.455 . . . . 0.0 110.356 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 46' ' ' ALA . 40.4 mt-10 -65.92 -32.04 73.32 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.739 0.815 . . . . 0.0 112.755 -175.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -66.18 -36.06 82.09 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 121.328 0.585 . . . . 0.0 109.768 174.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 23.6 mtm -75.71 -24.57 56.22 Favored 'General case' 0 CA--C 1.553 1.058 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.488 177.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.636 HD13 ' HG2' ' A' ' 34' ' ' ARG . 62.8 mt -71.93 -28.19 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 124.397 1.079 . . . . 0.0 111.018 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -65.16 -32.96 74.91 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.069 171.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -83.66 -23.75 31.63 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.864 0.866 . . . . 0.0 110.9 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.585 ' HB1' HG23 ' A' ' 64' ' ' VAL . . . -72.94 -49.28 30.38 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.764 0.826 . . . . 0.0 110.482 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -120.35 90.49 45.23 Favored Pre-proline 0 CA--C 1.546 0.825 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 172.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.24 -11.81 15.97 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 123.027 2.485 . . . . 0.0 111.384 168.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -70.17 -24.07 63.08 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.221 1.009 . . . . 0.0 111.65 -173.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 60.78 24.01 13.94 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 125.038 1.335 . . . . 0.0 110.384 -174.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.8 t -105.48 -5.25 20.45 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.407 1.083 . . . . 0.0 109.86 -177.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.24 43.81 62.01 Favored Glycine 0 C--N 1.347 1.175 0 O-C-N 123.851 0.719 . . . . 0.0 113.06 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.445 ' HB3' ' HE1' ' A' ' 27' ' ' TYR . 27.2 m-85 -131.02 109.86 10.81 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.671 0.789 . . . . 0.0 110.29 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.585 HG23 ' HB1' ' A' ' 56' ' ' ALA . 4.6 p -117.83 129.98 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 123.885 0.874 . . . . 0.0 110.824 -175.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -81.23 91.62 6.21 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 170.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.529 ' CE2' ' HA ' ' A' ' 27' ' ' TYR . 45.1 p90 -61.33 -23.59 65.84 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 122.968 0.507 . . . . 0.0 111.498 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -51.63 -56.78 11.64 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.302 1.041 . . . . 0.0 110.582 173.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.2 t -82.07 -30.54 31.26 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.004 -177.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -73.68 -63.06 1.28 Allowed 'General case' 0 N--CA 1.476 0.848 0 O-C-N 123.066 0.229 . . . . 0.0 111.038 -175.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.54 ' HA ' ' HB3' ' A' ' 73' ' ' LEU . 90.2 t -59.0 -24.81 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 124.366 1.067 . . . . 0.0 111.154 177.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -56.63 -54.62 35.0 Favored Glycine 0 CA--C 1.532 1.103 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.355 169.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.414 ' HA ' ' HG ' ' A' ' 75' ' ' LEU . 20.8 mmt -76.15 -32.25 59.0 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.334 0.653 . . . . 0.0 111.368 -178.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.54 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 18.7 tp -69.49 -31.11 69.17 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.551 1.54 . . . . 0.0 111.627 -178.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.459 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 16.0 m-85 -111.94 26.36 10.68 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.159 0.584 . . . . 0.0 111.315 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.414 ' HG ' ' HA ' ' A' ' 72' ' ' MET . 78.3 mt -72.85 -31.89 65.07 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 166.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 17.5 p-90 . . . . . 0 N--CA 1.478 0.972 0 C-N-CA 123.653 0.781 . . . . 0.0 111.777 177.181 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.7 pttp . . . . . 0 N--CA 1.473 0.677 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.89 -34.75 60.4 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.374 0.67 . . . . 0.0 112.631 -178.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -79.92 -38.72 31.9 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.428 0.691 . . . . 0.0 111.211 -176.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.4 p -72.74 -29.03 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 122.126 0.17 . . . . 0.0 110.602 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.7 mt -64.09 -34.22 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.568 0.747 . . . . 0.0 110.086 175.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -70.82 -22.96 62.27 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.25 0.62 . . . . 0.0 111.971 177.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.94 -41.29 95.63 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.248 0.547 . . . . 0.0 109.571 172.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -65.41 -35.22 80.28 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.861 173.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -84.92 -11.64 55.13 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -175.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.9 p -89.16 -29.27 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 172.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 93.5 t80 -70.37 -51.99 25.76 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.578 171.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -64.73 116.79 6.63 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 173.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -87.28 -53.37 4.87 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.32 0.648 . . . . 0.0 111.891 -169.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -95.65 -7.76 36.65 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.005 0.522 . . . . 0.0 112.378 -167.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.99 50.72 4.77 Favored Glycine 0 C--N 1.343 0.93 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -171.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -62.37 -28.63 69.9 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.058 1.743 . . . . 0.0 111.292 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.14 -22.46 29.34 Favored Glycine 0 C--N 1.347 1.147 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.984 178.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -154.03 167.62 29.18 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.696 0.798 . . . . 0.0 111.193 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.1 m -116.24 176.26 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.32 1.048 . . . . 0.0 109.823 176.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 42.6 p -79.27 150.38 31.56 Favored 'General case' 0 C--O 1.246 0.896 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.78 171.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.457 HG12 ' HA2' ' A' ' 62' ' ' GLY . 9.0 p -66.64 -23.69 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 122.65 0.38 . . . . 0.0 111.255 -177.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -57.64 -54.23 49.2 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.442 0.697 . . . . 0.0 111.538 176.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -64.14 -38.79 92.32 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.841 0.456 . . . . 0.0 110.752 176.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.7 tt -60.66 -35.61 76.66 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.238 -176.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 23.2 mtp180 -75.29 -34.41 61.3 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.186 0.594 . . . . 0.0 111.233 176.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.2 mttp -59.6 -50.97 71.81 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.96 0.904 . . . . 0.0 111.735 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.8 p -71.68 -40.21 70.15 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.47 -176.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 97.4 mt -76.39 -11.96 59.98 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.087 0.555 . . . . 0.0 112.184 -176.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -65.97 -29.74 70.19 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.373 0.669 . . . . 0.0 109.833 171.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -86.27 -8.09 58.01 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.483 1.113 . . . . 0.0 111.706 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -91.79 18.6 7.46 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.728 0.811 . . . . 0.0 111.251 177.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 140.17 88.42 0.15 Allowed Glycine 0 C--N 1.349 1.292 0 CA-C-O 119.864 -0.409 . . . . 0.0 112.407 173.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -77.99 -30.06 49.99 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.427 0.691 . . . . 0.0 110.225 175.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -76.89 -24.33 52.53 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.157 174.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 83.1 mtp -79.96 147.92 67.02 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 123.924 0.89 . . . . 0.0 109.524 176.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.63 110.84 2.41 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 121.785 1.657 . . . . 0.0 111.277 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.33 -21.86 66.75 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.628 174.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -48.83 -41.56 33.35 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.392 1.477 . . . . 0.0 112.327 177.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.486 ' O ' ' HG2' ' A' ' 52' ' ' MET . 38.7 tt0 -65.85 -50.28 65.13 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.489 0.493 . . . . 0.0 110.316 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 88.3 mt -58.61 -36.16 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 123.848 0.859 . . . . 0.0 110.74 178.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -63.45 -46.78 84.71 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.098 0.959 . . . . 0.0 110.285 176.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -62.38 -34.55 76.91 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.912 0.485 . . . . 0.0 111.209 177.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.486 ' HG2' ' O ' ' A' ' 48' ' ' GLU . 26.1 mmt -67.93 -35.97 79.35 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.556 0.742 . . . . 0.0 109.925 176.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 83.3 mt -66.19 -36.61 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 124.218 1.007 . . . . 0.0 110.729 176.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -70.93 -21.01 62.41 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.402 0.681 . . . . 0.0 111.126 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -80.2 -41.58 24.96 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 171.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.462 ' HB1' HG23 ' A' ' 64' ' ' VAL . . . -72.83 -30.04 63.72 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.061 0.944 . . . . 0.0 111.92 -176.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -150.63 83.07 5.94 Favored Pre-proline 0 CA--C 1.545 0.76 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.26 -20.57 21.11 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.904 2.403 . . . . 0.0 113.085 -178.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -87.09 -10.62 52.44 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.162 0.585 . . . . 0.0 111.619 -178.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.1 t30 61.46 40.63 13.67 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 122.422 1.106 . . . . 0.0 109.586 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.9 m -77.53 -15.03 59.51 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.569 -1.196 . . . . 0.0 112.03 -173.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.457 ' HA2' HG12 ' A' ' 30' ' ' VAL . . . 85.53 13.67 69.89 Favored Glycine 0 C--N 1.347 1.177 0 CA-C-N 115.91 -0.587 . . . . 0.0 112.327 -173.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -123.01 111.26 16.38 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.736 0.815 . . . . 0.0 109.509 -175.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.462 HG23 ' HB1' ' A' ' 56' ' ' ALA . 2.2 p -139.99 121.29 15.1 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 C-N-CA 123.383 0.673 . . . . 0.0 109.854 -178.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -69.49 94.77 0.77 Allowed 'General case' 0 C--N 1.348 0.514 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.057 173.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 48.2 p90 -57.35 -28.81 63.47 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 123.56 0.538 . . . . 0.0 111.19 177.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -62.19 -49.31 76.29 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.356 0.662 . . . . 0.0 110.851 -176.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 79.8 p -77.59 -33.75 53.76 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.467 0.707 . . . . 0.0 110.641 177.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -67.31 -68.75 0.36 Allowed 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.418 -176.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.621 ' HA ' ' HB3' ' A' ' 73' ' ' LEU . 75.9 t -50.37 -29.11 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 125.404 1.481 . . . . 0.0 112.781 176.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.76 -48.07 80.36 Favored Glycine 0 C--N 1.349 1.287 0 CA-C-O 121.123 0.291 . . . . 0.0 112.693 171.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 33.3 mmt -86.09 -5.72 59.15 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.929 0.892 . . . . 0.0 112.295 177.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.621 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 55.4 tp -88.97 -42.61 11.69 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.068 0.947 . . . . 0.0 109.424 -177.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -90.96 11.75 21.83 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.154 0.582 . . . . 0.0 112.474 -177.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 pp -70.8 -9.1 56.77 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 118.308 0.504 . . . . 0.0 111.895 178.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 14.2 m0 . . . . . 0 N--CA 1.476 0.849 0 C-N-CA 123.659 0.784 . . . . 0.0 109.895 175.946 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? . . . . . 0 N--CA 1.479 1.019 0 N-CA-C 111.372 0.138 . . . . 0.0 111.372 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.1 -51.17 69.01 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 122.995 0.518 . . . . 0.0 110.687 173.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.7 mm-40 -56.49 -37.82 70.88 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.428 1.091 . . . . 0.0 112.738 -175.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.5 p -85.53 -42.36 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 CA-C-O 119.052 -0.499 . . . . 0.0 111.36 -177.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 60.3 mt -59.77 -43.16 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 122.881 0.472 . . . . 0.0 110.876 178.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.461 ' O ' HG23 ' A' ' 19' ' ' VAL . 12.9 pt-20 -70.08 -27.13 64.37 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.692 -178.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.13 -34.6 77.94 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.134 0.573 . . . . 0.0 110.999 175.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.473 ' HA ' ' HE2' ' A' ' 32' ' ' TYR . 83.0 m-85 -64.46 -37.85 88.97 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.957 0.503 . . . . 0.0 110.964 172.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -72.68 -20.51 61.22 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.273 0.629 . . . . 0.0 111.23 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 15' ' ' GLU . 61.0 t -71.87 -34.58 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 123.133 0.573 . . . . 0.0 110.049 171.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -71.8 -54.08 11.3 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.176 0.59 . . . . 0.0 109.844 175.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -77.6 83.04 4.0 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.649 0.78 . . . . 0.0 109.355 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -71.71 -40.38 69.53 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.162 0.985 . . . . 0.0 111.127 -176.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -72.53 -26.22 61.67 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.357 0.663 . . . . 0.0 111.801 -173.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.2 59.42 2.42 Favored Glycine 0 C--N 1.347 1.145 0 N-CA-C 111.978 -0.449 . . . . 0.0 111.978 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -86.65 -11.19 52.03 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.616 1.166 . . . . 0.0 111.143 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.73 -27.04 21.34 Favored Glycine 0 C--N 1.343 0.957 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.962 175.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.41 ' HB2' ' O ' ' A' ' 64' ' ' VAL . 39.1 p90 -149.25 177.1 9.94 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.195 0.598 . . . . 0.0 111.205 -174.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.1 m -132.55 -178.33 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 124.141 0.976 . . . . 0.0 110.096 178.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.0 p -78.03 155.05 30.91 Favored 'General case' 0 C--O 1.245 0.862 0 C-N-CA 123.932 0.893 . . . . 0.0 111.268 174.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.6 p -69.76 -20.29 23.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.607 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -58.76 -59.46 5.39 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.79 0.836 . . . . 0.0 110.934 175.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.473 ' HE2' ' HA ' ' A' ' 17' ' ' PHE . 87.0 t80 -62.56 -35.52 79.72 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.538 0.735 . . . . 0.0 110.764 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.524 HD22 HG11 ' A' ' 64' ' ' VAL . 6.5 tp -59.59 -53.47 57.66 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.611 178.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.556 ' HG2' HD13 ' A' ' 53' ' ' ILE . 98.0 mtt180 -67.08 -28.91 68.57 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.358 0.663 . . . . 0.0 111.514 -176.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -64.62 -58.61 5.87 Favored 'General case' 0 CA--C 1.548 0.904 0 O-C-N 123.665 0.603 . . . . 0.0 111.1 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.1 p -64.57 -38.73 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 123.138 0.575 . . . . 0.0 111.849 -174.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.442 HD23 HD12 ' A' ' 40' ' ' LEU . 85.8 mt -74.79 -26.53 59.81 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.245 0.618 . . . . 0.0 111.285 -176.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.461 ' HA ' ' HB2' ' A' ' 46' ' ' ALA . 3.6 t-20 -67.51 -42.15 83.3 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 123.479 0.487 . . . . 0.0 109.817 171.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -70.42 -30.9 67.89 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.799 0.84 . . . . 0.0 111.717 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.442 HD12 HD23 ' A' ' 37' ' ' LEU . 95.8 mt -71.04 -28.41 64.37 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 122.759 0.424 . . . . 0.0 110.61 172.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -82.39 62.83 4.52 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 169.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -75.29 -36.64 61.13 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.237 0.615 . . . . 0.0 110.485 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 64.5 mtt -124.3 8.11 8.46 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.707 0.803 . . . . 0.0 110.768 173.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 22.8 mmt -116.99 140.92 27.58 Favored Pre-proline 0 N--CA 1.482 1.151 0 C-N-CA 124.045 0.938 . . . . 0.0 108.595 176.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.412 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 40.2 Cg_endo -66.95 133.03 29.87 Favored 'Trans proline' 0 C--N 1.368 1.567 0 C-N-CA 121.738 1.625 . . . . 0.0 111.367 173.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.461 ' HB2' ' HA ' ' A' ' 38' ' ' ASN . . . -73.33 -20.88 60.68 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.453 0.301 . . . . 0.0 110.286 174.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -54.84 -37.24 65.95 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.589 1.156 . . . . 0.0 112.571 -178.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 45' ' ' PRO . 17.1 pt-20 -67.14 -39.15 86.51 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.005 0.431 . . . . 0.0 110.309 177.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 89.6 mt -69.62 -33.25 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.41 1.084 . . . . 0.0 110.321 177.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -69.39 -32.96 72.31 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.806 0.842 . . . . 0.0 111.679 -176.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -62.29 -42.18 99.13 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 121.554 0.692 . . . . 0.0 109.983 171.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 60.4 mmm -67.9 -31.21 70.83 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.487 177.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.556 HD13 ' HG2' ' A' ' 34' ' ' ARG . 54.9 mt -67.72 -31.47 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 124.452 1.101 . . . . 0.0 110.932 178.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -77.54 -20.56 53.97 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.803 0.441 . . . . 0.0 111.291 172.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -79.46 -20.69 46.77 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.499 0.319 . . . . 0.0 110.671 171.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.47 -37.13 18.59 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.922 0.889 . . . . 0.0 111.041 175.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -132.25 80.5 63.53 Favored Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 124.334 1.054 . . . . 0.0 108.47 176.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -81.88 -12.58 10.84 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 123.268 2.646 . . . . 0.0 112.181 174.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 58.8 mm-40 -76.04 -17.03 59.83 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.632 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.6 m120 63.4 26.81 15.09 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.867 1.267 . . . . 0.0 110.611 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 53.1 m -88.89 -15.45 34.37 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.054 0.942 . . . . 0.0 111.245 -175.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.71 21.15 75.29 Favored Glycine 0 C--N 1.348 1.222 0 CA-C-N 116.32 -0.4 . . . . 0.0 113.052 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -116.92 117.22 29.11 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 178.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.524 HG11 HD22 ' A' ' 33' ' ' LEU . 3.9 p -135.02 124.42 42.92 Favored 'Isoleucine or valine' 0 C--O 1.245 0.822 0 C-N-CA 123.237 0.615 . . . . 0.0 110.805 -173.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -73.43 92.22 1.84 Allowed 'General case' 0 C--O 1.238 0.45 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 171.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -50.08 -46.27 53.23 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 114.465 -1.243 . . . . 0.0 113.761 -172.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -72.43 -34.48 67.85 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.32 0.648 . . . . 0.0 111.58 -175.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.4 m -63.48 -44.04 95.54 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.501 0.72 . . . . 0.0 109.625 175.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.468 ' HD2' HD11 ' A' ' 33' ' ' LEU . 17.6 t80 -71.71 -73.43 0.18 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.532 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.605 ' HA ' ' HB3' ' A' ' 73' ' ' LEU . 89.7 t -47.03 -28.44 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 C-N-CA 126.171 1.789 . . . . 0.0 113.149 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -59.53 -54.14 40.19 Favored Glycine 0 CA--C 1.538 1.503 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 169.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 84.7 mtp -72.89 -28.42 62.48 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.124 0.97 . . . . 0.0 111.996 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.605 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 54.6 tp -67.36 -46.83 72.2 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.38 1.072 . . . . 0.0 110.164 -177.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.435 ' HZ ' HD13 ' A' ' 40' ' ' LEU . 7.5 m-85 -84.17 21.51 1.37 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.595 0.758 . . . . 0.0 111.992 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 69.0 mt -95.22 31.26 1.97 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.434 0.694 . . . . 0.0 110.576 170.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 26.1 m0 . . . . . 0 N--CA 1.478 0.963 0 C-N-CA 123.047 0.539 . . . . 0.0 110.422 176.572 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.467 ' O ' HG12 ' A' ' 14' ' ' ILE . 19.5 pttp . . . . . 0 N--CA 1.481 1.097 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.8 -30.84 67.9 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.059 0.544 . . . . 0.0 111.565 176.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -68.94 -47.08 66.56 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.35 0.66 . . . . 0.0 110.927 176.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.8 p -71.87 -24.65 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 -177.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.491 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 33.2 mm -63.16 -38.21 81.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 173.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -61.17 -30.3 70.32 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 122.595 0.358 . . . . 0.0 111.468 176.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.16 -36.93 80.43 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 123.565 0.54 . . . . 0.0 110.421 175.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.496 ' HE1' ' HA ' ' A' ' 33' ' ' LEU . 84.4 m-85 -70.23 -32.65 70.61 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.326 0.65 . . . . 0.0 111.401 174.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 14' ' ' ILE . 3.3 mmmp? -70.95 -11.72 61.13 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.048 0.539 . . . . 0.0 111.481 -179.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 89.8 t -68.46 -42.53 83.92 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 122.841 0.456 . . . . 0.0 110.296 173.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -74.04 -48.21 31.58 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 173.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -83.01 76.78 9.81 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.127 0.971 . . . . 0.0 109.713 -178.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -94.18 -29.1 15.29 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.045 0.538 . . . . 0.0 110.929 176.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -85.83 -12.05 51.81 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.301 0.641 . . . . 0.0 111.942 -176.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.65 50.8 5.13 Favored Glycine 0 C--N 1.338 0.674 0 N-CA-C 112.097 -0.401 . . . . 0.0 112.097 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -68.53 -24.1 64.6 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.211 1.004 . . . . 0.0 110.628 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.65 -22.13 42.43 Favored Glycine 0 C--N 1.345 1.045 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.018 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.424 ' HB2' ' O ' ' A' ' 64' ' ' VAL . 43.4 p90 -156.07 172.42 18.44 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.72 0.808 . . . . 0.0 111.466 -175.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.2 m -121.42 -177.07 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 123.87 0.868 . . . . 0.0 110.232 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 70.7 p -83.14 162.17 21.38 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.699 0.8 . . . . 0.0 111.024 175.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.505 ' HB ' ' HA2' ' A' ' 62' ' ' GLY . 9.9 p -64.93 -27.79 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 123.019 0.527 . . . . 0.0 110.285 173.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -67.62 -47.52 69.39 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.51 1.124 . . . . 0.0 110.284 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -71.74 -34.02 69.18 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.251 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.496 ' HA ' ' HE1' ' A' ' 17' ' ' PHE . 5.8 tp -63.11 -55.62 23.79 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.991 0.916 . . . . 0.0 111.12 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.502 ' HG2' HD13 ' A' ' 53' ' ' ILE . 62.1 mtp180 -64.3 -31.46 72.68 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.412 0.685 . . . . 0.0 111.243 -178.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -59.32 -64.02 1.09 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.516 0.726 . . . . 0.0 111.271 178.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.2 p -62.6 -36.25 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.359 0.664 . . . . 0.0 111.726 -176.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 91.4 mt -82.07 -12.44 58.25 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.023 0.529 . . . . 0.0 111.667 -176.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -85.8 -36.35 20.13 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 171.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -66.07 -41.56 90.59 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.505 0.722 . . . . 0.0 110.341 174.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.408 HD21 ' HZ ' ' A' ' 74' ' ' PHE . 64.1 tp -78.55 -28.35 46.03 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.333 1.053 . . . . 0.0 110.192 174.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -88.3 53.69 4.16 Favored Glycine 0 C--N 1.344 1.021 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 175.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -88.09 -56.87 3.15 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.481 0.713 . . . . 0.0 109.367 175.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 57.5 mtm -82.49 -32.41 28.82 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.38 177.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 23.9 mmt -88.4 146.89 38.69 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 123.537 0.735 . . . . 0.0 109.305 174.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -70.21 119.28 6.24 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 121.952 1.768 . . . . 0.0 111.597 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.505 ' O ' ' HG2' ' A' ' 50' ' ' GLU . . . -62.91 -33.7 75.87 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.155 -0.684 . . . . 0.0 109.155 171.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -51.84 -41.07 61.52 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 125.352 1.461 . . . . 0.0 111.845 176.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -64.44 -48.31 75.81 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.217 1.007 . . . . 0.0 110.236 177.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.444 ' O ' HG13 ' A' ' 53' ' ' ILE . 68.3 mt -61.32 -36.46 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.466 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.505 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 15.9 mm-40 -56.63 -47.3 79.99 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.811 0.845 . . . . 0.0 111.075 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -66.03 -26.69 67.64 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 122.878 0.471 . . . . 0.0 111.427 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 43.8 mtp -77.23 -29.54 54.13 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.057 0.543 . . . . 0.0 110.459 175.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.502 HD13 ' HG2' ' A' ' 34' ' ' ARG . 96.8 mt -71.96 -24.42 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 123.964 0.906 . . . . 0.0 110.639 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -65.85 -26.1 67.5 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.044 0.538 . . . . 0.0 110.88 169.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -90.13 -28.63 18.83 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.228 0.611 . . . . 0.0 110.283 177.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.0 -42.27 76.7 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.795 0.838 . . . . 0.0 110.41 176.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -140.57 95.6 7.95 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 176.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -74.56 -23.54 14.7 Favored 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 122.749 2.299 . . . . 0.0 112.31 177.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -86.68 -12.24 48.92 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.864 0.865 . . . . 0.0 111.066 -174.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.435 HD22 ' N ' ' A' ' 60' ' ' ASN . 0.8 OUTLIER 64.11 25.74 13.79 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.783 1.233 . . . . 0.0 110.702 179.453 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 37.9 m -69.12 -22.41 63.97 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.703 1.201 . . . . 0.0 112.061 -177.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.505 ' HA2' ' HB ' ' A' ' 30' ' ' VAL . . . 79.33 26.59 57.06 Favored Glycine 0 C--N 1.339 0.733 0 CA-C-N 115.889 -0.596 . . . . 0.0 113.127 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -126.9 95.65 4.38 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.235 1.014 . . . . 0.0 108.693 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.477 HG11 HD22 ' A' ' 33' ' ' LEU . 2.0 p -119.94 125.24 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.958 0.903 . . . . 0.0 110.478 -171.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -72.77 91.03 1.45 Allowed 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 173.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -55.07 -38.03 67.52 Favored 'General case' 0 C--O 1.211 -0.966 0 CA-C-N 114.965 -1.016 . . . . 0.0 113.298 -173.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -65.96 -47.32 75.0 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 117.773 0.261 . . . . 0.0 110.633 -172.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 70.4 p -69.85 -32.28 70.58 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.067 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -68.51 -66.73 0.53 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 122.95 0.5 . . . . 0.0 110.879 176.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.65 ' HA ' ' HB3' ' A' ' 73' ' ' LEU . 52.9 t -47.89 -27.08 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.114 0 C-N-CA 126.435 1.894 . . . . 0.0 113.063 174.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.88 -53.48 37.28 Favored Glycine 0 CA--C 1.534 1.238 0 N-CA-C 112.28 -0.328 . . . . 0.0 112.28 169.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 91.0 mtp -75.26 -15.24 60.54 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.742 0.817 . . . . 0.0 111.944 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.65 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 59.4 tp -82.8 -43.73 16.35 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.882 1.273 . . . . 0.0 109.957 -178.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.408 ' HZ ' HD21 ' A' ' 40' ' ' LEU . 13.1 m-85 -88.5 22.65 2.49 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.821 0.848 . . . . 0.0 112.166 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 79.0 mt -70.73 -8.83 55.07 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 166.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 46.4 m0 . . . . . 0 C--N 1.355 0.84 0 C-N-CA 123.999 0.92 . . . . 0.0 109.778 168.556 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 56.8 tttm . . . . . 0 N--CA 1.478 0.955 0 CA-C-O 120.822 0.344 . . . . 0.0 111.434 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.1 -47.91 69.74 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.471 175.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -57.7 -38.77 75.79 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.985 0.914 . . . . 0.0 113.15 -174.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.9 p -66.26 -44.03 91.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 75.9 mt -66.62 -34.1 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.044 0.538 . . . . 0.0 109.97 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.458 ' O ' HG23 ' A' ' 19' ' ' VAL . 47.1 mt-10 -73.06 -25.94 61.1 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.331 0.653 . . . . 0.0 111.107 177.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.7 -37.63 86.99 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 121.231 0.538 . . . . 0.0 110.256 174.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.439 ' HE1' ' HA ' ' A' ' 33' ' ' LEU . 89.7 m-85 -67.28 -34.97 78.52 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.929 172.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.481 ' HE3' ' HE1' ' A' ' 66' ' ' TYR . 33.2 mmtp -66.44 -28.6 68.72 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.193 0.597 . . . . 0.0 110.862 176.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 15' ' ' GLU . 93.4 t -65.98 -44.13 92.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.018 0.527 . . . . 0.0 109.747 175.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -67.69 -48.7 65.82 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.355 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -88.04 72.24 9.23 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.697 0.799 . . . . 0.0 109.168 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -31.9 68.94 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.369 177.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -66.2 -28.92 69.12 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.967 178.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.04 41.25 95.26 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-N 115.976 -0.556 . . . . 0.0 113.319 176.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.9 -18.46 60.9 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 122.61 0.364 . . . . 0.0 110.842 178.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.32 -6.86 14.54 Favored Glycine 0 C--N 1.349 1.255 0 CA-C-O 119.625 -0.542 . . . . 0.0 113.737 172.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -157.48 173.82 16.32 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 117.563 0.682 . . . . 0.0 112.365 -175.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.2 m -130.66 179.63 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 124.134 0.973 . . . . 0.0 110.26 178.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 66.7 p -74.31 153.53 39.3 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.919 171.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.56 -26.4 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 122.707 0.403 . . . . 0.0 110.912 177.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -64.38 -50.71 66.6 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.062 0.545 . . . . 0.0 111.144 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -62.1 -41.04 97.81 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.157 0.583 . . . . 0.0 110.444 175.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.669 HD22 HG11 ' A' ' 64' ' ' VAL . 2.8 tp -56.67 -53.28 59.47 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.556 -178.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -65.31 -37.03 85.89 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.631 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -57.25 -58.77 6.78 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 124.258 0.974 . . . . 0.0 111.052 -177.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.462 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 7.5 p -63.26 -46.13 96.51 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 O-C-N 123.506 0.504 . . . . 0.0 111.341 -177.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 95.7 mt -65.57 -30.63 71.4 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.233 0.613 . . . . 0.0 111.761 -176.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -77.47 -38.73 48.65 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.018 0.527 . . . . 0.0 110.234 177.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -78.34 -9.54 59.3 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.303 0.641 . . . . 0.0 111.974 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 36' ' ' VAL . 87.8 mt -73.63 -42.59 61.24 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.653 0.381 . . . . 0.0 110.025 170.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -166.81 89.75 0.1 OUTLIER Glycine 0 C--N 1.35 1.328 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.636 -177.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -69.46 -20.44 63.76 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.75 0.82 . . . . 0.0 110.927 176.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 23.1 mmt -59.84 -32.34 70.59 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.233 1.013 . . . . 0.0 110.711 175.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 21.8 mmt -84.51 141.25 38.96 Favored Pre-proline 0 C--O 1.245 0.867 0 C-N-CA 124.201 1.0 . . . . 0.0 108.849 177.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.59 110.38 2.07 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 121.645 1.564 . . . . 0.0 111.331 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.28 -19.27 64.69 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.272 174.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -48.61 -39.64 24.67 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 125.383 1.473 . . . . 0.0 111.496 175.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.96 -49.25 78.21 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.496 1.118 . . . . 0.0 110.537 177.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.458 ' O ' HG13 ' A' ' 53' ' ' ILE . 87.5 mt -60.88 -43.63 96.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.367 -179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.525 ' HA ' HD12 ' A' ' 53' ' ' ILE . 0.5 OUTLIER -55.66 -37.5 68.35 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.935 0.894 . . . . 0.0 112.639 177.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -72.96 -40.44 65.34 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 121.563 0.697 . . . . 0.0 110.268 177.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 28.6 mmt -64.66 -26.86 68.57 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.669 -1.151 . . . . 0.0 111.201 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.525 HD12 ' HA ' ' A' ' 50' ' ' GLU . 90.8 mt -66.69 -40.04 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 123.566 0.746 . . . . 0.0 110.826 177.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -65.44 -28.2 69.06 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 122.601 0.361 . . . . 0.0 110.908 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -75.74 -42.67 49.94 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.435 0.694 . . . . 0.0 110.904 177.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.57 -26.67 45.59 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.76 0.824 . . . . 0.0 111.802 -176.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -124.51 86.7 55.03 Favored Pre-proline 0 CA--C 1.542 0.673 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 176.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -75.94 -8.51 19.02 Favored 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 123.011 2.474 . . . . 0.0 112.521 -177.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -88.6 -24.03 22.94 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.488 0.715 . . . . 0.0 110.8 174.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.425 HD22 ' N ' ' A' ' 60' ' ' ASN . 0.8 OUTLIER 60.89 37.04 18.7 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 124.323 1.014 . . . . 0.0 109.356 -174.25 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.9 t -74.79 -18.67 60.43 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.595 -176.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.79 23.85 34.55 Favored Glycine 0 C--N 1.337 0.617 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.597 -175.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -139.42 131.26 27.59 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.114 1.366 . . . . 0.0 108.937 -178.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.669 HG11 HD22 ' A' ' 33' ' ' LEU . 2.8 p -145.56 134.77 17.57 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 CA-C-O 121.266 0.555 . . . . 0.0 110.727 -170.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -75.89 89.06 2.9 Favored 'General case' 0 C--N 1.35 0.606 0 C-N-CA 124.294 1.038 . . . . 0.0 108.823 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.481 ' HE1' ' HE3' ' A' ' 18' ' ' LYS . 32.5 p90 -49.94 -39.83 41.68 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 115.629 1.714 . . . . 0.0 115.629 -171.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -67.07 -50.67 61.0 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 118.73 0.695 . . . . 0.0 111.366 -170.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.467 ' O ' ' HG2' ' A' ' 72' ' ' MET . 9.4 t -71.02 -21.2 62.31 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.854 178.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.446 ' CE2' HD21 ' A' ' 33' ' ' LEU . 55.6 t80 -81.97 -58.1 3.13 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.513 0.725 . . . . 0.0 111.307 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.8 t -66.23 -27.88 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.215 1.006 . . . . 0.0 110.743 -177.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -59.82 -32.29 74.23 Favored Glycine 0 CA--C 1.537 1.418 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.681 171.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.467 ' HG2' ' O ' ' A' ' 68' ' ' THR . 26.6 mmt -76.29 -49.76 16.14 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.57 0.748 . . . . 0.0 111.35 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.402 HD22 HG12 ' A' ' 49' ' ' ILE . 1.9 pp -81.02 -2.96 50.12 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -172.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -94.82 -2.37 50.97 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.589 0.356 . . . . 0.0 111.009 169.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 65.2 mt -78.72 -5.67 53.8 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.489 0.316 . . . . 0.0 111.052 173.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 52.5 m0 . . . . . 0 N--CA 1.487 1.39 0 C-N-CA 123.581 0.752 . . . . 0.0 111.078 176.035 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.523 ' HE2' ' HB3' ' A' ' 74' ' ' PHE . 16.2 ptpt . . . . . 0 CA--C 1.543 0.675 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.24 -38.38 90.85 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.147 0.579 . . . . 0.0 110.856 174.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -70.92 -38.11 72.92 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 112.432 0.531 . . . . 0.0 112.432 -176.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.83 -37.23 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 176.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.515 HG23 ' HE1' ' A' ' 66' ' ' TYR . 63.9 mt -63.01 -42.08 95.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.388 0.675 . . . . 0.0 110.219 173.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.417 ' O ' HG23 ' A' ' 19' ' ' VAL . 37.4 mt-10 -62.01 -32.95 73.48 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.852 0.861 . . . . 0.0 111.175 177.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.23 -38.07 79.06 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.161 0.584 . . . . 0.0 111.193 177.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.442 ' CZ ' HD12 ' A' ' 33' ' ' LEU . 96.2 m-85 -68.74 -37.08 79.16 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.269 175.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 14' ' ' ILE . 21.3 mtpp -71.76 -35.01 69.94 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.104 0.562 . . . . 0.0 111.045 -175.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 15' ' ' GLU . 91.4 t -71.01 -35.34 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.757 0.823 . . . . 0.0 110.07 176.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -66.48 -54.25 26.09 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.427 175.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.489 ' HB2' HG22 ' A' ' 28' ' ' VAL . 21.7 t70 -77.25 86.33 3.69 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.572 0.701 . . . . 0.0 109.922 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 42.5 mtp180 -88.96 -1.19 57.99 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.041 172.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -84.41 -26.85 28.02 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.004 0.922 . . . . 0.0 111.201 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.08 47.68 23.14 Favored Glycine 0 C--N 1.345 1.053 0 O-C-N 123.478 0.486 . . . . 0.0 112.274 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -91.38 17.6 8.27 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.442 0.697 . . . . 0.0 111.616 -178.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.33 -60.36 4.89 Favored Glycine 0 C--N 1.344 1.024 0 N-CA-C 111.784 -0.526 . . . . 0.0 111.784 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -124.73 -171.75 2.42 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.494 1.117 . . . . 0.0 110.322 -177.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.489 HG22 ' HB2' ' A' ' 21' ' ' ASP . 76.8 t -126.57 151.3 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.508 1.123 . . . . 0.0 109.675 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 58.5 p -66.98 165.32 15.83 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.143 0.977 . . . . 0.0 112.592 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.4 p -69.83 -18.92 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.491 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -63.63 -46.78 84.15 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.018 0.527 . . . . 0.0 111.41 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -79.83 -29.99 40.31 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.823 176.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.598 HD22 HG11 ' A' ' 64' ' ' VAL . 12.0 tp -57.02 -45.53 83.03 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.175 0.59 . . . . 0.0 110.689 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 75.5 mtt180 -67.28 -41.96 84.62 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.354 176.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -54.18 -51.08 65.51 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.812 0.845 . . . . 0.0 111.812 -176.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.5 p -73.82 -34.2 39.59 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.582 -175.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 91.8 mt -86.09 -10.42 54.93 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 122.04 -0.413 . . . . 0.0 111.883 -177.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -83.06 -42.08 17.87 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.128 0.571 . . . . 0.0 109.948 176.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -73.86 -40.1 63.49 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.507 0.723 . . . . 0.0 111.132 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 96.9 mt -76.69 -33.0 58.26 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.891 0.477 . . . . 0.0 110.61 177.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -87.52 65.07 3.65 Favored Glycine 0 C--N 1.347 1.18 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 176.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -84.07 -58.36 2.8 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.322 0.649 . . . . 0.0 109.443 177.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.3 -22.02 48.82 Favored 'General case' 0 CA--C 1.551 1.003 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.299 177.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 96.9 mmm -87.92 128.3 54.56 Favored Pre-proline 0 N--CA 1.478 0.969 0 C-N-CA 123.65 0.78 . . . . 0.0 110.204 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -65.54 121.78 9.27 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 122.86 2.373 . . . . 0.0 111.485 172.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.96 -12.83 61.76 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.81 0.844 . . . . 0.0 111.897 -177.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.484 ' O ' ' HG2' ' A' ' 51' ' ' GLU . 5.8 m-20 -52.45 -52.65 53.07 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.632 1.173 . . . . 0.0 111.363 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -60.19 -46.85 88.31 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 124.058 0.849 . . . . 0.0 111.02 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.0 mt -57.99 -38.56 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.056 178.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.4 ' O ' ' HD1' ' A' ' 54' ' ' TYR . 75.2 mm-40 -67.41 -41.43 84.89 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.127 0.571 . . . . 0.0 111.547 178.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 47' ' ' ASP . 8.7 mm-40 -60.35 -43.3 96.63 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.798 0.809 . . . . 0.0 109.791 177.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.434 ' HG3' ' HZ2' ' A' ' 76' ' ' TRP . 76.5 mmm -66.66 -32.88 74.49 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 113.57 -1.65 . . . . 0.0 111.52 176.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.4 mt -64.29 -42.72 96.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 C-N-CA 124.089 0.956 . . . . 0.0 110.235 176.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.4 ' HD1' ' O ' ' A' ' 50' ' ' GLU . 24.7 m-85 -78.07 -9.39 59.12 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.712 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -99.15 -16.95 18.41 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.287 0.635 . . . . 0.0 111.405 170.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.72 -28.97 22.76 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.626 0.77 . . . . 0.0 110.324 173.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -138.83 76.54 34.29 Favored Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 175.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -78.77 -11.56 15.28 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 123.252 2.635 . . . . 0.0 113.512 -176.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -87.43 -11.8 48.06 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.213 0.605 . . . . 0.0 111.254 -178.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.5 t30 60.31 54.83 3.79 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 122.167 0.984 . . . . 0.0 109.277 -175.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.9 m -99.19 -17.2 18.26 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.527 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.61 15.22 81.4 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.354 -172.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -114.79 109.94 18.94 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.684 0.794 . . . . 0.0 109.645 -173.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.598 HG11 HD22 ' A' ' 33' ' ' LEU . 2.7 p -136.84 123.2 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 123.731 0.812 . . . . 0.0 110.121 -175.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -72.57 100.62 2.8 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 172.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.515 ' HE1' HG23 ' A' ' 14' ' ' ILE . 48.1 p90 -59.94 -37.79 80.54 Favored 'General case' 0 C--O 1.214 -0.785 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.681 -171.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -66.75 -33.84 76.52 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 118.076 0.398 . . . . 0.0 110.316 -177.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 19.1 m -67.2 -50.73 59.84 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 123.81 0.844 . . . . 0.0 110.446 175.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.445 ' HD2' HD11 ' A' ' 33' ' ' LEU . 63.0 t80 -70.63 -62.35 1.42 Allowed 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.982 -174.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 74.5 t -57.19 -30.62 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.63 1.172 . . . . 0.0 110.83 175.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.68 -55.4 30.08 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-N 116.298 -0.41 . . . . 0.0 112.458 172.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 24.4 ptp -72.68 -24.18 60.98 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -175.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.53 -26.9 29.74 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.523 ' HB3' ' HE2' ' A' ' 10' ' ' LYS . 22.8 m-85 -86.69 6.3 31.9 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 122.612 0.365 . . . . 0.0 111.03 170.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 76.9 mt -100.72 15.41 28.38 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.684 0.794 . . . . 0.0 110.602 168.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.434 ' HZ2' ' HG3' ' A' ' 52' ' ' MET . 54.6 m0 . . . . . 0 CA--C 1.553 1.089 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 170.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 120.517 0.199 . . . . 0.0 110.848 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.17 -42.23 98.2 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.008 0.923 . . . . 0.0 112.077 -175.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -56.19 -41.91 76.28 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 124.038 0.935 . . . . 0.0 112.611 -173.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.434 HG13 HG11 ' A' ' 70' ' ' VAL . 4.3 p -82.71 -35.96 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 123.583 0.753 . . . . 0.0 109.941 -174.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 71.2 mt -61.84 -32.63 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 123.328 0.651 . . . . 0.0 110.052 172.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -67.88 -38.11 82.62 Favored 'General case' 0 C--N 1.349 0.548 0 C-N-CA 123.682 0.793 . . . . 0.0 110.781 175.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.27 -40.01 76.83 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 122.899 0.48 . . . . 0.0 111.268 177.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.426 ' CE1' HD12 ' A' ' 33' ' ' LEU . 80.6 m-85 -64.54 -53.2 51.77 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.472 0.709 . . . . 0.0 112.001 178.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.87 -25.99 64.9 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -175.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.3 t -70.37 -37.5 70.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 122.646 0.378 . . . . 0.0 110.11 172.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -66.68 -40.45 88.58 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.28 174.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -76.63 81.06 3.29 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.792 0.806 . . . . 0.0 109.887 -176.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 69.6 mtp180 -92.96 -14.86 26.95 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.036 -1.438 . . . . 0.0 109.703 175.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -74.65 -28.42 60.85 Favored 'General case' 0 C--N 1.356 0.848 0 C-N-CA 123.383 0.673 . . . . 0.0 110.253 176.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.22 56.09 3.32 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-N 116.329 -0.396 . . . . 0.0 113.279 175.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -88.27 -21.59 24.37 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.804 0.841 . . . . 0.0 110.413 175.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.33 -40.9 2.49 Favored Glycine 0 C--N 1.348 1.204 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 -173.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.401 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 44.5 p90 -119.47 -176.0 3.06 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.958 1.303 . . . . 0.0 109.518 174.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 55.2 t -127.64 159.51 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 124.244 1.017 . . . . 0.0 109.467 -177.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.3 p -72.81 166.81 22.18 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.655 1.182 . . . . 0.0 111.771 177.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.9 p -75.3 -14.8 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 122.999 0.52 . . . . 0.0 111.331 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -69.45 -57.63 5.0 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 122.578 0.351 . . . . 0.0 110.83 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -64.29 -30.56 71.61 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.643 0.377 . . . . 0.0 110.534 176.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.551 HD22 HG11 ' A' ' 64' ' ' VAL . 10.4 tp -56.69 -58.66 7.11 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.169 176.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 46.6 mtt85 -62.45 -28.24 69.67 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.794 0.838 . . . . 0.0 112.116 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -62.37 -62.79 1.51 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.278 0.631 . . . . 0.0 110.865 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.3 p -66.82 -28.3 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.169 0.588 . . . . 0.0 111.686 -175.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 84.1 mt -87.56 -11.93 47.24 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.223 0.609 . . . . 0.0 112.224 -177.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -76.84 -35.38 57.56 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 166.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -75.34 -35.03 61.23 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.129 0.971 . . . . 0.0 110.464 177.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -74.73 -43.36 55.4 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 175.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -87.2 61.32 4.28 Favored Glycine 0 C--N 1.345 1.078 0 N-CA-C 110.269 -1.133 . . . . 0.0 110.269 175.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -60.32 -47.91 84.0 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.358 1.063 . . . . 0.0 111.445 -173.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 64.4 mtm -125.88 1.0 7.36 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.699 0.8 . . . . 0.0 110.006 172.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 63.4 mtt -80.94 137.27 50.14 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 123.445 0.698 . . . . 0.0 109.38 175.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.7 122.54 10.67 Favored 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.64 2.227 . . . . 0.0 112.87 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.51 -18.48 65.39 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.702 0.801 . . . . 0.0 110.631 170.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -50.4 -43.13 54.58 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.766 1.227 . . . . 0.0 111.164 173.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -63.54 -53.28 54.29 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.431 0.693 . . . . 0.0 110.514 175.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.462 ' O ' HG13 ' A' ' 53' ' ' ILE . 88.5 mt -59.93 -37.26 71.4 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 CA-C-N 114.823 -1.08 . . . . 0.0 111.769 -174.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -71.68 -30.41 65.67 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.343 0.657 . . . . 0.0 112.024 -175.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -67.77 -39.96 84.07 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 121.53 0.681 . . . . 0.0 109.379 172.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.422 ' HG3' ' HZ2' ' A' ' 76' ' ' TRP . 69.7 mmm -68.55 -32.94 73.23 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.428 -1.26 . . . . 0.0 110.392 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 49' ' ' ILE . 58.4 mt -58.63 -42.59 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 123.821 0.848 . . . . 0.0 110.065 178.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -73.31 -9.74 59.02 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.556 0.743 . . . . 0.0 112.305 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -85.9 -29.94 23.25 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 120.975 0.417 . . . . 0.0 110.103 172.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -94.04 -19.68 20.64 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.791 0.837 . . . . 0.0 111.421 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -144.85 71.81 15.08 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 124.736 1.214 . . . . 0.0 107.897 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.03 -17.35 22.27 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 122.858 2.372 . . . . 0.0 112.609 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.592 ' HG3' ' H ' ' A' ' 61' ' ' SER . 27.7 pt20 -70.86 -20.26 62.55 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.303 1.041 . . . . 0.0 111.645 178.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.7 t30 67.7 6.95 5.34 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 124.877 1.271 . . . . 0.0 111.115 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.592 ' H ' ' HG3' ' A' ' 59' ' ' GLN . 34.8 t -78.61 -17.67 55.7 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.531 0.732 . . . . 0.0 111.313 -173.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.03 34.42 8.25 Favored Glycine 0 C--N 1.341 0.819 0 O-C-N 123.314 0.384 . . . . 0.0 113.87 172.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -127.38 96.14 4.48 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.252 1.021 . . . . 0.0 108.493 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.551 HG11 HD22 ' A' ' 33' ' ' LEU . 3.3 p -118.03 130.28 73.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 124.031 0.933 . . . . 0.0 111.312 -166.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -75.05 90.41 2.48 Favored 'General case' 0 C--N 1.351 0.644 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 170.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.401 ' CE2' ' HA ' ' A' ' 27' ' ' TYR . 42.3 p90 -57.37 -29.87 64.4 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.043 -0.981 . . . . 0.0 113.41 -173.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -60.65 -63.54 1.26 Allowed 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 118.105 0.411 . . . . 0.0 110.858 -174.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.7 t -64.68 -30.04 71.05 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.558 0.743 . . . . 0.0 111.623 -177.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.476 ' CD2' HD11 ' A' ' 33' ' ' LEU . 32.4 t80 -70.42 -55.11 9.83 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.522 0.729 . . . . 0.0 111.858 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.468 ' HA ' HD12 ' A' ' 73' ' ' LEU . 82.7 t -65.06 -24.86 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.472 0.709 . . . . 0.0 110.188 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.457 ' O ' ' HG ' ' A' ' 75' ' ' LEU . . . -56.4 -53.55 42.35 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.532 165.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.505 ' HA ' HD12 ' A' ' 75' ' ' LEU . 85.0 mtp -59.53 -35.97 75.23 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.896 0.878 . . . . 0.0 112.605 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.468 HD12 ' HA ' ' A' ' 70' ' ' VAL . 92.5 mt -62.88 -42.06 99.63 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 121.419 0.628 . . . . 0.0 110.584 176.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -88.23 -0.07 56.68 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.163 -178.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.505 HD12 ' HA ' ' A' ' 72' ' ' MET . 82.0 mt -86.06 4.15 39.31 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.581 0.752 . . . . 0.0 110.869 170.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.422 ' HZ2' ' HG3' ' A' ' 52' ' ' MET . 51.4 m0 . . . . . 0 CA--C 1.547 0.84 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 171.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt . . . . . 0 N--CA 1.481 1.097 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.458 ' O ' ' HG2' ' A' ' 15' ' ' GLU . . . -71.23 -30.46 66.37 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.09 0.556 . . . . 0.0 111.461 174.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -58.0 -36.82 73.2 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.615 0.766 . . . . 0.0 112.521 -176.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.6 p -77.33 -34.45 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 122.633 0.373 . . . . 0.0 110.487 177.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.5 mt -65.6 -30.14 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 123.556 0.743 . . . . 0.0 110.516 178.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.5 ' HA ' ' HE2' ' A' ' 18' ' ' LYS . 26.1 mm-40 -59.09 -43.49 91.84 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.474 0.709 . . . . 0.0 109.911 172.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.34 -28.36 67.91 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.812 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -73.82 -54.29 8.33 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.971 0.509 . . . . 0.0 111.609 176.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.5 ' HE2' ' HA ' ' A' ' 15' ' ' GLU . 64.4 pttt -73.99 -17.5 60.99 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -170.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.6 p -69.14 -33.48 58.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 CA-C-N 117.917 0.326 . . . . 0.0 110.124 172.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -77.71 -45.48 24.67 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.96 0.904 . . . . 0.0 109.64 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -78.21 72.9 4.77 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 174.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.423 ' HA ' ' NE ' ' A' ' 22' ' ' ARG . 1.6 tpm_? -80.5 -28.43 37.48 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.992 -166.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -70.3 -25.67 63.43 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.823 0.449 . . . . 0.0 110.927 176.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.22 50.16 5.94 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 -173.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -75.82 -10.68 59.63 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.58 0.752 . . . . 0.0 110.597 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.39 -29.27 12.25 Favored Glycine 0 C--N 1.35 1.358 0 CA-C-N 116.121 -0.49 . . . . 0.0 112.174 176.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -145.09 164.03 32.47 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-O 121.09 0.472 . . . . 0.0 111.312 -172.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.6 m -117.74 178.61 2.0 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.846 0 CA-C-N 114.77 -1.104 . . . . 0.0 109.864 176.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.8 p -81.38 156.36 25.47 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.652 173.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.592 HG23 HG21 ' A' ' 53' ' ' ILE . 7.7 p -57.97 -37.35 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.95 0.9 . . . . 0.0 112.041 177.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -62.54 -47.83 82.16 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 123.618 0.574 . . . . 0.0 111.197 -174.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -66.76 -41.82 87.13 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.298 176.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.436 HD21 ' CE2' ' A' ' 69' ' ' PHE . 5.1 tt -63.39 -32.78 74.3 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.568 -176.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 47.9 mtm105 -74.12 -38.88 63.67 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.921 0.488 . . . . 0.0 110.679 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -60.43 -52.52 64.86 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.052 0.845 . . . . 0.0 111.508 -176.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.1 p -62.77 -41.44 92.47 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.651 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 86.1 mt -78.28 -16.32 57.89 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -177.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -80.77 -46.7 15.01 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.933 0.493 . . . . 0.0 110.292 176.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -67.98 -23.54 65.05 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.042 0.537 . . . . 0.0 111.982 -175.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.6 pp -98.13 -32.24 11.7 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.54 0.336 . . . . 0.0 110.726 173.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -106.7 39.6 2.82 Favored Glycine 0 C--N 1.345 1.06 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.648 -175.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -75.66 -26.87 58.04 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.201 1.0 . . . . 0.0 110.355 175.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 53.9 mtm -73.86 -33.38 64.06 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.191 0.996 . . . . 0.0 110.846 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 64.1 mtm -92.95 156.31 40.63 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 123.788 0.835 . . . . 0.0 109.647 176.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.07 111.59 2.91 Favored 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 121.551 1.501 . . . . 0.0 111.311 169.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.02 -12.47 61.54 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.478 0.711 . . . . 0.0 110.92 174.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -51.62 -55.49 19.02 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.011 1.324 . . . . 0.0 110.766 174.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.467 ' O ' ' HG2' ' A' ' 52' ' ' MET . 38.8 tt0 -68.04 -35.16 77.79 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.11 -178.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.467 ' O ' HG13 ' A' ' 53' ' ' ILE . 93.6 mt -58.96 -39.81 78.96 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 123.219 0.607 . . . . 0.0 110.506 173.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.541 ' HA ' HD12 ' A' ' 53' ' ' ILE . 49.6 mt-10 -67.09 -35.1 79.06 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.78 0.432 . . . . 0.0 110.947 177.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -62.83 -36.32 82.83 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.575 0.35 . . . . 0.0 110.803 173.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.467 ' HG2' ' O ' ' A' ' 48' ' ' GLU . 30.2 mmt -69.68 -33.04 72.0 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.466 0.706 . . . . 0.0 110.453 177.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.592 HG21 HG23 ' A' ' 30' ' ' VAL . 81.3 mt -69.23 -32.2 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.823 0.849 . . . . 0.0 110.303 174.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -71.59 -12.43 61.35 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.577 0.751 . . . . 0.0 111.459 175.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -94.95 -35.19 12.1 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.52 0.728 . . . . 0.0 110.138 174.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.94 -31.13 56.41 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.765 0.826 . . . . 0.0 111.07 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -137.81 91.32 13.63 Favored Pre-proline 0 CA--C 1.55 0.973 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 172.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -85.12 4.73 6.61 Favored 'Trans proline' 0 C--N 1.371 1.746 0 C-N-CA 122.898 2.399 . . . . 0.0 113.855 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -103.6 -11.18 17.87 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.178 0.591 . . . . 0.0 111.851 -176.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.2 t30 66.71 22.83 10.3 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 124.177 0.991 . . . . 0.0 109.847 -176.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 46.9 m -64.47 -39.99 94.84 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 124.718 1.207 . . . . 0.0 110.807 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.97 24.7 16.41 Favored Glycine 0 C--N 1.344 0.976 0 CA-C-N 114.995 -1.002 . . . . 0.0 113.191 176.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -127.42 95.27 4.21 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.496 1.119 . . . . 0.0 108.787 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 p -119.11 126.02 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 123.527 0.731 . . . . 0.0 110.407 -171.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -70.24 98.98 1.45 Allowed 'General case' 0 C--N 1.347 0.458 0 C-N-CA 124.152 0.981 . . . . 0.0 110.593 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -63.27 -33.4 75.42 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -176.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -64.91 -46.73 80.44 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 120.883 0.373 . . . . 0.0 110.955 -175.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 54.6 p -77.31 -38.15 51.19 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.407 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.436 ' CE2' HD21 ' A' ' 33' ' ' LEU . 41.8 t80 -65.12 -72.05 0.17 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.062 0.545 . . . . 0.0 110.975 -178.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.589 ' HA ' ' HB3' ' A' ' 73' ' ' LEU . 96.9 t -50.08 -29.56 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 125.162 1.385 . . . . 0.0 112.309 177.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.75 -53.44 45.26 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 121.048 0.249 . . . . 0.0 112.769 170.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 67.7 mtm -87.03 -2.13 58.39 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.281 1.033 . . . . 0.0 111.956 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.589 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 50.7 tp -90.24 -48.01 7.42 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.263 1.025 . . . . 0.0 109.363 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -78.41 27.89 0.2 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.105 0.962 . . . . 0.0 112.608 -177.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.2 0.33 19.48 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.361 0.665 . . . . 0.0 112.033 172.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 13.3 m0 . . . . . 0 C--N 1.351 0.636 0 C-N-CA 124.632 1.173 . . . . 0.0 110.948 179.21 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.459 ' O ' ' HG2' ' A' ' 15' ' ' GLU . . . -58.75 -43.08 90.18 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.469 0.308 . . . . 0.0 110.572 170.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 -67.25 -34.39 77.33 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.492 0.717 . . . . 0.0 111.991 -173.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.6 p -75.3 -37.14 38.33 Favored 'Isoleucine or valine' 0 C--N 1.355 0.828 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -178.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.4 mt -62.85 -37.28 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 174.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 68.0 mm-40 -59.99 -45.03 94.05 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 122.877 0.471 . . . . 0.0 110.161 172.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.26 -27.45 69.02 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.657 0.783 . . . . 0.0 112.138 -178.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.459 ' HE1' ' HA ' ' A' ' 33' ' ' LEU . 65.2 m-85 -77.7 -42.61 33.84 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.719 0.408 . . . . 0.0 111.179 173.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -70.4 -23.18 62.71 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.924 0.49 . . . . 0.0 112.114 -174.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 23.8 m -75.95 -28.61 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-O 120.663 0.268 . . . . 0.0 110.552 175.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -74.6 -42.04 59.37 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.74 0.816 . . . . 0.0 109.052 174.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -75.2 85.2 2.4 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.026 0.93 . . . . 0.0 108.824 175.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 68.5 ttt-85 -65.61 -48.49 72.09 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.789 -1.096 . . . . 0.0 112.456 -172.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -87.47 -3.5 59.0 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -170.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.69 41.74 63.66 Favored Glycine 0 C--N 1.345 1.03 0 N-CA-C 112.171 -0.372 . . . . 0.0 112.171 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -70.51 -17.99 62.95 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.919 0.888 . . . . 0.0 110.701 -178.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.29 -43.58 1.61 Allowed Glycine 0 C--N 1.346 1.108 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.498 175.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.505 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 50.9 p90 -136.6 176.19 8.92 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.186 0.594 . . . . 0.0 111.799 -172.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.0 m -123.64 -177.97 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 124.02 0.928 . . . . 0.0 110.529 -177.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 49.7 p -75.75 153.82 36.76 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 123.554 0.742 . . . . 0.0 110.235 173.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.6 p -63.06 -27.0 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.327 0.651 . . . . 0.0 111.343 178.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -59.96 -58.79 7.03 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.526 1.13 . . . . 0.0 110.624 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -61.77 -34.16 75.37 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 123.752 0.657 . . . . 0.0 110.975 -178.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.643 HD22 HG11 ' A' ' 64' ' ' VAL . 7.1 tp -58.69 -52.15 66.91 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.768 178.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 54.9 mtt180 -64.58 -35.29 80.52 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.369 0.668 . . . . 0.0 111.435 -178.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -63.46 -51.85 63.87 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.475 0.71 . . . . 0.0 111.828 -177.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.2 p -73.0 -30.38 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.46 -175.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 81.2 mt -85.28 -11.95 53.56 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.672 0.389 . . . . 0.0 111.371 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -85.46 -33.01 21.97 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.198 0.599 . . . . 0.0 110.078 173.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -80.43 -41.4 24.56 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 110.624 -0.139 . . . . 0.0 110.624 178.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 94.3 mt -74.07 -27.65 61.01 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.601 0.361 . . . . 0.0 110.233 174.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -96.68 52.09 1.51 Allowed Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.4 173.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -65.95 -51.07 61.77 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.748 0.819 . . . . 0.0 111.041 -175.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -92.4 -3.28 55.52 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.134 0.574 . . . . 0.0 111.029 177.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 74.8 mtp -94.4 144.66 28.35 Favored Pre-proline 0 N--CA 1.48 1.071 0 C-N-CA 123.611 0.765 . . . . 0.0 110.141 -176.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -66.52 111.39 2.08 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.684 2.256 . . . . 0.0 111.828 172.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.36 -27.77 63.58 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.305 0.642 . . . . 0.0 111.293 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -62.02 -34.34 76.03 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 122.703 0.401 . . . . 0.0 111.738 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -71.2 -39.15 71.96 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 176.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.491 ' O ' HG13 ' A' ' 53' ' ' ILE . 89.1 mt -64.4 -42.13 94.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 123.234 0.614 . . . . 0.0 109.776 176.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.534 ' HA ' HD12 ' A' ' 53' ' ' ILE . 46.9 mt-10 -75.05 -19.84 59.83 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.918 0.887 . . . . 0.0 111.032 -178.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -72.13 -45.02 62.21 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.685 0.794 . . . . 0.0 109.149 169.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.457 ' SD ' ' HZ2' ' A' ' 76' ' ' TRP . 48.8 mtp -67.7 -18.99 65.11 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.344 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.534 HD12 ' HA ' ' A' ' 50' ' ' GLU . 73.6 mt -68.03 -29.31 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.405 0.682 . . . . 0.0 111.38 176.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -60.37 -32.96 71.78 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.106 0.562 . . . . 0.0 110.484 173.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -85.3 -35.8 21.26 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.334 1.054 . . . . 0.0 110.448 178.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.18 -33.01 74.79 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.985 0.914 . . . . 0.0 111.569 -178.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -123.82 90.07 50.96 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 105.056 -2.202 . . . . 0.0 105.056 171.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -65.65 -23.35 56.72 Favored 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 123.148 2.566 . . . . 0.0 112.788 -175.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -86.39 -17.27 34.83 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.765 0.826 . . . . 0.0 109.332 179.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.423 HD22 ' N ' ' A' ' 60' ' ' ASN . 0.8 OUTLIER 59.03 43.57 17.43 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.354 1.061 . . . . 0.0 110.318 178.843 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.0 m -79.76 -26.86 40.55 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.241 1.016 . . . . 0.0 112.156 -177.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 96.9 9.33 56.28 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.351 -169.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -118.35 99.89 7.13 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.63 1.172 . . . . 0.0 108.415 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.643 HG11 HD22 ' A' ' 33' ' ' LEU . 7.3 p -112.87 136.66 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-O 121.158 0.504 . . . . 0.0 111.425 -170.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -85.24 99.2 10.95 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.005 173.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.505 ' CE2' ' HA ' ' A' ' 27' ' ' TYR . 34.1 p90 -59.95 -35.4 74.86 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.615 -177.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -63.1 -45.04 93.91 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 122.791 0.436 . . . . 0.0 111.032 -173.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.5 t -78.48 -24.8 45.73 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.111 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.445 ' HD2' HD11 ' A' ' 33' ' ' LEU . 26.3 t80 -79.89 -74.14 0.32 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.349 0.259 . . . . 0.0 110.486 178.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.542 ' HA ' ' HB3' ' A' ' 73' ' ' LEU . 87.0 t -49.91 -24.22 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 C-N-CA 126.158 1.783 . . . . 0.0 113.083 178.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.466 ' O ' ' HG ' ' A' ' 75' ' ' LEU . . . -64.44 -57.87 11.88 Favored Glycine 0 CA--C 1.539 1.557 0 CA-C-O 119.911 -0.383 . . . . 0.0 112.379 171.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -75.61 -21.1 58.07 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 123.363 0.665 . . . . 0.0 111.345 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.542 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 51.2 tp -68.71 -42.87 77.11 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.147 1.379 . . . . 0.0 110.16 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -85.84 -5.83 59.18 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.708 176.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 71' ' ' GLY . 54.2 mt -91.9 21.22 5.05 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.155 0.582 . . . . 0.0 111.593 174.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.457 ' HZ2' ' SD ' ' A' ' 52' ' ' MET . 30.8 m0 . . . . . 0 N--CA 1.48 1.028 0 C-N-CA 122.481 0.312 . . . . 0.0 110.264 171.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt . . . . . 0 N--CA 1.48 1.034 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.03 -42.37 63.24 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 122.959 0.504 . . . . 0.0 109.899 169.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -55.72 -39.42 71.05 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.33 1.052 . . . . 0.0 112.973 -175.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.1 p -66.03 -41.55 89.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 178.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 64.3 mt -68.91 -29.96 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.35 0.66 . . . . 0.0 110.245 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.468 ' HA ' ' HE2' ' A' ' 18' ' ' LYS . 42.5 mt-10 -76.38 -24.01 54.11 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.832 0.853 . . . . 0.0 111.397 177.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.0 -34.56 78.03 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.222 0.609 . . . . 0.0 110.718 175.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -64.47 -31.57 72.83 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.032 173.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.468 ' HE2' ' HA ' ' A' ' 15' ' ' GLU . 54.3 mtmt -81.06 -12.59 59.29 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.36 0.664 . . . . 0.0 111.906 -178.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.0 t -75.16 -35.18 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 169.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -74.55 -55.75 5.59 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.113 0.565 . . . . 0.0 109.797 175.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -85.54 89.09 7.62 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.872 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 32.2 ttm-85 -85.07 -23.95 28.31 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.953 172.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -64.65 -25.63 68.04 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.542 1.137 . . . . 0.0 111.841 -176.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.89 38.21 23.89 Favored Glycine 0 C--N 1.344 1.015 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 178.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -64.66 -25.24 67.87 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.555 1.142 . . . . 0.0 110.502 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.79 -35.99 4.3 Favored Glycine 0 C--N 1.347 1.162 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.485 ' HB2' ' O ' ' A' ' 64' ' ' VAL . 44.0 p90 -133.15 179.9 5.9 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 124.049 0.939 . . . . 0.0 109.647 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.0 p -134.1 173.88 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.213 0.605 . . . . 0.0 110.152 -172.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 44.5 p -73.39 145.99 45.46 Favored 'General case' 0 C--O 1.245 0.82 0 C-N-CA 123.404 0.682 . . . . 0.0 110.601 171.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.436 HG22 HG23 ' A' ' 53' ' ' ILE . 0.8 OUTLIER -70.47 -20.65 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 122.633 0.373 . . . . 0.0 110.594 -179.315 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -62.62 -53.85 48.38 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.631 0.772 . . . . 0.0 110.639 174.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 93.2 t80 -61.64 -39.64 92.04 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 122.94 0.496 . . . . 0.0 110.686 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.4 HD22 HG11 ' A' ' 64' ' ' VAL . 6.6 tp -53.86 -46.61 71.33 Favored 'General case' 0 CA--C 1.554 1.125 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.442 176.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.429 ' HG3' ' O ' ' A' ' 30' ' ' VAL . 69.4 mtt180 -62.3 -35.84 80.28 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.758 0.823 . . . . 0.0 111.942 -178.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 55.1 mttm -63.27 -60.97 2.7 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 123.679 0.612 . . . . 0.0 110.901 -176.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.4 p -62.25 -34.19 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 123.672 0.789 . . . . 0.0 112.351 -174.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.422 ' HB3' HG21 ' A' ' 49' ' ' ILE . 96.7 mt -77.39 -26.51 51.86 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.752 0.421 . . . . 0.0 111.359 -178.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -79.31 -30.91 43.06 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.795 0.438 . . . . 0.0 110.126 173.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -60.48 -44.98 95.37 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.853 0.861 . . . . 0.0 110.153 174.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.443 ' O ' ' HG2' ' A' ' 44' ' ' MET . 80.2 mt -84.14 3.06 36.61 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.487 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -73.47 -5.03 66.51 Favored Glycine 0 C--N 1.355 1.626 0 C-N-CA 123.635 0.636 . . . . 0.0 113.211 -176.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -72.79 -22.76 60.77 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 122.887 0.475 . . . . 0.0 110.485 170.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 69.3 mtm -114.29 1.0 14.33 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.37 1.068 . . . . 0.0 112.091 -173.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.443 ' HG2' ' O ' ' A' ' 40' ' ' LEU . 20.8 ptp -158.23 154.64 24.34 Favored Pre-proline 0 N--CA 1.488 1.47 0 C-N-CA 122.875 0.47 . . . . 0.0 110.584 -175.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.76 110.17 2.49 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 122.215 1.943 . . . . 0.0 112.377 -178.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.18 -24.32 35.04 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.823 -174.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -68.35 -39.19 81.96 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-O 121.317 0.58 . . . . 0.0 110.768 176.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -68.02 -46.8 70.2 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.096 176.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.422 HG21 ' HB3' ' A' ' 37' ' ' LEU . 81.6 mt -59.43 -44.68 93.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.429 0.692 . . . . 0.0 111.69 178.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -66.86 -32.46 73.75 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 118.169 0.441 . . . . 0.0 110.954 -175.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -63.85 -45.99 87.02 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 120.98 0.419 . . . . 0.0 110.116 172.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 22.9 mmt -60.94 -30.36 70.17 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.833 177.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.436 HG23 HG22 ' A' ' 30' ' ' VAL . 55.9 mt -67.8 -37.94 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.295 1.038 . . . . 0.0 111.491 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -62.84 -34.85 78.21 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 122.787 0.435 . . . . 0.0 110.623 173.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -76.33 -30.92 57.86 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.244 0.618 . . . . 0.0 110.603 177.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.425 ' HB1' HG23 ' A' ' 64' ' ' VAL . . . -70.65 -24.49 62.72 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.206 1.003 . . . . 0.0 111.745 -179.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -129.37 81.5 70.01 Favored Pre-proline 0 CA--C 1.547 0.852 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 171.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -79.3 -8.33 15.12 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 123.065 2.51 . . . . 0.0 112.451 -178.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -82.65 -21.72 34.91 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.65 0.78 . . . . 0.0 110.862 176.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.1 m120 59.12 32.92 22.55 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.472 1.109 . . . . 0.0 110.825 -175.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.7 m -97.21 -17.52 19.81 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.342 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.407 ' HA2' HG12 ' A' ' 30' ' ' VAL . . . 92.5 41.51 4.77 Favored Glycine 0 C--N 1.339 0.712 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.611 177.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -137.86 138.63 39.3 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.039 0.536 . . . . 0.0 111.143 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.485 ' O ' ' HB2' ' A' ' 27' ' ' TYR . 5.9 p -147.5 137.59 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.763 0.825 . . . . 0.0 110.363 -174.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -84.08 87.91 7.16 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 170.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -58.91 -35.19 72.66 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 114.613 -1.176 . . . . 0.0 113.373 -171.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -65.05 -39.51 93.42 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.772 0.429 . . . . 0.0 110.909 -169.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.455 ' O ' ' HG2' ' A' ' 72' ' ' MET . 11.2 t -83.28 -33.02 26.07 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.432 177.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -71.44 -56.38 6.06 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.407 0.623 . . . . 0.0 111.507 -177.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 99.6 t -65.67 -25.4 36.48 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.07 0 C-N-CA 124.393 1.077 . . . . 0.0 109.754 172.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -71.99 2.03 28.61 Favored Glycine 0 CA--C 1.543 1.828 0 CA-C-N 115.253 -0.885 . . . . 0.0 113.825 168.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.455 ' HG2' ' O ' ' A' ' 68' ' ' THR . 25.1 mmt -107.85 -45.39 4.01 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.775 0.83 . . . . 0.0 109.673 168.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 88.3 mt -58.24 -49.8 75.83 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.816 0.846 . . . . 0.0 112.142 -174.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -84.47 -11.91 55.29 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.161 -177.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -104.35 27.76 7.52 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.821 0.849 . . . . 0.0 110.701 178.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 32.6 m0 . . . . . 0 N--CA 1.488 1.427 0 C-N-CA 123.116 0.567 . . . . 0.0 110.99 171.186 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt . . . . . 0 N--CA 1.47 0.575 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.43 ' O ' ' HG2' ' A' ' 15' ' ' GLU . . . -63.04 -38.95 93.25 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 122.516 0.327 . . . . 0.0 110.186 172.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -71.03 -33.02 69.93 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.339 0.655 . . . . 0.0 112.369 -175.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.5 p -71.87 -36.64 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 176.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.438 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 75.1 mt -65.47 -33.42 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 174.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 23.5 mm-40 -62.01 -33.46 74.38 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.17 0.588 . . . . 0.0 111.491 174.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.25 -42.17 99.15 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 121.116 0.484 . . . . 0.0 110.195 174.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -69.37 -25.81 64.36 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.017 175.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.438 ' HG2' ' O ' ' A' ' 14' ' ' ILE . 73.7 mmtt -73.4 -28.16 61.85 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.202 0.601 . . . . 0.0 111.18 177.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 15' ' ' GLU . 87.9 t -72.24 -40.94 66.2 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 C-N-CA 123.153 0.581 . . . . 0.0 110.167 176.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -73.12 -40.72 64.71 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.592 0.357 . . . . 0.0 110.375 176.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -97.25 45.64 1.04 Allowed 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.977 0.894 . . . . 0.0 108.846 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -63.09 -25.4 68.35 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.397 1.079 . . . . 0.0 110.965 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -72.19 -28.33 63.13 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.629 0.772 . . . . 0.0 111.088 177.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.08 58.56 2.94 Favored Glycine 0 C--N 1.344 0.987 0 CA-C-N 115.955 -0.566 . . . . 0.0 113.312 176.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -78.07 -17.32 57.15 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.33 0.652 . . . . 0.0 110.218 170.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.13 -18.57 56.92 Favored Glycine 0 C--N 1.354 1.53 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.961 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -150.55 166.11 31.23 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.272 1.029 . . . . 0.0 109.867 -174.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.405 HG13 ' CD2' ' A' ' 66' ' ' TYR . 23.4 m -116.36 177.94 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.609 0.764 . . . . 0.0 110.445 176.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 67.7 p -84.72 157.57 21.03 Favored 'General case' 0 C--O 1.246 0.876 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.516 170.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.9 p -67.09 -17.22 22.37 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 123.201 0.601 . . . . 0.0 111.547 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -63.63 -63.17 1.25 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.325 0.65 . . . . 0.0 111.04 177.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -60.6 -38.4 84.54 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.908 0.483 . . . . 0.0 110.504 178.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.531 HD22 HG11 ' A' ' 64' ' ' VAL . 6.3 tp -54.64 -58.75 6.27 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.82 -178.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 73.9 mtt180 -61.54 -33.41 73.79 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.045 0.538 . . . . 0.0 111.354 178.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -66.19 -46.33 77.69 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.755 0.822 . . . . 0.0 111.664 -174.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.4 p -76.65 -34.81 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 122.959 0.504 . . . . 0.0 110.86 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.471 HD23 HD12 ' A' ' 40' ' ' LEU . 84.6 mt -78.68 -5.88 54.26 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.03 0.532 . . . . 0.0 111.376 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 32.2 t-20 -72.26 -45.37 60.44 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.373 0.669 . . . . 0.0 109.77 178.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -71.38 -40.79 70.34 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.226 176.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.471 HD12 HD23 ' A' ' 37' ' ' LEU . 75.9 mt -67.57 -26.61 66.38 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.74 0.816 . . . . 0.0 110.549 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -89.62 63.17 3.31 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.062 171.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -81.72 -72.62 0.42 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.617 0.767 . . . . 0.0 109.701 178.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 20.6 ptp -85.85 -22.76 27.41 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.973 0.509 . . . . 0.0 110.367 175.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 25.3 mmt -81.8 112.41 34.49 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 172.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.06 130.64 37.39 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 122.113 1.875 . . . . 0.0 111.837 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.469 ' O ' ' HG2' ' A' ' 50' ' ' GLU . . . -63.05 -21.79 66.41 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.454 0.701 . . . . 0.0 110.527 174.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -52.67 -40.46 62.91 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.602 1.561 . . . . 0.0 111.887 173.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -65.12 -46.4 81.18 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.444 0.698 . . . . 0.0 110.114 175.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 66.8 mt -63.06 -32.07 54.9 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.416 -177.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 14.5 mm-40 -62.88 -44.15 96.89 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.99 0.516 . . . . 0.0 110.713 177.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -61.0 -42.66 98.88 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 121.414 0.626 . . . . 0.0 110.29 177.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.525 ' HB3' ' HE1' ' A' ' 69' ' ' PHE . 79.9 mmm -63.3 -34.21 77.18 Favored 'General case' 0 CA--C 1.558 1.273 0 CA-C-N 114.31 -1.314 . . . . 0.0 110.735 176.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 60.2 mt -69.35 -34.51 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 C-N-CA 124.469 1.108 . . . . 0.0 110.952 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 4.3 m-30 -64.62 -26.54 68.44 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.163 0.585 . . . . 0.0 110.251 176.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -93.45 -20.45 20.29 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.567 0.747 . . . . 0.0 111.117 178.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.522 ' HB1' HG23 ' A' ' 64' ' ' VAL . . . -77.27 -53.43 7.72 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.376 0.67 . . . . 0.0 110.229 177.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -116.14 95.75 45.58 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 124.801 1.241 . . . . 0.0 108.384 174.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -85.75 -1.61 8.9 Favored 'Trans proline' 0 C--N 1.368 1.553 0 C-N-CA 122.719 2.279 . . . . 0.0 112.028 170.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -92.06 -6.74 50.46 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.153 0.981 . . . . 0.0 112.042 -169.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 59.68 28.61 18.08 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.485 1.114 . . . . 0.0 110.847 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.3 m -105.28 -15.01 15.17 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.27 1.028 . . . . 0.0 110.571 -176.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.57 9.11 87.07 Favored Glycine 0 C--N 1.346 1.137 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.943 -175.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 22.2 m-30 -86.6 97.42 10.53 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.307 0.643 . . . . 0.0 109.519 -176.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.531 HG11 HD22 ' A' ' 33' ' ' LEU . 2.4 p -113.32 118.46 58.18 Favored 'Isoleucine or valine' 0 C--O 1.245 0.825 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.481 -175.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -73.58 86.59 1.61 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.225 175.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.405 ' CD2' HG13 ' A' ' 28' ' ' VAL . 35.4 p90 -53.62 -33.44 55.05 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -175.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -67.97 -36.47 80.11 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 120.755 0.312 . . . . 0.0 110.616 -170.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.0 p -82.32 -48.14 11.54 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.795 0.838 . . . . 0.0 110.19 174.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.525 ' HE1' ' HB3' ' A' ' 52' ' ' MET . 46.8 t80 -66.14 -54.05 30.17 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.246 1.018 . . . . 0.0 113.37 -170.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 56.3 t -68.31 -21.08 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 122.85 0.46 . . . . 0.0 109.831 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -62.18 -44.94 97.02 Favored Glycine 0 CA--C 1.538 1.473 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.147 164.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 65.0 mtt -66.09 -29.08 69.34 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 124.224 1.01 . . . . 0.0 112.041 178.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.4 mt -74.08 -43.03 59.2 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 121.374 0.606 . . . . 0.0 110.57 175.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -95.78 34.98 1.43 Allowed 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.647 -173.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.8 pp -125.6 10.09 7.8 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 122.701 0.4 . . . . 0.0 111.296 168.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 54.4 m0 . . . . . 0 N--CA 1.485 1.323 0 C-N-CA 123.252 0.621 . . . . 0.0 111.899 -176.4 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.472 ' HE3' ' HB3' ' A' ' 74' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.361 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.476 ' O ' ' HG2' ' A' ' 15' ' ' GLU . . . -52.98 -42.08 65.2 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.456 0.702 . . . . 0.0 111.656 -178.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -61.06 -46.86 88.98 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.736 0.815 . . . . 0.0 112.199 -176.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.3 p -74.8 -31.39 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 122.722 0.409 . . . . 0.0 110.562 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.5 HG23 ' HE1' ' A' ' 66' ' ' TYR . 61.6 mt -65.11 -34.24 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.737 0.815 . . . . 0.0 110.811 178.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 19.1 mm-40 -69.37 -32.99 72.39 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.637 174.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.38 -37.25 82.7 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 122.938 0.495 . . . . 0.0 111.072 177.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -62.56 -41.23 98.78 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.972 173.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.465 ' HE3' HG22 ' A' ' 14' ' ' ILE . 92.9 mttt -71.46 -27.61 63.38 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.025 0.53 . . . . 0.0 111.508 -178.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 15' ' ' GLU . 92.3 t -69.97 -33.44 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.494 0.718 . . . . 0.0 109.963 174.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -74.61 -43.74 54.07 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.443 174.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -72.27 104.94 3.85 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -176.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -94.79 -15.36 23.86 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.52 0.728 . . . . 0.0 112.234 -178.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.406 ' HB2' ' ND2' ' A' ' 25' ' ' ASN . 20.8 m-20 -92.43 -26.35 18.05 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 120.87 0.367 . . . . 0.0 111.069 -176.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.66 42.78 12.95 Favored Glycine 0 C--N 1.338 0.649 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.865 -171.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.406 ' ND2' ' HB2' ' A' ' 23' ' ' ASP . 48.5 m-80 -65.94 -23.86 66.69 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.613 0.765 . . . . 0.0 111.11 178.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.05 -32.82 6.47 Favored Glycine 0 C--N 1.347 1.17 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 -178.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.424 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 45.2 p90 -133.62 160.69 36.75 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.406 1.082 . . . . 0.0 109.636 175.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 55.0 t -110.5 161.14 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.178 0.991 . . . . 0.0 110.41 -174.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 63' ' ' TYR . 73.1 p -56.15 151.6 12.08 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 124.191 0.996 . . . . 0.0 111.982 172.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.8 p -67.21 -20.71 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.409 174.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -58.97 -62.19 2.07 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.74 1.216 . . . . 0.0 111.635 176.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -65.37 -30.11 70.9 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.973 0.509 . . . . 0.0 111.012 -178.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.692 HD22 HG11 ' A' ' 64' ' ' VAL . 6.5 tp -54.75 -50.92 67.24 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 123.717 0.635 . . . . 0.0 109.977 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.546 ' HG2' HD13 ' A' ' 53' ' ' ILE . 37.1 mtm180 -61.67 -37.96 86.02 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.862 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -65.7 -53.04 46.38 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.415 0.686 . . . . 0.0 112.179 -175.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.06 -26.88 35.47 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.957 -176.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 87.3 mt -86.81 -16.07 37.31 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.322 0.649 . . . . 0.0 111.779 178.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -74.79 -43.01 57.03 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.188 0.595 . . . . 0.0 110.124 175.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -72.75 -32.63 65.8 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 122.94 0.496 . . . . 0.0 110.794 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.424 HD13 ' HZ ' ' A' ' 74' ' ' PHE . 95.6 mt -78.46 -21.36 49.2 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.257 0.623 . . . . 0.0 110.514 174.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.73 ' HA2' ' HB2' ' A' ' 44' ' ' MET . . . -83.34 46.71 3.69 Favored Glycine 0 C--N 1.349 1.263 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 169.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -79.56 -55.16 5.23 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.886 0.874 . . . . 0.0 109.123 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 64.1 mtt -105.33 11.7 32.52 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.734 174.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.73 ' HB2' ' HA2' ' A' ' 41' ' ' GLY . 55.9 mtt -113.15 150.98 43.84 Favored Pre-proline 0 N--CA 1.48 1.068 0 C-N-CA 124.464 1.106 . . . . 0.0 108.579 176.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -68.7 115.39 3.91 Favored 'Trans proline' 0 C--N 1.374 1.886 0 C-N-CA 122.438 2.092 . . . . 0.0 110.926 172.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.44 -37.66 77.46 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.577 0.751 . . . . 0.0 110.824 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -63.46 -32.85 74.41 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.853 0.861 . . . . 0.0 111.644 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.473 ' O ' ' HG3' ' A' ' 52' ' ' MET . 40.3 tt0 -60.24 -39.4 86.56 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.625 1.17 . . . . 0.0 110.375 176.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 63.6 mt -77.89 -41.04 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.273 177.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -54.76 -46.0 74.27 Favored 'General case' 0 C--N 1.354 0.802 0 O-C-N 124.074 0.859 . . . . 0.0 111.091 -177.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -60.99 -37.37 82.24 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-O 120.66 0.267 . . . . 0.0 111.145 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.473 ' HG3' ' O ' ' A' ' 48' ' ' GLU . 43.0 mtm -72.73 -29.76 63.62 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.254 0.622 . . . . 0.0 110.653 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.546 HD13 ' HG2' ' A' ' 34' ' ' ARG . 77.1 mt -71.74 -33.87 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 124.136 0.975 . . . . 0.0 110.006 175.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -77.71 -10.6 59.61 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.02 0.928 . . . . 0.0 110.61 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -94.17 -27.61 16.11 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.316 1.047 . . . . 0.0 110.376 168.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.49 -30.74 59.97 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.55 0.74 . . . . 0.0 111.547 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -148.64 81.25 7.9 Favored Pre-proline 0 N--CA 1.478 0.961 0 C-N-CA 123.091 0.556 . . . . 0.0 109.836 172.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -83.32 -11.71 9.49 Favored 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.928 2.419 . . . . 0.0 113.132 172.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 20.7 tm0? -78.22 -23.35 47.5 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.671 0.789 . . . . 0.0 110.27 -174.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.3 t30 67.19 53.06 0.8 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.984 1.314 . . . . 0.0 108.926 -172.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.5 m -79.77 -24.36 41.56 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.742 173.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.91 23.9 63.06 Favored Glycine 0 C--N 1.346 1.113 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.995 -174.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 29' ' ' THR . 72.9 m-85 -144.44 159.84 42.07 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.768 0.827 . . . . 0.0 111.438 -174.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.692 HG11 HD22 ' A' ' 33' ' ' LEU . 5.4 p -167.58 143.93 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.379 1.072 . . . . 0.0 109.406 175.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -82.2 104.99 12.93 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 172.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.5 ' HE1' HG23 ' A' ' 14' ' ' ILE . 53.2 p90 -64.48 -32.27 73.83 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.999 0.52 . . . . 0.0 111.013 178.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -55.06 -42.03 72.23 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.818 0.847 . . . . 0.0 110.87 174.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 19.1 m -76.83 -53.46 7.88 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.576 179.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -69.39 -54.33 14.95 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.109 -169.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.59 ' HA ' ' HB3' ' A' ' 73' ' ' LEU . 57.8 t -62.72 -19.09 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.372 0 C-N-CA 123.288 0.635 . . . . 0.0 111.283 177.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -71.29 -35.26 63.77 Favored Glycine 0 C--N 1.351 1.388 0 CA-C-N 116.435 -0.348 . . . . 0.0 113.39 172.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 28.3 ptm -98.24 -3.99 36.24 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.543 0.737 . . . . 0.0 111.527 177.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.59 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 9.8 tp -97.61 -53.02 3.56 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.448 1.099 . . . . 0.0 110.576 -178.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.472 ' HB3' ' HE3' ' A' ' 10' ' ' LYS . 3.4 m-85 -83.81 27.87 0.61 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.688 0.795 . . . . 0.0 112.893 -174.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.7 pp -77.86 -0.09 25.99 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.956 0.503 . . . . 0.0 111.127 169.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 49.5 m0 . . . . . 0 CA--C 1.545 0.763 0 C-N-CA 124.874 1.269 . . . . 0.0 110.816 177.983 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? . . . . . 0 N--CA 1.476 0.845 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.463 ' O ' ' HG2' ' A' ' 15' ' ' GLU . . . -75.82 -39.79 56.11 Favored 'General case' 0 C--O 1.216 -0.705 0 C-N-CA 123.117 0.567 . . . . 0.0 110.738 171.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -58.5 -38.58 77.95 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 123.272 0.629 . . . . 0.0 112.588 -174.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.3 p -65.9 -40.14 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 175.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.432 HG22 ' HE3' ' A' ' 18' ' ' LYS . 64.3 mt -64.77 -31.82 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 123.393 0.677 . . . . 0.0 110.423 176.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 10.4 mm-40 -71.4 -27.73 63.52 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.082 0.553 . . . . 0.0 110.983 178.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.9 -35.63 81.76 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 122.919 0.488 . . . . 0.0 110.996 177.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.515 ' CZ ' HD12 ' A' ' 33' ' ' LEU . 95.7 m-85 -64.03 -35.65 81.43 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.482 0.713 . . . . 0.0 110.951 174.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.432 ' HE3' HG22 ' A' ' 14' ' ' ILE . 90.9 mttt -77.19 -29.67 54.45 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.0 -177.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 74.1 t -69.33 -37.76 76.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 123.452 0.701 . . . . 0.0 109.769 172.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -71.48 -46.95 58.48 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.718 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -83.76 81.05 8.93 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.878 0.847 . . . . 0.0 109.014 -177.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 29.6 mtm180 -86.04 -18.42 32.52 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 113.947 -1.478 . . . . 0.0 110.076 177.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -80.01 -25.86 40.06 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.766 0.826 . . . . 0.0 111.568 -175.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.27 52.53 3.97 Favored Glycine 0 C--N 1.341 0.837 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.637 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.448 ' N ' HD22 ' A' ' 25' ' ' ASN . 0.8 OUTLIER -80.76 -19.17 45.48 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.24 1.016 . . . . 0.0 109.827 173.475 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.82 -56.17 3.74 Favored Glycine 0 C--N 1.347 1.175 0 N-CA-C 111.164 -0.775 . . . . 0.0 111.164 -175.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -118.97 156.91 28.75 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.326 1.05 . . . . 0.0 110.194 178.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.5 t -110.56 157.25 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 123.636 0.775 . . . . 0.0 109.503 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 68.7 p -65.28 166.5 9.83 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.107 0.963 . . . . 0.0 112.345 178.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.656 HG23 HG21 ' A' ' 53' ' ' ILE . 7.2 p -63.42 -33.48 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.332 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -64.09 -49.19 73.24 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.311 0.244 . . . . 0.0 111.627 -172.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -67.59 -36.88 81.72 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.488 176.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.592 HD22 HG11 ' A' ' 64' ' ' VAL . 12.1 tp -56.1 -43.88 78.51 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.665 0.603 . . . . 0.0 110.687 177.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 34.8 mtm105 -72.26 -34.67 68.41 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.097 0.559 . . . . 0.0 110.411 177.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -63.05 -50.7 69.6 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.651 0.78 . . . . 0.0 111.899 -174.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.3 p -64.82 -33.48 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 122.889 0.475 . . . . 0.0 110.83 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.419 HD13 HG21 ' A' ' 49' ' ' ILE . 80.5 mt -85.51 -8.51 58.29 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 123.766 0.827 . . . . 0.0 111.367 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -87.09 -36.2 18.27 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.1 1.36 . . . . 0.0 108.934 171.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -69.21 -35.17 75.92 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.848 0.859 . . . . 0.0 109.635 173.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 93.2 mt -89.23 15.52 8.8 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.762 0.825 . . . . 0.0 110.491 169.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 44' ' ' MET . . . -74.92 -10.05 83.69 Favored Glycine 0 C--N 1.353 1.515 0 C-N-CA 123.851 0.739 . . . . 0.0 113.626 -173.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -68.13 -32.77 73.28 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.324 0.649 . . . . 0.0 110.342 174.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 93.6 mmm -107.46 -31.1 8.29 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.62 0.768 . . . . 0.0 111.699 178.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.618 ' HB3' HD11 ' A' ' 49' ' ' ILE . 24.9 mmt -113.21 104.92 55.72 Favored Pre-proline 0 N--CA 1.479 1.002 0 C-N-CA 123.539 0.735 . . . . 0.0 109.778 -173.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.42 117.93 4.73 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.69 2.26 . . . . 0.0 111.866 -178.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.92 -47.71 85.16 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.766 0.826 . . . . 0.0 111.572 -176.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -53.93 -40.66 66.93 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 123.798 0.839 . . . . 0.0 111.723 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -62.47 -52.17 64.58 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.216 178.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.618 HD11 ' HB3' ' A' ' 44' ' ' MET . 79.1 mt -62.75 -40.32 88.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.859 -178.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.513 ' HA ' HD12 ' A' ' 53' ' ' ILE . 51.2 mt-10 -63.17 -34.05 76.79 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.139 0.576 . . . . 0.0 111.06 -175.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -67.78 -36.3 80.22 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 121.146 0.498 . . . . 0.0 110.379 175.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 20.0 mmt -67.14 -29.7 69.49 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.587 0.755 . . . . 0.0 110.807 177.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.656 HG21 HG23 ' A' ' 30' ' ' VAL . 50.2 mt -71.39 -31.1 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 123.118 0.567 . . . . 0.0 110.754 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -64.35 -28.95 70.05 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 122.898 0.479 . . . . 0.0 110.711 175.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -78.91 -37.51 39.75 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.032 0.533 . . . . 0.0 110.466 174.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.02 -25.6 61.02 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.9 0.88 . . . . 0.0 112.183 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -140.47 81.8 17.06 Favored Pre-proline 0 CA--C 1.548 0.889 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 175.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -65.58 -14.44 44.83 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 123.462 2.775 . . . . 0.0 112.788 175.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -69.2 -26.05 64.64 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.408 0.683 . . . . 0.0 110.911 176.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.1 t30 59.15 24.1 12.43 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.482 1.113 . . . . 0.0 110.824 -178.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.8 m -83.6 -16.46 45.17 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.791 0.836 . . . . 0.0 110.682 -178.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.86 29.84 22.34 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-N 115.589 -0.732 . . . . 0.0 113.28 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -126.82 107.75 10.4 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.872 0.869 . . . . 0.0 109.135 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.592 HG11 HD22 ' A' ' 33' ' ' LEU . 3.3 p -136.01 135.8 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 123.162 0.585 . . . . 0.0 110.89 -173.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -76.13 98.38 4.36 Favored 'General case' 0 C--N 1.35 0.609 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 174.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -55.08 -34.43 63.62 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.238 1.015 . . . . 0.0 112.809 -178.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -58.05 -57.01 14.7 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.522 0.729 . . . . 0.0 110.162 -176.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.2 p -68.76 -39.87 80.03 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.389 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -67.4 -67.27 0.47 Allowed 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 119.21 -0.424 . . . . 0.0 111.974 -177.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.616 ' HA ' ' HB3' ' A' ' 73' ' ' LEU . 57.6 t -52.4 -26.06 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 C-N-CA 124.808 1.243 . . . . 0.0 112.232 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.96 -54.58 29.72 Favored Glycine 0 CA--C 1.541 1.67 0 N-CA-C 112.469 -0.252 . . . . 0.0 112.469 168.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 64.0 mtm -73.59 -12.1 60.64 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.705 0.802 . . . . 0.0 112.236 178.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.616 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 52.3 tp -86.49 -41.57 14.27 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.375 1.07 . . . . 0.0 110.094 -178.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.414 ' HA ' ' CD1' ' A' ' 76' ' ' TRP . 8.2 m-85 -89.74 34.26 0.84 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.379 0.672 . . . . 0.0 111.699 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 92.2 mt -77.42 -15.33 59.4 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.849 0.46 . . . . 0.0 110.877 170.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.414 ' CD1' ' HA ' ' A' ' 74' ' ' PHE . 0.3 OUTLIER . . . . . 0 CA--C 1.556 1.197 0 C-N-CA 124.286 1.035 . . . . 0.0 112.176 174.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.447 ' O ' HG12 ' A' ' 14' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.503 ' O ' ' HG2' ' A' ' 15' ' ' GLU . . . -54.95 -48.94 72.54 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.406 0.683 . . . . 0.0 110.381 175.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -63.25 -38.45 91.2 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.982 0.913 . . . . 0.0 112.753 -171.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.5 p -69.01 -41.0 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 177.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.467 HG22 ' HE3' ' A' ' 18' ' ' LYS . 48.1 mm -63.35 -37.84 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 123.37 0.668 . . . . 0.0 110.958 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.503 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 20.3 mm-40 -73.07 -28.53 62.36 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.014 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.76 -35.3 80.14 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.288 0.635 . . . . 0.0 110.985 177.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -61.94 -41.88 98.47 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.025 173.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.467 ' HE3' HG22 ' A' ' 14' ' ' ILE . 96.5 mttt -68.03 -27.55 66.64 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.444 0.698 . . . . 0.0 112.072 -173.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.2 t -71.26 -39.85 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.129 0.572 . . . . 0.0 109.851 175.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -71.17 -40.35 71.34 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.756 177.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.428 ' HB2' HG22 ' A' ' 28' ' ' VAL . 27.7 t0 -85.28 70.79 10.88 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 122.12 0.962 . . . . 0.0 108.993 -179.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -67.45 -29.35 68.78 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 113.834 -1.53 . . . . 0.0 109.681 176.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -69.84 -25.99 64.0 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.673 -178.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.16 41.45 47.03 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.55 173.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -68.56 -20.36 64.53 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.502 0.721 . . . . 0.0 111.312 176.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.37 -26.17 25.51 Favored Glycine 0 C--N 1.348 1.24 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.686 -177.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -136.04 166.89 22.32 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.161 0.984 . . . . 0.0 109.557 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.428 HG22 ' HB2' ' A' ' 21' ' ' ASP . 81.3 t -118.79 153.45 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.046 0.938 . . . . 0.0 109.233 176.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.8 p -60.93 155.95 18.68 Favored 'General case' 0 C--O 1.248 0.983 0 C-N-CA 123.551 0.74 . . . . 0.0 111.247 173.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.407 ' O ' ' HG3' ' A' ' 34' ' ' ARG . 9.7 p -62.82 -24.09 34.77 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-N 116.167 -0.47 . . . . 0.0 112.196 -175.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -60.33 -60.1 4.35 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.195 0.598 . . . . 0.0 111.851 -176.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -63.74 -32.67 74.23 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.069 0.548 . . . . 0.0 110.479 178.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.423 HD13 HG13 ' A' ' 64' ' ' VAL . 4.4 tt -61.37 -44.48 97.1 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.879 0.872 . . . . 0.0 111.551 179.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.407 ' HG3' ' O ' ' A' ' 30' ' ' VAL . 50.7 mtm180 -68.21 -38.99 82.51 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.941 0.496 . . . . 0.0 109.915 177.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -61.55 -47.14 86.91 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 124.165 0.916 . . . . 0.0 111.35 -177.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.4 p -73.43 -25.5 21.22 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.699 -176.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.633 HD11 HG22 ' A' ' 70' ' ' VAL . 96.6 mt -86.9 -15.19 39.74 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.821 0.448 . . . . 0.0 111.311 175.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -88.36 -30.95 19.15 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 176.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -78.15 -24.34 47.36 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 110.513 -0.18 . . . . 0.0 110.513 176.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 60.3 mt -95.81 12.22 30.85 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.595 0.758 . . . . 0.0 109.791 169.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.468 ' HA2' ' SD ' ' A' ' 44' ' ' MET . . . -144.84 55.83 0.55 Allowed Glycine 0 C--N 1.349 1.26 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 -175.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -68.69 -64.88 0.78 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.495 0.718 . . . . 0.0 110.359 -177.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.87 -4.34 43.81 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.75 177.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.468 ' SD ' ' HA2' ' A' ' 41' ' ' GLY . 1.2 mpt? -74.74 133.55 76.39 Favored Pre-proline 0 CA--C 1.546 0.801 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 172.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -65.54 114.99 3.12 Favored 'Trans proline' 0 C--N 1.37 1.69 0 C-N-CA 122.023 1.815 . . . . 0.0 110.438 173.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.85 -13.24 59.54 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.015 0.526 . . . . 0.0 111.343 177.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.42 ' O ' ' HG2' ' A' ' 51' ' ' GLU . 1.7 m-20 -53.59 -45.78 70.12 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.561 1.144 . . . . 0.0 111.925 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -59.88 -40.95 90.42 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.133 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 84.2 mt -67.89 -35.7 73.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 124.023 0.929 . . . . 0.0 110.274 178.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -66.09 -40.35 90.73 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.594 0.758 . . . . 0.0 110.769 177.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 47' ' ' ASP . 16.3 mm-40 -65.55 -33.48 76.01 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.249 0.62 . . . . 0.0 110.966 177.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.407 ' HB3' ' HE1' ' A' ' 69' ' ' PHE . 21.3 mmt -68.4 -37.45 80.37 Favored 'General case' 0 CA--C 1.55 0.96 0 O-C-N 123.939 0.774 . . . . 0.0 110.117 174.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 70.4 mt -62.05 -38.39 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 124.243 1.017 . . . . 0.0 111.676 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -57.71 -32.0 66.97 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.086 0.554 . . . . 0.0 111.649 178.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -87.8 -38.71 15.49 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.799 0.84 . . . . 0.0 110.591 178.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.66 -20.98 60.41 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.08 0.952 . . . . 0.0 111.917 -175.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -138.95 83.67 18.17 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 174.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -77.76 -13.84 15.95 Favored 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 122.958 2.438 . . . . 0.0 112.276 -177.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.487 ' HG3' ' H ' ' A' ' 61' ' ' SER . 27.3 pt20 -79.16 -16.16 57.04 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.491 1.116 . . . . 0.0 112.081 -178.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.3 t30 63.29 18.6 11.12 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 124.708 1.203 . . . . 0.0 111.254 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.487 ' H ' ' HG3' ' A' ' 59' ' ' GLN . 19.4 m -92.67 -25.92 18.04 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.51 0.724 . . . . 0.0 110.152 -175.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.25 41.84 6.07 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 115.763 -0.653 . . . . 0.0 113.325 175.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -124.36 94.58 4.25 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.258 1.023 . . . . 0.0 108.601 175.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.423 HG13 HD13 ' A' ' 33' ' ' LEU . 3.9 p -126.9 134.27 66.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 124.01 0.924 . . . . 0.0 110.257 -170.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -76.79 108.06 9.55 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.891 0.877 . . . . 0.0 109.82 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -65.77 -38.01 87.87 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -170.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -71.02 -32.87 69.75 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 118.3 0.5 . . . . 0.0 110.126 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 31.3 m -72.19 -30.56 65.07 Favored 'General case' 0 CA--C 1.553 1.079 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.882 174.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.42 ' CE2' HD21 ' A' ' 33' ' ' LEU . 45.8 t80 -93.22 -72.1 0.62 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.083 0.553 . . . . 0.0 111.726 -176.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.633 HG22 HD11 ' A' ' 37' ' ' LEU . 57.6 t -59.49 -36.21 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.819 1.248 . . . . 0.0 111.346 -177.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -59.47 -37.42 92.07 Favored Glycine 0 C--N 1.348 1.219 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.934 174.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 94.2 mmm -81.59 -37.02 28.3 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.432 0.693 . . . . 0.0 112.26 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 pp -75.65 -24.66 56.41 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 118.303 0.501 . . . . 0.0 110.286 -175.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.423 ' CD2' ' HB3' ' A' ' 10' ' ' LYS . 6.1 m-85 -74.76 -8.05 55.23 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.573 0.349 . . . . 0.0 111.547 172.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 60.5 mt -89.05 9.25 25.98 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.995 0.518 . . . . 0.0 111.963 175.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 43.7 m0 . . . . . 0 N--CA 1.484 1.266 0 CA-C-O 121.227 0.537 . . . . 0.0 109.986 174.594 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.429 ' HA ' HG12 ' A' ' 13' ' ' VAL . 14.0 ptmm? . . . . . 0 N--CA 1.476 0.85 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.03 -42.18 73.27 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 122.643 0.377 . . . . 0.0 110.36 170.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -64.54 -39.22 93.37 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.396 0.678 . . . . 0.0 112.146 -177.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.429 HG12 ' HA ' ' A' ' 10' ' ' LYS . 11.9 p -69.68 -35.51 66.12 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 CA-C-O 119.348 -0.358 . . . . 0.0 110.307 178.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 77.0 mt -61.92 -41.69 91.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 C-N-CA 122.824 0.45 . . . . 0.0 110.11 172.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.447 ' O ' HG23 ' A' ' 19' ' ' VAL . 33.7 mm-40 -63.19 -29.5 70.83 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.281 0.632 . . . . 0.0 111.21 176.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.92 -32.56 73.89 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.93 0.492 . . . . 0.0 111.616 178.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.406 ' HE2' ' HA ' ' A' ' 33' ' ' LEU . 93.6 m-85 -70.25 -40.42 74.43 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 171.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -74.23 -9.13 58.3 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.227 -177.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 15' ' ' GLU . 93.3 t -68.73 -44.62 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 167.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -69.51 -55.15 11.02 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.157 179.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -75.15 95.84 3.17 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.557 178.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -88.27 -38.77 14.95 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.327 -176.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -76.55 -22.36 54.45 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.833 0.853 . . . . 0.0 112.393 -173.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.3 53.6 3.6 Favored Glycine 0 C--N 1.343 0.969 0 N-CA-C 111.491 -0.644 . . . . 0.0 111.491 -176.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -68.71 -30.1 68.67 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.624 1.17 . . . . 0.0 109.334 173.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.05 -59.74 0.46 Allowed Glycine 0 C--N 1.342 0.868 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.084 175.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.402 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 43.9 p90 -115.29 -171.66 2.0 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.628 0.771 . . . . 0.0 110.834 -171.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.428 HG22 ' H ' ' A' ' 29' ' ' THR . 3.0 p -139.65 178.2 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.221 0 C-N-CA 123.343 0.657 . . . . 0.0 110.484 -173.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.428 ' H ' HG22 ' A' ' 28' ' ' VAL . 68.5 p -88.13 154.11 20.72 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.008 0.923 . . . . 0.0 110.358 175.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.6 p -67.59 -29.77 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-N 117.861 0.3 . . . . 0.0 110.856 178.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -62.5 -46.55 87.92 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.513 178.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -72.24 -32.79 67.02 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.614 179.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.426 HD21 ' CE2' ' A' ' 69' ' ' PHE . 2.9 tt -67.79 -39.12 84.07 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.947 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 37.4 mtp-105 -72.83 -30.59 64.16 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 122.42 0.288 . . . . 0.0 110.321 174.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -63.62 -49.33 73.72 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.593 1.157 . . . . 0.0 111.075 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.474 HG13 ' HG ' ' A' ' 37' ' ' LEU . 7.0 p -69.34 -40.17 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.137 0.575 . . . . 0.0 111.627 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.474 ' HG ' HG13 ' A' ' 36' ' ' VAL . 79.7 mt -82.1 -4.8 57.65 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.48 0.712 . . . . 0.0 111.862 -176.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -67.84 -29.12 68.19 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.489 0.716 . . . . 0.0 111.412 175.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -59.35 -40.04 85.14 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.292 0.637 . . . . 0.0 111.792 -177.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.2 pp -92.48 7.58 42.46 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.508 0.723 . . . . 0.0 110.919 -178.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -72.98 -19.33 79.53 Favored Glycine 0 C--N 1.352 1.447 0 O-C-N 123.48 0.487 . . . . 0.0 112.496 -178.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -75.28 -27.24 59.31 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.329 0.652 . . . . 0.0 111.215 177.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 82.3 mtp -100.02 -44.65 5.94 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.723 0.809 . . . . 0.0 110.769 -175.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 23.0 mmt -120.03 145.69 40.45 Favored Pre-proline 0 N--CA 1.482 1.171 0 C-N-CA 124.839 1.256 . . . . 0.0 109.649 -177.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -58.41 119.53 6.85 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.729 2.286 . . . . 0.0 112.761 179.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.01 -30.33 63.69 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.302 174.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -55.13 -40.89 71.06 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 124.026 0.93 . . . . 0.0 111.225 174.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -51.96 -53.81 36.93 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.382 1.073 . . . . 0.0 110.695 174.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.518 HG12 HD11 ' A' ' 73' ' ' LEU . 74.0 mt -60.39 -41.93 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.96 179.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.561 ' HA ' HD12 ' A' ' 53' ' ' ILE . 42.7 mt-10 -66.01 -34.69 78.68 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.502 0.721 . . . . 0.0 112.12 -175.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -70.07 -39.49 75.6 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 120.951 0.405 . . . . 0.0 110.32 175.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 48.0 mmm -59.53 -34.25 72.39 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.948 0.899 . . . . 0.0 110.568 174.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.561 HD12 ' HA ' ' A' ' 50' ' ' GLU . 85.1 mt -62.56 -34.42 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.851 0.86 . . . . 0.0 112.149 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -60.95 -25.96 67.18 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -177.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -89.91 -28.54 19.13 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 122.776 0.43 . . . . 0.0 111.219 176.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.2 -34.43 68.37 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.374 0.669 . . . . 0.0 111.164 178.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -132.03 80.81 63.8 Favored Pre-proline 0 CA--C 1.548 0.878 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 175.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -82.29 -3.8 11.59 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.988 2.459 . . . . 0.0 112.684 -179.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -86.73 -14.88 41.14 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.354 1.061 . . . . 0.0 111.586 -179.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 61.26 30.7 19.31 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 124.611 1.164 . . . . 0.0 110.615 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.6 t -109.19 -3.74 17.04 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.799 0.84 . . . . 0.0 111.111 -172.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.99 19.83 74.32 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 114.852 0.701 . . . . 0.0 114.852 172.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -110.05 94.75 5.18 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 177.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.3 p -111.99 130.64 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.55 0.74 . . . . 0.0 110.551 -174.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.402 ' HA ' ' HB2' ' A' ' 27' ' ' TYR . 46.0 mt-30 -85.71 93.98 8.99 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 175.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -55.26 -29.84 58.91 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.592 0.757 . . . . 0.0 111.746 176.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -48.84 -55.87 10.38 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.083 1.753 . . . . 0.0 111.168 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.1 t -87.43 -30.58 20.6 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 114.466 -1.243 . . . . 0.0 110.51 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.426 ' CE2' HD21 ' A' ' 33' ' ' LEU . 52.1 t80 -67.07 -65.3 0.7 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.865 0.466 . . . . 0.0 111.7 -174.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.55 ' HA ' ' HB3' ' A' ' 73' ' ' LEU . 99.1 t -50.41 -29.45 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 124.837 1.255 . . . . 0.0 112.3 175.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.17 -50.63 65.59 Favored Glycine 0 CA--C 1.535 1.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.849 171.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 24.7 ptm -84.59 -15.48 45.48 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.349 0.66 . . . . 0.0 111.706 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.55 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 66.8 tp -77.25 -51.76 10.37 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.186 0.994 . . . . 0.0 109.9 -174.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -83.59 34.96 0.49 Allowed 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 123.593 0.757 . . . . 0.0 111.546 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 53.5 mt -96.29 23.13 6.94 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.751 0.82 . . . . 0.0 110.989 169.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 7.0 m0 . . . . . 0 CA--C 1.545 0.751 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 170.962 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.464 ' HE3' ' HA2' ' A' ' 71' ' ' GLY . 13.3 ptmm? . . . . . 0 N--CA 1.479 0.981 0 CA-C-O 119.862 -0.113 . . . . 0.0 111.234 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.471 ' O ' ' HG2' ' A' ' 15' ' ' GLU . . . -55.84 -34.68 65.65 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.073 0.949 . . . . 0.0 111.703 178.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -60.41 -52.99 62.88 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.525 0.73 . . . . 0.0 112.176 -177.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.4 p -65.85 -29.87 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 122.5 0.32 . . . . 0.0 110.458 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.438 ' HA ' ' HD2' ' A' ' 17' ' ' PHE . 94.1 mt -70.05 -34.41 59.4 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 123.404 0.682 . . . . 0.0 110.873 177.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 18.7 mm-40 -62.49 -28.36 69.78 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.372 0.669 . . . . 0.0 110.961 175.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.14 -44.95 86.95 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.175 0.59 . . . . 0.0 110.444 175.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.438 ' HD2' ' HA ' ' A' ' 14' ' ' ILE . 99.6 m-85 -68.44 -32.96 73.35 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.489 178.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -79.24 -29.0 42.46 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.191 0.596 . . . . 0.0 112.097 -177.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.7 p -82.08 -15.55 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 CA-C-O 121.031 0.443 . . . . 0.0 110.079 173.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -78.38 -50.71 11.23 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 172.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -96.33 88.01 4.63 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.572 0.749 . . . . 0.0 109.627 178.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -94.44 1.95 55.76 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.502 173.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -90.95 -25.47 19.74 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.493 0.717 . . . . 0.0 111.279 -175.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.21 38.66 12.54 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.078 -175.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -64.23 -26.4 68.49 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.453 1.101 . . . . 0.0 109.049 169.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.32 -32.98 6.71 Favored Glycine 0 C--N 1.352 1.438 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.487 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.462 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 51.6 p90 -144.96 -179.42 6.6 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.476 0.71 . . . . 0.0 111.003 -176.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.6 t -126.43 156.01 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.528 1.131 . . . . 0.0 110.042 -172.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.4 p -66.3 149.57 50.17 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.856 0.862 . . . . 0.0 111.162 173.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.9 p -68.49 -19.1 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 122.74 0.416 . . . . 0.0 112.068 -173.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -56.49 -51.81 67.09 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.522 0.729 . . . . 0.0 111.313 175.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -69.73 -32.56 71.19 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.075 -179.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.422 HD12 ' CZ ' ' A' ' 17' ' ' PHE . 9.0 tp -58.41 -55.39 35.69 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 123.923 0.764 . . . . 0.0 110.331 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.561 ' HG2' HD13 ' A' ' 53' ' ' ILE . 94.3 mtt180 -65.94 -27.19 67.99 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.605 -178.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -70.01 -52.7 22.03 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.787 0.835 . . . . 0.0 111.27 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.5 p -75.19 -29.9 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.409 -175.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 95.4 mt -80.65 -10.51 59.73 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.917 0.487 . . . . 0.0 111.259 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -74.83 -44.24 50.31 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 165.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -62.88 -35.53 80.32 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.217 -179.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -85.43 -42.27 14.66 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.296 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -91.94 67.72 2.07 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.762 -168.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -86.62 -57.88 2.82 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.686 0.794 . . . . 0.0 109.539 173.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -71.73 -34.75 69.81 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.739 0.816 . . . . 0.0 110.758 178.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 19.5 mmt -95.99 101.19 7.79 Favored Pre-proline 0 N--CA 1.472 0.65 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 172.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.406 ' HB2' ' HG3' ' A' ' 48' ' ' GLU . 83.1 Cg_exo -48.85 129.68 21.5 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 123.338 2.692 . . . . 0.0 113.248 -171.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.02 -28.25 67.58 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.81 0.844 . . . . 0.0 111.336 -178.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -65.96 -41.76 90.81 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.958 0.903 . . . . 0.0 111.206 175.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 52' ' ' MET . 38.7 mt-10 -72.27 -31.72 66.0 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 122.566 0.346 . . . . 0.0 110.645 178.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.407 ' O ' HG13 ' A' ' 53' ' ' ILE . 96.4 mt -64.67 -36.89 78.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 123.261 0.624 . . . . 0.0 110.088 169.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.542 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 51.1 mt-10 -69.56 -28.31 65.88 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.457 0.303 . . . . 0.0 111.66 176.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -58.12 -34.13 69.9 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.562 0.696 . . . . 0.0 110.538 170.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.421 ' HG2' ' O ' ' A' ' 48' ' ' GLU . 11.4 mmt -81.03 -37.76 28.59 Favored 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.038 177.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.561 HD13 ' HG2' ' A' ' 34' ' ' ARG . 69.0 mt -65.41 -43.02 94.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 124.467 1.107 . . . . 0.0 111.503 -175.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -59.74 -19.22 48.79 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.881 0.472 . . . . 0.0 112.049 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -84.32 -37.11 22.03 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.434 0.694 . . . . 0.0 110.92 172.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.423 ' HB2' ' CD1' ' A' ' 69' ' ' PHE . . . -60.99 -46.41 90.88 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.104 0.961 . . . . 0.0 111.09 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -109.53 82.3 2.14 Favored Pre-proline 0 CA--C 1.552 1.046 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 168.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -68.84 -34.17 18.69 Favored 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 123.341 2.694 . . . . 0.0 112.496 -167.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -87.65 -1.68 58.11 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.916 0.886 . . . . 0.0 111.149 177.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 56.68 49.99 13.48 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 124.802 1.241 . . . . 0.0 109.562 -172.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.2 m -70.42 -13.64 62.22 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 114.502 -1.226 . . . . 0.0 112.782 -172.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.43 11.23 82.36 Favored Glycine 0 C--N 1.348 1.241 0 N-CA-C 112.003 -0.439 . . . . 0.0 112.003 -173.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -135.17 145.83 48.15 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.55 1.14 . . . . 0.0 108.822 -177.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.404 ' O ' ' HB2' ' A' ' 27' ' ' TYR . 7.5 p -147.79 129.58 6.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 CA-C-O 121.251 0.548 . . . . 0.0 110.541 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -75.03 93.73 2.77 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 166.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.462 ' CE2' ' HA ' ' A' ' 27' ' ' TYR . 42.9 p90 -57.85 -40.18 79.5 Favored 'General case' 0 C--O 1.211 -0.936 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.269 -173.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -69.89 -33.41 72.18 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 120.976 0.417 . . . . 0.0 110.852 -177.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 25.4 m -66.64 -38.82 87.7 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.763 173.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.423 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 39.3 t80 -80.71 -72.17 0.43 Allowed 'General case' 0 C--O 1.213 -0.864 0 C-N-CA 122.915 0.486 . . . . 0.0 111.979 -178.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.616 ' HA ' ' HB3' ' A' ' 73' ' ' LEU . 87.6 t -43.37 -31.96 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 126.116 1.767 . . . . 0.0 112.565 174.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.464 ' HA2' ' HE3' ' A' ' 10' ' ' LYS . . . -56.4 -49.02 71.53 Favored Glycine 0 C--N 1.348 1.233 0 O-C-N 123.453 0.471 . . . . 0.0 112.925 170.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 81.8 mtp -83.04 -23.43 33.2 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.475 1.11 . . . . 0.0 112.157 178.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.616 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 52.5 tp -74.93 -49.55 19.8 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.044 0.938 . . . . 0.0 110.447 -172.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -80.38 22.14 0.57 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.139 0.976 . . . . 0.0 112.441 -178.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 59.4 mt -91.0 14.04 15.02 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 123.484 0.714 . . . . 0.0 111.402 172.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 13.4 m0 . . . . . 0 C--N 1.355 0.827 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 172.012 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? . . . . . 0 N--CA 1.479 0.986 0 CA-C-O 120.628 0.252 . . . . 0.0 110.781 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.36 -38.47 91.27 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.973 0.909 . . . . 0.0 111.605 173.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -55.41 -41.14 72.32 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 123.472 0.709 . . . . 0.0 112.003 -172.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.9 p -77.5 -40.76 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.745 -175.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 88.1 mt -61.49 -41.63 90.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 C-N-CA 123.946 0.898 . . . . 0.0 110.522 177.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.456 ' O ' HG23 ' A' ' 19' ' ' VAL . 42.8 mt-10 -71.12 -29.12 64.86 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.143 0.977 . . . . 0.0 110.587 179.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.21 -37.23 85.06 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.934 0.494 . . . . 0.0 110.71 175.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.403 ' HE1' ' HA ' ' A' ' 33' ' ' LEU . 79.1 m-85 -67.48 -31.94 72.42 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.135 0.574 . . . . 0.0 110.967 174.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -67.96 -40.16 83.27 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.709 0.403 . . . . 0.0 109.93 175.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 15' ' ' GLU . 69.7 t -60.23 -34.01 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 123.989 0.916 . . . . 0.0 110.704 176.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -76.81 -57.86 3.61 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.742 0.417 . . . . 0.0 110.763 179.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -76.0 91.89 3.11 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.183 0.516 . . . . 0.0 109.933 -178.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 31.6 mmm180 -91.05 -14.01 32.14 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.304 1.042 . . . . 0.0 110.2 178.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -91.76 -10.66 39.18 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.017 0.927 . . . . 0.0 111.032 -173.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.46 45.35 30.0 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-N 116.582 -0.281 . . . . 0.0 113.386 170.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.464 ' N ' HD22 ' A' ' 25' ' ' ASN . 0.8 OUTLIER -76.17 -25.67 55.45 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.671 0.788 . . . . 0.0 110.78 178.193 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.17 -4.12 80.69 Favored Glycine 0 C--N 1.352 1.429 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.02 -174.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -154.21 174.27 14.99 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.705 1.202 . . . . 0.0 109.285 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.9 m -123.51 -174.99 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.413 0.685 . . . . 0.0 110.831 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.5 p -91.24 162.02 14.81 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 123.741 0.817 . . . . 0.0 110.482 174.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.638 HG23 HG21 ' A' ' 53' ' ' ILE . 7.7 p -61.92 -33.05 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.909 0.884 . . . . 0.0 112.109 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -67.0 -52.07 47.19 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 122.983 0.513 . . . . 0.0 112.119 -173.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -63.74 -38.43 91.08 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 120.529 0.204 . . . . 0.0 110.6 177.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.654 HD22 HG11 ' A' ' 64' ' ' VAL . 9.0 tp -52.92 -48.82 66.97 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 124.24 0.963 . . . . 0.0 110.316 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 28.4 mtm180 -66.28 -39.13 89.2 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.419 0.688 . . . . 0.0 111.516 178.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -59.75 -48.72 80.53 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.293 1.037 . . . . 0.0 111.224 -176.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.8 p -78.48 -32.55 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.883 -176.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 63.0 mt -80.19 -6.09 57.2 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 121.789 -0.569 . . . . 0.0 111.085 178.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -77.32 -45.16 27.09 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.428 0.691 . . . . 0.0 109.83 170.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -76.55 -29.37 56.65 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.944 -178.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -75.73 -36.6 59.87 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 122.72 0.408 . . . . 0.0 110.015 170.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.23 56.77 1.75 Allowed Glycine 0 C--N 1.347 1.147 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.1 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -72.53 -32.8 66.39 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.821 0.848 . . . . 0.0 111.51 -176.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 52.4 mtt -118.35 14.99 13.89 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.75 0.82 . . . . 0.0 110.471 175.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.426 ' N ' ' SD ' ' A' ' 44' ' ' MET . 1.4 mpt? -110.43 142.66 26.51 Favored Pre-proline 0 N--CA 1.475 0.818 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -67.55 113.29 2.88 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 121.932 1.755 . . . . 0.0 111.442 178.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.95 -26.49 68.23 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.523 0.729 . . . . 0.0 110.577 174.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -55.47 -46.27 76.86 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.61 1.164 . . . . 0.0 110.83 172.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -63.83 -52.01 62.08 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.286 -178.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.49 ' O ' HG13 ' A' ' 53' ' ' ILE . 91.7 mt -59.85 -43.66 92.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.483 -176.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.501 ' HA ' HD12 ' A' ' 53' ' ' ILE . 12.9 pt-20 -68.67 -31.61 70.85 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 123.188 0.305 . . . . 0.0 111.573 -175.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -72.02 -32.56 67.28 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.581 0.353 . . . . 0.0 110.91 176.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.439 ' HB3' ' HE1' ' A' ' 69' ' ' PHE . 76.4 mmm -67.79 -23.75 65.24 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.876 0.87 . . . . 0.0 111.182 175.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.638 HG21 HG23 ' A' ' 30' ' ' VAL . 72.5 mt -70.19 -30.79 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 123.396 0.679 . . . . 0.0 111.482 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -62.88 -25.27 68.22 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.223 0.535 . . . . 0.0 110.855 178.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -86.42 -36.22 19.25 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.475 1.11 . . . . 0.0 110.508 176.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.73 -29.81 69.14 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.145 0.978 . . . . 0.0 111.841 -178.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -118.13 87.42 29.04 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.231 1.013 . . . . 0.0 108.465 173.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.6 -32.89 69.03 Favored 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 123.088 2.525 . . . . 0.0 112.139 173.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -73.3 -6.29 45.07 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.168 0.987 . . . . 0.0 112.551 -172.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.0 p30 51.33 30.54 6.1 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 125.642 1.577 . . . . 0.0 112.064 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 71.8 p -87.93 -15.13 37.44 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.525 1.13 . . . . 0.0 112.187 -171.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.76 3.5 90.47 Favored Glycine 0 C--N 1.347 1.139 0 CA-C-N 116.322 -0.399 . . . . 0.0 112.478 -171.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -107.44 128.92 54.91 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 175.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.654 HG11 HD22 ' A' ' 33' ' ' LEU . 5.0 p -127.97 130.77 69.93 Favored 'Isoleucine or valine' 0 C--O 1.246 0.893 0 C-N-CA 123.113 0.565 . . . . 0.0 110.831 -172.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -73.86 91.57 1.98 Allowed 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 168.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -59.07 -30.94 68.44 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.046 176.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -61.98 -38.42 88.52 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.935 0.894 . . . . 0.0 110.567 -171.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 69.9 p -83.29 -44.03 15.37 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.464 177.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.439 ' HE1' ' HB3' ' A' ' 52' ' ' MET . 28.2 t80 -67.82 -60.88 2.17 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.701 0.8 . . . . 0.0 112.809 -172.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.7 t -65.07 -21.45 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.345 1.058 . . . . 0.0 111.151 -177.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.446 ' O ' ' HG ' ' A' ' 75' ' ' LEU . . . -58.63 -51.65 57.65 Favored Glycine 0 CA--C 1.534 1.254 0 N-CA-C 111.608 -0.597 . . . . 0.0 111.608 166.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 61.8 mtm -66.16 -32.83 74.51 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.982 0.913 . . . . 0.0 112.435 -179.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.4 mt -63.72 -35.31 80.14 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 121.219 0.533 . . . . 0.0 111.067 177.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -99.82 10.34 41.49 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.66 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 71' ' ' GLY . 81.8 mt -90.24 -13.18 35.94 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.164 0.586 . . . . 0.0 109.582 162.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 51.0 m0 . . . . . 0 N--CA 1.49 1.537 0 C-N-CA 123.532 0.733 . . . . 0.0 109.998 171.639 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.442 ' O ' HG12 ' A' ' 13' ' ' VAL . 10.2 ptpp? . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 111.55 0.204 . . . . 0.0 111.55 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.436 ' O ' ' HG2' ' A' ' 15' ' ' GLU . . . -57.17 -23.67 49.12 Favored 'General case' 0 C--O 1.209 -1.051 0 C-N-CA 123.177 0.591 . . . . 0.0 112.422 177.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -51.89 -45.64 64.25 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.402 0.681 . . . . 0.0 112.296 177.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 10' ' ' LYS . 12.4 p -80.3 -36.79 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 68.2 mt -64.8 -36.53 77.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 123.524 0.729 . . . . 0.0 111.13 -177.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.494 ' O ' HG23 ' A' ' 19' ' ' VAL . 37.4 mm-40 -73.25 -31.06 63.88 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.788 0.435 . . . . 0.0 110.526 178.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.91 -35.69 73.49 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.146 0.498 . . . . 0.0 110.599 175.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.445 ' CZ ' HG21 ' A' ' 70' ' ' VAL . 81.5 m-85 -65.49 -42.53 92.06 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.009 172.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -73.45 -17.52 61.23 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.463 0.705 . . . . 0.0 111.823 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 15' ' ' GLU . 70.7 t -76.93 -30.07 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.956 0.902 . . . . 0.0 109.565 171.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -77.88 -58.52 3.22 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 174.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -82.73 82.91 7.87 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.613 0.765 . . . . 0.0 109.822 178.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -93.26 -14.29 27.21 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 114.086 -1.415 . . . . 0.0 109.535 173.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -70.75 -25.4 62.9 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.813 0.845 . . . . 0.0 110.726 176.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.07 43.09 8.97 Favored Glycine 0 C--N 1.347 1.163 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.777 173.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -72.1 -16.92 62.02 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.508 0.723 . . . . 0.0 110.412 172.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.58 -28.71 13.69 Favored Glycine 0 C--N 1.348 1.22 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.08 178.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.493 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 36.9 p90 -142.13 164.28 30.59 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 124.397 1.079 . . . . 0.0 109.916 -178.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 79.6 t -109.65 149.29 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.03 0.932 . . . . 0.0 109.915 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 75.9 p -66.05 157.4 31.09 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.574 0.75 . . . . 0.0 111.0 174.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.572 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 7.1 p -65.25 -16.83 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 122.846 0.458 . . . . 0.0 111.463 178.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -55.38 -57.07 13.35 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.038 0.935 . . . . 0.0 111.219 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -76.99 -34.42 57.52 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.605 177.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.572 ' HB3' ' HA ' ' A' ' 30' ' ' VAL . 3.0 tt -61.46 -39.66 91.68 Favored 'General case' 0 CA--C 1.549 0.916 0 O-C-N 123.67 0.606 . . . . 0.0 111.723 -174.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.566 ' HG3' HG22 ' A' ' 30' ' ' VAL . 63.8 mtt180 -67.89 -40.34 83.53 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-O 119.559 -0.257 . . . . 0.0 110.923 175.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -55.07 -58.0 9.45 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 123.93 0.769 . . . . 0.0 111.458 -178.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.7 p -66.17 -34.22 68.72 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 CA-C-N 115.223 -0.898 . . . . 0.0 111.705 -175.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.536 HD11 HG22 ' A' ' 70' ' ' VAL . 92.7 mt -85.44 -7.97 58.64 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.074 0.55 . . . . 0.0 111.865 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -87.24 -35.02 18.75 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 170.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -62.88 -37.38 86.69 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.689 170.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.0 tt -73.9 -44.34 55.54 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.216 177.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.498 ' HA2' ' HB2' ' A' ' 44' ' ' MET . . . -90.59 50.82 3.26 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.778 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -74.96 -49.68 19.23 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.508 0.723 . . . . 0.0 110.147 -177.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 15.0 ptp -108.0 -1.03 20.92 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.606 0.762 . . . . 0.0 110.415 174.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.498 ' HB2' ' HA2' ' A' ' 41' ' ' GLY . 1.4 mpt? -97.65 147.05 32.46 Favored Pre-proline 0 N--CA 1.478 0.95 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 177.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -63.53 109.24 0.98 Allowed 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 121.787 1.658 . . . . 0.0 111.275 173.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.18 -13.96 60.17 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.28 176.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -53.83 -46.58 71.22 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.236 1.014 . . . . 0.0 110.88 172.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.464 ' O ' ' HG2' ' A' ' 52' ' ' MET . 46.8 mt-10 -58.95 -52.3 66.33 Favored 'General case' 0 C--N 1.356 0.866 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.842 178.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.434 ' O ' HG13 ' A' ' 53' ' ' ILE . 81.4 mt -57.36 -45.35 85.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.069 0.947 . . . . 0.0 111.549 -176.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.479 ' HA ' HD12 ' A' ' 53' ' ' ILE . 66.3 mt-10 -71.27 -31.52 67.59 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.738 0.415 . . . . 0.0 111.331 -179.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -68.36 -32.63 72.86 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-O 121.43 0.634 . . . . 0.0 109.671 176.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.464 ' HG2' ' O ' ' A' ' 48' ' ' GLU . 80.4 mmm -70.98 -34.29 71.25 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.243 1.017 . . . . 0.0 110.285 174.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.479 HD12 ' HA ' ' A' ' 50' ' ' GLU . 85.2 mt -60.11 -40.96 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 123.359 0.664 . . . . 0.0 110.629 178.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -69.05 -15.06 63.37 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.408 0.683 . . . . 0.0 111.539 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -90.21 -37.14 14.34 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.217 0.607 . . . . 0.0 110.658 172.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.8 -18.15 58.59 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.543 0.737 . . . . 0.0 111.524 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -152.6 83.23 4.92 Favored Pre-proline 0 CA--C 1.55 0.976 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 172.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -75.01 -8.44 20.06 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.389 2.726 . . . . 0.0 112.63 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -75.47 -22.34 57.34 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.243 177.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 58.21 30.82 19.99 Favored 'General case' 0 C--N 1.36 1.037 0 C-N-CA 124.656 1.182 . . . . 0.0 110.237 -176.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.3 t -75.62 -19.56 59.14 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 114.511 -1.222 . . . . 0.0 110.676 -176.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.94 24.56 31.93 Favored Glycine 0 C--N 1.338 0.685 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.848 -178.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -130.01 105.09 7.73 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.718 0.807 . . . . 0.0 109.899 -176.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.473 HG13 HD13 ' A' ' 33' ' ' LEU . 2.1 p -135.37 123.05 37.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 124.007 0.923 . . . . 0.0 109.857 -174.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -70.42 109.16 4.61 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.702 0.801 . . . . 0.0 110.352 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.493 ' CE2' ' HA ' ' A' ' 27' ' ' TYR . 38.1 p90 -64.25 -28.5 69.78 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.939 0.895 . . . . 0.0 112.96 -175.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -66.1 -54.77 21.53 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.374 0.27 . . . . 0.0 110.693 -177.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.5 t -71.8 -28.65 63.74 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.252 178.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.507 ' O ' ' HG2' ' A' ' 72' ' ' MET . 60.8 t80 -81.87 -73.78 0.37 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 122.59 0.356 . . . . 0.0 111.122 -178.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.536 HG22 HD11 ' A' ' 37' ' ' LEU . 38.7 t -60.26 -22.3 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 123.945 0.898 . . . . 0.0 111.655 -173.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -55.63 -53.46 41.35 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-N 116.242 -0.436 . . . . 0.0 112.662 169.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.507 ' HG2' ' O ' ' A' ' 69' ' ' PHE . 18.5 ptp -65.79 -26.15 67.57 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.977 0.511 . . . . 0.0 111.83 -176.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 70' ' ' VAL . 4.4 mm? -56.7 -38.66 72.61 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.73 0.812 . . . . 0.0 110.97 175.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -89.59 -16.99 29.36 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.284 1.034 . . . . 0.0 111.182 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.417 ' HB2' ' HA ' ' A' ' 72' ' ' MET . 85.4 mt -86.67 -3.32 59.02 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.357 0.663 . . . . 0.0 111.518 176.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 42.8 m0 . . . . . 0 N--CA 1.479 1.0 0 C-N-CA 122.969 0.507 . . . . 0.0 110.121 170.835 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.564 0 N-CA-C 112.397 -0.281 . . . . 0.0 112.397 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.6 m -76.52 86.22 3.23 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.113 0.565 . . . . 0.0 110.811 -176.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -167.76 105.72 0.52 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.214 1.005 . . . . 0.0 108.875 175.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 63.8 mtm 55.95 77.04 0.25 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.223 1.009 . . . . 0.0 111.573 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -112.38 124.76 53.21 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 27.9 m170 -68.89 84.51 0.32 Allowed 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 172.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.449 HG22 HG22 ' A' ' 9' ' ' THR . 49.2 mt -74.77 79.6 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.703 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -77.66 87.54 3.94 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.615 -173.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.449 HG22 HG22 ' A' ' 7' ' ' ILE . 9.5 t -150.86 150.6 31.11 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.472 176.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.429 ' HB3' ' CD2' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -76.11 -4.34 41.01 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.254 176.675 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.46 -47.18 85.16 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.83 0.452 . . . . 0.0 110.536 170.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -55.58 -41.86 73.97 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.495 1.118 . . . . 0.0 113.154 -174.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.0 p -67.76 -41.87 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 O-C-N 122.982 0.176 . . . . 0.0 110.542 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 62.0 mt -70.92 -27.62 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 123.603 0.761 . . . . 0.0 110.945 -178.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -75.49 -28.75 59.32 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.331 0.652 . . . . 0.0 110.751 175.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.66 -32.99 74.67 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.041 0.536 . . . . 0.0 110.629 174.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -64.55 -33.47 75.99 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.258 0.623 . . . . 0.0 111.018 171.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.1 mttp -78.67 -17.81 55.37 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.442 0.697 . . . . 0.0 111.725 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 67.0 t -72.88 -37.77 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 171.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -69.36 -55.3 10.79 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.996 173.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -80.04 77.92 6.71 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.777 0.831 . . . . 0.0 109.047 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.7 -21.12 61.83 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.097 1.359 . . . . 0.0 109.325 -178.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -76.01 -27.74 57.5 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.005 0.922 . . . . 0.0 111.358 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.93 45.9 54.99 Favored Glycine 0 C--N 1.344 1.015 0 O-C-N 123.486 0.491 . . . . 0.0 112.183 -176.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -68.58 -28.02 66.58 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.289 1.036 . . . . 0.0 111.312 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.41 -11.66 36.32 Favored Glycine 0 C--N 1.343 0.925 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 -175.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.4 ' HB2' ' O ' ' A' ' 64' ' ' VAL . 36.5 p90 -154.8 159.79 40.83 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.709 0.804 . . . . 0.0 110.535 -177.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.1 m -112.15 -177.15 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.762 0.825 . . . . 0.0 110.512 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 64.4 p -81.83 154.52 25.86 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.548 170.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.441 ' O ' ' HG3' ' A' ' 34' ' ' ARG . 9.8 p -68.41 -26.49 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 122.544 0.337 . . . . 0.0 111.062 -177.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -65.45 -48.14 73.73 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 122.978 0.511 . . . . 0.0 111.398 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -63.81 -39.02 93.23 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 123.313 0.383 . . . . 0.0 110.465 177.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.495 HD11 ' HD2' ' A' ' 69' ' ' PHE . 5.3 tp -55.47 -46.48 76.83 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.608 178.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.569 ' HG2' HD13 ' A' ' 53' ' ' ILE . 80.8 mtm180 -67.56 -35.64 79.41 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.443 0.697 . . . . 0.0 110.984 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -62.11 -52.11 65.19 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.274 1.03 . . . . 0.0 111.701 -176.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.9 p -74.25 -35.36 40.06 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.037 0 C-N-CA 123.085 0.554 . . . . 0.0 111.136 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.493 HD23 HD12 ' A' ' 40' ' ' LEU . 95.8 mt -80.22 -4.82 54.67 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.911 0.485 . . . . 0.0 111.295 178.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -75.68 -47.01 28.1 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.479 0.711 . . . . 0.0 109.964 173.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -75.35 -23.67 57.21 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.958 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.493 HD12 HD23 ' A' ' 37' ' ' LEU . 99.1 mt -82.94 -25.38 32.43 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.351 0.66 . . . . 0.0 110.025 170.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.29 14.13 46.91 Favored Glycine 0 C--N 1.354 1.562 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.278 174.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -75.76 -52.82 9.59 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 168.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -82.38 -37.62 25.33 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.284 0.634 . . . . 0.0 110.575 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 93.0 mmm -89.43 147.08 37.24 Favored Pre-proline 0 N--CA 1.477 0.925 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.69 111.57 0.83 Allowed 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 122.122 1.881 . . . . 0.0 111.2 170.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.14 -33.93 72.42 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.841 0.856 . . . . 0.0 111.047 -176.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -57.89 -38.98 76.79 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.101 0.96 . . . . 0.0 111.677 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.406 ' O ' ' HG2' ' A' ' 52' ' ' MET . 19.8 mm-40 -58.18 -53.25 60.38 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 123.848 0.718 . . . . 0.0 110.309 174.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 86.2 mt -58.17 -45.08 88.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.241 1.016 . . . . 0.0 111.023 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.499 ' HA ' HD12 ' A' ' 53' ' ' ILE . 45.3 mt-10 -63.75 -29.42 70.64 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.936 0.895 . . . . 0.0 111.843 -177.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -77.01 -41.7 41.66 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.301 0.572 . . . . 0.0 109.961 175.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.419 ' HB3' ' HE1' ' A' ' 69' ' ' PHE . 24.9 mmt -64.71 -24.67 67.64 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.036 177.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.569 HD13 ' HG2' ' A' ' 34' ' ' ARG . 41.6 mt -66.81 -32.52 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.766 1.226 . . . . 0.0 111.355 177.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -73.67 -27.4 61.22 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.801 0.44 . . . . 0.0 110.59 174.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -85.05 -17.38 37.62 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.177 0.591 . . . . 0.0 110.67 175.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.6 -51.25 10.95 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.816 0.846 . . . . 0.0 109.848 176.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -123.32 81.72 52.59 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 124.28 1.032 . . . . 0.0 108.468 175.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -73.34 -20.25 21.27 Favored 'Trans proline' 0 C--N 1.386 2.53 0 C-N-CA 123.076 2.517 . . . . 0.0 111.552 173.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -66.8 -23.57 66.07 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.578 174.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.5 m120 58.15 34.55 24.27 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 124.992 1.317 . . . . 0.0 111.122 175.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.7 m -82.61 -13.33 56.7 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.421 -176.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.05 25.39 44.94 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.268 -172.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -139.59 122.96 17.13 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.769 0.828 . . . . 0.0 109.759 -175.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.482 HG11 HD22 ' A' ' 33' ' ' LEU . 2.8 p -131.65 129.9 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.59 0.756 . . . . 0.0 110.685 -172.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -74.95 90.25 2.42 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 170.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -56.72 -27.06 58.42 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.072 177.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -51.33 -58.22 6.81 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.455 1.102 . . . . 0.0 111.544 178.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.1 t -79.15 -33.11 44.43 Favored 'General case' 0 CA--C 1.555 1.17 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.072 -178.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.495 ' HD2' HD11 ' A' ' 33' ' ' LEU . 37.9 t80 -76.08 -63.13 1.39 Allowed 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -173.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.487 ' HA ' HD23 ' A' ' 73' ' ' LEU . 57.5 t -60.91 -16.55 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 123.428 0.691 . . . . 0.0 110.585 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -56.06 -56.26 25.02 Favored Glycine 0 CA--C 1.536 1.352 0 CA-C-O 118.991 -0.894 . . . . 0.0 112.742 166.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 19.3 ptm -63.43 -30.6 71.7 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 118.068 0.934 . . . . 0.0 112.142 -176.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.487 HD23 ' HA ' ' A' ' 70' ' ' VAL . 4.0 mm? -59.83 -30.06 68.69 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.233 0.613 . . . . 0.0 110.92 176.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.429 ' CD2' ' HB3' ' A' ' 10' ' ' LYS . 76.7 m-85 -116.7 1.98 12.88 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.944 0.898 . . . . 0.0 111.799 -176.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 71.8 mt -97.55 5.8 49.01 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.497 0.719 . . . . 0.0 110.956 173.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 29.5 m0 -63.04 116.11 5.05 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.643 0.377 . . . . 0.0 110.322 174.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 . . . . . 0 C--O 1.254 1.293 0 C-N-CA 123.758 0.823 . . . . 0.0 110.228 -177.249 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.521 0 N-CA-C 112.178 -0.369 . . . . 0.0 112.178 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.3 t -91.22 -57.54 2.76 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.779 0.832 . . . . 0.0 109.997 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 69.4 m-70 -140.26 105.66 5.07 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.949 0.899 . . . . 0.0 108.718 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 60.1 mtt -74.11 -16.57 61.01 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 122.701 0.4 . . . . 0.0 111.082 175.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -125.52 167.97 14.29 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.885 0.874 . . . . 0.0 109.126 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -136.5 118.07 14.88 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.552 0.741 . . . . 0.0 109.629 -174.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.9 tp -137.76 111.44 8.28 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 CA-C-O 121.613 0.721 . . . . 0.0 109.734 176.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -102.63 118.56 37.12 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.248 -0.887 . . . . 0.0 108.784 173.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.584 ' HB ' ' HG2' ' A' ' 12' ' ' GLN . 19.9 m -149.96 141.88 23.82 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.305 0.642 . . . . 0.0 109.861 -178.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -63.03 -35.49 80.4 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.905 0.482 . . . . 0.0 111.026 176.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.471 ' H ' HG22 ' A' ' 9' ' ' THR . . . -56.78 -40.37 75.76 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.707 0.803 . . . . 0.0 111.559 176.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.584 ' HG2' ' HB ' ' A' ' 9' ' ' THR . 14.3 mm100 -70.72 -47.86 57.58 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.968 0.507 . . . . 0.0 111.434 -176.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.9 p -69.32 -33.17 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.014 -176.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 90.2 mt -66.92 -38.39 81.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 174.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.412 ' HA ' ' HB2' ' A' ' 18' ' ' LYS . 70.8 mm-40 -66.87 -23.44 66.01 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 119.304 -0.379 . . . . 0.0 111.639 173.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.29 -37.98 86.71 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 120.94 0.4 . . . . 0.0 110.199 175.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -73.86 -37.68 64.7 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.892 173.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.412 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 9.9 mtpm? -74.79 -24.19 58.61 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.481 0.712 . . . . 0.0 112.21 -176.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.6 p -86.4 -27.51 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 176.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -67.18 -56.26 10.68 Favored 'General case' 0 C--N 1.354 0.787 0 C-N-CA 123.704 0.802 . . . . 0.0 109.399 174.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -82.75 83.1 7.81 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.785 177.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -85.62 -14.95 44.07 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.474 169.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -70.19 -27.32 64.41 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.803 0.841 . . . . 0.0 110.676 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.59 44.28 8.64 Favored Glycine 0 C--N 1.347 1.14 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.961 173.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -78.8 -13.2 59.94 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 122.972 0.509 . . . . 0.0 110.38 173.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.39 -44.98 1.93 Allowed Glycine 0 C--N 1.348 1.235 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 177.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.419 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 46.8 p90 -126.78 162.59 25.49 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 123.851 0.86 . . . . 0.0 110.106 177.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 52.4 t -109.68 151.05 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.183 0.993 . . . . 0.0 109.507 -177.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 76.1 p -68.99 166.56 17.73 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.627 0.771 . . . . 0.0 111.578 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.7 p -71.7 -15.15 18.11 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 122.606 0.362 . . . . 0.0 111.518 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -54.39 -63.02 1.28 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.844 0.858 . . . . 0.0 111.806 175.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -72.33 -29.38 63.77 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.987 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.546 HD22 HG11 ' A' ' 64' ' ' VAL . 7.3 tp -55.35 -51.66 66.06 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 123.8 0.688 . . . . 0.0 110.208 176.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 67.1 mtp85 -62.06 -40.59 96.31 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.458 0.703 . . . . 0.0 111.489 177.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -60.35 -54.4 46.14 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 123.783 0.677 . . . . 0.0 111.877 -174.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.6 p -67.1 -29.16 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 122.812 0.445 . . . . 0.0 111.259 -178.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.408 HD13 HG21 ' A' ' 49' ' ' ILE . 66.6 mt -87.67 -6.65 58.14 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.165 0.586 . . . . 0.0 111.868 178.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -83.1 -44.77 14.76 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.499 0.72 . . . . 0.0 110.27 177.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -68.05 -28.78 67.68 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.534 175.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 91.9 mt -96.34 11.07 36.05 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.273 1.029 . . . . 0.0 110.838 175.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -73.2 -14.93 78.84 Favored Glycine 0 C--N 1.352 1.438 0 C-N-CA 123.354 0.502 . . . . 0.0 113.037 -177.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -66.53 -46.37 76.38 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.906 0.882 . . . . 0.0 110.706 176.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 59.9 mtt -90.32 -46.18 8.56 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.672 0.789 . . . . 0.0 110.234 -175.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -110.35 98.76 37.47 Favored Pre-proline 0 N--CA 1.474 0.751 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 176.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -48.93 111.54 0.49 Allowed 'Trans proline' 0 C--N 1.385 2.5 0 C-N-CA 123.789 2.992 . . . . 0.0 113.707 -173.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.402 ' O ' ' HG3' ' A' ' 50' ' ' GLU . . . -64.1 -30.28 71.36 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.183 0.993 . . . . 0.0 111.16 -178.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -56.95 -48.06 79.23 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.093 0.957 . . . . 0.0 111.899 174.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -68.54 -38.82 81.15 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.038 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 37' ' ' LEU . 96.6 mt -62.69 -36.5 75.56 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.819 177.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.499 ' HA ' HD12 ' A' ' 53' ' ' ILE . 40.0 mt-10 -59.95 -35.44 74.95 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.42 0.688 . . . . 0.0 111.641 176.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -69.41 -42.69 74.72 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.244 0.545 . . . . 0.0 109.992 176.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 49.9 mtt -69.68 -22.4 63.44 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.39 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.499 HD12 ' HA ' ' A' ' 50' ' ' GLU . 23.3 mt -64.27 -28.53 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.416 1.086 . . . . 0.0 111.558 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -59.5 -37.09 77.36 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 122.89 0.476 . . . . 0.0 111.064 174.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -81.44 -38.09 27.0 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.406 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.409 ' HB3' ' HA ' ' A' ' 53' ' ' ILE . . . -63.28 -32.31 73.69 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.592 1.157 . . . . 0.0 111.673 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -114.97 88.5 17.19 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 124.34 1.056 . . . . 0.0 108.416 172.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -85.2 3.35 7.37 Favored 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.647 2.231 . . . . 0.0 111.603 173.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -83.59 -21.87 32.46 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.749 0.82 . . . . 0.0 110.306 176.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.6 t30 64.51 30.65 12.84 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.52 1.128 . . . . 0.0 110.079 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.3 m -132.51 -4.65 3.32 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.581 0.752 . . . . 0.0 112.105 -172.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.71 37.26 8.07 Favored Glycine 0 N--CA 1.471 1.023 0 C-N-CA 122.885 0.278 . . . . 0.0 113.546 178.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -123.61 125.65 45.21 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.153 0.981 . . . . 0.0 109.993 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.546 HG11 HD22 ' A' ' 33' ' ' LEU . 3.1 p -139.86 135.6 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.347 0.659 . . . . 0.0 111.057 -171.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -79.87 103.6 9.88 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 167.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.419 ' CE2' ' HA ' ' A' ' 27' ' ' TYR . 39.3 p90 -64.06 -32.28 73.77 Favored 'General case' 0 C--O 1.208 -1.121 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.18 -177.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -61.4 -39.22 89.93 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 118.427 0.558 . . . . 0.0 111.343 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 77.8 p -77.01 -47.73 19.87 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.368 0.667 . . . . 0.0 110.805 -178.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.406 ' HD2' HD11 ' A' ' 33' ' ' LEU . 48.4 t80 -70.82 -53.5 15.08 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.751 0.82 . . . . 0.0 111.941 -176.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.413 ' HA ' HD12 ' A' ' 73' ' ' LEU . 45.4 t -67.77 -18.51 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.693 0.797 . . . . 0.0 110.85 178.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -59.24 -49.61 76.67 Favored Glycine 0 C--N 1.349 1.304 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 165.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 85.2 mtp -70.62 -24.43 62.73 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.78 0.832 . . . . 0.0 111.951 177.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 70' ' ' VAL . 86.2 mt -70.85 -10.92 60.54 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.127 0.571 . . . . 0.0 112.436 178.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -118.08 24.1 11.21 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.417 0.687 . . . . 0.0 109.636 174.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 85.9 mt -126.72 -31.05 2.72 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.166 0.986 . . . . 0.0 111.672 178.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -66.84 114.68 5.87 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 117.987 0.358 . . . . 0.0 111.262 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.9 t70 . . . . . 0 C--O 1.248 0.992 0 C-N-CA 123.636 0.775 . . . . 0.0 109.459 -177.395 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.825 0 N-CA-C 112.787 -0.125 . . . . 0.0 112.787 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.2 m -66.47 136.36 55.58 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.866 0.867 . . . . 0.0 110.543 176.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 73.8 m-70 -95.84 150.71 20.12 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.443 0.697 . . . . 0.0 111.044 -175.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 57.0 mtm -73.3 149.26 42.82 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.67 176.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -90.42 10.38 25.38 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.121 0.568 . . . . 0.0 111.399 176.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -73.23 82.57 1.34 Allowed 'General case' 0 C--N 1.353 0.73 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 168.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.6 tt -102.07 131.1 50.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.857 178.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -132.77 121.91 23.73 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 175.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.3 t -153.82 163.69 39.61 Favored 'General case' 0 C--O 1.244 0.804 0 C-N-CA 124.241 1.016 . . . . 0.0 109.429 -178.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.459 ' HB3' ' HB3' ' A' ' 74' ' ' PHE . 17.1 ptmt -64.94 -19.48 65.97 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.63 0.772 . . . . 0.0 112.079 177.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.85 -45.33 94.93 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.785 0.434 . . . . 0.0 110.362 172.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -59.57 -44.16 93.38 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.554 0.742 . . . . 0.0 111.558 -175.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.6 p -74.34 -34.56 37.08 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 CA-C-O 118.986 -0.531 . . . . 0.0 111.143 -179.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 90.2 mt -60.33 -40.38 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-N 118.584 0.629 . . . . 0.0 109.651 173.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -68.93 -24.16 64.25 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.004 0.921 . . . . 0.0 111.186 177.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.18 -13.13 61.1 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.448 0.699 . . . . 0.0 111.734 174.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.587 ' HA ' ' HE2' ' A' ' 32' ' ' TYR . 90.6 m-85 -93.58 -43.79 8.52 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.344 0.658 . . . . 0.0 110.539 170.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -67.95 -22.2 65.05 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.201 -175.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.8 p -59.95 -31.59 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.313 0.645 . . . . 0.0 111.088 175.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -78.72 -49.19 13.5 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.828 0.851 . . . . 0.0 110.433 176.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -65.32 105.18 1.08 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.543 0.737 . . . . 0.0 111.129 -173.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 19.2 tpp180 -71.15 -50.98 27.69 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.407 1.083 . . . . 0.0 110.577 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.421 ' HB2' ' HB2' ' A' ' 25' ' ' ASN . 5.6 m-20 -73.79 -20.7 60.39 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 114.701 -1.136 . . . . 0.0 112.155 -167.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.96 37.78 88.16 Favored Glycine 0 C--N 1.346 1.129 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -166.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.421 ' HB2' ' HB2' ' A' ' 23' ' ' ASP . 16.5 t-20 -67.71 -30.02 69.42 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.265 1.426 . . . . 0.0 111.074 -167.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 142.07 -60.82 0.54 Allowed Glycine 0 C--N 1.342 0.894 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 176.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.529 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 46.3 p90 -142.73 -176.01 4.71 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -176.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.9 m -126.85 -176.26 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.337 1.055 . . . . 0.0 110.511 -177.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 35.3 p -78.46 160.84 27.5 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 124.195 0.998 . . . . 0.0 111.387 177.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.2 p -78.45 -16.5 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.208 -176.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -69.39 -37.85 77.74 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 120.727 0.298 . . . . 0.0 110.548 173.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.587 ' HE2' ' HA ' ' A' ' 17' ' ' PHE . 45.6 t80 -73.73 -30.49 62.85 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.368 0.667 . . . . 0.0 110.36 178.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.408 HD12 ' CE2' ' A' ' 17' ' ' PHE . 8.6 tp -64.53 -55.29 21.55 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.52 175.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.636 ' HG2' HD13 ' A' ' 53' ' ' ILE . 63.3 mtm180 -69.54 -17.1 63.54 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.631 -177.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -66.52 -61.75 1.82 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.904 0.882 . . . . 0.0 110.75 174.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.4 p -68.67 -28.2 39.1 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.135 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.975 -175.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 71.8 mt -88.4 -8.98 54.12 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.937 -0.477 . . . . 0.0 111.857 -177.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -73.71 -46.96 42.95 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.252 0.621 . . . . 0.0 109.642 171.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -73.35 -25.65 60.69 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.903 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 97.9 mt -89.45 11.22 19.95 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.511 0.724 . . . . 0.0 111.107 173.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.8 3.24 61.21 Favored Glycine 0 C--N 1.358 1.764 0 CA-C-N 116.327 -0.397 . . . . 0.0 113.413 177.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -67.12 -40.99 86.93 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.1 0.96 . . . . 0.0 111.462 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 88.3 mmm -76.49 -46.98 24.43 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 122.993 0.517 . . . . 0.0 111.39 -178.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 90.9 mmm -135.2 139.16 30.9 Favored Pre-proline 0 N--CA 1.48 1.06 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.412 ' HB2' ' HG2' ' A' ' 48' ' ' GLU . 85.8 Cg_exo -49.27 133.92 30.61 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 122.625 2.217 . . . . 0.0 111.755 174.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.412 ' O ' ' HG3' ' A' ' 50' ' ' GLU . . . -58.55 -25.39 62.45 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 123.549 0.53 . . . . 0.0 111.206 178.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -60.07 -39.19 85.21 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.058 0.943 . . . . 0.0 111.972 175.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.412 ' HG2' ' HB2' ' A' ' 45' ' ' PRO . 9.6 mm-40 -56.73 -39.61 74.25 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.847 0.832 . . . . 0.0 109.776 176.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.407 ' O ' HG13 ' A' ' 53' ' ' ILE . 49.3 mt -77.37 -35.47 22.32 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 CA-C-N 113.999 -1.455 . . . . 0.0 110.356 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 46' ' ' ALA . 40.4 mt-10 -65.92 -32.04 73.32 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.739 0.815 . . . . 0.0 112.755 -175.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -66.18 -36.06 82.09 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 121.328 0.585 . . . . 0.0 109.768 174.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 23.6 mtm -75.71 -24.57 56.22 Favored 'General case' 0 CA--C 1.553 1.058 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.488 177.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.636 HD13 ' HG2' ' A' ' 34' ' ' ARG . 62.8 mt -71.93 -28.19 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 124.397 1.079 . . . . 0.0 111.018 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -65.16 -32.96 74.91 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.069 171.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -83.66 -23.75 31.63 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.864 0.866 . . . . 0.0 110.9 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.585 ' HB1' HG23 ' A' ' 64' ' ' VAL . . . -72.94 -49.28 30.38 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.764 0.826 . . . . 0.0 110.482 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -120.35 90.49 45.23 Favored Pre-proline 0 CA--C 1.546 0.825 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 172.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.24 -11.81 15.97 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 123.027 2.485 . . . . 0.0 111.384 168.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -70.17 -24.07 63.08 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.221 1.009 . . . . 0.0 111.65 -173.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 60.78 24.01 13.94 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 125.038 1.335 . . . . 0.0 110.384 -174.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.8 t -105.48 -5.25 20.45 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.407 1.083 . . . . 0.0 109.86 -177.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.24 43.81 62.01 Favored Glycine 0 C--N 1.347 1.175 0 O-C-N 123.851 0.719 . . . . 0.0 113.06 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.445 ' HB3' ' HE1' ' A' ' 27' ' ' TYR . 27.2 m-85 -131.02 109.86 10.81 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.671 0.789 . . . . 0.0 110.29 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.585 HG23 ' HB1' ' A' ' 56' ' ' ALA . 4.6 p -117.83 129.98 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 123.885 0.874 . . . . 0.0 110.824 -175.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -81.23 91.62 6.21 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 170.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.529 ' CE2' ' HA ' ' A' ' 27' ' ' TYR . 45.1 p90 -61.33 -23.59 65.84 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 122.968 0.507 . . . . 0.0 111.498 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -51.63 -56.78 11.64 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.302 1.041 . . . . 0.0 110.582 173.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.2 t -82.07 -30.54 31.26 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.004 -177.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -73.68 -63.06 1.28 Allowed 'General case' 0 N--CA 1.476 0.848 0 O-C-N 123.066 0.229 . . . . 0.0 111.038 -175.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.54 ' HA ' ' HB3' ' A' ' 73' ' ' LEU . 90.2 t -59.0 -24.81 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 124.366 1.067 . . . . 0.0 111.154 177.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -56.63 -54.62 35.0 Favored Glycine 0 CA--C 1.532 1.103 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.355 169.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.414 ' HA ' ' HG ' ' A' ' 75' ' ' LEU . 20.8 mmt -76.15 -32.25 59.0 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.334 0.653 . . . . 0.0 111.368 -178.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.54 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 18.7 tp -69.49 -31.11 69.17 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.551 1.54 . . . . 0.0 111.627 -178.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.459 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 16.0 m-85 -111.94 26.36 10.68 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.159 0.584 . . . . 0.0 111.315 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.414 ' HG ' ' HA ' ' A' ' 72' ' ' MET . 78.3 mt -72.85 -31.89 65.07 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 166.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 17.5 p-90 -97.96 24.13 7.32 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.653 0.781 . . . . 0.0 111.777 177.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.0 t70 . . . . . 0 C--O 1.249 1.058 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 170.69 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.569 0 N-CA-C 112.459 -0.256 . . . . 0.0 112.459 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.7 p -149.04 98.56 2.85 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.423 0.689 . . . . 0.0 109.985 177.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -112.32 95.83 5.67 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.572 0.749 . . . . 0.0 109.085 174.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 61.0 mtt -94.39 46.71 1.16 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.147 0.979 . . . . 0.0 110.124 -177.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -138.36 153.42 48.95 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.293 1.037 . . . . 0.0 108.565 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 46.4 t60 -68.0 99.05 0.81 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 177.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.542 HG12 ' HG3' ' A' ' 12' ' ' GLN . 8.7 tp -91.58 112.68 25.85 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 CA-C-O 121.492 0.663 . . . . 0.0 109.799 -174.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -83.61 -3.49 57.75 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.478 0.711 . . . . 0.0 111.717 -176.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 84.8 m -67.19 120.85 14.44 Favored 'General case' 0 C--O 1.246 0.894 0 C-N-CA 123.226 0.61 . . . . 0.0 110.848 -178.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -53.25 -42.22 66.23 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.032 177.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.89 -34.75 60.4 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.374 0.67 . . . . 0.0 112.631 -178.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.542 ' HG3' HG12 ' A' ' 7' ' ' ILE . 79.8 mm-40 -79.92 -38.72 31.9 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.428 0.691 . . . . 0.0 111.211 -176.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.4 p -72.74 -29.03 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 122.126 0.17 . . . . 0.0 110.602 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.7 mt -64.09 -34.22 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.568 0.747 . . . . 0.0 110.086 175.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -70.82 -22.96 62.27 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.25 0.62 . . . . 0.0 111.971 177.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.94 -41.29 95.63 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.248 0.547 . . . . 0.0 109.571 172.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -65.41 -35.22 80.28 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.861 173.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -84.92 -11.64 55.13 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -175.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.9 p -89.16 -29.27 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 172.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 93.5 t80 -70.37 -51.99 25.76 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.578 171.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -64.73 116.79 6.63 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 173.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -87.28 -53.37 4.87 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.32 0.648 . . . . 0.0 111.891 -169.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -95.65 -7.76 36.65 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.005 0.522 . . . . 0.0 112.378 -167.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.99 50.72 4.77 Favored Glycine 0 C--N 1.343 0.93 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -171.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -62.37 -28.63 69.9 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.058 1.743 . . . . 0.0 111.292 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.14 -22.46 29.34 Favored Glycine 0 C--N 1.347 1.147 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.984 178.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -154.03 167.62 29.18 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.696 0.798 . . . . 0.0 111.193 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.1 m -116.24 176.26 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.32 1.048 . . . . 0.0 109.823 176.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 42.6 p -79.27 150.38 31.56 Favored 'General case' 0 C--O 1.246 0.896 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.78 171.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.457 HG12 ' HA2' ' A' ' 62' ' ' GLY . 9.0 p -66.64 -23.69 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 122.65 0.38 . . . . 0.0 111.255 -177.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -57.64 -54.23 49.2 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.442 0.697 . . . . 0.0 111.538 176.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -64.14 -38.79 92.32 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.841 0.456 . . . . 0.0 110.752 176.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.7 tt -60.66 -35.61 76.66 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.238 -176.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 23.2 mtp180 -75.29 -34.41 61.3 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.186 0.594 . . . . 0.0 111.233 176.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.2 mttp -59.6 -50.97 71.81 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.96 0.904 . . . . 0.0 111.735 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.8 p -71.68 -40.21 70.15 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.47 -176.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 97.4 mt -76.39 -11.96 59.98 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.087 0.555 . . . . 0.0 112.184 -176.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -65.97 -29.74 70.19 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.373 0.669 . . . . 0.0 109.833 171.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -86.27 -8.09 58.01 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.483 1.113 . . . . 0.0 111.706 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -91.79 18.6 7.46 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.728 0.811 . . . . 0.0 111.251 177.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 140.17 88.42 0.15 Allowed Glycine 0 C--N 1.349 1.292 0 CA-C-O 119.864 -0.409 . . . . 0.0 112.407 173.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -77.99 -30.06 49.99 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.427 0.691 . . . . 0.0 110.225 175.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -76.89 -24.33 52.53 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.157 174.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 83.1 mtp -79.96 147.92 67.02 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 123.924 0.89 . . . . 0.0 109.524 176.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.63 110.84 2.41 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 121.785 1.657 . . . . 0.0 111.277 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.33 -21.86 66.75 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.628 174.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -48.83 -41.56 33.35 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.392 1.477 . . . . 0.0 112.327 177.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.486 ' O ' ' HG2' ' A' ' 52' ' ' MET . 38.7 tt0 -65.85 -50.28 65.13 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.489 0.493 . . . . 0.0 110.316 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 88.3 mt -58.61 -36.16 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 123.848 0.859 . . . . 0.0 110.74 178.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -63.45 -46.78 84.71 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.098 0.959 . . . . 0.0 110.285 176.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -62.38 -34.55 76.91 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.912 0.485 . . . . 0.0 111.209 177.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.486 ' HG2' ' O ' ' A' ' 48' ' ' GLU . 26.1 mmt -67.93 -35.97 79.35 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.556 0.742 . . . . 0.0 109.925 176.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 83.3 mt -66.19 -36.61 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 124.218 1.007 . . . . 0.0 110.729 176.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -70.93 -21.01 62.41 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.402 0.681 . . . . 0.0 111.126 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -80.2 -41.58 24.96 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 171.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.462 ' HB1' HG23 ' A' ' 64' ' ' VAL . . . -72.83 -30.04 63.72 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.061 0.944 . . . . 0.0 111.92 -176.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -150.63 83.07 5.94 Favored Pre-proline 0 CA--C 1.545 0.76 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.26 -20.57 21.11 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.904 2.403 . . . . 0.0 113.085 -178.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -87.09 -10.62 52.44 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.162 0.585 . . . . 0.0 111.619 -178.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.1 t30 61.46 40.63 13.67 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 122.422 1.106 . . . . 0.0 109.586 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.9 m -77.53 -15.03 59.51 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.569 -1.196 . . . . 0.0 112.03 -173.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.457 ' HA2' HG12 ' A' ' 30' ' ' VAL . . . 85.53 13.67 69.89 Favored Glycine 0 C--N 1.347 1.177 0 CA-C-N 115.91 -0.587 . . . . 0.0 112.327 -173.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -123.01 111.26 16.38 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.736 0.815 . . . . 0.0 109.509 -175.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.462 HG23 ' HB1' ' A' ' 56' ' ' ALA . 2.2 p -139.99 121.29 15.1 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 C-N-CA 123.383 0.673 . . . . 0.0 109.854 -178.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -69.49 94.77 0.77 Allowed 'General case' 0 C--N 1.348 0.514 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.057 173.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 48.2 p90 -57.35 -28.81 63.47 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 123.56 0.538 . . . . 0.0 111.19 177.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -62.19 -49.31 76.29 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.356 0.662 . . . . 0.0 110.851 -176.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 79.8 p -77.59 -33.75 53.76 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.467 0.707 . . . . 0.0 110.641 177.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -67.31 -68.75 0.36 Allowed 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.418 -176.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.621 ' HA ' ' HB3' ' A' ' 73' ' ' LEU . 75.9 t -50.37 -29.11 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 125.404 1.481 . . . . 0.0 112.781 176.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.76 -48.07 80.36 Favored Glycine 0 C--N 1.349 1.287 0 CA-C-O 121.123 0.291 . . . . 0.0 112.693 171.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 33.3 mmt -86.09 -5.72 59.15 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.929 0.892 . . . . 0.0 112.295 177.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.621 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 55.4 tp -88.97 -42.61 11.69 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.068 0.947 . . . . 0.0 109.424 -177.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -90.96 11.75 21.83 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.154 0.582 . . . . 0.0 112.474 -177.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 pp -70.8 -9.1 56.77 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 118.308 0.504 . . . . 0.0 111.895 178.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 14.2 m0 -60.89 119.9 9.14 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.659 0.784 . . . . 0.0 109.895 175.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 . . . . . 0 N--CA 1.483 1.177 0 C-N-CA 123.394 0.678 . . . . 0.0 111.657 -173.884 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.589 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.7 m -82.11 76.21 9.0 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.966 0.906 . . . . 0.0 110.59 -177.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 11.7 m170 70.47 -62.95 0.42 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 125.645 1.578 . . . . 0.0 112.696 177.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.6 ptt? -54.33 131.93 42.9 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.37 1.068 . . . . 0.0 111.839 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -109.48 163.16 13.68 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.832 0.853 . . . . 0.0 110.323 -178.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 24.9 m-70 -78.07 97.13 5.31 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 173.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.6 tt -142.92 114.62 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.113 0.965 . . . . 0.0 109.561 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -92.73 103.92 16.24 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.447 HG22 ' H ' ' A' ' 11' ' ' ALA . 85.1 m -141.13 149.0 40.96 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.639 1.176 . . . . 0.0 108.604 -176.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -59.58 -35.29 73.99 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.309 0.644 . . . . 0.0 111.372 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.447 ' H ' HG22 ' A' ' 9' ' ' THR . . . -62.1 -51.17 69.01 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 122.995 0.518 . . . . 0.0 110.687 173.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.7 mm-40 -56.49 -37.82 70.88 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.428 1.091 . . . . 0.0 112.738 -175.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.5 p -85.53 -42.36 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 CA-C-O 119.052 -0.499 . . . . 0.0 111.36 -177.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 60.3 mt -59.77 -43.16 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 122.881 0.472 . . . . 0.0 110.876 178.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.461 ' O ' HG23 ' A' ' 19' ' ' VAL . 12.9 pt-20 -70.08 -27.13 64.37 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.692 -178.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.13 -34.6 77.94 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.134 0.573 . . . . 0.0 110.999 175.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.473 ' HA ' ' HE2' ' A' ' 32' ' ' TYR . 83.0 m-85 -64.46 -37.85 88.97 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.957 0.503 . . . . 0.0 110.964 172.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -72.68 -20.51 61.22 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.273 0.629 . . . . 0.0 111.23 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 15' ' ' GLU . 61.0 t -71.87 -34.58 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 123.133 0.573 . . . . 0.0 110.049 171.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -71.8 -54.08 11.3 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.176 0.59 . . . . 0.0 109.844 175.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -77.6 83.04 4.0 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.649 0.78 . . . . 0.0 109.355 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -71.71 -40.38 69.53 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.162 0.985 . . . . 0.0 111.127 -176.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -72.53 -26.22 61.67 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.357 0.663 . . . . 0.0 111.801 -173.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.2 59.42 2.42 Favored Glycine 0 C--N 1.347 1.145 0 N-CA-C 111.978 -0.449 . . . . 0.0 111.978 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -86.65 -11.19 52.03 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.616 1.166 . . . . 0.0 111.143 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.73 -27.04 21.34 Favored Glycine 0 C--N 1.343 0.957 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.962 175.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.41 ' HB2' ' O ' ' A' ' 64' ' ' VAL . 39.1 p90 -149.25 177.1 9.94 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.195 0.598 . . . . 0.0 111.205 -174.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.1 m -132.55 -178.33 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 124.141 0.976 . . . . 0.0 110.096 178.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.0 p -78.03 155.05 30.91 Favored 'General case' 0 C--O 1.245 0.862 0 C-N-CA 123.932 0.893 . . . . 0.0 111.268 174.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.6 p -69.76 -20.29 23.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.607 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -58.76 -59.46 5.39 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.79 0.836 . . . . 0.0 110.934 175.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.473 ' HE2' ' HA ' ' A' ' 17' ' ' PHE . 87.0 t80 -62.56 -35.52 79.72 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.538 0.735 . . . . 0.0 110.764 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.524 HD22 HG11 ' A' ' 64' ' ' VAL . 6.5 tp -59.59 -53.47 57.66 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.611 178.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.556 ' HG2' HD13 ' A' ' 53' ' ' ILE . 98.0 mtt180 -67.08 -28.91 68.57 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.358 0.663 . . . . 0.0 111.514 -176.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -64.62 -58.61 5.87 Favored 'General case' 0 CA--C 1.548 0.904 0 O-C-N 123.665 0.603 . . . . 0.0 111.1 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.1 p -64.57 -38.73 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 123.138 0.575 . . . . 0.0 111.849 -174.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.442 HD23 HD12 ' A' ' 40' ' ' LEU . 85.8 mt -74.79 -26.53 59.81 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.245 0.618 . . . . 0.0 111.285 -176.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.461 ' HA ' ' HB2' ' A' ' 46' ' ' ALA . 3.6 t-20 -67.51 -42.15 83.3 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 123.479 0.487 . . . . 0.0 109.817 171.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -70.42 -30.9 67.89 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.799 0.84 . . . . 0.0 111.717 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.442 HD12 HD23 ' A' ' 37' ' ' LEU . 95.8 mt -71.04 -28.41 64.37 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 122.759 0.424 . . . . 0.0 110.61 172.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -82.39 62.83 4.52 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 169.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -75.29 -36.64 61.13 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.237 0.615 . . . . 0.0 110.485 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 64.5 mtt -124.3 8.11 8.46 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.707 0.803 . . . . 0.0 110.768 173.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 22.8 mmt -116.99 140.92 27.58 Favored Pre-proline 0 N--CA 1.482 1.151 0 C-N-CA 124.045 0.938 . . . . 0.0 108.595 176.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.412 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 40.2 Cg_endo -66.95 133.03 29.87 Favored 'Trans proline' 0 C--N 1.368 1.567 0 C-N-CA 121.738 1.625 . . . . 0.0 111.367 173.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.461 ' HB2' ' HA ' ' A' ' 38' ' ' ASN . . . -73.33 -20.88 60.68 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.453 0.301 . . . . 0.0 110.286 174.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -54.84 -37.24 65.95 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.589 1.156 . . . . 0.0 112.571 -178.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 45' ' ' PRO . 17.1 pt-20 -67.14 -39.15 86.51 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.005 0.431 . . . . 0.0 110.309 177.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 89.6 mt -69.62 -33.25 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.41 1.084 . . . . 0.0 110.321 177.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -69.39 -32.96 72.31 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.806 0.842 . . . . 0.0 111.679 -176.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -62.29 -42.18 99.13 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 121.554 0.692 . . . . 0.0 109.983 171.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 60.4 mmm -67.9 -31.21 70.83 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.487 177.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.556 HD13 ' HG2' ' A' ' 34' ' ' ARG . 54.9 mt -67.72 -31.47 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 124.452 1.101 . . . . 0.0 110.932 178.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -77.54 -20.56 53.97 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.803 0.441 . . . . 0.0 111.291 172.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -79.46 -20.69 46.77 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.499 0.319 . . . . 0.0 110.671 171.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.47 -37.13 18.59 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.922 0.889 . . . . 0.0 111.041 175.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -132.25 80.5 63.53 Favored Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 124.334 1.054 . . . . 0.0 108.47 176.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -81.88 -12.58 10.84 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 123.268 2.646 . . . . 0.0 112.181 174.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 58.8 mm-40 -76.04 -17.03 59.83 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.632 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.6 m120 63.4 26.81 15.09 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.867 1.267 . . . . 0.0 110.611 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 53.1 m -88.89 -15.45 34.37 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.054 0.942 . . . . 0.0 111.245 -175.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.71 21.15 75.29 Favored Glycine 0 C--N 1.348 1.222 0 CA-C-N 116.32 -0.4 . . . . 0.0 113.052 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -116.92 117.22 29.11 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 178.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.524 HG11 HD22 ' A' ' 33' ' ' LEU . 3.9 p -135.02 124.42 42.92 Favored 'Isoleucine or valine' 0 C--O 1.245 0.822 0 C-N-CA 123.237 0.615 . . . . 0.0 110.805 -173.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -73.43 92.22 1.84 Allowed 'General case' 0 C--O 1.238 0.45 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 171.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -50.08 -46.27 53.23 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 114.465 -1.243 . . . . 0.0 113.761 -172.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -72.43 -34.48 67.85 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.32 0.648 . . . . 0.0 111.58 -175.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.4 m -63.48 -44.04 95.54 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.501 0.72 . . . . 0.0 109.625 175.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.468 ' HD2' HD11 ' A' ' 33' ' ' LEU . 17.6 t80 -71.71 -73.43 0.18 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.532 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.605 ' HA ' ' HB3' ' A' ' 73' ' ' LEU . 89.7 t -47.03 -28.44 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 C-N-CA 126.171 1.789 . . . . 0.0 113.149 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -59.53 -54.14 40.19 Favored Glycine 0 CA--C 1.538 1.503 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 169.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 84.7 mtp -72.89 -28.42 62.48 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.124 0.97 . . . . 0.0 111.996 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.605 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 54.6 tp -67.36 -46.83 72.2 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.38 1.072 . . . . 0.0 110.164 -177.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.435 ' HZ ' HD13 ' A' ' 40' ' ' LEU . 7.5 m-85 -84.17 21.51 1.37 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.595 0.758 . . . . 0.0 111.992 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 69.0 mt -95.22 31.26 1.97 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.434 0.694 . . . . 0.0 110.576 170.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 26.1 m0 -65.34 88.76 0.08 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.047 0.539 . . . . 0.0 110.422 176.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.0 t70 . . . . . 0 C--O 1.248 1.004 0 C-N-CA 123.915 0.886 . . . . 0.0 108.948 -179.219 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.416 0 N-CA-C 112.24 -0.344 . . . . 0.0 112.24 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.8 m -74.65 106.87 6.42 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.994 0.918 . . . . 0.0 109.882 178.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -62.12 153.62 29.51 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 122.954 0.502 . . . . 0.0 110.251 176.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -61.78 108.59 1.03 Allowed 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 121.067 0.46 . . . . 0.0 110.383 178.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -68.58 -25.16 64.75 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.066 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -70.89 99.75 1.82 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.063 0.945 . . . . 0.0 110.455 -178.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 38.3 mm -83.08 86.94 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.025 178.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -67.9 -39.83 83.56 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.086 176.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.0 t -139.22 163.07 33.43 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.117 0.967 . . . . 0.0 109.108 178.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.467 ' O ' HG12 ' A' ' 14' ' ' ILE . 19.5 pttp -58.28 -27.12 63.75 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.403 0.681 . . . . 0.0 112.389 176.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.8 -30.84 67.9 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.059 0.544 . . . . 0.0 111.565 176.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -68.94 -47.08 66.56 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.35 0.66 . . . . 0.0 110.927 176.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.8 p -71.87 -24.65 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 -177.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.491 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 33.2 mm -63.16 -38.21 81.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 173.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -61.17 -30.3 70.32 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 122.595 0.358 . . . . 0.0 111.468 176.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.16 -36.93 80.43 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 123.565 0.54 . . . . 0.0 110.421 175.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.496 ' HE1' ' HA ' ' A' ' 33' ' ' LEU . 84.4 m-85 -70.23 -32.65 70.61 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.326 0.65 . . . . 0.0 111.401 174.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 14' ' ' ILE . 3.3 mmmp? -70.95 -11.72 61.13 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.048 0.539 . . . . 0.0 111.481 -179.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 89.8 t -68.46 -42.53 83.92 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 122.841 0.456 . . . . 0.0 110.296 173.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -74.04 -48.21 31.58 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 173.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -83.01 76.78 9.81 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.127 0.971 . . . . 0.0 109.713 -178.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -94.18 -29.1 15.29 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.045 0.538 . . . . 0.0 110.929 176.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -85.83 -12.05 51.81 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.301 0.641 . . . . 0.0 111.942 -176.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.65 50.8 5.13 Favored Glycine 0 C--N 1.338 0.674 0 N-CA-C 112.097 -0.401 . . . . 0.0 112.097 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -68.53 -24.1 64.6 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.211 1.004 . . . . 0.0 110.628 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.65 -22.13 42.43 Favored Glycine 0 C--N 1.345 1.045 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.018 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.424 ' HB2' ' O ' ' A' ' 64' ' ' VAL . 43.4 p90 -156.07 172.42 18.44 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.72 0.808 . . . . 0.0 111.466 -175.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.2 m -121.42 -177.07 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 123.87 0.868 . . . . 0.0 110.232 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 70.7 p -83.14 162.17 21.38 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.699 0.8 . . . . 0.0 111.024 175.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.505 ' HB ' ' HA2' ' A' ' 62' ' ' GLY . 9.9 p -64.93 -27.79 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 123.019 0.527 . . . . 0.0 110.285 173.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -67.62 -47.52 69.39 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.51 1.124 . . . . 0.0 110.284 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -71.74 -34.02 69.18 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.251 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.496 ' HA ' ' HE1' ' A' ' 17' ' ' PHE . 5.8 tp -63.11 -55.62 23.79 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.991 0.916 . . . . 0.0 111.12 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.502 ' HG2' HD13 ' A' ' 53' ' ' ILE . 62.1 mtp180 -64.3 -31.46 72.68 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.412 0.685 . . . . 0.0 111.243 -178.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -59.32 -64.02 1.09 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.516 0.726 . . . . 0.0 111.271 178.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.2 p -62.6 -36.25 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.359 0.664 . . . . 0.0 111.726 -176.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 91.4 mt -82.07 -12.44 58.25 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.023 0.529 . . . . 0.0 111.667 -176.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -85.8 -36.35 20.13 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 171.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -66.07 -41.56 90.59 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.505 0.722 . . . . 0.0 110.341 174.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.408 HD21 ' HZ ' ' A' ' 74' ' ' PHE . 64.1 tp -78.55 -28.35 46.03 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.333 1.053 . . . . 0.0 110.192 174.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -88.3 53.69 4.16 Favored Glycine 0 C--N 1.344 1.021 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 175.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -88.09 -56.87 3.15 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.481 0.713 . . . . 0.0 109.367 175.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 57.5 mtm -82.49 -32.41 28.82 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.38 177.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 23.9 mmt -88.4 146.89 38.69 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 123.537 0.735 . . . . 0.0 109.305 174.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -70.21 119.28 6.24 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 121.952 1.768 . . . . 0.0 111.597 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.505 ' O ' ' HG2' ' A' ' 50' ' ' GLU . . . -62.91 -33.7 75.87 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.155 -0.684 . . . . 0.0 109.155 171.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -51.84 -41.07 61.52 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 125.352 1.461 . . . . 0.0 111.845 176.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -64.44 -48.31 75.81 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.217 1.007 . . . . 0.0 110.236 177.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.444 ' O ' HG13 ' A' ' 53' ' ' ILE . 68.3 mt -61.32 -36.46 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.466 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.505 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 15.9 mm-40 -56.63 -47.3 79.99 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.811 0.845 . . . . 0.0 111.075 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -66.03 -26.69 67.64 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 122.878 0.471 . . . . 0.0 111.427 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 43.8 mtp -77.23 -29.54 54.13 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.057 0.543 . . . . 0.0 110.459 175.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.502 HD13 ' HG2' ' A' ' 34' ' ' ARG . 96.8 mt -71.96 -24.42 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 123.964 0.906 . . . . 0.0 110.639 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -65.85 -26.1 67.5 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.044 0.538 . . . . 0.0 110.88 169.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -90.13 -28.63 18.83 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.228 0.611 . . . . 0.0 110.283 177.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.0 -42.27 76.7 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.795 0.838 . . . . 0.0 110.41 176.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -140.57 95.6 7.95 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 176.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -74.56 -23.54 14.7 Favored 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 122.749 2.299 . . . . 0.0 112.31 177.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -86.68 -12.24 48.92 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.864 0.865 . . . . 0.0 111.066 -174.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.435 HD22 ' N ' ' A' ' 60' ' ' ASN . 0.8 OUTLIER 64.11 25.74 13.79 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.783 1.233 . . . . 0.0 110.702 179.453 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 37.9 m -69.12 -22.41 63.97 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.703 1.201 . . . . 0.0 112.061 -177.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.505 ' HA2' ' HB ' ' A' ' 30' ' ' VAL . . . 79.33 26.59 57.06 Favored Glycine 0 C--N 1.339 0.733 0 CA-C-N 115.889 -0.596 . . . . 0.0 113.127 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -126.9 95.65 4.38 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.235 1.014 . . . . 0.0 108.693 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.477 HG11 HD22 ' A' ' 33' ' ' LEU . 2.0 p -119.94 125.24 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.958 0.903 . . . . 0.0 110.478 -171.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -72.77 91.03 1.45 Allowed 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 173.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -55.07 -38.03 67.52 Favored 'General case' 0 C--O 1.211 -0.966 0 CA-C-N 114.965 -1.016 . . . . 0.0 113.298 -173.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -65.96 -47.32 75.0 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 117.773 0.261 . . . . 0.0 110.633 -172.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 70.4 p -69.85 -32.28 70.58 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.067 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -68.51 -66.73 0.53 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 122.95 0.5 . . . . 0.0 110.879 176.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.65 ' HA ' ' HB3' ' A' ' 73' ' ' LEU . 52.9 t -47.89 -27.08 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.114 0 C-N-CA 126.435 1.894 . . . . 0.0 113.063 174.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.88 -53.48 37.28 Favored Glycine 0 CA--C 1.534 1.238 0 N-CA-C 112.28 -0.328 . . . . 0.0 112.28 169.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 91.0 mtp -75.26 -15.24 60.54 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.742 0.817 . . . . 0.0 111.944 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.65 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 59.4 tp -82.8 -43.73 16.35 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.882 1.273 . . . . 0.0 109.957 -178.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.408 ' HZ ' HD21 ' A' ' 40' ' ' LEU . 13.1 m-85 -88.5 22.65 2.49 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.821 0.848 . . . . 0.0 112.166 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 79.0 mt -70.73 -8.83 55.07 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 166.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 46.4 m0 -62.24 131.25 48.79 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 123.999 0.92 . . . . 0.0 109.778 168.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 . . . . . 0 CA--C 1.554 1.106 0 C-N-CA 123.314 0.646 . . . . 0.0 110.76 -177.161 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.706 0 N-CA-C 112.384 -0.287 . . . . 0.0 112.384 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.1 p -152.95 103.28 2.73 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.949 0.9 . . . . 0.0 109.578 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 28.3 m80 -138.06 -160.08 1.02 Allowed 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.279 1.032 . . . . 0.0 109.45 177.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 23.9 mmt -50.92 128.71 21.89 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.181 0.592 . . . . 0.0 110.571 174.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -62.68 134.46 56.34 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 123.976 0.798 . . . . 0.0 111.213 -174.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -82.53 72.1 9.6 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.33 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.3 pp -97.75 85.73 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.022 177.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -75.95 76.6 2.84 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.418 -178.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.42 HG22 ' H ' ' A' ' 11' ' ' ALA . 35.0 m -153.98 132.65 12.21 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.317 1.047 . . . . 0.0 108.826 177.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -66.46 -30.06 70.32 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.127 0.971 . . . . 0.0 111.434 178.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.42 ' H ' HG22 ' A' ' 9' ' ' THR . . . -67.1 -47.91 69.74 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.471 175.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -57.7 -38.77 75.79 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.985 0.914 . . . . 0.0 113.15 -174.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.9 p -66.26 -44.03 91.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 75.9 mt -66.62 -34.1 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.044 0.538 . . . . 0.0 109.97 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.458 ' O ' HG23 ' A' ' 19' ' ' VAL . 47.1 mt-10 -73.06 -25.94 61.1 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.331 0.653 . . . . 0.0 111.107 177.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.7 -37.63 86.99 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 121.231 0.538 . . . . 0.0 110.256 174.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.439 ' HE1' ' HA ' ' A' ' 33' ' ' LEU . 89.7 m-85 -67.28 -34.97 78.52 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.929 172.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.481 ' HE3' ' HE1' ' A' ' 66' ' ' TYR . 33.2 mmtp -66.44 -28.6 68.72 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.193 0.597 . . . . 0.0 110.862 176.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 15' ' ' GLU . 93.4 t -65.98 -44.13 92.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.018 0.527 . . . . 0.0 109.747 175.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -67.69 -48.7 65.82 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.355 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -88.04 72.24 9.23 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.697 0.799 . . . . 0.0 109.168 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -31.9 68.94 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.369 177.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -66.2 -28.92 69.12 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.967 178.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.04 41.25 95.26 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-N 115.976 -0.556 . . . . 0.0 113.319 176.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.9 -18.46 60.9 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 122.61 0.364 . . . . 0.0 110.842 178.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.32 -6.86 14.54 Favored Glycine 0 C--N 1.349 1.255 0 CA-C-O 119.625 -0.542 . . . . 0.0 113.737 172.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -157.48 173.82 16.32 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 117.563 0.682 . . . . 0.0 112.365 -175.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.2 m -130.66 179.63 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 124.134 0.973 . . . . 0.0 110.26 178.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 66.7 p -74.31 153.53 39.3 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.919 171.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.56 -26.4 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 122.707 0.403 . . . . 0.0 110.912 177.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -64.38 -50.71 66.6 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.062 0.545 . . . . 0.0 111.144 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -62.1 -41.04 97.81 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.157 0.583 . . . . 0.0 110.444 175.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.669 HD22 HG11 ' A' ' 64' ' ' VAL . 2.8 tp -56.67 -53.28 59.47 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.556 -178.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -65.31 -37.03 85.89 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.631 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -57.25 -58.77 6.78 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 124.258 0.974 . . . . 0.0 111.052 -177.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.462 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 7.5 p -63.26 -46.13 96.51 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 O-C-N 123.506 0.504 . . . . 0.0 111.341 -177.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 95.7 mt -65.57 -30.63 71.4 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.233 0.613 . . . . 0.0 111.761 -176.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -77.47 -38.73 48.65 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.018 0.527 . . . . 0.0 110.234 177.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -78.34 -9.54 59.3 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.303 0.641 . . . . 0.0 111.974 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 36' ' ' VAL . 87.8 mt -73.63 -42.59 61.24 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.653 0.381 . . . . 0.0 110.025 170.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -166.81 89.75 0.1 OUTLIER Glycine 0 C--N 1.35 1.328 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.636 -177.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -69.46 -20.44 63.76 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.75 0.82 . . . . 0.0 110.927 176.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 23.1 mmt -59.84 -32.34 70.59 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.233 1.013 . . . . 0.0 110.711 175.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 21.8 mmt -84.51 141.25 38.96 Favored Pre-proline 0 C--O 1.245 0.867 0 C-N-CA 124.201 1.0 . . . . 0.0 108.849 177.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.59 110.38 2.07 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 121.645 1.564 . . . . 0.0 111.331 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.28 -19.27 64.69 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.272 174.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -48.61 -39.64 24.67 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 125.383 1.473 . . . . 0.0 111.496 175.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.96 -49.25 78.21 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.496 1.118 . . . . 0.0 110.537 177.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.458 ' O ' HG13 ' A' ' 53' ' ' ILE . 87.5 mt -60.88 -43.63 96.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.367 -179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.525 ' HA ' HD12 ' A' ' 53' ' ' ILE . 0.5 OUTLIER -55.66 -37.5 68.35 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.935 0.894 . . . . 0.0 112.639 177.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -72.96 -40.44 65.34 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 121.563 0.697 . . . . 0.0 110.268 177.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 28.6 mmt -64.66 -26.86 68.57 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.669 -1.151 . . . . 0.0 111.201 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.525 HD12 ' HA ' ' A' ' 50' ' ' GLU . 90.8 mt -66.69 -40.04 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 123.566 0.746 . . . . 0.0 110.826 177.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -65.44 -28.2 69.06 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 122.601 0.361 . . . . 0.0 110.908 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -75.74 -42.67 49.94 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.435 0.694 . . . . 0.0 110.904 177.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.57 -26.67 45.59 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.76 0.824 . . . . 0.0 111.802 -176.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -124.51 86.7 55.03 Favored Pre-proline 0 CA--C 1.542 0.673 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 176.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -75.94 -8.51 19.02 Favored 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 123.011 2.474 . . . . 0.0 112.521 -177.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -88.6 -24.03 22.94 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.488 0.715 . . . . 0.0 110.8 174.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.425 HD22 ' N ' ' A' ' 60' ' ' ASN . 0.8 OUTLIER 60.89 37.04 18.7 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 124.323 1.014 . . . . 0.0 109.356 -174.25 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.9 t -74.79 -18.67 60.43 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.595 -176.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.79 23.85 34.55 Favored Glycine 0 C--N 1.337 0.617 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.597 -175.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -139.42 131.26 27.59 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.114 1.366 . . . . 0.0 108.937 -178.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.669 HG11 HD22 ' A' ' 33' ' ' LEU . 2.8 p -145.56 134.77 17.57 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 CA-C-O 121.266 0.555 . . . . 0.0 110.727 -170.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -75.89 89.06 2.9 Favored 'General case' 0 C--N 1.35 0.606 0 C-N-CA 124.294 1.038 . . . . 0.0 108.823 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.481 ' HE1' ' HE3' ' A' ' 18' ' ' LYS . 32.5 p90 -49.94 -39.83 41.68 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 115.629 1.714 . . . . 0.0 115.629 -171.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -67.07 -50.67 61.0 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 118.73 0.695 . . . . 0.0 111.366 -170.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.467 ' O ' ' HG2' ' A' ' 72' ' ' MET . 9.4 t -71.02 -21.2 62.31 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.854 178.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.446 ' CE2' HD21 ' A' ' 33' ' ' LEU . 55.6 t80 -81.97 -58.1 3.13 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.513 0.725 . . . . 0.0 111.307 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.8 t -66.23 -27.88 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.215 1.006 . . . . 0.0 110.743 -177.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -59.82 -32.29 74.23 Favored Glycine 0 CA--C 1.537 1.418 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.681 171.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.467 ' HG2' ' O ' ' A' ' 68' ' ' THR . 26.6 mmt -76.29 -49.76 16.14 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.57 0.748 . . . . 0.0 111.35 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.402 HD22 HG12 ' A' ' 49' ' ' ILE . 1.9 pp -81.02 -2.96 50.12 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -172.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -94.82 -2.37 50.97 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.589 0.356 . . . . 0.0 111.009 169.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 65.2 mt -78.72 -5.67 53.8 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.489 0.316 . . . . 0.0 111.052 173.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 52.5 m0 -61.88 -20.08 63.34 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.581 0.752 . . . . 0.0 111.078 176.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.3 t70 . . . . . 0 C--O 1.256 1.44 0 C-N-CA 124.379 1.072 . . . . 0.0 109.101 173.102 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.358 0 N-CA-C 111.837 -0.505 . . . . 0.0 111.837 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.7 p -65.57 123.62 20.16 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.459 0.704 . . . . 0.0 111.494 -176.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -92.67 -0.92 57.22 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.86 0.864 . . . . 0.0 110.473 176.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 46.4 mtm -74.85 84.27 2.18 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 123.292 0.637 . . . . 0.0 109.315 177.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -74.42 100.26 3.77 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.775 -177.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -82.83 107.27 15.33 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.179 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.464 HD12 ' H ' ' A' ' 7' ' ' ILE . 4.1 mp -69.17 -29.04 41.34 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.178 0 C-N-CA 123.355 0.662 . . . . 0.0 109.37 178.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 67.28 21.7 9.81 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 125.207 1.403 . . . . 0.0 111.457 177.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.7 t -81.27 156.84 25.38 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.058 -178.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.523 ' HE2' ' HB3' ' A' ' 74' ' ' PHE . 16.2 ptpt -64.31 -20.75 66.3 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.665 173.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.24 -38.38 90.85 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.147 0.579 . . . . 0.0 110.856 174.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -70.92 -38.11 72.92 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 112.432 0.531 . . . . 0.0 112.432 -176.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.83 -37.23 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 176.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.515 HG23 ' HE1' ' A' ' 66' ' ' TYR . 63.9 mt -63.01 -42.08 95.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.388 0.675 . . . . 0.0 110.219 173.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.417 ' O ' HG23 ' A' ' 19' ' ' VAL . 37.4 mt-10 -62.01 -32.95 73.48 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.852 0.861 . . . . 0.0 111.175 177.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.23 -38.07 79.06 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.161 0.584 . . . . 0.0 111.193 177.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.442 ' CZ ' HD12 ' A' ' 33' ' ' LEU . 96.2 m-85 -68.74 -37.08 79.16 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.269 175.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 14' ' ' ILE . 21.3 mtpp -71.76 -35.01 69.94 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.104 0.562 . . . . 0.0 111.045 -175.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 15' ' ' GLU . 91.4 t -71.01 -35.34 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.757 0.823 . . . . 0.0 110.07 176.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -66.48 -54.25 26.09 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.427 175.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.489 ' HB2' HG22 ' A' ' 28' ' ' VAL . 21.7 t70 -77.25 86.33 3.69 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.572 0.701 . . . . 0.0 109.922 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 42.5 mtp180 -88.96 -1.19 57.99 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.041 172.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -84.41 -26.85 28.02 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.004 0.922 . . . . 0.0 111.201 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.08 47.68 23.14 Favored Glycine 0 C--N 1.345 1.053 0 O-C-N 123.478 0.486 . . . . 0.0 112.274 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -91.38 17.6 8.27 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.442 0.697 . . . . 0.0 111.616 -178.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.33 -60.36 4.89 Favored Glycine 0 C--N 1.344 1.024 0 N-CA-C 111.784 -0.526 . . . . 0.0 111.784 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -124.73 -171.75 2.42 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.494 1.117 . . . . 0.0 110.322 -177.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.489 HG22 ' HB2' ' A' ' 21' ' ' ASP . 76.8 t -126.57 151.3 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.508 1.123 . . . . 0.0 109.675 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 58.5 p -66.98 165.32 15.83 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.143 0.977 . . . . 0.0 112.592 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.4 p -69.83 -18.92 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.491 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -63.63 -46.78 84.15 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.018 0.527 . . . . 0.0 111.41 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -79.83 -29.99 40.31 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.823 176.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.598 HD22 HG11 ' A' ' 64' ' ' VAL . 12.0 tp -57.02 -45.53 83.03 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.175 0.59 . . . . 0.0 110.689 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 75.5 mtt180 -67.28 -41.96 84.62 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.354 176.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -54.18 -51.08 65.51 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.812 0.845 . . . . 0.0 111.812 -176.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.5 p -73.82 -34.2 39.59 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.582 -175.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 91.8 mt -86.09 -10.42 54.93 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 122.04 -0.413 . . . . 0.0 111.883 -177.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -83.06 -42.08 17.87 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.128 0.571 . . . . 0.0 109.948 176.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -73.86 -40.1 63.49 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.507 0.723 . . . . 0.0 111.132 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 96.9 mt -76.69 -33.0 58.26 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.891 0.477 . . . . 0.0 110.61 177.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -87.52 65.07 3.65 Favored Glycine 0 C--N 1.347 1.18 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 176.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -84.07 -58.36 2.8 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.322 0.649 . . . . 0.0 109.443 177.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.3 -22.02 48.82 Favored 'General case' 0 CA--C 1.551 1.003 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.299 177.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 96.9 mmm -87.92 128.3 54.56 Favored Pre-proline 0 N--CA 1.478 0.969 0 C-N-CA 123.65 0.78 . . . . 0.0 110.204 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -65.54 121.78 9.27 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 122.86 2.373 . . . . 0.0 111.485 172.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.96 -12.83 61.76 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.81 0.844 . . . . 0.0 111.897 -177.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.484 ' O ' ' HG2' ' A' ' 51' ' ' GLU . 5.8 m-20 -52.45 -52.65 53.07 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.632 1.173 . . . . 0.0 111.363 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -60.19 -46.85 88.31 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 124.058 0.849 . . . . 0.0 111.02 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.0 mt -57.99 -38.56 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.056 178.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.4 ' O ' ' HD1' ' A' ' 54' ' ' TYR . 75.2 mm-40 -67.41 -41.43 84.89 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.127 0.571 . . . . 0.0 111.547 178.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 47' ' ' ASP . 8.7 mm-40 -60.35 -43.3 96.63 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.798 0.809 . . . . 0.0 109.791 177.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.434 ' HG3' ' HZ2' ' A' ' 76' ' ' TRP . 76.5 mmm -66.66 -32.88 74.49 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 113.57 -1.65 . . . . 0.0 111.52 176.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.4 mt -64.29 -42.72 96.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 C-N-CA 124.089 0.956 . . . . 0.0 110.235 176.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.4 ' HD1' ' O ' ' A' ' 50' ' ' GLU . 24.7 m-85 -78.07 -9.39 59.12 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.712 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -99.15 -16.95 18.41 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.287 0.635 . . . . 0.0 111.405 170.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.72 -28.97 22.76 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.626 0.77 . . . . 0.0 110.324 173.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -138.83 76.54 34.29 Favored Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 175.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -78.77 -11.56 15.28 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 123.252 2.635 . . . . 0.0 113.512 -176.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -87.43 -11.8 48.06 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.213 0.605 . . . . 0.0 111.254 -178.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.5 t30 60.31 54.83 3.79 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 122.167 0.984 . . . . 0.0 109.277 -175.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.9 m -99.19 -17.2 18.26 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.527 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.61 15.22 81.4 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.354 -172.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -114.79 109.94 18.94 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.684 0.794 . . . . 0.0 109.645 -173.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.598 HG11 HD22 ' A' ' 33' ' ' LEU . 2.7 p -136.84 123.2 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 123.731 0.812 . . . . 0.0 110.121 -175.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -72.57 100.62 2.8 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 172.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.515 ' HE1' HG23 ' A' ' 14' ' ' ILE . 48.1 p90 -59.94 -37.79 80.54 Favored 'General case' 0 C--O 1.214 -0.785 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.681 -171.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -66.75 -33.84 76.52 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 118.076 0.398 . . . . 0.0 110.316 -177.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 19.1 m -67.2 -50.73 59.84 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 123.81 0.844 . . . . 0.0 110.446 175.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.445 ' HD2' HD11 ' A' ' 33' ' ' LEU . 63.0 t80 -70.63 -62.35 1.42 Allowed 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.982 -174.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 74.5 t -57.19 -30.62 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.63 1.172 . . . . 0.0 110.83 175.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.68 -55.4 30.08 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-N 116.298 -0.41 . . . . 0.0 112.458 172.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 24.4 ptp -72.68 -24.18 60.98 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -175.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.53 -26.9 29.74 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.523 ' HB3' ' HE2' ' A' ' 10' ' ' LYS . 22.8 m-85 -86.69 6.3 31.9 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 122.612 0.365 . . . . 0.0 111.03 170.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 76.9 mt -100.72 15.41 28.38 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.684 0.794 . . . . 0.0 110.602 168.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.434 ' HZ2' ' HG3' ' A' ' 52' ' ' MET . 54.6 m0 -80.25 59.95 3.55 Favored 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 170.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.6 t70 . . . . . 0 C--O 1.247 0.954 0 C-N-CA 123.926 0.891 . . . . 0.0 109.618 -175.834 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.407 0 N-CA-C 111.771 -0.531 . . . . 0.0 111.771 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.9 p -155.19 145.18 21.64 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.661 0.785 . . . . 0.0 110.069 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.4 p-80 -158.66 87.05 0.87 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.703 1.201 . . . . 0.0 108.652 177.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.4 ttt -88.0 41.89 1.03 Allowed 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.376 0.67 . . . . 0.0 110.78 -174.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 73.37 -30.66 0.21 Allowed 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 125.305 1.442 . . . . 0.0 113.878 173.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.8 t60 -83.11 72.61 10.12 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.659 0.784 . . . . 0.0 109.678 -176.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.463 HG22 HG22 ' A' ' 9' ' ' THR . 19.5 mm -122.52 110.8 27.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 172.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -109.0 91.18 3.54 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.463 HG22 HG22 ' A' ' 7' ' ' ILE . 11.6 t -173.2 157.36 3.39 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.808 0.843 . . . . 0.0 110.92 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.459 ' H ' ' HD2' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -81.15 -18.48 46.22 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.041 0.937 . . . . 0.0 110.848 171.714 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.17 -42.23 98.2 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.008 0.923 . . . . 0.0 112.077 -175.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -56.19 -41.91 76.28 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 124.038 0.935 . . . . 0.0 112.611 -173.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.434 HG13 HG11 ' A' ' 70' ' ' VAL . 4.3 p -82.71 -35.96 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 123.583 0.753 . . . . 0.0 109.941 -174.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 71.2 mt -61.84 -32.63 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 123.328 0.651 . . . . 0.0 110.052 172.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -67.88 -38.11 82.62 Favored 'General case' 0 C--N 1.349 0.548 0 C-N-CA 123.682 0.793 . . . . 0.0 110.781 175.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.27 -40.01 76.83 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 122.899 0.48 . . . . 0.0 111.268 177.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.426 ' CE1' HD12 ' A' ' 33' ' ' LEU . 80.6 m-85 -64.54 -53.2 51.77 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.472 0.709 . . . . 0.0 112.001 178.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.87 -25.99 64.9 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -175.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.3 t -70.37 -37.5 70.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 122.646 0.378 . . . . 0.0 110.11 172.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -66.68 -40.45 88.58 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.28 174.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -76.63 81.06 3.29 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.792 0.806 . . . . 0.0 109.887 -176.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 69.6 mtp180 -92.96 -14.86 26.95 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.036 -1.438 . . . . 0.0 109.703 175.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -74.65 -28.42 60.85 Favored 'General case' 0 C--N 1.356 0.848 0 C-N-CA 123.383 0.673 . . . . 0.0 110.253 176.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.22 56.09 3.32 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-N 116.329 -0.396 . . . . 0.0 113.279 175.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -88.27 -21.59 24.37 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.804 0.841 . . . . 0.0 110.413 175.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.33 -40.9 2.49 Favored Glycine 0 C--N 1.348 1.204 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 -173.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.401 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 44.5 p90 -119.47 -176.0 3.06 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.958 1.303 . . . . 0.0 109.518 174.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 55.2 t -127.64 159.51 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 124.244 1.017 . . . . 0.0 109.467 -177.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.3 p -72.81 166.81 22.18 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.655 1.182 . . . . 0.0 111.771 177.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.9 p -75.3 -14.8 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 122.999 0.52 . . . . 0.0 111.331 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -69.45 -57.63 5.0 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 122.578 0.351 . . . . 0.0 110.83 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -64.29 -30.56 71.61 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.643 0.377 . . . . 0.0 110.534 176.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.551 HD22 HG11 ' A' ' 64' ' ' VAL . 10.4 tp -56.69 -58.66 7.11 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.169 176.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 46.6 mtt85 -62.45 -28.24 69.67 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.794 0.838 . . . . 0.0 112.116 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -62.37 -62.79 1.51 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.278 0.631 . . . . 0.0 110.865 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.3 p -66.82 -28.3 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.169 0.588 . . . . 0.0 111.686 -175.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 84.1 mt -87.56 -11.93 47.24 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.223 0.609 . . . . 0.0 112.224 -177.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -76.84 -35.38 57.56 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 166.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -75.34 -35.03 61.23 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.129 0.971 . . . . 0.0 110.464 177.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -74.73 -43.36 55.4 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 175.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -87.2 61.32 4.28 Favored Glycine 0 C--N 1.345 1.078 0 N-CA-C 110.269 -1.133 . . . . 0.0 110.269 175.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -60.32 -47.91 84.0 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.358 1.063 . . . . 0.0 111.445 -173.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 64.4 mtm -125.88 1.0 7.36 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.699 0.8 . . . . 0.0 110.006 172.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 63.4 mtt -80.94 137.27 50.14 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 123.445 0.698 . . . . 0.0 109.38 175.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.7 122.54 10.67 Favored 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.64 2.227 . . . . 0.0 112.87 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.51 -18.48 65.39 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.702 0.801 . . . . 0.0 110.631 170.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -50.4 -43.13 54.58 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.766 1.227 . . . . 0.0 111.164 173.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -63.54 -53.28 54.29 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.431 0.693 . . . . 0.0 110.514 175.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.462 ' O ' HG13 ' A' ' 53' ' ' ILE . 88.5 mt -59.93 -37.26 71.4 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 CA-C-N 114.823 -1.08 . . . . 0.0 111.769 -174.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -71.68 -30.41 65.67 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.343 0.657 . . . . 0.0 112.024 -175.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -67.77 -39.96 84.07 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 121.53 0.681 . . . . 0.0 109.379 172.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.422 ' HG3' ' HZ2' ' A' ' 76' ' ' TRP . 69.7 mmm -68.55 -32.94 73.23 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.428 -1.26 . . . . 0.0 110.392 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 49' ' ' ILE . 58.4 mt -58.63 -42.59 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 123.821 0.848 . . . . 0.0 110.065 178.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -73.31 -9.74 59.02 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.556 0.743 . . . . 0.0 112.305 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -85.9 -29.94 23.25 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 120.975 0.417 . . . . 0.0 110.103 172.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -94.04 -19.68 20.64 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.791 0.837 . . . . 0.0 111.421 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -144.85 71.81 15.08 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 124.736 1.214 . . . . 0.0 107.897 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.03 -17.35 22.27 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 122.858 2.372 . . . . 0.0 112.609 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.592 ' HG3' ' H ' ' A' ' 61' ' ' SER . 27.7 pt20 -70.86 -20.26 62.55 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.303 1.041 . . . . 0.0 111.645 178.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.7 t30 67.7 6.95 5.34 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 124.877 1.271 . . . . 0.0 111.115 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.592 ' H ' ' HG3' ' A' ' 59' ' ' GLN . 34.8 t -78.61 -17.67 55.7 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.531 0.732 . . . . 0.0 111.313 -173.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.03 34.42 8.25 Favored Glycine 0 C--N 1.341 0.819 0 O-C-N 123.314 0.384 . . . . 0.0 113.87 172.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -127.38 96.14 4.48 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.252 1.021 . . . . 0.0 108.493 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.551 HG11 HD22 ' A' ' 33' ' ' LEU . 3.3 p -118.03 130.28 73.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 124.031 0.933 . . . . 0.0 111.312 -166.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -75.05 90.41 2.48 Favored 'General case' 0 C--N 1.351 0.644 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 170.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.401 ' CE2' ' HA ' ' A' ' 27' ' ' TYR . 42.3 p90 -57.37 -29.87 64.4 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.043 -0.981 . . . . 0.0 113.41 -173.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -60.65 -63.54 1.26 Allowed 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 118.105 0.411 . . . . 0.0 110.858 -174.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.7 t -64.68 -30.04 71.05 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.558 0.743 . . . . 0.0 111.623 -177.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.476 ' CD2' HD11 ' A' ' 33' ' ' LEU . 32.4 t80 -70.42 -55.11 9.83 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.522 0.729 . . . . 0.0 111.858 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.468 ' HA ' HD12 ' A' ' 73' ' ' LEU . 82.7 t -65.06 -24.86 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.472 0.709 . . . . 0.0 110.188 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.457 ' O ' ' HG ' ' A' ' 75' ' ' LEU . . . -56.4 -53.55 42.35 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.532 165.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.505 ' HA ' HD12 ' A' ' 75' ' ' LEU . 85.0 mtp -59.53 -35.97 75.23 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.896 0.878 . . . . 0.0 112.605 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.468 HD12 ' HA ' ' A' ' 70' ' ' VAL . 92.5 mt -62.88 -42.06 99.63 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 121.419 0.628 . . . . 0.0 110.584 176.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -88.23 -0.07 56.68 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.163 -178.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.505 HD12 ' HA ' ' A' ' 72' ' ' MET . 82.0 mt -86.06 4.15 39.31 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.581 0.752 . . . . 0.0 110.869 170.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.422 ' HZ2' ' HG3' ' A' ' 52' ' ' MET . 51.4 m0 -75.59 76.01 2.6 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 171.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 . . . . . 0 C--O 1.247 0.944 0 CA-C-O 118.286 -0.864 . . . . 0.0 109.254 178.163 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.632 0 CA-C-O 119.577 -0.568 . . . . 0.0 111.849 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.5 p -69.77 108.71 4.05 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.162 0.985 . . . . 0.0 110.488 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -79.89 -33.07 40.25 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.365 0.666 . . . . 0.0 111.091 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.9 mmt -68.38 97.07 0.72 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.966 0.506 . . . . 0.0 109.888 176.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -81.61 74.58 8.6 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 108.66 -0.866 . . . . 0.0 108.66 177.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -153.04 133.95 13.97 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.404 1.482 . . . . 0.0 107.533 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 36.8 mm -80.61 81.2 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -73.6 -41.98 62.13 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.402 -0.817 . . . . 0.0 108.902 173.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.2 t -131.98 164.07 26.98 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.769 176.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -68.94 -12.8 61.98 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.519 0.728 . . . . 0.0 111.785 -177.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.458 ' O ' ' HG2' ' A' ' 15' ' ' GLU . . . -71.23 -30.46 66.37 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.09 0.556 . . . . 0.0 111.461 174.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -58.0 -36.82 73.2 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.615 0.766 . . . . 0.0 112.521 -176.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.6 p -77.33 -34.45 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 122.633 0.373 . . . . 0.0 110.487 177.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.5 mt -65.6 -30.14 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 123.556 0.743 . . . . 0.0 110.516 178.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.5 ' HA ' ' HE2' ' A' ' 18' ' ' LYS . 26.1 mm-40 -59.09 -43.49 91.84 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.474 0.709 . . . . 0.0 109.911 172.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.34 -28.36 67.91 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.812 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -73.82 -54.29 8.33 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.971 0.509 . . . . 0.0 111.609 176.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.5 ' HE2' ' HA ' ' A' ' 15' ' ' GLU . 64.4 pttt -73.99 -17.5 60.99 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -170.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.6 p -69.14 -33.48 58.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 CA-C-N 117.917 0.326 . . . . 0.0 110.124 172.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -77.71 -45.48 24.67 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.96 0.904 . . . . 0.0 109.64 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -78.21 72.9 4.77 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 174.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.423 ' HA ' ' NE ' ' A' ' 22' ' ' ARG . 1.6 tpm_? -80.5 -28.43 37.48 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.992 -166.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -70.3 -25.67 63.43 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.823 0.449 . . . . 0.0 110.927 176.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.22 50.16 5.94 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 -173.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -75.82 -10.68 59.63 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.58 0.752 . . . . 0.0 110.597 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.39 -29.27 12.25 Favored Glycine 0 C--N 1.35 1.358 0 CA-C-N 116.121 -0.49 . . . . 0.0 112.174 176.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -145.09 164.03 32.47 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-O 121.09 0.472 . . . . 0.0 111.312 -172.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.6 m -117.74 178.61 2.0 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.846 0 CA-C-N 114.77 -1.104 . . . . 0.0 109.864 176.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.8 p -81.38 156.36 25.47 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.652 173.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.592 HG23 HG21 ' A' ' 53' ' ' ILE . 7.7 p -57.97 -37.35 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.95 0.9 . . . . 0.0 112.041 177.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -62.54 -47.83 82.16 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 123.618 0.574 . . . . 0.0 111.197 -174.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -66.76 -41.82 87.13 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.298 176.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.436 HD21 ' CE2' ' A' ' 69' ' ' PHE . 5.1 tt -63.39 -32.78 74.3 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.568 -176.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 47.9 mtm105 -74.12 -38.88 63.67 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.921 0.488 . . . . 0.0 110.679 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -60.43 -52.52 64.86 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.052 0.845 . . . . 0.0 111.508 -176.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.1 p -62.77 -41.44 92.47 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.651 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 86.1 mt -78.28 -16.32 57.89 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -177.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -80.77 -46.7 15.01 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.933 0.493 . . . . 0.0 110.292 176.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -67.98 -23.54 65.05 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.042 0.537 . . . . 0.0 111.982 -175.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.6 pp -98.13 -32.24 11.7 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.54 0.336 . . . . 0.0 110.726 173.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -106.7 39.6 2.82 Favored Glycine 0 C--N 1.345 1.06 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.648 -175.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -75.66 -26.87 58.04 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.201 1.0 . . . . 0.0 110.355 175.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 53.9 mtm -73.86 -33.38 64.06 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.191 0.996 . . . . 0.0 110.846 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 64.1 mtm -92.95 156.31 40.63 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 123.788 0.835 . . . . 0.0 109.647 176.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.07 111.59 2.91 Favored 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 121.551 1.501 . . . . 0.0 111.311 169.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.02 -12.47 61.54 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.478 0.711 . . . . 0.0 110.92 174.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -51.62 -55.49 19.02 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.011 1.324 . . . . 0.0 110.766 174.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.467 ' O ' ' HG2' ' A' ' 52' ' ' MET . 38.8 tt0 -68.04 -35.16 77.79 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.11 -178.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.467 ' O ' HG13 ' A' ' 53' ' ' ILE . 93.6 mt -58.96 -39.81 78.96 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 123.219 0.607 . . . . 0.0 110.506 173.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.541 ' HA ' HD12 ' A' ' 53' ' ' ILE . 49.6 mt-10 -67.09 -35.1 79.06 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.78 0.432 . . . . 0.0 110.947 177.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -62.83 -36.32 82.83 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.575 0.35 . . . . 0.0 110.803 173.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.467 ' HG2' ' O ' ' A' ' 48' ' ' GLU . 30.2 mmt -69.68 -33.04 72.0 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.466 0.706 . . . . 0.0 110.453 177.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.592 HG21 HG23 ' A' ' 30' ' ' VAL . 81.3 mt -69.23 -32.2 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.823 0.849 . . . . 0.0 110.303 174.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -71.59 -12.43 61.35 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.577 0.751 . . . . 0.0 111.459 175.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -94.95 -35.19 12.1 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.52 0.728 . . . . 0.0 110.138 174.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.94 -31.13 56.41 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.765 0.826 . . . . 0.0 111.07 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -137.81 91.32 13.63 Favored Pre-proline 0 CA--C 1.55 0.973 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 172.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -85.12 4.73 6.61 Favored 'Trans proline' 0 C--N 1.371 1.746 0 C-N-CA 122.898 2.399 . . . . 0.0 113.855 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -103.6 -11.18 17.87 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.178 0.591 . . . . 0.0 111.851 -176.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.2 t30 66.71 22.83 10.3 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 124.177 0.991 . . . . 0.0 109.847 -176.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 46.9 m -64.47 -39.99 94.84 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 124.718 1.207 . . . . 0.0 110.807 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.97 24.7 16.41 Favored Glycine 0 C--N 1.344 0.976 0 CA-C-N 114.995 -1.002 . . . . 0.0 113.191 176.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -127.42 95.27 4.21 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.496 1.119 . . . . 0.0 108.787 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 p -119.11 126.02 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 123.527 0.731 . . . . 0.0 110.407 -171.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -70.24 98.98 1.45 Allowed 'General case' 0 C--N 1.347 0.458 0 C-N-CA 124.152 0.981 . . . . 0.0 110.593 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -63.27 -33.4 75.42 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -176.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -64.91 -46.73 80.44 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 120.883 0.373 . . . . 0.0 110.955 -175.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 54.6 p -77.31 -38.15 51.19 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.407 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.436 ' CE2' HD21 ' A' ' 33' ' ' LEU . 41.8 t80 -65.12 -72.05 0.17 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.062 0.545 . . . . 0.0 110.975 -178.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.589 ' HA ' ' HB3' ' A' ' 73' ' ' LEU . 96.9 t -50.08 -29.56 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 125.162 1.385 . . . . 0.0 112.309 177.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.75 -53.44 45.26 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 121.048 0.249 . . . . 0.0 112.769 170.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 67.7 mtm -87.03 -2.13 58.39 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.281 1.033 . . . . 0.0 111.956 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.589 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 50.7 tp -90.24 -48.01 7.42 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.263 1.025 . . . . 0.0 109.363 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -78.41 27.89 0.2 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.105 0.962 . . . . 0.0 112.608 -177.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.2 0.33 19.48 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.361 0.665 . . . . 0.0 112.033 172.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 13.3 m0 -51.6 123.73 10.62 Favored 'General case' 0 C--N 1.351 0.636 0 C-N-CA 124.632 1.173 . . . . 0.0 110.948 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.2 t70 . . . . . 0 C--O 1.249 1.03 0 C-N-CA 123.5 0.72 . . . . 0.0 110.221 -176.872 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.297 0 CA-C-O 120.241 -0.199 . . . . 0.0 113.007 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.5 m -73.54 -47.98 36.61 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.397 0.679 . . . . 0.0 111.836 -175.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -120.45 146.39 46.28 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.038 0.535 . . . . 0.0 110.452 -177.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -78.21 -10.51 59.68 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.627 0.771 . . . . 0.0 111.705 -178.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -83.02 68.16 9.4 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.713 0.805 . . . . 0.0 110.368 -176.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -78.29 87.57 4.35 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 114.832 -1.077 . . . . 0.0 109.484 177.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.7 tt -75.81 124.78 34.54 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 CA-C-N 114.565 -1.198 . . . . 0.0 110.531 -175.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -106.24 83.83 1.95 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.183 0.993 . . . . 0.0 108.657 175.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.474 ' O ' ' HG2' ' A' ' 12' ' ' GLN . 91.1 m -144.21 123.78 13.24 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.027 0.931 . . . . 0.0 108.775 -177.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.511 ' H ' ' HD3' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -72.32 -4.98 33.01 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -176.927 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.459 ' O ' ' HG2' ' A' ' 15' ' ' GLU . . . -58.75 -43.08 90.18 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.469 0.308 . . . . 0.0 110.572 170.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 9' ' ' THR . 27.0 pt20 -67.25 -34.39 77.33 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.492 0.717 . . . . 0.0 111.991 -173.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.6 p -75.3 -37.14 38.33 Favored 'Isoleucine or valine' 0 C--N 1.355 0.828 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -178.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.4 mt -62.85 -37.28 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 174.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 68.0 mm-40 -59.99 -45.03 94.05 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 122.877 0.471 . . . . 0.0 110.161 172.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.26 -27.45 69.02 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.657 0.783 . . . . 0.0 112.138 -178.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.459 ' HE1' ' HA ' ' A' ' 33' ' ' LEU . 65.2 m-85 -77.7 -42.61 33.84 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.719 0.408 . . . . 0.0 111.179 173.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -70.4 -23.18 62.71 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.924 0.49 . . . . 0.0 112.114 -174.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 23.8 m -75.95 -28.61 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-O 120.663 0.268 . . . . 0.0 110.552 175.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -74.6 -42.04 59.37 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.74 0.816 . . . . 0.0 109.052 174.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -75.2 85.2 2.4 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.026 0.93 . . . . 0.0 108.824 175.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 68.5 ttt-85 -65.61 -48.49 72.09 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.789 -1.096 . . . . 0.0 112.456 -172.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -87.47 -3.5 59.0 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -170.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.69 41.74 63.66 Favored Glycine 0 C--N 1.345 1.03 0 N-CA-C 112.171 -0.372 . . . . 0.0 112.171 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -70.51 -17.99 62.95 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.919 0.888 . . . . 0.0 110.701 -178.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.29 -43.58 1.61 Allowed Glycine 0 C--N 1.346 1.108 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.498 175.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.505 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 50.9 p90 -136.6 176.19 8.92 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.186 0.594 . . . . 0.0 111.799 -172.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.0 m -123.64 -177.97 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 124.02 0.928 . . . . 0.0 110.529 -177.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 49.7 p -75.75 153.82 36.76 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 123.554 0.742 . . . . 0.0 110.235 173.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.6 p -63.06 -27.0 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.327 0.651 . . . . 0.0 111.343 178.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -59.96 -58.79 7.03 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.526 1.13 . . . . 0.0 110.624 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -61.77 -34.16 75.37 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 123.752 0.657 . . . . 0.0 110.975 -178.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.643 HD22 HG11 ' A' ' 64' ' ' VAL . 7.1 tp -58.69 -52.15 66.91 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.768 178.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 54.9 mtt180 -64.58 -35.29 80.52 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.369 0.668 . . . . 0.0 111.435 -178.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -63.46 -51.85 63.87 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.475 0.71 . . . . 0.0 111.828 -177.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.2 p -73.0 -30.38 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.46 -175.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 81.2 mt -85.28 -11.95 53.56 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.672 0.389 . . . . 0.0 111.371 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -85.46 -33.01 21.97 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.198 0.599 . . . . 0.0 110.078 173.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -80.43 -41.4 24.56 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 110.624 -0.139 . . . . 0.0 110.624 178.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 94.3 mt -74.07 -27.65 61.01 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.601 0.361 . . . . 0.0 110.233 174.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -96.68 52.09 1.51 Allowed Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.4 173.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -65.95 -51.07 61.77 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.748 0.819 . . . . 0.0 111.041 -175.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -92.4 -3.28 55.52 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.134 0.574 . . . . 0.0 111.029 177.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 74.8 mtp -94.4 144.66 28.35 Favored Pre-proline 0 N--CA 1.48 1.071 0 C-N-CA 123.611 0.765 . . . . 0.0 110.141 -176.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -66.52 111.39 2.08 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.684 2.256 . . . . 0.0 111.828 172.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.36 -27.77 63.58 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.305 0.642 . . . . 0.0 111.293 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -62.02 -34.34 76.03 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 122.703 0.401 . . . . 0.0 111.738 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -71.2 -39.15 71.96 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 176.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.491 ' O ' HG13 ' A' ' 53' ' ' ILE . 89.1 mt -64.4 -42.13 94.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 123.234 0.614 . . . . 0.0 109.776 176.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.534 ' HA ' HD12 ' A' ' 53' ' ' ILE . 46.9 mt-10 -75.05 -19.84 59.83 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.918 0.887 . . . . 0.0 111.032 -178.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -72.13 -45.02 62.21 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.685 0.794 . . . . 0.0 109.149 169.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.457 ' SD ' ' HZ2' ' A' ' 76' ' ' TRP . 48.8 mtp -67.7 -18.99 65.11 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.344 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.534 HD12 ' HA ' ' A' ' 50' ' ' GLU . 73.6 mt -68.03 -29.31 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.405 0.682 . . . . 0.0 111.38 176.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -60.37 -32.96 71.78 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.106 0.562 . . . . 0.0 110.484 173.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -85.3 -35.8 21.26 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.334 1.054 . . . . 0.0 110.448 178.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.18 -33.01 74.79 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.985 0.914 . . . . 0.0 111.569 -178.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -123.82 90.07 50.96 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 105.056 -2.202 . . . . 0.0 105.056 171.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -65.65 -23.35 56.72 Favored 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 123.148 2.566 . . . . 0.0 112.788 -175.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -86.39 -17.27 34.83 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.765 0.826 . . . . 0.0 109.332 179.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.423 HD22 ' N ' ' A' ' 60' ' ' ASN . 0.8 OUTLIER 59.03 43.57 17.43 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.354 1.061 . . . . 0.0 110.318 178.843 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.0 m -79.76 -26.86 40.55 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.241 1.016 . . . . 0.0 112.156 -177.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 96.9 9.33 56.28 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.351 -169.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -118.35 99.89 7.13 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.63 1.172 . . . . 0.0 108.415 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.643 HG11 HD22 ' A' ' 33' ' ' LEU . 7.3 p -112.87 136.66 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-O 121.158 0.504 . . . . 0.0 111.425 -170.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -85.24 99.2 10.95 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.005 173.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.505 ' CE2' ' HA ' ' A' ' 27' ' ' TYR . 34.1 p90 -59.95 -35.4 74.86 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.615 -177.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -63.1 -45.04 93.91 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 122.791 0.436 . . . . 0.0 111.032 -173.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.5 t -78.48 -24.8 45.73 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.111 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.445 ' HD2' HD11 ' A' ' 33' ' ' LEU . 26.3 t80 -79.89 -74.14 0.32 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.349 0.259 . . . . 0.0 110.486 178.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.542 ' HA ' ' HB3' ' A' ' 73' ' ' LEU . 87.0 t -49.91 -24.22 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 C-N-CA 126.158 1.783 . . . . 0.0 113.083 178.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.466 ' O ' ' HG ' ' A' ' 75' ' ' LEU . . . -64.44 -57.87 11.88 Favored Glycine 0 CA--C 1.539 1.557 0 CA-C-O 119.911 -0.383 . . . . 0.0 112.379 171.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -75.61 -21.1 58.07 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 123.363 0.665 . . . . 0.0 111.345 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.542 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 51.2 tp -68.71 -42.87 77.11 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.147 1.379 . . . . 0.0 110.16 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -85.84 -5.83 59.18 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.708 176.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 71' ' ' GLY . 54.2 mt -91.9 21.22 5.05 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.155 0.582 . . . . 0.0 111.593 174.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.457 ' HZ2' ' SD ' ' A' ' 52' ' ' MET . 30.8 m0 -64.12 104.64 0.76 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.481 0.312 . . . . 0.0 110.264 171.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 C--O 1.26 1.617 0 C-N-CA 123.715 0.806 . . . . 0.0 109.986 179.101 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.804 0 N-CA-C 112.284 -0.326 . . . . 0.0 112.284 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.7 m -114.56 171.49 7.6 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.814 0.846 . . . . 0.0 110.276 -179.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -70.76 -45.17 65.24 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.011 0.524 . . . . 0.0 110.43 176.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 62.5 mtm 61.55 97.96 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.113 1.365 . . . . 0.0 112.624 173.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -153.75 104.8 2.73 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.876 0.47 . . . . 0.0 110.077 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.8 p-80 -77.73 92.05 4.13 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 169.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.565 ' HB ' ' HG3' ' A' ' 12' ' ' GLN . 34.7 mt -71.04 133.0 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.348 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -73.41 7.63 2.2 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.974 0.909 . . . . 0.0 112.982 -176.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.493 HG22 ' H ' ' A' ' 11' ' ' ALA . 44.0 m -65.34 131.16 45.74 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.187 0.595 . . . . 0.0 110.262 173.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -74.85 -11.17 60.08 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.83 0.852 . . . . 0.0 112.65 -176.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.493 ' H ' HG22 ' A' ' 9' ' ' THR . . . -73.03 -42.37 63.24 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 122.959 0.504 . . . . 0.0 109.899 169.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.565 ' HG3' ' HB ' ' A' ' 7' ' ' ILE . 23.5 mm-40 -55.72 -39.42 71.05 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.33 1.052 . . . . 0.0 112.973 -175.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.1 p -66.03 -41.55 89.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 178.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 64.3 mt -68.91 -29.96 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.35 0.66 . . . . 0.0 110.245 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.468 ' HA ' ' HE2' ' A' ' 18' ' ' LYS . 42.5 mt-10 -76.38 -24.01 54.11 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.832 0.853 . . . . 0.0 111.397 177.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.0 -34.56 78.03 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.222 0.609 . . . . 0.0 110.718 175.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -64.47 -31.57 72.83 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.032 173.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.468 ' HE2' ' HA ' ' A' ' 15' ' ' GLU . 54.3 mtmt -81.06 -12.59 59.29 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.36 0.664 . . . . 0.0 111.906 -178.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.0 t -75.16 -35.18 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 169.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -74.55 -55.75 5.59 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.113 0.565 . . . . 0.0 109.797 175.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -85.54 89.09 7.62 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.872 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 32.2 ttm-85 -85.07 -23.95 28.31 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.953 172.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -64.65 -25.63 68.04 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.542 1.137 . . . . 0.0 111.841 -176.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.89 38.21 23.89 Favored Glycine 0 C--N 1.344 1.015 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 178.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -64.66 -25.24 67.87 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.555 1.142 . . . . 0.0 110.502 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.79 -35.99 4.3 Favored Glycine 0 C--N 1.347 1.162 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.485 ' HB2' ' O ' ' A' ' 64' ' ' VAL . 44.0 p90 -133.15 179.9 5.9 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 124.049 0.939 . . . . 0.0 109.647 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.0 p -134.1 173.88 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.213 0.605 . . . . 0.0 110.152 -172.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 44.5 p -73.39 145.99 45.46 Favored 'General case' 0 C--O 1.245 0.82 0 C-N-CA 123.404 0.682 . . . . 0.0 110.601 171.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.436 HG22 HG23 ' A' ' 53' ' ' ILE . 0.8 OUTLIER -70.47 -20.65 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 122.633 0.373 . . . . 0.0 110.594 -179.315 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -62.62 -53.85 48.38 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.631 0.772 . . . . 0.0 110.639 174.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 93.2 t80 -61.64 -39.64 92.04 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 122.94 0.496 . . . . 0.0 110.686 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.4 HD22 HG11 ' A' ' 64' ' ' VAL . 6.6 tp -53.86 -46.61 71.33 Favored 'General case' 0 CA--C 1.554 1.125 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.442 176.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.429 ' HG3' ' O ' ' A' ' 30' ' ' VAL . 69.4 mtt180 -62.3 -35.84 80.28 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.758 0.823 . . . . 0.0 111.942 -178.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 55.1 mttm -63.27 -60.97 2.7 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 123.679 0.612 . . . . 0.0 110.901 -176.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.4 p -62.25 -34.19 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 123.672 0.789 . . . . 0.0 112.351 -174.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.422 ' HB3' HG21 ' A' ' 49' ' ' ILE . 96.7 mt -77.39 -26.51 51.86 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.752 0.421 . . . . 0.0 111.359 -178.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -79.31 -30.91 43.06 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.795 0.438 . . . . 0.0 110.126 173.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -60.48 -44.98 95.37 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.853 0.861 . . . . 0.0 110.153 174.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.443 ' O ' ' HG2' ' A' ' 44' ' ' MET . 80.2 mt -84.14 3.06 36.61 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.487 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -73.47 -5.03 66.51 Favored Glycine 0 C--N 1.355 1.626 0 C-N-CA 123.635 0.636 . . . . 0.0 113.211 -176.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -72.79 -22.76 60.77 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 122.887 0.475 . . . . 0.0 110.485 170.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 69.3 mtm -114.29 1.0 14.33 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.37 1.068 . . . . 0.0 112.091 -173.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.443 ' HG2' ' O ' ' A' ' 40' ' ' LEU . 20.8 ptp -158.23 154.64 24.34 Favored Pre-proline 0 N--CA 1.488 1.47 0 C-N-CA 122.875 0.47 . . . . 0.0 110.584 -175.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.76 110.17 2.49 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 122.215 1.943 . . . . 0.0 112.377 -178.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.18 -24.32 35.04 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.823 -174.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -68.35 -39.19 81.96 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-O 121.317 0.58 . . . . 0.0 110.768 176.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -68.02 -46.8 70.2 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.096 176.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.422 HG21 ' HB3' ' A' ' 37' ' ' LEU . 81.6 mt -59.43 -44.68 93.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.429 0.692 . . . . 0.0 111.69 178.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -66.86 -32.46 73.75 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 118.169 0.441 . . . . 0.0 110.954 -175.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -63.85 -45.99 87.02 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 120.98 0.419 . . . . 0.0 110.116 172.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 22.9 mmt -60.94 -30.36 70.17 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.833 177.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.436 HG23 HG22 ' A' ' 30' ' ' VAL . 55.9 mt -67.8 -37.94 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.295 1.038 . . . . 0.0 111.491 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -62.84 -34.85 78.21 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 122.787 0.435 . . . . 0.0 110.623 173.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -76.33 -30.92 57.86 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.244 0.618 . . . . 0.0 110.603 177.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.425 ' HB1' HG23 ' A' ' 64' ' ' VAL . . . -70.65 -24.49 62.72 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.206 1.003 . . . . 0.0 111.745 -179.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -129.37 81.5 70.01 Favored Pre-proline 0 CA--C 1.547 0.852 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 171.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -79.3 -8.33 15.12 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 123.065 2.51 . . . . 0.0 112.451 -178.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -82.65 -21.72 34.91 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.65 0.78 . . . . 0.0 110.862 176.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.1 m120 59.12 32.92 22.55 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.472 1.109 . . . . 0.0 110.825 -175.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.7 m -97.21 -17.52 19.81 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.342 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.407 ' HA2' HG12 ' A' ' 30' ' ' VAL . . . 92.5 41.51 4.77 Favored Glycine 0 C--N 1.339 0.712 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.611 177.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -137.86 138.63 39.3 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.039 0.536 . . . . 0.0 111.143 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.485 ' O ' ' HB2' ' A' ' 27' ' ' TYR . 5.9 p -147.5 137.59 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.763 0.825 . . . . 0.0 110.363 -174.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -84.08 87.91 7.16 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 170.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -58.91 -35.19 72.66 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 114.613 -1.176 . . . . 0.0 113.373 -171.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -65.05 -39.51 93.42 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.772 0.429 . . . . 0.0 110.909 -169.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.455 ' O ' ' HG2' ' A' ' 72' ' ' MET . 11.2 t -83.28 -33.02 26.07 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.432 177.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -71.44 -56.38 6.06 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.407 0.623 . . . . 0.0 111.507 -177.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 99.6 t -65.67 -25.4 36.48 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.07 0 C-N-CA 124.393 1.077 . . . . 0.0 109.754 172.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -71.99 2.03 28.61 Favored Glycine 0 CA--C 1.543 1.828 0 CA-C-N 115.253 -0.885 . . . . 0.0 113.825 168.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.455 ' HG2' ' O ' ' A' ' 68' ' ' THR . 25.1 mmt -107.85 -45.39 4.01 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.775 0.83 . . . . 0.0 109.673 168.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 88.3 mt -58.24 -49.8 75.83 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.816 0.846 . . . . 0.0 112.142 -174.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -84.47 -11.91 55.29 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.161 -177.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -104.35 27.76 7.52 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.821 0.849 . . . . 0.0 110.701 178.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 32.6 m0 -67.08 -178.55 0.8 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.116 0.567 . . . . 0.0 110.99 171.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 . . . . . 0 CA--C 1.564 1.519 0 C-N-CA 123.72 0.808 . . . . 0.0 111.722 -175.007 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.572 0 N-CA-C 112.177 -0.369 . . . . 0.0 112.177 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.7 t -81.73 80.18 8.11 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.448 0.699 . . . . 0.0 110.295 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -150.39 28.34 0.73 Allowed 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.499 1.12 . . . . 0.0 110.069 175.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 68.9 mtm -66.18 -27.46 68.02 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.318 0.647 . . . . 0.0 112.095 -175.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 63.88 17.43 10.53 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.482 1.113 . . . . 0.0 112.834 167.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -72.61 82.19 1.12 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.138 0.575 . . . . 0.0 110.318 176.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.4 tt -124.46 115.92 46.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.366 1.066 . . . . 0.0 108.592 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -86.73 107.51 18.27 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.458 0.703 . . . . 0.0 109.352 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.7 t -163.44 158.95 21.67 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.52 0.676 . . . . 0.0 111.337 175.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -68.17 -17.42 64.34 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.759 1.224 . . . . 0.0 112.172 177.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.43 ' O ' ' HG2' ' A' ' 15' ' ' GLU . . . -63.04 -38.95 93.25 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 122.516 0.327 . . . . 0.0 110.186 172.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -71.03 -33.02 69.93 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.339 0.655 . . . . 0.0 112.369 -175.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.5 p -71.87 -36.64 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 176.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.438 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 75.1 mt -65.47 -33.42 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 174.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 23.5 mm-40 -62.01 -33.46 74.38 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.17 0.588 . . . . 0.0 111.491 174.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.25 -42.17 99.15 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 121.116 0.484 . . . . 0.0 110.195 174.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -69.37 -25.81 64.36 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.017 175.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.438 ' HG2' ' O ' ' A' ' 14' ' ' ILE . 73.7 mmtt -73.4 -28.16 61.85 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.202 0.601 . . . . 0.0 111.18 177.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 15' ' ' GLU . 87.9 t -72.24 -40.94 66.2 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 C-N-CA 123.153 0.581 . . . . 0.0 110.167 176.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -73.12 -40.72 64.71 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.592 0.357 . . . . 0.0 110.375 176.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -97.25 45.64 1.04 Allowed 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.977 0.894 . . . . 0.0 108.846 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -63.09 -25.4 68.35 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.397 1.079 . . . . 0.0 110.965 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -72.19 -28.33 63.13 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.629 0.772 . . . . 0.0 111.088 177.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.08 58.56 2.94 Favored Glycine 0 C--N 1.344 0.987 0 CA-C-N 115.955 -0.566 . . . . 0.0 113.312 176.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -78.07 -17.32 57.15 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.33 0.652 . . . . 0.0 110.218 170.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.13 -18.57 56.92 Favored Glycine 0 C--N 1.354 1.53 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.961 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -150.55 166.11 31.23 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.272 1.029 . . . . 0.0 109.867 -174.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.405 HG13 ' CD2' ' A' ' 66' ' ' TYR . 23.4 m -116.36 177.94 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.609 0.764 . . . . 0.0 110.445 176.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 67.7 p -84.72 157.57 21.03 Favored 'General case' 0 C--O 1.246 0.876 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.516 170.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.9 p -67.09 -17.22 22.37 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 123.201 0.601 . . . . 0.0 111.547 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -63.63 -63.17 1.25 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.325 0.65 . . . . 0.0 111.04 177.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -60.6 -38.4 84.54 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.908 0.483 . . . . 0.0 110.504 178.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.531 HD22 HG11 ' A' ' 64' ' ' VAL . 6.3 tp -54.64 -58.75 6.27 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.82 -178.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 73.9 mtt180 -61.54 -33.41 73.79 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.045 0.538 . . . . 0.0 111.354 178.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -66.19 -46.33 77.69 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.755 0.822 . . . . 0.0 111.664 -174.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.4 p -76.65 -34.81 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 122.959 0.504 . . . . 0.0 110.86 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.471 HD23 HD12 ' A' ' 40' ' ' LEU . 84.6 mt -78.68 -5.88 54.26 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.03 0.532 . . . . 0.0 111.376 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 32.2 t-20 -72.26 -45.37 60.44 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.373 0.669 . . . . 0.0 109.77 178.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -71.38 -40.79 70.34 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.226 176.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.471 HD12 HD23 ' A' ' 37' ' ' LEU . 75.9 mt -67.57 -26.61 66.38 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.74 0.816 . . . . 0.0 110.549 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -89.62 63.17 3.31 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.062 171.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -81.72 -72.62 0.42 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.617 0.767 . . . . 0.0 109.701 178.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 20.6 ptp -85.85 -22.76 27.41 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.973 0.509 . . . . 0.0 110.367 175.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 25.3 mmt -81.8 112.41 34.49 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 172.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.06 130.64 37.39 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 122.113 1.875 . . . . 0.0 111.837 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.469 ' O ' ' HG2' ' A' ' 50' ' ' GLU . . . -63.05 -21.79 66.41 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.454 0.701 . . . . 0.0 110.527 174.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -52.67 -40.46 62.91 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.602 1.561 . . . . 0.0 111.887 173.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -65.12 -46.4 81.18 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.444 0.698 . . . . 0.0 110.114 175.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 66.8 mt -63.06 -32.07 54.9 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.416 -177.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 14.5 mm-40 -62.88 -44.15 96.89 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.99 0.516 . . . . 0.0 110.713 177.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -61.0 -42.66 98.88 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 121.414 0.626 . . . . 0.0 110.29 177.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.525 ' HB3' ' HE1' ' A' ' 69' ' ' PHE . 79.9 mmm -63.3 -34.21 77.18 Favored 'General case' 0 CA--C 1.558 1.273 0 CA-C-N 114.31 -1.314 . . . . 0.0 110.735 176.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 60.2 mt -69.35 -34.51 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 C-N-CA 124.469 1.108 . . . . 0.0 110.952 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 4.3 m-30 -64.62 -26.54 68.44 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.163 0.585 . . . . 0.0 110.251 176.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -93.45 -20.45 20.29 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.567 0.747 . . . . 0.0 111.117 178.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.522 ' HB1' HG23 ' A' ' 64' ' ' VAL . . . -77.27 -53.43 7.72 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.376 0.67 . . . . 0.0 110.229 177.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -116.14 95.75 45.58 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 124.801 1.241 . . . . 0.0 108.384 174.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -85.75 -1.61 8.9 Favored 'Trans proline' 0 C--N 1.368 1.553 0 C-N-CA 122.719 2.279 . . . . 0.0 112.028 170.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -92.06 -6.74 50.46 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.153 0.981 . . . . 0.0 112.042 -169.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 59.68 28.61 18.08 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.485 1.114 . . . . 0.0 110.847 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.3 m -105.28 -15.01 15.17 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.27 1.028 . . . . 0.0 110.571 -176.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.57 9.11 87.07 Favored Glycine 0 C--N 1.346 1.137 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.943 -175.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 22.2 m-30 -86.6 97.42 10.53 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.307 0.643 . . . . 0.0 109.519 -176.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.531 HG11 HD22 ' A' ' 33' ' ' LEU . 2.4 p -113.32 118.46 58.18 Favored 'Isoleucine or valine' 0 C--O 1.245 0.825 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.481 -175.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -73.58 86.59 1.61 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.225 175.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.405 ' CD2' HG13 ' A' ' 28' ' ' VAL . 35.4 p90 -53.62 -33.44 55.05 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -175.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -67.97 -36.47 80.11 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 120.755 0.312 . . . . 0.0 110.616 -170.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.0 p -82.32 -48.14 11.54 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.795 0.838 . . . . 0.0 110.19 174.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.525 ' HE1' ' HB3' ' A' ' 52' ' ' MET . 46.8 t80 -66.14 -54.05 30.17 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.246 1.018 . . . . 0.0 113.37 -170.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 56.3 t -68.31 -21.08 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 122.85 0.46 . . . . 0.0 109.831 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -62.18 -44.94 97.02 Favored Glycine 0 CA--C 1.538 1.473 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.147 164.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 65.0 mtt -66.09 -29.08 69.34 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 124.224 1.01 . . . . 0.0 112.041 178.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.4 mt -74.08 -43.03 59.2 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 121.374 0.606 . . . . 0.0 110.57 175.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -95.78 34.98 1.43 Allowed 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.647 -173.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.8 pp -125.6 10.09 7.8 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 122.701 0.4 . . . . 0.0 111.296 168.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 54.4 m0 -66.05 166.75 11.05 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.252 0.621 . . . . 0.0 111.899 -176.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.7 t70 . . . . . 0 C--O 1.248 1.014 0 C-N-CA 123.532 0.733 . . . . 0.0 109.361 -176.72 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.799 0 N-CA-C 112.245 -0.342 . . . . 0.0 112.245 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 64.8 p -153.92 138.87 17.22 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.427 0.691 . . . . 0.0 109.859 176.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 52.4 m-70 -100.59 97.97 8.6 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.555 0.742 . . . . 0.0 109.727 -176.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 93.4 mmm -75.7 89.14 2.8 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 174.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -134.0 128.0 33.48 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.574 0.75 . . . . 0.0 109.152 -175.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -85.61 108.14 17.85 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.805 0.842 . . . . 0.0 109.326 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.6 tt -123.83 125.56 71.3 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.132 0 C-N-CA 124.12 0.968 . . . . 0.0 111.068 -173.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -86.07 97.82 10.51 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.658 0.783 . . . . 0.0 109.064 171.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.3 t -145.72 163.71 34.08 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.208 0.528 . . . . 0.0 110.718 176.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.601 ' H ' ' HD2' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -91.03 -24.66 19.99 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.931 174.49 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.476 ' O ' ' HG2' ' A' ' 15' ' ' GLU . . . -52.98 -42.08 65.2 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.456 0.702 . . . . 0.0 111.656 -178.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -61.06 -46.86 88.98 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.736 0.815 . . . . 0.0 112.199 -176.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.3 p -74.8 -31.39 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 122.722 0.409 . . . . 0.0 110.562 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.5 HG23 ' HE1' ' A' ' 66' ' ' TYR . 61.6 mt -65.11 -34.24 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.737 0.815 . . . . 0.0 110.811 178.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 19.1 mm-40 -69.37 -32.99 72.39 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.637 174.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.38 -37.25 82.7 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 122.938 0.495 . . . . 0.0 111.072 177.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -62.56 -41.23 98.78 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.972 173.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.465 ' HE3' HG22 ' A' ' 14' ' ' ILE . 92.9 mttt -71.46 -27.61 63.38 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.025 0.53 . . . . 0.0 111.508 -178.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 15' ' ' GLU . 92.3 t -69.97 -33.44 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.494 0.718 . . . . 0.0 109.963 174.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -74.61 -43.74 54.07 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.443 174.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -72.27 104.94 3.85 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -176.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -94.79 -15.36 23.86 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.52 0.728 . . . . 0.0 112.234 -178.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.406 ' HB2' ' ND2' ' A' ' 25' ' ' ASN . 20.8 m-20 -92.43 -26.35 18.05 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 120.87 0.367 . . . . 0.0 111.069 -176.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.66 42.78 12.95 Favored Glycine 0 C--N 1.338 0.649 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.865 -171.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.406 ' ND2' ' HB2' ' A' ' 23' ' ' ASP . 48.5 m-80 -65.94 -23.86 66.69 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.613 0.765 . . . . 0.0 111.11 178.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.05 -32.82 6.47 Favored Glycine 0 C--N 1.347 1.17 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 -178.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.424 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 45.2 p90 -133.62 160.69 36.75 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.406 1.082 . . . . 0.0 109.636 175.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 55.0 t -110.5 161.14 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.178 0.991 . . . . 0.0 110.41 -174.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 63' ' ' TYR . 73.1 p -56.15 151.6 12.08 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 124.191 0.996 . . . . 0.0 111.982 172.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.8 p -67.21 -20.71 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.409 174.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -58.97 -62.19 2.07 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.74 1.216 . . . . 0.0 111.635 176.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -65.37 -30.11 70.9 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.973 0.509 . . . . 0.0 111.012 -178.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.692 HD22 HG11 ' A' ' 64' ' ' VAL . 6.5 tp -54.75 -50.92 67.24 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 123.717 0.635 . . . . 0.0 109.977 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.546 ' HG2' HD13 ' A' ' 53' ' ' ILE . 37.1 mtm180 -61.67 -37.96 86.02 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.862 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -65.7 -53.04 46.38 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.415 0.686 . . . . 0.0 112.179 -175.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.06 -26.88 35.47 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.957 -176.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 87.3 mt -86.81 -16.07 37.31 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.322 0.649 . . . . 0.0 111.779 178.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -74.79 -43.01 57.03 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.188 0.595 . . . . 0.0 110.124 175.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -72.75 -32.63 65.8 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 122.94 0.496 . . . . 0.0 110.794 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.424 HD13 ' HZ ' ' A' ' 74' ' ' PHE . 95.6 mt -78.46 -21.36 49.2 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.257 0.623 . . . . 0.0 110.514 174.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.73 ' HA2' ' HB2' ' A' ' 44' ' ' MET . . . -83.34 46.71 3.69 Favored Glycine 0 C--N 1.349 1.263 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 169.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -79.56 -55.16 5.23 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.886 0.874 . . . . 0.0 109.123 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 64.1 mtt -105.33 11.7 32.52 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.734 174.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.73 ' HB2' ' HA2' ' A' ' 41' ' ' GLY . 55.9 mtt -113.15 150.98 43.84 Favored Pre-proline 0 N--CA 1.48 1.068 0 C-N-CA 124.464 1.106 . . . . 0.0 108.579 176.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -68.7 115.39 3.91 Favored 'Trans proline' 0 C--N 1.374 1.886 0 C-N-CA 122.438 2.092 . . . . 0.0 110.926 172.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.44 -37.66 77.46 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.577 0.751 . . . . 0.0 110.824 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -63.46 -32.85 74.41 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.853 0.861 . . . . 0.0 111.644 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.473 ' O ' ' HG3' ' A' ' 52' ' ' MET . 40.3 tt0 -60.24 -39.4 86.56 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.625 1.17 . . . . 0.0 110.375 176.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 63.6 mt -77.89 -41.04 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.273 177.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -54.76 -46.0 74.27 Favored 'General case' 0 C--N 1.354 0.802 0 O-C-N 124.074 0.859 . . . . 0.0 111.091 -177.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -60.99 -37.37 82.24 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-O 120.66 0.267 . . . . 0.0 111.145 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.473 ' HG3' ' O ' ' A' ' 48' ' ' GLU . 43.0 mtm -72.73 -29.76 63.62 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.254 0.622 . . . . 0.0 110.653 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.546 HD13 ' HG2' ' A' ' 34' ' ' ARG . 77.1 mt -71.74 -33.87 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 124.136 0.975 . . . . 0.0 110.006 175.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -77.71 -10.6 59.61 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.02 0.928 . . . . 0.0 110.61 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -94.17 -27.61 16.11 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.316 1.047 . . . . 0.0 110.376 168.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.49 -30.74 59.97 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.55 0.74 . . . . 0.0 111.547 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -148.64 81.25 7.9 Favored Pre-proline 0 N--CA 1.478 0.961 0 C-N-CA 123.091 0.556 . . . . 0.0 109.836 172.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -83.32 -11.71 9.49 Favored 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.928 2.419 . . . . 0.0 113.132 172.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 20.7 tm0? -78.22 -23.35 47.5 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.671 0.789 . . . . 0.0 110.27 -174.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.3 t30 67.19 53.06 0.8 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.984 1.314 . . . . 0.0 108.926 -172.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.5 m -79.77 -24.36 41.56 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.742 173.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.91 23.9 63.06 Favored Glycine 0 C--N 1.346 1.113 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.995 -174.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 29' ' ' THR . 72.9 m-85 -144.44 159.84 42.07 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.768 0.827 . . . . 0.0 111.438 -174.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.692 HG11 HD22 ' A' ' 33' ' ' LEU . 5.4 p -167.58 143.93 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.379 1.072 . . . . 0.0 109.406 175.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -82.2 104.99 12.93 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 172.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.5 ' HE1' HG23 ' A' ' 14' ' ' ILE . 53.2 p90 -64.48 -32.27 73.83 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.999 0.52 . . . . 0.0 111.013 178.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -55.06 -42.03 72.23 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.818 0.847 . . . . 0.0 110.87 174.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 19.1 m -76.83 -53.46 7.88 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.576 179.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -69.39 -54.33 14.95 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.109 -169.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.59 ' HA ' ' HB3' ' A' ' 73' ' ' LEU . 57.8 t -62.72 -19.09 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.372 0 C-N-CA 123.288 0.635 . . . . 0.0 111.283 177.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -71.29 -35.26 63.77 Favored Glycine 0 C--N 1.351 1.388 0 CA-C-N 116.435 -0.348 . . . . 0.0 113.39 172.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 28.3 ptm -98.24 -3.99 36.24 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.543 0.737 . . . . 0.0 111.527 177.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.59 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 9.8 tp -97.61 -53.02 3.56 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.448 1.099 . . . . 0.0 110.576 -178.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.472 ' HB3' ' HE3' ' A' ' 10' ' ' LYS . 3.4 m-85 -83.81 27.87 0.61 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.688 0.795 . . . . 0.0 112.893 -174.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.7 pp -77.86 -0.09 25.99 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.956 0.503 . . . . 0.0 111.127 169.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 49.5 m0 -65.16 107.77 1.67 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.874 1.269 . . . . 0.0 110.816 177.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.7 t70 . . . . . 0 C--O 1.247 0.938 0 C-N-CA 124.981 1.313 . . . . 0.0 107.791 -179.947 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.289 0 N-CA-C 112.221 -0.351 . . . . 0.0 112.221 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.1 p -81.2 -5.14 57.4 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.541 0.737 . . . . 0.0 111.766 177.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.0 m80 -62.32 121.63 13.66 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.589 0.756 . . . . 0.0 110.799 174.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 59.3 mtt -120.16 123.11 42.51 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.517 1.127 . . . . 0.0 108.147 178.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -86.77 63.91 8.22 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 122.261 1.029 . . . . 0.0 109.62 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 60.1 m80 -129.68 -24.7 2.69 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.96 173.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.9 tp -69.79 102.36 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 169.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -99.1 73.0 1.9 Allowed 'General case' 0 C--O 1.242 0.671 0 CA-C-N 115.418 -0.81 . . . . 0.0 108.967 -175.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.453 ' HB ' ' HG3' ' A' ' 12' ' ' GLN . 26.4 m -90.4 126.33 35.85 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.182 172.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -70.39 -11.84 61.18 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.15 0.58 . . . . 0.0 111.774 -177.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.463 ' O ' ' HG2' ' A' ' 15' ' ' GLU . . . -75.82 -39.79 56.11 Favored 'General case' 0 C--O 1.216 -0.705 0 C-N-CA 123.117 0.567 . . . . 0.0 110.738 171.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.453 ' HG3' ' HB ' ' A' ' 9' ' ' THR . 56.8 mt-30 -58.5 -38.58 77.95 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 123.272 0.629 . . . . 0.0 112.588 -174.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.3 p -65.9 -40.14 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 175.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.432 HG22 ' HE3' ' A' ' 18' ' ' LYS . 64.3 mt -64.77 -31.82 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 123.393 0.677 . . . . 0.0 110.423 176.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 10.4 mm-40 -71.4 -27.73 63.52 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.082 0.553 . . . . 0.0 110.983 178.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.9 -35.63 81.76 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 122.919 0.488 . . . . 0.0 110.996 177.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.515 ' CZ ' HD12 ' A' ' 33' ' ' LEU . 95.7 m-85 -64.03 -35.65 81.43 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.482 0.713 . . . . 0.0 110.951 174.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.432 ' HE3' HG22 ' A' ' 14' ' ' ILE . 90.9 mttt -77.19 -29.67 54.45 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.0 -177.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 74.1 t -69.33 -37.76 76.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 123.452 0.701 . . . . 0.0 109.769 172.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -71.48 -46.95 58.48 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.718 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -83.76 81.05 8.93 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.878 0.847 . . . . 0.0 109.014 -177.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 29.6 mtm180 -86.04 -18.42 32.52 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 113.947 -1.478 . . . . 0.0 110.076 177.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -80.01 -25.86 40.06 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.766 0.826 . . . . 0.0 111.568 -175.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.27 52.53 3.97 Favored Glycine 0 C--N 1.341 0.837 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.637 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.448 ' N ' HD22 ' A' ' 25' ' ' ASN . 0.8 OUTLIER -80.76 -19.17 45.48 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.24 1.016 . . . . 0.0 109.827 173.475 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.82 -56.17 3.74 Favored Glycine 0 C--N 1.347 1.175 0 N-CA-C 111.164 -0.775 . . . . 0.0 111.164 -175.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -118.97 156.91 28.75 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.326 1.05 . . . . 0.0 110.194 178.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.5 t -110.56 157.25 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 123.636 0.775 . . . . 0.0 109.503 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 68.7 p -65.28 166.5 9.83 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.107 0.963 . . . . 0.0 112.345 178.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.656 HG23 HG21 ' A' ' 53' ' ' ILE . 7.2 p -63.42 -33.48 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.332 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -64.09 -49.19 73.24 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.311 0.244 . . . . 0.0 111.627 -172.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -67.59 -36.88 81.72 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.488 176.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.592 HD22 HG11 ' A' ' 64' ' ' VAL . 12.1 tp -56.1 -43.88 78.51 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.665 0.603 . . . . 0.0 110.687 177.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 34.8 mtm105 -72.26 -34.67 68.41 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.097 0.559 . . . . 0.0 110.411 177.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -63.05 -50.7 69.6 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.651 0.78 . . . . 0.0 111.899 -174.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.3 p -64.82 -33.48 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 122.889 0.475 . . . . 0.0 110.83 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.419 HD13 HG21 ' A' ' 49' ' ' ILE . 80.5 mt -85.51 -8.51 58.29 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 123.766 0.827 . . . . 0.0 111.367 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -87.09 -36.2 18.27 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.1 1.36 . . . . 0.0 108.934 171.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -69.21 -35.17 75.92 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.848 0.859 . . . . 0.0 109.635 173.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 93.2 mt -89.23 15.52 8.8 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.762 0.825 . . . . 0.0 110.491 169.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 44' ' ' MET . . . -74.92 -10.05 83.69 Favored Glycine 0 C--N 1.353 1.515 0 C-N-CA 123.851 0.739 . . . . 0.0 113.626 -173.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -68.13 -32.77 73.28 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.324 0.649 . . . . 0.0 110.342 174.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 93.6 mmm -107.46 -31.1 8.29 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.62 0.768 . . . . 0.0 111.699 178.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.618 ' HB3' HD11 ' A' ' 49' ' ' ILE . 24.9 mmt -113.21 104.92 55.72 Favored Pre-proline 0 N--CA 1.479 1.002 0 C-N-CA 123.539 0.735 . . . . 0.0 109.778 -173.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.42 117.93 4.73 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.69 2.26 . . . . 0.0 111.866 -178.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.92 -47.71 85.16 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.766 0.826 . . . . 0.0 111.572 -176.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -53.93 -40.66 66.93 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 123.798 0.839 . . . . 0.0 111.723 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -62.47 -52.17 64.58 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.216 178.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.618 HD11 ' HB3' ' A' ' 44' ' ' MET . 79.1 mt -62.75 -40.32 88.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.859 -178.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.513 ' HA ' HD12 ' A' ' 53' ' ' ILE . 51.2 mt-10 -63.17 -34.05 76.79 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.139 0.576 . . . . 0.0 111.06 -175.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -67.78 -36.3 80.22 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 121.146 0.498 . . . . 0.0 110.379 175.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 20.0 mmt -67.14 -29.7 69.49 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.587 0.755 . . . . 0.0 110.807 177.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.656 HG21 HG23 ' A' ' 30' ' ' VAL . 50.2 mt -71.39 -31.1 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 123.118 0.567 . . . . 0.0 110.754 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -64.35 -28.95 70.05 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 122.898 0.479 . . . . 0.0 110.711 175.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -78.91 -37.51 39.75 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.032 0.533 . . . . 0.0 110.466 174.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.02 -25.6 61.02 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.9 0.88 . . . . 0.0 112.183 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -140.47 81.8 17.06 Favored Pre-proline 0 CA--C 1.548 0.889 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 175.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -65.58 -14.44 44.83 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 123.462 2.775 . . . . 0.0 112.788 175.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -69.2 -26.05 64.64 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.408 0.683 . . . . 0.0 110.911 176.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.1 t30 59.15 24.1 12.43 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.482 1.113 . . . . 0.0 110.824 -178.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.8 m -83.6 -16.46 45.17 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.791 0.836 . . . . 0.0 110.682 -178.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.86 29.84 22.34 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-N 115.589 -0.732 . . . . 0.0 113.28 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -126.82 107.75 10.4 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.872 0.869 . . . . 0.0 109.135 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.592 HG11 HD22 ' A' ' 33' ' ' LEU . 3.3 p -136.01 135.8 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 123.162 0.585 . . . . 0.0 110.89 -173.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -76.13 98.38 4.36 Favored 'General case' 0 C--N 1.35 0.609 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 174.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -55.08 -34.43 63.62 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.238 1.015 . . . . 0.0 112.809 -178.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -58.05 -57.01 14.7 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.522 0.729 . . . . 0.0 110.162 -176.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.2 p -68.76 -39.87 80.03 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.389 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -67.4 -67.27 0.47 Allowed 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 119.21 -0.424 . . . . 0.0 111.974 -177.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.616 ' HA ' ' HB3' ' A' ' 73' ' ' LEU . 57.6 t -52.4 -26.06 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 C-N-CA 124.808 1.243 . . . . 0.0 112.232 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.96 -54.58 29.72 Favored Glycine 0 CA--C 1.541 1.67 0 N-CA-C 112.469 -0.252 . . . . 0.0 112.469 168.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 64.0 mtm -73.59 -12.1 60.64 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.705 0.802 . . . . 0.0 112.236 178.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.616 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 52.3 tp -86.49 -41.57 14.27 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.375 1.07 . . . . 0.0 110.094 -178.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.414 ' HA ' ' CD1' ' A' ' 76' ' ' TRP . 8.2 m-85 -89.74 34.26 0.84 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.379 0.672 . . . . 0.0 111.699 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 92.2 mt -77.42 -15.33 59.4 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.849 0.46 . . . . 0.0 110.877 170.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.414 ' CD1' ' HA ' ' A' ' 74' ' ' PHE . 0.3 OUTLIER -82.6 2.27 34.11 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 124.286 1.035 . . . . 0.0 112.176 174.147 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.0 t70 . . . . . 0 C--O 1.251 1.168 0 C-N-CA 123.835 0.854 . . . . 0.0 111.06 -179.503 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.71 0 CA-C-O 120.073 -0.293 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.8 p -70.36 92.44 0.8 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.058 0.943 . . . . 0.0 111.649 -178.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -85.19 -43.09 14.12 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 170.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -93.34 106.33 18.3 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 170.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 33.2 p-10 -108.67 12.97 25.47 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.023 0.929 . . . . 0.0 110.822 -177.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 -67.86 -18.15 64.72 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.409 1.084 . . . . 0.0 111.594 -177.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.0 tt -74.35 103.16 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.142 0 CA-C-O 121.567 0.699 . . . . 0.0 110.502 176.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -102.59 98.77 8.78 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.389 1.076 . . . . 0.0 109.044 175.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.1 m -150.12 148.41 28.94 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.731 0.812 . . . . 0.0 109.998 -177.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.447 ' O ' HG12 ' A' ' 14' ' ' ILE . 0.0 OUTLIER -62.34 -20.17 64.09 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 175.243 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.503 ' O ' ' HG2' ' A' ' 15' ' ' GLU . . . -54.95 -48.94 72.54 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.406 0.683 . . . . 0.0 110.381 175.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -63.25 -38.45 91.2 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.982 0.913 . . . . 0.0 112.753 -171.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.5 p -69.01 -41.0 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 177.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.467 HG22 ' HE3' ' A' ' 18' ' ' LYS . 48.1 mm -63.35 -37.84 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 123.37 0.668 . . . . 0.0 110.958 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.503 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 20.3 mm-40 -73.07 -28.53 62.36 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.014 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.76 -35.3 80.14 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.288 0.635 . . . . 0.0 110.985 177.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -61.94 -41.88 98.47 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.025 173.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.467 ' HE3' HG22 ' A' ' 14' ' ' ILE . 96.5 mttt -68.03 -27.55 66.64 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.444 0.698 . . . . 0.0 112.072 -173.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.2 t -71.26 -39.85 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.129 0.572 . . . . 0.0 109.851 175.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -71.17 -40.35 71.34 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.756 177.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.428 ' HB2' HG22 ' A' ' 28' ' ' VAL . 27.7 t0 -85.28 70.79 10.88 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 122.12 0.962 . . . . 0.0 108.993 -179.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -67.45 -29.35 68.78 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 113.834 -1.53 . . . . 0.0 109.681 176.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -69.84 -25.99 64.0 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.673 -178.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.16 41.45 47.03 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.55 173.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -68.56 -20.36 64.53 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.502 0.721 . . . . 0.0 111.312 176.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.37 -26.17 25.51 Favored Glycine 0 C--N 1.348 1.24 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.686 -177.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -136.04 166.89 22.32 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.161 0.984 . . . . 0.0 109.557 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.428 HG22 ' HB2' ' A' ' 21' ' ' ASP . 81.3 t -118.79 153.45 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.046 0.938 . . . . 0.0 109.233 176.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.8 p -60.93 155.95 18.68 Favored 'General case' 0 C--O 1.248 0.983 0 C-N-CA 123.551 0.74 . . . . 0.0 111.247 173.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.407 ' O ' ' HG3' ' A' ' 34' ' ' ARG . 9.7 p -62.82 -24.09 34.77 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-N 116.167 -0.47 . . . . 0.0 112.196 -175.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -60.33 -60.1 4.35 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.195 0.598 . . . . 0.0 111.851 -176.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -63.74 -32.67 74.23 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.069 0.548 . . . . 0.0 110.479 178.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.423 HD13 HG13 ' A' ' 64' ' ' VAL . 4.4 tt -61.37 -44.48 97.1 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.879 0.872 . . . . 0.0 111.551 179.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.407 ' HG3' ' O ' ' A' ' 30' ' ' VAL . 50.7 mtm180 -68.21 -38.99 82.51 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.941 0.496 . . . . 0.0 109.915 177.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -61.55 -47.14 86.91 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 124.165 0.916 . . . . 0.0 111.35 -177.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.4 p -73.43 -25.5 21.22 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.699 -176.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.633 HD11 HG22 ' A' ' 70' ' ' VAL . 96.6 mt -86.9 -15.19 39.74 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.821 0.448 . . . . 0.0 111.311 175.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -88.36 -30.95 19.15 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 176.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -78.15 -24.34 47.36 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 110.513 -0.18 . . . . 0.0 110.513 176.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 60.3 mt -95.81 12.22 30.85 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.595 0.758 . . . . 0.0 109.791 169.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.468 ' HA2' ' SD ' ' A' ' 44' ' ' MET . . . -144.84 55.83 0.55 Allowed Glycine 0 C--N 1.349 1.26 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 -175.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -68.69 -64.88 0.78 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.495 0.718 . . . . 0.0 110.359 -177.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.87 -4.34 43.81 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.75 177.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.468 ' SD ' ' HA2' ' A' ' 41' ' ' GLY . 1.2 mpt? -74.74 133.55 76.39 Favored Pre-proline 0 CA--C 1.546 0.801 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 172.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -65.54 114.99 3.12 Favored 'Trans proline' 0 C--N 1.37 1.69 0 C-N-CA 122.023 1.815 . . . . 0.0 110.438 173.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.85 -13.24 59.54 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.015 0.526 . . . . 0.0 111.343 177.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.42 ' O ' ' HG2' ' A' ' 51' ' ' GLU . 1.7 m-20 -53.59 -45.78 70.12 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.561 1.144 . . . . 0.0 111.925 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -59.88 -40.95 90.42 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.133 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 84.2 mt -67.89 -35.7 73.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 124.023 0.929 . . . . 0.0 110.274 178.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -66.09 -40.35 90.73 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.594 0.758 . . . . 0.0 110.769 177.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 47' ' ' ASP . 16.3 mm-40 -65.55 -33.48 76.01 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.249 0.62 . . . . 0.0 110.966 177.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.407 ' HB3' ' HE1' ' A' ' 69' ' ' PHE . 21.3 mmt -68.4 -37.45 80.37 Favored 'General case' 0 CA--C 1.55 0.96 0 O-C-N 123.939 0.774 . . . . 0.0 110.117 174.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 70.4 mt -62.05 -38.39 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 124.243 1.017 . . . . 0.0 111.676 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -57.71 -32.0 66.97 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.086 0.554 . . . . 0.0 111.649 178.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -87.8 -38.71 15.49 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.799 0.84 . . . . 0.0 110.591 178.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.66 -20.98 60.41 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.08 0.952 . . . . 0.0 111.917 -175.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -138.95 83.67 18.17 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 174.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -77.76 -13.84 15.95 Favored 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 122.958 2.438 . . . . 0.0 112.276 -177.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.487 ' HG3' ' H ' ' A' ' 61' ' ' SER . 27.3 pt20 -79.16 -16.16 57.04 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.491 1.116 . . . . 0.0 112.081 -178.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.3 t30 63.29 18.6 11.12 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 124.708 1.203 . . . . 0.0 111.254 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.487 ' H ' ' HG3' ' A' ' 59' ' ' GLN . 19.4 m -92.67 -25.92 18.04 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.51 0.724 . . . . 0.0 110.152 -175.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.25 41.84 6.07 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 115.763 -0.653 . . . . 0.0 113.325 175.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -124.36 94.58 4.25 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.258 1.023 . . . . 0.0 108.601 175.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.423 HG13 HD13 ' A' ' 33' ' ' LEU . 3.9 p -126.9 134.27 66.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 124.01 0.924 . . . . 0.0 110.257 -170.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -76.79 108.06 9.55 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.891 0.877 . . . . 0.0 109.82 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -65.77 -38.01 87.87 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -170.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -71.02 -32.87 69.75 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 118.3 0.5 . . . . 0.0 110.126 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 31.3 m -72.19 -30.56 65.07 Favored 'General case' 0 CA--C 1.553 1.079 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.882 174.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.42 ' CE2' HD21 ' A' ' 33' ' ' LEU . 45.8 t80 -93.22 -72.1 0.62 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.083 0.553 . . . . 0.0 111.726 -176.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.633 HG22 HD11 ' A' ' 37' ' ' LEU . 57.6 t -59.49 -36.21 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.819 1.248 . . . . 0.0 111.346 -177.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -59.47 -37.42 92.07 Favored Glycine 0 C--N 1.348 1.219 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.934 174.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 94.2 mmm -81.59 -37.02 28.3 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.432 0.693 . . . . 0.0 112.26 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 pp -75.65 -24.66 56.41 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 118.303 0.501 . . . . 0.0 110.286 -175.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.423 ' CD2' ' HB3' ' A' ' 10' ' ' LYS . 6.1 m-85 -74.76 -8.05 55.23 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.573 0.349 . . . . 0.0 111.547 172.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 60.5 mt -89.05 9.25 25.98 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.995 0.518 . . . . 0.0 111.963 175.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 43.7 m0 -64.13 85.83 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 121.227 0.537 . . . . 0.0 109.986 174.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.5 t70 . . . . . 0 C--O 1.25 1.115 0 C-N-CA 125.367 1.467 . . . . 0.0 108.278 -170.458 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.271 0 N-CA-C 111.816 -0.514 . . . . 0.0 111.816 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.4 t -147.28 93.26 2.22 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.7 0.8 . . . . 0.0 109.071 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -79.87 80.17 6.3 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 176.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 17.0 tmm? -164.66 133.38 3.51 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -146.88 87.95 1.72 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.435 0.636 . . . . 0.0 109.832 179.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 18.4 t60 -55.49 108.33 0.42 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.801 1.24 . . . . 0.0 109.945 177.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.2 tt -74.75 85.08 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 CA-C-O 122.612 1.196 . . . . 0.0 111.011 -171.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -76.61 101.85 5.89 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.917 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.4 m -139.74 116.34 10.75 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -175.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.429 ' HA ' HG12 ' A' ' 13' ' ' VAL . 14.0 ptmm? -72.21 -15.84 61.94 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.029 0.532 . . . . 0.0 111.948 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.03 -42.18 73.27 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 122.643 0.377 . . . . 0.0 110.36 170.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -64.54 -39.22 93.37 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.396 0.678 . . . . 0.0 112.146 -177.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.429 HG12 ' HA ' ' A' ' 10' ' ' LYS . 11.9 p -69.68 -35.51 66.12 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 CA-C-O 119.348 -0.358 . . . . 0.0 110.307 178.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 77.0 mt -61.92 -41.69 91.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 C-N-CA 122.824 0.45 . . . . 0.0 110.11 172.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.447 ' O ' HG23 ' A' ' 19' ' ' VAL . 33.7 mm-40 -63.19 -29.5 70.83 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.281 0.632 . . . . 0.0 111.21 176.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.92 -32.56 73.89 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.93 0.492 . . . . 0.0 111.616 178.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.406 ' HE2' ' HA ' ' A' ' 33' ' ' LEU . 93.6 m-85 -70.25 -40.42 74.43 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 171.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -74.23 -9.13 58.3 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.227 -177.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 15' ' ' GLU . 93.3 t -68.73 -44.62 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 167.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -69.51 -55.15 11.02 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.157 179.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -75.15 95.84 3.17 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.557 178.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -88.27 -38.77 14.95 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.327 -176.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -76.55 -22.36 54.45 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.833 0.853 . . . . 0.0 112.393 -173.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.3 53.6 3.6 Favored Glycine 0 C--N 1.343 0.969 0 N-CA-C 111.491 -0.644 . . . . 0.0 111.491 -176.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -68.71 -30.1 68.67 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.624 1.17 . . . . 0.0 109.334 173.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.05 -59.74 0.46 Allowed Glycine 0 C--N 1.342 0.868 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.084 175.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.402 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 43.9 p90 -115.29 -171.66 2.0 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.628 0.771 . . . . 0.0 110.834 -171.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.428 HG22 ' H ' ' A' ' 29' ' ' THR . 3.0 p -139.65 178.2 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.221 0 C-N-CA 123.343 0.657 . . . . 0.0 110.484 -173.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.428 ' H ' HG22 ' A' ' 28' ' ' VAL . 68.5 p -88.13 154.11 20.72 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.008 0.923 . . . . 0.0 110.358 175.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.6 p -67.59 -29.77 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-N 117.861 0.3 . . . . 0.0 110.856 178.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -62.5 -46.55 87.92 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.513 178.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -72.24 -32.79 67.02 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.614 179.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.426 HD21 ' CE2' ' A' ' 69' ' ' PHE . 2.9 tt -67.79 -39.12 84.07 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.947 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 37.4 mtp-105 -72.83 -30.59 64.16 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 122.42 0.288 . . . . 0.0 110.321 174.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -63.62 -49.33 73.72 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.593 1.157 . . . . 0.0 111.075 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.474 HG13 ' HG ' ' A' ' 37' ' ' LEU . 7.0 p -69.34 -40.17 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.137 0.575 . . . . 0.0 111.627 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.474 ' HG ' HG13 ' A' ' 36' ' ' VAL . 79.7 mt -82.1 -4.8 57.65 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.48 0.712 . . . . 0.0 111.862 -176.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -67.84 -29.12 68.19 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.489 0.716 . . . . 0.0 111.412 175.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -59.35 -40.04 85.14 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.292 0.637 . . . . 0.0 111.792 -177.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.2 pp -92.48 7.58 42.46 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.508 0.723 . . . . 0.0 110.919 -178.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -72.98 -19.33 79.53 Favored Glycine 0 C--N 1.352 1.447 0 O-C-N 123.48 0.487 . . . . 0.0 112.496 -178.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -75.28 -27.24 59.31 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.329 0.652 . . . . 0.0 111.215 177.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 82.3 mtp -100.02 -44.65 5.94 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.723 0.809 . . . . 0.0 110.769 -175.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 23.0 mmt -120.03 145.69 40.45 Favored Pre-proline 0 N--CA 1.482 1.171 0 C-N-CA 124.839 1.256 . . . . 0.0 109.649 -177.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -58.41 119.53 6.85 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.729 2.286 . . . . 0.0 112.761 179.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.01 -30.33 63.69 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.302 174.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -55.13 -40.89 71.06 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 124.026 0.93 . . . . 0.0 111.225 174.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -51.96 -53.81 36.93 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.382 1.073 . . . . 0.0 110.695 174.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.518 HG12 HD11 ' A' ' 73' ' ' LEU . 74.0 mt -60.39 -41.93 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.96 179.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.561 ' HA ' HD12 ' A' ' 53' ' ' ILE . 42.7 mt-10 -66.01 -34.69 78.68 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.502 0.721 . . . . 0.0 112.12 -175.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -70.07 -39.49 75.6 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 120.951 0.405 . . . . 0.0 110.32 175.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 48.0 mmm -59.53 -34.25 72.39 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.948 0.899 . . . . 0.0 110.568 174.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.561 HD12 ' HA ' ' A' ' 50' ' ' GLU . 85.1 mt -62.56 -34.42 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.851 0.86 . . . . 0.0 112.149 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -60.95 -25.96 67.18 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -177.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -89.91 -28.54 19.13 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 122.776 0.43 . . . . 0.0 111.219 176.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.2 -34.43 68.37 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.374 0.669 . . . . 0.0 111.164 178.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -132.03 80.81 63.8 Favored Pre-proline 0 CA--C 1.548 0.878 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 175.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -82.29 -3.8 11.59 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.988 2.459 . . . . 0.0 112.684 -179.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -86.73 -14.88 41.14 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.354 1.061 . . . . 0.0 111.586 -179.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 61.26 30.7 19.31 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 124.611 1.164 . . . . 0.0 110.615 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.6 t -109.19 -3.74 17.04 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.799 0.84 . . . . 0.0 111.111 -172.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.99 19.83 74.32 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 114.852 0.701 . . . . 0.0 114.852 172.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -110.05 94.75 5.18 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 177.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.3 p -111.99 130.64 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.55 0.74 . . . . 0.0 110.551 -174.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.402 ' HA ' ' HB2' ' A' ' 27' ' ' TYR . 46.0 mt-30 -85.71 93.98 8.99 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 175.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -55.26 -29.84 58.91 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.592 0.757 . . . . 0.0 111.746 176.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -48.84 -55.87 10.38 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.083 1.753 . . . . 0.0 111.168 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.1 t -87.43 -30.58 20.6 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 114.466 -1.243 . . . . 0.0 110.51 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.426 ' CE2' HD21 ' A' ' 33' ' ' LEU . 52.1 t80 -67.07 -65.3 0.7 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.865 0.466 . . . . 0.0 111.7 -174.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.55 ' HA ' ' HB3' ' A' ' 73' ' ' LEU . 99.1 t -50.41 -29.45 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 124.837 1.255 . . . . 0.0 112.3 175.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.17 -50.63 65.59 Favored Glycine 0 CA--C 1.535 1.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.849 171.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 24.7 ptm -84.59 -15.48 45.48 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.349 0.66 . . . . 0.0 111.706 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.55 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 66.8 tp -77.25 -51.76 10.37 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.186 0.994 . . . . 0.0 109.9 -174.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -83.59 34.96 0.49 Allowed 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 123.593 0.757 . . . . 0.0 111.546 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 53.5 mt -96.29 23.13 6.94 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.751 0.82 . . . . 0.0 110.989 169.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 7.0 m0 -71.9 84.39 0.95 Allowed 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 170.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.9 t70 . . . . . 0 C--O 1.252 1.195 0 C-N-CA 123.65 0.78 . . . . 0.0 109.107 -176.611 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.318 0 CA-C-O 119.522 -0.599 . . . . 0.0 112.059 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.4 m 62.37 13.62 6.19 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 125.053 1.341 . . . . 0.0 112.411 -178.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 53.4 m80 -141.41 95.0 2.76 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.01 0.924 . . . . 0.0 110.043 -172.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 47.5 tpp -82.8 132.43 35.17 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.641 0.776 . . . . 0.0 109.955 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -83.19 73.71 10.07 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 122.148 0.975 . . . . 0.0 110.487 179.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -91.27 77.52 5.89 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.091 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.2 tt -101.41 100.74 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 CA-C-O 121.745 0.783 . . . . 0.0 109.496 -178.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -88.94 95.02 10.14 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.831 -174.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.1 t -154.67 152.02 29.46 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.162 177.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.464 ' HE3' ' HA2' ' A' ' 71' ' ' GLY . 13.3 ptmm? -70.68 -20.34 62.7 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.637 0.775 . . . . 0.0 111.234 175.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.471 ' O ' ' HG2' ' A' ' 15' ' ' GLU . . . -55.84 -34.68 65.65 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.073 0.949 . . . . 0.0 111.703 178.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -60.41 -52.99 62.88 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.525 0.73 . . . . 0.0 112.176 -177.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.4 p -65.85 -29.87 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 122.5 0.32 . . . . 0.0 110.458 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.438 ' HA ' ' HD2' ' A' ' 17' ' ' PHE . 94.1 mt -70.05 -34.41 59.4 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 123.404 0.682 . . . . 0.0 110.873 177.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 18.7 mm-40 -62.49 -28.36 69.78 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.372 0.669 . . . . 0.0 110.961 175.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.14 -44.95 86.95 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.175 0.59 . . . . 0.0 110.444 175.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.438 ' HD2' ' HA ' ' A' ' 14' ' ' ILE . 99.6 m-85 -68.44 -32.96 73.35 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.489 178.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -79.24 -29.0 42.46 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.191 0.596 . . . . 0.0 112.097 -177.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.7 p -82.08 -15.55 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 CA-C-O 121.031 0.443 . . . . 0.0 110.079 173.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -78.38 -50.71 11.23 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 172.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -96.33 88.01 4.63 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.572 0.749 . . . . 0.0 109.627 178.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -94.44 1.95 55.76 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.502 173.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -90.95 -25.47 19.74 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.493 0.717 . . . . 0.0 111.279 -175.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.21 38.66 12.54 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.078 -175.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -64.23 -26.4 68.49 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.453 1.101 . . . . 0.0 109.049 169.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.32 -32.98 6.71 Favored Glycine 0 C--N 1.352 1.438 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.487 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.462 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 51.6 p90 -144.96 -179.42 6.6 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.476 0.71 . . . . 0.0 111.003 -176.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.6 t -126.43 156.01 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.528 1.131 . . . . 0.0 110.042 -172.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.4 p -66.3 149.57 50.17 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.856 0.862 . . . . 0.0 111.162 173.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.9 p -68.49 -19.1 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 122.74 0.416 . . . . 0.0 112.068 -173.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -56.49 -51.81 67.09 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.522 0.729 . . . . 0.0 111.313 175.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -69.73 -32.56 71.19 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.075 -179.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.422 HD12 ' CZ ' ' A' ' 17' ' ' PHE . 9.0 tp -58.41 -55.39 35.69 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 123.923 0.764 . . . . 0.0 110.331 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.561 ' HG2' HD13 ' A' ' 53' ' ' ILE . 94.3 mtt180 -65.94 -27.19 67.99 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.605 -178.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -70.01 -52.7 22.03 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.787 0.835 . . . . 0.0 111.27 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.5 p -75.19 -29.9 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.409 -175.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 95.4 mt -80.65 -10.51 59.73 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.917 0.487 . . . . 0.0 111.259 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -74.83 -44.24 50.31 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 165.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -62.88 -35.53 80.32 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.217 -179.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -85.43 -42.27 14.66 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.296 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -91.94 67.72 2.07 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.762 -168.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -86.62 -57.88 2.82 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.686 0.794 . . . . 0.0 109.539 173.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -71.73 -34.75 69.81 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.739 0.816 . . . . 0.0 110.758 178.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 19.5 mmt -95.99 101.19 7.79 Favored Pre-proline 0 N--CA 1.472 0.65 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 172.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.406 ' HB2' ' HG3' ' A' ' 48' ' ' GLU . 83.1 Cg_exo -48.85 129.68 21.5 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 123.338 2.692 . . . . 0.0 113.248 -171.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.02 -28.25 67.58 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.81 0.844 . . . . 0.0 111.336 -178.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -65.96 -41.76 90.81 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.958 0.903 . . . . 0.0 111.206 175.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 52' ' ' MET . 38.7 mt-10 -72.27 -31.72 66.0 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 122.566 0.346 . . . . 0.0 110.645 178.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.407 ' O ' HG13 ' A' ' 53' ' ' ILE . 96.4 mt -64.67 -36.89 78.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 123.261 0.624 . . . . 0.0 110.088 169.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.542 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 51.1 mt-10 -69.56 -28.31 65.88 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.457 0.303 . . . . 0.0 111.66 176.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -58.12 -34.13 69.9 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.562 0.696 . . . . 0.0 110.538 170.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.421 ' HG2' ' O ' ' A' ' 48' ' ' GLU . 11.4 mmt -81.03 -37.76 28.59 Favored 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.038 177.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.561 HD13 ' HG2' ' A' ' 34' ' ' ARG . 69.0 mt -65.41 -43.02 94.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 124.467 1.107 . . . . 0.0 111.503 -175.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -59.74 -19.22 48.79 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.881 0.472 . . . . 0.0 112.049 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -84.32 -37.11 22.03 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.434 0.694 . . . . 0.0 110.92 172.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.423 ' HB2' ' CD1' ' A' ' 69' ' ' PHE . . . -60.99 -46.41 90.88 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.104 0.961 . . . . 0.0 111.09 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -109.53 82.3 2.14 Favored Pre-proline 0 CA--C 1.552 1.046 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 168.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -68.84 -34.17 18.69 Favored 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 123.341 2.694 . . . . 0.0 112.496 -167.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -87.65 -1.68 58.11 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.916 0.886 . . . . 0.0 111.149 177.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 56.68 49.99 13.48 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 124.802 1.241 . . . . 0.0 109.562 -172.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.2 m -70.42 -13.64 62.22 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 114.502 -1.226 . . . . 0.0 112.782 -172.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.43 11.23 82.36 Favored Glycine 0 C--N 1.348 1.241 0 N-CA-C 112.003 -0.439 . . . . 0.0 112.003 -173.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -135.17 145.83 48.15 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.55 1.14 . . . . 0.0 108.822 -177.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.404 ' O ' ' HB2' ' A' ' 27' ' ' TYR . 7.5 p -147.79 129.58 6.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 CA-C-O 121.251 0.548 . . . . 0.0 110.541 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -75.03 93.73 2.77 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 166.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.462 ' CE2' ' HA ' ' A' ' 27' ' ' TYR . 42.9 p90 -57.85 -40.18 79.5 Favored 'General case' 0 C--O 1.211 -0.936 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.269 -173.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -69.89 -33.41 72.18 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 120.976 0.417 . . . . 0.0 110.852 -177.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 25.4 m -66.64 -38.82 87.7 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.763 173.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.423 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 39.3 t80 -80.71 -72.17 0.43 Allowed 'General case' 0 C--O 1.213 -0.864 0 C-N-CA 122.915 0.486 . . . . 0.0 111.979 -178.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.616 ' HA ' ' HB3' ' A' ' 73' ' ' LEU . 87.6 t -43.37 -31.96 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 126.116 1.767 . . . . 0.0 112.565 174.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.464 ' HA2' ' HE3' ' A' ' 10' ' ' LYS . . . -56.4 -49.02 71.53 Favored Glycine 0 C--N 1.348 1.233 0 O-C-N 123.453 0.471 . . . . 0.0 112.925 170.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 81.8 mtp -83.04 -23.43 33.2 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.475 1.11 . . . . 0.0 112.157 178.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.616 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 52.5 tp -74.93 -49.55 19.8 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.044 0.938 . . . . 0.0 110.447 -172.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -80.38 22.14 0.57 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.139 0.976 . . . . 0.0 112.441 -178.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 59.4 mt -91.0 14.04 15.02 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 123.484 0.714 . . . . 0.0 111.402 172.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 13.4 m0 -61.48 91.89 0.03 OUTLIER 'General case' 0 C--N 1.355 0.827 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 172.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 . . . . . 0 CA--C 1.555 1.165 0 C-N-CA 124.07 0.948 . . . . 0.0 110.931 -177.422 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.209 0 N-CA-C 112.227 -0.349 . . . . 0.0 112.227 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.5 m -84.38 121.0 26.93 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.434 0.693 . . . . 0.0 109.211 175.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -108.19 89.11 2.89 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.099 0.56 . . . . 0.0 109.638 -179.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.404 ' SD ' ' N ' ' A' ' 4' ' ' MET . 2.5 mpp? -80.12 85.77 5.64 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.155 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.454 HD22 ' N ' ' A' ' 5' ' ' ASN . 0.7 OUTLIER -79.5 114.5 18.48 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.307 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 74.2 t60 -70.47 88.93 0.68 Allowed 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 172.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.1 tt -76.84 -47.01 29.07 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.498 -176.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.7 t30 59.28 15.06 4.01 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 125.449 1.499 . . . . 0.0 112.918 171.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 91.5 m -74.77 127.59 33.51 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 176.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.585 ' H ' ' HD2' ' A' ' 10' ' ' LYS . 3.0 mptp? -68.34 -16.17 63.84 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 122.93 0.492 . . . . 0.0 110.781 -170.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.36 -38.47 91.27 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.973 0.909 . . . . 0.0 111.605 173.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -55.41 -41.14 72.32 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 123.472 0.709 . . . . 0.0 112.003 -172.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.9 p -77.5 -40.76 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.745 -175.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 88.1 mt -61.49 -41.63 90.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 C-N-CA 123.946 0.898 . . . . 0.0 110.522 177.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.456 ' O ' HG23 ' A' ' 19' ' ' VAL . 42.8 mt-10 -71.12 -29.12 64.86 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.143 0.977 . . . . 0.0 110.587 179.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.21 -37.23 85.06 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.934 0.494 . . . . 0.0 110.71 175.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.403 ' HE1' ' HA ' ' A' ' 33' ' ' LEU . 79.1 m-85 -67.48 -31.94 72.42 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.135 0.574 . . . . 0.0 110.967 174.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -67.96 -40.16 83.27 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.709 0.403 . . . . 0.0 109.93 175.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 15' ' ' GLU . 69.7 t -60.23 -34.01 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 123.989 0.916 . . . . 0.0 110.704 176.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -76.81 -57.86 3.61 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.742 0.417 . . . . 0.0 110.763 179.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -76.0 91.89 3.11 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.183 0.516 . . . . 0.0 109.933 -178.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 31.6 mmm180 -91.05 -14.01 32.14 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.304 1.042 . . . . 0.0 110.2 178.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -91.76 -10.66 39.18 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.017 0.927 . . . . 0.0 111.032 -173.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.46 45.35 30.0 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-N 116.582 -0.281 . . . . 0.0 113.386 170.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.464 ' N ' HD22 ' A' ' 25' ' ' ASN . 0.8 OUTLIER -76.17 -25.67 55.45 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.671 0.788 . . . . 0.0 110.78 178.193 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.17 -4.12 80.69 Favored Glycine 0 C--N 1.352 1.429 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.02 -174.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -154.21 174.27 14.99 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.705 1.202 . . . . 0.0 109.285 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.9 m -123.51 -174.99 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.413 0.685 . . . . 0.0 110.831 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.5 p -91.24 162.02 14.81 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 123.741 0.817 . . . . 0.0 110.482 174.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.638 HG23 HG21 ' A' ' 53' ' ' ILE . 7.7 p -61.92 -33.05 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.909 0.884 . . . . 0.0 112.109 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -67.0 -52.07 47.19 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 122.983 0.513 . . . . 0.0 112.119 -173.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -63.74 -38.43 91.08 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 120.529 0.204 . . . . 0.0 110.6 177.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.654 HD22 HG11 ' A' ' 64' ' ' VAL . 9.0 tp -52.92 -48.82 66.97 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 124.24 0.963 . . . . 0.0 110.316 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 28.4 mtm180 -66.28 -39.13 89.2 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.419 0.688 . . . . 0.0 111.516 178.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -59.75 -48.72 80.53 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.293 1.037 . . . . 0.0 111.224 -176.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.8 p -78.48 -32.55 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.883 -176.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 63.0 mt -80.19 -6.09 57.2 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 121.789 -0.569 . . . . 0.0 111.085 178.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -77.32 -45.16 27.09 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.428 0.691 . . . . 0.0 109.83 170.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -76.55 -29.37 56.65 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.944 -178.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -75.73 -36.6 59.87 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 122.72 0.408 . . . . 0.0 110.015 170.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.23 56.77 1.75 Allowed Glycine 0 C--N 1.347 1.147 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.1 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -72.53 -32.8 66.39 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.821 0.848 . . . . 0.0 111.51 -176.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 52.4 mtt -118.35 14.99 13.89 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.75 0.82 . . . . 0.0 110.471 175.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.426 ' N ' ' SD ' ' A' ' 44' ' ' MET . 1.4 mpt? -110.43 142.66 26.51 Favored Pre-proline 0 N--CA 1.475 0.818 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -67.55 113.29 2.88 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 121.932 1.755 . . . . 0.0 111.442 178.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.95 -26.49 68.23 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.523 0.729 . . . . 0.0 110.577 174.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -55.47 -46.27 76.86 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.61 1.164 . . . . 0.0 110.83 172.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -63.83 -52.01 62.08 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.286 -178.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.49 ' O ' HG13 ' A' ' 53' ' ' ILE . 91.7 mt -59.85 -43.66 92.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.483 -176.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.501 ' HA ' HD12 ' A' ' 53' ' ' ILE . 12.9 pt-20 -68.67 -31.61 70.85 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 123.188 0.305 . . . . 0.0 111.573 -175.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -72.02 -32.56 67.28 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.581 0.353 . . . . 0.0 110.91 176.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.439 ' HB3' ' HE1' ' A' ' 69' ' ' PHE . 76.4 mmm -67.79 -23.75 65.24 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.876 0.87 . . . . 0.0 111.182 175.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.638 HG21 HG23 ' A' ' 30' ' ' VAL . 72.5 mt -70.19 -30.79 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 123.396 0.679 . . . . 0.0 111.482 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -62.88 -25.27 68.22 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.223 0.535 . . . . 0.0 110.855 178.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -86.42 -36.22 19.25 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.475 1.11 . . . . 0.0 110.508 176.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.73 -29.81 69.14 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.145 0.978 . . . . 0.0 111.841 -178.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -118.13 87.42 29.04 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.231 1.013 . . . . 0.0 108.465 173.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.6 -32.89 69.03 Favored 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 123.088 2.525 . . . . 0.0 112.139 173.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -73.3 -6.29 45.07 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.168 0.987 . . . . 0.0 112.551 -172.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.0 p30 51.33 30.54 6.1 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 125.642 1.577 . . . . 0.0 112.064 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 71.8 p -87.93 -15.13 37.44 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.525 1.13 . . . . 0.0 112.187 -171.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.76 3.5 90.47 Favored Glycine 0 C--N 1.347 1.139 0 CA-C-N 116.322 -0.399 . . . . 0.0 112.478 -171.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -107.44 128.92 54.91 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 175.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.654 HG11 HD22 ' A' ' 33' ' ' LEU . 5.0 p -127.97 130.77 69.93 Favored 'Isoleucine or valine' 0 C--O 1.246 0.893 0 C-N-CA 123.113 0.565 . . . . 0.0 110.831 -172.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -73.86 91.57 1.98 Allowed 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 168.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -59.07 -30.94 68.44 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.046 176.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -61.98 -38.42 88.52 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.935 0.894 . . . . 0.0 110.567 -171.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 69.9 p -83.29 -44.03 15.37 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.464 177.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.439 ' HE1' ' HB3' ' A' ' 52' ' ' MET . 28.2 t80 -67.82 -60.88 2.17 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.701 0.8 . . . . 0.0 112.809 -172.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.7 t -65.07 -21.45 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.345 1.058 . . . . 0.0 111.151 -177.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.446 ' O ' ' HG ' ' A' ' 75' ' ' LEU . . . -58.63 -51.65 57.65 Favored Glycine 0 CA--C 1.534 1.254 0 N-CA-C 111.608 -0.597 . . . . 0.0 111.608 166.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 61.8 mtm -66.16 -32.83 74.51 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.982 0.913 . . . . 0.0 112.435 -179.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.4 mt -63.72 -35.31 80.14 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 121.219 0.533 . . . . 0.0 111.067 177.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -99.82 10.34 41.49 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.66 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 71' ' ' GLY . 81.8 mt -90.24 -13.18 35.94 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.164 0.586 . . . . 0.0 109.582 162.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 51.0 m0 -56.8 -44.16 81.66 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.532 0.733 . . . . 0.0 109.998 171.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.2 t70 . . . . . 0 C--O 1.249 1.066 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.744 174.07 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.351 0 N-CA-C 111.859 -0.496 . . . . 0.0 111.859 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.3 t -70.35 113.4 7.46 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.741 0.816 . . . . 0.0 109.941 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -160.16 119.8 2.84 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.652 0.781 . . . . 0.0 109.068 177.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 59.9 ttp -75.63 134.33 40.66 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.159 0.584 . . . . 0.0 110.129 177.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -150.56 146.46 26.58 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.234 1.014 . . . . 0.0 109.32 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 19.3 t-80 -93.98 -57.38 2.55 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.717 0.407 . . . . 0.0 109.923 178.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.5 tt -120.46 74.36 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 122.828 1.299 . . . . 0.0 110.81 -174.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -91.9 -17.25 25.49 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.619 165.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.1 t -155.5 166.4 33.64 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.642 1.177 . . . . 0.0 109.655 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.442 ' O ' HG12 ' A' ' 13' ' ' VAL . 10.2 ptpp? -75.35 -6.42 49.83 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.09 0.956 . . . . 0.0 111.55 178.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.436 ' O ' ' HG2' ' A' ' 15' ' ' GLU . . . -57.17 -23.67 49.12 Favored 'General case' 0 C--O 1.209 -1.051 0 C-N-CA 123.177 0.591 . . . . 0.0 112.422 177.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -51.89 -45.64 64.25 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.402 0.681 . . . . 0.0 112.296 177.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 10' ' ' LYS . 12.4 p -80.3 -36.79 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 68.2 mt -64.8 -36.53 77.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 123.524 0.729 . . . . 0.0 111.13 -177.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.494 ' O ' HG23 ' A' ' 19' ' ' VAL . 37.4 mm-40 -73.25 -31.06 63.88 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.788 0.435 . . . . 0.0 110.526 178.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.91 -35.69 73.49 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.146 0.498 . . . . 0.0 110.599 175.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.445 ' CZ ' HG21 ' A' ' 70' ' ' VAL . 81.5 m-85 -65.49 -42.53 92.06 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.009 172.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -73.45 -17.52 61.23 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.463 0.705 . . . . 0.0 111.823 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 15' ' ' GLU . 70.7 t -76.93 -30.07 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.956 0.902 . . . . 0.0 109.565 171.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -77.88 -58.52 3.22 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 174.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -82.73 82.91 7.87 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.613 0.765 . . . . 0.0 109.822 178.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -93.26 -14.29 27.21 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 114.086 -1.415 . . . . 0.0 109.535 173.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -70.75 -25.4 62.9 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.813 0.845 . . . . 0.0 110.726 176.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.07 43.09 8.97 Favored Glycine 0 C--N 1.347 1.163 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.777 173.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -72.1 -16.92 62.02 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.508 0.723 . . . . 0.0 110.412 172.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.58 -28.71 13.69 Favored Glycine 0 C--N 1.348 1.22 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.08 178.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.493 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 36.9 p90 -142.13 164.28 30.59 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 124.397 1.079 . . . . 0.0 109.916 -178.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 79.6 t -109.65 149.29 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.03 0.932 . . . . 0.0 109.915 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 75.9 p -66.05 157.4 31.09 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.574 0.75 . . . . 0.0 111.0 174.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.572 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 7.1 p -65.25 -16.83 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 122.846 0.458 . . . . 0.0 111.463 178.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -55.38 -57.07 13.35 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.038 0.935 . . . . 0.0 111.219 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -76.99 -34.42 57.52 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.605 177.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.572 ' HB3' ' HA ' ' A' ' 30' ' ' VAL . 3.0 tt -61.46 -39.66 91.68 Favored 'General case' 0 CA--C 1.549 0.916 0 O-C-N 123.67 0.606 . . . . 0.0 111.723 -174.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.566 ' HG3' HG22 ' A' ' 30' ' ' VAL . 63.8 mtt180 -67.89 -40.34 83.53 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-O 119.559 -0.257 . . . . 0.0 110.923 175.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -55.07 -58.0 9.45 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 123.93 0.769 . . . . 0.0 111.458 -178.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.7 p -66.17 -34.22 68.72 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 CA-C-N 115.223 -0.898 . . . . 0.0 111.705 -175.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.536 HD11 HG22 ' A' ' 70' ' ' VAL . 92.7 mt -85.44 -7.97 58.64 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.074 0.55 . . . . 0.0 111.865 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -87.24 -35.02 18.75 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 170.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -62.88 -37.38 86.69 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.689 170.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.0 tt -73.9 -44.34 55.54 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.216 177.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.498 ' HA2' ' HB2' ' A' ' 44' ' ' MET . . . -90.59 50.82 3.26 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.778 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -74.96 -49.68 19.23 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.508 0.723 . . . . 0.0 110.147 -177.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 15.0 ptp -108.0 -1.03 20.92 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.606 0.762 . . . . 0.0 110.415 174.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.498 ' HB2' ' HA2' ' A' ' 41' ' ' GLY . 1.4 mpt? -97.65 147.05 32.46 Favored Pre-proline 0 N--CA 1.478 0.95 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 177.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -63.53 109.24 0.98 Allowed 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 121.787 1.658 . . . . 0.0 111.275 173.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.18 -13.96 60.17 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.28 176.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -53.83 -46.58 71.22 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.236 1.014 . . . . 0.0 110.88 172.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.464 ' O ' ' HG2' ' A' ' 52' ' ' MET . 46.8 mt-10 -58.95 -52.3 66.33 Favored 'General case' 0 C--N 1.356 0.866 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.842 178.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.434 ' O ' HG13 ' A' ' 53' ' ' ILE . 81.4 mt -57.36 -45.35 85.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.069 0.947 . . . . 0.0 111.549 -176.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.479 ' HA ' HD12 ' A' ' 53' ' ' ILE . 66.3 mt-10 -71.27 -31.52 67.59 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.738 0.415 . . . . 0.0 111.331 -179.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -68.36 -32.63 72.86 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-O 121.43 0.634 . . . . 0.0 109.671 176.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.464 ' HG2' ' O ' ' A' ' 48' ' ' GLU . 80.4 mmm -70.98 -34.29 71.25 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.243 1.017 . . . . 0.0 110.285 174.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.479 HD12 ' HA ' ' A' ' 50' ' ' GLU . 85.2 mt -60.11 -40.96 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 123.359 0.664 . . . . 0.0 110.629 178.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -69.05 -15.06 63.37 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.408 0.683 . . . . 0.0 111.539 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -90.21 -37.14 14.34 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.217 0.607 . . . . 0.0 110.658 172.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.8 -18.15 58.59 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.543 0.737 . . . . 0.0 111.524 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -152.6 83.23 4.92 Favored Pre-proline 0 CA--C 1.55 0.976 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 172.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -75.01 -8.44 20.06 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.389 2.726 . . . . 0.0 112.63 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -75.47 -22.34 57.34 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.243 177.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 58.21 30.82 19.99 Favored 'General case' 0 C--N 1.36 1.037 0 C-N-CA 124.656 1.182 . . . . 0.0 110.237 -176.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.3 t -75.62 -19.56 59.14 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 114.511 -1.222 . . . . 0.0 110.676 -176.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.94 24.56 31.93 Favored Glycine 0 C--N 1.338 0.685 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.848 -178.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -130.01 105.09 7.73 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.718 0.807 . . . . 0.0 109.899 -176.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.473 HG13 HD13 ' A' ' 33' ' ' LEU . 2.1 p -135.37 123.05 37.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 124.007 0.923 . . . . 0.0 109.857 -174.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -70.42 109.16 4.61 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.702 0.801 . . . . 0.0 110.352 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.493 ' CE2' ' HA ' ' A' ' 27' ' ' TYR . 38.1 p90 -64.25 -28.5 69.78 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.939 0.895 . . . . 0.0 112.96 -175.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -66.1 -54.77 21.53 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.374 0.27 . . . . 0.0 110.693 -177.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.5 t -71.8 -28.65 63.74 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.252 178.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.507 ' O ' ' HG2' ' A' ' 72' ' ' MET . 60.8 t80 -81.87 -73.78 0.37 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 122.59 0.356 . . . . 0.0 111.122 -178.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.536 HG22 HD11 ' A' ' 37' ' ' LEU . 38.7 t -60.26 -22.3 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 123.945 0.898 . . . . 0.0 111.655 -173.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -55.63 -53.46 41.35 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-N 116.242 -0.436 . . . . 0.0 112.662 169.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.507 ' HG2' ' O ' ' A' ' 69' ' ' PHE . 18.5 ptp -65.79 -26.15 67.57 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.977 0.511 . . . . 0.0 111.83 -176.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 70' ' ' VAL . 4.4 mm? -56.7 -38.66 72.61 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.73 0.812 . . . . 0.0 110.97 175.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -89.59 -16.99 29.36 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.284 1.034 . . . . 0.0 111.182 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.417 ' HB2' ' HA ' ' A' ' 72' ' ' MET . 85.4 mt -86.67 -3.32 59.02 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.357 0.663 . . . . 0.0 111.518 176.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 42.8 m0 -59.86 114.77 2.97 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.969 0.507 . . . . 0.0 110.121 170.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 . . . . . 0 C--O 1.255 1.349 0 C-N-CA 123.445 0.698 . . . . 0.0 110.703 179.868 . . . . . . . . 0 0 . 1 stop_ save_